Citrus Sinensis ID: 003375
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.271 | 0.237 | 0.277 | 2e-19 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.299 | 0.406 | 0.314 | 6e-18 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.212 | 0.295 | 0.300 | 6e-18 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.248 | 0.301 | 0.269 | 7e-18 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.248 | 0.301 | 0.269 | 8e-18 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.260 | 0.161 | 0.298 | 9e-18 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.210 | 0.255 | 0.293 | 1e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.195 | 0.107 | 0.330 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.248 | 0.189 | 0.307 | 1e-17 | |
| O96013 | 591 | Serine/threonine-protein | no | no | 0.263 | 0.367 | 0.274 | 2e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.6 bits (244), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 520 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 579 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 697
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 757
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.6 bits (231), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 499 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 556
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 616
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 736
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 737 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 797 EENPTERPTAGDLYEM-FVAR 816
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 93.6 bits (231), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 41/216 (18%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 365 LFNEVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVT 410
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VK
Sbjct: 411 HTRMNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILLT-----HDGR--VK 457
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L DF C + +P VGTP WMAPE++ + YG EVDIWS
Sbjct: 458 LSDFG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSL 503
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
G +++E++ + PY L+ +I+ PRL +
Sbjct: 504 GVMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/265 (29%), Positives = 121/265 (45%), Gaps = 50/265 (18%)
Query: 497 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 556
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 613
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 614 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 672
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 673 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 733 YMGLSELEIHDLI-QMGKRPRLTDE 756
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPDN 1297
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 537 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 596
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 657 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 714
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 715 DIWSYGCLLLELLTLQVPYMGLS 737
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 504 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 549
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 550 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 606
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 607 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 666
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 667 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O96013|PAK4_HUMAN Serine/threonine-protein kinase PAK 4 OS=Homo sapiens GN=PAK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 67/284 (23%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 363 LFNEVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVT 408
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VK
Sbjct: 409 HTRMNEEQIAAVCLA------VLQALSVLHAQGVIHRDIKSDSILL-----THDGR--VK 455
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L DF C + +P VGTP WMAPE++ + YG EVDIWS
Sbjct: 456 LSDFG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSL 501
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
G +++E++ + PY L+ +I+ PRL + H+V+ S GF
Sbjct: 502 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN---------LHKVSPSLKGF---- 548
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 822
R +P +R TA +L + F+A+ S
Sbjct: 549 ------------LDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 580
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.720 | 0.693 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.984 | 0.704 | 0.654 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.967 | 0.822 | 0.600 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.967 | 0.705 | 0.597 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.943 | 0.701 | 0.610 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.865 | 0.588 | 0.651 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.964 | 0.715 | 0.562 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.966 | 0.714 | 0.556 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.836 | 0.675 | 0.617 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.943 | 0.699 | 0.475 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1128 bits (2918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/822 (69%), Positives = 670/822 (81%), Gaps = 17/822 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQT-S 65
GS +TSSS T SSNSR AR S K WKR ++LQQRARQERLNNSRKW+ E HA+ +
Sbjct: 309 GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQRARQERLNNSRKWKSEDHAEVLT 368
Query: 66 MKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 125
+K ++ + G L L E+ +E A DI+ LD+DDKQLLS EAESENLL SVED +
Sbjct: 369 IKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQLLSEEAESENLLNSVEDAESGPRK 428
Query: 126 GLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRH 183
G SCA L+S + EC+ D+S S + GA+E++EGSSSE SK+ K+KRH
Sbjct: 429 G------SCAVLDSIAINQGSKSECNDDDASLSSLSKGASEKNEGSSSEVSKSTPKSKRH 482
Query: 184 SDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQ 243
SDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IEDRLPDGFYDAGRDRPFM LT YEQ
Sbjct: 483 SDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIEDRLPDGFYDAGRDRPFMPLTVYEQ 542
Query: 244 TPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLAL 303
H DSREVIL+DR+ DEELDAI LSAQALV LKQLNGLTK+ DNLQIA LLAL
Sbjct: 543 NFHFDSREVILLDRERDEELDAITLSAQALVSQLKQLNGLTKERKQVTDDNLQIASLLAL 602
Query: 304 FVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLS 363
FVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CSTGN ++ +TS KQ LD VEDIV+S
Sbjct: 603 FVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCSTGNRNNISTSNKQNLDTVEDIVVS 662
Query: 364 DLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP 423
DLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+KYLCDR+EPPVPCELVRGYLDF P
Sbjct: 663 DLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMKYLCDRMEPPVPCELVRGYLDFLP 722
Query: 424 HAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSG 483
HAWN + K+GDSW+RMIVDACRPHDIREE DPEYF RYIPL R P ST+S +P +G
Sbjct: 723 HAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFCRYIPLSRINVPLSTQS--TPVTG 780
Query: 484 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 543
GSFPSLS+CDE + SSSL +CKFGS +AAAKVR L+VCG S DE+RNFEY CLGE
Sbjct: 781 ---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKVRILEVCGDSVDEVRNFEYCCLGE 837
Query: 544 VRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE 603
VR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +LQSAI ME+VKGGS+K+Y+EKLSE
Sbjct: 838 VRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVLQSAILMEHVKGGSLKSYLEKLSE 897
Query: 604 TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 663
GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKSENILIDL++K+ADG PVVKLCDF
Sbjct: 898 AGEKHVPVELALCIARDVASALAELHSKHIIHRDIKSENILIDLDKKRADGTPVVKLCDF 957
Query: 664 DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723
DRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEVLRAMHK +YGLEVDIWSYGCLL
Sbjct: 958 DRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEVLRAMHKREIYGLEVDIWSYGCLL 1017
Query: 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783
LELLTLQVPY LSE + HD +QMGKRP+L +ELEALGS E E+AQSG E PE E+E
Sbjct: 1018 LELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEALGS-QEPEMAQSGKE-EGPETEVE 1075
Query: 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 825
L FLVD+ R CT+ NPT+RPTA +LY+M + +T + SSRS
Sbjct: 1076 KLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRTFTSSRS 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/825 (65%), Positives = 645/825 (78%), Gaps = 13/825 (1%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM 66
GS++ +SS+ T SNS+ AR+ +K+WKR H+LQQRARQERLNNSRKW+GEG A S
Sbjct: 334 GSQNATSSLLTGPPSNSKCFAARRLNKRWKRRHYLQQRARQERLNNSRKWKGEGRADLST 393
Query: 67 -KEGQRYKSGNLDALASETPSEEASDIIGL-----DDDDKQLLSPEAESENLLFSVEDDK 120
KE + KS NLD L SET + SDIIGL D +DK + S E E+ENLL S +DD+
Sbjct: 394 PKESKNCKSDNLDLLTSETCEDGTSDIIGLVDNNEDKEDKVVPSSEVEAENLLVSGKDDR 453
Query: 121 IRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKT 180
+ S G ++++CS ES DEC H+ S T NG + +DEGSSSEN+K + K+
Sbjct: 454 MNSKKGFYIKSCS-HNPESVSNGEEDECCVHEKSLALTQNGVSGEDEGSSSENTKFILKS 512
Query: 181 KRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG 240
KRH D LDNPKPCK R+ ++ + S KYS +SFCS ED LPDGFYDAGRDRPFM L
Sbjct: 513 KRHFDGALDNPKPCKCRRPTEDSLSLSHKYSDLSFCSTEDHLPDGFYDAGRDRPFMPLRR 572
Query: 241 YEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALL 300
YEQ HLDSREVIL+DR+ DE+LDA LSAQALV LK+LNG ++G + VD LQIA L
Sbjct: 573 YEQILHLDSREVILLDREKDEKLDATVLSAQALVCRLKRLNGFFEEGNKDAVDVLQIASL 632
Query: 301 LALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDI 360
LALFVSDHFGGSDRS +ERTRK VSGSNY+KPFVCTCSTGN +S NTS KQIL + EDI
Sbjct: 633 LALFVSDHFGGSDRSFTIERTRKAVSGSNYKKPFVCTCSTGNDESINTSTKQILGSAEDI 692
Query: 361 VLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD 420
V SDLCEKSLRS+K+KRNS++VP+G++QFGVCRHRA+L KYLCDR++PP+PCELVRGYLD
Sbjct: 693 VFSDLCEKSLRSVKAKRNSIIVPLGNLQFGVCRHRALLFKYLCDRMDPPIPCELVRGYLD 752
Query: 421 FQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSP 480
F PHAWNTILVK+GDSW+RM+VDACRPHDIREE DPEYF RY+PL T P STES HSP
Sbjct: 753 FIPHAWNTILVKRGDSWVRMLVDACRPHDIREETDPEYFCRYVPLSHTRVPLSTESIHSP 812
Query: 481 CSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSC 540
S S S+ DE K+V S++ +CKF S +AAAKVRTL++C + DEIRNFEYSC
Sbjct: 813 GC-----SITSFSTHDELEKTVLSTVIQCKFESVEAAAKVRTLEICETPVDEIRNFEYSC 867
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
+GEVR+L ALRH CIVE+YGH+ISSKW+ + DG P H +L+S I ME+VKGGS+K+YIEK
Sbjct: 868 IGEVRILRALRHPCIVELYGHQISSKWIHAEDGKPPHQILRSTILMEHVKGGSLKSYIEK 927
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+S+T +KHV + AL IA+D++ A+ +LHSKHI+HRD+KSENILIDL+ K+ADG PVVKL
Sbjct: 928 MSKTSKKHVPMDFALCIARDISCAMADLHSKHIIHRDVKSENILIDLDSKRADGMPVVKL 987
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
CDFDRAVPLRSFLHTCCIAH GIP PDVCVGTPRWMAPEVLRAMHK N YGLEVDIWS+G
Sbjct: 988 CDFDRAVPLRSFLHTCCIAHNGIPPPDVCVGTPRWMAPEVLRAMHKRNPYGLEVDIWSFG 1047
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
CLLLELLTLQ+PY GLSE I +L+QMG+RP LTDELE L S +E QSGS PEA
Sbjct: 1048 CLLLELLTLQIPYSGLSEFHIKELLQMGERPPLTDELETLVSMNEPVATQSGSDVAAPEA 1107
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 825
E ETL FLVD+FRRCTE NP RPTA ++YE+ + +S+ SSRS
Sbjct: 1108 ESETLRFLVDLFRRCTEANPASRPTAAEIYELLLGCSSAFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/818 (60%), Positives = 627/818 (76%), Gaps = 20/818 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM 66
G R+ SS++ S+NSRS +++S K+W+R H+LQQ+ARQERLN+SRKW+G H T +
Sbjct: 154 GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQKARQERLNSSRKWKGVDH-HTEV 212
Query: 67 KEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 125
K + + LD A SET ++S I L D K+ + AE EN + S E+D
Sbjct: 213 KIHENQEPERLDSASISETTVGDSSAIDELFDS-KETCAVGAERENHIESHENDNFDPKK 271
Query: 126 GLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRH 183
VE+CS C T +EC + + T NGA +Q EGSSS+ SK K KR
Sbjct: 272 EFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRC 330
Query: 184 SDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQ 243
S+R+LDNPKPCKSRK + +S+ S KY+S SFC++ED LPDGFYDAGRDRPFM L YEQ
Sbjct: 331 SERELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQ 390
Query: 244 TPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLT--KDGVIEPVDNLQIALLL 301
HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N LT +D VI D++ IA LL
Sbjct: 391 NFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQINQLTQERDQVI---DDVYIAQLL 447
Query: 302 ALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIV 361
ALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCSTG+ D+ +S K +D EDI+
Sbjct: 448 ALFVSDHFGGSDRSAMVEKTRRAVSGSKYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDIL 507
Query: 362 LSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDF 421
+D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF
Sbjct: 508 FTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLLKYLCDRMEPPVPCELVRGYLDF 567
Query: 422 QPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC 481
PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF RYIPL R P S SP
Sbjct: 568 LPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYFCRYIPLSRAKLPISFGVTSSP- 626
Query: 482 SGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCL 541
G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK+R +VC SS +EIRNFE+SCL
Sbjct: 627 -GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAKLRKREVCESSFEEIRNFEFSCL 682
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
GEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL
Sbjct: 683 GEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKL 742
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
+ G++HV + LAL +A+DVA+ALVELHSKHI+HRDIKSENIL+D + +K+DG P+VKLC
Sbjct: 743 YKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIKSENILMDFD-EKSDGVPIVKLC 801
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPEVLRAMH PN+YGLEVDIWS+GC
Sbjct: 802 DFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPEVLRAMHTPNVYGLEVDIWSFGC 861
Query: 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQSG-SGFEKPE 779
LLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E LG+ + ++QS E E
Sbjct: 862 LLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEEELGTIKQSTMSQSSVQESEGQE 921
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817
+ ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 922 KDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2461), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/818 (59%), Positives = 626/818 (76%), Gaps = 20/818 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM 66
G R+ SS++ S+NSRS +++S K+W+R H+LQQ+ARQERLN+SRKW+G H T +
Sbjct: 315 GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQKARQERLNSSRKWKGVDH-HTEV 373
Query: 67 KEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 125
K + + LD A SET ++S I L D K+ AE EN + S E+D
Sbjct: 374 KIHENQEPERLDSASISETTVGDSSAIDELFDS-KETCDVGAERENHIESHENDNFDPKK 432
Query: 126 GLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRH 183
VE+CS C T +EC + + T NGA +Q EGSSS+ SK K KR
Sbjct: 433 EFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRC 491
Query: 184 SDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQ 243
S+++LDNPKPCKSRK + +S+ S KY+S SFC++ED LPDGFYDAGRDRPFM L YEQ
Sbjct: 492 SEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQ 551
Query: 244 TPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLT--KDGVIEPVDNLQIALLL 301
HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N LT +D VI D++ IA LL
Sbjct: 552 NFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQINQLTQERDQVI---DDVYIAQLL 608
Query: 302 ALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIV 361
ALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCSTG+ D+ +S K +D EDI+
Sbjct: 609 ALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDIL 668
Query: 362 LSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDF 421
+D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF
Sbjct: 669 FTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLLKYLCDRMEPPVPCELVRGYLDF 728
Query: 422 QPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC 481
PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF RYIPL R P S SP
Sbjct: 729 LPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYFCRYIPLSRAKLPISFGVTSSP- 787
Query: 482 SGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCL 541
G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK+R +VC SS +EIRNFE+SCL
Sbjct: 788 -GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAKLRKREVCESSFEEIRNFEFSCL 843
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
GEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL
Sbjct: 844 GEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKL 903
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
+ G++HV + LAL +A+DVA+ALVELHSKHI+HRDIKSENIL+D + +K+DG P+VKLC
Sbjct: 904 YKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIKSENILMDFD-EKSDGVPIVKLC 962
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPEVLRAMH P++YGLEVDIWS+GC
Sbjct: 963 DFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPEVLRAMHTPHVYGLEVDIWSFGC 1022
Query: 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQSG-SGFEKPE 779
LLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E LG+ + ++QS E E
Sbjct: 1023 LLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEEELGTIKQSTMSQSSVQESEGQE 1082
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817
+ ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 1083 KDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2412), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/796 (61%), Positives = 598/796 (75%), Gaps = 18/796 (2%)
Query: 25 RSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALA 81
R +RKS K+WKR HHLQQ+ARQERLNNSRKW+ H S K + + N D+LA
Sbjct: 324 RCFASRKSGKRWKRRHHLQQKARQERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLA 383
Query: 82 SETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG 141
SE+ +E S+ LDD++K++ S A ++N + + +D++ + E+C
Sbjct: 384 SESCAEIVSENGSLDDNNKRISSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT------ 437
Query: 142 KEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMG 201
E DE + S S +EQDE S E + V K+KRH DRDLDNPKPCKSRKS+
Sbjct: 438 -ESKDE---KEESLCSLDKRPSEQDEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSIS 493
Query: 202 ENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDE 261
+S S KYS +SFC IED L DGFYDAGRDR FM L YEQ L SREVIL+DRK DE
Sbjct: 494 SSSLLSCKYSKISFCGIEDHLSDGFYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDE 553
Query: 262 ELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERT 321
ELDA+ L+AQALV +LK+LNGL++ G + VDNLQ+A LLALFVSDHFGGSDRSGIVERT
Sbjct: 554 ELDAVMLAAQALVYNLKKLNGLSRYGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERT 613
Query: 322 RKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVV 381
RK+VSGSNY KPFVCTCS G+S S ++ + + + +EDI LS + EKSL SIK +RNS++
Sbjct: 614 RKSVSGSNYNKPFVCTCSAGSSTSISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSII 673
Query: 382 VPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMI 441
+PIGSVQ+GVCRHRA+L KYLCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM+
Sbjct: 674 IPIGSVQYGVCRHRALLFKYLCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRML 733
Query: 442 VDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKS 501
+DACRP DIREE DPEYF RYIPL RT P S+ P SFPSL++CDE
Sbjct: 734 IDACRPLDIREEKDPEYFCRYIPLNRTTIPISSIGSPGP-----DYSFPSLTTCDELETK 788
Query: 502 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561
S++L +CKFGS +AAAKVRTL+ GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH
Sbjct: 789 ASTTLVKCKFGSVEAAAKVRTLEEQGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGH 848
Query: 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 621
+IS +W SADGNPEH +L+SAIFMEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV
Sbjct: 849 QISCQWSVSADGNPEHRVLRSAIFMEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDV 908
Query: 622 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 681
+ AL ELHSKHI+HRDIKSENIL +L+RK+ DG P VKLCDFD AVPLRS LH CCIAH
Sbjct: 909 SCALSELHSKHIIHRDIKSENILFNLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHA 968
Query: 682 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 741
G P P +CVGTPRWMAPEV+R M+K N YGLE DIWS+GCLLLE+LTLQ+PY GLS+
Sbjct: 969 GTPPPCICVGTPRWMAPEVMRTMYKKNSYGLEADIWSFGCLLLEMLTLQIPYSGLSDSHF 1028
Query: 742 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
D +QMGKRP+LTDEL L S + + SG EK +A ++ L FLVD+F +C EENP+
Sbjct: 1029 LDSLQMGKRPQLTDELRVLSSMNGPTMIPSGEELEKSDAGVDMLKFLVDLFHKCVEENPS 1088
Query: 802 ERPTAGDLYEMFVART 817
+RPTA ++++M +A T
Sbjct: 1089 KRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/741 (65%), Positives = 566/741 (76%), Gaps = 27/741 (3%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKRHHLQQRARQERLNNSRKWRGEGHAQT-SM 66
GS H+ SSI T SSN + R S + +RH+LQQ+ARQERLNNSRKW+GEG A+ ++
Sbjct: 327 GSNHSMSSIVTGPSSNRSFASRRSSKRWKRRHYLQQKARQERLNNSRKWKGEGCAEALAL 386
Query: 67 KEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL-LSPEAESENLLFSVEDDKIRSGT 125
KE + +KS NLD L E SD++G+DDD++++ LS EAE ENL SVEDDKI S
Sbjct: 387 KESESFKSNNLDVLTPEVHEGGTSDVVGVDDDNEKVELSVEAEGENLHTSVEDDKISSKK 446
Query: 126 GLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSD 185
VE+CSC L S K + C D ST + A QDE SSSE SK K+KRH D
Sbjct: 447 VFSVESCSC-DLGSINKSEEEVCCVQDEPLASTRDEAASQDESSSSEKSKITYKSKRHHD 505
Query: 186 RDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTP 245
RD+DNPKPCK R+ ++SN S KYS +SFCSIEDRLPDGFYDAGRDRPFM L +EQ
Sbjct: 506 RDIDNPKPCKCRRPTEDSSNFSCKYSELSFCSIEDRLPDGFYDAGRDRPFMPLRRFEQIL 565
Query: 246 HLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFV 305
LDSREVIL+DR+ DE+LDA+ALSAQALV K+ NG TK+ VDNLQIA LLALFV
Sbjct: 566 PLDSREVILLDREKDEQLDAVALSAQALVFRFKRSNGSTKERNKVAVDNLQIASLLALFV 625
Query: 306 SDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDL 365
SDHFGGSDRSG VERTRK VSGSNYRKPFVCTC TGN++S + + KQ L+ VEDI+ SDL
Sbjct: 626 SDHFGGSDRSGAVERTRKAVSGSNYRKPFVCTCPTGNNESISLAGKQALETVEDIIFSDL 685
Query: 366 CEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHA 425
CE+SLRSIK++R S+V+P+GS+QFGVCRHRA+L+KYLCDR++PPVPCELVRGYLDF PHA
Sbjct: 686 CERSLRSIKARRGSIVIPLGSLQFGVCRHRALLMKYLCDRMDPPVPCELVRGYLDFMPHA 745
Query: 426 WNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLD 485
WN IL ++GDS +RM+VDAC PHDIREE DPEYF RYIPL RT P STES P
Sbjct: 746 WNVILRRRGDSLVRMVVDACHPHDIREETDPEYFCRYIPLSRTKVPLSTESVPGPGC--- 802
Query: 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR 545
SFP++S+ D+ K+ SS+L RCKFGS +AAAKVRTL+VC +SADEIRNFEY CLGE
Sbjct: 803 --SFPTMSTSDKIEKAGSSTLIRCKFGSVEAAAKVRTLEVCEASADEIRNFEYICLGE-- 858
Query: 546 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 605
+SSKW+PS DGNPE +LQS I MEYV GGS+KNY+E++S+TG
Sbjct: 859 -----------------LSSKWVPSEDGNPERRILQSVILMEYVDGGSLKNYLEEVSKTG 901
Query: 606 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 665
EKHV V++AL IA+DVA AL E+HSK I+HRDIKSENILIDL+ +ADG PVVKLCDFDR
Sbjct: 902 EKHVPVEMALCIARDVACALAEIHSKDIIHRDIKSENILIDLDDTRADGMPVVKLCDFDR 961
Query: 666 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
AVP +SFLHTCCIAHRGI PDVCVGTPRWMAPEVLR M K N Y LEVDIWSYGCLLLE
Sbjct: 962 AVPRKSFLHTCCIAHRGIAPPDVCVGTPRWMAPEVLRTMDKRNTYALEVDIWSYGCLLLE 1021
Query: 726 LLTLQVPYMGLSELEIHDLIQ 746
LLTLQVPY GL E IH+L+Q
Sbjct: 1022 LLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/813 (56%), Positives = 582/813 (71%), Gaps = 17/813 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTS 65
GS ++ST SS SR +ARKSSK+WKR ++ QQRARQERLNNSRKW+GE +
Sbjct: 309 GSHRNPLNMSTGISSISRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGL 368
Query: 66 MKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 125
+ + ++G + + D D++DK E + + E+++
Sbjct: 369 SLKMEVEETGKQGMKVPQNTDRGSVDNSCSDENDKLF------EEASVITSEEEESSLKA 422
Query: 126 GLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSD 185
+ +N C + T + N E + +SS S+ + D SSSE K K+KR S+
Sbjct: 423 DVVSDNSQCVETQLTSERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSE 482
Query: 186 RDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTP 245
+ LDNPK K K + +N S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+
Sbjct: 483 KYLDNPKGSKCHKLSTDITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVL 542
Query: 246 HLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFV 305
LDSREVIL+DR DE LDAI LSA+ALV LK+LN LT D +DNLQ+A LALFV
Sbjct: 543 PLDSREVILLDRAKDEVLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFV 602
Query: 306 SDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDL 365
SDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED +LSD+
Sbjct: 603 SDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDV 662
Query: 366 CEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHA 425
CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHA
Sbjct: 663 CEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHA 722
Query: 426 WNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLD 485
WN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYIPL R + L+
Sbjct: 723 WNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRIKEK------LE 776
Query: 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR 545
PG S S + + +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR
Sbjct: 777 PGCSVSSLSTGKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVR 836
Query: 546 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 605
+LGAL+H CIVE+YGH+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G
Sbjct: 837 ILGALKHDCIVELYGHEISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAG 895
Query: 606 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 665
+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDR
Sbjct: 896 KHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDR 955
Query: 666 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
AVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ E
Sbjct: 956 AVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFE 1015
Query: 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELE 783
LLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S E E + + F+ E++L+
Sbjct: 1016 LLTLQNPYFDLSELQIHESLQNGKRPKLPKKLETLISETEEEESTNKLSEVFDLTESDLD 1075
Query: 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816
T+ FL+DVF +CTEE+P++R AGDL+EM ++R
Sbjct: 1076 TMRFLIDVFHQCTEESPSDRLNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/817 (55%), Positives = 578/817 (70%), Gaps = 20/817 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGE---GHA 62
GS ++ST SS SR +ARKSSK+WKR H+ QQRARQERLNNSRKW+GE G
Sbjct: 309 GSHRNPLNMSTGISSISRCFSARKSSKRWKRRQHYFQQRARQERLNNSRKWKGEVPPGGL 368
Query: 63 QTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIR 122
M+ + K G E + D D+DK L E+ + E+++
Sbjct: 369 SLKMEVEETGKQG---MKVPENTDRGSVDSTYSGDNDKLL----EEASVITSEEEEEESS 421
Query: 123 SGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKR 182
+N + T + N+E + +SS S+ + D SSSE K K+KR
Sbjct: 422 LKAKFASDNSRFVETQLTSERDNNESCEIKASSPSSGDAPGTADYNSSSERKKPNNKSKR 481
Query: 183 HSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYE 242
S++ LDNPK K + + +N S KYS SFCS ED LPDGF+DAGRDRPFM L+ YE
Sbjct: 482 CSEKYLDNPKGSKCHRPSTDFANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMSLSKYE 541
Query: 243 QTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLA 302
+ LDSREVIL+DR DE LDAI LSA+ LV LK+LN LT D +DNLQ+A LA
Sbjct: 542 EILPLDSREVILLDRAKDEVLDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQVASFLA 601
Query: 303 LFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVL 362
LFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED++L
Sbjct: 602 LFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDVIL 661
Query: 363 SDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQ 422
SD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF
Sbjct: 662 SDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFM 721
Query: 423 PHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCS 482
PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYIPL R T+ +
Sbjct: 722 PHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN----- 776
Query: 483 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLG 542
L+PG S + + +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLG
Sbjct: 777 -LEPGCSVSSLLTGKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLG 835
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EVR+LGAL+H CIVE+YGH+ISSKW+ S +G+ +LQS+I ME++KGGS+K +IEKLS
Sbjct: 836 EVRILGALKHDCIVELYGHEISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGHIEKLS 895
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +VKLCD
Sbjct: 896 EAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEAIVKLCD 955
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
FDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL
Sbjct: 956 FDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCL 1015
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEA 780
+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S E + + + F+ E+
Sbjct: 1016 IFELLTLQNPYFDLSELQIHESLQKGKRPKLPKKLETLSSETEEDESTNKLCEEFDLTES 1075
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817
+L+T+ FL+DVF +CTEE+P++R AGDL+EM ++RT
Sbjct: 1076 DLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/708 (61%), Positives = 535/708 (75%), Gaps = 18/708 (2%)
Query: 8 GSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQT-- 64
G +TSSS+ T SS+SR +RKS K+WKR ++LQQ+ARQERLNNSRKW+ H
Sbjct: 307 GPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQKARQERLNNSRKWKAVDHDDLLL 366
Query: 65 SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSG 124
S K + +SGN D+LASE+ +E S+ LDD++K++ S A ++N + + +D++ +
Sbjct: 367 SKKIHRISESGNHDSLASESCAEIESENGSLDDNNKRIFSERAVNDNAIDNDNNDEVITE 426
Query: 125 TGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHS 184
E+C E DE D+S S +EQ+E S E ++V K+KRH
Sbjct: 427 KQFSGEDCCTT-------ESKDE---KDASLCSLEKRQSEQEEASCLELLESVSKSKRHL 476
Query: 185 DRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQT 244
DRDLDNPKPCKSRKS+ +S S KYS +SFC ED L DGFYDAGRDRPFM L YEQ
Sbjct: 477 DRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDHLSDGFYDAGRDRPFMPLESYEQN 536
Query: 245 PHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALF 304
L SREVIL+DRK DEELDA+ L+AQALV +LK+LNGL + G VDNLQ A LLALF
Sbjct: 537 QCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLNGLNRHGNQVGVDNLQTASLLALF 596
Query: 305 VSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD 364
VSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G+S S ++ + + + +EDI LS
Sbjct: 597 VSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAGSSTSISSPTEPVANTIEDITLSK 656
Query: 365 LCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPH 424
+ EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KYLCD +EPPVPCELVRGYLDF PH
Sbjct: 657 MSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKYLCDHMEPPVPCELVRGYLDFSPH 716
Query: 425 AWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGL 484
AWN IL+K+G +W+RM++DAC+P DIREE DPEYF RYIPL RT P ST C G
Sbjct: 717 AWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCRYIPLNRTTIPLSTIG----CPGP 772
Query: 485 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEV 544
D SFPSL++CDE S+SL +CKFGS +AAAKVRTL+ GSSAD+I+NF+Y+CLGE+
Sbjct: 773 D-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVRTLEEQGSSADKIKNFKYNCLGEI 831
Query: 545 RMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET 604
R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+SAIFMEYV+GGS+K+Y+EKLSE
Sbjct: 832 RILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRSAIFMEYVEGGSLKSYLEKLSEA 891
Query: 605 GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD 664
GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSENIL DL+RK+ DG P VKLCDFD
Sbjct: 892 GEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSENILFDLDRKRDDGTPTVKLCDFD 951
Query: 665 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712
AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+R M+K N YGL
Sbjct: 952 SAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVMRTMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/821 (47%), Positives = 519/821 (63%), Gaps = 43/821 (5%)
Query: 20 SSSNSRSLTARKSSKQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------S 65
+S+N + +K+ K WKR LQQ+ARQERL +SR + +
Sbjct: 302 ASANLKVHPTQKTKKGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHD 361
Query: 66 MKEGQRYKSGNLDALASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIR 122
M+ K + +A + P E +S D+ + DDD + ++ +++ +
Sbjct: 362 MENKSEMKGIDEEASLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEK 418
Query: 123 SGTGLHVE-NCSCAG----LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV 177
G + NCSC + S + + E DS+S + + A E + SE SK
Sbjct: 419 PGLSMKSHGNCSCISGNTDILSRRRIRSVENELEDSAS--SVHDAAVVVEENPSETSKHS 476
Query: 178 CKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 237
K+KRH D D NPKP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM
Sbjct: 477 WKSKRHPDMDC-NPKPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMP 535
Query: 238 LTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQI 297
L YE++ L +REVIL+DR+ DEELDAIA SAQ L+ +LK + D + +L
Sbjct: 536 LEEYERSIGLYAREVILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLR 593
Query: 298 ALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAV 357
A +LALFVSD FGG DRS + RTR+ + +PFVCTCS G+ + + K+I +
Sbjct: 594 ASVLALFVSDCFGGCDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLY 653
Query: 358 EDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG 417
+ LC+KS+ IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG
Sbjct: 654 GHFDFTGLCDKSIHIIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRG 713
Query: 418 YLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESD 477
+LD+ PHAWN + V+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R +
Sbjct: 714 HLDYTPHAWNVVPVRKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ-- 771
Query: 478 HSPCSGLDPGS-FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF 536
G P S FPS+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NF
Sbjct: 772 -----GYTPRSPFPSVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNF 826
Query: 537 EYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 595
EY L EVRMLGALR H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K
Sbjct: 827 EYKLLAEVRMLGALRKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLK 885
Query: 596 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655
Y+ KL + G+KH + LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG
Sbjct: 886 GYLTKLLKEGKKHAPIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGT 945
Query: 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
PVVKL DFD A+PL S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGLEVD
Sbjct: 946 PVVKLSDFDNAIPLHSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGLEVD 1005
Query: 716 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSG 774
IWS+GC LLE+LTL++PY GL + EI+DLI K RPRLT ELEA + + + + G
Sbjct: 1006 IWSFGCFLLEMLTLRIPYQGLPDSEIYDLIMRKKQRPRLTQELEAFWTL-DKPITRLELG 1064
Query: 775 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815
+A E L L+D+F +CT+ +ERP A +Y + +
Sbjct: 1065 ITS-DAHAEKLRLLIDLFYQCTKGIASERPKAEAVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.933 | 0.692 | 0.569 | 5.6e-235 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.078 | 0.065 | 0.420 | 1.3e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.078 | 0.063 | 0.420 | 1.4e-18 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.106 | 0.1 | 0.320 | 2.9e-15 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.242 | 0.247 | 0.243 | 1.9e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.086 | 0.076 | 0.448 | 3.8e-14 | |
| UNIPROTKB|F5H1S7 | 184 | ULK1 "Serine/threonine-protein | 0.189 | 0.847 | 0.305 | 3.8e-13 | |
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.082 | 0.111 | 0.434 | 6.1e-13 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.081 | 0.163 | 0.402 | 7.5e-13 | |
| UNIPROTKB|F1N1A8 | 324 | MKNK1 "MAP kinase-interacting | 0.167 | 0.425 | 0.348 | 8.6e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2266 (802.7 bits), Expect = 5.6e-235, P = 5.6e-235
Identities = 448/787 (56%), Positives = 569/787 (72%)
Query: 34 KQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEASD 91
K+WKR ++ QQRARQERLNNSRKW+GE + + + ++G + + D
Sbjct: 335 KRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSVD 394
Query: 92 IIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKH 151
D++DK L EA + + E+++ + +N C + T + N E +
Sbjct: 395 NSCSDENDK--LFEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCEI 448
Query: 152 DSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYS 211
+SS S+ + D SSSE K K+KR S++ LDNPK K K + +N S+KYS
Sbjct: 449 KTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKYS 508
Query: 212 SVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQ 271
S SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA+
Sbjct: 509 SNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSAR 568
Query: 272 ALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYR 331
ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+
Sbjct: 569 ALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQ 628
Query: 332 KPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGV 391
KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG+
Sbjct: 629 KPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFGI 688
Query: 392 CRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIR 451
CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDIR
Sbjct: 689 CRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIR 748
Query: 452 EEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKF 511
E+ D EYF RYIPL R ES L+PG S S + + +SSL RCK
Sbjct: 749 EDTDQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRCKL 802
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S
Sbjct: 803 GSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITSE 862
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
+GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHSK
Sbjct: 863 NGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHSK 921
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CVG
Sbjct: 922 DIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVG 981
Query: 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
TPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP
Sbjct: 982 TPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGKRP 1041
Query: 752 RLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AGDL
Sbjct: 1042 KLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDL 1101
Query: 810 YEMFVAR 816
+EM ++R
Sbjct: 1102 HEMILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 1.3e-19, Sum P(5) = 1.3e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 372 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 429
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 430 LVKKGDSWI 438
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.4e-18, Sum P(4) = 1.4e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 372 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 429
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 430 LVKKGDSWI 438
G +I
Sbjct: 364 KADDGREYI 372
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 2.9e-15, Sum P(4) = 2.9e-15
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 657 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 758
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 1.9e-14, Sum P(4) = 1.9e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 331 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 390
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 391 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 444
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 445 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 498
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 499 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 539
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 3.8e-14, Sum P(3) = 3.8e-14
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 356 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 413
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 414 LVRG--YLDFQPHAWNTI 429
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
| UNIPROTKB|F5H1S7 ULK1 "Serine/threonine-protein kinase ULK1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 184 (69.8 bits), Expect = 3.8e-13, P = 3.8e-13
Identities = 55/180 (30%), Positives = 91/180 (50%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ MEY GG + +Y+ + E + LF+ Q +A A+ LHSK I+HRD+K +NI
Sbjct: 7 LVMEYCNGGDLADYLHAMRTLSEDTIR----LFL-QQIAGAMRLLHSKGIIHRDLKPQNI 61
Query: 644 LIDLER-KKADGKPV-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
L+ ++A+ + VK+ DF A L+S + A +C G+P +MAPEV+
Sbjct: 62 LLSNPAGRRANPNSIRVKIADFGFARYLQS----------NMMAATLC-GSPMYMAPEVI 110
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEA 759
+ H Y + D+WS G ++ + LT + P+ S ++ + K P + E A
Sbjct: 111 MSQH----YDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSA 166
|
|
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 144 (55.7 bits), Expect = 6.1e-13, Sum P(4) = 6.1e-13
Identities = 30/69 (43%), Positives = 37/69 (53%)
Query: 689 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 748
C GTP WMAPEV+ YG DIWS GC +LE+ T Q+PY L ++ I G
Sbjct: 489 CKGTPFWMAPEVINRKDSDG-YGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRG 547
Query: 749 KRPRLTDEL 757
P + D L
Sbjct: 548 TLPEVPDTL 556
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 125 (49.1 bits), Expect = 7.5e-13, Sum P(4) = 7.5e-13
Identities = 29/72 (40%), Positives = 45/72 (62%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I EY KGGSV+ + L+ + V +KLA+ A DVA + +H ++ +HRD+KS+N+
Sbjct: 206 IVTEYAKGGSVRQF---LTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNL 262
Query: 644 LIDLER--KKAD 653
LI ++ K AD
Sbjct: 263 LISADKSIKIAD 274
|
|
| UNIPROTKB|F1N1A8 MKNK1 "MAP kinase-interacting serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 197 (74.4 bits), Expect = 8.6e-13, P = 8.6e-13
Identities = 54/155 (34%), Positives = 85/155 (54%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ E ++GGS+ +I+K +KH + + A + +DVAAAL LH+K I HRD+K ENI
Sbjct: 110 LVFEKLQGGSILAHIQK-----QKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENI 164
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV--GTPRWMAPEVL 701
L + K + PV K+CDFD ++ L+ C I P++ G+ +MAPEV+
Sbjct: 165 LCESPEKVS---PV-KICDFDLGSGVK--LNNSCTP---ITTPELTTPCGSAEYMAPEVV 215
Query: 702 RAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
+ Y D+WS G +L +L+ P++G
Sbjct: 216 EVFTDEATFYDKRCDLWSLGVVLYIMLSGYPPFVG 250
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 825 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 6e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 531 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 590
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 591 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 651 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 767
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 768 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 531 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 590
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 591 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 499 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 556
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 616
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 580 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 754
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 809
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 508 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 565
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 624
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 684
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 685 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 744
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 745 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 803
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 804 PTAGDL 809
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 527 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 586
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 766
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 722 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 580 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 594
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 595 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 655 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 768
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 769 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 716
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 722 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDL 809
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 600
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 601 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 778
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 779 EAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 657
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 658 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 543 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDL 809
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 534 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 592
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 593 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 772
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 773 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 825
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 542 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 722 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 777
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 574
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 630
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 690
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 691 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 750 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 810 YE 811
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 5e-21
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 539 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 594
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 595 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 655 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF F C + +P VGTP WMAPEV+ + YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVISRL----PYGTEVDIWSLG 202
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDL 809
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 6e-21
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 204 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 253
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 254 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 313
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 314 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 373
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 374 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 431
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 432 KKGDSWIRMIVDACR 446
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 646 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 695
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 746
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 573
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 633
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 634 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 693
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 694 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 752
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 753 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 813 -FVARTSS 819
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 603 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 782 LETLSFLVDVFRRCTEENPTERPTAGDL 809
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 663 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 766
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 496 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 553
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 554 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 610
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 611 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 671 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 791 VFRRCTEENPTERPTAGDLYE 811
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 819
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 759
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 526 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 585
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 755
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQ 746
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 693
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 701
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 783 ETLSFLVDVFRRCTEENPTERPTAGDL 809
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 538 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 658 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 723 LLELLTLQVPY 733
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 63/297 (21%)
Query: 529 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 587
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 588 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 706
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKRPRLTDELEALGSCH 764
YG VD+W+ GC++ ELL + + G S+++ LIQ +G P EL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF------ 229
Query: 765 EHEVAQSGSGFEKPEAELETL---------SFLVDVFRRCTEENPTERPTAGDLYEM 812
+G F +P + E+L S +D + C +P ER T +L +
Sbjct: 230 SSNPRFAGVAFPEPS-QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 723 LLELLTLQVPY 733
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 531 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 590
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 591 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 745
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 685
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 686 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 736
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 737 SELE 740
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGK 749
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 646 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 584 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 643 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 757
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 758 EA-----LGSCHEHEVAQSGSGFE 776
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 641
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 642 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 751
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 703
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 741
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 509 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 623
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 683
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 684 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 756
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 598
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 659 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 713
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 714 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 772
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 773 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 553
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 554 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 613
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 614 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 673
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 674 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 792
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 793 -RRCTEENPTERPTAGDLYE 811
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-17
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 755
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 642
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 757
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 703
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 703
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 629
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 689
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 690 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 748
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 749 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 721 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 756
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 644 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 756
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 757 ---LEALGSCHEHEVAQSGSGFE 776
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 584 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 643 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 757
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 758 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 799
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 514 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 566
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 567 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 609
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 610 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 670 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 729 LQVPY 733
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 703
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 584 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 643 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 757
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 758 EA-----LGSCHEHEVAQSGSGFE 776
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 663 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 721 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 777
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 778 PEAE 781
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 489 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 548
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 549 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 584
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 585 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 703
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 508 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 622
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 623 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 682
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 683 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 741
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 742 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 802 ERPTAGDLYEM 812
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 57/215 (26%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 677 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 736 LSELEIHDLIQMGKRPRLTDEL----EALGSCHE------HEVAQSGSGFEKPEAE---L 782
SE D+L LG+ + +++A GF P+ L
Sbjct: 202 SSE---------------IDQLYKICSVLGTPTKQDWPEGYKLASK-LGFRFPQFAPTSL 245
Query: 783 ETL-----SFLVDVFRRCTEENPTERPTAGDLYEM 812
L +D+ + +P +RPTA +
Sbjct: 246 HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 519 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 574
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 575 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 614
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 675 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 DT-----DGH--IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 56/213 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 599
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 600 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNLYGL 712
KL DF A R + T R W PE+L + YG
Sbjct: 140 KLADFGLA---RPY------------TKRNSADYTNRVITLWYRPPELL--LGATR-YGP 181
Query: 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
EVD+WS GC+L EL + + G +ELE + I
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 683
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 684 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 737
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 786
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 787 FLVDVFRRCTEENPTERPTAGDLYEM 812
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 68/285 (23%)
Query: 543 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 660 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
LCDF A L + ++T +A R AP++ VG + YG VDIW
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK---------------YGRAVDIW 185
Query: 718 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 775
+ GCL+ E+LT + + G S++ D + + L L H+ ++ +G
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 776 EKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 811
PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 37/193 (19%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L ++H IV + A L I MEY GG + I +
Sbjct: 49 EVILLAKMKHPNIVTFF-----------ASFQENGRLF---IVMEYCDGGDLMKRINR-- 92
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ G ++ + Q ++ L +H + I+HRDIKS+NI + +G V KL D
Sbjct: 93 QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNIFL-----SKNGM-VAKLGD 145
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A R + +A+ CVGTP +++PE+ + ++P Y + DIWS GC+
Sbjct: 146 FGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ--NRP--YNNKTDIWSLGCV 191
Query: 723 LLELLTLQVPYMG 735
L EL TL+ P+ G
Sbjct: 192 LYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 815
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 717
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 718 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 775
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 737
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 738 ELEIHDLIQMGKRPRL 753
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 82/311 (26%), Positives = 135/311 (43%), Gaps = 70/311 (22%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 696 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 754
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 813
K E D + +++P RP+A L E F
Sbjct: 237 QP-------------------SKWSMEFR------DFLKTALDKHPETRPSAAQLLEHPF 271
Query: 814 VARTSSSISSR 824
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 577 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 693 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 644
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 764
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 765 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 812
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 777
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 778 PEAE 781
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 518 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 576
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
DIK +N+L+ + VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLTENAE-------VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 697 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 704 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 753
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 754 ----TDELEALGSCHEHEVAQSG 772
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 541 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
L E+++L L H I+ +++ HK L + E++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHK--------------GDL---YLVFEFMDTD----- 83
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 712
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 713 EVDIWSYGCLLLELLTLQVPYMGLSELE 740
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 600 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 774
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 775 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 720 GCLLLELLTLQVPYMG 735
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 642
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 757
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 758 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 807
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 808 DLYEMFVA 815
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 683
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 684 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 742
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 743 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 794
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 795 CTEENPTERPTA 806
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 646 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 541 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 659 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 716 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 774
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 775 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 820
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 822
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 580 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 630
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 631 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 689 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 744
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 745 IQMGK---RPR 752
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 497 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 556
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 598
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 599 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 658 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 708
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 709 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 767
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 768 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 816
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 704 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 700
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 564 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 621
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 622 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 681
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 682 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 723 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 766
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 700
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 759
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 644 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 701
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 644 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 701 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 756
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 757 LEAL 760
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 704 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 780 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 812
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 688
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 689 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 741
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 501 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 620
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 678
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 679 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 734
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 735 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 795 CTEENPTERPTAGDLYEMF 813
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 702
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 62/235 (26%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 593
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 594 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 711
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 712 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 766
+D+W+ GC+L ELL + G SE+E DLI ++ LG+ +E
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI-----------IQLLGTPNES 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 721 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 778
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 779 EAELETLSFLVDVFRRCTEENPTERPT 805
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 598
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 599 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 710 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 753
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 683
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 684 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 740
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 741 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 795
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 796 TEENPTERPTA 806
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 737
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 536 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 576
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 691
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 692 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 750
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 751 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 798
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 799 -NPTERPTAGD 808
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 759
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 760 --LGSCHEHEVAQSGSGFEKPEAELE 783
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 701
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 57/226 (25%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I E++ GS+ ++++ S+ G K KL F AQ +A + + ++ +HRD+++ NI
Sbjct: 77 IITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANI 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ V K+ DF A + +T A G P +W APE +
Sbjct: 134 LVS-------ASLVCKIADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN- 176
Query: 704 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 759
+G ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R +
Sbjct: 177 ------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---- 226
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+C E L ++ RC + P ERPT
Sbjct: 227 --NCPEE---------------------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 594 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 653 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 747
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 584 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 761
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 762 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 820
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 821 IS 822
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 646 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 759
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 760 L 760
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 584 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 760
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 520 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 577
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 578 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 637 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 753
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 541 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 659 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 716 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 520 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 579 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 639 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 660
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 723 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 776
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 541 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 712
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 769
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 770 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 812
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 693
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 750
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 751 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 811 E 811
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 644 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 701 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 759
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 646 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 699
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 700 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 723 LLELLTL-QVPYMGLSELEIHDLIQMGKR 750
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 488 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 543
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 544 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 721
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 752
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 584 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 631
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 692 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 744
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 745 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 805 TAGDLYE 811
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 688
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 689 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 580 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 631
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 749
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 750 --RPR 752
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 531 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 585
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 586 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 642 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 753
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 754 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 805 TAGD 808
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 646 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 752
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 657 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 767
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 768 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 806
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 624 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 682
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 683 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 634
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 689
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 690 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 744
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 745 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 805 TAGDLYEMF 813
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 557
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 617
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 618 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 677
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 678 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 736
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 737 SELEIHDLIQMGKRPR 752
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 783 ETLSFLVDVFRRCTEENPTERPTAGDL 809
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 683
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 684 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 617 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 675
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 676 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 794
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 795 CTEENPTERPTAGDLYEM 812
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 700
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 738
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 580 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 636
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 697 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 751
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 591 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSE 738
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 683
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 684 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 595 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 655 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 598
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 599 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 655 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 709 LYGLEVDIWSYGCLLLELLTLQVPY 733
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 675 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 729 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 788 LVDVFRRCTEENPTERPTAGDLY 810
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-10
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 60/204 (29%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LHS +++HRD+K NIL++ +K+CDF A RG+ +
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 688 VCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
G RW APE+L + + Y +DIWS GC+ ELLT + + G ++
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRRC 795
+LI +E LG+ E ++ S EK L++L L +F
Sbjct: 215 QLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPGA 261
Query: 796 TEE-----------NPTERPTAGD 808
+ E +P +R TA +
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 580 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 629
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 630 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 746
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 747 MGK---RPR 752
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 588 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 699
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 754
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SLVN----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 755 DELEALGSC 763
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 511 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 560
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 620
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 677
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 678 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 737
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 794
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 795 -CTEENPTERPTAGDLYE-MFVAR 816
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 704 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 759
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 647 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 595
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 596 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 714
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 772
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 773 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 806
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 659
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 660 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 681
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 682 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 577 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 689
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 690 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 712 LEVDIWSYGCLLLELLTL-QVPYMGL 736
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 702
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 661 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 715 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 774 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 616
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 673
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 674 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 734 MGLSELE 740
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 644
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 645 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 52/235 (22%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 700 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 684
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 685 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 743
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 744 LIQMGKRP 751
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 646 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 668
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 669 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 726 LLTLQVPYMGLSELE 740
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 755
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 756 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 26/160 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D + G V L DF L I H G + C GTP ++APEVL H
Sbjct: 130 D-----SQGHIV--LTDFG--------LCKENIEHNGTTS-TFC-GTPEYLAPEVL---H 169
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 528 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 587
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 588 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 648 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 700
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 760
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 761 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 809
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 717
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 718 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPT 805
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 822
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 723 LLELLTLQ 730
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 640
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 760
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 761 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 799
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 800 PTERPTAGDLYEMFV 814
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 688 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 746
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 747 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 646 DLERKKADGKPVVKLCDF-----------------------------------------D 664
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 665 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 722 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 681 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 738
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 797
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 798 ENPTERPTAGDLYEM 812
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 717
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 718 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 646 DLERKKADGKPVVKLCDF-----------------------------------------D 664
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 665 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 722 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 700
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 632
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 642
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 703 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 735
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 696
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 755
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 756 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 598
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 719 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 584 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 693 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 745
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 746 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 806 AGDLYE 811
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 632
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 723 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 778
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 779 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 585 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 698 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 733
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 760
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 729
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 730 QVPYMGLSELEIHDLIQ 746
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 640
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 586 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 688
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 689 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 696
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 590 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 703
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 763 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 586 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 753
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 681 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 736
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 737 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 765
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 539 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 583
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 644 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLEL 726
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMG 748
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 700
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 701 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 756
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 641
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 699
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 598
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 719 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 7e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 584 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 633
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 634 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 681
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 682 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 501 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 618
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 676
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 735
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 796 TEENPTERPTAGDL 809
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 616 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 675
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 676 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 728 TLQVPYMG 735
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 616 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 675
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 676 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 736 LSELEIHDLIQM 747
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 589 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 705
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPY 733
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELL 727
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 537 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 596
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 597 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 712 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 676
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 736
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 737 SELEIHDLIQMGK 749
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 584 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 757
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 522 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 581
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 582 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 702 RAMH-KPNLYGLEVDIWSYGCLLLEL 726
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 690
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 691 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 749
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 750 R 750
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 584 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 681 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 736
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 594 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 713
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 536 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 594
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 595 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 711
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 712 LEVDIWSYGCLLLELLTLQVPYM-GLSE 738
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 684
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 685 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 744
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 745 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 802 ERPTAGDLYEM 812
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 601
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 662 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 717 WSYGCLLLELLTLQVPYMGLSELE 740
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 609 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 669 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 722 LLLELL 727
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 690
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 691 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 749
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 750 R 750
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 681 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 738
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 739 LEIHDLIQMGKR 750
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 576
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 577 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 692
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 750
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 643 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+L+ E + G P +KL D V + L IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIP----------WVPPE 174
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLEL 726
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 616 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 673
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 674 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 624 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 679
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 680 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 689 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 36/156 (23%)
Query: 597 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 713
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
VD+WS GC+ E+ + + G S+++ Q+GK
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 584 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 632
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 585 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 698
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 699 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 756
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 795
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 796 TEENPTERPTAGDL 809
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 681 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 733
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 794 RCTEENPTERPTAGDLYEMF 813
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 681 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 734
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 735 GL 736
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 657 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 716 IWSYGCLLLELLTLQVPYMG 735
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 689 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 644 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 761
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 762 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 815 A 815
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 661 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 720 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 584 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 632
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 633 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 685
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 686 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 744
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 745 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 686
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 583 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 642 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 739
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 707
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 708 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 745
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 663 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 718 SYGCLLLELLT 728
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 600
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 721 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 753
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 16/105 (15%)
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 683
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T I
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT----PTAI 161
Query: 684 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
D V T + APE+ + Y +DIWS GC+ E+LT
Sbjct: 162 FWTDY-VATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 688 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 580 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 633
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 634 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 692 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 747
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 748 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 808 DLYEMFVAR 816
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 729
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 730 QVPYMGLSELEIHDLIQ 746
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 681 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 739
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 740 EIHDLIQMGKR 750
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 663 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 718 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 751
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 606 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 665
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 666 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 726 LLTL-QVPYMGLSELEIHDLIQMGKR 750
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 681 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 739
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 740 EI 741
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 663 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 718 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 751
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 733
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 734 MGLSELEIHDLIQ 746
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 580 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDF 663
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 686
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 745
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 746 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 801
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 802 ERPTAGDLY-EMFVARTSSSIS 822
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 692 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 747
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 748 GKR 750
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 613 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 660
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 721 CLLLELLTLQVPY 733
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 686
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 546
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 547 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 606
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 607 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 664
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 665 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 725 ELLTLQVPYMGLSELE 740
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 21/140 (15%)
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++NIL+
Sbjct: 84 EFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
E + P +KL D +P+ C+ IP W+APE +
Sbjct: 140 REGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE--DS 183
Query: 707 PNLYGLEVDIWSYGCLLLEL 726
NL + D WS+G L E+
Sbjct: 184 KNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 688
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 689 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 731
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 732 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 781
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 782 LETLSFLVDVFRRCTEENPTERPTA 806
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 647 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 705 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 757
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 758 EAL-GSCHEHEVAQSGS 773
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 681 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 738
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 739 LEIHDLIQMGKR 750
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 616 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 675
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 676 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 734 MGLSELE 740
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 688 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 522 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 577
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 578 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 630
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 683
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 684 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 719 YGCLLLELLTLQVPY 733
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 712 LEVDIWSYGCLLLELLTLQVPYMG 735
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 41/208 (19%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKIS-SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
E++ L + + I+++YG I LP ++ +EY G ++ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL-----------SLILEYCTRGYLREVL 113
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV 657
+K EK +S K L +A D L L+ + ++++ S + L+ + K
Sbjct: 114 DK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-----ENYKLK 163
Query: 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
+ ++ + F + + + + ++L + Y ++ DI+
Sbjct: 164 IICHGLEKILSSPPFKNVNFMVYF---------------SYKMLNDIFSE--YTIKDDIY 206
Query: 718 SYGCLLLELLTLQVPYMGLSELEIHDLI 745
S G +L E+ T ++P+ L+ EI+DLI
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 47/181 (25%), Positives = 67/181 (37%), Gaps = 53/181 (29%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ ME++ GG + + K E + F + A+ +H +HRDIK +NI
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132
Query: 644 LIDLERKKADGKPVVKLCDF----------DRAV---PLRSFLHTCCIAHRGIPAPDV-- 688
LID G +KL DF D A L+ + I +R A D
Sbjct: 133 LID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 689 ----------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726
VGTP ++APE+ YG E D WS G ++ E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG----YGQECDWWSLGAIMFEC 241
Query: 727 L 727
L
Sbjct: 242 L 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 547 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 606
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 607 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 666
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 667 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 722 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 750
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 17/84 (20%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
I + + AL LHS I+HRD+K +NI+ K+ D A LR
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS------FKIIDLGAAADLRV----- 308
Query: 677 CIAHRGIP-APDVCVGTPRWMAPE 699
GI P + PR+ APE
Sbjct: 309 -----GINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.84 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.76 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.72 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.25 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.75 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.5 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.9 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.38 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.3 | |
| PLN02236 | 344 | choline kinase | 94.07 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.02 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 90.57 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.52 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.16 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.75 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 89.21 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 87.54 | |
| PTZ00296 | 442 | choline kinase; Provisional | 85.64 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=401.32 Aligned_cols=189 Identities=35% Similarity=0.516 Sum_probs=162.7
Q ss_pred CcccccceecccccccCCCCCCCCccccCCCCC----------CCcccccccc-CCCCCcceEEEEcCCCCHHHHHHHHH
Q 003375 201 GENSNASQKYSSVSFCSIEDRLPDGFYDAGRDR----------PFMQLTGYEQ-TPHLDSREVILVDRKSDEELDAIALS 269 (825)
Q Consensus 201 ~~~~~~s~~~~~~~~~~~~d~~~dgfy~~~~~~----------~~~~l~~~~~-~~~~~~~evilvdr~~d~~l~~~~~~ 269 (825)
++++.+|||||++|||+|+|||||||||++++. .+++|++|+. ++...++|||||||.+|++|++|++.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 468999999999999999999999999999872 3557999994 46789999999999999999999999
Q ss_pred HHHHHHHhhhccCcccCCccCccchHHHHHHHHHHHHhhcCCCCcccccccccccccCCCCCCCceeccCCCCCCCcccc
Q 003375 270 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTS 349 (825)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~la~~v~~~~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (825)
|+.++..+. .+..+++++||+|||++|||++..+
T Consensus 81 a~~~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~--------------------------------- 114 (204)
T PF14381_consen 81 AHELSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDA--------------------------------- 114 (204)
T ss_pred HHHHHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcc---------------------------------
Confidence 999995542 1245699999999999999998433
Q ss_pred hhhhhcccchhhhhhHHHHHHHHHHhhcCccEEeccceeeeccccceeeeeeeccccCCCcccccccccccCCC-CCCcc
Q 003375 350 QKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNT 428 (825)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~v~pig~l~~g~~~~rallfk~l~d~~~~~~p~rLVrG~~~~~~-~a~~~ 428 (825)
+ .....|+..++.||+ +++++|||+|++|+|||||||||+|||+|+ ||||||||+|||+. +..+.
T Consensus 115 ---------~-~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~ 180 (204)
T PF14381_consen 115 ---------E-DMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDAS 180 (204)
T ss_pred ---------h-hhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCce
Confidence 1 123489998888888 899999999999999999999999999999 99999999999987 55567
Q ss_pred eEEeeCCceEEEEeccc-CCCcc
Q 003375 429 ILVKKGDSWIRMIVDAC-RPHDI 450 (825)
Q Consensus 429 ~lVrrG~~~~~~~~d~~-~p~~~ 450 (825)
+.|+.++.+ +|++|.+ .||.+
T Consensus 181 ~~V~~~~~~-eyiVDLm~~PG~L 202 (204)
T PF14381_consen 181 NLVKFDDGR-EYIVDLMGAPGQL 202 (204)
T ss_pred EEEEcCCCc-EEEEEcCCCCCCc
Confidence 888888765 8999998 47764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=408.69 Aligned_cols=268 Identities=29% Similarity=0.446 Sum_probs=224.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCee-EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+.+.++.+.+.||.|+||+||+|.|.+.. ||+|++.-. ....... ..|.+|+.+|.+|+|||||+++|++...
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~--~~~~~~~----~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDP--DFDDESR----KAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecch--hcChHHH----HHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 56777788888999999999999999988 999986432 2222223 3459999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g-IVHrDLKP~NIL 644 (825)
.. .++|||||+++|+|.+++... ....+++..++.|+.||++||+|||+++ ||||||||+|||
T Consensus 112 ~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 112 PG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 41 359999999999999999862 3467999999999999999999999999 999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+. .++||+|||+++........ .+...||+.|||||++.+. ...|+.|+||||||++||
T Consensus 176 v~~~~------~~~KI~DFGlsr~~~~~~~~----------~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 176 VDLKG------KTLKIADFGLSREKVISKTS----------MTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred EcCCC------CEEEECCCccceeecccccc----------ccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHH
Confidence 99872 27999999999876543211 1224799999999999953 367999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHH-cCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+||+.||.+..+.++...+. .+.+|.++.. .++.+..||.+||..||.+|
T Consensus 238 El~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~---------------------------~~~~l~~l~~~CW~~dp~~R 290 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE---------------------------CPPHLSSLMERCWLVDPSRR 290 (362)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---------------------------CCHHHHHHHHHhCCCCCCcC
Confidence 9999999999998887777765 5577776642 25579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 003375 804 PTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 804 PSa~EIL~hL~~l~sss~ 821 (825)
|++.+|+..|+.+.....
T Consensus 291 P~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 291 PSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCHHHHHHHHHHHHHhhc
Confidence 999999999998766443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=403.63 Aligned_cols=273 Identities=22% Similarity=0.265 Sum_probs=223.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..+.|.+.+.||+|+||.|-+|.. .++.||||++.............. ...+.+|+++|++|+|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345678899999999999999986 678999999865443332211111 11348999999999999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ||||||++||.|.+++-. .+.+.+..-+.+++||+.|+.|||++||+||||||+|||+
T Consensus 249 ds~--------------YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 249 DSS--------------YMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred Cce--------------EEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 754 999999999999999976 4678888889999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
..+. ..+.+||+|||+|+....... ..+.+|||.|.|||++.+.. ...+..++||||+||+||-
T Consensus 310 ~~~~----e~~llKItDFGlAK~~g~~sf-----------m~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 310 SNDA----EDCLLKITDFGLAKVSGEGSF-----------MKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred ccCC----cceEEEecccchhhcccccee-----------hhhhcCCccccChhheecCC-eecccchheeeeccceEEE
Confidence 8763 347899999999998764332 35568999999999998622 2334569999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~-i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+++|.+||.+..... +.++|.++.....+.. +..++++..+||.+||..||++||
T Consensus 374 cLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~------------------------w~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ------------------------WDRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred EeccCCCcccccCCccHHHHHhcCcccccChh------------------------hhhhhHHHHHHHHHhhEeCcccCc
Confidence 999999998765444 8888988876554432 344678899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.|+|+|.|....+.
T Consensus 430 s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 430 SADEALNHPWFKDAPC 445 (475)
T ss_pred CHHHHhcChhhhcccc
Confidence 9999999998876553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=395.28 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=220.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
+...+++.++.||+|..|+||++++ ++..+|+|++.+. .... +..++.+|+++++..+|||||.+||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPA----LQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHH----HHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 5567888999999999999999998 4778888886432 2223 33455999999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NI 643 (825)
+.. ..+|+||||+||||+.++.. .+++++...-.|+.+|++||.|||. ++||||||||+||
T Consensus 149 ~~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 149 NGE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred CCc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 663 24999999999999999986 3679999999999999999999996 8999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+..+ .|||||||.+..+.... .++++||..|||||.+.+ ..|+.++||||||++|
T Consensus 211 LvNskG-------eVKicDFGVS~~lvnS~------------a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 211 LVNSKG-------EVKICDFGVSGILVNSI------------ANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSL 267 (364)
T ss_pred eeccCC-------CEEeccccccHHhhhhh------------cccccccccccChhhhcC----CcCCcccceecccHHH
Confidence 999885 59999999998876531 256789999999999998 7899999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 724 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 724 yELLTG~~PF~~~-----~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
+|+++|+.||... ...+++..|..+..|.++.. ..++++++|+..||++
T Consensus 268 lE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 268 LELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRK 321 (364)
T ss_pred HHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcC
Confidence 9999999999763 67788888888877776642 1367899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 003375 799 NPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l 816 (825)
||.+||++.|+++|.+-.
T Consensus 322 dp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 322 DPSERPSAKQLLQHPFIK 339 (364)
T ss_pred CcccCCCHHHHhcCHHHh
Confidence 999999999999996544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=384.93 Aligned_cols=263 Identities=28% Similarity=0.429 Sum_probs=220.7
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee-E
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-K 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~-~ 562 (825)
..++.+|+++++||+|+||.||++.. .+..+|.|-+.. ........ +.+..|+.+|++|+|||||+++++ |
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f--~~md~k~r----q~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF--GMMDAKAR----QDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch--hhccHHHH----HHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 46788999999999999999999986 666777775432 22333333 345999999999999999999994 3
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh--CC--ccccCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDI 638 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs--~g--IVHrDL 638 (825)
..++. .++||||||.+|+|..+|+...+ ....+++.++|+++.|++.||.++|. .. |+||||
T Consensus 89 ~~~~e-------------vlnivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDI 154 (375)
T KOG0591|consen 89 IEDNE-------------VLNIVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDI 154 (375)
T ss_pred hccch-------------hhHHHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccC
Confidence 33332 26999999999999999997544 45789999999999999999999999 44 999999
Q ss_pred CCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 003375 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718 (825)
Q Consensus 639 KP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWS 718 (825)
||.||+|+.+ +.|||+|||+++.+...... ....+|||.||+||.+.+ ..|+.||||||
T Consensus 155 KPaNIFl~~~-------gvvKLGDfGL~r~l~s~~tf----------A~S~VGTPyYMSPE~i~~----~~Y~~kSDiWs 213 (375)
T KOG0591|consen 155 KPANIFLTAN-------GVVKLGDFGLGRFLSSKTTF----------AHSLVGTPYYMSPERIHE----SGYNFKSDIWS 213 (375)
T ss_pred cchheEEcCC-------CceeeccchhHhHhcchhHH----------HHhhcCCCcccCHHHHhc----CCCCcchhHHH
Confidence 9999999977 56999999999988654322 355789999999999997 88999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 719 LGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
+||++|||+.-++||.+.+-.++...|.++..|++++.. .+..+..||..|+..
T Consensus 214 lGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~--------------------------YS~~l~~li~~ci~v 267 (375)
T KOG0591|consen 214 LGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH--------------------------YSTDLRELINMCIAV 267 (375)
T ss_pred HHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH--------------------------hhhHHHHHHHHHccC
Confidence 999999999999999999999999999999888777432 366899999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 003375 799 NPTERPTAGDLYEMFVA 815 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~ 815 (825)
||..||+.-.++..+..
T Consensus 268 d~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 268 DPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcccCCCcchHHHHHHH
Confidence 99999996666665554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=407.57 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=221.5
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
|+.. .+|...+.||+|||+.+|.+++ .+..||+|++..+.... ....+ ++.+||+|.+.|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~re----Kv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQRE----KVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHH----HHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3344 7799999999999999999997 78899999986543322 22333 449999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
++.+++ |||+|+|+.++|..+++. .+.+++.+++.+++||+.||.|||+++|||||||..|
T Consensus 88 EDs~nV--------------YivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNNV--------------YIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCce--------------EEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 998876 999999999999999986 5789999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+.+ ..|||+|||+|..+..... ...+.+|||.|.|||++.. ...+..+||||+|||
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~E----------rk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDGE----------RKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCccc----------ccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999988 5699999999988764321 1355689999999999985 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||-||+|++||+..+..+.+..|...... +|. ..+.+.++||.+||+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~---------------------------~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYS-MPS---------------------------HLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCcc-ccc---------------------------ccCHHHHHHHHHHhcCCccc
Confidence 99999999999999999999888876331 111 23557899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003375 803 RPTAGDLYEMFVA 815 (825)
Q Consensus 803 RPSa~EIL~hL~~ 815 (825)
|||+++||.|-..
T Consensus 260 Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 260 RPSLDEVLDHPFF 272 (592)
T ss_pred CCCHHHHhcCHhh
Confidence 9999999999766
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=387.47 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=208.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|.+.+.||+|+||+||+|++ .+..||||.+..+.. .....+. +..|+.+|+.++|||||++++++..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~----L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVEL----LLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHH----HHHHHHHHHhcCCcceeeEEEEEec
Confidence 5678999999999999999999998 557888887654322 2333333 4899999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+.+ |||||||+||+|..||+. ...+++.+++.++.||+.||++||+++||||||||+|||
T Consensus 81 ~~~i--------------~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 81 DDFI--------------YLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CCeE--------------EEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 7754 999999999999999997 458999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+..... +....+||+|||+|+.+...... .+..|+|.|||||+++. ..|+.|+|+||+|+|||
T Consensus 142 Ls~~~~~-~~~~~LKIADFGfAR~L~~~~~a-----------~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 142 LSTTARN-DTSPVLKIADFGFARFLQPGSMA-----------ETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTILY 205 (429)
T ss_pred eccCCCC-CCCceEEecccchhhhCCchhHH-----------HHhhCCccccCHHHHHh----ccccchhhHHHHHHHHH
Confidence 9876221 11278999999999988753322 34579999999999986 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC--CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|++|+.||...+..+++..+.++. .+.++..+ +..+.+|+...|..+|..
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~---------------------------s~~~~~Ll~~ll~~~~~~ 258 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL---------------------------SNPLRELLISLLQRNPKD 258 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhccccccCchhhhc---------------------------cCchhhhhhHHHhcCccc
Confidence 9999999999999999988887762 22222211 223456666666666666
Q ss_pred CCCHHHHHHH
Q 003375 803 RPTAGDLYEM 812 (825)
Q Consensus 803 RPSa~EIL~h 812 (825)
|.++.+-+.|
T Consensus 259 ~~~~~~~~~~ 268 (429)
T KOG0595|consen 259 RISFEDFFDH 268 (429)
T ss_pred cCchHHhhhh
Confidence 6666665544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=366.18 Aligned_cols=279 Identities=24% Similarity=0.332 Sum_probs=218.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++.|+.+.++|+|+||+||+|++ .++-||||.+. ..... +.++ +-.+||+++|++|+|||+|.++++|....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~--Esedd-~~Vk---KIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV--ESEDD-PVVK---KIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeec--cCCcc-HHHH---HHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 46789999999999999999997 56667777653 22222 2222 23499999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ++||+|||+. ++.+-+.. . ...++.+.+.++++|++.|+.|+|++++|||||||+||||+
T Consensus 75 k--------------lhLVFE~~dh-TvL~eLe~---~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 75 K--------------LHLVFEYCDH-TVLHELER---Y-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT 135 (396)
T ss_pred e--------------eEEEeeecch-HHHHHHHh---c-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence 4 5999999985 55555543 1 34588999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +++||||||+|+.+...... .+..+.|..|.|||.+.+ ...|+..+||||+||++.||
T Consensus 136 ~~-------gvvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 136 QN-------GVVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred cC-------CcEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHH
Confidence 88 57999999999988642221 345689999999999987 46799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc---ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|.+.|++.++.+....|.....+-++.....+.+.+. -.+......-......+..+..+.+|+..||+.||.+|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 999999999999999989888766666665554432210 00111111111222344556789999999999999999
Q ss_pred CCHHHHHHH
Q 003375 804 PTAGDLYEM 812 (825)
Q Consensus 804 PSa~EIL~h 812 (825)
++.++++.|
T Consensus 276 ~sc~qll~H 284 (396)
T KOG0593|consen 276 LSCEQLLHH 284 (396)
T ss_pred ccHHHHhcC
Confidence 999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=386.79 Aligned_cols=285 Identities=24% Similarity=0.250 Sum_probs=223.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
..+++|.++++||.|+||.||+|+. .+..||||. ++.....-++.-+ +||+..|++|. |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~--MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKK--MKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHH--HHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhh
Confidence 4578999999999999999999996 566677776 4444444333333 79999999999 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... .+|+|||||+ .+|+++++. .+..|++..++.|++||++||+|+|++|+.||||||+||
T Consensus 80 d~~~-------------~L~fVfE~Md-~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 80 DNDR-------------ILYFVFEFMD-CNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred ccCc-------------eEeeeHHhhh-hhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 7652 4699999998 799999987 257899999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|+... ..+||+|||+|+.+..... .+..+.|..|.|||++.. ...|+.+.||||+|||+
T Consensus 142 Li~~~-------~~iKiaDFGLARev~SkpP-----------YTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 142 LISGN-------DVIKIADFGLAREVRSKPP-----------YTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIM 200 (538)
T ss_pred Eeccc-------ceeEecccccccccccCCC-----------cchhhhcccccchHHhhh---ccccCCchHHHHHHHHH
Confidence 99854 5799999999998865332 355689999999999986 47899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhh-----ccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEAL-----GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
+|+.+-++.|.|.+..+.+.+|... ..|......... ..+..+.. .+..........+.++.+||.+||.
T Consensus 201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~----~~~~l~~L~p~~s~~~~~li~~ll~ 276 (538)
T KOG0661|consen 201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQV----KPSPLKDLLPNASSEAASLIERLLA 276 (538)
T ss_pred HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcC----CCCChHHhCcccCHHHHHHHHHHhc
Confidence 9999999999999988877777654 333322211110 00000100 1111222334467889999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 798 ENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
+||.+||||.|+++|.........
T Consensus 277 WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 277 WDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred CCCccCccHHHHhcCccccccccc
Confidence 999999999999999766554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.16 Aligned_cols=254 Identities=28% Similarity=0.353 Sum_probs=216.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||.++. .++.+|+|+.+.+..... .+.+. ...|..||.+++||.||.++-.|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~----~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRH----TKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHH----HHHHHHHHHhCCCCcEeeeEEeccc
Confidence 5578999999999999999999986 677899998654433222 23333 3899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...+ |+|+||+.||.|...|.+ ...|++..+..++..|+.||.|||++|||||||||+|||
T Consensus 97 ~~kL--------------ylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 97 EEKL--------------YLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred CCeE--------------EEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 7754 999999999999999986 578999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ ++++|+|||+++....... .+.+++||+.|||||++.+ ..|+..+|.||||++||
T Consensus 158 Ld~~-------GHi~LtDFgL~k~~~~~~~----------~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGillY 216 (357)
T KOG0598|consen 158 LDEQ-------GHIKLTDFGLCKEDLKDGD----------ATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILLY 216 (357)
T ss_pred ecCC-------CcEEEeccccchhcccCCC----------ccccccCCccccChHHHhc----CCCCcccchHhHHHHHH
Confidence 9988 5699999999986543221 1345789999999999997 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|.+||.+.+...+.+.|.++..+..+.. .+...++|+.++|+.||.+|.
T Consensus 217 eML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~---------------------------ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 217 EMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY---------------------------LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc---------------------------CCHHHHHHHHHHhccCHHHhc
Confidence 99999999999999999999998864444422 145789999999999999995
Q ss_pred ----CHHHHHHH
Q 003375 805 ----TAGDLYEM 812 (825)
Q Consensus 805 ----Sa~EIL~h 812 (825)
.+.+|-+|
T Consensus 270 g~~~d~~~ik~H 281 (357)
T KOG0598|consen 270 GGPGDAEEIKRH 281 (357)
T ss_pred CCCCChHHhhcC
Confidence 67777766
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=381.73 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=219.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
....+|.+++.||+|+|++|++|+. .+..+|+||...+ ....+...+. +.+|-.+|.+| .||.|+++|-.|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~-~Iike~KvkY----V~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR-YIIKEKKVKY----VTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH-HHHhhcccch----hhHHHHHHHHhhCCCCeEEEEEEee
Confidence 5678999999999999999999996 6788999985322 1112222222 47888999999 7999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
++..+ |+|+||+++|+|.++|++ -+.|++..++.++.+|+.||+|||++|||||||||+||
T Consensus 145 D~~sL--------------YFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 145 DEESL--------------YFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred cccce--------------EEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 88765 999999999999999997 36899999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCccccccccccccc---ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~---s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
||+.+ +.+||+|||.|+.+......... ..........++||..|.+||+|.. ...++.+|||+||
T Consensus 206 LLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAlG 274 (604)
T KOG0592|consen 206 LLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWALG 274 (604)
T ss_pred eEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHHH
Confidence 99988 56999999999988764433110 0011111256899999999999987 7789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||||+|+.|++||.+.++--+++.|...... ++ ...++.+.+||.++|..||
T Consensus 275 CilyQmlaG~PPFra~NeyliFqkI~~l~y~-fp---------------------------~~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 275 CILYQMLAGQPPFRAANEYLIFQKIQALDYE-FP---------------------------EGFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHHHHHhcCCCCCccccHHHHHHHHHHhccc-CC---------------------------CCCCHHHHHHHHHHHccCc
Confidence 9999999999999999999888888765332 11 1124578999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003375 801 TERPTAGDLYEMFV 814 (825)
Q Consensus 801 ~eRPSa~EIL~hL~ 814 (825)
.+|+|+++|.+|..
T Consensus 327 ~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 327 SDRLTSQQIKAHPF 340 (604)
T ss_pred cccccHHHHhhCcc
Confidence 99999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=351.05 Aligned_cols=288 Identities=21% Similarity=0.228 Sum_probs=230.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|...+.||+|.||.||+|++ +++.||+|-+++..... .+....+||++.|+.++|+||+.++++|.....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 4788999999999999999998 67778888766553222 223344899999999999999999999987765
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+ .||+||++ .+|+..|+. ....++...+..++.++++||+|||.+.|+||||||.|+||+.
T Consensus 76 l--------------~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 76 L--------------SLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred e--------------EEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 5 99999998 799999986 4567899999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+|+.+...... ....+-|..|.|||.+.| ...|+..+||||.|||+.||+
T Consensus 137 ~-------g~lKiADFGLAr~f~~p~~~----------~~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 137 D-------GQLKIADFGLARFFGSPNRI----------QTHQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred C-------CcEEeecccchhccCCCCcc----------cccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHH
Confidence 8 56999999999988764432 122378999999999997 577999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
-|.+.|.|.++.+.+..|......+.++.++.+...++....+..+..........++.++.+|+.+||.+||.+|+|+.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99999999998888877776644444555555444433322221111111223455677889999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 003375 808 DLYEMFVARTSSSIS 822 (825)
Q Consensus 808 EIL~hL~~l~sss~S 822 (825)
|+++|--....+.+.
T Consensus 277 qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 277 QALKHPYFKSLPLPT 291 (318)
T ss_pred HHhcchhhhcCCCCC
Confidence 999997776655444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=384.98 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=220.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+...|....+||+|+.|.||.|+. .+..||+|.+.+..+... +.+.+|+.+|+.++|+|||.+++.|...
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 456788889999999999999986 566788887766543321 1248999999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. +|+||||++||+|.+.+.. ..+++.++..|++++++||+|||.+||+|||||.+|||+
T Consensus 343 de--------------LWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL 402 (550)
T KOG0578|consen 343 DE--------------LWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL 402 (550)
T ss_pred ce--------------eEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence 54 5999999999999999986 569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++ .+||+|||++..+..... .....+|||.|||||++.. ..|++|.||||||++++|
T Consensus 403 ~~~g-------~vKltDFGFcaqi~~~~~----------KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 403 TMDG-------SVKLTDFGFCAQISEEQS----------KRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred ccCC-------cEEEeeeeeeeccccccC----------ccccccCCCCccchhhhhh----cccCccccchhhhhHHHH
Confidence 9885 499999999987765322 2466799999999999986 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+.|++||-..++...++.|.....|.+.. ....+..|.+||.+||+.||.+|++
T Consensus 462 MveGEPPYlnE~PlrAlyLIa~ng~P~lk~-------------------------~~klS~~~kdFL~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 462 MVEGEPPYLNENPLRALYLIATNGTPKLKN-------------------------PEKLSPELKDFLDRCLVVDVEQRAS 516 (550)
T ss_pred HhcCCCCccCCChHHHHHHHhhcCCCCcCC-------------------------ccccCHHHHHHHHHHhhcchhcCCC
Confidence 999999999999999999998887776652 1234678999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
|.|+|+|-.-..+
T Consensus 517 A~eLL~HpFl~~a 529 (550)
T KOG0578|consen 517 AKELLEHPFLKMA 529 (550)
T ss_pred HHHHhcChhhhhc
Confidence 9999999655433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=380.67 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=219.9
Q ss_pred CCceeeeeecccCceEEEEEEECCe-eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
..+.+++.||+|-||.||.|.|++. +||+|..+.. .... +. |.+|+.+|++|+|+|||+++|++..+..+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~---~~----f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSP---EA----FLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccCh---hH----HHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 4467899999999999999999766 9999986533 2222 23 38999999999999999999999976644
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
||||||++.|+|.+||+. ..+..+.....+.++.|||+||+||+++++|||||-+.||||+.+
T Consensus 277 --------------yIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 277 --------------YIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED 339 (468)
T ss_pred --------------EEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC
Confidence 999999999999999986 345779999999999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..+||+|||+|+.+.....+.. ....-...|.|||.+.. ..++.|||||||||+||||+|
T Consensus 340 -------~~vKIsDFGLAr~~~d~~Y~~~---------~~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 340 -------LVVKISDFGLARLIGDDEYTAS---------EGGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred -------ceEEEcccccccccCCCceeec---------CCCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhc
Confidence 5799999999995544332211 11123568999999986 789999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|+.||.+++..+++..+.++.+.+-|+ .+++.+.+||..||+.+|++||||+
T Consensus 400 ~G~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 400 YGRVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred cCCCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHH
Confidence 999999999999999999997654442 2477899999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 003375 808 DLYEMFVARTSSSI 821 (825)
Q Consensus 808 EIL~hL~~l~sss~ 821 (825)
.+...|+.+.....
T Consensus 453 ~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 453 TLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHhhhccc
Confidence 99999988876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=364.07 Aligned_cols=273 Identities=26% Similarity=0.376 Sum_probs=225.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.....|++.+.||.|..++||+|+. .+..||||++.++.+... ++.+ .+|+..|..++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld~l----~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LDAL----RKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HHHH----HHHHHHhhhcCCCCcceEEEEEEe
Confidence 4567899999999999999999997 678999999988766433 3444 899999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+..+ |+||+||.+||+.++++.....+ +++..+..|++++++||.|||.+|.||||||+.|||
T Consensus 96 ~~~L--------------WvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 96 DSEL--------------WVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ccee--------------EEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 7755 99999999999999999866655 999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.|||+|||.+..+.... .+.....+.++||+.|||||+++.. -..|+.|+||||||++..
T Consensus 159 i~~d-------G~VkLadFgvsa~l~~~G------~R~~~rf~tfvgtp~wmAPEvl~q~--~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 159 IDSD-------GTVKLADFGVSASLFDSG------DRQVTRFNTFVGTPCWMAPEVLMQQ--LHGYDFKADIWSFGITAC 223 (516)
T ss_pred EcCC-------CcEEEcCceeeeeecccC------ceeeEeeccccCcccccChHHhhhc--ccCccchhhhhhhhHHHH
Confidence 9988 459999999887665422 1111222677999999999997642 356899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|..||....+.+++..-.++..|.+.. .....+.....+..+..++..||++||.+||
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t------------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT------------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCccc------------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 9999999999999998877766665543220 0011222233455899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
||+++++|-...
T Consensus 286 tAskLlkh~FFk 297 (516)
T KOG0582|consen 286 TASKLLKHAFFK 297 (516)
T ss_pred CHHHHhccHHHh
Confidence 999999986543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.40 Aligned_cols=264 Identities=33% Similarity=0.448 Sum_probs=207.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+|...+.||+|+||.||++... +...|||...+.. ....+ .+.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~----~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSE----SLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHH----HHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456889999999999999999985 5899999876541 11133 3489999999999999999999744332
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..++|+|||+++|+|.+++.. .+. .+++..++.+++||++||.|||++|||||||||+||||+
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 246999999999999999987 232 699999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.. ++.+||+|||+++........ ........||+.|||||++.. +.....++|||||||++.||
T Consensus 152 ~~------~~~~KlaDFG~a~~~~~~~~~-------~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 152 PS------NGDVKLADFGLAKKLESKGTK-------SDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred CC------CCeEEeccCcccccccccccc-------ccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEec
Confidence 83 146999999999877531110 011234679999999999984 12334699999999999999
Q ss_pred HhCCCCCCC-CCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMG-LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~-~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+||++||.. ....+....+... ..|.++.. .+.+..+||.+|+..||.+||
T Consensus 216 ~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~---------------------------ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 216 LTGKPPWSEFFEEAEALLLIGREDSLPEIPDS---------------------------LSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred cCCCCcchhhcchHHHHHHHhccCCCCCCCcc---------------------------cCHHHHHHHHHHhhcCcccCc
Confidence 999999987 3444433344333 34444432 356799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
||.++|+|.......
T Consensus 269 ta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 269 TAEELLEHPFLKQNS 283 (313)
T ss_pred CHHHHhhChhhhccc
Confidence 999999998775543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=373.07 Aligned_cols=263 Identities=23% Similarity=0.282 Sum_probs=215.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
...+.|.+.+.||+|+||.|++|.+ .+..||+|+...+...... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 5578999999999999999999987 6789999976543211111 112233478999999999 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .|+||||+.||+|.+++.. ..++.+..+..+++||+.|++|||++||+||||||+||
T Consensus 91 t~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 7664 4999999999999999986 46789999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+. +.+||+|||++...... .....+..||+.|+|||++.+.. ...+.++||||+||+|
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~~----------~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPGE----------DGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCC------CCEEEeccccccccCCC----------CCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHH
Confidence 999871 34999999999876311 11235568999999999998721 1446999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh-HHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET-LSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~L~dLI~~CL~~DP~e 802 (825)
|.|++|+.||...+...++..|..+.. .++.. . +..+.+|+.+||..||.+
T Consensus 214 y~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~---------------------------~~S~~~~~Li~~mL~~~P~~ 265 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSY---------------------------LLSPEARSLIEKMLVPDPST 265 (370)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCC---------------------------cCCHHHHHHHHHHcCCCccc
Confidence 999999999999888888888776633 12211 1 457899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|+|+.+|++|-+...
T Consensus 266 R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 266 RITLLEILEHPWFQK 280 (370)
T ss_pred CCCHHHHhhChhhcc
Confidence 999999999988776
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.79 Aligned_cols=295 Identities=21% Similarity=0.234 Sum_probs=227.1
Q ss_pred CCCCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 483 GLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 483 ~~d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
.+-+...+.|+.+++||+|+||.||+|++ .+..||+|-+.+..... .|-....+||.||++|.|||||++.+
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~------~~~~t~~REI~ILr~l~HpNIikL~e 183 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE------GFPITAIREIKILRRLDHPNIIKLEE 183 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC------cchHHHHHHHHHHHhcCCCcccceee
Confidence 34557778999999999999999999998 56668888876654222 22233489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
...... ...+|||+|||+ .+|..++.. +...|++.+++.+++||+.||+|+|.+||+|||||.
T Consensus 184 ivt~~~------------~~siYlVFeYMd-hDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 184 IVTSKL------------SGSIYLVFEYMD-HDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG 246 (560)
T ss_pred EEEecC------------CceEEEEEeccc-chhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence 988652 124699999998 599999875 456899999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+||||+.+ +.+||+|||+|+++....... .+..+-|..|.|||++.| ...|+.++|+||.|
T Consensus 247 SNiLidn~-------G~LKiaDFGLAr~y~~~~~~~---------~T~rVvTLWYRpPELLLG---~t~Yg~aVDlWS~G 307 (560)
T KOG0600|consen 247 SNILIDNN-------GVLKIADFGLARFYTPSGSAP---------YTSRVVTLWYRPPELLLG---ATSYGTAVDLWSVG 307 (560)
T ss_pred cceEEcCC-------CCEEeccccceeeccCCCCcc---------cccceEEeeccChHHhcC---Ccccccceeehhhh
Confidence 99999988 569999999999876533221 345578999999999998 56799999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC--CCCCchhhhhhHHHHHHHHHHhccc
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS--GFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
|||.||++|++.|++.+..+.+..|.+-...+-.+.|. ...++.....+... .....+.....+....+|+..||..
T Consensus 308 CIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~l 386 (560)
T KOG0600|consen 308 CILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSL 386 (560)
T ss_pred HHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhcc
Confidence 99999999999999999888887776643332233322 11111000000000 0111222444567889999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCCC
Q 003375 799 NPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~sss 820 (825)
||.+|.||.++|++=.......
T Consensus 387 dP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 387 DPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred CccccccHHHHhcCcccccCCC
Confidence 9999999999999865544333
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=380.17 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=221.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++.+.+.+.+.||+|.||+||+|+|.|. ||||+.++ .....+..+.| .+|+.++++-+|.||+-|+|++....
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv--~~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNV--DDPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc-eEEEEEec--CCCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCCc
Confidence 7778889999999999999999999874 99999654 44555666666 99999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
+.||+.+|+|.+|+.+|+. .+..|.....+.|++||++||.|||.++|||||||..|||+.
T Consensus 462 ---------------~AIiTqwCeGsSLY~hlHv----~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 462 ---------------LAIITQWCEGSSLYTHLHV----QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH 522 (678)
T ss_pred ---------------eeeeehhccCchhhhhccc----hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence 3899999999999999986 246799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
++ .+|||+|||++..-...... .. ....-|...|||||+++. ....+|++.+||||||+++|||
T Consensus 523 ~~-------~kVkIgDFGLatvk~~w~g~-----~q---~~qp~gsilwmAPEvIRm-qd~nPfS~qSDVYaFGiV~YEL 586 (678)
T KOG0193|consen 523 ED-------LKVKIGDFGLATVKTRWSGE-----QQ---LEQPHGSLLWMAPEVIRM-QDDNPFSFQSDVYAFGIVWYEL 586 (678)
T ss_pred cC-------CcEEEecccceeeeeeeccc-----cc---cCCCccchhhhcHHHHhh-cccCCCCcccchhhhhHHHHHH
Confidence 87 56999999999754432111 11 122248899999999984 4457899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+||..||......+++..+.++. .+.... .....+.++.+|+..||.+++++||.
T Consensus 587 ltg~lPysi~~~dqIifmVGrG~l~pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 587 LTGELPYSIQNRDQIIFMVGRGYLMPDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred HhCcCCcCCCChhheEEEecccccCccchh------------------------hhccCHHHHHHHHHHHHhcCcccCcc
Confidence 99999999778888887777773 222221 12335678999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.+||..|+.+..
T Consensus 643 F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 643 FPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhhh
Confidence 9999998887766
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=372.98 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=215.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|.+.+.||+|+||.||+|+. ..+.||+|. +.+......+++.+ .+|++|++.|+|||||.++++|+...
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~--i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKF--IDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEE--ehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccc
Confidence 46899999999999999999986 455677776 55666666677777 99999999999999999999999776
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. +|+|+|||.| +|..+|.. ...++++.+..|+.|++.||.|||+.+|+|||+||.|||+.
T Consensus 75 ~--------------~~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 75 H--------------LWVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred e--------------EEEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 5 4999999985 99999987 57899999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.. +++|+||||+|+.+...... ...+.|||.|||||++.+ ..|+..+|+||+|||+|||
T Consensus 135 ~~-------~~~KlcdFg~Ar~m~~~t~v----------ltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~ 193 (808)
T KOG0597|consen 135 KG-------GTLKLCDFGLARAMSTNTSV----------LTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYEL 193 (808)
T ss_pred CC-------CceeechhhhhhhcccCcee----------eeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHH
Confidence 77 67999999999877543221 244579999999999987 8899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|++||......++...|.....+.. ...+..+.+|+..+|.+||.+|.|.
T Consensus 194 ~~G~PPF~a~si~~Lv~~I~~d~v~~p----------------------------~~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 194 YVGQPPFYARSITQLVKSILKDPVKPP----------------------------STASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred hcCCCCchHHHHHHHHHHHhcCCCCCc----------------------------ccccHHHHHHHHHHhhcChhhcccH
Confidence 999999998888888888776532211 1235679999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.+++.|..
T Consensus 246 ~~Ll~HpF 253 (808)
T KOG0597|consen 246 TDLLGHPF 253 (808)
T ss_pred HHHhcChH
Confidence 99999843
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=366.96 Aligned_cols=277 Identities=24% Similarity=0.252 Sum_probs=218.1
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChH-----HHH-hhHHhHHHHHHHHhhCCCCCcce
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSAD-----EIR-NFEYSCLGEVRMLGALRHSCIVE 557 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~-----~~~-~~~~~~lrEv~iLk~L~HPNIV~ 557 (825)
...++.|++++.||+|.||.|-+|+. .+..||+||+..+....... ... .-.+++.+||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 36789999999999999999999997 67899999976443221110 000 00135699999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCc-cCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHR 636 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~-ls~~~i~~Ia~QIa~AL~yLHs~gIVHr 636 (825)
++++..+... ..+|||+|||..|.+...-. ... +++.++++++++++.||+|||.+|||||
T Consensus 173 LiEvLDDP~s------------~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 173 LIEVLDDPES------------DKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred EEEeecCccc------------CceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999775442 35799999999888765422 244 8999999999999999999999999999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
||||+|+||+.+ ++|||+|||.+..+......... ..-...+|||.|||||.+.+.......+.+.||
T Consensus 235 DIKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~~d-----~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di 302 (576)
T KOG0585|consen 235 DIKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEGSD-----DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDI 302 (576)
T ss_pred ccchhheEEcCC-------CcEEeeccceeeecccCCccccH-----HHHhhcCCCccccchHhhcCCCCccccchhhhh
Confidence 999999999988 56999999999876433111000 001225899999999999874444556899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 717 WSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||+||+||.|+.|+.||.+....++++.|.+.... ++. ..++.+.+.+||.+||
T Consensus 303 WalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~-fP~-------------------------~pe~~e~~kDli~~lL 356 (576)
T KOG0585|consen 303 WALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE-FPE-------------------------NPEINEDLKDLIKRLL 356 (576)
T ss_pred hhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc-CCC-------------------------cccccHHHHHHHHHHh
Confidence 99999999999999999999999999999876321 111 0134568999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 003375 797 EENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~s 818 (825)
.+||.+|.+..+|..|++--..
T Consensus 357 ~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 357 EKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcChhheeehhhheecceeccC
Confidence 9999999999999999876544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=359.17 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=202.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
.+.++|++.+.||+|+||.||+|.+ .+..||+|+.... ........ +.+|+.+|..+ +||||+++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKA----LMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHH----HHHHHHHHHHhccCcceeeE
Confidence 4567899999999999999999974 2356899985421 12223333 48999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 604 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 604 (825)
++++...+. ..++||||+++|+|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 77 LGACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred EeEecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 998864432 359999999999999999752110
Q ss_pred -----------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEe
Q 003375 605 -----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661 (825)
Q Consensus 605 -----------------------~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~ 661 (825)
....+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~ 216 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKIC 216 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEe
Confidence 01347888999999999999999999999999999999999876 459999
Q ss_pred ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 003375 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE 740 (825)
Q Consensus 662 DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~ 740 (825)
|||+++........ .......+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.....
T Consensus 217 DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 217 DFGLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred ecccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 99999765322111 01122346788999999976 668899999999999999997 999998764332
Q ss_pred -HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 741 -IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 741 -i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+...+..+..+..+ ...++.+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 285 ~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 285 EFCQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33333333221111 1234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.10 Aligned_cols=279 Identities=20% Similarity=0.235 Sum_probs=207.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||.|+||.||+|.. .+..||+|+........ .. ..+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---AP----CTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cc----hhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3578899999999999999999987 56789999875432111 11 123789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~~--------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (288)
T cd07871 75 ERC--------------LTLVFEYLD-SDLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL 135 (288)
T ss_pred CCe--------------EEEEEeCCC-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 543 499999998 599999875 2245789999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++........ .....+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 136 ~~~~-------~~~kl~DfG~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 136 INEK-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILY 195 (288)
T ss_pred ECCC-------CCEEECcCcceeeccCCCcc----------ccCceecccccChHHhcC---CcccCcHHHHHHHHHHHH
Confidence 9877 45999999998754322111 122368999999999864 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC-C---CCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G---FEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~---~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|+||++||.+.+..+....+.........+.+...... ..+..... . ..........+..+.+||.+||++||
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN--EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc--hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCc
Confidence 999999999988877766666544333333322221110 00000000 0 00011112345678999999999999
Q ss_pred CCCCCHHHHHHHH
Q 003375 801 TERPTAGDLYEMF 813 (825)
Q Consensus 801 ~eRPSa~EIL~hL 813 (825)
.+|||+.|+++|.
T Consensus 274 ~~R~t~~~~l~hp 286 (288)
T cd07871 274 KSRISAEAALRHS 286 (288)
T ss_pred ccCCCHHHHhcCC
Confidence 9999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=350.06 Aligned_cols=288 Identities=25% Similarity=0.286 Sum_probs=223.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.++++|+.++.|++|+||.||+|+++ +.-||+|-++.+. +...|...-+|||.+|.+++|||||.+-.+...
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 56789999999999999999999985 4566666655443 233444455899999999999999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. ...|||||||+ .+|..++... .++|...+++.++.|+++||+|||.+.|+||||||+|+|
T Consensus 147 ~~~------------d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 147 SNM------------DKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred ccc------------ceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 542 24799999998 6999999873 367999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.. +.+||+|||+|+.+...... .+..+-|..|.|||++.+ ...|+++.|+||+|||+.
T Consensus 210 m~~~-------G~lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~a 269 (419)
T KOG0663|consen 210 LSHK-------GILKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFA 269 (419)
T ss_pred eccC-------CcEEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHH
Confidence 9987 56999999999998764322 345678999999999998 567999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc--------cccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--------EHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||+++++.|.|.+..+.++.|.+-...+-...++.+...+ ...+......+... ..++.-.+|+..+|
T Consensus 270 E~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~----~lse~g~~Lln~ll 345 (419)
T KOG0663|consen 270 ELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL----SLSEQGFDLLNKLL 345 (419)
T ss_pred HHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccc----ccchhHHHHHHHHh
Confidence 9999999999998888777776643222222222221111 11111111111111 13567889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 797 EENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+||.+|.||.+.|+|=.....+.+
T Consensus 346 t~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 346 TYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccCccccccHHHhhcccccccCCCC
Confidence 9999999999999999766655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.25 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=210.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.++|+...-++-||.|+.|.||+|+..+..||||.++ +.+ ..+|+-|++|+|||||.|.|+|...
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~---------elk------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR---------ELK------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh---------hhh------hhhHHHHHhccCcceeeEeeeecCC
Confidence 4778888888899999999999999999999998642 112 3478889999999999999999854
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. .+|||||||..|-|.++|+. +..+.......|..+||.||+|||.+.|||||||..||||
T Consensus 185 P--------------cyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 185 P--------------CYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred c--------------eeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 4 45999999999999999986 5678899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
..+ ..|||+|||-++....... ...+.||..|||||+++. .+.++|+|||||||+|||
T Consensus 246 s~~-------d~VKIsDFGTS~e~~~~ST-----------kMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWE 303 (904)
T KOG4721|consen 246 SYD-------DVVKISDFGTSKELSDKST-----------KMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWE 303 (904)
T ss_pred ecc-------ceEEeccccchHhhhhhhh-----------hhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHH
Confidence 988 4699999999988765422 245689999999999997 788999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
||||..||...+...++.-+..+.. ....+..+++.|+-||+.||+..|..||+
T Consensus 304 mLT~EiPYkdVdssAIIwGVGsNsL--------------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPS 357 (904)
T KOG4721|consen 304 MLTGEIPYKDVDSSAIIWGVGSNSL--------------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPS 357 (904)
T ss_pred HHhcCCCccccchheeEEeccCCcc--------------------------cccCcccCchHHHHHHHHHHhcCCCCCcc
Confidence 9999999988877666544443311 11122345678899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
|.+|+.||.-.
T Consensus 358 Frqil~HldIa 368 (904)
T KOG4721|consen 358 FRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHhhc
Confidence 99999999754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.43 Aligned_cols=282 Identities=22% Similarity=0.252 Sum_probs=204.0
Q ss_pred CCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeeeEe
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~~~ 563 (825)
.+|++.+.||+|+||.||+|.+ ++..+|+|++........ .... +.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~----~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLS----TIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHH----HHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 3789999999999999999987 356789998754432211 1112 25677776665 6999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..... .....++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccCC---------CCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 43211 1234699999997 699999875 2234589999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99877 459999999997653321 1133468999999999975 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|++||.+.+..+....+........+..+..........+ ...............+..+.+|+.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc-cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 999999999998887776666654422222222211111110000 0000000111122356778999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
||+.++++|.
T Consensus 279 ~s~~~~l~hp 288 (290)
T cd07862 279 ISAYSALSHP 288 (290)
T ss_pred CCHHHHhcCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.61 Aligned_cols=250 Identities=28% Similarity=0.366 Sum_probs=204.7
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+. +..+|+|+....... .... ...+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQ----EQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHH----HHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 47899999999999999999984 788999987543211 1111 233588999999999999999998877554
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
..|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 35999999999999999976 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDRT-------------WTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCCc-------------ccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 459999999987653211 22368999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 805 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS-- 805 (825)
+|+.||.+.+...+...+..+.. .++. ..+..+.+||.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKL-EFPR---------------------------HLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCc-CCCc---------------------------cCCHHHHHHHHHHcCCCHHHccCCc
Confidence 99999998888777777665422 1111 12447899999999999999995
Q ss_pred ---HHHHHHHHHh
Q 003375 806 ---AGDLYEMFVA 815 (825)
Q Consensus 806 ---a~EIL~hL~~ 815 (825)
+.++++|.+.
T Consensus 245 ~~~~~~~l~h~~~ 257 (291)
T cd05612 245 KNGADDVKNHRWF 257 (291)
T ss_pred cCCHHHHhcCccc
Confidence 9999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=357.93 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|++ .+..+|+|++...... ..... ..+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQV----QHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhH----HHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 5678999999999999999999998 4678999987532111 11112 345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. .|+||||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 90 ENR--------------VYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150 (329)
T ss_pred CCE--------------EEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence 654 4999999999999999976 356889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 151 l~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 206 (329)
T PTZ00263 151 LDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVLLY 206 (329)
T ss_pred ECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHHHH
Confidence 9877 459999999997653311 12369999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|..||.+.+.......+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 207 elltg~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 207 EFIAGYPPFFDDTPFRIYEKILAGRL-KFPN---------------------------WFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred HHHcCCCCCCCCCHHHHHHHHhcCCc-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHcC
Confidence 99999999998888777776665421 1111 1244689999999999999999
Q ss_pred C-----HHHHHHHHH
Q 003375 805 T-----AGDLYEMFV 814 (825)
Q Consensus 805 S-----a~EIL~hL~ 814 (825)
+ +.+|+.|.+
T Consensus 259 ~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 259 GTLKGGVADVKNHPY 273 (329)
T ss_pred CCCCCCHHHHhcCCc
Confidence 7 799998854
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.79 Aligned_cols=277 Identities=24% Similarity=0.255 Sum_probs=202.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|++ .+..+|+|++..... .... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEV----KETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccc----hhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 4799999999999999999998 466789998654321 1112 2234889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 75 --------------LYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred --------------EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 5999999997666554432 346899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 45999999999876432111 1123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC-C-----CCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-F-----EKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|++||.+.+..+....+.....+.....+....... .+...... . .........+..+.+||.+||++||.
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~ 273 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP--RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT 273 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc--hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc
Confidence 9999998877655544444332222222221111100 00000000 0 00011123467899999999999999
Q ss_pred CCCCHHHHHHHH
Q 003375 802 ERPTAGDLYEMF 813 (825)
Q Consensus 802 eRPSa~EIL~hL 813 (825)
+|||++++++|.
T Consensus 274 ~R~s~~~~l~hp 285 (287)
T cd07848 274 DRYLTEQCLNHP 285 (287)
T ss_pred cCCCHHHHhcCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=349.82 Aligned_cols=284 Identities=20% Similarity=0.264 Sum_probs=217.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|...+.||.|+||.|+.|.+ .+..||+|- +.......... ++..+|+++|+.++|+||+.+++++....
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKK--i~~~F~~~~~a----kRtlRElklLr~~~HeNIi~l~di~~p~~-- 94 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKK--ILNPFENQIDA----KRTLRELKLLRHLRHENIIGLLDIFRPPS-- 94 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhh--hhhhhhchHHH----HHHHHHHHHHHHhcCCCcceEEeeccccc--
Confidence 345579999999999999998 456677765 33223333333 34499999999999999999999987522
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.......|+|+|+|+ .+|...|+. +..++...+..+++||++||.|+|+.+|+||||||.|+|++.+
T Consensus 95 -------~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 95 -------RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred -------ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC
Confidence 123456899999996 799999986 3559999999999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||+|+....... ...-+..+.|..|.|||++.. ...|+.+.||||+||||.||++
T Consensus 162 -------c~lKI~DFGLAR~~~~~~~--------~~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 162 -------CDLKICDFGLARYLDKFFE--------DGFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred -------CCEEeccccceeeccccCc--------ccchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHc
Confidence 5599999999998754311 111245678999999999975 4679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++.|.|.+....+..|......+-.+.+..+.......+.+... ........+...+...+|+++||..||.+|+|
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit 303 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT 303 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence 999999998888777777653333334443332111111221111 12223344566788999999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
++|+|+|.
T Consensus 304 a~eAL~hP 311 (359)
T KOG0660|consen 304 AEEALAHP 311 (359)
T ss_pred HHHHhcCh
Confidence 99999984
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=348.43 Aligned_cols=289 Identities=20% Similarity=0.239 Sum_probs=205.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.+ .+..||+|...... ....... ++.+|+.+++.++||||+++++++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDAT----RILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHH----HHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 589999999999999999997 56789999764221 1112222 348999999999999999999988644321
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 75 ---------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred ---------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1235799999996 799999875 3468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||+++......... .......||+.|+|||++.+. ...++.++|||||||++|||+|
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCcc-------ccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 469999999997653221110 011234699999999998642 1457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++||.+.+.......+...........+..........+.. ..............++.+.+||.+||..||.+|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 999998876655444333321111111111110000000000 00000011112234567899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.++++|.+..
T Consensus 284 ~~e~l~hp~f~ 294 (338)
T cd07859 284 AEEALADPYFK 294 (338)
T ss_pred HHHHhcCchhh
Confidence 99999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.73 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
.++++|++.+.||+|+||.||+|...+ ..+++|..... ..... ...+.+|+.++.+++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~----~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKV----QQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHH----HHHHHHHHHHHHhcCCcccceEE
Confidence 356789999999999999999998733 35777764321 11222 23458999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCC-----------CccCHHHHHHHHHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVEL 628 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~-----------~~ls~~~i~~Ia~QIa~AL~yL 628 (825)
+++..... .+++|||+++++|.+++........ ..+++..++.++.||+.||.||
T Consensus 75 ~~~~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 75 GVCTKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEEcCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99876553 4999999999999999976322111 4588899999999999999999
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
|++||+|+||||+|||++.+ +.++|+|||++......... .......+++.|+|||.+.+ .
T Consensus 141 H~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05048 141 SSHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----G 201 (283)
T ss_pred HhCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----C
Confidence 99999999999999999876 45999999999765332111 01122356889999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
.++.++|||||||+||||++ |..||.+....++...+.....+..+ ...+..
T Consensus 202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~ 254 (283)
T cd05048 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP---------------------------EDCPAR 254 (283)
T ss_pred cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHH
Confidence 67899999999999999998 99999988888777777655433222 123568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 255 ~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 255 VYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=369.63 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=219.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..++-|++++.||.|+.|.|-+|++ +|+.+|||++...... .... .+.+.+|+.||+.|.||||+++|+++..
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~----~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQ----PAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeecccccc-cccc----ccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4567899999999999999999997 7899999998654322 1111 2345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +|+|.||++||-|.+|+-. .+.+++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~~--------------lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQH--------------LYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cce--------------EEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 664 5999999999999999986 478999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+..++ +||+|||+|..-..... -.+.+|+|.|+|||+++| ..+.+.++||||.|||||
T Consensus 145 Ld~~~n-------IKIADFGMAsLe~~gkl-----------LeTSCGSPHYA~PEIV~G---~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVKNN-------IKIADFGMASLEVPGKL-----------LETSCGSPHYAAPEIVSG---RPYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhcccC-------EeeeccceeecccCCcc-----------ccccCCCcccCCchhhcC---CCCCCCccccchhHHHHH
Confidence 998843 99999999975443221 134479999999999998 355689999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
.||||++||.+.+...++.++.++... +| ..++.++++||.+||..||.+|.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~-MP---------------------------s~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFE-MP---------------------------SNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCccc-CC---------------------------CcCCHHHHHHHHHHhccCccccc
Confidence 999999999999999999999988542 12 22466899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|.+||++|.+-.--
T Consensus 256 T~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 256 TTEEILKHPFLSGY 269 (786)
T ss_pred cHHHHhhCchhhcC
Confidence 99999999765433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=343.31 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=203.2
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
..||+|++|.||+|.+++..||+|.+.... .. .+.+.+.+.+|+.+|++++||||++++|++.+...
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~--~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~-------- 92 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFH--KG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD-------- 92 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccc--cc---cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc--------
Confidence 578999999999999999999999864321 11 11222344899999999999999999999875110
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEEecCccCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 654 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~~~~~~ 654 (825)
.....++||||+++|+|.+++.. ...+++...+.++.|++.||.|||+. +++||||||+|||++.+
T Consensus 93 --~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 93 --DLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred --CCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 11246999999999999999976 35688999999999999999999984 99999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~ 734 (825)
+.+||+|||+++...... ....||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~~--~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDIF--SEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhcc--ccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 469999999987653311 1235889999999997521 467899999999999999999999999
Q ss_pred CCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 735 GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 735 ~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
+.+..++...+... .++.++ ...++.+.+|+.+||+.||.+|||+.+|++.|
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 88877777666443 222211 12356799999999999999999999999999
Q ss_pred Hhhc
Q 003375 814 VART 817 (825)
Q Consensus 814 ~~l~ 817 (825)
+.+.
T Consensus 277 ~~~~ 280 (283)
T PHA02988 277 SLYK 280 (283)
T ss_pred HHHH
Confidence 8764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=365.08 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=212.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|+..+.||+|+||.||+|.+ .++.||+|+..+... .++++.+ .+|+.+|..++++||.++|+.|.....+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHH----HHHHHHHHhcCcchHHhhhhheeecccH
Confidence 467779999999999999998 567899999776543 3344444 8999999999999999999999876654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
||+||||.||++.+.++. ...+.+..+..++++++.||.|||.++.+|||||+.|||+..+
T Consensus 87 --------------wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 87 --------------WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred --------------HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 999999999999999985 3445888999999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ .|||+|||.+..+..... ...+++|||.|||||++.+ ..|+.|+||||||++.+||++
T Consensus 148 g-------~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla~ 206 (467)
T KOG0201|consen 148 G-------DVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELAK 206 (467)
T ss_pred C-------cEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHhc
Confidence 4 499999999987765332 2366899999999999986 789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|.+||....++.++..|-+...|.+.. ..++.+++|+..||.+||+.||+|.+
T Consensus 207 GePP~s~~hPmrvlflIpk~~PP~L~~---------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 207 GEPPHSKLHPMRVLFLIPKSAPPRLDG---------------------------DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CCCCCcccCcceEEEeccCCCCCcccc---------------------------ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999998877666666655544432 23567999999999999999999999
Q ss_pred HHHHHH
Q 003375 809 LYEMFV 814 (825)
Q Consensus 809 IL~hL~ 814 (825)
+|+|-.
T Consensus 260 LLKh~F 265 (467)
T KOG0201|consen 260 LLKHKF 265 (467)
T ss_pred HhhhHH
Confidence 999943
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.96 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
+.||+|+||.||+|.. .+..+|+|+...... ....... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVA----HTLTESRVLQNTRHPFLTALKYSFQTHDR------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHH----HHHHHHHHHHhCCCCCCCCEEEEEEcCCE------
Confidence 4699999999999987 567899998753321 1112222 34889999999999999999999886654
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
.||||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 70 --------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003375 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF 733 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 132 --~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCCC----------cccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 4599999999875322111 1123469999999999976 66889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003375 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 808 (825)
Q Consensus 734 ~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~E 808 (825)
.+.+...+...+..... .++ ...++.+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 88877766666554321 111 11245789999999999999999 8999
Q ss_pred HHHHHH
Q 003375 809 LYEMFV 814 (825)
Q Consensus 809 IL~hL~ 814 (825)
+++|-+
T Consensus 248 ll~h~~ 253 (323)
T cd05571 248 IMEHRF 253 (323)
T ss_pred HHcCCC
Confidence 998843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=349.78 Aligned_cols=280 Identities=21% Similarity=0.248 Sum_probs=213.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|.-.+++|.|+||.||+|.. .+..+|||-.-.+.. .+ .+|+.+|+.+.|||||++.-+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YK------NRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cC------cHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 577899999999999999997 557888886532211 11 5699999999999999999888754321
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
......+||||++ .+|.++++..... +..++...++-+++||.+||+|||+.||+||||||.|||+|.+
T Consensus 93 ---------d~~~lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 93 ---------DEVYLNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred ---------chhHHHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 1345689999998 7999999864333 3678889999999999999999999999999999999999987
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
. +.+||||||.|+.+...... .....|..|.|||.+.+ ...|+.+.||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEhhhhHHHHHHhc
Confidence 3 78999999999987653321 33468899999999997 5679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccC-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|++.|.|.+..+.+..|.+....+-.+.+..+... .+..+.+.....-........++++.+|+.++|+++|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999999887777666665333333333332111 11111111111100113345577899999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
|++.|-
T Consensus 302 ~~l~h~ 307 (364)
T KOG0658|consen 302 EALAHP 307 (364)
T ss_pred HHhcch
Confidence 999883
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.12 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=200.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhh
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 549 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~------------------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~ 549 (825)
+.++|++.++||+|+||.||+|.+. +..+|+|+.... ....... .+.+|+.+|.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARN----DFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHH----HHHHHHHHHhh
Confidence 3468999999999999999999752 235888886432 1222223 34899999999
Q ss_pred CCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc--------------cCCCccCHHHHH
Q 003375 550 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------------TGEKHVSVKLAL 615 (825)
Q Consensus 550 L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~--------------~~~~~ls~~~i~ 615 (825)
++||||+++++++..... .++||||+++++|.+++..... .....+++..++
T Consensus 76 l~h~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred cCCCCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 999999999999986553 4999999999999999975211 011346788999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcc
Q 003375 616 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695 (825)
Q Consensus 616 ~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~Y 695 (825)
.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++.+....... ......++..|
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~~--------~~~~~~~~~~y 206 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYYR--------IQGRAVLPIRW 206 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCceeE--------ecCcCCCCccc
Confidence 999999999999999999999999999999876 459999999997653321110 01223467899
Q ss_pred cchhhhhcccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC
Q 003375 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773 (825)
Q Consensus 696 mAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT--G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~ 773 (825)
||||++.+ ..++.++|||||||++|||++ +..||.+.+..++...+...........
T Consensus 207 ~aPE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------- 265 (304)
T cd05096 207 MAWECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV----------------- 265 (304)
T ss_pred cCHHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc-----------------
Confidence 99999876 568999999999999999987 6688887776665544432211000000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 774 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 774 ~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
........+..+.+|+.+||..||.+|||+.+|.+.|+
T Consensus 266 ---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 ---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00001123567999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.10 Aligned_cols=258 Identities=19% Similarity=0.290 Sum_probs=204.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
+...+|++.+.||+|+||.||+|.+. +..+|+|+.+.. ....... .+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRR----GFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHH----HHHHHHHHHhcCCCCCcCeEEEE
Confidence 34568999999999999999999762 457778875422 1222223 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+..... .++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|++||||||+
T Consensus 75 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ 136 (266)
T cd05064 75 ITRGNT--------------MMIVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136 (266)
T ss_pred EecCCC--------------cEEEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHh
Confidence 876553 4999999999999999975 1246899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ ..++|+|||.+......... ......++..|+|||.+.+ ..++.++|||||||
T Consensus 137 nili~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 196 (266)
T cd05064 137 KVLVNSD-------LVCKISGFRRLQEDKSEAIY---------TTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGI 196 (266)
T ss_pred hEEEcCC-------CcEEECCCcccccccccchh---------cccCCCCceeecCHHHHhh----CCccchhHHHHHHH
Confidence 9999876 56999999987653221110 0112235678999999876 67889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
++|||++ |..||.+.+..++...+..+..+..+ ...+..+.+++.+||+.+|
T Consensus 197 ~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p 249 (266)
T cd05064 197 VMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP---------------------------RNCPNLLHQLMLDCWQKER 249 (266)
T ss_pred HHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCc
Confidence 9999775 99999988887777776655332222 1134578999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003375 801 TERPTAGDLYEMFVAR 816 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l 816 (825)
.+||++.+|++.|.++
T Consensus 250 ~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 250 GERPRFSQIHSILSKM 265 (266)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.50 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=215.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|+++..||+|+||.||+|+- .+..+|+|+.+.... ....+++.. +.|-.+|....+|+||++|-.|.+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecC
Confidence 5788999999999999999999985 788899998653322 222334444 889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
..++ ||||||++||++..+|.. ...|++..++.++.+++.|++.||+.|+|||||||+|+|
T Consensus 213 ~~~L--------------YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 213 KEYL--------------YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred CCee--------------EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 8765 999999999999999987 478999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccc----------c---ccCC------------------------CCCCC
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------I---AHRG------------------------IPAPD 687 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~----------~---s~~~------------------------~~~~~ 687 (825)
||.. +++||+|||++..+........ . .... .....
T Consensus 274 iD~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 274 IDAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ecCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9988 5699999999965433111100 0 0000 00112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccc
Q 003375 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEH 766 (825)
Q Consensus 688 ~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~ 766 (825)
..+|||.|||||++.+ ..|+..+|.|||||||||||.|.+||.+.++.+.+..|.+.. .-..|.
T Consensus 347 StVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------- 411 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------- 411 (550)
T ss_pred cccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------
Confidence 4589999999999997 679999999999999999999999999999999998887652 111111
Q ss_pred cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHh
Q 003375 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVA 815 (825)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP---Sa~EIL~hL~~ 815 (825)
....+++..+||.+||. ||.+|. .++||.+|...
T Consensus 412 --------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 412 --------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred --------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 11234688999999999 999996 59999888543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=343.63 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=197.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++.+.||+|+||.||+|.+ .+..+|+|+........ ... ...+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~- 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG----EAMALNEKRILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhh----HHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-
Confidence 378899999999999999987 57889999865332111 111 1234889999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++|+|..++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 -------------~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 75 -------------LCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred -------------EEEEEEecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4999999999999988864 223468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 4599999999976532111 123468999999999986 678899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS--- 805 (825)
|+.||.+.........+......... ......+..+.+||.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKEDQE------------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhcccc------------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 99999876543222222211000000 001123567899999999999999997
Q ss_pred --HHHHHHHHH
Q 003375 806 --AGDLYEMFV 814 (825)
Q Consensus 806 --a~EIL~hL~ 814 (825)
++++++|.+
T Consensus 253 ~~~~~~~~h~~ 263 (285)
T cd05631 253 NGAAGVKQHPI 263 (285)
T ss_pred CCHHHHhcCHh
Confidence 899999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.08 Aligned_cols=282 Identities=20% Similarity=0.264 Sum_probs=199.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.. .+..+|+|+........ ... .+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG---TPF----TAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc---cch----hHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 346899999999999999999997 56789999865432111 111 237899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 76 ET--------------LTLVFEYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred Ce--------------EEEEEECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 53 499999996 689888865 23458899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||+||+
T Consensus 137 ~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 137 SDT-------GELKLADFGLARAKSVPSHT----------YSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred CCC-------CCEEECCCCcceeccCCCcc----------CCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHHH
Confidence 876 45999999998754321111 122458999999999865 2457889999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHcC-CCCCchhHHhhhc---cCcccccccc-CCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 726 LLTLQVPYMGLSEL-EIHDLIQMG-KRPRLTDELEALG---SCHEHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 726 LLTG~~PF~~~~~~-~i~~~I~~~-~~p~l~~~l~~~~---~~~~~~~~~~-~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|..||.+.... .....+... ..+. ...+.... ......+... .............++.+.+|+.+||+.|
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 275 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPN-EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCC-hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccC
Confidence 99999999876432 222222221 1111 00000000 0000000000 0000000001112457889999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003375 800 PTERPTAGDLYEMFVAR 816 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l 816 (825)
|.+|||+.|+++|-...
T Consensus 276 p~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 276 PKNRLSAQAALSHEYFS 292 (303)
T ss_pred chhccCHHHHhcCcccc
Confidence 99999999999986653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.57 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=214.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++++.||.|+||.|.+++. ++..+|+|+..... .....+.+ ...+|..+|+.+.||+|+++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-vVklKQve----H~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-VVKLKQVE----HTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-HHHHHHHH----HHhhHHHHHhhccCceeEEEEEeecc
Confidence 6789999999999999999999986 78899999964322 11122233 34899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...+ |+||||++||-|..++++ .++|++..++.++.||+.||+|||+.+|++|||||+|||
T Consensus 116 ~~~l--------------ymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 116 NSNL--------------YMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred CCeE--------------EEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 7754 999999999999999987 478999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
||.+ +.+||+|||+|+...... -+.+|||.|+|||+++. ..++.++|-|||||++|
T Consensus 177 lD~~-------G~iKitDFGFAK~v~~rT-------------~TlCGTPeYLAPEii~s----k~ynkavDWWalGVLIY 232 (355)
T KOG0616|consen 177 LDQN-------GHIKITDFGFAKRVSGRT-------------WTLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLIY 232 (355)
T ss_pred eccC-------CcEEEEeccceEEecCcE-------------EEecCCccccChHHhhc----CCCCcchhHHHHHHHHH
Confidence 9988 569999999999876532 23579999999999997 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC-
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER- 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR- 803 (825)
||+.|.+||...++.++++.|..+... +|. -.+.++.+||.++|+.|-.+|
T Consensus 233 EMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~---------------------------~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 233 EMLAGYPPFYDDNPIQIYEKILEGKVK-FPS---------------------------YFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHcCCCCCcCCChHHHHHHHHhCccc-CCc---------------------------ccCHHHHHHHHHHHhhhhHhhh
Confidence 999999999999999999999987431 121 124578999999999999999
Q ss_pred ----CCHHHHHHHHH
Q 003375 804 ----PTAGDLYEMFV 814 (825)
Q Consensus 804 ----PSa~EIL~hL~ 814 (825)
....+|..|-+
T Consensus 285 gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 285 GNLKNGVEDIKNHPW 299 (355)
T ss_pred cCcCCCccccccCcc
Confidence 34556666643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=353.38 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=206.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
...+++|++.+.||+|+||.||+|.+.+ ..+|+|++...... .....+ .+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVD----HVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHH----HHHHHHHHHHhCCCCCCcceEEEE
Confidence 3678899999999999999999998632 47899986533211 112222 348899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... .|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 101 ~~~~~--------------~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 101 KDESY--------------LYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred EeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 86653 5999999999999999976 3568999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++...... .....||+.|||||++.+ ..++.++|||||||+
T Consensus 162 ILl~~~-------~~ikL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvi 217 (340)
T PTZ00426 162 LLLDKD-------GFIKMTDFGFAKVVDTR-------------TYTLCGTPEYIAPEILLN----VGHGKAADWWTLGIF 217 (340)
T ss_pred EEECCC-------CCEEEecCCCCeecCCC-------------cceecCChhhcCHHHHhC----CCCCccccccchhhH
Confidence 999876 46999999999765321 122469999999999976 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|||++|..||.+.++..+...+..+.. .++ ...++.+.++|.+||+.||.+
T Consensus 218 l~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~dp~~ 269 (340)
T PTZ00426 218 IYEILVGCPPFYANEPLLIYQKILEGII-YFP---------------------------KFLDNNCKHLMKKLLSHDLTK 269 (340)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHcccCHHH
Confidence 9999999999998887777766665421 111 012446889999999999999
Q ss_pred CC-----CHHHHHHHHHh
Q 003375 803 RP-----TAGDLYEMFVA 815 (825)
Q Consensus 803 RP-----Sa~EIL~hL~~ 815 (825)
|+ +++++++|.+.
T Consensus 270 R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 270 RYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred cCCCCCCCHHHHHcCCCc
Confidence 95 89999999543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=350.18 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=205.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|++ .+..||+|++...... ..... ..+.+|+.++..++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEV----RHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHH----HHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 4799999999999999999998 4678999997543211 11122 234889999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 76 --------------LYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred --------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 4999999999999999975 356889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVTY-------------ANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCcccccc-------------cCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 45999999999765431 123469999999999986 57889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|..||.+.+..+....+...... ..+. . .......++.+.+||.+||..+|.+||++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------~---------~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETLQRPV------------Y---------DDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccccCCC------------C---------CccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 999999988887776665543110 0000 0 00002235678999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.++++|.+
T Consensus 252 ~~ll~h~~ 259 (333)
T cd05600 252 EDIKNHPF 259 (333)
T ss_pred HHHHhCcc
Confidence 99999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.89 Aligned_cols=255 Identities=27% Similarity=0.345 Sum_probs=219.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|..++++|+|+||.++++++ .+..+++|.+.+....... .+. ..+|+.++++++|||||.+++.|..+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~--r~~----A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE--RRS----AIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh--hHH----HHHHHHHHHhccCCCeeeeccchhcC
Confidence 367899999999999999999886 5668888887766543322 223 38999999999999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+.+ ++|||+||+||+|.+.|... ....|+++.++.|+.||+.|++|||+++|+|||||+.|||+
T Consensus 76 ~~~-------------l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 76 GQL-------------LCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred Cce-------------EEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 752 59999999999999999873 24679999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++ .|+|+|||+|+.+...... ....+||+.||.||++.+ .+|+.|+|||||||++||
T Consensus 140 tk~~-------~VkLgDfGlaK~l~~~~~~----------a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 140 TKDK-------KVKLGDFGLAKILNPEDSL----------ASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred cccC-------ceeecchhhhhhcCCchhh----------hheecCCCcccCHHHhCC----CCCCccCcchhhcchHHH
Confidence 9884 4899999999988764311 245689999999999997 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++-+++|.+.+...+...|.+.....++.. .+.++..||..||..+|..||+
T Consensus 199 m~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~---------------------------ys~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 199 MCTLKPAFKASNMSELILKINRGLYSPLPSM---------------------------YSSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred HHhcccccCccchHHHHHHHhhccCCCCCcc---------------------------ccHHHHHHHHHHhhcCCccCCC
Confidence 9999999999999999988888765444432 3568999999999999999999
Q ss_pred HHHHHHH
Q 003375 806 AGDLYEM 812 (825)
Q Consensus 806 a~EIL~h 812 (825)
+.++|.+
T Consensus 252 a~~LL~~ 258 (426)
T KOG0589|consen 252 ALELLRR 258 (426)
T ss_pred HHHHhhC
Confidence 9999987
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.53 Aligned_cols=282 Identities=19% Similarity=0.262 Sum_probs=208.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|.+.+.||+|+||.||+|++ .+..+|+|......... ... .+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APC----TAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cch----hHHHHHHHHHhCCCCCcceEEEEEee
Confidence 4678899999999999999999987 56678999865432211 111 23789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nil 136 (309)
T cd07872 76 DKS--------------LTLVFEYLD-KDLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLL 136 (309)
T ss_pred CCe--------------EEEEEeCCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 553 499999998 589988875 2345789999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 137 l~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 196 (309)
T cd07872 137 INER-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIFF 196 (309)
T ss_pred ECCC-------CCEEECccccceecCCCccc----------cccccccccccCCHHHhC---CCCCCcHHHHHHHHHHHH
Confidence 9877 45999999998754322111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC-CCCC---CchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFE---KPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~---~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|+||++||.+.+..+....+...........+........ +.... .... ........++.+.+||.+||..||
T Consensus 197 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE--FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh--hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCCh
Confidence 99999999998877666655554422222222221111000 00000 0000 001112346678999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003375 801 TERPTAGDLYEMFVAR 816 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l 816 (825)
.+|||+.|+++|.+..
T Consensus 275 ~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 275 KKRISAEEAMKHAYFR 290 (309)
T ss_pred hhCCCHHHHhcChhhh
Confidence 9999999999986654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=360.85 Aligned_cols=285 Identities=19% Similarity=0.238 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..-.+|++.+.||+|+||.||+|.. .+..||+|...... .. ..+|+.+|+.++|||||++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~----~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QY----KNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------ch----HHHHHHHHHhcCCCCCcceeeeEee
Confidence 3456899999999999999999987 56789999753211 11 1579999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .......+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 131 ~~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NIL 202 (440)
T PTZ00036 131 ECFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202 (440)
T ss_pred cccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEE
Confidence 3211 0112234689999997 588888764322 2357899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.++ ..+||+|||+++.+..... .....||+.|+|||++.+ ...++.++|||||||+||
T Consensus 203 l~~~~------~~vkL~DFGla~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 203 IDPNT------HTLKLCDFGSAKNLLAGQR-----------SVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred EcCCC------CceeeeccccchhccCCCC-----------cccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHH
Confidence 98652 3699999999986543211 123468999999999875 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC-CCC----chhhhhhHHHHHHHHHHhcccC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEK----PEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~----~~~~~~~s~~L~dLI~~CL~~D 799 (825)
||++|.+||.+.+..+....+.........+.+.... +.+...... ... ...+...++++.+||.+||.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d 338 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN----PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc----hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC
Confidence 9999999999887666555554332211122211110 000000000 000 0011124568999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 003375 800 PTERPTAGDLYEMFVA 815 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~ 815 (825)
|.+|||+.|+++|.+.
T Consensus 339 P~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 339 PLKRLNPIEALADPFF 354 (440)
T ss_pred hhHCcCHHHHhCChhH
Confidence 9999999999999663
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.76 Aligned_cols=279 Identities=22% Similarity=0.287 Sum_probs=204.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||++.+. +..+|+|+..... ... ....+.+|+.+|++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHH----HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 3578999999999999999999984 6678888865431 122 223458999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NIL 644 (825)
+. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 76 GE--------------ISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred CE--------------EEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 53 4999999999999999976 34689999999999999999999986 6999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++..+.... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 137 ~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ 193 (331)
T cd06649 137 VNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLV 193 (331)
T ss_pred EcCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHH
Confidence 9877 459999999987653211 123468999999999986 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCC---chhHHhhhccCcccc----------------ccccCCC-CCCchhhhhh
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPR---LTDELEALGSCHEHE----------------VAQSGSG-FEKPEAELET 784 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~---l~~~l~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~ 784 (825)
||++|+.||...+..++...+....... ............... ....... ..........
T Consensus 194 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
T cd06649 194 ELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVF 273 (331)
T ss_pred HHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccc
Confidence 9999999998776655544332211000 000000000000000 0000000 0000001124
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+..+.+||.+||+.||++|||+.+|++|.+-
T Consensus 274 ~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 274 TPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 6689999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.98 Aligned_cols=244 Identities=24% Similarity=0.302 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||+|+||.||+|.+ .+..+|+|+...... ....... .+.+|+.++++++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------- 67 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPEK-------- 67 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCCe--------
Confidence 79999999999998 466799998653211 1122223 34889999999999999999999876553
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 68 ------LYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred ------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 4999999999999999975 3568999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD----------KTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCCC----------ccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 4599999999875422111 1233469999999999986 6688999999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 003375 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 812 (825)
Q Consensus 736 ~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP---Sa~EIL~h 812 (825)
.+..++...+..... .++ ...++.+.+||.+||..||.+|| ++.+++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFP---------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 877776666554321 111 11345789999999999999997 57899888
Q ss_pred HH
Q 003375 813 FV 814 (825)
Q Consensus 813 L~ 814 (825)
.+
T Consensus 248 p~ 249 (312)
T cd05585 248 PF 249 (312)
T ss_pred CC
Confidence 44
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.06 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|++ .+..||+|++...... .... ...+.+|+.+|..++||||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~----~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQ----VAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhH----HHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 4799999999999999999997 5678999997532211 1112 2334889999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 76 --------------LYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred --------------EEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 4999999999999999976 346899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccc---c-------------------------CCCCCCCcccCCCcccchh
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---H-------------------------RGIPAPDVCVGTPRWMAPE 699 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s---~-------------------------~~~~~~~~~vGT~~YmAPE 699 (825)
+ +.++|+|||++..+.......... . .........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 459999999987653221100000 0 0000011246999999999
Q ss_pred hhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCc
Q 003375 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 778 (825)
Q Consensus 700 vl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 778 (825)
++.. ..++.++|||||||++|||++|..||.+.+..+....+..... ..++.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9975 6688999999999999999999999998887776666654321 11110
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 003375 779 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFV 814 (825)
Q Consensus 779 ~~~~~~s~~L~dLI~~CL~~DP~eRPS---a~EIL~hL~ 814 (825)
....++.+.+||.+||. +|.+|++ +.++++|.+
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 01235678999999996 9999997 999999854
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.78 Aligned_cols=261 Identities=26% Similarity=0.320 Sum_probs=218.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-+.|++.+.||+|.|+.||++.. .+..+|+|++..+..... ..+.+ .+|++|-+.|+||||+++.+.+...
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL----EREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHH----HHHHHHHHhcCCCcEeehhhhhccc
Confidence 346789999999999999999986 678899999766544332 44444 8999999999999999999988776
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... |||+|++.|++|..-|-. +..+++..+-..++||+.||.|+|.+||||||+||+|+|+
T Consensus 83 ~~~--------------ylvFe~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 83 SFH--------------YLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL 143 (355)
T ss_pred cee--------------EEEEecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee
Confidence 654 999999999999876655 2568889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
-...+ .--+||+|||+|..+..... -...+|||.|||||++.. .+|+..+|||+.|||||-
T Consensus 144 ASK~~----~A~vKL~~FGvAi~l~~g~~-----------~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfi 204 (355)
T KOG0033|consen 144 ASKAK----GAAVKLADFGLAIEVNDGEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYI 204 (355)
T ss_pred eeccC----CCceeecccceEEEeCCccc-----------cccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHH
Confidence 77643 34599999999988763221 244689999999999986 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+.|.+||.+.+...+++.|..+....-+. ....+++..++|+++||..||.+|+|
T Consensus 205 LL~G~~PF~~~~~~rlye~I~~g~yd~~~~------------------------~w~~is~~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 205 LLVGYPPFWDEDQHRLYEQIKAGAYDYPSP------------------------EWDTVTPEAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred HHhCCCCCCCccHHHHHHHHhccccCCCCc------------------------ccCcCCHHHHHHHHHHhccChhhhcc
Confidence 999999999999999999999884322111 12334678999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.|.|+|.+-.
T Consensus 261 a~EAL~HpWi~ 271 (355)
T KOG0033|consen 261 ADEALKHPWIC 271 (355)
T ss_pred HHHHhCCchhc
Confidence 99999997643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.55 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=197.1
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
+.||+|+||.||++.. .+..+|+|+...... ....... .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------ 69 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVA----HTLTESRVLKNTRHPFLTSLKYSFQTKDR------ 69 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCCCcceEEEEEcCCE------
Confidence 4699999999999987 577899998753321 1122223 34889999999999999999999886653
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
.||||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 70 --------LCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred --------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 4999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003375 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF 733 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDAA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCccc----------ccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 4599999999875322111 1123469999999999976 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003375 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 808 (825)
Q Consensus 734 ~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~E 808 (825)
.+.+.......+..... .++ ...+..+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFP---------------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCC---------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 88777666655543321 111 11345789999999999999997 8999
Q ss_pred HHHHHH
Q 003375 809 LYEMFV 814 (825)
Q Consensus 809 IL~hL~ 814 (825)
+++|.+
T Consensus 248 il~h~~ 253 (328)
T cd05593 248 IMRHSF 253 (328)
T ss_pred HhcCCC
Confidence 999843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.41 Aligned_cols=248 Identities=26% Similarity=0.317 Sum_probs=197.8
Q ss_pred eeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
++.||+|+||.||+++. .+..+|+|+............ ...+.+|+.+|+.++||||+++++++...+.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-- 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGGK-- 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCCe--
Confidence 36899999999999985 467899998753221111111 1234789999999999999999999886654
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.|+||||+++++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~- 136 (323)
T cd05584 75 ------------LYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ- 136 (323)
T ss_pred ------------EEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-
Confidence 4999999999999999976 3567889999999999999999999999999999999999877
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 137 ------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 137 ------GHVKLTDFGLCKESIHEGT----------VTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ------CCEEEeeCcCCeecccCCC----------cccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcC
Confidence 4599999999875422111 1123469999999999976 5678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 804 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP----- 804 (825)
+.||.+.+.......+..+.. .++ ...++.+.+||.+||+.||.+||
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~ 248 (323)
T cd05584 197 APPFTAENRKKTIDKILKGKL-NLP---------------------------PYLTPEARDLLKKLLKRNPSSRLGAGPG 248 (323)
T ss_pred CCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHcccCHhHcCCCCCC
Confidence 999998877766666654421 111 11245789999999999999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
++.++++|.+
T Consensus 249 ~~~~l~~h~~ 258 (323)
T cd05584 249 DAAEVQSHPF 258 (323)
T ss_pred CHHHHhcCCC
Confidence 8999999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=349.62 Aligned_cols=262 Identities=20% Similarity=0.218 Sum_probs=200.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.. .+..+|+|+...... .... ....+.+|+.++..++||||+++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~----~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKE----QVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhh----HHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 4789999999999999999987 567899998753211 1111 12345889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 76 --------------LYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred --------------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 4999999999999999976 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhh
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 702 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s-------------------------~~~~~~~~~~vGT~~YmAPEvl~ 702 (825)
+ +.+||+|||+++.+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 6 459999999997654211100000 00000112357999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 703 ~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
+ ..++.++|||||||+||||++|+.||.+.+..+....+.... ...++. .
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP-------------------------E 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC-------------------------c
Confidence 6 568899999999999999999999999888877777766532 111111 0
Q ss_pred hhhHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 003375 782 LETLSFLVDVFRRCTEENPT---ERPTAGDLYEM 812 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~---eRPSa~EIL~h 812 (825)
...++.+.+||.+|+. +|. .||+++||++|
T Consensus 261 ~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 261 VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 1134578889988664 444 56899999999
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=327.78 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=205.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.++||+|+||.||+|.. .+..+++|..... ....+ .+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQ----AFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHH----HHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 5678899999999999999999987 4566888874321 11223 348999999999999999999988765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+++||||||+||++
T Consensus 74 ~~--------------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili 136 (261)
T cd05072 74 EP--------------IYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136 (261)
T ss_pred CC--------------cEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence 53 49999999999999999752 23568889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 196 (261)
T cd05072 137 SES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYE 196 (261)
T ss_pred cCC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHH
Confidence 876 46999999999876432211 0122346678999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+| |..||...........+......... ...+..+.+|+.+||..+|.+||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 197 IVTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCc
Confidence 998 99999888777766666554321111 11245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
+++++++.|+.+
T Consensus 250 ~~~~i~~~l~~~ 261 (261)
T cd05072 250 TFDYLQSVLDDF 261 (261)
T ss_pred CHHHHHHHHhcC
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.99 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
+.||+|+||.||++.. .+..||+|+....... ...... .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVA----HTVTESRVLQNTRHPFLTALKYAFQTHDR------ 69 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCcceeeEEecCCE------
Confidence 4799999999999987 5678999987543211 112222 34789999999999999999999886553
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 70 --------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 4999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003375 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF 733 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCCC----------ccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 4599999999875322111 1123469999999999976 66889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 003375 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 808 (825)
Q Consensus 734 ~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~E 808 (825)
...+.......+..... .++ ...++.+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 88877766665543321 111 11355789999999999999998 8999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|-
T Consensus 248 ~l~h~ 252 (323)
T cd05595 248 VMEHR 252 (323)
T ss_pred HHcCC
Confidence 99884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.94 Aligned_cols=254 Identities=25% Similarity=0.270 Sum_probs=196.5
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
+|++.+.||+|+||.||+++. .+..+|+|+............ .+.+.+|+.++..++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKT----VEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhH----HHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999885 467899998753221111111 233488999999995 9999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EAK--------------LHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 553 4999999999999999975 356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||+||
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9877 45999999998765322111 1123469999999999975 234688999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||+||..||.... ...+...+.... +.++ ...+..+.+||.+||+.||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 9999999996432 222222222211 1111 1135578999999999999
Q ss_pred CCCC-----CHHHHHHHHH
Q 003375 801 TERP-----TAGDLYEMFV 814 (825)
Q Consensus 801 ~eRP-----Sa~EIL~hL~ 814 (825)
.+|| +++++++|.+
T Consensus 251 ~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHcCCCCCCCHHHHHcCCC
Confidence 9999 8889999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.65 Aligned_cols=265 Identities=20% Similarity=0.330 Sum_probs=203.1
Q ss_pred ceeeeeecccCceEEEEEEECCe----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
|.+.+.||+|+||.||+|.+... .+|+|..+.. .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 45778999999999999997432 5788875432 2233334444 889999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh-ccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ......++||||+.+|+|.+++.... ......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~--------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 S--------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred c--------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 1 11234699999999999999885321 12234588999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||+++.+....... ......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCccccee--------cCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 76 459999999998764322110 0122246778999999876 6688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |+.||.+....++...+..+..+..+ ...+..+.++|.+||..||.+|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQP---------------------------PDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccCcC
Confidence 99 89999888777777666654332211 112456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+|+++|+.+
T Consensus 261 ~~~l~~~l~~~ 271 (272)
T cd05075 261 FETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHhh
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=362.00 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..-.+|++.+.||+|+||.||+|++ .+..||+|++.... ........ +.+|+.++..++|+||+++++.+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHH----HHHHHHHHhcCCCCcEEEeecceec
Confidence 3457999999999999999999987 67889999875432 23333333 3889999999999999999887764
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ........++||||+++|+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 103 ~~~~------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NIL 175 (496)
T PTZ00283 103 KDPR------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175 (496)
T ss_pred cccc------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 3211 11122346899999999999999975322 2356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 176 l~~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvily 236 (496)
T PTZ00283 176 LCSN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLY 236 (496)
T ss_pred EeCC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHH
Confidence 9877 45999999999866432111 01233569999999999986 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|+.||.+.+...+...+..+..+.++. ..++.+.+|+.+||+.||.+||
T Consensus 237 eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~L~~dP~~RP 289 (496)
T PTZ00283 237 ELLTLKRPFDGENMEEVMHKTLAGRYDPLPP---------------------------SISPEMQEIVTALLSSDPKRRP 289 (496)
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCc
Confidence 9999999999888777776666553332221 1345799999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
++.++++|.
T Consensus 290 s~~ell~~p 298 (496)
T PTZ00283 290 SSSKLLNMP 298 (496)
T ss_pred CHHHHHhCH
Confidence 999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=353.08 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=201.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|+||.||+|.. .+..+|+|+...... ...... ..+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQL----AHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHH----HHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 4789999999999999999987 667899998643211 111222 345889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 76 --------------LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred --------------eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 4999999999999999975 356889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCccccccccccccc--------ccC-----------------------------CCCCCCccc
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI--------AHR-----------------------------GIPAPDVCV 690 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~--------s~~-----------------------------~~~~~~~~v 690 (825)
+ +.+||+|||+++.+......... ... ........+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 6 45999999999644221100000 000 000001246
Q ss_pred CCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCcccccc
Q 003375 691 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVA 769 (825)
Q Consensus 691 GT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~ 769 (825)
||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.+..+....+.... ...++.
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------- 271 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-------------- 271 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--------------
Confidence 9999999999976 568899999999999999999999998887776666655421 111110
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHh
Q 003375 770 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVA 815 (825)
Q Consensus 770 ~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR---PSa~EIL~hL~~ 815 (825)
....+..+.+||.+||. +|.+| +++.+++.|.+.
T Consensus 272 -----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 272 -----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred -----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence 01134578999999998 77765 599999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.99 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
....+|.+.+.||+|+||.||+|.+ .+..+++|+.... ......+ .+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHH----HHHHHHHHhCCCCChhheEEEEcC
Confidence 3456789999999999999999997 4677888875321 1223333 889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...+ ++||||+++++|.+++.. .....+++..++.++.|++.||+|||++|++||||||+|||
T Consensus 74 ~~~~--------------~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 74 EPPF--------------YIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred CCCc--------------EEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 6543 999999999999999975 22346889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~ 196 (263)
T cd05052 137 VGEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 196 (263)
T ss_pred EcCC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHH
Confidence 9876 46999999999766432211 0111234678999999876 56788999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++ |..||.+....+....+.....+..+ ...+..+.+++.+||..||.+|
T Consensus 197 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 197 EIATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccC
Confidence 9998 99999888777766666544322221 1134679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
|++.++++.|+.+
T Consensus 250 p~~~~l~~~l~~~ 262 (263)
T cd05052 250 PSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHhh
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.27 Aligned_cols=289 Identities=21% Similarity=0.258 Sum_probs=218.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC-cceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN-IV~l~g~~~~~ 565 (825)
+..|...++||+|+||+||+|+. .+..||+|..++.....+ ......+|+.+|+.|+|+| ||.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 66788899999999999999997 677899998877644211 1123389999999999999 99999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+.. .....+++|+||++ .+|..++....+.. ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 631 12335799999998 79999998743221 357778999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+...-.... ....++|..|.|||++.+ ...|+...||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlG---s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLG---STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcC---CCcCCCCcchHhHHHHHHH
Confidence 987 56999999999866532221 234478999999999997 3469999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccc--cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV--AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+++++.|.+.+..+....|......+-.+.++.......... .....................+++.+||+++|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 9999999999998887777766533222233333222221111 11100111111112222578999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
.|+..++.|-
T Consensus 294 ~Sa~~al~h~ 303 (323)
T KOG0594|consen 294 ISAKGALTHP 303 (323)
T ss_pred cCHHHHhcCh
Confidence 9999999993
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.97 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=201.0
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.++|++.+.||+|+||.||++.++. ..+|+|... ..... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~--~~~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMS---EED----FIEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecc--cCCcc---HHH----HHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 4578999999999999999999844 478888743 21111 123 3889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 74 --------------LYIVTEFMENGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred --------------EEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 4999999999999999875 1235889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 6 56999999998765322111 0112235678999999875 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+ |+.||...+..+....+..+..+..+. ..+..+.+|+.+||..+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 899998888777777776654322221 013468999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.++++.|
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.04 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=197.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHH---hhCCCCCcceeeeeEecCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iL---k~L~HPNIV~l~g~~~~~~ 566 (825)
|++.+.||+|+||.||+|.+ .+..+|+|+....... .....+ .+.+|+.++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVE----SLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 67899999999999999987 5678999997533211 111222 336666554 5677999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~--------------~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 H--------------VCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred E--------------EEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 3 5999999999999988864 4689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFGD----------RTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCCC----------cccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 77 4599999999865322111 1123569999999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 804 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-- 804 (825)
++|+.||.+.+..++...+..... .++ ...+..+.+||.+||+.||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEV-RYP---------------------------RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 999999998887777766655421 111 11245789999999999999999
Q ss_pred ---CHHHHHHHH
Q 003375 805 ---TAGDLYEMF 813 (825)
Q Consensus 805 ---Sa~EIL~hL 813 (825)
++.++++|.
T Consensus 247 ~~~~~~~l~~~~ 258 (324)
T cd05589 247 GEKDAEDVKKQP 258 (324)
T ss_pred CCCCHHHHhhCC
Confidence 689999885
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=352.16 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=208.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4578999999999999999999997 5678999986432111 11111 224789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 115 ~~~--------------~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 174 (370)
T cd05596 115 DKY--------------LYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (370)
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 654 4999999999999999875 35888999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......||+.|+|||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 175 LDKS-------GHLKLADFGTCMKMDANGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred EcCC-------CCEEEEeccceeeccCCCcc---------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 9877 46999999999765432111 1133469999999999976433345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e- 802 (825)
||++|..||.+.+....+..+..... ..++. ....+..+.+||.+||..+|.+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhcc
Confidence 99999999998887777666654321 11110 0123567899999999999998
Q ss_pred -CCCHHHHHHHHHh
Q 003375 803 -RPTAGDLYEMFVA 815 (825)
Q Consensus 803 -RPSa~EIL~hL~~ 815 (825)
||++.++++|.+-
T Consensus 294 ~R~s~~ell~h~~~ 307 (370)
T cd05596 294 GRNGVDEIKSHPFF 307 (370)
T ss_pred CCCCHHHHhcCccc
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=332.38 Aligned_cols=281 Identities=21% Similarity=0.209 Sum_probs=199.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeeeEecC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 565 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~~~~~ 565 (825)
+|++.+.||+|+||.||+|.+ ++..+|+|+.......... .. .+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~~----~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--PL----STVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC--ch----HHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 589999999999999999997 5678999986543222111 11 125677666655 699999999988643
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... .....++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RTD---------RETKVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cCC---------CCceEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 211 2235799999998 599999875 223458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCccc-----------CCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 877 4599999999976542111 123468999999999976 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|.+||.+.........+...........+..........+.. .............+..+.+||.+||++||.+|||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCC-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 999999998876665554443321111111110000000000000 0000011122345667899999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.+++.|.
T Consensus 279 ~~~~l~hp 286 (288)
T cd07863 279 AFRALQHP 286 (288)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=349.87 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
.+.++|++.+.||+|+||.||+|++ .+..||+|+.+.. . .....+ .+.+|+.+|..+ +||||+++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~----~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--A-HLTERE----ALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--c-CcHHHH----HHHHHHHHHHHhcCCcceeee
Confidence 4456899999999999999999974 2457899985422 1 112223 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 603 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 603 (825)
++++...... ++||||+++|+|.+++.....
T Consensus 105 ~~~~~~~~~~--------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (375)
T cd05104 105 LGACTVGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD 170 (375)
T ss_pred eeeeccCCcc--------------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence 9999766543 999999999999999975210
Q ss_pred -----------------------------------cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 604 -----------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 604 -----------------------------------~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~ 250 (375)
T cd05104 171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG 250 (375)
T ss_pred cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC
Confidence 011257888999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||+||||++
T Consensus 251 -------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt 311 (375)
T cd05104 251 -------RITKICDFGLARDIRNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFS 311 (375)
T ss_pred -------CcEEEecCccceeccCccccc--------ccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHh
Confidence 469999999997654322110 0112235678999999976 678899999999999999998
Q ss_pred -CCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 -LQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 -G~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|..||...... .....+..+.++..+. ..+.++.+||.+||+.||.+||++
T Consensus 312 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 312 LGSSPYPGMPVDSKFYKMIKEGYRMLSPE---------------------------CAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred cCCCCCCCCCchHHHHHHHHhCccCCCCC---------------------------CCCHHHHHHHHHHccCChhHCcCH
Confidence 89999776533 3333333332221110 124578999999999999999999
Q ss_pred HHHHHHHHhh
Q 003375 807 GDLYEMFVAR 816 (825)
Q Consensus 807 ~EIL~hL~~l 816 (825)
.+|++.|+..
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.44 Aligned_cols=264 Identities=25% Similarity=0.316 Sum_probs=206.5
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|+||.||+|.+. +..+|+|++....... .... ..+.+|+.++..++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQI----AHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHH----HHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 47999999999999999999985 7889999975332111 1122 234889999999999999999999876554
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 76 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 76 --------------LYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 4999999999999999986 256899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
+ +.+||+|||++............ ............||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 45999999999876543200000 0000011234579999999999986 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
.++.++|||||||+||||++|+.||...+.......+.... ...++. ....++.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-------------------------DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-------------------------CCCCCHH
Confidence 78999999999999999999999998888776666655421 111110 0113567
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHHH
Q 003375 788 LVDVFRRCTEENPTERPT-AGDLYEMFV 814 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPS-a~EIL~hL~ 814 (825)
+.+||.+||. ||.+||+ +.++++|.+
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 9999999997 9999999 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.27 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=205.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|.+.+.||+|+||.||+|.+ .+..+++|...... ........ +.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREE----AIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHH----HHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 588999999999999999987 56788998865432 22233333 489999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 359999999999999999862 23568899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++..+...... .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTNF----------ANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccch----------hhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 45999999998866432211 123358899999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||...+.......+..+..+.++. ..+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998888776666666554443332 12457899999999999999999999
Q ss_pred HHHH
Q 003375 809 LYEM 812 (825)
Q Consensus 809 IL~h 812 (825)
++++
T Consensus 250 ll~~ 253 (256)
T cd08529 250 LLRN 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=359.79 Aligned_cols=255 Identities=26% Similarity=0.362 Sum_probs=204.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...|.+.+.||+|+||.||+|... +..+++|..... ...... .+.+|+.+|+.++|||||++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~----~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAA----YARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHH----HHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 445999999999999999999863 456777764322 122222 347899999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. .||||||++||+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 138 ~~--------------~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll 202 (478)
T PTZ00267 138 DK--------------LLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202 (478)
T ss_pred CE--------------EEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE
Confidence 54 5999999999999999875322 23568899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 203 ~~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~e 263 (478)
T PTZ00267 203 MPT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYE 263 (478)
T ss_pred CCC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHH
Confidence 877 46999999999876432111 01233469999999999976 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||.+.+..++...+..+..+.++. ..+..+.+||.+||..||.+||+
T Consensus 264 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps 316 (478)
T PTZ00267 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPT 316 (478)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcC
Confidence 999999999888877777766554322221 12457899999999999999999
Q ss_pred HHHHHHH
Q 003375 806 AGDLYEM 812 (825)
Q Consensus 806 a~EIL~h 812 (825)
+.+++.+
T Consensus 317 ~~~~l~~ 323 (478)
T PTZ00267 317 TQQLLHT 323 (478)
T ss_pred HHHHHhC
Confidence 9999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.21 Aligned_cols=285 Identities=18% Similarity=0.219 Sum_probs=203.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||++.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAK----RAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHH----HHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 3468999999999999999999987 56789999864322 1222223 34889999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ......|+||||++ ++|...+.. .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl 155 (359)
T cd07876 92 QKSL--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155 (359)
T ss_pred CCCc--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 4422 11234699999997 577777643 4788999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 156 VKSD-------CTLKILDFGLARTACTNFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 213 (359)
T ss_pred ECCC-------CCEEEecCCCccccccCcc-----------CCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHH
Confidence 9877 4599999999975432111 123468999999999976 66889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh-------cc----CccccccccCCCC---CCchhhhhhHHHHHH
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-------GS----CHEHEVAQSGSGF---EKPEAELETLSFLVD 790 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~-------~~----~~~~~~~~~~~~~---~~~~~~~~~s~~L~d 790 (825)
+|++|+.||.+.+.......+...........+... .. .....+......+ .........+..+.+
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 999999999887665544333332111111111000 00 0000000000000 000111123467899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
||.+||..||.+|||+.|+++|.+-
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCchh
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.98 Aligned_cols=262 Identities=21% Similarity=0.343 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
.++.+|++.+.||+|+||.||+|.+ .+..+++|.... . ........ +.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~--~-~~~~~~~~----~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--I-NNPQQWGE----FQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC--C-CCHHHHHH----HHHHHHHHhhCCCCCeeeEEE
Confidence 4578899999999999999999985 335677776532 1 12222233 488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc------------cCCCccCHHHHHHHHHHHHHHHHHH
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVEL 628 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------~~~~~ls~~~i~~Ia~QIa~AL~yL 628 (825)
++..... .|+||||+++++|.+++..... .....+++..++.++.||+.||.||
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 75 VVTQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9876554 4999999999999999864211 0123578889999999999999999
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
|++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+ .
T Consensus 141 H~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYYR--------VQPKSLLPIRWMPPEAIMY----G 201 (283)
T ss_pred HhcCeehhccccceEEEcCC-------CcEEeccccccccccCCccee--------cccCCCccceecChHHhcc----C
Confidence 99999999999999999876 459999999997654321110 1122346778999999975 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
.++.++|||||||+||||++ |..||.+.....+...+.....+..+. ..+..
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 254 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE---------------------------DCPPR 254 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHH
Confidence 67899999999999999998 999998887776666665543322211 12457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+.+++.+||+.||.+||++.+|+++|.+
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 255 MYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=343.97 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=213.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-.+|++.+.||+|.||.|-+|.. .+..||||.++.... ....++-. +.+|++||..|+||||+++|.+|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvh----IRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVH----IRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHH----HHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 35799999999999999999985 678899997653332 22233333 489999999999999999999998776
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.+ .|||||..+|.|++|+.. ...+++.++..+++||+.|+.|+|+++++|||||.+|||+|
T Consensus 127 KI--------------vivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD 187 (668)
T KOG0611|consen 127 KI--------------VIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD 187 (668)
T ss_pred eE--------------EEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence 54 999999999999999987 47899999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+++ +||+|||++..+...... .+++|+|.|.+||++.+ ..+-++.+|-|||||+||-|
T Consensus 188 ~N~N-------iKIADFGLSNly~~~kfL-----------qTFCGSPLYASPEIvNG---~PY~GPEVDsWsLGvLLYtL 246 (668)
T KOG0611|consen 188 QNNN-------IKIADFGLSNLYADKKFL-----------QTFCGSPLYASPEIVNG---TPYKGPEVDSWSLGVLLYTL 246 (668)
T ss_pred CCCC-------eeeeccchhhhhccccHH-----------HHhcCCcccCCccccCC---CCCCCCccchhhHHHHHHHH
Confidence 8854 999999999877653322 45689999999999987 23457899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+.|..||.+.+...+..+|..+..-.-+ .+....-||+.||..||.+|.|+
T Consensus 247 VyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----------------------------~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 247 VYGTMPFDGRDHKRLVRQISRGAYREPE-----------------------------TPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred hhcccccCCchHHHHHHHhhcccccCCC-----------------------------CCchHHHHHHHHHhcCcccchhH
Confidence 9999999999999999999887321111 12245779999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.+|..|+|-
T Consensus 298 eDiAsHWWv 306 (668)
T KOG0611|consen 298 EDIASHWWV 306 (668)
T ss_pred HHHhhhhee
Confidence 999999874
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.07 Aligned_cols=283 Identities=17% Similarity=0.207 Sum_probs=207.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHH----HHHHHHHHHHhcCCCCccccceeeccc
Confidence 468999999999999999999987 56778999864321 1222223 338899999999999999999988654
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ......|+||||++ ++|.+++.. .++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 96 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll 159 (364)
T cd07875 96 KSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159 (364)
T ss_pred ccc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE
Confidence 321 11235699999997 588887753 47888999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||+
T Consensus 160 ~~~-------~~~kL~DfG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 217 (364)
T cd07875 160 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 217 (364)
T ss_pred CCC-------CcEEEEeCCCccccCCCCc-----------ccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHHH
Confidence 877 4599999999976533211 123468999999999986 668899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc------cccc---------cccCCCCCCchhhhhhHHHHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH------EHEV---------AQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~s~~L~d 790 (825)
|++|+.||.+.+.......+........++.+..+.... .+.+ ....... ...........+.+
T Consensus 218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d 296 (364)
T cd07875 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQARD 296 (364)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHHH
Confidence 999999999888777666665443322222221111000 0000 0000000 00111123457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
||.+||+.||.+|||+.++++|.+-
T Consensus 297 ll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 297 LLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHHhcCcCcccCCCHHHHhcCccc
Confidence 9999999999999999999999543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.74 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+.+|++.+.||+|+||.||++...+..+++|..... ...+. +.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHHH----HHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 45678999999999999999999999999999986421 11223 488999999999999999999865433
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..++||||+++++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~-------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 73 G-------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred C-------------ceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 2 25999999999999999975 2234588999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 137 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 137 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred CC-------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHH
Confidence 77 459999999987543211 11235578999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |+.||......++...+.....+..+ ...+..+.+++.+||..+|.+|||
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 193 YSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 97 99999887777766666554332221 123457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+++++|+.+
T Consensus 246 ~~~l~~~l~~~ 256 (256)
T cd05082 246 FLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcC
Confidence 99999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.21 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=209.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
...+|.+.+.||+|+||.||++.. .+..+++|... .. ...... .+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DA--SDNARK----DFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC--Cc--CHHHHH----HHHHHHHHHHhCCCCCcceEEE
Confidence 456899999999999999999985 22346666642 11 122233 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc--------cCCCccCHHHHHHHHHHHHHHHHHHHhCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKH 632 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~--------~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g 632 (825)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 75 VCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred EEecCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9886554 4999999999999999975321 11235899999999999999999999999
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
|+||||||+|||++.+ +.++|+|||++.......... ......++..|+|||++.+ ..++.
T Consensus 141 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~ 201 (288)
T cd05093 141 FVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTT 201 (288)
T ss_pred eeecccCcceEEEccC-------CcEEeccCCccccccCCceee--------cCCCCCccccccCHHHhcc----CCCCc
Confidence 9999999999999877 469999999997654321110 0122346788999999976 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003375 713 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 713 kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
++|||||||++|+|++ |..||...........+..+..+..+. ..+..+.+|
T Consensus 202 ~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~l 254 (288)
T cd05093 202 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDL 254 (288)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999998 999998888777777776654322221 124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
+.+||+.||.+|||+.++++.|+.+...+.
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=350.07 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=199.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++++.||+|+||.||+|++ .+..+|+|++..... ...... ..+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~----~~~~~E~~il~~l~h~~iv~l~~~~~~~~~- 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQV----AHVKAERDILAEADNEWVVKLYYSFQDKDN- 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHH----HHHHHHHHHHHhcCCCCeeeeEEEEecCCE-
Confidence 589999999999999999997 567899998753221 111222 344899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||||+.+
T Consensus 76 -------------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 76 -------------LYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred -------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 5999999999999999976 3568899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccc-------------------------------------cCCCCCCCcccC
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 691 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s-------------------------------------~~~~~~~~~~vG 691 (825)
+++||+|||++..+.......... ..........+|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 469999999986442111000000 000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccc
Q 003375 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQ 770 (825)
Q Consensus 692 T~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~ 770 (825)
|+.|+|||++.+ ..++.++|||||||+||||+||..||...+.......+... ....++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999976 56889999999999999999999999887766555444432 1111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHHH
Q 003375 771 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMFV 814 (825)
Q Consensus 771 ~~~~~~~~~~~~~~s~~L~dLI~~CL--~~DP~eRPSa~EIL~hL~ 814 (825)
....++++.+||.+|+ ..+|..||++.+|++|..
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 0123567889999854 556666999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=330.64 Aligned_cols=268 Identities=23% Similarity=0.340 Sum_probs=227.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
..+..|.-.+.||.|..++|-++.+ ++..+|+|++.........+...++.+.-.+|+.||+++. ||||+++.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4567888999999999999999876 6678888887665555455556677777799999999985 999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.+..+ ++|+|.|+.|-|.+||.. ...++++....|++|+..|+.|||.++||||||||+||
T Consensus 94 s~sF~--------------FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENI 154 (411)
T KOG0599|consen 94 SDAFV--------------FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENI 154 (411)
T ss_pred Ccchh--------------hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhe
Confidence 88765 999999999999999987 46799999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGC 721 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~--~~~~~s~kSDVWSLGv 721 (825)
|++.+. .+||+|||+|..+...... ...+|||+|.|||.+.... +...|+...|+||+||
T Consensus 155 Llddn~-------~i~isDFGFa~~l~~GekL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 155 LLDDNM-------NIKISDFGFACQLEPGEKL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred eecccc-------ceEEeccceeeccCCchhH-----------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 999884 4999999999888654322 3457999999999997643 2346889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|||.|+.|.+||......-++..|..+....-.. .+.+.+...++||.+||+.||.
T Consensus 217 ImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp------------------------eWadis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP------------------------EWADISATVKDLISRLLQVDPT 272 (411)
T ss_pred HHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc------------------------chhhccccHHHHHHHHHeeCch
Confidence 9999999999998888888888888886533222 2234567899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|.|++|+|+|...
T Consensus 273 ~Ritake~LaHpff 286 (411)
T KOG0599|consen 273 KRITAKEALAHPFF 286 (411)
T ss_pred hcccHHHHhcChHH
Confidence 99999999999766
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.08 Aligned_cols=262 Identities=19% Similarity=0.304 Sum_probs=204.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|.+ .+. .+|+|+.... ......+ .+.+|+.+++.++||||++++|
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANK----EILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHH----HHHHHHHHHHhCCCCCCCeEEE
Confidence 3456799999999999999999986 233 3788875321 1222223 3488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.... .++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 77 ~~~~~~---------------~~~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp 137 (316)
T cd05108 77 ICLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA 137 (316)
T ss_pred EEcCCC---------------ceeeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 987532 3899999999999999985 234588899999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ ..+||+|||+++.+....... ......++..|+|||++.+ ..++.++||||||
T Consensus 138 ~Nill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG 198 (316)
T cd05108 138 RNVLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYG 198 (316)
T ss_pred hheEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHH
Confidence 99999876 459999999998765322110 0111234678999999976 6688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+....++...+........+ ...+..+.+++.+||..+
T Consensus 199 v~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~ 251 (316)
T cd05108 199 VTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMID 251 (316)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHccCC
Confidence 99999998 99999887776665555444322111 112346899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 003375 800 PTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~sss 820 (825)
|.+||++.+++.+|..+....
T Consensus 252 p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 252 ADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred hhhCcCHHHHHHHHHHHHcCC
Confidence 999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=330.51 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=197.8
Q ss_pred eeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.+.+.||.|+||.||+|.+. +..|+||+... .......+.+ .+|+.++++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceee----eecccccccccccccccccccccccc
Confidence 57889999999999999987 67888888632 2233334444 89999999999999999999998544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++|+|.++|... ....+++..++.|+.||+.||.|||+++|+|++|+++|||++
T Consensus 75 ~--------------~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 P--------------LFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp S--------------EEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred c--------------cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 3 49999999999999999872 235789999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++........... .........|+|||.+.. ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKYKN--------DSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSEEE--------STTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------cccccccccccccccccccccc--------cccccccccccccccccc----ccccccccccccccccccc
Confidence 87 5699999999987632211100 122346789999999987 5589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |+.||...+..++...+..+.++..+. ..+..+.+||.+||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT---------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceecc---------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 99 789999888888888886665433332 12457899999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.+|++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.34 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=205.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|+. .+..+|+|....... ....... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQ----DCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHH----HHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 46899999999999999999987 678899997643221 1222223 3488999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+|||++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 E--------------LNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 3 4999999999999999875322 235588999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|||
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhHH----------HhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999998766432211 122358899999999976 5578899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~--~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|+.||.... .......+.....+..+ ....+..+.+|+.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLP--------------------------TEHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCC--------------------------hhhcCHHHHHHHHHHCCCCcccCc
Confidence 99999996543 23444444433322221 012345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
++.+|++.|+.+.
T Consensus 254 ~~~~vl~~~~~~~ 266 (267)
T cd08228 254 DIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.14 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=206.3
Q ss_pred ceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
|.+.+.||+|+||.||+|... ...+|+|+.... .........+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 578899999999999999863 256899986532 2223333444 89999999999999999999877544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ......++||||+++++|..++..... .....+++..++.++.||+.||.|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 112346999999999999999865321 123468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ ..+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeecccccccc--------ccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 876 469999999998664322110 0112235678999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||.+....++...+..+..+..+. ..+..+.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQPE---------------------------DCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------CCCHHHHHHHHHHcCCChhhCc
Confidence 999 999998888777776666554332221 1345799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.+++++|+.+
T Consensus 261 ~~~e~~~~l~~~ 272 (273)
T cd05035 261 TFTKLREVLENI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.02 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=206.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
...+|.+.+.||+|+||.||+|.+. ...+|+|+.... ...+..+ .+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARK----DFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHH----HHHHHHHHHHhcCCCCchheee
Confidence 3567899999999999999999862 357888885422 1122223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh---------ccCCCccCHHHHHHHHHHHHHHHHHHHhC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGEKHVSVKLALFIAQDVAAALVELHSK 631 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---------~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~ 631 (825)
++..... .++||||+++++|.+++.... ......+++..+..++.||+.||.|||++
T Consensus 76 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 76 VCTEGDP--------------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred EEecCCC--------------eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 9886543 499999999999999997531 11224578899999999999999999999
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s 711 (825)
||+||||||+|||++.+ +.++|+|||++......... .......+++.|+|||++.+ ..++
T Consensus 142 ~i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05049 142 HFVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFT 202 (280)
T ss_pred CeeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcc
Confidence 99999999999999877 56999999998755322110 00122346789999999976 6688
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 712 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 712 ~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
.++|||||||++|||++ |..||.+.+.......+..+..+..+. ..+..+.+
T Consensus 203 ~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 255 (280)
T cd05049 203 TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR---------------------------TCPSEVYD 255 (280)
T ss_pred hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHH
Confidence 99999999999999998 999998888777777766543322211 12457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
|+.+||..||.+||++.||++.|++
T Consensus 256 li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=334.79 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=202.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..|++|++.+.||+|+||.||+|.+. +..++++++.++.. ........ +.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~----~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRD----FAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHH----HHHHHHHHHHhcCCCCcceEEEEEC
Confidence 67889999999999999999999873 34444444433322 12222333 48899999999 7999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHHHHhCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKH 632 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g 632 (825)
..... |+||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 79 ~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 79 HRGYL--------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred CCCCc--------------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 66543 999999999999999975211 11235789999999999999999999999
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
|+||||||+|||++.+ ..+||+|||++........ .....++..|+|||++.+ ..++.
T Consensus 145 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 202 (303)
T cd05088 145 FIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 202 (303)
T ss_pred ccccccchheEEecCC-------CcEEeCccccCcccchhhh-----------cccCCCcccccCHHHHhc----cCCcc
Confidence 9999999999999876 4599999999864321100 111234678999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003375 713 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 713 kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
++|||||||++|||+| |..||.+.+..+....+.....+..+ ...+..+.+|
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 255 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDL 255 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999887776665554433211111 1124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+.+||+.+|.+||++.+++.+|+.+..
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=341.87 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=198.4
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCC-CcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HP-NIV~l~g~~~~~~~ 567 (825)
+|++.+.||+|+||.||+|.+. +..+|+|++...... .....+ .+..|+.++..+.|+ +|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVE----CTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 5899999999999999999974 467999987543211 112223 337899999999765 57888888876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 5999999999999999975 356889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 4599999999864321111 1123469999999999986 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa- 806 (825)
||+.||.+.+..++...+..... .++ ...+..+.+|+.+||..||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998888777766654321 111 1124578999999999999999976
Q ss_pred ----HHHHHHH
Q 003375 807 ----GDLYEMF 813 (825)
Q Consensus 807 ----~EIL~hL 813 (825)
.++++|.
T Consensus 248 ~~~~~~~~~hp 258 (324)
T cd05587 248 PTGERDIREHA 258 (324)
T ss_pred CCCHHHHhcCC
Confidence 7888773
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=369.35 Aligned_cols=269 Identities=25% Similarity=0.360 Sum_probs=222.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
++..+.++.+.||+|+||.||+|+. ...-||||. ++... .... ++.|.+|+++|..|+|||||+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~--LKd~a-~~~~----~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKA--LKDKA-ENQA----RQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhh--hcccc-cHHH----HHHHHHHHHHHHhccCCCeEEEE
Confidence 4556778899999999999999985 234566665 44322 1223 33459999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccC---------CCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------EKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~---------~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
|+|...+.+ ++|+|||..|+|.+||....... ..+++..+.+.|+.|||.||.||-+
T Consensus 556 GVC~~~~P~--------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 556 GVCREGDPL--------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred EEEccCCee--------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999987765 99999999999999998754322 2338899999999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~ 710 (825)
+.+|||||-..|+||.++ .+|||+|||+++.+-....... .....-..+|||||.++. +.|
T Consensus 622 ~~FVHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYYk~--------~~~t~lPIRWMppEsIly----~kF 682 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYYKV--------RGNTLLPIRWMPPESILY----GKF 682 (774)
T ss_pred Ccccccchhhhhceeccc-------eEEEecccccchhhhhhhhhcc--------cCCceeeeecCCHHHhhc----Ccc
Confidence 999999999999999987 7899999999987755433211 011234679999999996 889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003375 711 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 789 (825)
Q Consensus 711 s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 789 (825)
+.+||||||||+|||+++ |..||.+.+..++++.|..+....-+ ..++..++
T Consensus 683 TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY 735 (774)
T KOG1026|consen 683 TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVY 735 (774)
T ss_pred cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHH
Confidence 999999999999999998 99999999999999999988643333 23577899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFVARTSSSIS 822 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~S 822 (825)
+||..||+.+|.+||++.||-..|+.....+.-
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999999999999999999999998877653
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.84 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=198.1
Q ss_pred eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 497 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+||+|+||.||+|.+ .+..+|+|+.... ....... +.+.+|+.+++.+.||||+++++++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALK----DELLREANVMQQLDNPYIVRMIGICEAES------ 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCC------
Confidence 689999999999975 4577899985422 2222223 34489999999999999999999875322
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||.|||++.+
T Consensus 70 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 70 ---------WMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred ---------cEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 3899999999999999975 3468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 731 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~ 731 (825)
..+||+|||++........... ......++..|+|||.+.. ..++.++|||||||++|||++ |..
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYYK-------AKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCeee-------ecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 4699999999987643221100 0112235679999999865 567889999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003375 732 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811 (825)
Q Consensus 732 PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~ 811 (825)
||.......+...+..+..+.++. ..+..+.+||.+||+.||.+||++.+|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998888777777776654433321 13457899999999999999999999999
Q ss_pred HHHh
Q 003375 812 MFVA 815 (825)
Q Consensus 812 hL~~ 815 (825)
.|+.
T Consensus 251 ~l~~ 254 (257)
T cd05116 251 RLRN 254 (257)
T ss_pred HHhc
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.22 Aligned_cols=285 Identities=19% Similarity=0.205 Sum_probs=206.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.+ .+..||+|.... ........+ ++.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN--VFQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccc--cccchHHHH----HHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478899999999999999996 577899997532 112222223 348999999999999999999998754411
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 75 ---------PFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ---------ccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 1235699999997 689888864 3568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||+++........ ......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 46999999999765322111 1122358899999999875 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+.||.+.++.+....+...........+................... ........++.+.+||.+||+.||.+||
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 999999888777666665432211112211110000000000000000 0011122356789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.++++|.+-
T Consensus 281 t~~e~l~hp~~ 291 (372)
T cd07853 281 SAADALAHPYL 291 (372)
T ss_pred CHHHHhcCHhh
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.97 Aligned_cols=267 Identities=22% Similarity=0.344 Sum_probs=209.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
..+.+|.+.+.||+|+||.||+|.+. ...+++|... . ......+ .+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--D--PTLAARK----DFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC--C--ccHHHHH----HHHHHHHHHhcCCCCCcceEE
Confidence 34678999999999999999999852 2346666542 1 1122223 348999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVEL 628 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~yL 628 (825)
+++..... .++||||+++++|.+++..... .....+++..++.++.||+.||+||
T Consensus 74 ~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 139 (291)
T cd05094 74 GVCGDGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 139 (291)
T ss_pred EEEccCCc--------------eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 99876543 4999999999999999975211 1123588999999999999999999
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
|++||+||||||+|||++.+ +.++|+|||++.......... ......++..|+|||++.+ .
T Consensus 140 H~~~i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 200 (291)
T cd05094 140 ASQHFVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----R 200 (291)
T ss_pred HhCCeeecccCcceEEEccC-------CcEEECCCCcccccCCCceee--------cCCCCCcceeecChHHhcc----C
Confidence 99999999999999999877 469999999997654322110 0123357889999999876 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
.++.++|||||||++|||+| |..||...+..+....+..+..+..+. ..+..
T Consensus 201 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 253 (291)
T cd05094 201 KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR---------------------------VCPKE 253 (291)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCc---------------------------cCCHH
Confidence 67889999999999999999 999998887777666665543322211 12457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
+.+|+.+||+.+|.+||++.+|++.|+.+..+.+
T Consensus 254 ~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 254 VYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 8999999999999999999999999999977654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.39 Aligned_cols=283 Identities=17% Similarity=0.218 Sum_probs=204.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..+|+|+.... ......... +.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc--ccChHHHHH----HHHHHHHHHHhCCCchhceeeeeec
Confidence 3568999999999999999999986 5677888875422 222222233 3789999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ......|+||||++ ++|.+++.. .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nil 151 (355)
T cd07874 88 QKSL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_pred cccc--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence 4322 12235699999997 578777753 4788999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 152 l~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 209 (355)
T cd07874 152 VKSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 209 (355)
T ss_pred ECCC-------CCEEEeeCcccccCCCccc-----------cCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHH
Confidence 9876 4599999999976533211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccC------cccccc---------ccCCCCCCchhhhhhHHHHH
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC------HEHEVA---------QSGSGFEKPEAELETLSFLV 789 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~s~~L~ 789 (825)
+|++|+.||.+.+.......+........++.+...... ..+.+. +..... ...........+.
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 288 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQAR 288 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccc-ccccccccchHHH
Confidence 999999999887766554444332221122111111000 000000 000000 0111122346789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
+||.+||..||.+|||+.|+++|.+
T Consensus 289 ~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 289 DLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHHHHHhcCCchhcCCHHHHhcCcc
Confidence 9999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=345.29 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
+.||+|+||.||++.. .+..+|+|+....... ...... .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~----~~~~e~~~l~~~~hp~i~~~~~~~~~~~~------ 69 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQTHDR------ 69 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCCCCceEEEEEcCCE------
Confidence 4699999999999987 5678999987533211 112222 33789999999999999999999876553
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEecCccCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.||||||+++|+|..++.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 70 --------~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 70 --------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred --------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 5999999999999998875 3568999999999999999999997 799999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCcc----------cccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 45999999998753221111 123469999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 807 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~ 807 (825)
|.+.+.......+..... .++ ...++.+.+||.+||+.||.+|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 988877766665544321 111 11245789999999999999996 999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
++++|.+
T Consensus 248 ~il~h~~ 254 (325)
T cd05594 248 EIMQHKF 254 (325)
T ss_pred HHhcCCC
Confidence 9998844
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=359.44 Aligned_cols=254 Identities=28% Similarity=0.363 Sum_probs=213.3
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeE
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~ 562 (825)
...+++|.++++||+|+||.|+++.. ++..+|||+.+... -...++++.. +.|.+|+.... ||.++.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~-Il~~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGD-ILQRDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccc-eeccccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 56789999999999999999999997 56789999975433 3344555555 88888888775 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.+..++ |+||||+.||++..+++ ...|++..+..++..|+.||.|||++|||+||||.+|
T Consensus 439 QT~~~l--------------~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKEHL--------------FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCCeE--------------EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 987754 99999999999555444 3679999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||||.+ +.+||+|||+++....... .+.++.|||.|||||++.+ ..|+.++|-|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~g~----------~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQGD----------RTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCCCC----------ccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999998 5699999999986532111 2466789999999999997 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||||.|+.||.+.+..++++.|..... .+| ...+.+..+||+++|..||++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~-~yP---------------------------~~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEV-RYP---------------------------RFLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCC---------------------------CcccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999987632 122 123568899999999999999
Q ss_pred CCC-----HHHHHHHH
Q 003375 803 RPT-----AGDLYEMF 813 (825)
Q Consensus 803 RPS-----a~EIL~hL 813 (825)
|.. +.+|.+|.
T Consensus 610 RLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHP 625 (694)
T ss_pred ccCCCCCCchhhhhCC
Confidence 974 57777763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.43 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
.+.++|++.+.||+|+||.||+|.+. ...||+|+..... ...... .+.+|+.+++.+ +|||||++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDERE----ALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHH----HHHHHHHHHHhhccCCceeeE
Confidence 45668999999999999999999852 2368888864321 122223 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 603 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 603 (825)
++++..... .++||||+++|+|.+++.....
T Consensus 108 ~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (374)
T cd05106 108 LGACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF 173 (374)
T ss_pred eeEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence 999876654 4999999999999999865211
Q ss_pred ------------------------------cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 604 ------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 604 ------------------------------~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
.....+++..++.|+.||+.||.|||++||+||||||+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~----- 248 (374)
T cd05106 174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG----- 248 (374)
T ss_pred cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-----
Confidence 011347888999999999999999999999999999999999876
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003375 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 732 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~P 732 (825)
.++||+|||+++........ .......+++.|||||++.. ..++.++|||||||++|||++ |+.|
T Consensus 249 --~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~P 314 (374)
T cd05106 249 --RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSP 314 (374)
T ss_pred --CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 56999999999765432111 00122235678999999975 668999999999999999997 9999
Q ss_pred CCCCCHHHHHHH-HHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003375 733 YMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811 (825)
Q Consensus 733 F~~~~~~~i~~~-I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~ 811 (825)
|........... +.....+..+ ...++.+.+|+.+||+.||.+|||+.+|++
T Consensus 315 f~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 315 YPGILVNSKFYKMVKRGYQMSRP---------------------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CccccccHHHHHHHHcccCccCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 977654333222 2222211111 012457999999999999999999999999
Q ss_pred HHHhhc
Q 003375 812 MFVART 817 (825)
Q Consensus 812 hL~~l~ 817 (825)
.|+++.
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.79 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=200.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|++.+.||+|+||.||+|+. .+..+|+|++..... ........+.+|+.+|+.++||||+++++.+...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 3699999999999999999997 467899998642211 011112344889999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 76 --------------LYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred --------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 4999999999999999976 356889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCccccccccccccc---------------------------------ccCCCCCCCcccCCCc
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---------------------------------AHRGIPAPDVCVGTPR 694 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~---------------------------------s~~~~~~~~~~vGT~~ 694 (825)
+ +.+||+|||+|..+......... ...........+||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 46999999998543211000000 0000001123579999
Q ss_pred ccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCC
Q 003375 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGS 773 (825)
Q Consensus 695 YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~ 773 (825)
|||||++.+ ..++.++|||||||+||||++|+.||.+.+..+....+..... ..++
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------- 266 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIP------------------- 266 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCC-------------------
Confidence 999999976 6678999999999999999999999988877665555443211 0000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 003375 774 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFV 814 (825)
Q Consensus 774 ~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP---Sa~EIL~hL~ 814 (825)
.....+..+.+||.+|+ .+|.+|+ ++.++++|.+
T Consensus 267 ------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 267 ------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred ------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 00123557888999977 5999999 9999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.30 Aligned_cols=260 Identities=21% Similarity=0.345 Sum_probs=202.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
-++|++.+.||+|+||.||+|.+. +..+|+|+... . ....... .+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~--~-~~~~~~~----~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE--A-ASMRERI----EFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc--c-CCHHHHH----HHHHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999863 34688887431 1 1112222 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----CCCccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHr 636 (825)
+..... .++||||+++++|.+++...... ....+++..+..++.|++.||.|||+.|++|+
T Consensus 78 ~~~~~~--------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~ 143 (277)
T cd05062 78 VSQGQP--------------TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR 143 (277)
T ss_pred EcCCCC--------------eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 875543 49999999999999999763211 11346788899999999999999999999999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
||||+|||++.+ +.++|+|||++.......... ......+++.|||||++.+ ..++.++||
T Consensus 144 dlkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05062 144 DLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDV 204 (277)
T ss_pred CcchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHH
Confidence 999999999876 459999999987654322110 0111246788999999976 668899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003375 717 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795 (825)
Q Consensus 717 WSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~C 795 (825)
|||||++|||++ |..||.+.........+.....+.++. ..+..+.+|+.+|
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRMC 257 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999999 789998887777666665543322221 1245789999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 003375 796 TEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 796 L~~DP~eRPSa~EIL~hL~~ 815 (825)
|+.||.+|||+.+++++|+.
T Consensus 258 l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 258 WQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCChhhCcCHHHHHHHhhC
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.56 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=203.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
...++|.+.+.||+|+||.||+|.+.. ..+++|.. .... ....... +.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~--~~~~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESC-SEQDESD----FLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEc--CCCC-CHHHHHH----HHHHHHHHHhCCCCCEeeEE
Confidence 456789999999999999999999854 45566653 2221 1222223 48899999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc--CCCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
+++...... ++||||++|++|.+++...... ....+++..++.++.||+.||+|||+++++|||
T Consensus 76 ~~~~~~~~~--------------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d 141 (277)
T cd05036 76 GVSFERLPR--------------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRD 141 (277)
T ss_pred EEEccCCCc--------------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 988765543 9999999999999999763211 113588999999999999999999999999999
Q ss_pred CCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003375 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717 (825)
Q Consensus 638 LKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVW 717 (825)
|||+|||++..+. ...+||+|||+++.+....... .......+..|+|||++.+ ..++.++|||
T Consensus 142 lkp~nil~~~~~~----~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw 205 (277)
T cd05036 142 IAARNCLLTCKGP----GRVAKIADFGMARDIYRASYYR--------KGGRAMLPIKWMPPEAFLD----GIFTSKTDVW 205 (277)
T ss_pred cchheEEEeccCC----CcceEeccCccccccCCcccee--------cCCCCCccHhhCCHHHHhc----CCcCchhHHH
Confidence 9999999986531 2469999999998763221110 0111234568999999976 5689999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 718 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 718 SLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||||++|||++ |..||.+.+...+...+.....+..+ ...+..+.+++.+||
T Consensus 206 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl 258 (277)
T cd05036 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 99999999997 99999888777766655544322211 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 003375 797 EENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~ 815 (825)
+.+|.+||++.+|+++|+.
T Consensus 259 ~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 259 QHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCcccCcCHHHHHHHhhC
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=342.39 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|+....... .....+ .+..|+.++..+ +||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~----- 70 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVE----CTMTEKRILSLARNHPFLTQLYCCFQTPDR----- 70 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHH----HHHHHHHHHHhccCCCchhceeeEEEcCCE-----
Confidence 4799999999999997 4678999987533211 112222 337888888877 59999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
+|+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 71 ---------LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred ---------EEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 5999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNGK----------TTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCCC----------cccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 4599999999875322111 1123469999999999976 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 806 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa------ 806 (825)
|.+.+..++...+..... .++ ...+..+.+||.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEV-VYP---------------------------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 998888877777665421 111 0124578999999999999999998
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
++++.|.+
T Consensus 248 ~~~~~h~~ 255 (320)
T cd05590 248 EAILRHPF 255 (320)
T ss_pred HHHHcCCC
Confidence 88888843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.96 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=204.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
.++|++.+.||+|+||.||+|.+. ...+++|+.... ........ +.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLD----FLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHH----HHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999873 346788875322 12222233 488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+|+||||+||
T Consensus 76 ~~~~--------------~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSRP--------------VMIITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCCc--------------eEEEEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 6553 4999999999999999975 124689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ ..++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99877 459999999998775211110 0111235678999999876 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++ |..||.......+...+........+ ...+..+.+|+.+||+.+|.+
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999888777777666654332211 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
||++.+|+++|.++
T Consensus 252 Rp~~~ei~~~l~~~ 265 (266)
T cd05033 252 RPTFSQIVSTLDKM 265 (266)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.89 Aligned_cols=281 Identities=19% Similarity=0.235 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||.|+||.||+|.+ .+..||+|.+........ . ..+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---~----~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA---P----CTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc---h----hHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 5688999999999999999999987 467889998654322111 1 123789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 76 ~~~--------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil 136 (301)
T cd07873 76 EKS--------------LTLVFEYLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLL 136 (301)
T ss_pred CCe--------------EEEEEeccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEE
Confidence 553 499999997 699998875 2346889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 137 INER-------GELKLADFGLARAKSIPTKT----------YSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFY 196 (301)
T ss_pred ECCC-------CcEEECcCcchhccCCCCCc----------ccccceeecccCcHHHhC---CCCCccHHHHHHHHHHHH
Confidence 9877 45999999998754322111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC-CC---CchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FE---KPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~---~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||+||++||.+.+..+....+...........+....... .+...... .. ........++.+.+||.+||+.||
T Consensus 197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 274 (301)
T cd07873 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE--EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEG 274 (301)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc--cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCc
Confidence 9999999998887766555554432222222221110000 00000000 00 011122346678999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 003375 801 TERPTAGDLYEMFVA 815 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~ 815 (825)
.+|||+.|+++|.+.
T Consensus 275 ~~R~t~~eil~h~~f 289 (301)
T cd07873 275 RKRISAEEAMKHPYF 289 (301)
T ss_pred ccCcCHHHHhcCccc
Confidence 999999999998553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.23 Aligned_cols=245 Identities=26% Similarity=0.312 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~-iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|++........ ... ..+..|.. +++.++||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~----~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~----- 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQ----KHIMAERNVLLKNVKHPFLVGLHYSFQTADK----- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHH----HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-----
Confidence 4799999999999998 577899998753321111 111 22255554 5678999999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 71 ---------LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred ---------EEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHSK----------TTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCCC----------ccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 4599999999865322111 1223469999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 808 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa----~E 808 (825)
|.+.+..++...+...... ++ ...+..+.+||.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9988877777666544211 11 1124578999999999999999987 57
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 248 il~~~ 252 (323)
T cd05575 248 IKNHV 252 (323)
T ss_pred HHcCC
Confidence 77764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=341.51 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+. +..+|+|++...... .....+ .+..|..++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~i~~~~~~~~~~~~----- 70 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVD----CTMTEKRILALAAKHPFLTALHCCFQTKDR----- 70 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCCe-----
Confidence 46999999999999984 568999987533211 112222 237788888876 69999999999986654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 71 ---------LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 4999999999999999875 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNGV----------TTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCCc----------cccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 4599999999875422111 1123468999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 805 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-------S 805 (825)
|.+.+.......+...... ++ ...+..+.+||.+||+.||.+|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~p---------------------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVL-YP---------------------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 9998888777776654211 11 01245789999999999999999 8
Q ss_pred HHHHHHHHH
Q 003375 806 AGDLYEMFV 814 (825)
Q Consensus 806 a~EIL~hL~ 814 (825)
+.++++|.+
T Consensus 248 ~~~~~~hp~ 256 (321)
T cd05591 248 EDAIKQHPF 256 (321)
T ss_pred HHHHhcCCc
Confidence 999998853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=340.53 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=198.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
+|.+.+.||+|+||.||+|.+ .+..+|+|+...... ......+ .+..|..++..+. ||+|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 588999999999999999987 456899998753321 1112222 2367888888774 8999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 76 --------------LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 4999999999999999875 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCCC----------ccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 4599999999875432111 1123469999999999986 66899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa- 806 (825)
||+.||.+.+...+...+..... .++ ...+..+.+|+.+||+.||.+|+++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNV-AYP---------------------------KSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------CcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 99999998888777776665421 111 1124578999999999999999974
Q ss_pred ----HHHHHH
Q 003375 807 ----GDLYEM 812 (825)
Q Consensus 807 ----~EIL~h 812 (825)
.++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05616 248 PEGERDIKEH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 788776
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=349.13 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=200.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++++.||+|+||.||+|+. .+..+|+|+...... ........+.+|+.+++.++||||+++++.+.....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~- 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN- 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-
Confidence 589999999999999999997 567789998643211 111222345899999999999999999999986654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 76 -------------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 76 -------------LYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred -------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 4999999999999999975 2468899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCccccccccccccc-------------------------------------ccCCCCCCCcccC
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 691 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------------------------s~~~~~~~~~~vG 691 (825)
+.+||+|||++..+......... ...........+|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 46999999998643211000000 0000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccc
Q 003375 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQ 770 (825)
Q Consensus 692 T~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~ 770 (825)
|+.|+|||++.+ ..++.++|||||||+||||++|++||.+.++.+....+.... ...++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999976 568899999999999999999999999887766655554321 111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 003375 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFV 814 (825)
Q Consensus 771 ~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS---a~EIL~hL~ 814 (825)
....++.+.+||.+|+ .+|.+|++ +.++++|..
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 0123557888998876 59999987 999999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.94 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=201.8
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..+|++.+.||+|+||.||++.+.+ ..+|+|..... ... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDE----FIEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--ccc---HHH----HHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 4578999999999999999998754 45888875422 111 123 3889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||||.|||++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3999999999999999975 1236899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 6 46999999998765332111 0112235678999999976 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+ |..||...+...+...+..+.++..+. ..+..+.+++.+||+.+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 8 999998887777777666554332221 124578999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.+|++.|+
T Consensus 249 ~~ll~~~~ 256 (256)
T cd05113 249 QQLLSSIE 256 (256)
T ss_pred HHHHHhhC
Confidence 99998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.33 Aligned_cols=270 Identities=26% Similarity=0.339 Sum_probs=202.5
Q ss_pred CCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
++|.-...||+|+||.||+|...+ ..||||.. ....... ..+| .+|+.++.+++|||||+++|||.+.+.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~--~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRL--SSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEe--cCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 567777899999999999999865 78999953 3322221 2335 999999999999999999999987652
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEE
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 645 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~---gIVHrDLKP~NILL 645 (825)
+.+||+||+++|+|.++|... ... .++|..+++|+.++|+||+|||.. .||||||||+||||
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 249999999999999999861 111 789999999999999999999996 49999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccc-cccccccccCCCCCCCcc-cCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~s~~~~~~~~~~-vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|.+ +.+||+|||+|+.... .... ... .||.+|+|||++.. +..+.|+|||||||+|
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 987 6699999999966543 1111 111 69999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhh-hhHHHHHHHHHHhccc
Q 003375 724 LELLTLQVPYMGLS---ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVFRRCTEE 798 (825)
Q Consensus 724 yELLTG~~PF~~~~---~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~L~dLI~~CL~~ 798 (825)
.||+||+.|..... ...+....... ....+. .+.+..... ..... .....+..+..+|++.
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~------------eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~ 334 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR------------EIVDPRLKE--GEYPDEKEVKKLAELALRCLRP 334 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh------------heeCCCccC--CCCChHHHHHHHHHHHHHHcCc
Confidence 99999998876432 11122221110 000111 122222110 01111 4556688999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 003375 799 NPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ss 819 (825)
+|.+||++.+|++.|+.+...
T Consensus 335 ~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 335 DPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCcCcCHHHHHHHHHhhccc
Confidence 999999999999999776544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.19 Aligned_cols=262 Identities=29% Similarity=0.355 Sum_probs=219.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
.-..|++.+.||+|.||.||+++. ++..+|+|++..+..... ...+ .+.+|+.+|++|. |||||.++++|.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~----~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDRE----DVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHH----HHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 345789999999999999999997 578899999754433222 2223 3489999999999 9999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...+ ++|||+|.||.|.+.|... .+++..+..++.||+.|+.|||+.||+||||||+|+|
T Consensus 108 ~~~~--------------~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 108 PDSV--------------YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred CCeE--------------EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 7754 9999999999999999872 3999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
+....+ +...+|++|||++........ ....+||+.|+|||++.. ..|+..+||||+||++|
T Consensus 168 ~~~~~~---~~~~ik~~DFGla~~~~~~~~-----------~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~y 229 (382)
T KOG0032|consen 168 LASKDE---GSGRIKLIDFGLAKFIKPGER-----------LHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILY 229 (382)
T ss_pred eccccC---CCCcEEEeeCCCceEccCCce-----------EeeecCCccccCchhhcC----CCCCcccchhHHHHHHH
Confidence 987632 235799999999988765211 245689999999999986 68999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
.|++|.+||.+.+.......+..+..... .+.+..++..+.++|.+||..||.+|+
T Consensus 230 iLL~G~~PF~~~~~~~~~~~i~~~~~~f~------------------------~~~w~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 230 ILLSGVPPFWGETEFEIFLAILRGDFDFT------------------------SEPWDDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred HHhhCCCCCcCCChhHHHHHHHcCCCCCC------------------------CCCccccCHHHHHHHHHhcccCcccCC
Confidence 99999999999998888888877744211 112234467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.++|+|.|-.
T Consensus 286 ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 286 TAAQALQHPWIK 297 (382)
T ss_pred CHHHHhcCcccc
Confidence 999999997643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=348.53 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=206.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||++.+ .+..+|+|+...... ....... .+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSA----FFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHH----HHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3457899999999999999999998 467899998643211 1111222 34789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~~--------------~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NIL 174 (370)
T cd05621 115 DKY--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174 (370)
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 654 4999999999999999975 35889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......||+.|||||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ily 238 (370)
T cd05621 175 LDKH-------GHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238 (370)
T ss_pred ECCC-------CCEEEEecccceecccCCce---------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHH
Confidence 9877 45999999999865432111 1134569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e- 802 (825)
||++|+.||.+.+.......+.... ...++. ....+..+.+|+.+||..++.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (370)
T cd05621 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE-------------------------DVEISKHAKNLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-------------------------cccCCHHHHHHHHHHccCchhcc
Confidence 9999999999887776666665432 111111 1123567899999999865544
Q ss_pred -CCCHHHHHHHHHhh
Q 003375 803 -RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 -RPSa~EIL~hL~~l 816 (825)
|+++.++++|.+..
T Consensus 294 ~R~~~~e~l~hp~~~ 308 (370)
T cd05621 294 GRNGVEEIKQHPFFK 308 (370)
T ss_pred CCCCHHHHhcCcccC
Confidence 89999999996543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.83 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=197.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+.+|++.+.||+|+||.||+|.+ .+..||+|+..... .. .....+.+|+.+++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---ED----TVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cH----HHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 4578899999999999999999997 46789999864221 11 222345899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. .++||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~--------------~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 200 (353)
T PLN00034 144 NGE--------------IQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200 (353)
T ss_pred CCe--------------EEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 553 4999999999998653 23567788899999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvIL 723 (825)
++.+ +.+||+|||+++.+...... .....||..|+|||++.... .....+.++|||||||+|
T Consensus 201 l~~~-------~~~kL~DfG~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 201 INSA-------KNVKIADFGVSRILAQTMDP----------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred EcCC-------CCEEEcccccceeccccccc----------ccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 9877 45999999999866432111 12346999999999985321 123446799999999999
Q ss_pred HHHHhCCCCCCCCCHHH---HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 724 LELLTLQVPYMGLSELE---IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~---i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|||++|+.||......+ +...+.....+.. ....+..+.+||.+||..||
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~P 316 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA---------------------------PATASREFRHFISCCLQREP 316 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC---------------------------CCccCHHHHHHHHHHccCCh
Confidence 99999999997433222 2222211111111 11235679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003375 801 TERPTAGDLYEMFVARTS 818 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~s 818 (825)
.+|||+.||++|-+-...
T Consensus 317 ~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 317 AKRWSAMQLLQHPFILRA 334 (353)
T ss_pred hhCcCHHHHhcCcccccC
Confidence 999999999999665544
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.03 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=206.1
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..++|++.+.||.|+||.||+|...+..+++|....... ..+. +.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-----~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-----AAQA----FLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-----HHHH----HHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 467889999999999999999999999999998753321 2333 4899999999999999999999876443
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||++||+|+||||+|||++.
T Consensus 75 --------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~ 137 (256)
T cd05039 75 --------------LYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137 (256)
T ss_pred --------------eEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC
Confidence 4999999999999999976 22236899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||.+........ ....+..|+|||++.. ..++.++||||||+++|||+
T Consensus 138 ~-------~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 138 D-------LVAKVSDFGLAKEASQGQD-------------SGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred C-------CCEEEcccccccccccccc-------------cCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHH
Confidence 6 4599999999976632111 1134568999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+ |..||...+...+...+.....+..+ ...++.+.+||.+||..+|.+|||+
T Consensus 194 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 194 SFGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred hcCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCH
Confidence 7 99999888777766665544322211 1124678999999999999999999
Q ss_pred HHHHHHHHhh
Q 003375 807 GDLYEMFVAR 816 (825)
Q Consensus 807 ~EIL~hL~~l 816 (825)
.++++.|+.+
T Consensus 247 ~~l~~~l~~~ 256 (256)
T cd05039 247 KQLREQLALI 256 (256)
T ss_pred HHHHHHHhcC
Confidence 9999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.07 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=206.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
+..++|++.+.||+|+||.||+|.+.+ ..+++|+.... ....... .+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~----~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERI----EFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHH----HHHHHHHHHHhCCCCceeEEE
Confidence 456789999999999999999998743 56888885321 1122222 348899999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----CCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
+++..... .++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+|+
T Consensus 76 ~~~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 141 (277)
T cd05032 76 GVVSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV 141 (277)
T ss_pred EEEcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99876554 49999999999999999753211 123478889999999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+|||++.+ +.+||+|||+++.+...... .......++..|+|||.+.. ..++.++
T Consensus 142 H~di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 202 (277)
T cd05032 142 HRDLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKS 202 (277)
T ss_pred ccccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCccc
Confidence 99999999999877 45999999998765432211 01122346789999999875 5678999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 715 DVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
|||||||++|||++ |..||.+.+..+....+.....+.++. ..+..+.+|+.
T Consensus 203 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 255 (277)
T cd05032 203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMR 255 (277)
T ss_pred chHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 999998888777776666443322221 12457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHh
Q 003375 794 RCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+||+.+|.+|||+.+|++.|+.
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.83 Aligned_cols=261 Identities=20% Similarity=0.315 Sum_probs=206.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
.+.+|++.+.||.|+||.||+|.+. +..+|+|+...+. ... +...+.+|+.++..++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~----~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGP----LREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHH----HHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4567899999999999999999863 3568888754221 112 2234588999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHHHH
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 629 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~yLH 629 (825)
++..... .++++||+.+++|.+++..... .....+++..++.++.|++.||.|||
T Consensus 76 ~~~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 76 VVTKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred EEcCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876554 4999999999999999863110 11235788899999999999999999
Q ss_pred hCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003375 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709 (825)
Q Consensus 630 s~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~ 709 (825)
++||+||||||+|||++.+ ..+||+|||+++......... ......+++.|+|||++.+ ..
T Consensus 142 ~~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYYK--------LMGNSLLPIRWMSPEAIMY----GK 202 (283)
T ss_pred HcCccccccchhheEecCC-------CceEecccccccccccchhee--------eccCccCCccccCHHHHhc----CC
Confidence 9999999999999999876 459999999987654322110 0122346789999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 710 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 710 ~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
++.++|||||||++|||++ |..||.+....++...+.......++. ..+..+
T Consensus 203 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (283)
T cd05091 203 FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD---------------------------DCPAWV 255 (283)
T ss_pred CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHH
Confidence 7899999999999999998 889998888877777776654332221 235578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 256 ~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 256 YTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.31 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..||+|+++...... ....+. +..|..++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~hp~i~~~~~~~~~~~~----- 70 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVEC----TMVERRVLALAWEHPFLTHLFCTFQTKEH----- 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHH----HHHHHHHHHhccCCCCccceeeEEEcCCE-----
Confidence 4699999999999997 45679999876432111 112222 25666776654 79999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 71 ---------LFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred ---------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 5999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGEG----------KASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCCC----------ccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 4599999999975432111 1233469999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 811 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~-EIL~ 811 (825)
|.+.+..++...+.... +.++. ..+..+.+||.+||..||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILNDR-PHFPR---------------------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99888877776665431 11111 1245689999999999999999864 6776
Q ss_pred H
Q 003375 812 M 812 (825)
Q Consensus 812 h 812 (825)
|
T Consensus 248 h 248 (316)
T cd05592 248 H 248 (316)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.71 Aligned_cols=262 Identities=21% Similarity=0.362 Sum_probs=204.1
Q ss_pred CceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+|++.+.||+|+||.||+|.... ..+++|+.... ........ +.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRD----LLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHHH----HHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998632 35777764321 12222333 489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-------------------cCCCccCHHHHHHHHHHHHHH
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 624 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------------~~~~~ls~~~i~~Ia~QIa~A 624 (825)
..... ++||||+.+++|.+++..... .....+++..++.++.||+.|
T Consensus 74 ~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDGPL--------------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCCCc--------------EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 65543 999999999999999875211 112357889999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003375 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704 (825)
Q Consensus 625 L~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~ 704 (825)
|.|||+++|+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccchh--------cccCCCCCccccCHHHHcc-
Confidence 999999999999999999999876 469999999987653321110 0112245678999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 705 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 705 ~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
..++.++||||||+++|||++ |..||.+..+..+...+........+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 568899999999999999998 99999888877776665544322211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
.+..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 245789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.66 Aligned_cols=277 Identities=22% Similarity=0.242 Sum_probs=198.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
....+|++.+.||+|+||.||+|.+ .+..||+|... ... +.+|+.+|++|+||||+++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~----~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGG----TATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhh----hHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 4456899999999999999999997 46678888532 112 3789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++|||++. ++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 155 ~~~--------------~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 155 NKF--------------TCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred CCe--------------eEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 554 499999996 799998875 346889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 215 l~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ 274 (391)
T PHA03212 215 INHP-------GDVCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLF 274 (391)
T ss_pred EcCC-------CCEEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9877 45999999999654321110 1123469999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCC-------HHHHHHHHHcC-C-CC-Cch----hHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 725 ELLTLQVPYMGLS-------ELEIHDLIQMG-K-RP-RLT----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 725 ELLTG~~PF~~~~-------~~~i~~~I~~~-~-~p-~l~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
||++|..||.... .......+... . .| .++ ..+...........................+..+.+
T Consensus 275 elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 354 (391)
T PHA03212 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEY 354 (391)
T ss_pred HHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHH
Confidence 9999998875421 11222222221 1 11 010 000000000000000000000011112234668999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
||.+||+.||.+|||+.|+++|-+...
T Consensus 355 Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 355 LICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 999999999999999999999976544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=337.54 Aligned_cols=279 Identities=24% Similarity=0.316 Sum_probs=202.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||++.+ .+..+|+|+..... ...... .+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHH----HHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 46899999999999999999998 46678888765431 222222 3489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILL 645 (825)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 77 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili 137 (333)
T cd06650 77 E--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137 (333)
T ss_pred E--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence 4 4999999999999999975 34688999999999999999999975 79999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ 194 (333)
T cd06650 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (333)
T ss_pred cCC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 876 459999999987553211 122468999999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhH------------HhhhccCccc-----cccccCCCCC-CchhhhhhHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDE------------LEALGSCHEH-----EVAQSGSGFE-KPEAELETLSF 787 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~------------l~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~s~~ 787 (825)
|++|+.||......++...+........... +........+ .......... ........+.+
T Consensus 195 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T cd06650 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAE 274 (333)
T ss_pred HHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHH
Confidence 9999999987665544333221100000000 0000000000 0000000000 00000123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
+.+||.+||++||.+|||+.|++.|..-.
T Consensus 275 ~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 275 FQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred HHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 89999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.65 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=204.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|+||.||+|.. .+..+|+|+....... .... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQET----VSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhH----HHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 4799999999999999999987 5678999987543211 1112 2334889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 76 --------------LYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred --------------EEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 49999999999999999861 246899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~--~~~~s~kSDVWSLGvILyE 725 (825)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||+|||
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 45999999999766432211 1123368999999999874221 2457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++|..||...+....+..+..... ..++. ....+..+.+||.+||. +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999988877666666554321 11110 01235678999999998 999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
++.++++|..
T Consensus 256 t~~~l~~h~~ 265 (330)
T cd05601 256 GYEGLCCHPF 265 (330)
T ss_pred CHHHHhCCCC
Confidence 9999999844
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=325.36 Aligned_cols=262 Identities=20% Similarity=0.282 Sum_probs=203.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...+|++.+.||+|+||.||+|.+ .+. .+++|.... ........ .+..|+.+++++.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~----~~~~~~~~l~~l~h~~iv~~~~~ 77 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQ----EITDHMLAMGSLDHAYIVRLLGI 77 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHH----HHHHHHHHHhcCCCCCcceEEEE
Confidence 456889999999999999999998 333 355555321 11112222 34788889999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+... ..+++|||+++|+|.+++.. ....+++..++.|+.||+.||.|||++|++||||||+
T Consensus 78 ~~~~---------------~~~~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 78 CPGA---------------SLQLVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred ECCC---------------ccEEEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 7432 23899999999999999975 2346899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 nili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~ 199 (279)
T cd05111 139 NILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHH
Confidence 9999876 46999999999765432111 01122347788999999976 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
++|||++ |..||.+.....+...+..+..+..+. ..+..+.+++.+||..||
T Consensus 200 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCc
Confidence 9999998 999998887776666665544332221 013467889999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+|||+.|+++.|..+...++
T Consensus 253 ~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 253 NVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred ccCcCHHHHHHHHHHHHhCCc
Confidence 999999999999988766553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.11 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=205.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+ .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4568999999999999999999998 5678899986432111 11112 234789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 115 ~~~--------------~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIl 174 (371)
T cd05622 115 DRY--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (371)
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 553 5999999999999999975 35888999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......||+.|||||++........++.++|||||||+||
T Consensus 175 l~~~-------~~ikL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvily 238 (371)
T cd05622 175 LDKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (371)
T ss_pred ECCC-------CCEEEEeCCceeEcCcCCcc---------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHH
Confidence 9877 45999999999765432111 1134569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e- 802 (825)
||++|..||.+.+.......+..... ..++. ....+..+.+||.+||..++.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (371)
T cd05622 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRL 293 (371)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhc
Confidence 99999999998887777766654321 11110 1123567899999999844433
Q ss_pred -CCCHHHHHHHHHh
Q 003375 803 -RPTAGDLYEMFVA 815 (825)
Q Consensus 803 -RPSa~EIL~hL~~ 815 (825)
|+++.+|++|.+.
T Consensus 294 ~r~~~~ei~~h~~~ 307 (371)
T cd05622 294 GRNGVEEIKRHLFF 307 (371)
T ss_pred CCCCHHHHhcCccc
Confidence 7899999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=328.70 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=200.9
Q ss_pred CCCceeeeeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
|++|++.+.||+|+||.||+|.... . .+++|..+ .. ......+ .+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~--~~-~~~~~~~----~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EF-ASENDHR----DFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcc--cc-CCHHHHH----HHHHHHHHHHhhcCCCchhheEEEEc
Confidence 5789999999999999999998733 2 35666533 21 1222223 348899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHHHHHHhCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 632 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL~yLHs~g 632 (825)
.... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||++|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRGY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6554 39999999999999999752110 1135889999999999999999999999
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
|+||||||+|||++.+ ..+||+|||++........ ......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCccccceec-----------cCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999876 4699999999864321100 011123457999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003375 713 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 713 kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
++|||||||++|||++ |..||......++...+.....+..+ ...+..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP---------------------------RNCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999997 99999888877766665544322222 1134578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+.+||..+|.+||++++|++.|..+..
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.82 Aligned_cols=284 Identities=18% Similarity=0.213 Sum_probs=204.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||.|+||.||+|.+ .+..||+|+..... ...... ..+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHA----RRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHH----HHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 55678998754221 111122 23478999999999999999999876432
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 88 SI--------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred cc--------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 21 1223569999998 6899988764 4689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 153 ED-------CELRILDFGLARQADDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcCCccceecCCC-------------cCCccccccccCchHhcC---CccCCchhhhHhHHHHHHHH
Confidence 77 45999999999765331 123468999999999875 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||.+.+..+....+........+..+..........+........ .........+.+.+||.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999998877666555554332212222211111000000000000000 001111234568899999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
||+.|+++|.+..
T Consensus 290 ~s~~ell~hp~~~ 302 (343)
T cd07878 290 ISASEALAHPYFS 302 (343)
T ss_pred CCHHHHhcCcchh
Confidence 9999999996543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=320.79 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=204.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+|.+...||.|+||.||+|.. .+..+++|.+........ ......+.+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999986 567899998754433222 22223344566899999999999999999999887654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.|++||||+|+||+++.
T Consensus 81 ~--------------~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 L--------------NIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred c--------------EEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 4 999999999999999976 356888999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||+++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 6 4699999999987653221100 0011123458899999999876 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|+.||...+.......+.....+.++. ..+..+.++|.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIPS---------------------------NISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCCc---------------------------ccCHHHHHHHHHHccCCchhCcCHH
Confidence 9999998776555444444333322221 1345789999999999999999999
Q ss_pred HHHHH
Q 003375 808 DLYEM 812 (825)
Q Consensus 808 EIL~h 812 (825)
+|++|
T Consensus 260 ~il~~ 264 (267)
T cd06628 260 ELLKH 264 (267)
T ss_pred HHhhC
Confidence 99986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.63 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
+.||+|+||.||+|.+ .+..+|+|+.... ...... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLK----AKFLQEARILKQYSHPNIVRLIGVCTQKQP------ 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCCC------
Confidence 4699999999999987 5777899875311 122222 334899999999999999999999876554
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 --------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 68 --------IYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred --------eEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 4999999999999999975 22458899999999999999999999999999999999999876
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003375 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 732 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~P 732 (825)
..+||+|||++........... ......+..|+|||.+.+ ..++.++|||||||++|||++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYAST--------GGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCccccccccccc--------CCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 4599999999875432111000 011123467999999876 567899999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
|...........+........+ ...+..+.+|+.+||+.+|.+|||+.+|++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCP---------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCc---------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9877766655555443222211 1124578999999999999999999999998
Q ss_pred HHh
Q 003375 813 FVA 815 (825)
Q Consensus 813 L~~ 815 (825)
|+.
T Consensus 250 l~~ 252 (252)
T cd05084 250 LQS 252 (252)
T ss_pred HhC
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.08 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=190.8
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~-iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|+......... ... ..+..|.. +++.++||||+++++++...+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~----~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~----- 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEE----KHIMSERNVLLKNVKHPFLVGLHFSFQTADK----- 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHH----HHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-----
Confidence 4799999999999997 456799998753321111 111 12244444 5778999999999999886654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 71 ---------LYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred ---------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 4999999999999999975 3568888999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHNG----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCCC----------CcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 4599999999875422111 1233469999999999986 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 808 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~----E 808 (825)
|.+.+..+.+..+...... +. ...+..+.+||.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcC-CC---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9988877776666543211 00 12345789999999999999999876 5
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 248 i~~~~ 252 (325)
T cd05602 248 IKNHI 252 (325)
T ss_pred HhcCc
Confidence 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.48 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=207.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|++.+.||+|+||.||++.+.+ ..+|+|+.... ........ +.+|+.+++++ +||||+++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHH----HHHHHHHHHhhcCCCCeeeE
Confidence 456789999999999999999998632 56788875422 12222333 48999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
++++..... .++||||+++++|..++..... .....+++..++.++.||+.||.|
T Consensus 82 ~~~~~~~~~--------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 82 LGVCTQEGP--------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred EEEEcCCCC--------------eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 999876553 4999999999999999975210 123568899999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||+.||+||||||+|||++.+ ..+||+|||+++.+........ .....++..|+|||++.+
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---- 208 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYYRK--------TTNGRLPVKWMAPEALFD---- 208 (293)
T ss_pred HHHCCccccccceeeEEEcCC-------CeEEeCccccccccccccceec--------cCCCCCCccccCHHHhcc----
Confidence 999999999999999999876 4699999999987643221100 111235678999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 708 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
..++.++|||||||++|||++ |..||.+....++...+.....+..+ ...+.
T Consensus 209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 261 (293)
T cd05053 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------------------------QNCTQ 261 (293)
T ss_pred CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCH
Confidence 667899999999999999997 99999888877777666554332211 11245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.+.+|+.+||..||.+|||+.+++++|+.+.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.04 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=206.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+-.+|++.+.||.|+||.||+|.+ .+..+++|+..... ...... +.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQD----FQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHH----HHHHHHHHhcCCCcchhheeeeEecCC
Confidence 345789999999999999999997 45778888754321 112223 388999999999999999999987665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 76 P--------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred C--------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 4 4999999999999999975 2235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||++......... .....++..|+|||++.. ..++.++||||||+++|+|
T Consensus 139 ~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l 197 (261)
T cd05148 139 ED-------LVCKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEM 197 (261)
T ss_pred CC-------ceEEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHH
Confidence 77 46999999999766432111 112236778999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |+.||.+.+..+....+.....+..+ ...++.+.+++.+||+.||.+|||
T Consensus 198 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 198 FTYGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HcCCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcC
Confidence 98 89999888877777766654332211 123457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+|++.|+.+
T Consensus 251 ~~~l~~~L~~~ 261 (261)
T cd05148 251 FKALREELDNI 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.99 Aligned_cols=243 Identities=24% Similarity=0.297 Sum_probs=195.0
Q ss_pred eeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+.||+|+||.||+++. .+..+|+|++..... ..... ..+.+|+.+|++++||||+++++++.....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDR----VRTKMERDILAEVNHPFIVKLHYAFQTEGK--- 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhH----HHHHHHHHHHHhCCCCCcccEEEEEEcCCE---
Confidence 6799999999999875 467899998753321 11111 234789999999999999999999886553
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 -----------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 73 -----------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred -----------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 5999999999999999975 3568999999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 4599999999876433211 1123468999999999976 56788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 805 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS----- 805 (825)
.||.+.+..+....+..... .++ ...++.+.+||.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKL-GMP---------------------------QFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 99998887777666654321 111 112457899999999999999999
Q ss_pred HHHHHHH
Q 003375 806 AGDLYEM 812 (825)
Q Consensus 806 a~EIL~h 812 (825)
+.+++.|
T Consensus 248 ~~~~~~~ 254 (318)
T cd05582 248 VEEIKRH 254 (318)
T ss_pred HHHHhCC
Confidence 6667766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.96 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=200.1
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+..+|++.+.||+|+||.||++.+. +..+++|+.... ... ... +.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMS---EDD----FIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCC---HHH----HHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3457889999999999999999874 447899885321 111 122 378999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 73 ~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 73 P--------------IFIVTEYMANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG 134 (256)
T ss_pred c--------------eEEEEecCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC
Confidence 3 4999999999999999975 123689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l 194 (256)
T cd05059 135 ED-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEV 194 (256)
T ss_pred CC-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 76 46999999998765432111 0111224567999999976 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |..||...+..+....+.....+..+ ...+..+.+|+.+||..+|.+|||
T Consensus 195 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 195 FSEGKMPYERFSNSEVVESVSAGYRLYRP---------------------------KLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred hccCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 99 89999887777766666544322211 113557999999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.++++.|
T Consensus 248 ~~~~l~~l 255 (256)
T cd05059 248 FKKLLSQL 255 (256)
T ss_pred HHHHHHHh
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.51 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=204.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||+||+|.+ .+. .||+|+.... ....... .+.+|+.+++.+.||||+++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANK----EILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHH----HHHHHHHHHHhcCCCCCceEEE
Confidence 3456889999999999999999986 232 4788875422 1222222 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 77 ~~~~~~---------------~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp 137 (279)
T cd05109 77 ICLTST---------------VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA 137 (279)
T ss_pred EEcCCC---------------cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 886432 3899999999999999875 234689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ ..+||+|||+++......... ......+++.|+|||.+.+ ..++.++||||||
T Consensus 138 ~Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG 198 (279)
T cd05109 138 RNVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYG 198 (279)
T ss_pred ceEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHH
Confidence 99999776 459999999998764321110 0111235678999999975 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.......+...+..+..+..+ ...+..+.+++.+||..|
T Consensus 199 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~d 251 (279)
T cd05109 199 VTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---------------------------PICTIDVYMIMVKCWMID 251 (279)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---------------------------ccCCHHHHHHHHHHcCCC
Confidence 99999998 99999877776666655554332211 112457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+||++.++++.|..+...
T Consensus 252 p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 252 SECRPRFRELVDEFSRMARD 271 (279)
T ss_pred hhhCcCHHHHHHHHHHhhcC
Confidence 99999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.86 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=202.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||++.+ .+..+++|.+.... .....+. +.+|+.+++.++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVED----SRKEAVLLAKMKHPNIVAFKESFEADGH- 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHH----HHHHHHHHHhCCCCCcceEEEEEEECCE-
Confidence 588999999999999999987 56788999865432 1222333 3889999999999999999999886654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 73 -------------~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 73 -------------LYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred -------------EEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 5999999999999999875 223458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGAY----------ACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeecccccc----------cccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 45999999998765432111 123468899999999976 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...+.......+..+..+.++. ..+..+.+||.+||+.||.+||++.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998877766666665554332221 12346899999999999999999999
Q ss_pred HHHH
Q 003375 809 LYEM 812 (825)
Q Consensus 809 IL~h 812 (825)
|+..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=331.02 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=207.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
...++|.+.+.||+|+||.||+|.+.+ ..+|+|+.... ........ +.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNII 87 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHH----HHHHHHHHHHhcCCCCEe
Confidence 445789999999999999999998622 35888875422 12222333 38899999999 799999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++..... .|+||||+++++|.+++...... ....+++..++.++.||+.||
T Consensus 88 ~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 88 NLLGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred eEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999876553 49999999999999999763211 123588899999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
+|||++|++||||||+|||++.+ +.+||+|||++.......... ......+++.|+|||++.+
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 216 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD-- 216 (307)
T ss_pred HHHHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc--
Confidence 99999999999999999999876 469999999987654321110 0111124578999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||++|||++ |..||.+....++...+........+ ...
T Consensus 217 --~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 267 (307)
T cd05098 217 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------------------------SNC 267 (307)
T ss_pred --CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CcC
Confidence 567899999999999999998 89999887777766666554332221 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
+..+.+|+.+||..+|.+|||+.+|+++|+.+...
T Consensus 268 ~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 268 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 45789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.35 Aligned_cols=245 Identities=26% Similarity=0.337 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|++...... ...... .+.+|+.++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~h~~i~~~~~~~~~~~~----- 70 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVE----CTMTEKRVLALAGKHPFLTQLHSCFQTKDR----- 70 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCCE-----
Confidence 4799999999999998 4568999987533211 112222 237888999888 69999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||++|++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 71 ---------LFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 5999999999999999876 3468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGGV----------TTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCCC----------cccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 4599999999864322111 1123468999999999986 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 807 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa-----~ 807 (825)
|.+.+...+...+..... .++ ...+..+.+||.+||..||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYP---------------------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 988887777666554321 111 1124578999999999999999999 9
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
++++|-
T Consensus 248 ~ll~~~ 253 (318)
T cd05570 248 DIKGHP 253 (318)
T ss_pred HHhcCC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.95 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=203.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
...+|++.+.||+|+||.||+|.+ .+..+|+|..... .. ..+. +.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~---~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TM---DPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cc---cHHH----HHHHHHHHHHCCCCCccceeEEEecCC
Confidence 456799999999999999999987 4467888875422 11 1223 388999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 75 ~--------------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 137 (261)
T cd05068 75 P--------------IYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG 137 (261)
T ss_pred C--------------eeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc
Confidence 4 49999999999999999752 234689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .......+..|+|||++.+ ..++.++||||||+++|||
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 138 EN-------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred CC-------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999999876532111 0011123468999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |+.||.+.+...+...+........+ ...+..+.+++.+||+.+|.+||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQGYRMPCP---------------------------PGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHhhcCcccCCC
Confidence 99 99999888877776666544321111 112457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+|++.|+.+
T Consensus 251 ~~~l~~~l~~~ 261 (261)
T cd05068 251 FETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.64 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=201.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|++|.||++.. .+..+++|...... ......+. +.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKA----AEQEAQLLSQLKHPNIVAYRESWEGEDG- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHH----HHHHHHHHHhCCCCCeeeeeeeecCCCC-
Confidence 589999999999999999987 45678988865332 12222233 3889999999999999999987753321
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.+|+||||+++++|.+++.. .....+++..++.++.||+.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 74 ------------LLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred ------------EEEEEecccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 35999999999999999975 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 4699999999876643211 1123458899999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||...+.......+..+..+.++ ...++.+.+|+.+||+.||.+||++.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMP---------------------------KDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------cccCHHHHHHHHHHhccCcccCCCHHH
Confidence 99999877766655555444332222 123457999999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 251 ~l~~~ 255 (257)
T cd08223 251 ILRQP 255 (257)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.20 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=197.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++.+.||+|+||.||++.+ .+..+|+|+....... . ......+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--K---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--h---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-
Confidence 488999999999999999997 4678999986432211 1 1112234789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 75 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 75 -------------LCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred -------------EEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 5999999999999998865 223468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGET-----------IRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCCc-----------cccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 4599999999876532111 122368999999999975 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 804 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP---- 804 (825)
|+.||.+.........+......... ......+..+.+||.+||..||.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQE------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhccc------------------------ccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 99999876543332222211000000 00112355789999999999999999
Q ss_pred -CHHHHHHHH
Q 003375 805 -TAGDLYEMF 813 (825)
Q Consensus 805 -Sa~EIL~hL 813 (825)
++.++++|.
T Consensus 253 ~~~~~l~~~~ 262 (285)
T cd05605 253 EGAEEVKAHP 262 (285)
T ss_pred CCHHHHhcCc
Confidence 899999883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.06 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|+.+..... ...... .+.+|+.++..+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~----- 70 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDID----WVQTEKHVFETASNHPFLVGLHSCFQTESR----- 70 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCCCCceEEEEEcCCE-----
Confidence 4699999999999997 5678999987533211 112222 347899999998 69999999999886654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 71 ---------LFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred ---------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 4999999999999998875 3569999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCCC----------ccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 4599999999864321111 1123469999999999986 6678999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 733 YMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 733 F~~~~~---------~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|..... ..+...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 963211 1112222211 11111 1234578999999999999999
Q ss_pred CC------HHHHHHHHHh
Q 003375 804 PT------AGDLYEMFVA 815 (825)
Q Consensus 804 PS------a~EIL~hL~~ 815 (825)
|+ +.++++|.+.
T Consensus 248 ~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCCCCCCHHHHhcCCCC
Confidence 87 7899988443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.41 Aligned_cols=245 Identities=26% Similarity=0.298 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~-iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|++ .+..+|+|++...... ..... ..+.+|.. +++.++||||+++++++...+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~----- 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQ----NHIMAERNVLLKNLKHPFLVGLHYSFQTAEK----- 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHH----HHHHHHHHHHHHhCCCCCccceeeEEEcCCE-----
Confidence 4799999999999997 5678999987532211 11111 22355554 6788999999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 71 ---------LYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 4999999999999988875 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPEE----------TTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCCC----------ccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 4599999999875322111 1233468999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 808 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa----~E 808 (825)
|.+.+..++...+..... .++ ...+..+.++|.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 998877776666654321 111 1124578999999999999999875 47
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 248 ~~~~~ 252 (321)
T cd05603 248 IKNHV 252 (321)
T ss_pred HhCCC
Confidence 76654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=336.36 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|+........ ..... .+..|..++..+ +||||+++++++...+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~----- 70 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVE----CTMVEKRVLALAWENPFLTHLYCTFQTKEH----- 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCCccCeeEEEEeCCE-----
Confidence 4799999999999998 56689999875432111 11122 236788887765 79999999999986654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+.+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 71 ---------LFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred ---------EEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.++|+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGDN----------RASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCCC----------ceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 4599999999864321110 1233569999999999986 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 811 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa-~EIL~ 811 (825)
|.+.+..++...+.... +.++. ..+..+.+||.+||+.||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDT-PHYPR---------------------------WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 98888777666654432 11111 124578999999999999999997 57776
Q ss_pred HH
Q 003375 812 MF 813 (825)
Q Consensus 812 hL 813 (825)
|.
T Consensus 248 h~ 249 (316)
T cd05620 248 HP 249 (316)
T ss_pred CC
Confidence 63
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.07 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=203.2
Q ss_pred CCCCceeeeeecccCceEEEEEEECC------------------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhh
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 549 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------------------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~ 549 (825)
...+|++.+.||+|+||.||+|.+.. ..+|+|+..... .....+ .+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~----~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNARE----DFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHH----HHHHHHHHHHh
Confidence 45689999999999999999998632 347888754221 122233 34899999999
Q ss_pred CCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc------CCCccCHHHHHHHHHHHHH
Q 003375 550 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAA 623 (825)
Q Consensus 550 L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~i~~Ia~QIa~ 623 (825)
++||||+++++++..... .++||||+++++|.+++...... ....+++..++.++.||+.
T Consensus 76 l~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 76 LSDPNIARLLGVCTVDPP--------------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred cCCCCEeEEEEEEecCCC--------------cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 999999999999876554 49999999999999999763211 1236899999999999999
Q ss_pred HHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 624 AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
||.|||++||+|+||||+|||++.+ +.++|+|||++......... .......+++.|+|||++.+
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc
Confidence 9999999999999999999999877 46999999998765332111 01123356789999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLT--G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
..++.++|||||||++|||++ +..||...+..++...+.......-... .....
T Consensus 207 ----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~ 262 (296)
T cd05051 207 ----GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQI--------------------YLPRP 262 (296)
T ss_pred ----CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccc--------------------cCCCc
Confidence 568899999999999999998 7889987766665555443211000000 00001
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 263 ~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=337.35 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=202.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
.+.++|++.+.||+|+||.||+|... +..||+|++... ......+. +.+|+.++.++ +||||+++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~----~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKA----LMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHH----HHHHHHHHHhhccCcchhhe
Confidence 34568999999999999999999752 256999986422 12223333 38899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 604 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 604 (825)
++++..... .++++|||+++++|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 77 LGACTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred eeeEecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 998875432 358999999999999999642110
Q ss_pred ----------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEee
Q 003375 605 ----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662 (825)
Q Consensus 605 ----------------------~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~D 662 (825)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~D 216 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICD 216 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEec
Confidence 01367899999999999999999999999999999999999876 4699999
Q ss_pred cCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 003375 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI 741 (825)
Q Consensus 663 FGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i 741 (825)
||++..+...... .......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.
T Consensus 217 fG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~ 284 (337)
T cd05054 217 FGLARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284 (337)
T ss_pred cccchhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence 9999876432111 01123356778999999976 678999999999999999998 9999977543332
Q ss_pred -HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 742 -HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 742 -~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
...+..+..+..+ ...++.+.+++.+||+.+|.+||++.+|+++|..+..
T Consensus 285 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 285 FCRRLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2233222221111 1124578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.49 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=202.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+ .+..+++|...... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~---~~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MS---PE----SFLEEAQIMKKLRHDKLVQLYAVVSEE 73 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CC---HH----HHHHHHHHHHhcCCCceEEEEeEECCC
Confidence 3467899999999999999999987 44578888764322 11 12 248999999999999999999887432
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili 135 (260)
T cd05070 74 ---------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135 (260)
T ss_pred ---------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence 13899999999999999975 223458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05070 136 GDG-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (260)
T ss_pred eCC-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHH
Confidence 876 56999999999765432111 0112235678999999875 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||.+.+..+....+.....+..+ ...+..+.+|+.+||..+|.+||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 196 LVTKGRVPYPGMNNREVLEQVERGYRMPCP---------------------------QDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcccCcccCc
Confidence 999 89999888777766666554322211 12245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.++.+.|+.
T Consensus 249 t~~~l~~~l~~ 259 (260)
T cd05070 249 TFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.55 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.+|++.+.||+|+||.||+|.+ .+..+++|....... ...... ..+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKAR----ADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHH----HHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46799999999999999999996 677889887543211 111222 34489999999999999999999988665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 76 ~--------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 4 4999999999999999875322 235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCcc----------cccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 76 45999999998765432111 123358899999999976 5678899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~~--~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|..||.+... ......+.....+.++ ....+..+.+|+.+||..||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCC--------------------------cccccHHHHHHHHHhcCCCcccCC
Confidence 999999975532 2233333222211111 112356799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.+|++.+.++.
T Consensus 254 t~~~i~~~~~~~~ 266 (267)
T cd08229 254 DITYVYDVAKRMH 266 (267)
T ss_pred CHHHHHHHHhhhc
Confidence 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=368.80 Aligned_cols=271 Identities=25% Similarity=0.394 Sum_probs=219.1
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE---CCe--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF---GSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
+.......++.+.||+|+||.||.|.. .+. ++.|+++.++... ...+...| ++|..+|++++|||||+++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~F----l~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDF----LKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHH----HHHHHHHhcCCCcceeeEE
Confidence 335567788999999999999999997 222 4455555555432 34445555 9999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc--CCCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
|++...... +|++|||+||+|..||++.... ....++....+.++.|||+|+.||+++++||||
T Consensus 762 Gv~l~~~~~--------------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 762 GVCLDSGPP--------------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred EeecCCCCc--------------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 999975543 9999999999999999974221 245688999999999999999999999999999
Q ss_pred CCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003375 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717 (825)
Q Consensus 638 LKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVW 717 (825)
|-..|+||+.. .+|||+|||+|+.+...... ... ....-...|||||.+.. ..++.|+|||
T Consensus 828 LAaRNCLL~~~-------r~VKIaDFGlArDiy~~~yy---r~~-----~~a~lPvkWm~PEsl~d----~iFtskSDvW 888 (1025)
T KOG1095|consen 828 LAARNCLLDER-------RVVKIADFGLARDIYDKDYY---RKH-----GEAMLPVKWMPPESLKD----GIFTSKSDVW 888 (1025)
T ss_pred hhhhheeeccc-------CcEEEcccchhHhhhhchhe---ecc-----CccccceecCCHHHHhh----cccccccchh
Confidence 99999999987 67999999999955432221 111 11234478999999997 7899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 718 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 718 SLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||||+|||++| |..||.+.+..+++..+..+.+...+. .+++.+++||..||
T Consensus 889 sFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~---------------------------~CP~~ly~lM~~CW 941 (1025)
T KOG1095|consen 889 SFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS---------------------------YCPEKLYQLMLQCW 941 (1025)
T ss_pred hhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC---------------------------CCChHHHHHHHHHc
Confidence 99999999999 899999999999988777765543332 24667899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 797 EENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
+.+|++||++..|++.+..+.+..
T Consensus 942 ~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 942 KHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cCChhhCccHHHHHhhhhhhhhhh
Confidence 999999999999999988876543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.07 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=190.5
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||+|+||+||++.+ .+..+|+|+....... ..... ..+..|+.+++.++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-------- 67 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGY----EGAMVEKRILAKVHSRFIVSLAYAFQTKTD-------- 67 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHH----HHHHHHHHHHHhCCCCcEeeeeEEEcCCCe--------
Confidence 79999999999987 5678999986432211 11112 234789999999999999999998876543
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.|+||||+++|+|..++..... ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 68 ------LCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred ------EEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 5999999999999988864222 23568999999999999999999999999999999999999876
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
+.++|+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4599999999876543211 1123468999999999986 5678999999999999999999999976
Q ss_pred CCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 003375 736 LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 809 (825)
Q Consensus 736 ~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~EI 809 (825)
.........+... ..... ......+..+.+|+.+||+.||.+|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSV-------------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCC-------------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 5332111111111 00000 00112356789999999999999999 88999
Q ss_pred HHHHH
Q 003375 810 YEMFV 814 (825)
Q Consensus 810 L~hL~ 814 (825)
++|.+
T Consensus 255 l~h~~ 259 (280)
T cd05608 255 RTHPL 259 (280)
T ss_pred hcChh
Confidence 99853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.67 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=202.1
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+.||+|+||.||+|.+. +..+++|+..... ... ..+. +.+|+.++..++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~-~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEE-ERKD----FLKEARVMKKLGHPNVVRLLGVCTEEEP--- 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--chh-HHHH----HHHHHHHHhhcCCCChheeeeeecCCCc---
Confidence 47999999999999985 6788888864332 111 2333 4899999999999999999999886543
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 71 -----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 71 -----------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred -----------eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 49999999999999999862110 026689999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||.+......... .......+++.|+|||.+.. ..++.++|||||||++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 45999999999876543210 01123457889999999876 4688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |..||......++...+..+.....+. ..+..+.+++.+||..+|.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKPE---------------------------YCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCChHHHHHHHHHccCCcccCcC
Confidence 99 699999888877777766543322221 12557999999999999999999
Q ss_pred HHHHHHHHH
Q 003375 806 AGDLYEMFV 814 (825)
Q Consensus 806 a~EIL~hL~ 814 (825)
+.+++++|+
T Consensus 254 ~~~l~~~l~ 262 (262)
T cd00192 254 FSELVERLE 262 (262)
T ss_pred HHHHHHhhC
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.02 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=201.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|++|.||+|.. .+..+++|+........ .. ......+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~--~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP--ET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch--hh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence 4688999999999999999986 56889999865432211 11 1112345899999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. ...++...+..++.||+.||.|||+.||+||||+|+||+++.
T Consensus 79 --------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 79 --------------LSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred --------------EEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 5999999999999999976 246889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||+++........ ........|+..|+|||++.+ ..++.++||||||+++|||+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 6 45999999998765432111 000122357889999999986 55889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|+.||...+.......+... ..+.++ ...+..+.++|.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQLP---------------------------SHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCCC---------------------------ccCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999776555444333322 111111 1235578999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.++++|.+
T Consensus 255 ~~ll~~~~ 262 (263)
T cd06625 255 EELLRHFF 262 (263)
T ss_pred HHHhhCCC
Confidence 99999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.55 Aligned_cols=268 Identities=22% Similarity=0.356 Sum_probs=206.9
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..++|++.+.||+|+||.||+|... +..+|+|+.... ....... .+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERI----EFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHH----HHHHHHHHHHhCCCCCeeeEEE
Confidence 4568999999999999999998753 346788874321 1112222 3488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----CCCccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMH 635 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVH 635 (825)
++..... .++||||+++|+|.+++...... ....+....+..++.||+.||.|||+++|+|
T Consensus 77 ~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 77 VVSKGQP--------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred EEcCCCC--------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 9876553 39999999999999999763211 1234567788999999999999999999999
Q ss_pred cCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhh
Q 003375 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715 (825)
Q Consensus 636 rDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSD 715 (825)
|||||+|||++.+ ..++|+|||+++......... ......++..|+|||.+.+ ..++.++|
T Consensus 143 ~dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~----~~~~~~~D 203 (288)
T cd05061 143 RDLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMAPESLKD----GVFTTSSD 203 (288)
T ss_pred CCCChheEEEcCC-------CcEEECcCCcccccccccccc--------ccCCCcccccccCHHHhcc----CCCChHhH
Confidence 9999999999876 459999999987653321110 0112245678999999876 56789999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 716 IWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 716 VWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
||||||++|||++ |..||.+....++...+..+..+..+. ..++.+.+++.+
T Consensus 204 vwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~ 256 (288)
T cd05061 204 MWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD---------------------------NCPERVTDLMRM 256 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHH
Confidence 9999999999998 789998887777666655443222211 124579999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 003375 795 CTEENPTERPTAGDLYEMFVARTSSSIS 822 (825)
Q Consensus 795 CL~~DP~eRPSa~EIL~hL~~l~sss~S 822 (825)
||+.||.+|||+.++++.|+....++..
T Consensus 257 ~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 257 CWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 9999999999999999999987766544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=348.99 Aligned_cols=257 Identities=29% Similarity=0.423 Sum_probs=214.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|.-++.||.|+||.||.|++ +...||||... .... ...+. .+.+++||..|.+|+|||+|.+-|+|..+.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMs--ySGK--Qs~EK-WqDIlKEVrFL~~l~HPntieYkgCyLre~-- 99 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGK--QSNEK-WQDILKEVRFLRQLRHPNTIEYKGCYLREH-- 99 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecc--cccc--ccHHH-HHHHHHHHHHHHhccCCCcccccceeeccc--
Confidence 466788999999999999998 44556666533 2221 11222 345699999999999999999999998665
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+.|||||||- ||-.+++.-. .+++.+.++..|+.+.+.||+|||+.+.||||||..|||++..
T Consensus 100 ------------TaWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~ 162 (948)
T KOG0577|consen 100 ------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP 162 (948)
T ss_pred ------------hHHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC
Confidence 3599999997 6888888752 3678899999999999999999999999999999999999987
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.|||+|||.|..... .+.++|||.|||||++..+. .+.|+-++||||||++..||..
T Consensus 163 -------g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIELAE 220 (948)
T KOG0577|consen 163 -------GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 220 (948)
T ss_pred -------CeeeeccccchhhcCc--------------hhcccCCccccchhHheecc-ccccCCccceeeccchhhhhhh
Confidence 6799999999876543 35679999999999998754 4788999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
.++|+.+++.+..+..|.++..|.+.. .+.++.+..|+..||++-|.+|||.++
T Consensus 221 RkPPlFnMNAMSALYHIAQNesPtLqs--------------------------~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 221 RKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred cCCCccCchHHHHHHHHHhcCCCCCCC--------------------------chhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 999999999999999999987776662 123668999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 003375 809 LYEMFVARTSS 819 (825)
Q Consensus 809 IL~hL~~l~ss 819 (825)
++.|..-...-
T Consensus 275 ll~H~fv~R~R 285 (948)
T KOG0577|consen 275 LLKHRFVLRER 285 (948)
T ss_pred HhhcchhccCC
Confidence 99997655443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.94 Aligned_cols=244 Identities=27% Similarity=0.368 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.+ .+..+|+|+........ ..... .+..|..++..+ +||||+++++++.+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~----- 70 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKEN----- 70 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCcCcceEEEEEeCCE-----
Confidence 4799999999999997 45679999876432111 11122 236677787764 89999999999886654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
+||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 71 ---------LFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 4999999999999999975 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGDA----------KTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCCC----------ceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 4599999999865322111 1123468999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 811 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~-EIL~ 811 (825)
|.+.+..++...+.... +.++. ..+..+.+||.+||+.||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDN-PCYPR---------------------------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCc---------------------------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 99888777666654332 11111 1245689999999999999999996 7877
Q ss_pred H
Q 003375 812 M 812 (825)
Q Consensus 812 h 812 (825)
|
T Consensus 248 h 248 (316)
T cd05619 248 H 248 (316)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=338.50 Aligned_cols=244 Identities=25% Similarity=0.303 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~-iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.. .+..+|+|++..+.... ..... .+..|.. +++.++||||+++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~----- 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTTEK----- 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHHhCCCCCCccEEEEEecCCE-----
Confidence 4699999999999987 56789999975432211 11122 2355554 4777999999999999886654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 71 ---------LYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 4999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQSD----------TTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCCC----------CcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 4599999999865322111 1233469999999999976 6678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 808 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa----~E 808 (825)
|...+..++...+....... . ...+..+.++|.+||..+|.+||++ .+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVL-R---------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccC-C---------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 99888777766665432110 0 1124568899999999999999977 46
Q ss_pred HHHH
Q 003375 809 LYEM 812 (825)
Q Consensus 809 IL~h 812 (825)
+++|
T Consensus 248 i~~h 251 (325)
T cd05604 248 IQEH 251 (325)
T ss_pred HhcC
Confidence 7766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=315.86 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=205.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|.. .+..+++|.+...... .....+ .+.+|+.++++++|+||+++++++...+
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~----~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQ----DCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHH----HHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 36899999999999999999998 5788999986532221 122233 3489999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 76 E--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140 (267)
T ss_pred e--------------EEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC
Confidence 3 4999999999999999975322 235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CcEEEeccceeeeccCCCcc----------cceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHH
Confidence 77 45999999998765432111 122358889999999875 5678899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~--~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|+.||.... ...+...+..+..+.++. ...+..+.++|.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRP 253 (267)
T ss_pred HHCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCC
Confidence 99999996543 223333333332222211 12345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.+|++.|+.+.
T Consensus 254 ~~~~il~~~~~~~ 266 (267)
T cd08224 254 DISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.25 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=216.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
-.+++|++++.||+|-||.||+|+. +..-+|+||.... .-.......++.+|++|-..|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs-----qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-----QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH-----HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 5688999999999999999999997 4556777875322 12333445667999999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+... ||++||..+|.|...|.. .....+++.....+++|+|.||.|+|..+||||||||+|+|
T Consensus 94 ~~ri--------------yLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 94 SKRI--------------YLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred ccee--------------EEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 8755 999999999999999985 34567999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++..+ .+||+|||-+..... ....+..||..|.+||+..+ ...+..+|+|++|++.|
T Consensus 157 lg~~~-------~lkiAdfGwsV~~p~------------~kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 157 LGSAG-------ELKIADFGWSVHAPS------------NKRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVLCY 213 (281)
T ss_pred cCCCC-------CeeccCCCceeecCC------------CCceeeecccccCCHhhcCC----CCccchhhHHHHHHHHH
Confidence 99885 499999998865432 12355689999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++.|.+||...+..+.+..|.+... .++ ..++....+||.+||..+|.+|.
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~-~~p---------------------------~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDL-KFP---------------------------STISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccc-cCC---------------------------cccChhHHHHHHHHhccCccccc
Confidence 99999999998888888888876532 111 12356789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
+..|+++|.+-
T Consensus 266 ~l~~v~~hpwI 276 (281)
T KOG0580|consen 266 ALTEVMDHPWI 276 (281)
T ss_pred cHHHHhhhHHH
Confidence 99999999764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.35 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEE-C---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF-G---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~-~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
+.||+|+||.||+|.. . ...+++|... . ........ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~--~-~~~~~~~~----~~~~e~~~~~~l~h~nii~~~~~~~~~~~---- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--A-SATPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESIP---- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecC--c-cCChHHHH----HHHHHHHHHHhCCCCCcceEEEEECCCCc----
Confidence 3699999999999975 2 2345665432 1 11222223 34889999999999999999999876554
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.++||||+++|+|.+++..........+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 70 ----------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ----------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 4999999999999999986332222345678889999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCchhhHHHHHHHHHHHHh
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~---~~~~~s~kSDVWSLGvILyELLT 728 (825)
..+||+|||++.......... ......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYYI--------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhee--------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 459999999986543211100 012234677899999986421 12456889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|..||......+....+.......++. +......+..+.+++..|| .||.+|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 789998777666555544332222221 0111223557788999999 5999999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
+|++.|.
T Consensus 262 ~v~~~l~ 268 (269)
T cd05042 262 EVHELLT 268 (269)
T ss_pred HHHHHhc
Confidence 9999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.42 Aligned_cols=283 Identities=20% Similarity=0.251 Sum_probs=190.5
Q ss_pred eeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
.++||+|+||.||+|.. .+..+|+|..... ... ..+.+|+.+|++++||||+++++++.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GIS--------MSACREIALLRELKHPNVISLQKVFLSHAD--- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCC---
Confidence 46899999999999986 3457888875322 111 123789999999999999999998864331
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhc----cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
...|+||||+. ++|..++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 24699999996 699988864211 1123588999999999999999999999999999999999996
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
..+. ..+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 4321 2357999999999866432111 011234578999999999975 24578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHHcCCCCCchhHHhhhccCccc-----cccccCC---CC--CCchhhhhhHHH
Q 003375 727 LTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEH-----EVAQSGS---GF--EKPEAELETLSF 787 (825)
Q Consensus 727 LTG~~PF~~~~~---------~~i~~~I~~~~~p~l~~~l~~~~~~~~~-----~~~~~~~---~~--~~~~~~~~~s~~ 787 (825)
++|++||.+... ......+...........+......... .+..... .. ............
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChH
Confidence 999999965432 1112222221111111111111000000 0000000 00 000001112346
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
+.+||.+||++||.+|||++|+++|-
T Consensus 290 ~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 290 AFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCC
Confidence 88999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.15 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=202.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.. .+..+|+|++...... . ......+.+|+.++..++||||+++++.+.....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-E----KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-h----hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4689999999999999999987 5678999987532111 1 1122345889999999999999999999886654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 76 --------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 76 --------------LYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred --------------EEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 4999999999999999975 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhh
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 702 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s-------------------------~~~~~~~~~~vGT~~YmAPEvl~ 702 (825)
+ +.++|+|||++..+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 6 469999999987653221100000 00000112357999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 703 ~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
+ ..++.++|||||||+||||++|+.||.+.++......+.... ...++. .
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------------------------E 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------------------------C
Confidence 6 668899999999999999999999999888877766665431 111110 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 003375 782 LETLSFLVDVFRRCTEENPTERP---TAGDLYEMFV 814 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRP---Sa~EIL~hL~ 814 (825)
...++.+.+||.+|+. ||.+|+ ++.++++|.+
T Consensus 261 ~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 261 VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 1134578999999874 999998 5899999954
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.74 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=202.7
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 559 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~ 559 (825)
+-++|++.+.||+|+||.||+|.+. ...||+|++... ......+ .+.+|+.+|+++. ||||++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~----~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQ----ALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHH----HHHHHHHHHHhcCCCCCeeeEE
Confidence 4568899999999999999999862 235899985422 1222223 3489999999996 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc------------------------------------
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 603 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------------------------------ 603 (825)
+++..... .|||||||++|+|.+++.....
T Consensus 108 ~~~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 108 GACTKSGP--------------IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred EEEccCCc--------------eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 99976554 4999999999999999875211
Q ss_pred -------------------------------------------------------cCCCccCHHHHHHHHHHHHHHHHHH
Q 003375 604 -------------------------------------------------------TGEKHVSVKLALFIAQDVAAALVEL 628 (825)
Q Consensus 604 -------------------------------------------------------~~~~~ls~~~i~~Ia~QIa~AL~yL 628 (825)
.....+++..++.++.||+.||.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 0113477888999999999999999
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
|+.+|+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+ .
T Consensus 254 H~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 314 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----N 314 (400)
T ss_pred HhCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----C
Confidence 99999999999999999876 46999999999765432111 01123357789999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 709 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~-i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
.++.++|||||||+||||++ |..||....... +...+..+..+..+ ...+.
T Consensus 315 ~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 367 (400)
T cd05105 315 LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQ 367 (400)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCH
Confidence 67899999999999999997 999997654333 33333333221111 12355
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
.+.+|+.+||+.||.+||++.+|.+.|+.+..
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 78999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.89 Aligned_cols=266 Identities=22% Similarity=0.343 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
...++|.+.+.||+|+||.||+|++. ...+++|+.... ........ +.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNII 84 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHH----HHHHHHHHHhhccCCCch
Confidence 45678999999999999999999751 235788875321 12223333 38999999999 799999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++..... .|+||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 85 ~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 150 (304)
T cd05101 85 NLLGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150 (304)
T ss_pred heeEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHH
Confidence 99999876553 49999999999999999863211 123578889999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+|||++.+ +.+||+|||+++......... ......+++.|+|||++.+
T Consensus 151 ~~LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 213 (304)
T cd05101 151 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD-- 213 (304)
T ss_pred HHHHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc--
Confidence 99999999999999999999876 469999999998664322110 0112235678999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++||||||+++|+|++ |..||.+.+..++...+........+ ...
T Consensus 214 --~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 264 (304)
T cd05101 214 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANC 264 (304)
T ss_pred --CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCC
Confidence 567899999999999999998 88999888887777776554332211 123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
+..+.+|+.+||..+|.+|||+.+|++.|..+...
T Consensus 265 ~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 265 TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 45789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=333.56 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=197.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
+|++.+.||+|+||.||+|.. .+..||+|+....... .....+. +..|+.++..+. |++|+++++++.....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVEC----TMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHH----HHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 478899999999999999987 5678999987533211 1122222 377888888886 5778889888876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 4999999999999999875 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 4599999999875422111 1123469999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 805 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS-- 805 (825)
+|..||.+.+...+...+..... .++ ...+..+.+|+.+||+.+|.+|++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 99999998888777766654321 111 012456899999999999999997
Q ss_pred ---HHHHHHH
Q 003375 806 ---AGDLYEM 812 (825)
Q Consensus 806 ---a~EIL~h 812 (825)
..++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05615 248 PEGERDIREH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 4677776
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.66 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=201.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.++||+|+||.||+|.+. ...+++|+.... ... .+ .+.+|+.++++++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~---~~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PE----AFLQEAQVMKKLRHEKLVQLYAVVSEE 73 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccC---HH----HHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 34567999999999999999999874 346888875421 111 12 348899999999999999999876432
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.+|+|+||||+||++
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 74 ---------------PIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred ---------------CcEEEEEcCCCCcHHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 23899999999999999975 122457899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ ..++|+|||.+..+...... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 136 ~~~-------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~e 195 (262)
T cd05071 136 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (262)
T ss_pred cCC-------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHH
Confidence 876 45999999999766432211 0112346778999999875 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+| |..||.+....++...+......... ...+..+.+|+.+||+.+|.+||
T Consensus 196 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 196 LTTKGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred HHcCCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCC
Confidence 999 89999887776666555443221111 12345789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
++.++++.|+..
T Consensus 249 ~~~~~~~~l~~~ 260 (262)
T cd05071 249 TFEYLQAFLEDY 260 (262)
T ss_pred CHHHHHHHHHHh
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.99 Aligned_cols=276 Identities=23% Similarity=0.279 Sum_probs=214.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-C-----CCcceeeeeE
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 562 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-H-----PNIV~l~g~~ 562 (825)
+|.+.+.||+|+||.|.+|.+ +++.|||||++-+ ..|..+...|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 899999999999999999997 5789999997533 223334478999999997 4 5799999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...++ +|||+|.+. .+|+++|+. .....++...++.|+.||+.||.+||..||||+||||+|
T Consensus 258 ~fr~H--------------lciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRNH--------------LCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred ccccc--------------eeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 87664 599999997 799999997 445569999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||...+. ..+||+|||.|........ ..+.+..|.|||++.| .+|+.+.||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99987643 6899999999987655332 3467889999999998 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc--------------------------------
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-------------------------------- 770 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~-------------------------------- 770 (825)
++||++|.+.|.|.+..+.+..|......+-+..++.. ......+..
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~-~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA-KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc-cccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999988887777664322212222111 100000000
Q ss_pred c-CC-CC--CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 771 S-GS-GF--EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 771 ~-~~-~~--~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
. .+ .. -...........++++|.+||.+||.+|+|+.++|+|.+--
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 0 00 00 00111123456789999999999999999999999997654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.89 Aligned_cols=255 Identities=23% Similarity=0.385 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+.-++|++.++||+|+||.||+|.. .+..+|+|...... . .... +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~---~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--M---SPEA----FLAEANLMKQLQHPRLVRLYAVVTQE 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--C---cHHH----HHHHHHHHHhcCCcCeeeEEEEEccC
Confidence 3456899999999999999999987 55789999864221 1 1223 38899999999999999999886432
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
..++||||+.+++|.+++.. .....+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 74 ---------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i 135 (260)
T cd05067 74 ---------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135 (260)
T ss_pred ---------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE
Confidence 24999999999999999875 233568899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... ......++..|+|||++.. ..++.++||||||+++||
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~e 195 (260)
T cd05067 136 SET-------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 195 (260)
T ss_pred cCC-------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHH
Confidence 877 46999999999766422111 0122346778999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |++||.+.+..+....+........+ ...+..+.+++.+||..+|.+||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRP---------------------------DNCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred HHhCCCCCCCCCChHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCC
Confidence 999 99999888777766666544322211 11245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
++++++..|+.
T Consensus 249 ~~~~l~~~l~~ 259 (260)
T cd05067 249 TFEYLRSVLED 259 (260)
T ss_pred CHHHHHHHhhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.77 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=188.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.. .+..+|+|+....... ...... .+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~----- 70 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQTESR----- 70 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHH----HHHHHHHHHHhcCCCCcCCceeeEEEeCCE-----
Confidence 4799999999999997 4668999987543221 122222 337888888877 79999999999886653
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 71 ---------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred ---------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 4999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 4599999999875322111 1123469999999999986 6678999999999999999999999
Q ss_pred CCCCC---------HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 733 YMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 733 F~~~~---------~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|.... ...+...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcC-CCCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 95321 11112222211 11111 1234578999999999999999
Q ss_pred CC------HHHHHHHH
Q 003375 804 PT------AGDLYEMF 813 (825)
Q Consensus 804 PS------a~EIL~hL 813 (825)
|+ +.++++|.
T Consensus 248 ~~~~~~~~~~~i~~hp 263 (329)
T cd05618 248 LGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCCCCCCHHHHhcCC
Confidence 98 57888884
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.89 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=196.1
Q ss_pred eecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 497 EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
.||+|+||.||+|.+. +..+|+|+.... .... ..+.+.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~----~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKS----VRDEMMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChH----HHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999763 345888875422 1122 223448999999999999999999987532
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 24999999999999999874 23568999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 731 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~ 731 (825)
..+||+|||++........... ......+++.|+|||++.. ..++.++|||||||++|||++ |..
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYYK-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCcccee-------ccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 4699999999976543221100 0111224678999999875 567889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003375 732 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811 (825)
Q Consensus 732 PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~ 811 (825)
||.......+...+..+..+.++ ...++++.+||.+||..+|.+||++.+|++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCP---------------------------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99988887777776665443322 123567899999999999999999999999
Q ss_pred HHHhh
Q 003375 812 MFVAR 816 (825)
Q Consensus 812 hL~~l 816 (825)
.|+..
T Consensus 251 ~l~~~ 255 (257)
T cd05115 251 RMRTY 255 (257)
T ss_pred HHhhh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.65 Aligned_cols=257 Identities=32% Similarity=0.449 Sum_probs=198.1
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||+|+||+||+++. ++..+|+|+..... .... ......+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-- 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEE----EREENIREIKILRRLRHPNIVQILDVFQDDNY-- 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHH----HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE--
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--cccc----ccchhhhhhhcccccccccccccccccccccc--
Confidence 78999999999999999998 44579999975432 1111 11222569999999999999999999987554
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 73 ------------~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 73 ------------LYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp ------------EEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred ------------ccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 4999999998899999984 2678999999999999999999999999999999999999976
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||.+........ ......++..|+|||++.. ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENNE----------NFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTTS----------EBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------ccccccccccccccccccc----------ccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 4599999999976411111 1133468999999999871 26789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
..||...........+.......+..... ........+.+||.+||+.||.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhccccccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998774333333333221111111000 000113689999999999999999999999
Q ss_pred HHHHH
Q 003375 810 YEMFV 814 (825)
Q Consensus 810 L~hL~ 814 (825)
++|.+
T Consensus 255 ~~~~~ 259 (260)
T PF00069_consen 255 LKHPW 259 (260)
T ss_dssp HTSGG
T ss_pred hcCCC
Confidence 98753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.45 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=207.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
+.-++|++.+.||+|+||.||+|.+. +..+++|+.. . .......+. +.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~--~-~~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK--D-HASEIQVTL----LLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEcc--C-CCCHHHHHH----HHHHHHHHHhCCCCCCCeEEE
Confidence 34578999999999999999999974 3677887743 1 122333333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc---CCCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
++..... ..++++||+++++|.+++...... ....+++..++.++.||+.||+|||+++++|||
T Consensus 76 ~~~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 142 (280)
T cd05043 76 VCIEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKD 142 (280)
T ss_pred EEecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 8775432 249999999999999999763211 114688999999999999999999999999999
Q ss_pred CCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003375 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717 (825)
Q Consensus 638 LKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVW 717 (825)
|||+|||++.+ ..+||+|||+++.+........ .....++..|+|||++.+ ..++.++|||
T Consensus 143 i~p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~~--------~~~~~~~~~y~apE~~~~----~~~~~~~Di~ 203 (280)
T cd05043 143 IAARNCVIDEE-------LQVKITDNALSRDLFPMDYHCL--------GDNENRPVKWMALESLVN----KEYSSASDVW 203 (280)
T ss_pred cCHhhEEEcCC-------CcEEECCCCCcccccCCceEEe--------CCCCCcchhccCHHHHhc----CCCCchhhHH
Confidence 99999999876 5699999999976543221100 112246778999999976 5678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 718 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 718 SLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||||++||+++ |+.||...++.++...+........+ ...++.+.+++.+||
T Consensus 204 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l 256 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCW 256 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHc
Confidence 99999999999 99999888777766655544321111 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 003375 797 EENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~s 818 (825)
..||++|||+.++++.|..+..
T Consensus 257 ~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 257 ALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=364.43 Aligned_cols=270 Identities=20% Similarity=0.318 Sum_probs=205.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+..+++|++++.||.|+||.||+|.+ .+..+|+|++.... ....... .+..|+.+|+.|+|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~----~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKS----QLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHH----HHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 36688999999999999999999998 45678888865432 2223333 3489999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-------Ccccc
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHR 636 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-------gIVHr 636 (825)
.... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||.. +||||
T Consensus 83 de~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 83 NKAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred ecCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 5432 2469999999999999999763222 24689999999999999999999984 49999
Q ss_pred CCCCCCEEEecCcc----------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003375 637 DIKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706 (825)
Q Consensus 637 DLKP~NILLd~~~~----------~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~ 706 (825)
||||+||||+.... ..++...+||+|||++..+..... .....||+.|+|||++.+.
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----------~~s~vGTp~YmAPEvL~ge-- 216 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----------AHSCVGTPYYWSPELLLHE-- 216 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-----------ccccCCCccccCHHHHhcc--
Confidence 99999999975321 112345699999999976533211 1234699999999998652
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 785 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 785 (825)
...++.++||||||||||||+||..||...... .+...+.... .++ ....+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lp--------------------------i~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLP--------------------------IKGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCC--------------------------cCCCC
Confidence 245789999999999999999999999765433 3333333221 111 00124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 786 SFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 786 ~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
..+.+||..||..+|.+||++.++|.|...
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 578999999999999999999999977443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.43 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=199.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
....+|++.+.||+|+||.||+|.. .+..+|+|+...+.. ..... +.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSL----IQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHH----HHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3456899999999999999999997 567789998754321 12222 3789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus 78 ~~~--------------~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 138 (267)
T cd06646 78 REK--------------LWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 543 4999999999999999875 346899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++........ ......|++.|+|||.+.... ...++.++|||||||++|
T Consensus 139 l~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~-~~~~~~~~Dvws~G~il~ 200 (267)
T cd06646 139 LTDN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVEK-NGGYNQLCDIWAVGITAI 200 (267)
T ss_pred ECCC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHccccc-CCCCcchhhHHHHHHHHH
Confidence 9876 4599999999976542111 112345889999999985321 244678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|+.||....+......+...... .+ ........+..+.+||.+||..+|.+||
T Consensus 201 el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 201 ELAELQPPMFDLHPMRALFLMSKSNFQ-PP----------------------KLKDKTKWSSTFHNFVKISLTKNPKKRP 257 (267)
T ss_pred HHHhCCCCccccchhhhheeeecCCCC-CC----------------------CCccccccCHHHHHHHHHHhhCChhhCc
Confidence 999999999665443322222111000 00 0000112346789999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
|+++|++||
T Consensus 258 ~~~~il~~l 266 (267)
T cd06646 258 TAERLLTHL 266 (267)
T ss_pred CHHHHhcCC
Confidence 999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.14 Aligned_cols=282 Identities=20% Similarity=0.222 Sum_probs=198.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC------CCCcceeee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYG 560 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~------HPNIV~l~g 560 (825)
.++|++.++||+|+||.||+|.+ .+..||||+++... .... .+..|+.++..++ |++|+.+++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~----~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTR----DAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHH----HHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 47899999999999999999987 56789999864211 1111 1255666666664 456888888
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIK 639 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLK 639 (825)
++.... .+.+||||++ |++|.+++.. ...+++..+..|+.||+.||.|||. .||||||||
T Consensus 199 ~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 199 YFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 886432 2469999999 6899998875 3568999999999999999999998 599999999
Q ss_pred CCCEEEecCccCC---------CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003375 640 SENILIDLERKKA---------DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710 (825)
Q Consensus 640 P~NILLd~~~~~~---------~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~ 710 (825)
|+|||++.++... ...+.+||+|||.+...... ....+||+.|+|||++.+ ..+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------------~~~~~gt~~Y~APE~~~~----~~~ 322 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------------RTAIVSTRHYRSPEVVLG----LGW 322 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-------------cccccCCccccCcHHhhc----CCC
Confidence 9999998763210 11236999999987532211 133579999999999986 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-ccccccCC----C----------C
Q 003375 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGS----G----------F 775 (825)
Q Consensus 711 s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~----~----------~ 775 (825)
+.++|||||||+||||++|++||.+.+..+....+..... .++..+...+.... ..+..... . .
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 9999999999999999999999988877666555544321 11222211100000 00000000 0 0
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 776 ~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
..........+.+.+||.+||++||.+|||+.|+|+|.+..
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 00000111245688999999999999999999999996654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.70 Aligned_cols=280 Identities=21% Similarity=0.232 Sum_probs=199.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.. .+..+|+|+....... .... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVP----STAIREISLLKELQHPNIVCLQDVLMQESR- 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCch----HHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-
Confidence 588999999999999999987 5678999986543211 1111 233789999999999999999999886553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.|+||||++ ++|.+++... .....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 74 -------------~~~v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 74 -------------LYLIFEFLS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred -------------EEEEEecCC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 499999997 6999988752 223568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVRV----------YTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCccc----------ccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 45999999998755322110 122357899999999865 2356889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|++||.+.........+...........+........ ...................++++.+||.+||..||.+|||+.
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 9999987765544333322111111111100000000 000000000000111223467889999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
+|++|-
T Consensus 278 ~ll~~~ 283 (285)
T cd07861 278 KALNHP 283 (285)
T ss_pred HHhcCC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.44 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=204.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||++.+ .+..+++|+.... .......+. +.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG--NMTEKEKQQ----LVSEVNILRELKHPNIVRYYDRIIDRSN- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc--cCCHHHHHH----HHHHHHHHHhcCCCccceeeeeeecCCC-
Confidence 588999999999999999987 5567888876433 222333333 4889999999999999999998764332
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCE
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 643 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH-----s~gIVHrDLKP~NI 643 (825)
...+++|||+++++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 74 -----------~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 74 -----------QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred -----------CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 246999999999999999976322 2356899999999999999999999 88999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
+++.+ +.+||+|||++......... .....+++.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99876 46999999999876542211 122368999999999876 5578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|+.||...+...+...+..+..+.++. ..+..+.+|+.+||..+|.+|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPY---------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccC
Confidence 99999999998887666666665554333221 124578999999999999999
Q ss_pred CCHHHHHHH
Q 003375 804 PTAGDLYEM 812 (825)
Q Consensus 804 PSa~EIL~h 812 (825)
|++.+|++|
T Consensus 254 p~~~~il~~ 262 (265)
T cd08217 254 PSTEELLQL 262 (265)
T ss_pred CCHHHHhhC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.93 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=202.4
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+.+|++.+.||+|+||.||++...+..+|+|+..... ... .+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQ----AFLEETAVMTKLHHKNLVRLLGVILHNG- 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------hHH----HHHHHHHHHHhCCCCCcCeEEEEEcCCC-
Confidence 46789999999999999999999989999999864321 122 3488999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+.|++||||||+|||++.
T Consensus 73 --------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 73 --------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred --------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3899999999999999976 22345889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++....... .....+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 136 D-------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C-------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHH
Confidence 6 459999999987543211 11234568999999875 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+ |..||...+.......+..+..+..+ ...+..+.+|+.+||+.+|.+||++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCH
Confidence 7 99999888777666665544322111 1234578999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.+|++.|+.
T Consensus 245 ~~l~~~l~~ 253 (254)
T cd05083 245 HKLREKLEK 253 (254)
T ss_pred HHHHHHHcc
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.64 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=202.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
..+|++.+.||+|+||.||+|.+. ...+|+|... ... .....+. +.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~--~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGY-TEKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECC--CCC-CHHHHHH----HHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999862 2256777643 221 2223333 488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 76 KSKP--------------VMIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred cCCc--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 6554 3999999999999999975 224689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ ..++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l 199 (267)
T cd05066 138 LVNSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 199 (267)
T ss_pred EECCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHH
Confidence 99876 569999999998764321110 00111224568999999976 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||+++ |..||......+....+.....+..+ ...+..+.+++.+||+.+|.+
T Consensus 200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred HHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchh
Confidence 99886 99999887777666666554322111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
||++.++++.|.++
T Consensus 253 Rp~~~~i~~~l~~~ 266 (267)
T cd05066 253 RPKFEQIVSILDKL 266 (267)
T ss_pred CCCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.40 Aligned_cols=260 Identities=20% Similarity=0.325 Sum_probs=202.0
Q ss_pred CCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+..|++.+.||+|+||.||+|.+.. ..+++|+.... ........ +..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHH----HHHHHHHHHhCCCcCcceEEEEEC
Confidence 4678999999999999999998732 35888875322 12233334 489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 76 KSRP--------------VMIITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCCc--------------eEEEEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 6553 4999999999999999875 234688999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
+++.+ ..++|+|||++........... .........+..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l 201 (269)
T cd05065 138 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 201 (269)
T ss_pred EEcCC-------CcEEECCCccccccccCccccc-----cccccCCCcceeecCHhHhcc----CcccchhhhhhhHHHH
Confidence 99866 5699999999876543221100 000011112457999999975 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++ |..||...+...+...+........+ ...+..+.+++.+||..+|.+
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 99886 99999888777766666443221111 122456899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
||++.+|+..|+.+
T Consensus 255 Rp~~~~i~~~l~~~ 268 (269)
T cd05065 255 RPKFGQIVSTLDKM 268 (269)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.23 Aligned_cols=261 Identities=29% Similarity=0.472 Sum_probs=207.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+.++|++.+.||.|+||.||++.+ .+..+++|+.... .....+.+ .+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHH----HHHHHHHHhCCCCceeEEEEEEecC
Confidence 456799999999999999999997 4678899986532 22333334 8899999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||++
T Consensus 75 ~~--------------~~lv~e~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili 136 (280)
T cd06611 75 NK--------------LWILIEFCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136 (280)
T ss_pred Ce--------------EEEEeeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 53 4999999999999999875 23468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILy 724 (825)
+.+ +.++|+|||++........ ......+++.|+|||++.... ....++.++|||||||++|
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 137 TLD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CCC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 877 4599999998865433211 112346899999999986321 1245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||...+.......+.....+.+.. ....+..+.++|.+||+.+|.+||
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCCCCCcCC-------------------------cccCCHHHHHHHHHHhccChhhCc
Confidence 9999999998887766665555443322210 011245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
++.++++|-+-.
T Consensus 255 s~~~il~~~~~~ 266 (280)
T cd06611 255 TAAELLKHPFVS 266 (280)
T ss_pred CHHHHhcChhhc
Confidence 999999996543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.63 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=201.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+++. .+..+|+|++..... ...... ..+.+|+.++..++||||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAET----ACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhH----HHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 4799999999999999999997 467899998652111 111122 234889999999999999999999886654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||++||+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 76 --------------LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred --------------EEEEEecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 4999999999999999975 1346899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~-~~~~s~kSDVWSLGvILyEL 726 (825)
+ +.+||+|||++..+...... ......||+.|||||++..... ...++.++|||||||++|||
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGTV---------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCCc---------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 7 45999999998765432111 1123469999999999974221 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e--R 803 (825)
++|+.||.+.+..+....+.... ...++ ......++.+.+||.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFP------------------------PDVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCC------------------------CccCCCCHHHHHHHHHHccCcccccCC
Confidence 99999998887766665554331 11111 001124567899999988654443 7
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
|++.++++|.+
T Consensus 258 ~~~~~~l~hp~ 268 (331)
T cd05597 258 NGLQDFKDHPF 268 (331)
T ss_pred CCHHHHhcCCC
Confidence 89999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.17 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=200.6
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..++|.+.+.||+|+||.||+|.+.+ ..+++|+.... .. . .+.+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~---~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 73 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TM---M----PEAFLQEAQIMKKLRHDKLVPLYAVVSE-E 73 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--Cc---c----HHHHHHHHHHHHhCCCCCeeeEEEEEcC-C
Confidence 34679999999999999999998744 46788864321 11 1 1234889999999999999999988642 2
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..++||||+.+++|.+++.. .....+++..+..++.||+.||.|||+.||+|+||||+|||++
T Consensus 74 --------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 74 --------------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred --------------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 13899999999999999975 2234578999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|||
T Consensus 137 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 137 DN-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred CC-------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHH
Confidence 76 46999999999765432111 0112246778999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+| |..||.+....+....+.....+..+ ...+..+.+|+.+||..||.+||+
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERGYRMPCP---------------------------QGCPESLHELMKLCWKKDPDERPT 249 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcC
Confidence 99 99999888777766666554322211 112457999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+++|++.|+.
T Consensus 250 ~~~i~~~l~~ 259 (260)
T cd05069 250 FEYIQSFLED 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.82 Aligned_cols=279 Identities=21% Similarity=0.254 Sum_probs=199.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.+ .+..+++|........ .. ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~- 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EG----VPSSALREICLLKELKHKNIVRLYDVLHSDKK- 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--cc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCc-
Confidence 588999999999999999998 5678899986543211 11 11234789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 -------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 74 -------------LTLVFEYCD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred -------------eEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 499999997 689888764 13468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 45999999998765332111 122357899999999875 2446889999999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHcCCCCCchhHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~PF-~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|..|| .+.+.......+...........+......... .+................++.+.+||.+||..||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 98885 444444444443332111111111111000000 0000000000011122356788999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.++++|.+
T Consensus 276 ~~il~h~~ 283 (284)
T cd07839 276 EEALQHPY 283 (284)
T ss_pred HHHhcCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.71 Aligned_cols=247 Identities=20% Similarity=0.360 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEC--------------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 496 DEAGKSVSSSLFRCKFG--------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~--------------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
+.||+|+||.||+|++. ...+++|+.... . ......+.+|+.++..++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----H----RDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----h----hhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46899999999999852 124666663221 1 1222345889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... ++||||+++++|..++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 73 ~~~~~~~--------------~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDVEN--------------IMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCCCC--------------EEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 8765543 999999999999998864 2345899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.++........++++|||++...... ....++..|+|||++.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR--------------QECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc--------------ccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 9999876432333445999999998654321 22357889999998863 256788999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELL-TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||+ +|..||......+...... ..... ....+..+.+||.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~----------------------------~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERFYE-GQCML----------------------------VTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHHHh-cCccC----------------------------CCCChHHHHHHHHHHcCCCh
Confidence 999998 5888887655443322111 11000 00124578999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003375 801 TERPTAGDLYEMFV 814 (825)
Q Consensus 801 ~eRPSa~EIL~hL~ 814 (825)
.+||++.+|+++|+
T Consensus 249 ~~Rp~~~~il~~~~ 262 (262)
T cd05077 249 NQRPFFRAIMRDIN 262 (262)
T ss_pred hhCcCHHHHHHhcC
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=332.14 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=216.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+..|++++.||.|.-|+||+++..+ ..+|+||+.... ....... .++..|-+||+.+.||.++.+|..|..
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-l~~rkKl----~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-LASRKKL----KRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-HhhhhHH----HHHHHHHHHHHhcCCCccchhhheeec
Confidence 457789999999999999999999855 789999964221 1112222 344889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+.+. |+|||||+||+|..++++ +....|++..++.++..|+.||+|||-.|||.|||||+|||
T Consensus 149 ~~~~--------------cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 149 DKYS--------------CLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred ccee--------------EEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 8865 999999999999999886 56688999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccc---------------------c-------ccc-----------------
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHT---------------------C-------CIA----------------- 679 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~---------------------~-------~~s----------------- 679 (825)
|.++ +++.|+||.++......... + ...
T Consensus 212 vred-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 212 VRED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred EecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9988 56999999988654211000 0 000
Q ss_pred -cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh
Q 003375 680 -HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758 (825)
Q Consensus 680 -~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~ 758 (825)
.......+.++||-+|.|||++.| ...+.++|.|+|||+||||+.|..||.|.+..+.+..|..... .++.
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~--- 356 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPE--- 356 (459)
T ss_pred cCCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCC---
Confidence 011133467899999999999998 6678999999999999999999999999998888877765421 1111
Q ss_pred hhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHHHH
Q 003375 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFV 814 (825)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS----a~EIL~hL~ 814 (825)
...++..++|||+++|.+||.+|.. |.||.+|..
T Consensus 357 ----------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 357 ----------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred ----------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 0134568999999999999999998 999998843
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.36 Aligned_cols=262 Identities=27% Similarity=0.473 Sum_probs=213.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC---C--ee-EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG---S--AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~---~--~~-vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
-.+..+.++||+|+||.||+|+.. + .. ||+|..+.+ .........+| ++|+++|+.++|||||++||+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEE
Confidence 355667799999999999999972 1 22 677775431 22344555555 9999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.....+ +||||+|.||+|.++|++ ....++..+...++.+.+.||+|||++++|||||-..|
T Consensus 231 ~~~~Pl--------------~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 231 VLEEPL--------------MLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred cCCCcc--------------EEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 877765 999999999999999997 22369999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
+|++.+ .++||+|||+++.-...... .....-...|+|||.+.. ..|++++|||||||+
T Consensus 293 cL~~~~-------~~vKISDFGLs~~~~~~~~~----------~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~ 351 (474)
T KOG0194|consen 293 CLYSKK-------GVVKISDFGLSRAGSQYVMK----------KFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVL 351 (474)
T ss_pred heecCC-------CeEEeCccccccCCcceeec----------cccccCcceecChhhhcc----Cccccccchhheeee
Confidence 999876 45899999998765311111 011124578999999986 689999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHH-HcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 723 LLELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 723 LyELLT-G~~PF~~~~~~~i~~~I-~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||+++ |..||.+....++...| ..+.+...+. ..+..+..++.+||..+|
T Consensus 352 ~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 352 LWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDP 404 (474)
T ss_pred EEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCCh
Confidence 999999 88999999999999998 4455544432 225678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
+.||++.++.+.|+.+.....
T Consensus 405 ~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 405 EDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred hhccCHHHHHHHHHHHHhccc
Confidence 999999999999998876644
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.10 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=201.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
.+.+|.+.++||+|+||.||++.. .+..+++|... .. ...... .+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EA--SESARQ----DFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC--cC--CHHHHH----HHHHHHHHHhcCCCCCCceEEE
Confidence 456789999999999999999974 23466777642 21 222233 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----------CCCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----------~~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
++..... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||+
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 75 VCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred EEecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 9876553 49999999999999999763210 11357889999999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~ 710 (825)
+||+||||||+|||++.+ ..+||+|||++.......... ......+++.|+|||++.+ ..+
T Consensus 141 ~~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~ 201 (280)
T cd05092 141 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYYR--------VGGRTMLPIRWMPPESILY----RKF 201 (280)
T ss_pred CCeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCceee--------cCCCccccccccCHHHhcc----CCc
Confidence 999999999999999876 469999999987553221110 0122345788999999876 568
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003375 711 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 789 (825)
Q Consensus 711 s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 789 (825)
+.++|||||||++|||++ |.+||...........+..+..+..+ ...++.+.
T Consensus 202 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 254 (280)
T cd05092 202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP---------------------------RTCPPEVY 254 (280)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC---------------------------CCCCHHHH
Confidence 899999999999999998 99999877776666665554322211 11245789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+||.+||+.||.+||++.+|++.|++
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.17 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=204.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.+.||+|+||.||+|.. ....+++|..... ... .+. +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMS---PEA----FLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccC---HHH----HHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 4567899999999999999999987 3456888875422 111 223 38899999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 74 ~~--------------~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili 136 (261)
T cd05034 74 EP--------------IYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136 (261)
T ss_pred Cc--------------eEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE
Confidence 43 4999999999999999975 223468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++..+....... .....++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~~~---------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 137 GEN-------LVCKIADFGLARLIEDDEYTA---------REGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTE 196 (261)
T ss_pred cCC-------CCEEECccccceeccchhhhh---------hhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHH
Confidence 877 459999999987664311110 111234578999999976 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |+.||.+.+.......+........+. ..+..+.+++.+||..+|.+||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVERGYRMPRPP---------------------------NCPEELYDLMLQCWDKDPEERP 249 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcccCcccCC
Confidence 998 999998887777776665543222111 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
++.++++.|+.
T Consensus 250 ~~~~l~~~l~~ 260 (261)
T cd05034 250 TFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHhc
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.99 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=203.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..++|++.+.||+|+||.||+|.+ .+..+|+|+.... ........ +.+|+.+++++.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQAD----FQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHH----HHHHHHHHHhcCCCchheEEE
Confidence 457899999999999999999986 3467888875322 12222233 488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------------cCCCccCHHHHHHHHHHHHH
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAA 623 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------------~~~~~ls~~~i~~Ia~QIa~ 623 (825)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.
T Consensus 76 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 76 VCAVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred EEcCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 9876553 3999999999999999975211 11234788899999999999
Q ss_pred HHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 624 AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
||.|||+++++||||||+|||++.+ +.++|+|||++.......... .......+..|+|||.+.+
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYYK--------ASENDAIPIRWMPPESIFY 206 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCcccc--------ccCCCccChhhcCHHHHhc
Confidence 9999999999999999999999876 469999999987653321110 0112235678999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (825)
..++.++|||||||++|||++ |..||.+....+....+..+.....+ .
T Consensus 207 ----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~ 255 (288)
T cd05050 207 ----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP---------------------------D 255 (288)
T ss_pred ----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------C
Confidence 568899999999999999997 88999888777766666544322111 1
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 783 ~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
..+..+.+||.+||+.+|.+|||+.||++.|+.
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 256 NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 124578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.81 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=207.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
.+..+|.+.+.||+|+||.||+|... ...+|+|+.... ........ +.+|+.+++++ +||||+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLAD----LISEMELMKLIGKHKNII 81 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHH----HHHHHHHHHhccCCCCee
Confidence 45678999999999999999999752 346888875322 12223333 38899999999 599999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++..... .++||||+++|+|.+++..... .....+++..+..++.||+.||
T Consensus 82 ~~~~~~~~~~~--------------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 82 NLLGVCTQEGP--------------LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred eEEEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999876553 4999999999999999976321 1124588999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+|||++.+ +.+||+|||+++.......... .....++..|||||++.+
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-- 210 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYKK--------TSNGRLPVKWMAPEALFD-- 210 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCC-------CcEEEccccccccccccccccc--------cccCCCCccccCHHHHcc--
Confidence 99999999999999999999876 4599999999986643211100 011124568999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||++|||++ |..||.+....++...+..+.....+ ...
T Consensus 211 --~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 261 (314)
T cd05099 211 --RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------------------------SNC 261 (314)
T ss_pred --CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCC
Confidence 568899999999999999999 89999888877777766554322211 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+..+.+|+.+||..+|.+|||+.++++.|+.+..
T Consensus 262 ~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 262 THELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 4578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.36 Aligned_cols=273 Identities=22% Similarity=0.292 Sum_probs=197.0
Q ss_pred CCc-eeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 490 PSL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 490 ~~y-~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
++| ++.+.||+|+||+||++.+ .+..+|+|+..... ...... .+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTS----GWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHH----HHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345 8999999999999998763 35678999864321 112223 348899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 76 ~~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 76 SEQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred ecCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 64321 135999999999999999975 458999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ ..++|+|||++........... ......++..|+|||++.+ ..++.++||||||++
T Consensus 138 ili~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~ 199 (283)
T cd05080 138 VLLDND-------RLVKIGDFGLAKAVPEGHEYYR-------VREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVT 199 (283)
T ss_pred EEEcCC-------CcEEEeecccccccCCcchhhc-------cCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHH
Confidence 999876 4599999999986643221100 0111235677999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|||+||..||...... ....+...........+... ..... ........+..+.+|+.+||+.+|.+
T Consensus 200 l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 200 LYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL--------LERGM---RLPCPKNCPQEVYILMKNCWETEAKF 267 (283)
T ss_pred HHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh--------hhcCC---CCCCCCCCCHHHHHHHHHHhccChhh
Confidence 99999999998654321 11111110000000000000 00000 00112234568999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|||+++|++.|+.+.
T Consensus 268 Rps~~~i~~~l~~~~ 282 (283)
T cd05080 268 RPTFRSLIPILKEMH 282 (283)
T ss_pred CCCHHHHHHHHHHhh
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.00 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=202.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||.|+||.||+|.. .+..+++|+...... ...+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFE----IIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHH----HHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999999997 457799998764321 1223 3489999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. +|++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 74 ~--------------~~l~~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 74 K--------------LWIVMEYCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred E--------------EEEEEeCCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 3 5999999999999999876 125689999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....++..|+|||++.+... ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 136 ED-------GDVKLADFGVSAQLTATIAK----------RKSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CC-------CCEEECccccchhhhhhhhc----------cccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHH
Confidence 77 45999999998765432111 123468889999999875211 2678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||...+.......+......... .......+..+.+||.+||..+|.+|||+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPK-----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCH
Confidence 9999999887765554444332111000 00112235679999999999999999999
Q ss_pred HHHHHH
Q 003375 807 GDLYEM 812 (825)
Q Consensus 807 ~EIL~h 812 (825)
.+|+.|
T Consensus 255 ~~il~~ 260 (262)
T cd06613 255 TKLLQH 260 (262)
T ss_pred HHHhcC
Confidence 999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.44 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
++||+|+||.||+|.+.. ..+++|+..... .. ... ..+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~--~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IA-AGK----KEFLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc--ch-HHH----HHHHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998622 468888754221 11 222 3448999999999999999999987532
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||.++++|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 24999999999999999986 2468999999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 729 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G 729 (825)
+.+||+|||+++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYYR-------ATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCcccc-------cccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 4599999999986643221100 0111124568999999875 568899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
..||...+..++...+........+ ...+..+.+||.+||..+|.+||++.+|
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRP---------------------------EECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999888777776666554322111 1124578999999999999999999999
Q ss_pred HHHHHhhc
Q 003375 810 YEMFVART 817 (825)
Q Consensus 810 L~hL~~l~ 817 (825)
++.|+.+.
T Consensus 249 ~~~l~~~~ 256 (257)
T cd05060 249 ESTFRRDP 256 (257)
T ss_pred HHHHHhcc
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.29 Aligned_cols=246 Identities=21% Similarity=0.334 Sum_probs=186.5
Q ss_pred eecccCceEEEEEEEC--------------------------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC
Q 003375 497 EAGKSVSSSLFRCKFG--------------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 550 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~~--------------------------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L 550 (825)
.||+|+||.||+|... ...+++|+.... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 6999999999998741 124666664211 112223458899999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 551 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 551 ~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
+||||+++++++..... .++||||+++++|..++.. ....+++..+..++.||+.||+|||+
T Consensus 74 ~h~niv~~~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 74 SHIHLAFVHGVCVRGSE--------------NIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCeeeEEEEEEeCCc--------------eEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 99999999999986654 3999999999999999864 23568899999999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~ 710 (825)
+||+||||||+|||++..+........+||+|||++...... ....++..|+|||.+.+ ...+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~ 198 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSL 198 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCC
Confidence 999999999999999875432223456899999987543221 11247888999999865 2457
Q ss_pred CchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003375 711 GLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 789 (825)
Q Consensus 711 s~kSDVWSLGvILyELL-TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 789 (825)
+.++|||||||++|||+ +|..||....+.+....+.... .++ ......+.
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~ 249 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH--RLP---------------------------EPSCKELA 249 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc--CCC---------------------------CCCChHHH
Confidence 89999999999999995 7999998766554433222111 001 00124689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
+||.+||+.+|.+|||+.+|+++|.
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHhhC
Confidence 9999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.11 Aligned_cols=289 Identities=21% Similarity=0.219 Sum_probs=208.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||+|.+ .+..+++|.+........ .......+..|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~- 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN- 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE-
Confidence 488899999999999999997 467899998754432211 11122344789999999999999999999986543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 77 -------------~~lv~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 77 -------------INLVFEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred -------------EEEEEccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 59999999 8999999975 11368999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....+++.|+|||.+.+ ...++.++|||||||++|||++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNRK----------MTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCcc----------ccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 45999999999766432111 122356889999999864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|.+||.+.+.......+...........+...........................+..+.+||.+||.+||.+|||+.+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 99889877766555544432211111111111000000000000111111122334678999999999999999999999
Q ss_pred HHHHHHhhcCCCC
Q 003375 809 LYEMFVARTSSSI 821 (825)
Q Consensus 809 IL~hL~~l~sss~ 821 (825)
+++|-+-.....+
T Consensus 279 ~l~~~~~~~~~~~ 291 (298)
T cd07841 279 ALEHPYFSNDPAP 291 (298)
T ss_pred HhhCccccCCCCC
Confidence 9999655544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.33 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=201.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|++.+.||+|+||.||+|.. .+..+++|....... ...+. +.+|+.+++.+.||||+++++.+...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 457899999999999999999986 567888887654321 12233 38899999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. ..|+||||+++++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 90 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 90 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 35999999999999999875 457899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....|++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~ 208 (296)
T cd06654 150 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 208 (296)
T ss_pred cCC-------CCEEECccccchhccccccc----------cCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHH
Confidence 876 45999999998765332110 122368899999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||....+......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 209 MIEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred HHhCCCCCCCCCHHHhHHHHhcCCCCCCC-------------------------CccccCHHHHHHHHHHCcCCcccCcC
Confidence 99999999877654433322222111111 01123457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.+|++|-....
T Consensus 264 ~~eil~~~~~~~ 275 (296)
T cd06654 264 AKELLQHQFLKI 275 (296)
T ss_pred HHHHhhChhhhc
Confidence 999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.27 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=202.4
Q ss_pred CCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
-.+|.+.+.||+|+||.||+|.+.. ..+++|..... ......+ .+.+|+.+++++.||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVRE----KFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHH----HHHHHHHHHHhCCCCchhceeEEEc
Confidence 4568899999999999999998632 35777765322 1122223 3489999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
... .++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.|++|+||||+||
T Consensus 78 ~~~---------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni 138 (270)
T cd05056 78 ENP---------------VWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138 (270)
T ss_pred CCC---------------cEEEEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence 432 3899999999999999975 224589999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ ..++|+|||++.......... .....++..|+|||.+.. ..++.++|||||||++
T Consensus 139 li~~~-------~~~~l~d~g~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 198 (270)
T cd05056 139 LVSSP-------DCVKLGDFGLSRYLEDESYYK---------ASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 198 (270)
T ss_pred EEecC-------CCeEEccCceeeeccccccee---------cCCCCccccccChhhhcc----CCCCchhhhHHHHHHH
Confidence 99876 469999999987664321110 111234568999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++ |..||.+....+....+.++.....+ ...+..+.+||.+||..+|.+
T Consensus 199 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhh
Confidence 99986 99999888776666666554332221 112457999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003375 803 RPTAGDLYEMFVARTS 818 (825)
Q Consensus 803 RPSa~EIL~hL~~l~s 818 (825)
|||+.+++..|..+..
T Consensus 252 Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 252 RPRFTELKAQLSDILQ 267 (270)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.00 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=192.8
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeeeEecCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
||+|+||.||+|++ .+..+|+|++....... ..... .+..|..++..+ .||||+++++++.....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----- 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVA----HTIGERNILVRTLLDESPFIVGLKFSFQTDSD----- 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHH----HHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----
Confidence 79999999999987 46789999865322111 11111 225677776665 69999999999886654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 71 ---------LYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred ---------EEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 4999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.++|+|||++........ ......||+.|+|||++.+ ...++.++|||||||+||+|++|..|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDNK----------TTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCCC----------CccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 4599999999875322111 1133469999999999875 23478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 808 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP----Sa~E 808 (825)
|.+.+..++...+..+... ++. ...++.+.+||.+||..||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~-~~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVR-FPK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 9988877777666544221 110 01245789999999999999998 7899
Q ss_pred HHHHHHh
Q 003375 809 LYEMFVA 815 (825)
Q Consensus 809 IL~hL~~ 815 (825)
+++|.+.
T Consensus 250 ll~h~~~ 256 (330)
T cd05586 250 LKEHPFF 256 (330)
T ss_pred HhcCccc
Confidence 9988543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.67 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=207.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
-.+|++.+.||+|+||.||+|.+. ...+|+|+.... ......+.+ .+|+.+++++ +||||+++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~----~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDL----VSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHH----HHHHHHHHhhcCCCCeeee
Confidence 347899999999999999999752 235788875421 122233334 8999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
++++..... .++||||+++|+|.+++..... .....+++..+..++.||+.||+|
T Consensus 84 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 149 (334)
T cd05100 84 LGACTQDGP--------------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149 (334)
T ss_pred eEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 999876553 4999999999999999976321 112357888999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+
T Consensus 150 LH~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 210 (334)
T cd05100 150 LASQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD---- 210 (334)
T ss_pred HHHCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----
Confidence 999999999999999999876 459999999997654321110 0111234568999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 708 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
..++.++|||||||+||||++ |..||.+.+..+....+.....+..+. ..+.
T Consensus 211 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 263 (334)
T cd05100 211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTH 263 (334)
T ss_pred CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCH
Confidence 667889999999999999998 899998888777777665543322211 1245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+.+|+.+||+.+|.+||++.+|+++|+.+.....
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 78999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.34 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=185.2
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||+|+||.||++.. .+..+|+|....+..... ... ..+..|+.++++++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~----~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-------- 67 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGE----KMALLEKEILEKVNSPFIVNLAYAFESKTH-------- 67 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhh----HHHHHHHHHHHhcCCCcEEEEEEEEecCCe--------
Confidence 79999999999987 467888887643221111 111 123679999999999999999999876543
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.|+||||++|++|..++.. .....+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 68 ------~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 68 ------LCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred ------EEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 4999999999999998865 233458899999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
..++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4599999999876543211 122358999999999976 5588999999999999999999999976
Q ss_pred CCHH----HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----
Q 003375 736 LSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG---- 807 (825)
Q Consensus 736 ~~~~----~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~---- 807 (825)
.... ++......... . ......+..+.+||.+||+.||.+||++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEV---K------------------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CcchhhHHHHHHHhhcccc---c------------------------cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 4321 11111111100 0 00012355789999999999999999994
Q ss_pred HHHHH
Q 003375 808 DLYEM 812 (825)
Q Consensus 808 EIL~h 812 (825)
+++.|
T Consensus 250 ~~~~h 254 (277)
T cd05607 250 DPRKH 254 (277)
T ss_pred hhhcC
Confidence 45555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.23 Aligned_cols=279 Identities=24% Similarity=0.295 Sum_probs=202.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..+|+|+...... .... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVI----KKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--Cccc----cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 4789999999999999999997 467899998653321 1111 1234889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 75 --------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 75 --------------LHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred --------------EEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 4999999998888877654 346899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++......... .....++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGDD----------YTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCccc----------ccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 6 46999999999876432210 122357889999999875 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|..||.+....+....+.......+........... ....................+..+.+|+.+||..+|.+||
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 9999998877655554444322211111110000000 0000000000000111223467899999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
++.+++.|.
T Consensus 276 ~~~eil~~~ 284 (286)
T cd07847 276 SCEELLEHP 284 (286)
T ss_pred CHHHHhcCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=311.86 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=200.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..+|++.+.||+|+||.||++.+. +..+++|+.... ... ... +.+|+.+++++.||||+++++++.....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMS---EED----FIEEAQVMMKLSHPKLVQLYGVCTERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCC---HHH----HHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence 457899999999999999999874 677888875422 111 122 3889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+++.
T Consensus 74 --------------~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 74 --------------ICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 4999999999999999875 2245789999999999999999999999999999999999986
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 46999999998765332111 0112235678999999876 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+ |..||.......+...+..+..+..+. ..+..+.+|+.+||..+|.+|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKPR---------------------------LASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCCCH
Confidence 8 999998877777666665443221111 024579999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.+++++|.
T Consensus 249 ~~~l~~l~ 256 (256)
T cd05112 249 SLLLHQLA 256 (256)
T ss_pred HHHHHhhC
Confidence 99999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.97 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=188.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||+|+||.||+|.. ++..+|+|+...... ......+ .+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----- 70 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDID----WVQTEKHVFEQASSNPFLVGLHSCFQTTSR----- 70 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-----
Confidence 4799999999999987 567899998753321 1112222 348899999888 59999999999876553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 71 ---------LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 5999999999999998875 3569999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCCc----------eecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 45999999998753221111 123469999999999976 6788999999999999999999999
Q ss_pred CCCCC------H-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 733 YMGLS------E-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 733 F~~~~------~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|.... . ..+...+... ...++ ...+..+.++|.+||..||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-PIRIP---------------------------RFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHcCC
Confidence 95421 1 1122222211 11111 112456899999999999999998
Q ss_pred ------HHHHHHHH
Q 003375 806 ------AGDLYEMF 813 (825)
Q Consensus 806 ------a~EIL~hL 813 (825)
+.++++|.
T Consensus 248 ~~~~~~~~~i~~h~ 261 (327)
T cd05617 248 CQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCCHHHHHcCC
Confidence 56888874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.27 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=204.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||.++. .+..+++|...... ........+ .+|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~----~~e~~~l~~~~h~~i~~~~~~~~~~~~- 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDA----LNEIVILSLLQHPNIIAYYNHFMDDNT- 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHH----HHHHHHHHhCCCCCeeEEEeEEecCCe-
Confidence 589999999999999988886 56778888765433 222333334 899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 74 -------------~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 74 -------------LLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred -------------EEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 59999999999999999862 23568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..+||+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|||++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 4599999999876543221 1123468999999999876 456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...+..+....+..+..+... ...+..+.++|.+||..+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999887777766666554322211 122457899999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++++
T Consensus 250 ll~~~ 254 (256)
T cd08221 250 VLDQP 254 (256)
T ss_pred HhhCc
Confidence 99885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=312.64 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=202.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.. .+..+++|.+.... ........ +.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERLA----AQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc--cccHHHHH----HHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 589999999999999999887 67788998865332 22233333 489999999999999999999887554
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 359999999999999999762 23458899999999999999999999999999999999999755
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ ..++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 4689999999987643211 122458899999999875 557889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||.+.+.......+.......++. ..+..+.+++.+||..+|.+|||+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISD---------------------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCC---------------------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998877666555554443222221 12457899999999999999999999
Q ss_pred HHHH
Q 003375 809 LYEM 812 (825)
Q Consensus 809 IL~h 812 (825)
+++|
T Consensus 250 ll~~ 253 (256)
T cd08220 250 IMAQ 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=315.22 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEECC----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
+.||+|+||.||+|.+.+ ..+++|..... .. ..... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~--~~-~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--AS-VQEQM----KFLEEAQPYRSLQHSNLLQCLGQCTEVTP---- 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC--CC-hHHHH----HHHHHHHHHHhCCCCCEeeEEEEEcCCCC----
Confidence 368999999999998632 35677764322 11 22222 34889999999999999999999876554
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.++||||+++|+|.+++..........+++..+..++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 70 ----------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ----------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 3999999999999999976332223456778888999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC---CCCCchhhHHHHHHHHHHHHh
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~---~~~s~kSDVWSLGvILyELLT 728 (825)
.+++|+|||++......... .......++..|+|||++.+.... ..++.++|||||||++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 56999999998654322111 011234578899999998642111 235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|..||......+............++ .+......++.+.+++.+|| .+|.+|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLP----------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCC----------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 99999877665544332222111111 01111123456889999999 6899999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
+|+..|.
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=347.50 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=218.2
Q ss_pred CCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-+-|.|+..||.|+||.||+|.... ...|.|++.. ...++++.| +-||.||..+.||+||++++.|..++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDy----lVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDY----LVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccC
Confidence 3457899999999999999998754 3456666432 245666666 89999999999999999999988777
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.+ ||+.|||.||..+.++-.. ...+.+.++..+++|++.||.|||+++|||||||..|||++
T Consensus 103 kL--------------wiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 103 KL--------------WILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT 164 (1187)
T ss_pred ce--------------EEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE
Confidence 55 9999999999999988763 46799999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyE 725 (825)
.+|+ ++|+|||.+....... .....++|||+|||||++++.. ...+|..++||||||++|.|
T Consensus 165 ldGd-------irLADFGVSAKn~~t~----------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE 227 (1187)
T KOG0579|consen 165 LDGD-------IRLADFGVSAKNKSTR----------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE 227 (1187)
T ss_pred ecCc-------EeeecccccccchhHH----------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence 9954 9999999986544322 1246778999999999987542 33679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|..+.+|....+++.++-.|.+...|.+-.. ...+..+.+|+.+||..||..||+
T Consensus 228 MAqiEPPHhelnpMRVllKiaKSePPTLlqP-------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 228 MAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-------------------------SHWSRSFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred HhccCCCccccchHHHHHHHhhcCCCcccCc-------------------------chhhhHHHHHHHHHHhcCCccCCC
Confidence 9999999999999999999988766655421 112457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.+|++|.+.-.
T Consensus 283 aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 283 AAQLLKHPFVQN 294 (1187)
T ss_pred HHHHhhCccccc
Confidence 999999976543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.91 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+.||+|+||.||+|.+. ...+|+|... .. ......+.+ .+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~--~~-~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQF----LKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecC--cc-CCHHHHHHH----HHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 46899999999999862 2457777642 11 122233333 889999999999999999997764332
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
..++||||+.+++|.+++.. ....+++..+..++.||+.||+|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 24899999999999999975 12346778889999999999999999999999999999999876
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 729 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G 729 (825)
+.+||+|||+++.+........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYSV------HNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCcceee------cccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 4599999999976543211100 00122346778999999875 567899999999999999999 5
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
.+||...+.......+..+..+..+. ..+..+.+++.+||..+|.+||++.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 67787776666655554443222111 124578999999999999999999999
Q ss_pred HHHHHhhcC
Q 003375 810 YEMFVARTS 818 (825)
Q Consensus 810 L~hL~~l~s 818 (825)
++.|+.+..
T Consensus 253 l~~l~~~~~ 261 (262)
T cd05058 253 VSRIEQIFS 261 (262)
T ss_pred HHHHHHHhc
Confidence 999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.21 Aligned_cols=265 Identities=24% Similarity=0.360 Sum_probs=200.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 559 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~ 559 (825)
+.++|++.+.||+|+||.||+|.+ .+..||||+.+... ....... +.+|+.+|.++ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA----LMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHH----HHHHHHHHHhccCCccHhhhc
Confidence 346899999999999999999974 35679999864321 2222333 38999999999 589999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------------------------------
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------------------------------- 604 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----------------------------------- 604 (825)
+++..... ..++||||+++|+|.+++......
T Consensus 78 ~~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 78 GACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred ceeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 98865432 258999999999999999752100
Q ss_pred ---------------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCe
Q 003375 605 ---------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657 (825)
Q Consensus 605 ---------------------------~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~ 657 (825)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~ 217 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NV 217 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------Cc
Confidence 01246788889999999999999999999999999999999876 46
Q ss_pred EEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003375 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGL 736 (825)
Q Consensus 658 vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~ 736 (825)
+||+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 218 ~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 218 VKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred EEEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 999999998765332111 00122345678999999876 567899999999999999997 99999765
Q ss_pred CHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 737 SEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 737 ~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
... .....+..+..+..+. ..++.+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred cccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 432 2333333332222111 123468999999999999999999999999998
Q ss_pred hcC
Q 003375 816 RTS 818 (825)
Q Consensus 816 l~s 818 (825)
+..
T Consensus 339 ~~~ 341 (343)
T cd05103 339 LLQ 341 (343)
T ss_pred HHh
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.75 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=201.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC--C---eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~---~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
-++|+..+.||+|+||.||+|... + ..+++|..... ......+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQD----FLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHH----HHHHHHHHhcCCCCCeeEEEEEEc
Confidence 357889999999999999999873 2 25777764322 12222333 489999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.||+|+||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 77 KFKP--------------AMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred cCCC--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 6554 3999999999999999975 234689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ ..+||+|||++........... .......++.|+|||++.. ..++.++|||||||++
T Consensus 139 li~~~-------~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il 200 (268)
T cd05063 139 LVNSN-------LECKVSDFGLSRVLEDDPEGTY-------TTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 200 (268)
T ss_pred EEcCC-------CcEEECCCccceecccccccce-------eccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHH
Confidence 99876 4699999999876643211100 0111123467999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++ |..||...+...+...+......... ...+..+.+|+.+||+.+|.+
T Consensus 201 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 201 WEVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99997 99999887777766666544221111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
||++.+|++.|.++
T Consensus 254 Rp~~~~i~~~l~~~ 267 (268)
T cd05063 254 RPRFVDIVNLLDKL 267 (268)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.40 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=203.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||++.. .+..+++|....... .....+. +.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREE----SRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHH----HHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 589999999999999999987 567889998654322 2222333 389999999999999999999987554
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+.+++|.+++.. .....+++..++.++.||+.||.|||++|++|+||+|+|||++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 35999999999999999875 222457899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVEL----------ARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchhh----------hhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 45999999999765432211 122358889999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...+..+....+..+..+..+. ..+..+.++|.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998877777766666554332221 12457899999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
|++|-
T Consensus 250 vl~~~ 254 (256)
T cd08218 250 ILEKN 254 (256)
T ss_pred HhhCc
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.93 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=200.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||++.+ .+..+|+|+...... ..... ...+.+|+.++..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAE----TACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhH----HHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 4789999999999999999997 456788888642111 01111 1234789999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 76 --------------LYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred --------------EEEEEeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 5999999999999999975 1246899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyEL 726 (825)
+ +.+||+|||++..+...... ......||+.|+|||++.+.. ....++.++|||||||+||||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCcc---------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 6 45999999998755321111 112346999999999997422 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e--R 803 (825)
++|+.||...+..+....+.... ...++. .....+..+.+||.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFPA------------------------QVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCCC------------------------ccccCCHHHHHHHHHHccChhhhcCC
Confidence 99999999888777776665432 111111 11223567899999999665544 6
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
+++.++++|.
T Consensus 258 ~~~~~~~~h~ 267 (332)
T cd05623 258 NGIEDFKQHP 267 (332)
T ss_pred CCHHHHhCCC
Confidence 8999999994
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=321.89 Aligned_cols=268 Identities=20% Similarity=0.287 Sum_probs=199.7
Q ss_pred CCCCceeeeeecccCceEEEEEEECC----------------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 551 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~ 551 (825)
+..+|++.+.||+|+||.||+|...+ ..+|+|+.... ........ +.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARND----FLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHH----HHHHHHHHHhCC
Confidence 45689999999999999999987632 24777775322 12222333 489999999999
Q ss_pred CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-------cCCCccCHHHHHHHHHHHHHH
Q 003375 552 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------TGEKHVSVKLALFIAQDVAAA 624 (825)
Q Consensus 552 HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------~~~~~ls~~~i~~Ia~QIa~A 624 (825)
||||+++++++..... .++||||+++++|.+++..... .....+++..++.++.||+.|
T Consensus 76 h~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 76 NPNIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred CCCcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 9999999999876554 4999999999999999965210 011246788999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003375 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704 (825)
Q Consensus 625 L~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~ 704 (825)
|+|||++|++|+||||+|||++.+ +.+||+|||++......... .......++..|+|||++..
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 205 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL- 205 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc-
Confidence 999999999999999999999876 45999999998765332111 00122345778999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 003375 705 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782 (825)
Q Consensus 705 ~~~~~~s~kSDVWSLGvILyELLT--G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (825)
..++.++|||||||++|+|++ +..||...+..+....+........... ......
T Consensus 206 ---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~ 262 (295)
T cd05097 206 ---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI--------------------YLSQTP 262 (295)
T ss_pred ---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc--------------------cCCCCC
Confidence 568899999999999999998 6788887776665544432111000000 000011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 783 ~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
..++.+.+|+.+||..||.+||++.+|++.|+.
T Consensus 263 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 235679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=315.24 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~--~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~ 570 (825)
+.||+|+||.||+|.+.+ . .+++|.. +.. ......+. +.+|+.++.++ +||||+++++++......
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-- 71 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEY-ASKDDHRD----FAGELEVLCKLGHHPNIINLLGACEHRGYL-- 71 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEc--ccc-CCHHHHHH----HHHHHHHHHhhccCCCeeeEEEEEecCCCc--
Confidence 368999999999999743 2 3455543 221 11222233 38899999999 799999999998866543
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLK 639 (825)
++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|++|||||
T Consensus 72 ------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dik 139 (270)
T cd05047 72 ------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 139 (270)
T ss_pred ------------eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 999999999999999975211 112357899999999999999999999999999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSL 719 (825)
|+|||++.+ +.+||+|||++........ ......+..|+|||++.. ..++.++|||||
T Consensus 140 p~nili~~~-------~~~kl~dfgl~~~~~~~~~-----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 197 (270)
T cd05047 140 ARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTTNSDVWSY 197 (270)
T ss_pred cceEEEcCC-------CeEEECCCCCccccchhhh-----------ccCCCCccccCChHHHcc----CCCCchhhHHHH
Confidence 999999876 5699999999853221100 011124567999999875 567899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 720 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 720 GvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
||++|||++ |..||.+.+.......+........+ ...+..+.+|+.+||..
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 250 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWRE 250 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHccc
Confidence 999999997 99999887766666555443221111 11245789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003375 799 NPTERPTAGDLYEMFVART 817 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ 817 (825)
||.+|||+.++++.|..+.
T Consensus 251 ~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 251 KPYERPSFAQILVSLNRML 269 (270)
T ss_pred ChhhCCCHHHHHHHHHHhh
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.49 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=201.4
Q ss_pred CceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
+|++.+.||.|+||.||+|.. .+..+|+|+...+... .....+....+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-- 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe--
Confidence 478899999999999999986 6677999986654322 12222223456899999999999999999999886653
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+|+|+||+|+||+++.+
T Consensus 77 ------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 77 ------------ISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred ------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 4999999999999999975 2457899999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||++............ ........|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGTH----SNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhccccccc----cccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 46999999998765321111000 001123458999999999976 5678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC--CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 730 QVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
..||...+.......+... ..+.++ ...+..+.++|.+||..+|.+||++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP---------------------------DSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC---------------------------CCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 9999876554433333222 111111 12356789999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
+++.|-
T Consensus 258 ~~l~~~ 263 (265)
T cd06631 258 QLLRHD 263 (265)
T ss_pred HHhcCC
Confidence 999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.38 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=202.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.+.||+|+||.||++.+ .+..+++|..... ....+. +.+|+.++++++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEA----FLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHH----HHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4567899999999999999999986 4456888875321 122233 4889999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. ..++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus 73 ~--------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i 135 (260)
T cd05073 73 E--------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 135 (260)
T ss_pred C--------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 2 24999999999999999975 223457888999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.. +.+||+|||++..+...... ......++..|+|||++.. ..++.++|||||||++|+
T Consensus 136 ~~~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 136 SAS-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLME 195 (260)
T ss_pred cCC-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHH
Confidence 876 56999999999765432111 1112245678999999975 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+| |..||.+.+...+...+........+ ...+..+.+++.+||+.+|.+||
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCc
Confidence 999 99999888777666665544221111 11245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
++.++++.|+.
T Consensus 249 ~~~~l~~~L~~ 259 (260)
T cd05073 249 TFEYIQSVLDD 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.76 Aligned_cols=267 Identities=26% Similarity=0.368 Sum_probs=201.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|.. .+..+++|+.... . .... .+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~---~~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--H---DIDE----EIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--c---chHH----HHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4578999999999999999999987 5678899975321 1 1112 237899999999 6999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..... .....++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 86 KKDVK---------NGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred ecccC---------CCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 43211 12357999999999999999875322 235688999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvI 722 (825)
+++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||+
T Consensus 156 li~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 156 LLTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99877 3499999999876543211 112346899999999986421 12457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|||++|+.||...........+.....+.+. . ....+..+.+||.+||+.||.+
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------Q---PELWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------C---CCCcCHHHHHHHHHHccCCccc
Confidence 99999999999876654433322222111110 0 0012346899999999999999
Q ss_pred CCCHHHHHHHHH
Q 003375 803 RPTAGDLYEMFV 814 (825)
Q Consensus 803 RPSa~EIL~hL~ 814 (825)
|||+.||++|+.
T Consensus 274 Rps~~ell~~~~ 285 (286)
T cd06638 274 RPTVSDLLQHVF 285 (286)
T ss_pred CCCHHHHhhccc
Confidence 999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.72 Aligned_cols=254 Identities=30% Similarity=0.448 Sum_probs=206.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||.|+||.||+|.+ .+..+++|+..... .......+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDI----QQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHH----HHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 4688999999999999999997 56789999875432 12223333 889999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++++|+||+|+||+++.
T Consensus 74 --------------~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 74 --------------LWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred --------------EEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 5999999999999999975 37899999999999999999999999999999999999988
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||+++.+...... .....+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMSK----------RNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeecccccc----------cccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 45999999999877543211 123468899999999986 45889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
||..||...++......+.....+.+... ..+..+.+++.+||..+|.+|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEGN--------------------------KFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCccc--------------------------ccCHHHHHHHHHHhhCChhhCcCHH
Confidence 99999987776655555544433322210 0345789999999999999999999
Q ss_pred HHHHHHHhhc
Q 003375 808 DLYEMFVART 817 (825)
Q Consensus 808 EIL~hL~~l~ 817 (825)
++++|-.-..
T Consensus 247 ~il~~~~~~~ 256 (274)
T cd06609 247 ELLKHKFIKK 256 (274)
T ss_pred HHhhChhhcC
Confidence 9999865543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.75 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=200.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||.|+||.||+|.+. +..+++|...... ..+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQ----EIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHH----HHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 468999999999999999999984 5788888864321 123 3489999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|++|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+|+|+||+|.||+++
T Consensus 72 ~--------------~~l~~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 72 D--------------LWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred c--------------EEEEEecCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 3 4999999999999999975 235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 134 ~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l 192 (256)
T cd06612 134 EE-------GQAKLADFGVSGQLTDTMAK----------RNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEM 192 (256)
T ss_pred CC-------CcEEEcccccchhcccCccc----------cccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999998876432211 123458899999999976 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|+.||...........+.....+.+. .....+..+.++|.+||+.||.+|||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 193 AEGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred HhCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 9999999876654433333222111111 011234578999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+|++|-
T Consensus 248 ~~il~~~ 254 (256)
T cd06612 248 IQLLQHP 254 (256)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.34 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--C----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--S----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|.+. + ..+++|+.... ....... .+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANK----EILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC---CCHHHHH----HHHHHHHHHHhCCCCCcceEEE
Confidence 44578999999999999999999863 2 24677764322 1122223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.. . ..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 77 ~~~~-~--------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 77 ICLS-S--------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEec-C--------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 9875 2 24999999999999999975 234589999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ ..+||+|||+++......... ......++..|+|||.+.. ..++.++||||||
T Consensus 138 ~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG 198 (279)
T cd05057 138 RNVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYG 198 (279)
T ss_pred ceEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHH
Confidence 99999876 459999999998765322110 0111224578999999875 5678999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+....++...+..+.....+. ..+..+.+++.+||..+
T Consensus 199 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 199 VTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMID 251 (279)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCC
Confidence 99999998 999999888777776666543222111 12346889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+||++.++++.|..+...
T Consensus 252 p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 252 AESRPTFKELINEFSKMARD 271 (279)
T ss_pred hhhCCCHHHHHHHHHHHHhC
Confidence 99999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=313.32 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=205.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
.+.++|++.+.||+|+||.||+|.+ .+..+++|+..... ...+ .+.+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~----~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEE----EIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHH----HHHHHHHHHHHhcCCCChheEEEEEE
Confidence 4578999999999999999999998 45678998865332 1222 348999999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..... ......++||||+++++|.+++..... ....+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 65420 122357999999999999999875322 235689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvI 722 (825)
+++.+ +.++|+|||++......... .....|+..|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLGR----------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchhh----------hcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99877 45999999998765432111 12346899999999986422 12456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||+|++|+.||...........+.....+.+.. ....+..+.+||.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------------------------PENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCCc-------------------------hhhcCHHHHHHHHHHhhcChhh
Confidence 999999999998765554444444332221110 1123557899999999999999
Q ss_pred CCCHHHHHHHH
Q 003375 803 RPTAGDLYEMF 813 (825)
Q Consensus 803 RPSa~EIL~hL 813 (825)
|||+.+|++|-
T Consensus 263 Rpt~~~ll~~~ 273 (275)
T cd06608 263 RPFMEELLEHP 273 (275)
T ss_pred CcCHHHHhcCC
Confidence 99999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.51 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=194.6
Q ss_pred eeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 574 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~ 574 (825)
+.||+|+||.||+|.. .+..+|+|+.... ..... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~---~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED---LPQEL----KIKFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc---CCHHH----HHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 4689999999999986 4567888875321 11222 2234899999999999999999999876654
Q ss_pred CccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCC
Q 003375 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654 (825)
Q Consensus 575 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~ 654 (825)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRK----KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 3999999999999999875 22457899999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 733 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF 733 (825)
+.+||+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIYS---------SSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceeccccccc---------cCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 46999999998754321111 0111234678999999875 567889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 734 ~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
.+.........+....+...+ ...+..+.+|+.+||..+|.+||++.++++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCP---------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 888776666655544322111 11345799999999999999999999999987
Q ss_pred H
Q 003375 814 V 814 (825)
Q Consensus 814 ~ 814 (825)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.49 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=198.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..+++|+.+... ...... +.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~----~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAV----VQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHH----HHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 346899999999999999999987 57789999865432 112222 37899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||+
T Consensus 79 ~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 139 (267)
T cd06645 79 DK--------------LWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred CE--------------EEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 53 4999999999999999875 3568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++........ ......|++.|+|||++... ....++.++|||||||++|+
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~ 201 (267)
T cd06645 140 TDN-------GHVKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred CCC-------CCEEECcceeeeEccCccc----------ccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHH
Confidence 876 4599999999876532111 11234689999999998521 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++|..||....+......+.... .+... ......+..+.++|.+||..+|++||
T Consensus 202 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~ 257 (267)
T cd06645 202 LAELQPPMFDLHPMRALFLMTKSNFQPPKL------------------------KDKMKWSNSFHHFVKMALTKNPKKRP 257 (267)
T ss_pred HhcCCCCcccccchhhHHhhhccCCCCCcc------------------------cccCCCCHHHHHHHHHHccCCchhCc
Confidence 999999997665443332222221 10000 00011245689999999999999999
Q ss_pred CHHHHHHH
Q 003375 805 TAGDLYEM 812 (825)
Q Consensus 805 Sa~EIL~h 812 (825)
++.+|++|
T Consensus 258 ~~~~ll~~ 265 (267)
T cd06645 258 TAEKLLQH 265 (267)
T ss_pred CHHHHhcC
Confidence 99999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.95 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=201.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+++. .+..+|+|+...... ...... ..+.+|+.++..++|+||+++++++...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAET----ACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4799999999999999999997 456789998642111 111112 234789999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 76 --------------LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred --------------EEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 49999999999999999751 246889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~-~~~s~kSDVWSLGvILyEL 726 (825)
+ +.+||+|||++..+...... ......||+.|+|||++.+.... ..++.++|||||||+||||
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 6 45999999999765432111 11234699999999998753211 3467899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e--R 803 (825)
++|+.||...+..+....+.... +..++. .....++.+.+||.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPS------------------------HITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCC------------------------ccccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998887776666655431 111111 11123567899999999876655 4
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
++++++++|.+
T Consensus 258 ~~~~~~~~h~~ 268 (331)
T cd05624 258 NGIEDFKKHAF 268 (331)
T ss_pred CCHHHHhcCCC
Confidence 78999998843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=321.83 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=200.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|.+.+.||+|+||.||++.+ ....+|+|+.... . .....+ .+.+|+.+++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~----~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--A-HSSERE----ALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc--C-ChHHHH----HHHHHHHHHHhccCCCCcceE
Confidence 4567899999999999999999975 2336777774322 1 122223 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL 638 (825)
++++...+. .++||||+.+++|.+++.. .....+++..+..++.||+.||.|||+++|+|+||
T Consensus 105 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 105 LGACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred EEEEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999876554 4999999999999999975 12234899999999999999999999999999999
Q ss_pred CCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 003375 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718 (825)
Q Consensus 639 KP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWS 718 (825)
||+|||++.+ ..++|+|||+++.+....... ......++..|+|||++.+ ..++.++||||
T Consensus 168 kp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws 228 (302)
T cd05055 168 AARNVLLTHG-------KIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVWS 228 (302)
T ss_pred ccceEEEcCC-------CeEEECCCcccccccCCCcee--------ecCCCCcccccCCHhhhcc----CCCCcHhHHHH
Confidence 9999999866 469999999997654322110 0122346788999999876 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 719 YGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 719 LGvILyELLT-G~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|||++|||++ |..||......... ..+..+..+..+ ...+..+.+|+.+||
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl 281 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCW 281 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 9999999998 99999876544333 222222111111 112457999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 003375 797 EENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l 816 (825)
..+|.+|||+.+|++.|+++
T Consensus 282 ~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 282 DADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCchhCcCHHHHHHHHHhh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=336.84 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l 558 (825)
++.++|.+.+.||+|+||.||+|++.+ ..||+|+.... ......+ .+.+|+.+|.++. ||||+++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~----~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST---ARSSEKQ----ALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC---CChhHHH----HHHHHHHHHHhcCCCCCeEEE
Confidence 566789999999999999999998632 57999986432 1122222 3489999999997 9999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 603 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------------------------------- 603 (825)
++++..... .++||||+++|+|.+++.....
T Consensus 107 ~~~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (401)
T cd05107 107 LGACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS 172 (401)
T ss_pred EEEEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence 999986654 3999999999999999975211
Q ss_pred ----------------------------------------------------------cCCCccCHHHHHHHHHHHHHHH
Q 003375 604 ----------------------------------------------------------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 604 ----------------------------------------------------------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
.....+++..++.++.||+.||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 252 (401)
T cd05107 173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM 252 (401)
T ss_pred ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence 0112467778899999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||+.+|+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+
T Consensus 253 ~~LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 315 (401)
T cd05107 253 EFLASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN-- 315 (401)
T ss_pred HHHhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC--
Confidence 99999999999999999999876 56999999999765332111 01122357889999999975
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
..++.++|||||||++|||++ |..||......+.. ..+..+.++..+ ..
T Consensus 316 --~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~ 366 (401)
T cd05107 316 --NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AH 366 (401)
T ss_pred --CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CC
Confidence 567899999999999999998 89999776544433 333333322211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.+..+.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2457999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=319.47 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=202.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+-+.|++.+.||.|+||.||+|.. .+..+++|+.... .....+.+ .+|+.+++.++||||+++++.+...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 346799999999999999999997 4577888876432 22333334 8899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|..++.+ ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 82 ~~--------------~~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 82 GK--------------LWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred Ce--------------EEEEEecCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 53 4999999999999988764 13468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILy 724 (825)
+.+ +.++|+|||++......... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 144 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 144 TLD-------GDIKLADFGVSAKNVKTLQR----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred cCC-------CCEEEccCccceeccccccc----------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 876 45999999988654321111 12345889999999985321 1245688999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|..||...+.......+.....+.+.. ....+..+.+||.+||..+|.+||
T Consensus 207 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 207 EMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred HHhcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCc
Confidence 9999999998776655554444332221110 012245689999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
++.++++|..-
T Consensus 262 ~~~~il~~~~~ 272 (292)
T cd06644 262 SAAQLLEHPFV 272 (292)
T ss_pred CHHHHhcCccc
Confidence 99999998553
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=315.42 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=199.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~ 566 (825)
+.|++.+.||+|+||.||+|.+ .+..+|+|+..... ..... +.+|+.++.++ +||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHH----HHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4688899999999999999987 56678888865321 11223 37899999998 6999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......|+||||+.+++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||||+||+++
T Consensus 77 ~~--------~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~ 145 (272)
T cd06637 77 PP--------GMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145 (272)
T ss_pred CC--------CCCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence 11 112357999999999999999975 2234688999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyE 725 (825)
.+ ..++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++||
T Consensus 146 ~~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 146 EN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred CC-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 77 4599999999876533111 123346899999999986422 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||...........+.....+.+. ....+..+.+||.+||..+|.+|||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCC--------------------------CCCcCHHHHHHHHHHcCCChhhCCC
Confidence 99999999766554433332221111100 0112457899999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.++++|-
T Consensus 263 ~~~il~~~ 270 (272)
T cd06637 263 TEQLMKHP 270 (272)
T ss_pred HHHHhhCC
Confidence 99999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.35 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=202.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..|+..+.||.|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.+++++.||||+++++++.....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 4578889999999999999987 56789999865332 122333 34899999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||++|++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 77 --------------LWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred --------------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 4999999999999999864 45888999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~ 195 (277)
T cd06640 137 Q-------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELA 195 (277)
T ss_pred C-------CCEEEcccccceeccCCccc----------cccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHH
Confidence 6 45999999999765432111 122358889999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||....+......+.....+.+. ...+..+.+|+.+||..+|.+||++.
T Consensus 196 tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06640 196 KGEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAK 248 (277)
T ss_pred HCCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHH
Confidence 999999877766555444333222221 12356789999999999999999999
Q ss_pred HHHHHHHh
Q 003375 808 DLYEMFVA 815 (825)
Q Consensus 808 EIL~hL~~ 815 (825)
+++.|...
T Consensus 249 ~il~~~~~ 256 (277)
T cd06640 249 ELLKHKFI 256 (277)
T ss_pred HHHhChHh
Confidence 99998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.79 Aligned_cols=267 Identities=20% Similarity=0.305 Sum_probs=198.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 550 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~------------------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L 550 (825)
.++|++.+.||+|+||.||++.+. ...+|+|+.... ....... .+.+|+.+++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~----~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARN----DFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHH----HHHHHHHHHHhC
Confidence 457999999999999999998642 235777775422 1122223 348999999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc------CCCccCHHHHHHHHHHHHHH
Q 003375 551 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAA 624 (825)
Q Consensus 551 ~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~i~~Ia~QIa~A 624 (825)
+||||+++++++...... ++||||+++++|.+++...... ....+++..++.++.||+.|
T Consensus 77 ~~~~i~~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05095 77 KDPNIIRLLAVCITSDPL--------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG 142 (296)
T ss_pred CCCCcceEEEEEecCCcc--------------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence 999999999998766543 9999999999999999763211 11347788999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 003375 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704 (825)
Q Consensus 625 L~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~ 704 (825)
|+|||+.||+|+||||+|||++.+ +.++|+|||++..+...... .......+++.|+|||...+
T Consensus 143 l~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~- 206 (296)
T cd05095 143 MKYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL- 206 (296)
T ss_pred HHHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc-
Confidence 999999999999999999999876 45999999998765332111 00122245678999998875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 003375 705 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782 (825)
Q Consensus 705 ~~~~~~s~kSDVWSLGvILyELLT--G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (825)
..++.++|||||||++|||++ |..||...+..+.............. . . ......
T Consensus 207 ---~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------~------~---~~~~~~ 263 (296)
T cd05095 207 ---GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR-----------Q------V---YLPKPA 263 (296)
T ss_pred ---CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc-----------c------c---cCCCCC
Confidence 568899999999999999998 78999877666554433211000000 0 0 000011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 783 ~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 264 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 264 LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.42 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=197.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|+..+.||+|+||.||+|.+ .+..+|+|+....... ... ....+.+|+.+|+.++|+||+.+++.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~----~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~- 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRK----GESMALNEKQILEKVNSQFVVNLAYAYETKDA- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhh----HHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-
Confidence 377889999999999999998 4678999986433211 111 11234789999999999999999998876553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|..++.. .+...+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 75 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 75 -------------LCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred -------------EEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 4999999999999998875 223468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 139 -------GHIRISDLGLAVKIPEGES-----------IRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEecCCcceecCCCCc-----------ccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHh
Confidence 4599999999865432111 122368999999999976 568899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS--- 805 (825)
|..||.+.........+......... ......+..+.+|+.+||+.||.+||+
T Consensus 197 g~~P~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 197 GQSPFRGRKEKVKREEVDRRVLETEE------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHhhhcccc------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 99999877654433333221110000 000122456899999999999999999
Q ss_pred --HHHHHHHH
Q 003375 806 --AGDLYEMF 813 (825)
Q Consensus 806 --a~EIL~hL 813 (825)
+.++++|-
T Consensus 253 ~~~~~l~~~~ 262 (285)
T cd05632 253 EGAGEVKRHP 262 (285)
T ss_pred cChHHHHcCh
Confidence 88999883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.33 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=195.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++.+.||+|+||.||++.+ .+..+|+|........ .... ...+.+|+.+++.++|+||+.+++.+.....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~----~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~- 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKG----ESMALNEKQILEKVNSRFVVSLAYAYETKDA- 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHH----HHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-
Confidence 377889999999999999998 4668888876433211 1111 1234789999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||++|++|.+++.. .....+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 75 -------------~~lv~e~~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 75 -------------LCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred -------------EEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4999999999999999865 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCcc-----------ccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 4599999999865432111 122368999999999976 568899999999999999999
Q ss_pred CCCCCCCCCHHHH---HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~~~i---~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+.||........ ...+.......+ ....++.+.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVKEVQEEY---------------------------SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhhhhhhhc---------------------------CccCCHHHHHHHHHHhhcCHHHccC
Confidence 9999976532211 111111100000 0113457899999999999999999
Q ss_pred -----HHHHHHHHHh
Q 003375 806 -----AGDLYEMFVA 815 (825)
Q Consensus 806 -----a~EIL~hL~~ 815 (825)
+.|+++|.+-
T Consensus 250 ~~~~~~~~~~~h~~~ 264 (285)
T cd05630 250 CQGGGAREVKEHPLF 264 (285)
T ss_pred CCCCchHHHHcChhh
Confidence 9999998554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.54 Aligned_cols=283 Identities=20% Similarity=0.229 Sum_probs=189.4
Q ss_pred eeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
..+||+|+||.||+|+.. +..+|+|..... .. . ..+.+|+.+++.++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~----~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GI----S----MSACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CC----c----HHHHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 468999999999999863 356888875321 11 1 123789999999999999999999864321
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhc----cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
...++||||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 24699999997 688888764211 1123588999999999999999999999999999999999996
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++. ..+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 4321 2357999999999866432211 011233468999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCHH---------HHHHHHHcCCCCCchhHHhhhccCcc-----cccccc-----CCCCCCchhhhhhHHH
Q 003375 727 LTLQVPYMGLSEL---------EIHDLIQMGKRPRLTDELEALGSCHE-----HEVAQS-----GSGFEKPEAELETLSF 787 (825)
Q Consensus 727 LTG~~PF~~~~~~---------~i~~~I~~~~~p~l~~~l~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~s~~ 787 (825)
+||++||...... .....+...........+........ ..+... ................
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChH
Confidence 9999999654321 11111111111111111111100000 000000 0000000111123456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
+.+||.+||+.||.+|||+.|+++|.
T Consensus 290 ~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 290 VFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHHHHHhccCcccccCHHHHhcCC
Confidence 88999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.94 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=200.7
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||+|+||.||++.+. +..+++|..... .....+.+ .+|+.+++.++||||+++++++.....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~h~~ii~~~~~~~~~~~-- 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYENN-- 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHH----HHHHHHHHHCCCCCeeeEEEEEeeCCE--
Confidence 678899999999999999985 445566654321 22333334 889999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||+++++|..++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 77 ------------~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~- 139 (282)
T cd06643 77 ------------LWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD- 139 (282)
T ss_pred ------------EEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-
Confidence 4999999999999998864 23468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHHHh
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++........ ......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 140 ------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 140 ------GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred ------CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 4599999999876532111 112346899999999985321 22457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|++||...+.......+.....+.+.. ....+..+.+||.+||+.||.+||++.+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 204 IEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCccccCHHHHHHHHhhcCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999998877666555554432221110 0112457899999999999999999999
Q ss_pred HHHHHHhhcC
Q 003375 809 LYEMFVARTS 818 (825)
Q Consensus 809 IL~hL~~l~s 818 (825)
+++|......
T Consensus 259 il~~~~~~~~ 268 (282)
T cd06643 259 LLQHPFVTVN 268 (282)
T ss_pred HhcCCCEecc
Confidence 9998765433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.12 Aligned_cols=280 Identities=20% Similarity=0.248 Sum_probs=205.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.+ .+..+++|+....... ..... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~~- 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPN----QALREIKALQACQHPYVVKLLDVFPHGSG- 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhH----HHHHHHHHHHhCCCCCCcceeeEEecCCe-
Confidence 589999999999999999997 5678999986543221 12222 34899999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+|+||||+||+++.+
T Consensus 74 -------------~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 74 -------------FVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred -------------eEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 49999999 89999998752 2568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... ......|+..|+|||++.+ ...++.++|||||||++|||++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEPR---------LYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCCC---------ccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 45999999998766432210 1122368999999999864 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|.+||.+.........+...........+.......... .................+..+.+||.+||..+|.+|||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 999998777665555544332211111111110000000 000000000011122345789999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.++++|.+
T Consensus 277 ~~~l~h~~ 284 (286)
T cd07832 277 AEALRHPY 284 (286)
T ss_pred HHHhhCcC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=318.01 Aligned_cols=289 Identities=18% Similarity=0.216 Sum_probs=202.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~ 566 (825)
++|++.+.||+|+||.||+|.+ .+..||+|+....... ... ...+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGI----PPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCC----chHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4789999999999999999997 5678999986543211 111 123488999999996 699999999887554
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. .....|+||||++ ++|.+++..........+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~~---------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 KN---------GKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred CC---------CCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 31 2234699999998 4899998763322235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++ +.+||+|||++..+...... .....+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 145 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 145 KQK------GLLKIADLGLGRAFSIPVKS----------YTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred cCC------CeEEEeecccceecCCCccc----------cCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHH
Confidence 721 56999999998765332111 112257889999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.+.......+...........+...........................+..+.+||.+||.+||.+||++
T Consensus 206 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 206 SRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 99999998877655444433321100010000000000000000000000001112346779999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.|-
T Consensus 286 ~eil~~~ 292 (295)
T cd07837 286 KAALTHP 292 (295)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.13 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=205.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|++.+.||.|+||.||+|.+ .+..+++|.+..... ...+. +.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKEL----IINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHH----HHHHHHHHHhcCCCceeeeeeeEecC
Confidence 457899999999999999999986 677899998754321 12223 38899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+++++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 89 ~~--------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili 148 (296)
T cd06655 89 DE--------------LFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148 (296)
T ss_pred ce--------------EEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 43 5999999999999999875 458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~~ 207 (296)
T cd06655 149 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (296)
T ss_pred CCC-------CCEEEccCccchhccccccc----------CCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHHH
Confidence 876 45999999998765432111 122358899999999875 567889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.++......+.....+.+. .....++.+.+||.+||..||.+||+
T Consensus 208 lltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 208 MVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCcccC-------------------------CcccCCHHHHHHHHHHhhcChhhCCC
Confidence 99999999887765544444332221111 01123457899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 003375 806 AGDLYEMFVARTSS 819 (825)
Q Consensus 806 a~EIL~hL~~l~ss 819 (825)
+.+|+.|-+.....
T Consensus 263 ~~~il~~~~~~~~~ 276 (296)
T cd06655 263 AKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhChHhhhcc
Confidence 99999996655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.73 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=212.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-+=|.+.+.||+|.|+.|-+|++ .+..|||||+. ........... +.+|++.|+.++|||||++|++..+..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviD--KTKlD~~st~h----lfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVID--KTKLDTLSTGH----LFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEec--ccccchhhhhH----HHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 45588999999999999999985 89999999964 33222222223 389999999999999999999977544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.+|||+|+-++|+|.+||-+. ...+.+..+.+++.||+.|+.|+|+..+|||||||+|+.+.
T Consensus 91 --------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF 152 (864)
T KOG4717|consen 91 --------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF 152 (864)
T ss_pred --------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe
Confidence 469999999999999999873 35689999999999999999999999999999999999987
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
+. .+.|||+|||++..+..... -++.+|+..|.|||++.+ ..+..+++||||||||||.|
T Consensus 153 EK------lGlVKLTDFGFSNkf~PG~k-----------L~TsCGSLAYSAPEILLG---DsYDAPAVDiWSLGVILyML 212 (864)
T KOG4717|consen 153 EK------LGLVKLTDFGFSNKFQPGKK-----------LTTSCGSLAYSAPEILLG---DSYDAPAVDIWSLGVILYML 212 (864)
T ss_pred ee------cCceEeeeccccccCCCcch-----------hhcccchhhccCchhhhc---CccCCcchhhhHHHHHHHHH
Confidence 76 36799999999976654322 245679999999999998 24456899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|++||+..++.+.+..|..... .+| ..++.++.+||..||..||.+|.+.
T Consensus 213 VCGq~PFqeANDSETLTmImDCKY-tvP---------------------------shvS~eCrdLI~sMLvRdPkkRAsl 264 (864)
T KOG4717|consen 213 VCGQPPFQEANDSETLTMIMDCKY-TVP---------------------------SHVSKECRDLIQSMLVRDPKKRASL 264 (864)
T ss_pred HhCCCccccccchhhhhhhhcccc-cCc---------------------------hhhhHHHHHHHHHHHhcCchhhccH
Confidence 999999999998888888876643 222 2346789999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
++|..+-|-
T Consensus 265 EeI~s~~Wl 273 (864)
T KOG4717|consen 265 EEIVSTSWL 273 (864)
T ss_pred HHHhccccc
Confidence 999987543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.99 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=204.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||.|+||.||+|.. .+..+++|+....... ..... +.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDE----LRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHH----HHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 4789999999999999999987 5677888886433221 13333 3899999999999999999998876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 74 --------------LWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred --------------EEEEEeccCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 599999999999999997621 1246899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||++..+....... ........|+..|+|||++... ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 6 459999999987765432210 0112334689999999998751 36788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|+.||...+.......+.....+.+... ......+..+.+|+.+||..||.+||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETG----------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCc----------------------cccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 99999987766555544443322211110 00123456789999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
+|++|-
T Consensus 260 ~ll~~p 265 (267)
T cd06610 260 ELLKHK 265 (267)
T ss_pred HHhhCC
Confidence 999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.68 Aligned_cols=273 Identities=24% Similarity=0.355 Sum_probs=196.6
Q ss_pred CCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
.+|++.+.||+|+||.||++.. .+..+++|.+... .....+. +.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRD----FEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEEc
Confidence 3688999999999999999974 3567888875422 2233333 489999999999999999999875
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... ...++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ni 139 (284)
T cd05081 76 SAGR------------RNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139 (284)
T ss_pred cCCC------------CceEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhE
Confidence 4321 135999999999999999975 124588999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++
T Consensus 140 li~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 201 (284)
T cd05081 140 LVESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVL 201 (284)
T ss_pred EECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHH
Confidence 99876 4699999999987643221100 0011124456999999876 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++|..|+..... .....+..... +.+...+.... .... ........+..+.+|+.+||..+|.+
T Consensus 202 ~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 202 YELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL--------KNNG---RLPAPPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH--------hcCC---cCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999877644322 11222111111 11111110000 0000 00111234567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.+|++.|+.+
T Consensus 270 Rpt~~ei~~~l~~~ 283 (284)
T cd05081 270 RPSFSELALQVEAI 283 (284)
T ss_pred CCCHHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.02 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=198.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|+..+.||+|+||.||+|.+ .+..+|+|+..... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 76 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEI----EDIQQEITVLSQCDSPYITRYYGSYLKGTK- 76 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHH----HHHHHHHHHHHcCCCCccHhhhcccccCCc-
Confidence 477888999999999999987 46678998864321 11222 344899999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 77 -------------LWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred -------------eEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 4999999999999999864 468899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++..+...... .....|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcchh----------hhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 45999999998765432111 122358899999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||....+......+.....+.+. ...+..+.++|.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTLE---------------------------GQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999766555444433332221111 123457899999999999999999999
Q ss_pred HHHHHH
Q 003375 809 LYEMFV 814 (825)
Q Consensus 809 IL~hL~ 814 (825)
+++|.+
T Consensus 250 il~~~~ 255 (277)
T cd06642 250 LLKHKF 255 (277)
T ss_pred HHHhHH
Confidence 999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.66 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=198.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.+|++.+.||+|+||.||++.. .+..+++|.......... ....+ .+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN----ALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHH----HHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 4789999999999999999987 467899998654332211 12233 3488999999999999999999876532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++|+|+||||+|||++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 146899999999999999975 24578899999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++.......... .......|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCccccccccccccc-------cccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 76 459999999987654321110 01123358899999999875 5578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|+.||...........+... ..+.++ ...+..+.++|.+||. +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVLP---------------------------PHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCCc---------------------------hhhCHHHHHHHHHHhc-ChhhCCC
Confidence 9999999876544433333222 111111 1234578899999995 9999999
Q ss_pred HHHHHHHHH
Q 003375 806 AGDLYEMFV 814 (825)
Q Consensus 806 a~EIL~hL~ 814 (825)
+++|++|..
T Consensus 255 ~~~il~~~~ 263 (265)
T cd06652 255 ADELLRHTF 263 (265)
T ss_pred HHHHhcCcc
Confidence 999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.35 Aligned_cols=288 Identities=19% Similarity=0.227 Sum_probs=199.0
Q ss_pred eeeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 494 SCDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 494 i~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
++++||+| +|++||++.. ++..||+|.+.... ......+ .+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~l~~l~hpniv~~~~~~~~~~~-- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA--CTNEMVT----FLQGELHVSKLFNHPNIVPYRATFIADNE-- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh--ccHHHHH----HHHHHHHHHHhcCCCCeeeEEEEEEECCE--
Confidence 56789999 7889999987 56788888864332 1222222 34789999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 ------------~~lv~e~~~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 74 ------------LWVVTSFMAYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred ------------EEEEEeccCCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 49999999999999999752 12358899999999999999999999999999999999999877
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++++|||.............. .........++..|+|||++.+. ...++.++|||||||++|||++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhccccccccccc---cccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHC
Confidence 45999999876543221110000 00011223577889999999751 13578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHh----hhccCccc-----cccc------cC---CCCCCchhhhhhHHHHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELE----ALGSCHEH-----EVAQ------SG---SGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~----~~~~~~~~-----~~~~------~~---~~~~~~~~~~~~s~~L~dL 791 (825)
+.||..............+..+.+.+... ........ .... .. ............++.+.+|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 99998766554443333332221111000 00000000 0000 00 0000011122346689999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
|.+||+.||.+|||++++++|.+..
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhh
Confidence 9999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=336.97 Aligned_cols=276 Identities=20% Similarity=0.213 Sum_probs=197.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
-.+|.+.+.||.|+||.||+|... +..+++|..... .. +.+|+.+|++|+||||+++++++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~----~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KT----PGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------cc----HHHHHHHHHhcCCCCccceeeeEee
Confidence 357999999999999999999763 356777764311 11 2679999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 158 ~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 158 KST--------------VCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred CCE--------------EEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 553 499999996 799998854 356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 218 l~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~ 278 (392)
T PHA03207 218 LDEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLF 278 (392)
T ss_pred EcCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHH
Confidence 9877 45999999999765432211 11223569999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHH---HHHHHHHcC-CC--CCchh-----HHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 725 ELLTLQVPYMGLSEL---EIHDLIQMG-KR--PRLTD-----ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 725 ELLTG~~PF~~~~~~---~i~~~I~~~-~~--p~l~~-----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
||++|+.||.+.... ..+..+... .. ..++. ....+..... .................+..+.+||.
T Consensus 279 el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~ 356 (392)
T PHA03207 279 EMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI--VLRPPYTIPPVIRKYGMHMDVEYLIA 356 (392)
T ss_pred HHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc--cccCCccccchhhccCcchhHHHHHH
Confidence 999999999765321 222222211 10 01110 0000000000 00000000000011123457889999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 794 RCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+||..||.+|||+.+++.|......
T Consensus 357 ~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 357 KMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHhccChhhCCCHHHHhhCchhhcc
Confidence 9999999999999999999766543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.04 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEECC--------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~--------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.||+|+||.||+|++.. ..+++|..... ........ +.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKE----FLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHH----HHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 368999999999998743 45788875321 11122333 4889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc--CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+++|+||||+|||+
T Consensus 74 --------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 74 --------------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred --------------eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 49999999999999999753211 22447889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++. +....++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYYR--------KEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCcccccccccccccc--------cCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87631 122369999999997654321110 0122346788999999976 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||...+..+....+........+ ...+..+.+||.+||..+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKP---------------------------ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCc---------------------------ccchHHHHHHHHHHcCCCcccCC
Confidence 998 99999887776666555443322111 12356789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
++.+|++.|+.
T Consensus 259 ~~~~i~~~l~~ 269 (269)
T cd05044 259 TFDRIQEILQN 269 (269)
T ss_pred CHHHHHHHHhC
Confidence 99999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.82 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 574 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~ 574 (825)
++||+|+||.||++.+. +..+++|+...... ..... .+.+|+.+++++.||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKR----KFLQEAEILKQYDHPNIVKLIGVCVQKQP------- 66 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHH----HHHHHHHHHHhCCCCCeEEEEEEEecCCC-------
Confidence 47999999999999975 78899997543221 12223 34899999999999999999999886654
Q ss_pred CccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCC
Q 003375 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654 (825)
Q Consensus 575 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~ 654 (825)
.++||||+++++|.+++.. ....++...+..++.+++.||.|||+++++||||||+|||++.+
T Consensus 67 -------~~~v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 67 -------IYIVMELVPGGSLLTFLRK----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred -------eEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 4999999999999999975 12457899999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 733 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF 733 (825)
..++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|||+| |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYTV--------SDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCccee--------ccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 459999999987654211110 0011224567999999876 567899999999999999999 89999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 734 ~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
...........+........+ ...+..+.+|+.+||..+|.+|||+.|+++.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAP---------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 887766655555443221111 11245799999999999999999999999998
Q ss_pred Hh
Q 003375 814 VA 815 (825)
Q Consensus 814 ~~ 815 (825)
+.
T Consensus 250 ~~ 251 (251)
T cd05041 250 QI 251 (251)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=352.18 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=205.7
Q ss_pred CceeeeeecccCceEEEEEEE-CC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF-GS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~-~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
++++.+.|.+|||+.||+|.+ ++ ..+|+|..... .+...+.. .+||.+|+.|. |+|||.|++.......
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v----~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAV----KREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHH----HHHHHHHHHhcCCCceeeEecccccccc
Confidence 568999999999999999998 33 78999976433 33444444 99999999998 9999999994222110
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEE
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 645 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILL 645 (825)
.....-++.|+||||.||+|-+++..+.. ..|++.++++|++|+++|+++||... |||||||-+||||
T Consensus 110 -------~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 110 -------SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred -------CCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 01123468999999999999999987432 34999999999999999999999986 9999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCccccccccccc---ccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTC---CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~---~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
..++ ..||||||.|.......... ..... .-....|+.|+|||++.- ..+..+++|+|||||||+
T Consensus 180 s~~g-------~~KLCDFGSatt~~~~~~~~~e~~~ve~----eI~k~TTp~YRsPEMIDl-ysg~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 180 SADG-------NYKLCDFGSATTKILSPTSAQEVNYVEE----EIEKYTTPQYRSPEMIDL-YSGLPIGEKSDIWALGCL 247 (738)
T ss_pred cCCC-------CEEeCcccccccccCCCccHHHHHHHHH----HHHhhCCccccChHHHhh-hcCCCCcchhHHHHHHHH
Confidence 9884 59999999986443221100 00000 011247899999999964 334778999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||-|+....||.+..... |.++. .|.. +..+..+.+||..||+.||
T Consensus 248 LYkLCy~t~PFe~sg~la----Ilng~Y~~P~~----------------------------p~ys~~l~~LI~~mL~~nP 295 (738)
T KOG1989|consen 248 LYKLCYFTTPFEESGKLA----ILNGNYSFPPF----------------------------PNYSDRLKDLIRTMLQPNP 295 (738)
T ss_pred HHHHHHhCCCcCcCccee----EEeccccCCCC----------------------------ccHHHHHHHHHHHHhccCc
Confidence 999999999997664433 22321 1111 2347789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+||++-+++.++..+.....
T Consensus 296 ~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 296 DERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ccCCCHHHHHHHHHHHhcCCC
Confidence 999999999999998876543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.52 Aligned_cols=290 Identities=21% Similarity=0.219 Sum_probs=211.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.++++|++.+.||+|+||.||+|.+ .+..||+|++........ ....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 4678999999999999999999997 577899998765432111 11123679999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... ...++||||+. ++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+
T Consensus 78 ~~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 78 KHL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred CCC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 431 23599999997 5899988752 256899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~ 200 (309)
T cd07845 141 LTDK-------GCLKIADFGLARTYGLPAKP----------MTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILA 200 (309)
T ss_pred ECCC-------CCEEECccceeeecCCccCC----------CCcccccccccChhhhcC---CCCcCchHHHHHHHHHHH
Confidence 9877 45999999999766432111 112246788999999865 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC-CC-CCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GF-EKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~~-~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||++|++||.+.+..+....+...........+..+............. .. .........++.+.+||.+||++||.+
T Consensus 201 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9999999999888877776666542222221111110000000000000 00 000011123667899999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003375 803 RPTAGDLYEMFVARTSS 819 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ss 819 (825)
|||+.+++.|.+....+
T Consensus 281 R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 281 RATAEEALESSYFKEKP 297 (309)
T ss_pred CcCHHHHhcChhhccCC
Confidence 99999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.54 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=195.5
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+.||+|+||.||+|.+.. ..+|+|....... . ... ..+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--S-DIM----DDFLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--H-HHH----HHHHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 468999999999998732 2578887543221 1 223 344899999999999999999999875 3
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
..++||||+++++|.+++... ....+++..++.++.||+.||+|||++|++|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 359999999999999999862 11468999999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 729 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G 729 (825)
+.+||+|||++..+........ ......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHYV-------MEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEecccccccccccccccee-------cccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 4699999999987644221100 0112357789999999876 568899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
..||...+..++...+..... .+. .....+..+.+++.+||..+|.+||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGE-RLE-------------------------RPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCC-cCC-------------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 999988877776665543210 000 001124578999999999999999999999
Q ss_pred HHHHH
Q 003375 810 YEMFV 814 (825)
Q Consensus 810 L~hL~ 814 (825)
++.|.
T Consensus 252 ~~~l~ 256 (257)
T cd05040 252 REFLP 256 (257)
T ss_pred HHHhc
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.05 Aligned_cols=259 Identities=20% Similarity=0.315 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEE-CCee---EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF-GSAD---AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~-~~~~---vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
+.||+|+||.||++.. .+.. +++|.... .......+ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~----~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---- 69 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQN----EFLQQGDPYRILQHPNILQCLGQCVEAIP---- 69 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecC---CCChHHHH----HHHHHHHHHhccCCcchhheEEEecCCCc----
Confidence 3699999999999975 3332 34443321 12222233 34999999999999999999999876543
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.|+||||+++|+|.+++..... ....++...++.++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~--- 135 (268)
T cd05086 70 ----------YLLVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--- 135 (268)
T ss_pred ----------cEEEEecCCCCcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---
Confidence 4999999999999999976211 12346777888999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC---CCCCCchhhHHHHHHHHHHHHh
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~---~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .......++..|+|||++..... ...++.++|||||||++|||++
T Consensus 136 ----~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (268)
T cd05086 136 ----LTVKVGDYGIGPSRYKEDYI--------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203 (268)
T ss_pred ----ccEEecccccccccCcchhh--------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence 46999999997543211100 00123457889999999853211 1245789999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+..||......+....+.......+.. +......++.+.+++..|| .+|.+||++.
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~ 260 (268)
T cd05086 204 NAAQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAE 260 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence 577888777766655544332211110 0001113457888999999 6899999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
+|++.|.
T Consensus 261 ~i~~~l~ 267 (268)
T cd05086 261 EVHRLLT 267 (268)
T ss_pred HHHHHhc
Confidence 9998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.45 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=199.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|+..+.||+|+||.||++.. .+..+|+|+........ .........+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH- 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-
Confidence 478889999999999999986 67889999865433221 1222233455999999999999999999999876553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus 78 -------------~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 78 -------------FNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred -------------EEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4999999999999999975 2468899999999999999999999999999999999999765
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ ..++|+|||.+......... .........++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 3 35999999999776543111 0011223468899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH---HcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLI---QMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I---~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|..||...........+ ... ..+.+ ....+..+.+++.+||..+|.+||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSI---------------------------PEHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCC---------------------------chhhCHHHHHHHHHHcCCCcccCc
Confidence 99999654322211111 111 11111 122356789999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
++.++++|-
T Consensus 257 ~~~~ll~~~ 265 (268)
T cd06630 257 PSRELLKHP 265 (268)
T ss_pred CHHHHhcCc
Confidence 999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.09 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEECCee------------EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 496 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~------------vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+.||+|+||.||+|.+.... +++|+..... .... .+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSL----AFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHH----HHHHHHHHHHcCCCcchhheeeEEe
Confidence 46899999999999984433 5666543211 1123 3488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
. .. .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 72 ~-~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-DE--------------NIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-CC--------------cEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 5 32 39999999999999999861 22688999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++........+||+|||++...... ....++..|+|||++.+.. ..++.++|||||||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCCC--CCcchhhHHHHHHHHH
Confidence 99877522223346999999998765331 1234678899999987611 3678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++ |..||...+................+ ....+.++|.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLPMP-----------------------------DCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCCCCC-----------------------------CchHHHHHHHHHhccChhh
Confidence 99999 58888666543332222211100000 0157899999999999999
Q ss_pred CCCHHHHHHHHH
Q 003375 803 RPTAGDLYEMFV 814 (825)
Q Consensus 803 RPSa~EIL~hL~ 814 (825)
|||+.+|++.|.
T Consensus 248 Rpt~~~il~~l~ 259 (259)
T cd05037 248 RPSFRAILRDLN 259 (259)
T ss_pred CCCHHHHHHhcC
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.61 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=196.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||+|.. .+..+++|+......... .......+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE- 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch---hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC-
Confidence 688999999999999999986 567889987654332111 11122344899999999999999999998865321
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
...+++|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.+
T Consensus 79 -----------~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~ 142 (266)
T cd06651 79 -----------KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142 (266)
T ss_pred -----------CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 246899999999999999975 2458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 143 -------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~~ 204 (266)
T cd06651 143 -------GNVKLGDFGASKRLQTICMSG-------TGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEMLT 204 (266)
T ss_pred -------CCEEEccCCCccccccccccC-------CccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHHH
Confidence 459999999987654311110 01122458899999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|+.||...........+... ..+.++ ...++.+.+|+ +||..+|.+||++.
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li-~~~~~~p~~Rp~~~ 256 (266)
T cd06651 205 EKPPWAEYEAMAAIFKIATQPTNPQLP---------------------------SHISEHARDFL-GCIFVEARHRPSAE 256 (266)
T ss_pred CCCCccccchHHHHHHHhcCCCCCCCc---------------------------hhcCHHHHHHH-HHhcCChhhCcCHH
Confidence 99999876554433332221 222221 12245677888 68889999999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
||++|-.
T Consensus 257 eil~hp~ 263 (266)
T cd06651 257 ELLRHPF 263 (266)
T ss_pred HHhcCcc
Confidence 9998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.06 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=201.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|++.+.||+|+||.||++.. .+..+|+|....... ...+. +.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 357899999999999999999986 578899998654321 12222 38899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 89 ~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 89 DE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred CE--------------EEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 53 5999999999999999875 457889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~ 207 (297)
T cd06656 149 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (297)
T ss_pred CCC-------CCEEECcCccceEccCCccC----------cCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 876 45999999998765332111 123358899999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.++......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 208 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 208 MVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred HHhCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcC
Confidence 99999999776543322222221111111 01123456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+|++|-+-.
T Consensus 263 ~~~il~~~~~~ 273 (297)
T cd06656 263 AKELLQHPFLK 273 (297)
T ss_pred HHHHhcCchhc
Confidence 99999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.70 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=193.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQK----QIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHH----HHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 3678899999999999999986 66789999865331 222223 34899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 74 --------------ISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred --------------EEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 49999999999996542 3678889999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 131 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 131 R-------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred C-------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHH
Confidence 7 459999999997653321 123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHH-------HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 728 TLQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 728 TG~~PF~~~~~~-------~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|+.||...... .....+.....+.++ ....++.+.+|+.+||+.+|
T Consensus 188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--------------------------VGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred hCCCCchhhcccccccchHHHHHHHhccCCCCCC--------------------------CCcCCHHHHHHHHHHhhCCh
Confidence 999999653211 111111111111100 01134578999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003375 801 TERPTAGDLYEMFVART 817 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ 817 (825)
.+||++.++++|.+-..
T Consensus 242 ~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 242 KERPAPENLMDHPFIVQ 258 (279)
T ss_pred hhCCCHHHHhcCccccc
Confidence 99999999999966443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.65 Aligned_cols=279 Identities=23% Similarity=0.288 Sum_probs=199.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..+|+|+..... ......+ .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKK----IAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc--CcchhhH----HHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 4789999999999999999998 46789999754222 1111222 34889999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|..+... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 75 --------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 75 --------------LYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred --------------EEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 4999999999888887654 245899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++..+...... .....++..|+|||++.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGEV----------YTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCccc----------cCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 45999999998765432211 123458899999999875 234678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++||......+....+................... ....................+..+.+|+.+||..+|.+||
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 9999998766554443333211110010000000000 0000000000000011223467899999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
++.+|++|-
T Consensus 276 ~~~~il~~~ 284 (286)
T cd07846 276 SSSQLLHHE 284 (286)
T ss_pred hHHHHhcCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.61 Aligned_cols=279 Identities=23% Similarity=0.298 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||++.+ .+..+++|+.... ..... ...+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAI----RNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 3689999999999999999997 4566777765432 11222 2344899999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd 646 (825)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++
T Consensus 74 --------------~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 74 --------------ISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred --------------EEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 4999999999999999976 2568999999999999999999997 5999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++....... .....|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 135 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 135 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred cC-------CcEEEccCCCcccccccc------------cccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHH
Confidence 76 459999999986543211 123468899999999875 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh-hhcc---Ccccc------ccccCCCCCCch-hhhhhHHHHHHHHHHh
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELE-ALGS---CHEHE------VAQSGSGFEKPE-AELETLSFLVDVFRRC 795 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~-~~~~---~~~~~------~~~~~~~~~~~~-~~~~~s~~L~dLI~~C 795 (825)
++|..||...+.......+..... .+..... .... ..... ..+.......+. .....+..+.+|+.+|
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 270 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC 270 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence 999999977665444433322110 0000000 0000 00000 000000000000 0012456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 003375 796 TEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 796 L~~DP~eRPSa~EIL~hL~~l~s 818 (825)
|..+|.+|||+.+|++|.+-...
T Consensus 271 l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 271 LKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccCChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999775543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.30 Aligned_cols=265 Identities=20% Similarity=0.334 Sum_probs=202.1
Q ss_pred ceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
|.+.+.||+|+||.||+|.+ .+..+|+|++..+. ......+.+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEF----LREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHH----HHHHHHHhcCCCCCcceEEEEEccCC
Confidence 67788999999999999986 25779999864332 222333334 89999999999999999999886543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh-ccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ......++++||+.+|+|..++.... ......++...++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 AK--------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred CC--------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 11 01223588999999999999886421 1122357889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ ..+||+|||+++......... ......+++.|++||.+.. ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYYR--------QGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCccee--------cCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 866 459999999988654321110 0112235678999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |.+||.+.+.......+........+ ...+..+.+++.+||+.+|.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999887776666555543221111 11245799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
++.++++.|+.+
T Consensus 261 s~~~~~~~l~~~ 272 (273)
T cd05074 261 SFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.54 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=200.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC--hHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS--ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~--~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+|.+.+.||.|+||.||+|.. .+..+|+|.......... ........+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999986 567899998654322111 1122223345688999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ...++...+..++.||+.||.|||++|++||||+|+||+++
T Consensus 82 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 Y--------------LSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred c--------------eEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 3 4999999999999999976 25688999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .......|+..|+|||.+.... ..++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHH
Confidence 76 56999999998765322111 0112345889999999987521 2478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|..||...........+... ..+.++. ......+..+.++|.+||.++|.+||+
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-----------------------DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCc-----------------------cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 9999999765544333222211 1111111 011223568999999999999999999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.+|++|.
T Consensus 263 ~~~il~~~ 270 (272)
T cd06629 263 ARELLQHP 270 (272)
T ss_pred HHHHhhCC
Confidence 99999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.19 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=198.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+|+..+.||+|+||.||+|.. .+..+++|+......... ....+ .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK----QLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHH----HHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 477889999999999999997 578899998754332211 22223 34899999999999999999998875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 77 --------------LYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred --------------EEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 4999999999999999976 245889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++........ .....|+..|+|||.+.. ...++.++|+|||||++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~~-----------~~~~~~~~~y~~pe~~~~---~~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFSF-----------AKSFKGSPYWMAPEVIAQ---QGGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceecccccc-----------ccccCCCcceeCHHHhcC---CCCCCchhhhHHHHHHHHHHH
Confidence 7 4599999999876543220 123458899999999875 123788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|+.||...........+.. ...+.++ ...+..+.+++.+||..+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPIP---------------------------DHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCcC---------------------------CCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999977665444333332 1111111 1234578999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.|-
T Consensus 250 ~~~l~~~ 256 (258)
T cd06632 250 AELLEHP 256 (258)
T ss_pred HHHhcCC
Confidence 9999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.94 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=202.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||++.+ .+..+|+|+...... ..... ...+.+|+.+++++.||||+++++++.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQ----VEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhH----HHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 4789999999999999999997 567899998643211 11112 2345899999999999999999999876554
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|.|||++.
T Consensus 76 --------------~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 76 --------------LYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred --------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 4999999999999999976 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++...... .....+++.|+|||.+.+ ...+.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 45999999998765432 122358899999999875 46788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP--- 804 (825)
+|..||...+.......+..+.. .++. ..+..+.++|.+||..||.+||
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999988776666655553321 1111 1245789999999999999999
Q ss_pred --CHHHHHHHHH
Q 003375 805 --TAGDLYEMFV 814 (825)
Q Consensus 805 --Sa~EIL~hL~ 814 (825)
++.++++|..
T Consensus 245 ~~~~~~l~~~~~ 256 (290)
T cd05580 245 KNGVNDIKNHPW 256 (290)
T ss_pred cCCHHHHHcCcc
Confidence 8999998864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.70 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=186.2
Q ss_pred eeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 496 DEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.||+|+||.||+|.... ..+++|+.... .....+.+.+|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 469999999999998632 23566653211 1122234588999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~~--------------~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 ES--------------IMVQEYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred Cc--------------EEEEecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 43 999999999999999975 223688999999999999999999999999999999999998
Q ss_pred cCccCC-CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 647 LERKKA-DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 647 ~~~~~~-~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
.++... .....++++|||++...... ....+++.|+|||++.+ ...++.++|||||||++||
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK--------------EILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCCc--------------hhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 764311 12345899999988654321 22357889999999875 2356889999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++| ..||...+.......... ...++ ......+.+||.+||+.||.+||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLP---------------------------APKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCC---------------------------CCCcHHHHHHHHHHhccChhhCC
Confidence 9998 566665554433222211 11111 01234689999999999999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
|+++|++.|+
T Consensus 249 s~~~il~~l~ 258 (258)
T cd05078 249 SFRAIIRDLN 258 (258)
T ss_pred CHHHHHHhcC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.69 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|++.+.||+|+||.||+|.. .+..+|+|........ .... ...+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNK----VKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHH----HHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 3689999999999999999997 4688999986533211 1112 2345899999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+.+++|.+++.. .....+++..++.++.||+.||.|||+.|++|+||||+|||++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 76 --------------LCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred --------------EEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 5999999999999999875 22356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-------------------s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
+ +.++|+|||++............ ...........+||..|+|||++.+ .
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~ 207 (316)
T cd05574 139 S-------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----D 207 (316)
T ss_pred C-------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----C
Confidence 6 45999999998765432111000 0001111234578999999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
.++.++||||||+++|+|++|..||.+.+.......+..... .++. ....+..+
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~ 261 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPG-------------------------SPPVSSSA 261 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCC-------------------------ccccCHHH
Confidence 678999999999999999999999988776655544433211 1110 01135679
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHHHH
Q 003375 789 VDVFRRCTEENPTERPT----AGDLYEMFV 814 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPS----a~EIL~hL~ 814 (825)
.++|.+||..||.+||| +++++.|-+
T Consensus 262 ~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 99999999999999999 999999844
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.40 Aligned_cols=278 Identities=19% Similarity=0.251 Sum_probs=197.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||+|+||.||+|.. .+..+|+|......... ... .+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APF----TAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---Cch----hHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 568899999999999999999987 56789999865432211 111 237899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~ 136 (291)
T cd07844 76 KT--------------LTLVFEYLD-TDLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136 (291)
T ss_pred Ce--------------EEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE
Confidence 53 499999998 599998875 12468899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++........ .....++..|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~~ 196 (291)
T cd07844 137 SER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFYE 196 (291)
T ss_pred cCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHHH
Confidence 877 45999999998654321111 112246889999999875 2457889999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCC-CCc---hh--hhhhHHHHHHHHHHhccc
Q 003375 726 LLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF-EKP---EA--ELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 726 LLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~-~~~---~~--~~~~s~~L~dLI~~CL~~ 798 (825)
|++|+.||.+.. ..+....+...........+........ ........ ... .. .......+.+++.+||+.
T Consensus 197 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 197 MATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE--FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc--cccccccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 999999997664 3333333322211111111111100000 00000000 000 00 001125788999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 003375 799 NPTERPTAGDLYEMF 813 (825)
Q Consensus 799 DP~eRPSa~EIL~hL 813 (825)
+|.+|||+.++++|.
T Consensus 275 ~p~~Rps~~e~l~~~ 289 (291)
T cd07844 275 EPKKRISAAEAMKHP 289 (291)
T ss_pred CcccccCHHHHhcCC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.91 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=194.7
Q ss_pred CceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
-|++.+.||+|+||.||+|.+ .+..+++|..... ....... .+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIA----DLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHH----HHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 368899999999999999974 3567888875322 1122223 34899999999999999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... ...++||||++|++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~~------------~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil 141 (284)
T cd05079 78 DGG------------NGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 141 (284)
T ss_pred CCC------------CceEEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEE
Confidence 421 135999999999999999865 1235899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++|
T Consensus 142 ~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T cd05079 142 VESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLY 203 (284)
T ss_pred EcCC-------CCEEECCCccccccccCccce-------eecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhh
Confidence 9876 459999999998664322110 01123457788999999875 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCC--CchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p--~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||+|++.|+..... ........... .+........ .... .......+..+.+|+.+||+.+|.+
T Consensus 204 ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~ 269 (284)
T cd05079 204 ELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLVRVLE---------EGKR---LPRPPNCPEEVYQLMRKCWEFQPSK 269 (284)
T ss_pred hhhcCCCCCccccc--hhhhhcccccccccHHHHHHHHH---------cCcc---CCCCCCCCHHHHHHHHHHccCCccc
Confidence 99998776532211 10000000000 0000000000 0000 0011224668999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.++++.|+.+
T Consensus 270 Rpt~~~il~~l~~~ 283 (284)
T cd05079 270 RTTFQNLIEGFEAI 283 (284)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.86 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=200.6
Q ss_pred ceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+++.+.||.|+||.||++.+.. ..+|+|+.... . .....+. +.+|+.++..++||||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--A-DEQQIEE----FLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--C-ChHHHHH----HHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4678899999999999999854 67888886422 1 1113333 48999999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. .+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus 74 ~~--------------~~~i~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 EP--------------LMIVMEYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred Ce--------------eEEEEeccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 53 49999999999999999761 11228999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ ..++|+|||++.......... .....+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYYK---------KKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceecccccccc---------cccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 877 469999999997765432110 011236789999999865 667899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |.+||...+...+...+.....+..+. ..+..+.+++.+||..||.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 899998877777777766554332221 1355799999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
|+.++++.|
T Consensus 250 t~~~ll~~l 258 (258)
T smart00219 250 TFSELVEIL 258 (258)
T ss_pred CHHHHHhhC
Confidence 999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=323.16 Aligned_cols=284 Identities=17% Similarity=0.210 Sum_probs=205.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.. .+..+|+|+.... ......... +.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--FQNVTHAKR----AYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc--ccChhHHHH----HHHHHHHHHhcCCCCCcceeeeeccC
Confidence 457899999999999999999997 5678899975322 112222233 37899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ......|+||||+. ++|.+++.. .++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~ 151 (353)
T cd07850 88 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (353)
T ss_pred CCc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 322 11234699999997 699988864 28889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+
T Consensus 152 ~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~ 209 (353)
T cd07850 152 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 209 (353)
T ss_pred CCC-------CCEEEccCccceeCCCCCC-----------CCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHH
Confidence 877 4599999999976543211 122358899999999976 668899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-----------ccccccCCC----CCCchhhhhhHHHHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-----------HEVAQSGSG----FEKPEAELETLSFLVD 790 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~s~~L~d 790 (825)
|++|+.||...+.......+.........+.+..+..... ..+...... ..........+..+.+
T Consensus 210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 9999999988776555555443322221111111100000 000000000 0000001234667899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
||.+||+.||.+|||+.|+++|-+-
T Consensus 290 li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 290 LLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred HHHHHcCCChhhCcCHHHHhcChhH
Confidence 9999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=311.03 Aligned_cols=263 Identities=30% Similarity=0.442 Sum_probs=201.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|...+.||.|++|.||++.. .+..+|+|+..... ..... ..+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQ----KQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHH----HHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4688999999999999999998 56889999865321 11222 334899999999999999999999865431
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
..+++||||+++++|.+++..... ....++...+..++.||+.||.|||+.|++|+||+|.||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 246999999999999998875332 2356889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||++........ ....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~~------------~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSLA------------GTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeecccccccccccc------------ccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 4599999999865532111 12347889999999876 56788999999999999999
Q ss_pred hCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 728 TLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 728 TG~~PF~~~-----~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|..||... ...+....+.....+.+... .......++.+.+||.+||..+|.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 999999755 22333333333222211110 0000123567899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.||++|.+-.
T Consensus 257 Rpt~~eil~~~~~~ 270 (287)
T cd06621 257 RPTPWDMLEHPWIK 270 (287)
T ss_pred CCCHHHHHhCcccc
Confidence 99999999986653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.68 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=200.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||++.+ .+..+|+|.+.... ....... +.+|+.++++++||||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQ----IIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 3689999999999999999998 47788888764321 2222333 4899999999999999999998876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd 646 (825)
.++||||+++++|..++... .....+++..+..++.||+.||.|||. .||+|+||||+|||++
T Consensus 74 --------------~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 74 --------------VYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred --------------EEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 49999999999999998751 112468999999999999999999997 5999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~--~~~~~s~kSDVWSLGvILy 724 (825)
.+ +.++|+|||++..+.... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 76 459999999987653211 12235888999999986522 1134588999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHH---HcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I---~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|++|..||...........+ .....+.++ ...+..+.+||.+||..+|.
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLP---------------------------SGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC---------------------------cccCHHHHHHHHHHcccCcc
Confidence 999999999765544433332 222222211 12356789999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003375 802 ERPTAGDLYEMFVART 817 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ 817 (825)
+||++.++++|.+-..
T Consensus 252 ~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 252 RRPTYAQLLEHPWLVK 267 (286)
T ss_pred cCCCHHHHhcChhhhh
Confidence 9999999999866433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=312.75 Aligned_cols=266 Identities=25% Similarity=0.337 Sum_probs=202.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
..++|.+.+.||+|+||.||++.. .+..+|+|+.... ..... .+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~----~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDE----EIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHH----HHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 467899999999999999999997 5678899986421 11112 337899999999 79999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .....++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 91 ~~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nil 160 (291)
T cd06639 91 ADKL---------VGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160 (291)
T ss_pred cccc---------CCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 4321 12246999999999999999875322 2356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvIL 723 (825)
++.+ +.+||+|||++......... .....|+..|+|||++.... ....++.++|||||||++
T Consensus 161 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 161 LTTE-------GGVKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred EcCC-------CCEEEeecccchhccccccc----------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 9877 45999999998765432111 12345889999999986421 112367899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|+.||...........+.....+.+.. .......+.+||.+||+.+|.+|
T Consensus 224 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~R 278 (291)
T cd06639 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH-------------------------PEKWCRSFNHFISQCLIKDFEAR 278 (291)
T ss_pred HHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc-------------------------ccccCHHHHHHHHHHhhcChhhC
Confidence 99999999998776655444444332221110 01123468999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
|++.+|++|-+
T Consensus 279 ps~~~il~~~~ 289 (291)
T cd06639 279 PSVTHLLEHPF 289 (291)
T ss_pred cCHHHHhcCcc
Confidence 99999999843
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.67 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.|.....||+|+||.||++.. .+..+|+|...... ....+ .+.+|+.+++.++||||+++++.+...+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHH----HHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 4455567899999999999987 56788998754321 12222 34899999999999999999999875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 94 --------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 153 (292)
T cd06658 94 --------------LWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153 (292)
T ss_pred --------------EEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence 4999999999999998864 45889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|||+
T Consensus 154 ~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~ 212 (292)
T cd06658 154 D-------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMI 212 (292)
T ss_pred C-------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 6 4599999999875532211 1123468999999999875 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||...+.......+.....+.+.. ....+..+.+++.+||..||.+|||+.
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHH
Confidence 9999998877666554443322211110 011345789999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC
Q 003375 808 DLYEMFVARTSSSISS 823 (825)
Q Consensus 808 EIL~hL~~l~sss~S~ 823 (825)
++++|........+++
T Consensus 268 ~il~~~~~~~~~~~~~ 283 (292)
T cd06658 268 ELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHhhChhhhccCCccc
Confidence 9999977766666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.37 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=199.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
+-+.|++.+.||.|+||.||+|.+ .+..+|+|+..... ..... +..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEE----IKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHH----HHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 347899999999999999999997 56788999865321 12223 37899999998 69999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ......|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus 85 ~~~~--------~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPP--------GHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153 (282)
T ss_pred cccc--------CCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3210 1123579999999999999999752 2345788899999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvIL 723 (825)
++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||++
T Consensus 154 i~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 154 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred ECCC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 9876 4599999999876532111 123346899999999986321 124578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|..||....+......+.....+.+. ....+..+.+||.+||..||.+|
T Consensus 217 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~R 270 (282)
T cd06636 217 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSR 270 (282)
T ss_pred HHHHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhC
Confidence 9999999999776554433333222111110 01235679999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
|++.||++|-
T Consensus 271 p~~~ell~~~ 280 (282)
T cd06636 271 PSTEQLLKHP 280 (282)
T ss_pred cCHHHHhcCC
Confidence 9999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.24 Aligned_cols=283 Identities=22% Similarity=0.279 Sum_probs=205.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||.|+||.||+|.+. +..+++|..+..... +.+...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 4578999999999999999999984 567888876543221 11222347899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. ....|+||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||+
T Consensus 77 ~------------~~~~~lv~e~~~-~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 N------------LDKIYMVMEYVE-HDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred C------------CCcEEEEehhcC-cCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 2 124699999997 599999875 12368999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....+++.|+|||.+.+ ...++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLKP----------YTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCccc----------cccccccccccCchhhcC---CccccchhhHHHHHHHHHH
Confidence 877 45999999998866542111 122357889999999875 2346889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc---ccccCCCCCCchhhhh-hHHHHHHHHHHhcccCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE---VAQSGSGFEKPEAELE-TLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~-~s~~L~dLI~~CL~~DP~ 801 (825)
|++|.+||......+....+...........+.......... ................ .++.+.+||.+||+.||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 999999998887776665554432222222222111100000 0000000000000011 366789999999999999
Q ss_pred CCCCHHHHHHHH
Q 003375 802 ERPTAGDLYEMF 813 (825)
Q Consensus 802 eRPSa~EIL~hL 813 (825)
+|||+.|+++|-
T Consensus 280 ~R~t~~ell~~~ 291 (293)
T cd07843 280 KRISAEDALKHP 291 (293)
T ss_pred ccCCHHHHhcCC
Confidence 999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=353.43 Aligned_cols=276 Identities=23% Similarity=0.267 Sum_probs=203.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.++||+|+||.||+|.+ .+..||+|+...... .. .....++.+|+.++++++||||+++++++...+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-EN----PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cC----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 47899999999999999999997 467899998643221 11 122334599999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc------CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
. .|+||||++|++|.+++...... ....++...++.++.||+.||+|||++||+||||||
T Consensus 76 ~--------------lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 P--------------VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred E--------------EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 3 49999999999999999753211 123456778899999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCccccccccccc--------ccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC--------CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~--------~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
+|||++.+ +.++|+|||+++......... .............+||+.|||||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999877 459999999998762211000 000011112234579999999999976 66799
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003375 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 792 (825)
Q Consensus 713 kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 792 (825)
++|||||||++|||+||..||.......+........ +..+ ......++.+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~----P~~~---------------------~p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS----PIEV---------------------APYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccC----hhhc---------------------cccccCCHHHHHHH
Confidence 9999999999999999999997754433221110000 0000 00123456789999
Q ss_pred HHhcccCCCCCC-CHHHHHHHHHhhcCC
Q 003375 793 RRCTEENPTERP-TAGDLYEMFVARTSS 819 (825)
Q Consensus 793 ~~CL~~DP~eRP-Sa~EIL~hL~~l~ss 819 (825)
.+||..||.+|| +++++++.|+.....
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999996 567777777776543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=338.15 Aligned_cols=272 Identities=19% Similarity=0.253 Sum_probs=195.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
...|.+.+.||+|+||.||+|.+. +..||+|.... . .+.+|+.+|++|+|||||++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~----~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------A----SSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------c----CHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 457999999999999999999984 46678874211 1 1278999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++|||++. ++|..++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+
T Consensus 234 ~--------------~~lv~e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 234 L--------------TCLVLPKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred E--------------EEEEEEccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 3 499999996 799998875 224689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 295 ~~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 295 GP-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred CC-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHH
Confidence 76 45999999999765432111 01123469999999999986 5688999999999999999
Q ss_pred HhCCCCCCCC--------CHHHHHHHHHcCCC--CCchhH----H-hhhccCccccccccCCCCCC--chhhhhhHHHHH
Q 003375 727 LTLQVPYMGL--------SELEIHDLIQMGKR--PRLTDE----L-EALGSCHEHEVAQSGSGFEK--PEAELETLSFLV 789 (825)
Q Consensus 727 LTG~~PF~~~--------~~~~i~~~I~~~~~--p~l~~~----l-~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~L~ 789 (825)
++|..|+... ...++...+..... ..++.. + ..+..... ......... ..........+.
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 432 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAA---RNRRPAYTRPAWTRYYKLDLDVE 432 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhh---cccCCccCCcchhhhccccchHH
Confidence 9987655322 12334444433211 111100 0 00000000 000000000 011112345789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+||.+||+.||.+|||+.|||+|-+.
T Consensus 433 dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 433 YLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred HHHHHHcccChhhCcCHHHHhhCccc
Confidence 99999999999999999999999654
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.18 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=208.1
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEE--ecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVR--TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~--~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+...+||+|+|-+||+|.+....+.|..- ++..........++| ..|+.+|+.|+|||||++|.++.+....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~----~~Ev~lLKsL~H~NIirfy~SW~d~~n~-- 116 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERL----YSEVHLLKSLKHPNIIRFYDSWVDTDNK-- 116 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHH----HHHHHHHccCCCCceeeeeeheecCCCc--
Confidence 45678999999999999986555544432 233333444455555 9999999999999999999999876542
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEEecC
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLE 648 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~--gIVHrDLKP~NILLd~~ 648 (825)
..-+|+|++..|+|..|+++ .+.++.+.++.|++||++||.|||++ .|||||||-+||||+.+
T Consensus 117 ----------~in~iTEL~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 117 ----------TINFITELFTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ----------eeeeeeecccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 46899999999999999998 36788999999999999999999998 69999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
.+.|||+|+|+|....... ...++|||.|||||++. ..|++.+||||||++|+||+|
T Consensus 182 ------~G~VKIGDLGLAtl~r~s~------------aksvIGTPEFMAPEmYE-----E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 182 ------LGEVKIGDLGLATLLRKSH------------AKSVIGTPEFMAPEMYE-----ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred ------cCceeecchhHHHHhhccc------------cceeccCccccChHHHh-----hhcchhhhhhhhhHHHHHHHh
Confidence 3689999999998765432 23468999999999997 578999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~-~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+..||.. .++.++++++..+..|. .+.+. ..+++++||.+||.. ..+|||+.
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~---sl~kV-----------------------~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPA---ALSKV-----------------------KDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHH---Hhhcc-----------------------CCHHHHHHHHHHhcC-chhccCHH
Confidence 9999965 57889999999986543 22111 134799999999999 99999999
Q ss_pred HHHHHHHh
Q 003375 808 DLYEMFVA 815 (825)
Q Consensus 808 EIL~hL~~ 815 (825)
|+|++-..
T Consensus 292 eLL~d~Ff 299 (632)
T KOG0584|consen 292 ELLKDPFF 299 (632)
T ss_pred HHhhChhh
Confidence 99998543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=369.04 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=214.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|+-...||.|.||.||-|.. +|...|+|-.++.... ......+ .+|+.+|..|+|||||++||+-.....+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i----~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLI----AEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcch----HHHHHHHHhccCccccccCceeecHHHH
Confidence 466788999999999999996 5666777765544332 3333333 8999999999999999999998766544
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+|.||||+||+|.+++.. ....++.....+..|++.||+|||++|||||||||.|||++.+
T Consensus 1310 --------------~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1310 --------------YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred --------------HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 999999999999999986 3456777778899999999999999999999999999999987
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+|++|||.|..+.....+.. ..-...+||+.|||||++.+... ....-+.|||||||++.||+|
T Consensus 1371 -------g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~~-kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1371 -------GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTKG-KGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccccc-CCCCcchhhhcccceEEEeec
Confidence 5799999999998866432211 12245689999999999987443 344669999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|+.||... +..++...+..+..|.+|+.+ +.+-.++|.+||..||.+|.++.
T Consensus 1437 GkrPW~~~dne~aIMy~V~~gh~Pq~P~~l---------------------------s~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1437 GKRPWAELDNEWAIMYHVAAGHKPQIPERL---------------------------SSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhccchhHHHhHHhccCCCCCchhh---------------------------hHhHHHHHHHHHhcCchhhhHHH
Confidence 99999775 567889999999999888653 55779999999999999999999
Q ss_pred HHHHHHHhhc
Q 003375 808 DLYEMFVART 817 (825)
Q Consensus 808 EIL~hL~~l~ 817 (825)
||++|=....
T Consensus 1490 qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1490 QLLEHAFGKS 1499 (1509)
T ss_pred HHHHhhcccc
Confidence 9999865443
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.86 Aligned_cols=270 Identities=18% Similarity=0.188 Sum_probs=189.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-.+|++.+.||+|+||.||+|.+. +..+|+|+.... . ...|+.++++++||||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------T----TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------c----cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 357999999999999999999984 457888863211 1 156999999999999999999988665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++
T Consensus 131 ~--------------~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 131 I--------------TCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred e--------------eEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 4 499999996 699998875 235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 192 ~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~el 249 (357)
T PHA03209 192 DV-------DQVCIGDLGAAQFPVVAPA-----------FLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEM 249 (357)
T ss_pred CC-------CCEEEecCccccccccCcc-----------cccccccccccCCeecCC----CCCCchhhHHHHHHHHHHH
Confidence 77 4599999999874322111 123468999999999976 5688999999999999999
Q ss_pred HhCCCCC-CCCCH----------HHHHHHHHcC--CCCCch-----hHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 727 LTLQVPY-MGLSE----------LEIHDLIQMG--KRPRLT-----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 727 LTG~~PF-~~~~~----------~~i~~~I~~~--~~p~l~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
+++..|+ ..... ..+...+... ....++ .....+..... ..+..............+..+
T Consensus 250 l~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 327 (357)
T PHA03209 250 LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYAS--LERQPYTRYPCFQRVNLPIDG 327 (357)
T ss_pred HHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcc--cCCCcccccHHHhccCCCchH
Confidence 9865554 32211 1111111111 000111 00000000000 000000000000111334567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.+||.+||+.||.+|||+.|+++|-+.
T Consensus 328 ~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 328 EFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred HHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 789999999999999999999999654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.79 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|.+.+.||+|+||.||++.. .+..+|+|....... .....+ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~E~~~l~~~~h~~i~~~~~~~~~~~~- 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKE----ASKKEVILLAKMKHPNIVTFFASFQENGR- 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhH----HHHHHHHHHHhCCCCChhhhhheeccCCe-
Confidence 588999999999999999998 457788888654321 112222 33789999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.+|+|+||||+||+++.+
T Consensus 74 -------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 74 -------------LFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred -------------EEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 4999999999999999975 223457899999999999999999999999999999999999866
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ ..++|+|||.+......... .....|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSMEL----------AYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCccc----------ccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 3 35799999998765432111 122458899999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...+..+....+.....+.+. ...+..+.++|.+||..+|.+|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999877665555444433222111 122457999999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
|++|.
T Consensus 251 ll~~~ 255 (257)
T cd08225 251 ILKRP 255 (257)
T ss_pred HhhCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.46 Aligned_cols=260 Identities=21% Similarity=0.333 Sum_probs=199.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
..+|++.+.||.|+||.||+|+.. ...+++|..... ...... ..+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQ----SEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHH----HHHHHHHHHHHhcCCcceeeeEEE
Confidence 467899999999999999999963 345777764321 111122 334899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccC----CCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~----~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
+..... .++||||+++++|.+++....... ...+++..+..++.||+.||.|||+++|+|||
T Consensus 77 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d 142 (275)
T cd05046 77 CREAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD 142 (275)
T ss_pred ECCCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCc
Confidence 876553 399999999999999998621110 12589999999999999999999999999999
Q ss_pred CCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003375 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717 (825)
Q Consensus 638 LKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVW 717 (825)
|||+|||++.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++|||
T Consensus 143 lkp~Nili~~~-------~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~ 202 (275)
T cd05046 143 LAARNCLVSSQ-------REVKVSLLSLSKDVYNSEYY---------KLRNALIPLRWLAPEAVQE----DDFSTKSDVW 202 (275)
T ss_pred CccceEEEeCC-------CcEEEcccccccccCccccc---------ccCCceeEEeecChhhhcc----CCCCchhhHH
Confidence 99999999877 45999999998654321110 1122346778999999875 4578899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 718 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 718 SLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|||+++|+|++ |..||.......+...+..+.... + .....+..+.+++.+||
T Consensus 203 slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~-------------------------~~~~~~~~l~~~i~~~l 256 (275)
T cd05046 203 SFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-P-------------------------VPEGCPSRLYKLMTRCW 256 (275)
T ss_pred HHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-C-------------------------CCCCCCHHHHHHHHHHc
Confidence 99999999998 889998776666655554332110 0 00123457999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 003375 797 EENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~ 815 (825)
+.+|.+||++.+++.+|.+
T Consensus 257 ~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 257 AVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCcccCCCHHHHHHHhcC
Confidence 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.17 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=202.0
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 574 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~ 574 (825)
.-+||+|.||+||-|++..+.|-+.|+.+.... .++.+-+..||.+-++|+|.|||+++|.+...+.
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf------- 646 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF------- 646 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-------
Confidence 346899999999999986666655555444322 2223345889999999999999999999876664
Q ss_pred CccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCC
Q 003375 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654 (825)
Q Consensus 575 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~ 654 (825)
+-|.||-++||+|.++++. +.+...=.+.++-.+.+||++||.|||.+.|||||||-+|+||+.-
T Consensus 647 -------~kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy------ 711 (1226)
T KOG4279|consen 647 -------FKIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY------ 711 (1226)
T ss_pred -------EEEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec------
Confidence 4899999999999999986 3333333788999999999999999999999999999999999754
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~ 734 (825)
.+.+||+|||-++.+..-. +.+.++.||..|||||++.. +...|+.++|||||||++.||.||++||.
T Consensus 712 SGvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDq--G~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 712 SGVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQ--GPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred cceEEecccccchhhccCC----------ccccccccchhhhChHhhcc--CCcCCCchhhhhhccceeEeeccCCCCee
Confidence 4789999999998775422 22456789999999999976 34679999999999999999999999997
Q ss_pred CCC-HHHHHHHHH-cCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 735 GLS-ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 735 ~~~-~~~i~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
... +......+. ....|++|+.+ +.+.+++|.+|+.+||..||+|.++|..
T Consensus 780 ElgspqAAMFkVGmyKvHP~iPeel---------------------------saeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 780 ELGSPQAAMFKVGMYKVHPPIPEEL---------------------------SAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ecCChhHhhhhhcceecCCCCcHHH---------------------------HHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 653 333333333 33566666543 6688999999999999999999999875
Q ss_pred H
Q 003375 813 F 813 (825)
Q Consensus 813 L 813 (825)
.
T Consensus 833 p 833 (1226)
T KOG4279|consen 833 P 833 (1226)
T ss_pred c
Confidence 3
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.35 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=211.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+-|.++.+||+|+||.||+|.+ .+..+|+|.+.+. .+++++ .+|+.||+++..|++|++||.|.....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHH----HHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 3477899999999999999987 4566677765432 344444 899999999999999999998875554
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+|||||||..|++.+.++. .++.+++.++..+++..+.||+|||...-||||||..|||++.
T Consensus 103 --------------LWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 103 --------------LWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred --------------eEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 4999999999999999986 3578999999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +++||+|||.|..+...... .++..|||.|||||++.. -.|+.++||||||++..||.
T Consensus 165 ~-------G~AKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMA 223 (502)
T KOG0574|consen 165 D-------GIAKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMA 223 (502)
T ss_pred c-------chhhhhhccccchhhhhHHh----------hCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhh
Confidence 8 56999999999877654322 356789999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
.|++||....++..+..|-....|.+. +++ .-+.++.+++++||...|++|-|+.
T Consensus 224 EG~PPYsDIHPMRAIFMIPT~PPPTF~----------------------KPE---~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 224 EGRPPYSDIHPMRAIFMIPTKPPPTFK----------------------KPE---EWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred cCCCCcccccccceeEeccCCCCCCCC----------------------ChH---hhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 999999988877655555444333322 121 2356799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 003375 808 DLYEMFVARTS 818 (825)
Q Consensus 808 EIL~hL~~l~s 818 (825)
++++|..-.++
T Consensus 279 ~L~~H~FiknA 289 (502)
T KOG0574|consen 279 RLCEHTFIKNA 289 (502)
T ss_pred HHhhhhhhcCC
Confidence 99999765544
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.28 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=196.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHH-HhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~i-Lk~L~HPNIV~l~g~~~~~~ 566 (825)
++|++.+.||+|+||.||++.+ .+..||+|...... ..... .. +..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~-~~----~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQ-KR----LLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHHH-HH----HHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 4789999999999999999998 47889999865332 12221 22 2556665 66678999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILL 645 (825)
. .|+||||++ ++|.+++...... ...+++..++.++.||+.||.|||++ +++||||||+|||+
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 D--------------VWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred c--------------EEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 4 499999997 7999998753322 25689999999999999999999998 99999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ ..+||+|||++..+..... .....++..|+|||++.+......++.++|||||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSVA-----------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeecccccccccccc-----------cccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 877 4599999999876532111 1223588999999998753333456889999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++|+.||... ...+....+.....+.++. ...+..+.+||.+||..+|.+||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 99999999643 2222222222222222110 11345789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
++.+|++|-+-...
T Consensus 254 ~~~~il~~~~~~~~ 267 (283)
T cd06617 254 NYPELLQHPFFELH 267 (283)
T ss_pred CHHHHhcCchhhhc
Confidence 99999998654443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.79 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=200.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|++.+.||+|+||.||++.+. +..+|+|+..... .... ...+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSV----RKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchH----HHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 3568999999999999999999984 7788999865321 1122 23448999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NIL 644 (825)
. ..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .+|+||||||+||+
T Consensus 76 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 76 N--------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred C--------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 4 35999999999999999875 3468999999999999999999997 59999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~ 193 (284)
T cd06620 137 VNSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISII 193 (284)
T ss_pred ECCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHH
Confidence 9876 469999999986542211 123468999999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 725 ELLTLQVPYMGLSEL-----------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 725 ELLTG~~PF~~~~~~-----------~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
+|++|..||...... .....+.....+.++ ....+..+.+|+.
T Consensus 194 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~ 247 (284)
T cd06620 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVD 247 (284)
T ss_pred HHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHH
Confidence 999999999765432 111111111111110 0113457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 794 RCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
+||+.||.+|||+.|+++|+..+...
T Consensus 248 ~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 248 ACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999987665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.77 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=201.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|+..+.||+|+||.||+|.+ .+. .+|+|+.... ....... .+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANV----EFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHH----HHHHHHHHHHhCCCCCcccEEE
Confidence 3456788999999999999999987 333 3567764311 1122222 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+|+||||
T Consensus 77 ~~~~~~---------------~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp 137 (303)
T cd05110 77 VCLSPT---------------IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAA 137 (303)
T ss_pred EEcCCC---------------ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccc
Confidence 886432 2799999999999999875 224588999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ ..+||+|||+++.+...... .......++..|+|||++.+ ..++.++||||||
T Consensus 138 ~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG 198 (303)
T cd05110 138 RNVLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYG 198 (303)
T ss_pred ceeeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHH
Confidence 99999876 45999999999866432211 01122346778999999875 6688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+.........+..+..+..+ ...+..+.+++.+||..+
T Consensus 199 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~ 251 (303)
T cd05110 199 VTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP---------------------------PICTIDVYMVMVKCWMID 251 (303)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCC
Confidence 99999997 99999887766665555544322111 012346899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+||++.++++.|..+...
T Consensus 252 p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 252 ADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.25 Aligned_cols=276 Identities=19% Similarity=0.262 Sum_probs=203.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|++|.||+|++ .+..+|+|+....... .... .+.+|+.++++++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPS----TAIREISLMKELKHENIVRLHDVIHTENK- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchH----HHHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence 589999999999999999997 5778999987543221 1122 23789999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.+|||||++ ++|.+++... .....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 73 -------------~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 73 -------------LMLVFEYMD-KDLKKYMDTH--GVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred -------------EEEEEecCC-ccHHHHHHhc--CCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 499999998 5999988752 122468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....++..|++||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVNT----------FSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCccc----------cccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 45999999998755332111 122357889999999865 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+.||.+.+..+....+...........+..+.... .+....... .........+..+.++|.+||+.||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 999998877666555544432222222222211100 000000000 001111234667899999999999999999
Q ss_pred HHHHHHH
Q 003375 806 AGDLYEM 812 (825)
Q Consensus 806 a~EIL~h 812 (825)
+.++++|
T Consensus 275 ~~~~l~~ 281 (284)
T cd07836 275 AHDALQH 281 (284)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.57 Aligned_cols=284 Identities=19% Similarity=0.239 Sum_probs=202.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..||+|+.... . .... ...+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~-~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--E-HQTF----CQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--c-cchh----HHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 5899999999999999999987 5678999985321 1 1111 2334889999999999999999998765432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .....|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 2235699999997 589888764 56899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... ........||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 45999999998765432111 001123468999999998764 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+.......+.........+.+..........+.... ............+..+.+||.+||+.+|.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 999999877655544444332221112222111100000000000 00000111223466799999999999999999
Q ss_pred CHHHHHHHH
Q 003375 805 TAGDLYEMF 813 (825)
Q Consensus 805 Sa~EIL~hL 813 (825)
|+.++++|-
T Consensus 285 t~~e~l~hp 293 (336)
T cd07849 285 TVEEALAHP 293 (336)
T ss_pred CHHHHhcCc
Confidence 999999993
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=310.99 Aligned_cols=283 Identities=20% Similarity=0.244 Sum_probs=201.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||.|++|.||+|.+ .+..+++|....... .....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPS----TAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchH----HHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 46899999999999999999997 466789987643321 111122 3378999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+|+||+|+||+++
T Consensus 75 ~--------------~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 R--------------LYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred e--------------EEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 3 499999996 688888764 2223467888999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
..+ ..+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVRT----------FTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCccc----------cccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 642 46999999999765332111 122357889999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
+||++||...+..+....+...........+....... .+...... ..........++.+.+++.+||+.+|.+|
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP--DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch--hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 99999998776655544433221111111111000000 00000000 00001122345678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
|++.++++|-+..
T Consensus 276 ps~~~~l~~~~~~ 288 (294)
T PLN00009 276 ITARAALEHEYFK 288 (294)
T ss_pred cCHHHHhcCchHh
Confidence 9999999985543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.91 Aligned_cols=292 Identities=21% Similarity=0.244 Sum_probs=200.7
Q ss_pred CceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+|++.+.||+|+||.||+|.+ .+..+|+|++..... ....+...+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 488999999999999999998 457899998764321 01111223478999999999999999999998652
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ...++||||++ ++|.+++..........+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 D------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred C------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 1 24699999997 5888887654333334789999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++. ..+.+||+|||++......... ........+++.|+|||++.+ ...++.++|||||||+||+|
T Consensus 143 ~~~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEGP---ERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCCC---ccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 7321 2367999999999876442211 111233468899999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHHHcCCCCCchhHHhhhccCccccc---cccCCCCCCchh----h--hhhHHHH
Q 003375 727 LTLQVPYMGLSELE---------IHDLIQMGKRPRLTDELEALGSCHEHEV---AQSGSGFEKPEA----E--LETLSFL 788 (825)
Q Consensus 727 LTG~~PF~~~~~~~---------i~~~I~~~~~p~l~~~l~~~~~~~~~~~---~~~~~~~~~~~~----~--~~~s~~L 788 (825)
++|++||.+..... ....+........+..+........... ............ . ...+..+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 99999997654321 1111111100001110100000000000 000000000000 0 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
.++|.+||+.||.+|||+.|+++|-
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCC
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.34 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=200.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||++.. .+..|++|....... ........+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 4689999999999999999997 456789987543211 111112344889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 76 --------------LCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred --------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 4999999999999999976 346899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCccccccccccccc-----ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
+ +.++|+|||+++........... ............++..|+|||.+.. ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 6 46999999998742211111000 0000011123457889999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|||++|..||.+....++...+.....+... .....+..+.+||.+||+.||.+
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-------------------------GDEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------ccccCCHHHHHHHHHHhccChhh
Confidence 99999999999888777766665543211100 00123557899999999999999
Q ss_pred CCC---HHHHHHHHH
Q 003375 803 RPT---AGDLYEMFV 814 (825)
Q Consensus 803 RPS---a~EIL~hL~ 814 (825)
||+ +.++++|..
T Consensus 261 R~~~~~~~~ll~~~~ 275 (305)
T cd05609 261 RLGTGGAFEVKQHRF 275 (305)
T ss_pred ccCccCHHHHHhCcc
Confidence 998 566666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=304.13 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=200.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||++.. .+..+++|+...... ..... ..+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTI----KEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHH----HHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588999999999999999986 567899998754432 22233 34499999999999999999999876544
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 35999999999999999975 3457889999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||++........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 4599999999987654322110 0012245789999999997622 1237889999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|+.||.... .......+.....+.++.. ...+..+.++|.+||+.+|.+||++.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 999997653 3333333333322222210 11245688999999999999999999
Q ss_pred HHHHH
Q 003375 808 DLYEM 812 (825)
Q Consensus 808 EIL~h 812 (825)
+++.|
T Consensus 257 ~i~~~ 261 (264)
T cd06626 257 ELLQH 261 (264)
T ss_pred HHhcC
Confidence 99876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.61 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=203.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
...|.+.+.||+|+||.||+|.. .+..+++|+..... .......+. +.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~----~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQD----IIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 45689999999999999999987 57789999864322 122222233 489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+.||+||||+|.||+++
T Consensus 89 ~--------------~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~ 149 (307)
T cd06607 89 T--------------AWLVMEYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT 149 (307)
T ss_pred e--------------EEEEHHhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC
Confidence 3 499999997 688887764 124689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++||||||+++|||
T Consensus 150 ~~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 150 EP-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred CC-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeeccC-CCCCCcccchHHHHHHHHHH
Confidence 77 45999999998654321 2235888999999985321 25578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+||+.||.+.+.......+.....+.+.. ...+..+.+||.+||..+|.+||++
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIAQNDSPTLSS--------------------------NDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred HcCCCCCCCccHHHHHHHHhcCCCCCCCc--------------------------hhhCHHHHHHHHHHhcCChhhCcCH
Confidence 99999998877665554444332222110 1124578999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 003375 807 GDLYEMFVARTSS 819 (825)
Q Consensus 807 ~EIL~hL~~l~ss 819 (825)
.+|+.|.+.....
T Consensus 262 ~~il~~~~~~~~~ 274 (307)
T cd06607 262 EELLKHRFVLRER 274 (307)
T ss_pred HHHhcChhhcccC
Confidence 9999987765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=309.78 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=200.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
-|++.+.||.|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.++.+++||||+++++++.....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 76 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYVTKYYGSYLKDTK- 76 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHH----HHHHHHHHHHhcCCCCEeEEEEEEEeCCe-
Confidence 367888999999999999986 56788999854321 112223 34899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~ 137 (277)
T cd06641 77 -------------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 137 (277)
T ss_pred -------------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC
Confidence 4999999999999999864 468899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++..+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (277)
T cd06641 138 -------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEeecccceecccchhh----------hccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHc
Confidence 45999999998765432111 122358889999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...........+.....+.+. ...+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 197 GEPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred CCCCCCccchHHHHHHHhcCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999877666555555443322221 112457899999999999999999999
Q ss_pred HHHHHHhh
Q 003375 809 LYEMFVAR 816 (825)
Q Consensus 809 IL~hL~~l 816 (825)
+++|....
T Consensus 250 ~l~~~~~~ 257 (277)
T cd06641 250 LLKHKFIV 257 (277)
T ss_pred HHhCHHHh
Confidence 99985443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=303.68 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=201.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||.|++|.||+|.. .+..+++|+....... .... .+.+|+.++.+++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRK----QLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHH----HHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 3688999999999999999997 4778999986543211 2223 3489999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd 646 (825)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 -------------EISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred -------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 35999999999999999986 2568999999999999999999999 9999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++......... .....++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l 193 (264)
T cd06623 135 SK-------GEVKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLEC 193 (264)
T ss_pred CC-------CCEEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999998766432211 123458899999999876 5678999999999999999
Q ss_pred HhCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~---~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|..||... ...+....+.....+.++.. ..+..+.++|.+||..+|.+|
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~l~~li~~~l~~~p~~R 247 (264)
T cd06623 194 ALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE--------------------------EFSPEFRDFISACLQKDPKKR 247 (264)
T ss_pred HhCCCCCccccccCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHccCChhhC
Confidence 9999999766 33444444443322221110 035579999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
|++.++++|-.
T Consensus 248 ~~~~~ll~~~~ 258 (264)
T cd06623 248 PSAAELLQHPF 258 (264)
T ss_pred CCHHHHHhCHH
Confidence 99999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.33 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=203.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..|.....||+|+||.||+|.. .+..+++|+...... ...+ .+.+|+.++..++||||+++++.+.....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRE----LLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHH----HHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 3455566899999999999987 578899998654321 1122 24889999999999999999999876553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 93 --------------~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~ 152 (297)
T cd06659 93 --------------LWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152 (297)
T ss_pred --------------EEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc
Confidence 4999999999999998864 45889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++..+...... .....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~ 211 (297)
T cd06659 153 D-------GRVKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMV 211 (297)
T ss_pred C-------CcEEEeechhHhhccccccc----------ccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 45999999998755332111 123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|+.||...........+.....+... .....+..+.++|.+||+.+|.+||++.
T Consensus 212 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~ 266 (297)
T cd06659 212 DGEPPYFSDSPVQAMKRLRDSPPPKLK-------------------------NAHKISPVLRDFLERMLTREPQERATAQ 266 (297)
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCcc-------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 999999877766655544432211110 0012345789999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 003375 808 DLYEMFVARTSSSI 821 (825)
Q Consensus 808 EIL~hL~~l~sss~ 821 (825)
+|++|........+
T Consensus 267 ~ll~~~~~~~~~~~ 280 (297)
T cd06659 267 ELLDHPFLLQTGLP 280 (297)
T ss_pred HHhhChhhccCCCc
Confidence 99998766655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=309.29 Aligned_cols=254 Identities=31% Similarity=0.499 Sum_probs=199.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEecC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 565 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~~ 565 (825)
.|++.+.||+|+||.||+|.+ .+..+++|+..... .......+ .+|+.+++.++ ||||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~----~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDI----QREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHH----HHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 478889999999999999997 56789999865332 12223333 78999999997 99999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 35999999999999999864 368899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....|+..|+|||.+.+ ...++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSSK----------RSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCccc----------cccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 876 45999999998766432211 123368899999999864 2456889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.........+.....+.++. ...+..+.+++.+||+.||.+||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998766544333322221111110 013457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.+++.|-+-..
T Consensus 249 ~~~il~~~~~~~ 260 (277)
T cd06917 249 AEELLKSKWIKA 260 (277)
T ss_pred HHHHhhChHhhc
Confidence 999999866544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.70 Aligned_cols=276 Identities=23% Similarity=0.279 Sum_probs=198.1
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 568 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~ 568 (825)
|++.+.||+|+||.||+|.. .+..+|+|+..... ...... . ..+|+.++.++. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~~-~----~~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQV-N----NLREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CCchhh-h----HHHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 67899999999999999987 56788999764322 111111 1 257899999996 9999999999876521
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
...++||||++ ++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 13599999997 688888865 1246899999999999999999999999999999999999986
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ .+||+|||++..+..... .....++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 ~-------~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 D-------ILKLADFGSCRGIYSKPP-----------YTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred C-------CeEEEecccccccccCCC-----------cCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 3 499999999976543211 122357899999998754 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc-cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|..||.+.+..+....+......................+.. ..............+..+.+||.+||.++|.+||++.
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 999998887766655554332211111111100000000000 0000000111224468899999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
++++|-
T Consensus 275 ~~l~~~ 280 (282)
T cd07831 275 QALRHP 280 (282)
T ss_pred HHhhCC
Confidence 999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.80 Aligned_cols=294 Identities=17% Similarity=0.211 Sum_probs=203.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.. .+..+|+|......... .+...+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 4578899999999999999999997 57789999865332111 111233689999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ........++||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus 83 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 83 KATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 5421 0112335799999997 589888865 2246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++..+....... ........++..|+|||++.+ ...++.++||||||+++|
T Consensus 152 ~~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 152 ITKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMA 215 (310)
T ss_pred ECCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHH
Confidence 9877 469999999998664322110 011123357889999999865 234678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccc---cccccC-CCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~---~~~~~~-~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||++|..||.+.+.......+........+..++........ ...... ...............+.+||.+||..||
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 999999999887765544444332111001100000000000 000000 0000000000123567899999999999
Q ss_pred CCCCCHHHHHHHH
Q 003375 801 TERPTAGDLYEMF 813 (825)
Q Consensus 801 ~eRPSa~EIL~hL 813 (825)
.+|||++++++|-
T Consensus 296 ~~R~t~~e~l~h~ 308 (310)
T cd07865 296 AKRIDADTALNHD 308 (310)
T ss_pred hhccCHHHHhcCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.82 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=201.7
Q ss_pred CceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCCh--HHHHhhHHhHHHHHHHHhh-CCCCCcceeeeeEec
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 564 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~--~~~~~~~~~~lrEv~iLk~-L~HPNIV~l~g~~~~ 564 (825)
.|++.+.||+|+||.||++.+. +..+|+|........... .........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788999999999999999974 477899986544322110 0111111234788888875 789999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NI 643 (825)
... .++||||+++++|.+++...... ...+++..++.++.|++.||.|||. .+|+|+||||+||
T Consensus 81 ~~~--------------~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 NDR--------------LYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CCe--------------EEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 553 49999999999999998653222 3568999999999999999999996 6899999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.++|+|||++........ .....|+..|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPESK-----------LTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeecccccc-----------cccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99877 4599999999976543210 123458899999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|+.||...........+.......... ...++.+.++|.+||+.||.+|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--------------------------GMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCCc--------------------------ccCCHHHHHHHHHHCCCCCccC
Confidence 99999999998776666555554432221110 0124578999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
|++.|+.+++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.84 Aligned_cols=278 Identities=20% Similarity=0.246 Sum_probs=198.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||+|.+ .+..+++|....... ..... ..+.+|++++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVP----STAIREISLLKELNHPNIVKLLDVIHTENK- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccc----hHHHHHHHHHHhcCCCCCcchhhhcccCCc-
Confidence 488999999999999999987 567889987654321 11111 234889999999999999999999875543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+. ++|.+++.. .....+++..++.++.||+.||+|||+.|++|+||+|+||+++.+
T Consensus 74 -------------~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 74 -------------LYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred -------------EEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 499999996 689998875 223568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|||+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 45999999998765432111 122247889999998865 2346889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|+.||.+.+.......+...........+........ ..+..... ..........+..+.++|.+||+.||.+|||+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR-QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc-cCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 9999987765544433332211111111000000000 00000000 00001112245678999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.++++|-
T Consensus 276 ~~~l~~~ 282 (284)
T cd07860 276 KAALAHP 282 (284)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=330.75 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=196.2
Q ss_pred CCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
..|+++++||.||.+.||++... ...+|+|.+.+. ......+..| .+|+.+|.+|+ |.+||++|+|-..++.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 46999999999999999999974 344555543222 2334445555 99999999997 9999999999887765
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+ |+||||-+ .+|..+|.+ ....++...++.+..||+.|+.++|.+||||.||||.|+|+-.
T Consensus 435 l--------------YmvmE~Gd-~DL~kiL~k----~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 L--------------YMVMECGD-IDLNKILKK----KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred E--------------EEEeeccc-ccHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 4 99999987 799999987 2233444588899999999999999999999999999999864
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-------CCCCchhhHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 720 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~-------~~~s~kSDVWSLG 720 (825)
+.+||+|||+|..+...... + .....+||+.||+||.+..+... -..+.++||||||
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--I------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--I------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--e------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 46999999999887653322 1 12456899999999999865432 1367899999999
Q ss_pred HHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
||||+|+.|++||.... ...-+..|... .-. .++.... ...+++++++.||..|
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~P---~~~-----------Iefp~~~-----------~~~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITDP---NHE-----------IEFPDIP-----------ENDELIDVMKCCLARD 614 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcCC---Ccc-----------ccccCCC-----------CchHHHHHHHHHHhcC
Confidence 99999999999996543 22222233221 110 0010000 1224899999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 003375 800 PTERPTAGDLYEMFVA 815 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~ 815 (825)
|.+||++.++|+|..-
T Consensus 615 PkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 615 PKKRWSIPELLQHPFL 630 (677)
T ss_pred cccCCCcHHHhcCccc
Confidence 9999999999998543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.92 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=199.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~-~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.+|++.+.||+|+||.||+|.+ .+..+++|+........ ..... ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV----NALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHH----HHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 3689999999999999999986 56789999865432111 12222 34489999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 E------------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred C------------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1 246899999999999999975 24578999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..++|+|||++......... ........++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMS-------GTGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECcccccccccccccc-------CccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 76 45999999999865431110 001123458899999999976 5578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|+.||...........+... ..+.++ ...++.+.++|.+||. +|..||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLP---------------------------DGVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCC---------------------------cccCHHHHHHHHHHhc-CcccCcc
Confidence 9999999877655444333322 222222 1235679999999999 5799999
Q ss_pred HHHHHHHH
Q 003375 806 AGDLYEMF 813 (825)
Q Consensus 806 a~EIL~hL 813 (825)
+.+++.|.
T Consensus 255 ~~~~~~~~ 262 (264)
T cd06653 255 AEFLLRHP 262 (264)
T ss_pred HHHHhcCC
Confidence 99999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.73 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=196.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||+|.+ .+..+++|+...... ......+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVR----NVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHH----HHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 589999999999999999998 478899998753321 1112233 3489999999999999999999887554
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+.|++|.+++.. ...+++..+..++.||+.||.|||.+||+|+||+|+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 35999999999999999976 2478999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++........ .....|+..|+|||++.. ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDTL-----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCcc-----------ccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 4599999999876543211 123458889999999976 457899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|..||...+. ..+...... ..+.++ ...+..+.++|.+||..||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLYP---------------------------ATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccCc---------------------------ccCcHHHHHHHHHHccCChhHcCC
Confidence 9999987653 222222111 111111 112467899999999999999999
Q ss_pred H--HHHHHH
Q 003375 806 A--GDLYEM 812 (825)
Q Consensus 806 a--~EIL~h 812 (825)
+ .|+++|
T Consensus 247 ~~~~~l~~~ 255 (258)
T cd05578 247 DNLKDLKNH 255 (258)
T ss_pred ccHHHHhcC
Confidence 9 888765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.06 Aligned_cols=252 Identities=30% Similarity=0.438 Sum_probs=199.5
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||.|+||.||++.+. +..+++|...... ...... .+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQK----QILRELDILHKCNSPYIVGFYGAFYNNG- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHH----HHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence 36888999999999999999984 6788888765332 112223 3489999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd 646 (825)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+ .|++|+||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 -------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred -------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 359999999999999999862 1568899999999999999999999 9999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||.+........ ....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~------------~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 136 SR-------GQIKLCDFGVSGQLVNSLA------------KTFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred CC-------CCEEEeecccchhhHHHHh------------hcccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHH
Confidence 76 4599999999876543211 11458899999999976 5788999999999999999
Q ss_pred HhCCCCCCCCC-----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 727 LTLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 727 LTG~~PF~~~~-----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|..||.... ..+....+.....+.++.. ..+..+.++|.+||..||.
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~l~~~p~ 246 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--------------------------KFSPDFQDFVNLCLIKDPR 246 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCChh--------------------------hcCHHHHHHHHHHcCCCch
Confidence 99999996542 2233333333322222211 1355789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.+++.|.+.
T Consensus 247 ~Rpt~~~ll~~~~~ 260 (265)
T cd06605 247 ERPSYKELLEHPFI 260 (265)
T ss_pred hCcCHHHHhhCchh
Confidence 99999999998553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.03 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=205.0
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|.+.+.||.|+||.||++.+. +..+++|+..... ........ +.+|+++++.++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHH----HHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999985 7889999865432 22223333 488999999999999999999987554
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+++++|.+++..... ....+++..+..++.+|+.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 35999999999999999986321 23678999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||++........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 4599999999976644221 1123468899999999876 557889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...+..++...+.....+.++. ..+..+.+++.+||..+|.+|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998877766666655443332221 22457899999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|-
T Consensus 252 ll~~~ 256 (258)
T cd08215 252 ILQSP 256 (258)
T ss_pred HhcCC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.80 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=204.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|+||.||++.+ .+..+++|...... ........ +.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS--MSQKERED----AVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh--ccHHHHHH----HHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 588999999999999999987 45678888865332 22222333 378999999999999999999887554
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.|++|+||+|.||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 45999999999999999976332 23568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..+||+|||++....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~------------~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNM------------AKTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCC------------cccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 459999999997764421 112357889999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||...+...+...+.....+.++. ..+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998888776666665544333321 22457999999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 250 ~l~~p 254 (256)
T cd08530 250 ILASP 254 (256)
T ss_pred HhcCC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.10 Aligned_cols=274 Identities=23% Similarity=0.353 Sum_probs=197.2
Q ss_pred CCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
..|++.+.||+|+||.||+|.+. +..+|+|+...... . ...+ .+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~-~~~~----~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--E-QHRS----DFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--h-HHHH----HHHHHHHHHHhCCCCChheEEeeee
Confidence 46788899999999999999863 56899998653321 1 2223 3489999999999999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... ...++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.||+|+||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPGG------------RSLRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCCC------------CceEEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 5321 235999999999999999975 123589999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.++|+|||++........... ......++..|+|||.+.+ ..++.++|||||||++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYYY-------VKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCccee-------ccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99877 4699999999987653221100 0111235567999999876 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|..||......... .............+.... ...... ......+..+.+|+.+||+.+|.+|
T Consensus 203 ~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELL--------KEGERL---PRPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccCCCcccccchhcc-ccccccccccHHHHHHHH--------HcCCcC---CCCccCCHHHHHHHHHHhccChhhC
Confidence 9999999998654221100 000000000000000000 000000 0011234679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
||+.+|++.|+.+
T Consensus 271 pt~~ei~~~l~~i 283 (284)
T cd05038 271 PSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHhhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.86 Aligned_cols=280 Identities=21% Similarity=0.242 Sum_probs=194.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|.+.+.||+|+||.||+|.. .+..+++|++..+.... .. ..+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VP----FTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---Cc----HHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 357899999999999999999986 57789999875432111 11 1237899999999999999999998755
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||+.||+|+||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 ET--------------LTFVFEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred Ce--------------EEEEEeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 43 499999996 788887754 12457788899999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 876 45999999998754332111 122357899999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCcc--cccccc--CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 726 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHE--HEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 726 LLTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~--~~~~~~--~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|++|..||.+.... +....+...........+......+. ..+... .............+..+.+|+.+||..||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999765432 22222211100000100000000000 000000 00000000001124578899999999999
Q ss_pred CCCCCHHHHHHHH
Q 003375 801 TERPTAGDLYEMF 813 (825)
Q Consensus 801 ~eRPSa~EIL~hL 813 (825)
.+|||+.+++.|-
T Consensus 277 ~~R~t~~~~l~h~ 289 (291)
T cd07870 277 KDRISAQDALLHP 289 (291)
T ss_pred ccCcCHHHHhcCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=341.11 Aligned_cols=294 Identities=19% Similarity=0.196 Sum_probs=191.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe---eEEEEEEecccCC---------CChHHHHhhHHhHHHHHHHHhhCCCCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCG---------SSADEIRNFEYSCLGEVRMLGALRHSC 554 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKI~~lk~~~---------~~~~~~~~~~~~~lrEv~iLk~L~HPN 554 (825)
..+++|++++.||+|+||.||+|..... ..++|........ ............+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3467899999999999999999875321 1122210000000 000001112334589999999999999
Q ss_pred cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 555 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 555 IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
||++++++..... .|+||+++. ++|.+++...............++.|+.||+.||.|||++|||
T Consensus 225 Iv~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi 289 (501)
T PHA03210 225 ILKIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289 (501)
T ss_pred cCcEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999987654 399999996 6888887642111122344677889999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+||||+.+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++
T Consensus 290 HrDLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 349 (501)
T PHA03210 290 HRDIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEIT 349 (501)
T ss_pred cCCCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHH
Confidence 99999999999877 45999999999876432111 1123469999999999986 5689999
Q ss_pred hHHHHHHHHHHHHhCCCC-CCCC--CH-HHHHHHHHcCC--CCCchhHHhhhccC-ccccccccCCCCCCchhhhhhHHH
Q 003375 715 DIWSYGCLLLELLTLQVP-YMGL--SE-LEIHDLIQMGK--RPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 715 DVWSLGvILyELLTG~~P-F~~~--~~-~~i~~~I~~~~--~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
|||||||+||||++|..+ |... .+ .++...+.... ...+++....++.. ....+................+..
T Consensus 350 DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 429 (501)
T PHA03210 350 DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPAD 429 (501)
T ss_pred HHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChH
Confidence 999999999999998754 4322 22 22322222111 11111110000000 000000000000000111123456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+.++|.+||++||.+|||+.|++.|.+.
T Consensus 430 ~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 430 FEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 8899999999999999999999998664
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.36 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=217.6
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+....++||-|.||.||.|.|+.-...|.++.++.. .-++++| ++|+.+|+.++|||+|+++|+|..+..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~EpPF-- 338 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEPPF-- 338 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCCCe--
Confidence 456789999999999999999765544444445543 2345556 9999999999999999999999876654
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
|||+|||..|+|.+||+.. .+..++.-..+.|+.||..||.||..+++|||||-..|.|+.++
T Consensus 339 ------------YIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 339 ------------YIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred ------------EEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 9999999999999999873 33557788889999999999999999999999999999999987
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 729 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G 729 (825)
-.||++|||+++.+.....+. + ....-.+.|.|||-+.- ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYTA---H------AGAKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYTA---H------AGAKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCceec---c------cCccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 579999999999987654331 1 11223568999999975 678999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
..||.+.+..+++..+.++.+..-++ .+++.+++||+.||+++|..||++.||
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~Pe---------------------------GCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGPE---------------------------GCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCCC---------------------------CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 99999999999999999887644332 346789999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 003375 810 YEMFVARTSSSI 821 (825)
Q Consensus 810 L~hL~~l~sss~ 821 (825)
-+.++.+..+++
T Consensus 517 HqafEtmf~~sS 528 (1157)
T KOG4278|consen 517 HQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhcccc
Confidence 999998876643
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.43 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=201.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
....+|.+.+.||+|+||.||++.. .+..+++|...... ....+ .+.+|+.+++.++||||+++++.+..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKE----LIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHH----HHHHHHHHHhhcCCCCeeehhheeee
Confidence 3467999999999999999999986 56779999864321 11222 34889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 88 ~~~--------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nil 147 (293)
T cd06647 88 GDE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 147 (293)
T ss_pred CCc--------------EEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEE
Confidence 553 4999999999999999975 45788999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++......... .....|++.|+|||.+.. ..++.++|||||||++|
T Consensus 148 i~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~ 206 (293)
T cd06647 148 LGMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAI 206 (293)
T ss_pred EcCC-------CCEEEccCcceecccccccc----------cccccCChhhcCchhhcc----CCCCchhhHHHHHHHHH
Confidence 9876 45999999988755432111 123458899999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||...+.......+.....+.+. .....+..+.++|.+||..+|.+||
T Consensus 207 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 207 EMVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred HHHhCCCCCCCCChhhheeehhcCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCc
Confidence 999999999776554332222222111111 0112345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
++.+++.|-....
T Consensus 262 ~~~~il~h~~~~~ 274 (293)
T cd06647 262 SAKELLQHPFLKI 274 (293)
T ss_pred CHHHHhcCHHHhc
Confidence 9999999955443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.92 Aligned_cols=278 Identities=26% Similarity=0.322 Sum_probs=199.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..+++|+...... ... +...+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DED----VKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--ccc----chhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 4799999999999999999997 466788887543322 111 22344899999999999999999999976543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||++++.|..++.. ...+++..++.++.||+.||.|||.+||+|+||+|+||+++.
T Consensus 75 --------------~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 75 --------------LYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred --------------EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 5999999997666655543 345899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPAS---------PLTDYVATRWYRAPELLVG---DTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCccc---------cccCcccccCCcCCchhcC---CCCcCchhhHHHHHHHHHHHH
Confidence 6 45999999998776543210 1123467899999999976 126789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC-CCCCCc-----hhhhhhHHHHHHHHHHhcccCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFEKP-----EAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|++||.+....+....+........+..... .... ..+.... .....+ ......+..+.+||.+||..+|.
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 274 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL-FSSN-PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK 274 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh-cccC-ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCch
Confidence 99999987765544433332211111111100 0000 0000000 000000 00112367899999999999999
Q ss_pred CCCCHHHHHHHH
Q 003375 802 ERPTAGDLYEMF 813 (825)
Q Consensus 802 eRPSa~EIL~hL 813 (825)
+||+++++++|-
T Consensus 275 ~Rps~~~il~~~ 286 (288)
T cd07833 275 ERLTCDELLQHP 286 (288)
T ss_pred hcccHHHHhcCC
Confidence 999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.81 Aligned_cols=245 Identities=27% Similarity=0.325 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||.|+||.||+|... +..+++|++...... .... ...+.+|+.+++.++||||+++++.+.....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQ----QEHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhH----HHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 799999999999985 788999987533211 1112 2345899999999999999999999876654
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.++||||+++++|.+++.. ...++...+..++.||+.||.|||++|++|+||+|.||+++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 4999999999999999976 2458899999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
+.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQK-----------TWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCcccc-----------cccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 4599999999976643211 122358899999999875 5678899999999999999999999977
Q ss_pred CC--HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 003375 736 LS--ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 807 (825)
Q Consensus 736 ~~--~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS-----a~ 807 (825)
.. .......+..+ ..+..+ ...++.+.++|.+||..+|.+||+ +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFP---------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 66 55555444432 111111 111457999999999999999999 99
Q ss_pred HHHHHHHh
Q 003375 808 DLYEMFVA 815 (825)
Q Consensus 808 EIL~hL~~ 815 (825)
|+++|-+.
T Consensus 248 ~l~~~~~~ 255 (262)
T cd05572 248 DIKKHKWF 255 (262)
T ss_pred HHhcChhh
Confidence 99998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.36 Aligned_cols=299 Identities=20% Similarity=0.208 Sum_probs=206.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||.|+||.||+|.+ .+..+++|+......... ... .+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPI----TALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cch----hHHHHHHHHHhcCCCCccchhhheecc
Confidence 378999999999999999999997 467789998654432111 111 237899999999999999999987654
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... .......+++||||+. ++|...+.. ....+++..+..++.||++||.|||++||+|+||||+|||+
T Consensus 80 ~~~------~~~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~ 148 (311)
T cd07866 80 PDK------SKRKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI 148 (311)
T ss_pred ccc------ccccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 321 0112335799999997 578777764 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccc-cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s-~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
+.+ +.++|+|||++............. ...........+++.|+|||++.+ ...++.++|||||||++|
T Consensus 149 ~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 149 DNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHH
Confidence 877 459999999998664322211100 001111233467899999999865 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||++|++||.+.+.......+........+..+.......... ....................+.++|.+||..||.+
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCccc
Confidence 9999999998887766555544322111111111100000000 00000000001111223467899999999999999
Q ss_pred CCCHHHHHHHH
Q 003375 803 RPTAGDLYEMF 813 (825)
Q Consensus 803 RPSa~EIL~hL 813 (825)
|||+.+++.|-
T Consensus 299 R~t~~ell~~~ 309 (311)
T cd07866 299 RLTASDALEHP 309 (311)
T ss_pred CcCHHHHhcCC
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.76 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=189.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.+.....||+|+||.||+|.+ .+..+++|..... .....+. +.+|+.+++.++|+||+++++++.....
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQP----LHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHH----HHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 3344456899999999999987 4556888865422 1222333 4899999999999999999999876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCcc--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV--SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~l--s~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.++||||+++++|.+++... ...+ +...+..++.||+.||+|||++||+||||||+||++
T Consensus 80 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 80 --------------FKIFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred --------------EEEEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 59999999999999999751 1234 788889999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+. ..++|+|||++......... .....|++.|+|||++... ...++.++||||||+++|+
T Consensus 142 ~~~~------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 142 NTYS------GVVKISDFGTSKRLAGINPC----------TETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred cCCC------CeEEEecchhheecccCCCc----------cccCCCCccccChhhhccc--cccCCchhhhHHHHHHHHH
Confidence 7632 46999999998765321110 1223588999999998651 1347889999999999999
Q ss_pred HHhCCCCCCCCCHHHH-HHHHH-cCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 726 LLTLQVPYMGLSELEI-HDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i-~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|++|..||........ ..... ....+.++ ...++.+.+|+.+||..+|.+|
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~R 256 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEIP---------------------------ESLSAEAKNFILRCFEPDPDKR 256 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhhhccCCCCC---------------------------cccCHHHHHHHHHHcCCCchhC
Confidence 9999999975432211 11111 11111111 1234578999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
||+.+++.|.
T Consensus 257 pt~~~ll~~~ 266 (268)
T cd06624 257 ASAHDLLQDP 266 (268)
T ss_pred CCHHHHHhCC
Confidence 9999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.19 Aligned_cols=282 Identities=18% Similarity=0.232 Sum_probs=201.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|.+.+.||+|+||.||+|.. .+..+|+|...... ........ +.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKR----TLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHH----HHHHHHHHHhcCCCCccchHHheecccc
Confidence 5799999999999999999997 56789999754221 11122222 3789999999999999999998764431
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++++||||||+|||++.
T Consensus 79 ~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 79 E---------AFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred c---------ccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 1 1124699999996 799998875 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++........ ......++..|+|||.+.. ...++.++|||||||++|+|+
T Consensus 144 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 144 N-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLN---CSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred C-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhc---CCCCCCcccHHHHHHHHHHHH
Confidence 7 4599999999976543211 0122357889999999864 134788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++||.+.+.......+.....+...+.+..........+..... ...........++.+.+||.+||+.+|.+||
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 9999998776554444433321111111111000000000000000 0000111234567899999999999999999
Q ss_pred CHHHHHHH
Q 003375 805 TAGDLYEM 812 (825)
Q Consensus 805 Sa~EIL~h 812 (825)
|+.++++|
T Consensus 284 s~~ell~h 291 (337)
T cd07858 284 TVEEALAH 291 (337)
T ss_pred CHHHHHcC
Confidence 99999999
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.99 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=195.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
..+|...+.||+|+||.||++.+ .+..+|+|...... .. .... .+.+|+.++.++. ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~-~~~~----~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DE-KEQK----RLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--Ch-HHHH----HHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 35677889999999999999997 56788888754322 11 2222 3489999999996 99999999988765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NIL 644 (825)
.. .+++|||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 76 ~~--------------~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 76 GD--------------CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred Cc--------------EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 43 499999996 5777665432223346789999999999999999999975 9999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ ..++|+|||++..+..... .....|++.|+|||++.+.. ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 141 LDRN-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLY 201 (288)
T ss_pred EccC-------CcEEEeecchhHHhccCCc-----------cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHH
Confidence 9876 4599999999876543211 12235889999999997521 135788999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
+|++|+.||..... .+....+.....+.+.. ......+..+.+||.+||+.+|.+|
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-----------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999976542 11111221121111110 0012245679999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003375 804 PTAGDLYEMFVA 815 (825)
Q Consensus 804 PSa~EIL~hL~~ 815 (825)
||+.+|++|-..
T Consensus 259 pt~~~i~~~~~~ 270 (288)
T cd06616 259 PKYKELLEHPFI 270 (288)
T ss_pred cCHHHHhcChhh
Confidence 999999998543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.82 Aligned_cols=289 Identities=17% Similarity=0.222 Sum_probs=206.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|++.+.||+|+||.||+|.. .+..+++|+..... ....... .+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAK----RTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchH----HHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 5789999999999999999986 57789999864321 1112222 33789999999999999999998764331
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.....++||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1235799999996 699998864 345899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... .........|+..|+|||++.+ ...++.++|||||||++|||+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 45999999999765432211 0011123468899999999864 234789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+.......+...........+............+ ..............+..+.++|.+||+.+|.+||
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 9999998876655444443321111111111110000000000 0000101111233467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
++.+++.|.+..
T Consensus 287 t~~~~l~~~~~~ 298 (334)
T cd07855 287 TVEQALQHPFLA 298 (334)
T ss_pred CHHHHHhChhhh
Confidence 999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.26 Aligned_cols=257 Identities=21% Similarity=0.376 Sum_probs=212.5
Q ss_pred CceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
...+.+.||.|-||.||.|.+ ++...||.|+..+.. ...+..+.| +.|..+|+.++|||||+++|++.+..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~P 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQP 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHH----HHHHHHHHhCCCcchhheeeeeeccc
Confidence 345678899999999999997 344455554444432 233445555 99999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.|||||+++-|-|..|++. ....++......+++||+.||.|||+.++|||||-..|||+.
T Consensus 465 ---------------~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs 525 (974)
T KOG4257|consen 465 ---------------MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS 525 (974)
T ss_pred ---------------eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec
Confidence 3999999999999999986 346789999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.. -.|||+|||+++.+........ ....-...|||||.+.- ..++.++|||-|||++||+
T Consensus 526 Sp-------~CVKLaDFGLSR~~ed~~yYka---------S~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 526 SP-------QCVKLADFGLSRYLEDDAYYKA---------SRGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred Cc-------ceeeecccchhhhccccchhhc---------cccccceeecCccccch----hcccchhhHHHHHHHHHHH
Confidence 77 4699999999998866443211 11224568999999976 7899999999999999998
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+. |..||.+....+++..+.++.+++.|. .+++.+..|+.+||.+||.+||.
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~---------------------------nCPp~LYslmskcWayeP~kRPr 638 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENGERLPCPP---------------------------NCPPALYSLMSKCWAYEPSKRPR 638 (974)
T ss_pred HHhcCCccccccccceEEEecCCCCCCCCC---------------------------CCChHHHHHHHHHhccCcccCCc
Confidence 76 999999999988888888887766553 34678999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.+|...|..+..
T Consensus 639 ftei~~~lsdv~q 651 (974)
T KOG4257|consen 639 FTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHHHHHHH
Confidence 9999998877654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.24 Aligned_cols=278 Identities=21% Similarity=0.225 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
+.-++|++.+.||+|||+.||+++. ++..+|+|.+.... .++.+.. ++|++..++++||||++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEA----LREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHH----HHHHHHHHhhCCcchHHHHHHHHH
Confidence 3346899999999999999999985 77788988765432 3444444 999999999999999999998775
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSEN 642 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~N 642 (825)
+.. + .....||+++|+..|||.+.+...... +..+++..++.|+.+|++||++||... +.||||||.|
T Consensus 90 ~~~----D-----~~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~N 159 (302)
T KOG2345|consen 90 EEK----D-----GKHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPAN 159 (302)
T ss_pred hhc----c-----CceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcce
Confidence 432 1 344679999999999999999875443 367999999999999999999999998 9999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||+..+ +.++|.|||.+....-.........+ ...-..-..|..|.|||.+.- ......++++|||||||+
T Consensus 160 ILls~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~-lQe~a~e~Ct~pyRAPELf~v-k~~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 160 ILLSDS-------GLPVLMDLGSATQAPIQIEGSRQALR-LQEWAEERCTIPYRAPELFNV-KSHCTITERTDIWSLGCT 230 (302)
T ss_pred eEecCC-------CceEEEeccCccccceEeechHHHHH-HHHHHHHhCCCcccCchheec-ccCcccccccchhhhhHH
Confidence 999886 46999999998765432211100000 000001136899999999975 334668899999999999
Q ss_pred HHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 723 LLELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 723 LyELLTG~~PF~~~~~--~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||+|+.|..||...-. ..+...+.+++ ...+.. ...++.+.+||+.||+.||
T Consensus 231 LYa~mf~~sPfe~~~~~GgSlaLAv~n~q-------------------------~s~P~~-~~yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 231 LYAMMFGESPFERIYQQGGSLALAVQNAQ-------------------------ISIPNS-SRYSEALHQLIKSMLQVDP 284 (302)
T ss_pred HHHHHHcCCcchHHhhcCCeEEEeeeccc-------------------------cccCCC-CCccHHHHHHHHHHhcCCc
Confidence 9999999999942100 00001111110 001111 1257789999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003375 801 TERPTAGDLYEMFVART 817 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ 817 (825)
.+||++.+++.++..+.
T Consensus 285 ~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 285 NQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccCCCHHHHHHHHHhhc
Confidence 99999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.11 Aligned_cols=276 Identities=21% Similarity=0.242 Sum_probs=199.1
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||.|++|.||+|.+ .+..+++|+....... ..... .+.+|+.+++.++||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~----~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-- 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPS----TAIREISLLKELNHPNIVRLLDVVHSENK-- 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchh----HHHHHHHHHHhcCCCCccCHhheeccCCe--
Confidence 67889999999999999987 5788999987544221 11112 23789999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.|+||||++ ++|.+++... ....+++..++.++.||+.||+|||+++++||||+|+||+++.+
T Consensus 73 ------------~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 73 ------------LYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred ------------EEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 499999996 6999998751 22468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 45999999998755322111 112246889999998864 23568899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++||...+.......+...........+...... +.+...... ..........+..+.++|.+||+.||.+|||+
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL--PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc--hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999887765544444332111111111000000 000000000 00111122345678999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.++++|.
T Consensus 275 ~~il~~~ 281 (283)
T cd07835 275 KAALQHP 281 (283)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=294.46 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=200.2
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|++|.||++.+. +..+++|+...... .... .+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKE----KIINEIQILKKCKHPNIVKYYGSYLKKDE- 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHH----HHHHHHHHHHhCCCCCEeEEEEEEecCCe-
Confidence 4788999999999999999984 67889988653321 2223 34899999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.+++|||+++++|.+++.. ....+++..+..++.|++.||.|||..|++||||+|.||+++.+
T Consensus 72 -------------~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 72 -------------LWIVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred -------------EEEEEecCCCCcHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 4999999999999999876 12468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 4599999999876644221 123468899999999976 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||...+.......+.....+.+.. ....+..+.++|.+||+.||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRN-------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCc-------------------------ccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998775555444443332222211 0112457899999999999999999999
Q ss_pred HHHHH
Q 003375 809 LYEMF 813 (825)
Q Consensus 809 IL~hL 813 (825)
+++|.
T Consensus 248 ~l~~~ 252 (253)
T cd05122 248 LLKHP 252 (253)
T ss_pred HhcCC
Confidence 99873
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.76 Aligned_cols=249 Identities=31% Similarity=0.448 Sum_probs=199.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||+|++|.||++.. .+..+++|...... ....... .+.+|+.++.+++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEALK----SIMQEIDLLKNLKHPNIVKYIGSIETSDS- 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc--cCHHHHH----HHHHHHHHHHhCCCCCccEEEEEEEeCCE-
Confidence 588999999999999999987 45689999865332 2222333 44999999999999999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+
T Consensus 74 -------------~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 74 -------------LYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred -------------EEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 4999999999999999976 2568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 46999999999876542211 123358899999999876 447889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||...........+.....+.++ ...+..+.+++.+||..+|++|||+.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLP---------------------------EGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 99999876655444444333222222 112457899999999999999999999
Q ss_pred HHHH
Q 003375 809 LYEM 812 (825)
Q Consensus 809 IL~h 812 (825)
++.+
T Consensus 248 ~l~~ 251 (254)
T cd06627 248 LLKH 251 (254)
T ss_pred HhcC
Confidence 9875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.58 Aligned_cols=273 Identities=18% Similarity=0.204 Sum_probs=188.5
Q ss_pred CCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHH--Hh-hHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEI--RN-FEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~--~~-~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
.+|++.+.||+|+||.||+|.+.+ ..+++|+..+.......+.. .. .......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 589999999999999999999743 36677765433221111100 00 00112344455667789999999997
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... ....+++||++. .++.+++.. ....++..++.++.||+.||.|||+++|+||||||+
T Consensus 92 ~~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRCR----------MYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecCC----------ceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 6543321 123588999885 578777764 233578889999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ ..++|+|||+|+.+......... .........||+.|+|||++.+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999866 45999999999876432211100 0111233469999999999886 66899999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||++|..||.+... ..+...........+.. . .. .....++.+.+++..||..+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----------~-----~~------~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE----------G-----KI------KIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh----------h-----hh------ccCCCCHHHHHHHHHHHhCCC
Confidence 99999999999987632 22222111100000000 0 00 001124679999999999999
Q ss_pred CCCCCHHHHHHHH
Q 003375 801 TERPTAGDLYEMF 813 (825)
Q Consensus 801 ~eRPSa~EIL~hL 813 (825)
.+||++.+|++.|
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.08 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=196.4
Q ss_pred CceeeeeecccCceEEEEEEECC--eeEEEEEEecccC-CCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~-~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+|.+.+.||+|+||.||++.+.. ..+++|+.+.-.. ........ .+..|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHH----HHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 58899999999999999998743 3455555432111 11111222 23679999999999999999998875543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 77 --------------FCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred --------------eEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 4999999999999999875322 2356899999999999999999999999999999999999964
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ .++|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 142 ~--------~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 N--------LLKIGDFGVSRLLMGSCDL----------ATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred C--------CEeecccCceeecCCCccc----------ccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 3 4999999998765432111 123357889999999875 55778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||...........+..+..+.++ ...+..+.++|.+||..+|.+||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLP---------------------------ETYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCc---------------------------chhcHHHHHHHHHHhcCChhhCcCHH
Confidence 999999876665555555444332222 12345789999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
++++|-
T Consensus 253 ~il~~~ 258 (260)
T cd08222 253 EILRNP 258 (260)
T ss_pred HHhhCC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.40 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=199.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|...+.||+|++|.||++.. .+..+++|...... ....+ .+.+|+.+++.+.||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~----~~~~e~~~l~~~~h~~vv~~~~~~~~~~~- 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYQHPNIVEMYSSYLVGDE- 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHH----HHHHHHHHHHHcCCCChheEEEEEEcCCe-
Confidence 345567999999999999986 56778888754321 12222 24889999999999999999999875543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.+
T Consensus 91 -------------~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 91 -------------LWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred -------------EEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 4999999999999999875 458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 152 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 152 -------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred -------CcEEEcccccchhhccCCc----------ccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHh
Confidence 4699999998865432111 1123458999999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||...++......+.....+.+.. ....+..+.+||.+||..+|.+||++.+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 211 GEPPYFNEPPLQAMKRIRDNLPPKLKN-------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCCCcCCCHHHHHHHHHhcCCCCCcc-------------------------cccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998877666655554432211110 0113457999999999999999999999
Q ss_pred HHHHHHhhc
Q 003375 809 LYEMFVART 817 (825)
Q Consensus 809 IL~hL~~l~ 817 (825)
+++|-....
T Consensus 266 il~~~~~~~ 274 (285)
T cd06648 266 LLNHPFLAK 274 (285)
T ss_pred HccCccccc
Confidence 999855433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.25 Aligned_cols=280 Identities=23% Similarity=0.285 Sum_probs=201.1
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||.|+||.||+|.+. +..+++|+..... .... +...+.+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--cccc----chHHHHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 678999999999999999984 5789999876442 1111 1223488999999999999999999987651
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
....++||||++ ++|.+++.. ....+++..++.++.||+.||+|||+.|++|+||||+|||++.+
T Consensus 72 ---------~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEecccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 113599999997 599998875 12468999999999999999999999999999999999999977
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||++......... ......++..|+|||.+.+ ...++.++||||||+++|||++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 45999999999766443210 0122356889999998764 23578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCC--CCchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELE-TLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~-~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+.||...+.......+...........+.................. ........ .+..+.+++.+||..+|.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999887766655555443211111111110000000000000000 00011111 26688999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++++.
T Consensus 279 ~~~l~~~ 285 (287)
T cd07840 279 DQALQHE 285 (287)
T ss_pred HHHhhCc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.31 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=205.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..+.|++.+.||+|+||.||++.+. +..+++|+...... ..+ .+.+|+.+++.++|+||+++++.+...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKE----LIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHH----HHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 4567899999999999999999985 77899998754322 222 348899999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+++++|.+++... ...+++..+..++.||+.||.|||+.||+|+||+|+||++
T Consensus 88 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 88 DE--------------LWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred CE--------------EEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 53 59999999999999999862 1378999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 150 SKD-------GSVKLADFGFAAQLTKEKSK----------RNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred cCC-------CCEEECccchhhhhccchhh----------hccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHH
Confidence 876 45999999988655332110 123357889999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||...++......+.....+.+.. ....+..+.+||.+||+.+|.+||+
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLITTKGIPPLKN-------------------------PEKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCcc-------------------------hhhCCHHHHHHHHHHhccChhhCcC
Confidence 999999998777665555444332222110 0113457899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.+|++|..-..
T Consensus 264 ~~~il~~~~~~~ 275 (286)
T cd06614 264 AEELLQHPFLKK 275 (286)
T ss_pred HHHHhhChHhhc
Confidence 999999866544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.99 Aligned_cols=295 Identities=22% Similarity=0.242 Sum_probs=204.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|.+.+.||.|+||.||+|.. .+..+++|....+.. ...+. +.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKH----ALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHH----HHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 6899999999999999999987 467888888654422 22233 3889999999999999999988765431
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
....+..........|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 10000000111235799999997 699888864 46889999999999999999999999999999999999975
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
.+ ..++|+|||++..+....... .......++..|+|||++.. ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSHK-------GYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCccccc-------cccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 468999999997653321110 00122357889999998764 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+|+.||.+.++......+.......................... .............+..+.+||.+||..||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 99999988877665555444321111111111100000000000 0000001111234567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.+++.|-+.
T Consensus 294 ~~ell~h~~~ 303 (342)
T cd07854 294 AEEALMHPYM 303 (342)
T ss_pred HHHHhCCCcc
Confidence 9999988444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.73 Aligned_cols=265 Identities=21% Similarity=0.350 Sum_probs=219.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---C--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF---G--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
++-....|.++||.|-||.|++|+. . ...||+|. ++.. ..+.....| +.|+.||.++.|||||++.|+
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKT--LK~G-ytekqrrdF----L~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKT--LKAG-YTEKQRRDF----LSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEee--eccC-ccHHHHhhh----hhhhhhcccCCCCcEEEEEEE
Confidence 4455678999999999999999997 2 34556655 5432 334444455 999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
......+ .||+|||++|+|+.||+. ....|...+...|++.|+.||.||-+.|+|||||-+.
T Consensus 699 VTks~Pv--------------MIiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAAR 760 (996)
T KOG0196|consen 699 VTKSKPV--------------MIITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAAR 760 (996)
T ss_pred EecCcee--------------EEEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhh
Confidence 9877655 999999999999999987 3356999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ .++|++|||+++.+.......+. ...-.-..+|.|||.+.- ..++.+|||||||+
T Consensus 761 NILVNsn-------LvCKVsDFGLSRvledd~~~~yt-------t~GGKIPiRWTAPEAIa~----RKFTsASDVWSyGI 822 (996)
T KOG0196|consen 761 NILVNSN-------LVCKVSDFGLSRVLEDDPEAAYT-------TLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGI 822 (996)
T ss_pred heeeccc-------eEEEeccccceeecccCCCcccc-------ccCCccceeecChhHhhh----cccCchhhccccce
Confidence 9999977 78999999999987654322111 111112468999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|||.++ |..||..++..+++..|..+.+.+-| .+++..|..|+..||++|-
T Consensus 823 VmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 823 VMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred EEEEecccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHh
Confidence 9999876 99999999999999999998653322 3457789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+||.+.+|+.+|.++.-.+.
T Consensus 876 ~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred hcCCCHHHHHHHHHHHhcCch
Confidence 999999999999999876544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.75 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHH-HhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~i-Lk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
+.||.|+||.||+|.. .+..+|+|+....... ...... .+..|..+ ...+.||||+++++++...+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----- 71 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVT----NVKAERAIMMIQGESPYVAKLYYSFQSKDY----- 71 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHH----HHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-----
Confidence 5799999999999987 5678999986422111 111111 22445444 445579999999999976553
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+|+||||+|+|||++.+
T Consensus 72 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 72 ---------LYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred ---------EEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 4999999999999999975 2468899999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
..++|+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 4599999998865432 122358899999999876 4578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDL 809 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa---~EI 809 (825)
|...+...+...+...... .+. ......+..+.+++.+||+.+|.+||++ .|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRIN-WPE-----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccC-CCC-----------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 9888777766655443211 000 0001235678999999999999999955 688
Q ss_pred HHHHHh
Q 003375 810 YEMFVA 815 (825)
Q Consensus 810 L~hL~~ 815 (825)
+.|..-
T Consensus 249 l~~~~~ 254 (260)
T cd05611 249 KSHPFF 254 (260)
T ss_pred HcChHh
Confidence 777543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=308.39 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=201.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..|...+.||+|+||.||++.+ .+..+++|+...... ....... .+.+|+.+++.++||||+++++++.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQ----DIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHH----HHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 4588899999999999999997 567788887643211 1222222 34899999999999999999999886553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||+|+||+++.
T Consensus 100 --------------~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 100 --------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred --------------EEEEEeCCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 499999997 588887764 1345899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||++...... ....|++.|+|||++.... ...++.++|||||||++|||+
T Consensus 161 ~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 161 P-------GQVKLADFGSASIASPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred C-------CCEEEecCCCccccCCc--------------ccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHH
Confidence 6 45999999988654321 2235889999999985321 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||...........+.....+.... ...+..+.+|+.+||+.+|.+||++.
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred hCCCCCCCccHHHHHHHHHhccCCCCCC--------------------------ccccHHHHHHHHHHccCCcccCcCHH
Confidence 9999998776666555554443221110 11245789999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003375 808 DLYEMFVARTSS 819 (825)
Q Consensus 808 EIL~hL~~l~ss 819 (825)
+|++|+..+...
T Consensus 273 ~il~~~~~~~~~ 284 (317)
T cd06635 273 ELLKHMFVLRER 284 (317)
T ss_pred HHHhChhhhccC
Confidence 999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=312.62 Aligned_cols=284 Identities=20% Similarity=0.228 Sum_probs=204.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.. .+..||+|+..... ... .....+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cch----HHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999987 56789999864221 111 12234489999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......++||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07880 88 SL--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152 (343)
T ss_pred cc--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 22 1123469999999 6899988864 4689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++....... ....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 153 ED-------CELKILDFGLARQTDSEM-------------TGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred CC-------CCEEEeecccccccccCc-------------cccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 76 459999999987553211 22357889999999864 23478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|..||.+.+.......+..............+.......+........ ........+..+.++|.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 99999998776655544443322211111111111000000000000000 011122345678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
||+.++++|-...
T Consensus 290 ~t~~~~l~~~~~~ 302 (343)
T cd07880 290 ITAAEALAHPYFE 302 (343)
T ss_pred CCHHHHhcCccHh
Confidence 9999999885443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=293.61 Aligned_cols=254 Identities=32% Similarity=0.491 Sum_probs=199.6
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|.+.+.||+|++|.||+|... +..+++|+...... .....+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELE----ALEREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHH----HHHHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788999999999999999985 77899998654322 123333 3489999999999999999999987651
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 0135999999999999999986 2378999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||.+......... .......++..|+|||.+.+ ...+.++||||||+++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 45999999998876543211 00123458899999999876 457899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHc-CCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~PF~~~~-~~~i~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|..||.... .......+.. ...+.++ ...+..+.++|.+||..+|.+||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPEIP---------------------------EHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcCCC---------------------------cccCHHHHHHHHHhCcCChhhCCCH
Confidence 999997765 2222222221 1111111 1125679999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.|.
T Consensus 252 ~~ll~~~ 258 (260)
T cd06606 252 DELLQHP 258 (260)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.83 Aligned_cols=280 Identities=23% Similarity=0.219 Sum_probs=200.8
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeeeEecCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 566 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~~~~~~ 566 (825)
|++.+.||+|+||.||+|.+. +..+|+|+........ .... .+.+|+.+++++ .||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPL----STLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhh----hHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999984 6889999876543211 1111 236677777666 5999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. .....+++|||+. ++|.+++... ....+++..++.++.||+.||.|||+.+++|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 31 1224699999997 5899988752 223589999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCcc-----------cccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 77 4599999999876643211 122357889999999976 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|.+||.+....+....+...........+....... ...................+..+.++|.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc-hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 99999998887766555554321111010000000000 00000000111122223456788999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.|-
T Consensus 279 ~~il~~~ 285 (287)
T cd07838 279 FEALQHP 285 (287)
T ss_pred HHHhcCc
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=330.05 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=213.8
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
+...++.|.+.+.||+|.|+.|.+|++ .+..||+|++ +...........+ .+|+.+|+.|.|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~i--dkt~ln~~~~~k~----~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKII--DKTQLNPSKRQKL----GREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEe--hhcccChHHHHHH----HHHHHHHHhcCCcceeeeeeee
Confidence 346788999999999999999999997 7889999985 3333333333333 8999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.....+ |+||||+.+|.+.+|+.+ ...+.+..+..++.|+++|++|||+++|||||||++|
T Consensus 125 ~t~~~l--------------ylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEATL--------------YLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eeccee--------------EEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 877754 999999999999999987 4567779999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+.+. .+||+|||++..+..... ..+..|++.|.|||++.+ ....++.+|+||+|++
T Consensus 186 ilL~~~m-------nikIaDfgfS~~~~~~~~-----------lqt~cgsppyAaPEl~~g---~~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDENM-------NIKIADFGFSTFFDYGLM-----------LQTFCGSPPYAAPELFNG---KKYDGPEVDIWSLGVV 244 (596)
T ss_pred ccccccc-------ceeeeccccceeeccccc-----------ccccCCCCCccChHhhcC---cccCCcceehhhhhhh
Confidence 9999884 499999999988864332 244579999999999998 3466899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||-|+.|.+||.+.+...+...+..+.. .++. -.+.++.+||.++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~---------------------------~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKY-RIPF---------------------------YMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeee-cccc---------------------------eeechhHHHHHHhhccCccc
Confidence 9999999999998877666555554421 1111 12346899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003375 803 RPTAGDLYEMFVA 815 (825)
Q Consensus 803 RPSa~EIL~hL~~ 815 (825)
|++.++|+++-+.
T Consensus 297 r~~~dqim~~~W~ 309 (596)
T KOG0586|consen 297 RGPCDQIMKDRWR 309 (596)
T ss_pred cCCHHHhhhhccc
Confidence 9999999998654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.20 Aligned_cols=290 Identities=19% Similarity=0.194 Sum_probs=200.5
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
+.+.+.+|.|+++.||++...+..+|+|+..... ......+. +.+|+.+++.++||||+++++++.....
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~---- 73 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKL----LQQEIITSRQLQHPNILPYVTSFIVDSE---- 73 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHH----HHHHHHHHHhcCCcchhhhhheeecCCe----
Confidence 3456667777777888877788999999976432 22233334 4899999999999999999999886654
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.+++|||+++++|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 ----------~~~~~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~--- 137 (314)
T cd08216 74 ----------LYVVSPLMAYGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--- 137 (314)
T ss_pred ----------EEEEEeccCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---
Confidence 49999999999999999862 22458899999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 731 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~ 731 (825)
+.+||+|||.+.......... ...........++..|+|||++... ...++.++|||||||++|||++|..
T Consensus 138 ----~~~kl~d~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 138 ----GKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ----CceEEecCccceeeccccccc---cccccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCC
Confidence 459999999987654322110 0001112334578899999998751 1347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCc-hhH-Hhhh-ccCccc--ccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 732 PYMGLSELEIHDLIQMGKRPRL-TDE-LEAL-GSCHEH--EVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 732 PF~~~~~~~i~~~I~~~~~p~l-~~~-l~~~-~~~~~~--~~~~~-~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
||..............+..+.+ ... .... ...... ..... .............+..+.+|+.+||..||.+|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 9987654433222222111110 000 0000 000000 00000 0000011122334568899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.++++|..-.
T Consensus 289 ~~~ll~~p~~~ 299 (314)
T cd08216 289 ASQLLNHSFFK 299 (314)
T ss_pred HHHHhcCchHh
Confidence 99999996543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=305.85 Aligned_cols=293 Identities=20% Similarity=0.211 Sum_probs=203.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||.|+||.||+|.+ .+..+++|+......... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 3467899999999999999999998 467899998764432111 11233789999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...... ........++||||+++ +|..++.. ....+++..++.++.||+.||+|||+.||+|+||||+||+
T Consensus 78 ~~~~~~----~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 148 (302)
T cd07864 78 KQDALD----FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL 148 (302)
T ss_pred cchhhh----ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 431000 00112257999999985 88887764 2346899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......++..|+|||++.+ ...++.++|||||||++|
T Consensus 149 i~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 149 LNNK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILG 209 (302)
T ss_pred ECCC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHH
Confidence 9876 46999999999766432211 0112246788999999864 234688999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC--CCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||++|++||...+.......+........+..+..+.........+.... ..........+..+.+|+.+||..||.+
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhh
Confidence 99999999987766555544444311111111111000000000000000 0000011123568999999999999999
Q ss_pred CCCHHHHHHHH
Q 003375 803 RPTAGDLYEMF 813 (825)
Q Consensus 803 RPSa~EIL~hL 813 (825)
||++.+++.|-
T Consensus 290 Rp~~~~il~~~ 300 (302)
T cd07864 290 RCTAEEALNSP 300 (302)
T ss_pred CCCHHHHhcCC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.98 Aligned_cols=301 Identities=17% Similarity=0.199 Sum_probs=206.0
Q ss_pred CCCCce-eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHH------hhHHhHHHHHHHHhhCCCCCccee
Q 003375 488 SFPSLS-SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIR------NFEYSCLGEVRMLGALRHSCIVEM 558 (825)
Q Consensus 488 ~~~~y~-i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~------~~~~~~lrEv~iLk~L~HPNIV~l 558 (825)
.-++|. +.+.||.|+||.||+|.+ .+..+|+|+.............. .+...+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 345675 457799999999999986 56789999875433221110000 111235889999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL 638 (825)
++++..... .++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||
T Consensus 86 ~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl 145 (335)
T PTZ00024 86 VDVYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDL 145 (335)
T ss_pred eEEEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999876654 499999997 699999875 356899999999999999999999999999999
Q ss_pred CCCCEEEecCccCCCCCCeEEEeecCCccccccccccccccc----CCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 639 KP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~----~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||+|||++.+ +.++|+|||++.............. ..........+++.|+|||++.+ ...++.++
T Consensus 146 ~~~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~ 215 (335)
T PTZ00024 146 SPANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAV 215 (335)
T ss_pred cHHHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHH
Confidence 9999999876 4699999999976642111100000 00011122357889999999875 23468899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 715 DVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
|||||||++|||++|.+||.+.+.......+...........+...........................+..+.++|.+
T Consensus 216 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 216 DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH
Confidence 99999999999999999998887766555443321111111010000000000000000000011112335678999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 003375 795 CTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 795 CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
||+.+|.+|||+++++.|.+....
T Consensus 296 ~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 296 LLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HcCCCchhccCHHHHhcCcccCCC
Confidence 999999999999999999776543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.89 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=189.2
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||+|+||.||+|.. .+..+++|+........ ... ...+.+|+.+++.++||||+++++++...+.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-------- 67 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKG----EQMALNEKKILEKVSSRFIVSLAYAFETKDD-------- 67 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhh----hHHHHHHHHHHHhCCCCCEeeeeeEEecCCe--------
Confidence 69999999999986 46789999865322111 111 2234789999999999999999999876543
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.|+||||+++++|.+++... ....+++..++.++.||+.||.|||+.|++||||+|+|||++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 68 ------LCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred ------EEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 49999999999999999762 22468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
+.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGKK-----------IKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCCc-----------cccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 4599999999876533111 122357889999999876 4578899999999999999999999976
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 003375 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 810 (825)
Q Consensus 736 ~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa~EIL 810 (825)
.........+....... + .......++.+.++|.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEM-A-----------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhccccc-c-----------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 54321111221111000 0 000112356789999999999999999 888899
Q ss_pred HHHH
Q 003375 811 EMFV 814 (825)
Q Consensus 811 ~hL~ 814 (825)
.|.+
T Consensus 253 ~h~~ 256 (277)
T cd05577 253 EHPL 256 (277)
T ss_pred hChh
Confidence 8753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.75 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=203.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~ 566 (825)
++|.+.+.||+|+||.||+|.. .+..+++|+....... ..... ..+.+|+.++++++ ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKV----KYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHH----HHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4799999999999999999997 6788999987542211 11222 23488999999999 999999999887554
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.|++|+||+|+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 N--------------LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred e--------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 3 4999999999999999986 24699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccc----------cccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~----------~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
.+ +.++|+|||++........... .............++..|+|||++.. ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 76 4599999999987654321100 00001122334568899999999876 557889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 717 WSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
||||+++|+|++|+.||...........+..... .++ ...++.+.+||.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-SFP---------------------------PNFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC-CCC---------------------------CccCHHHHHHHHHHh
Confidence 9999999999999999987776555544432211 111 112457899999999
Q ss_pred ccCCCCCCCH----HHHHHHH
Q 003375 797 EENPTERPTA----GDLYEMF 813 (825)
Q Consensus 797 ~~DP~eRPSa----~EIL~hL 813 (825)
+.+|.+||++ .++++|.
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCC
Confidence 9999999999 9998874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=328.07 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=212.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
+..+...+.++||+|.||.|++|.|+ ...||||+.+.... .. ....| ++|+.+|.+|+|||+|++||+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~-~mddf----lrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NA-IMDDF----LREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--ch-hHHHH----HHHHHHHHhccCcceeEEeee
Confidence 56677889999999999999999993 34678887543322 21 34444 999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
..+.. +.+|||+++.|+|.+.|++ .....|.......++.|||.||.||..+++|||||-..
T Consensus 180 Vl~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 180 VLDQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred eccch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 88633 3799999999999999987 33467888999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
||||... -+|||+|||+.+.+........... ...-...|+|||.+.. ..++.++|||+|||
T Consensus 242 Nlllasp-------rtVKI~DFGLmRaLg~ned~Yvm~p-------~rkvPfAWCaPEsLrh----~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 242 NLLLASP-------RTVKICDFGLMRALGENEDMYVMAP-------QRKVPFAWCAPESLRH----RKFSHASDVWMYGV 303 (1039)
T ss_pred hheeccc-------ceeeeecccceeccCCCCcceEecC-------CCcCcccccCHhHhcc----ccccccchhhhhhh
Confidence 9999876 4699999999998876443321111 1123568999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||+| |+.||.|....++++.|..+.+..-+ ..+++.+++++..||..+|
T Consensus 304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred hHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCc
Confidence 9999998 89999999999999999866443222 2357889999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003375 801 TERPTAGDLYEMFVAR 816 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l 816 (825)
.+||||..|.+.+-..
T Consensus 357 aDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 357 ADRPTFSAIREDLVLA 372 (1039)
T ss_pred cccccHHHHHHhHHHH
Confidence 9999999997554433
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=312.53 Aligned_cols=286 Identities=23% Similarity=0.265 Sum_probs=204.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|.+ .+..+++|..... ......... +.+|+.+++++ +||||+++++++.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~----~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQR----TFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhh----hhHHHHHHHHhcCCCCccceeeeec
Confidence 4567899999999999999999987 4677888875321 111122223 37899999999 9999999999886
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... ...|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 78 ~~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 78 AEND------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred cCCC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4332 24699999997 699998875 2678889999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++.......... .........||..|+|||++.+ ...++.++|||||||++
T Consensus 139 ll~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l 203 (337)
T cd07852 139 LLNSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCIL 203 (337)
T ss_pred EEcCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHH
Confidence 99877 469999999998664322110 0111233468999999998864 24567899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|+|++|+.||.+.........+...........+..+........... .............+..+.+||.+||+.||
T Consensus 204 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence 999999999988776655544443321111111111100000000000 00000111112246789999999999999
Q ss_pred CCCCCHHHHHHH
Q 003375 801 TERPTAGDLYEM 812 (825)
Q Consensus 801 ~eRPSa~EIL~h 812 (825)
.+|||+.++++|
T Consensus 284 ~~Rps~~~il~~ 295 (337)
T cd07852 284 NKRLTAEEALEH 295 (337)
T ss_pred ccccCHHHHhhC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.45 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=183.7
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHH---HHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 497 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR---MLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~---iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
.||+|+||.||++.. .+..+|+|+........... ...+ .+|.. ++....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA----LNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHH----HHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 489999999999997 46789999865332222111 1111 33433 3444579999999999886553
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 72 ----------~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 72 ----------LCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ----------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 4999999999999999875 3568999999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 731 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~ 731 (825)
..++|+|||++....... .....||+.|+|||.+.. ...++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 459999999986543211 112358999999999863 2457889999999999999999999
Q ss_pred CCCCCCHHHH--HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 003375 732 PYMGLSELEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 804 (825)
Q Consensus 732 PF~~~~~~~i--~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP----- 804 (825)
||........ ...........+ ....+..+.++|.+||..||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVEL---------------------------PDSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcCC---------------------------ccccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 9975432211 111111111111 112356789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
+++++++|...
T Consensus 248 ~~~~~~~h~~~ 258 (279)
T cd05633 248 GAQEVKEHVFF 258 (279)
T ss_pred CHHHHHhCccc
Confidence 69999998544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.78 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=210.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+-..+.+.++||+|-||.|.+|...+ ..||||+.+-.. .... ...|.+|+++|.+|+|||||+++|+|..+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~----r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNA----RNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhH----HHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 344567889999999999999999865 899999854221 1122 23459999999999999999999999988
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+.+ ++||||+++|+|.+|+..... ..+.......|+.||+.||+||.+.++|||||.+.|+|+
T Consensus 608 ePi--------------cmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv 670 (807)
T KOG1094|consen 608 DPL--------------CMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV 670 (807)
T ss_pred Cch--------------HHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceee
Confidence 766 999999999999999987321 123455667799999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +++||+|||+++.+-...... .....+-...|||||.+.. +.++.++|||+||++|||
T Consensus 671 ~~e-------~~iKiadfgmsR~lysg~yy~--------vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 671 DGE-------FTIKIADFGMSRNLYSGDYYR--------VQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWE 731 (807)
T ss_pred cCc-------ccEEecCcccccccccCCcee--------eecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHH
Confidence 977 679999999998664432211 1233456789999999986 789999999999999999
Q ss_pred HHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 726 LLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 726 LLT--G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
+++ ...||...+..++.+.........-... ....+.-++..+.+||.+||..|-.+|
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--------------------~l~~P~~cp~~lyelml~Cw~~es~~R 791 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--------------------VLSRPPACPQGLYELMLRCWRRESEQR 791 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--------------------eccCCCcCcHHHHHHHHHHhchhhhcC
Confidence 876 7899999988888776554321111100 111223356788999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
|+++++-.+|+..
T Consensus 792 PsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 792 PSFEQLHLFLQED 804 (807)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999999864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.35 Aligned_cols=278 Identities=20% Similarity=0.222 Sum_probs=200.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|.+.+.||+|+||.||+|.+ .+..+|+|+..... .... +...+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEI----FAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--cccc----chhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5899999999999999999986 57789999864321 1111 12234889999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ......++||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 11234699999997 57777653 35889999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.++|+|||+++..... .....+++.|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCC-------------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 45999999998754321 122357889999999864 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+.......+........+.............+........ ........+..+.+||.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999887666555554432222222221111100000000000000 0111123456789999999999999999
Q ss_pred CHHHHHHH
Q 003375 805 TAGDLYEM 812 (825)
Q Consensus 805 Sa~EIL~h 812 (825)
++.+++.|
T Consensus 290 ~~~e~l~h 297 (342)
T cd07879 290 TATEALEH 297 (342)
T ss_pred CHHHHhcC
Confidence 99999988
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.27 Aligned_cols=286 Identities=20% Similarity=0.268 Sum_probs=196.0
Q ss_pred eeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 495 CDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 495 ~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
...||.| +||+||+|.+ .+..||+|+..... ......+ .+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~~~~~~~-- 74 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLK----ALQNEVVLSHFFRHPNIMTSWTVFTTGSWL-- 74 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHH----HHHHHHHHHHhCCCCCcceEeeeEecCCce--
Confidence 3456666 9999999987 67899999975432 2222333 348899999999999999999999876544
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
++||||+.+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-- 137 (328)
T cd08226 75 ------------WVISPFMAYGSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-- 137 (328)
T ss_pred ------------EEEEecccCCCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC--
Confidence 9999999999999998862 22358899999999999999999999999999999999999876
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|.
T Consensus 138 -----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 138 -----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred -----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCC
Confidence 45999999865433221111000 00001122356789999999752 134688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcC-CCCCchhH-H----hhhccC--------cccccc-----ccCCCCCCchhhhhhHHHHHHH
Q 003375 731 VPYMGLSELEIHDLIQMG-KRPRLTDE-L----EALGSC--------HEHEVA-----QSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~-~~p~l~~~-l----~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~s~~L~dL 791 (825)
.||............... ........ . ...... ...... ...............+..+.+|
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 208 VPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 999876554433332222 11000000 0 000000 000000 0000000111223456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
|.+||..||.+|||+.++++|.+.
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHHH
Confidence 999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.13 Aligned_cols=286 Identities=20% Similarity=0.242 Sum_probs=202.1
Q ss_pred CceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
+|++.+.||+|+||.||++.+. +..+|+|...... ...... ..+.+|+.++++++ ||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILA----KRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhH----HHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 5889999999999999999984 5578999754221 111122 23488999999995 99999999875432
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .....|++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~----------~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 PG----------NFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred cc----------cCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 10 1124689999996 699999864 3568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.++|+|||++..+...... .........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 877 45999999999866432211 0011223468999999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|++|.+||.+.+.......+.........+.+..........+... .............+..+.+|+.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 9999999988776666555544322221221111110000000000 0000001111223567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003375 803 RPTAGDLYEMFV 814 (825)
Q Consensus 803 RPSa~EIL~hL~ 814 (825)
|||+.+++.|-+
T Consensus 283 R~t~~~ll~~~~ 294 (332)
T cd07857 283 RISVEEALEHPY 294 (332)
T ss_pred CCCHHHHhcChh
Confidence 999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.48 Aligned_cols=276 Identities=23% Similarity=0.280 Sum_probs=202.1
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||.|++|.||+|.. ++..+++|....... .... ...+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGI----PKTALREIKLLKELNHPNIIKLLDVFRHKGD-- 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchh----HHHHHHHHHHHHHhcCCCcchHHHhhccCCC--
Confidence 57788999999999999997 567788887643322 1112 2234889999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||++ ++|.+++.. ....+++..+..++.||+.||.|||.++|+|+||||+||+++.+
T Consensus 73 ------------~~~v~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 73 ------------LYLVFEFMD-TDLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred ------------EEEEEeccC-CCHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 499999997 599888875 12468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
..++|+|||.+......... .....++..|+|||.+.+ ...++.++||||||+++|+|+||
T Consensus 135 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVRP----------YTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCccc----------ccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 45999999998766442210 122357889999999875 23678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc---CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS---CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+.||...+..+....+........+..+..... .....+... ............+..+.++|.+||.+||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK-AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc-cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 999988776665554443322111211111100 000000000 0001112233457789999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.|-
T Consensus 275 ~~ll~~~ 281 (283)
T cd05118 275 EQALAHP 281 (283)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.43 Aligned_cols=282 Identities=20% Similarity=0.221 Sum_probs=205.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..+|+|+.... ....... ..+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHA----KRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHH----HHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 46899999999999999999998 4678899975422 1111222 23478999999999999999998876543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 88 SL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred cc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 21 1223469999999 5799999874 4689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 153 ED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcccccccccccc-------------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHHH
Confidence 77 45999999998765331 122357889999999864 23568899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||.+.........+........+..+..........+........ ........++.+.+||.+||..||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 99999998877766665555443222222221111000000000000000 011112346789999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
||+.+|++|-+
T Consensus 290 pt~~ell~h~~ 300 (343)
T cd07851 290 ITAAEALAHPY 300 (343)
T ss_pred CCHHHHhcCCC
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.78 Aligned_cols=302 Identities=19% Similarity=0.247 Sum_probs=216.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..+..|+++..||+|.||.||+|... ...+|+|.++-.... ..+.....+|+.+++.|+||||+.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------tGiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------TGISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------CCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 45678999999999999999999641 235777765433221 122334489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
+|...+. .+++++||++ -+|...|+-........++...++.|+.||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d~-------------~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHDK-------------KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccCc-------------eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 9886321 4699999998 6999999876666667899999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
.||||..++. ..+.|||+|||+++.+....... ...+..+-|..|.|||.+.| ...|+++.||||+|
T Consensus 161 aNIlvmgdgp---erG~VKIaDlGlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLG---a~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDGP---ERGRVKIADLGLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLG---ARHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccCC---ccCeeEeecccHHHHhhcccccc-------ccCCceEEEEEecChHHhcc---cccccchhhhHHHH
Confidence 9999998854 46789999999999987654332 12345678999999999998 56799999999999
Q ss_pred HHHHHHHhCCCCCCCCCH-------H--HHHHHHHcCCCCCchhHHhhhccCcccc--ccccCC-CCCC------chhhh
Q 003375 721 CLLLELLTLQVPYMGLSE-------L--EIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGS-GFEK------PEAEL 782 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~-------~--~i~~~I~~~~~p~l~~~l~~~~~~~~~~--~~~~~~-~~~~------~~~~~ 782 (825)
||+.||+|..+.|.+... . +....|..-...+-.+.++.+...++.. ..+... .... .....
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999999999876421 1 2233333321111111222221111110 000000 0000 00011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 783 ~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
..++...+|+.+||.+||.+|.|+++.++|.-......+
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 123447899999999999999999999999776665433
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.17 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=201.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-..|...+.||+|+||.||+|+. .+..+++|....... ....... .+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHH----HHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 44578889999999999999997 566788887643211 1122223 3488999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 89 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~ 149 (308)
T cd06634 89 T--------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (308)
T ss_pred e--------------eEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC
Confidence 3 499999997 688887764 134588999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 150 EP-------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred CC-------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHH
Confidence 76 45999999998754321 2235889999999986422 14568899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||...+.......+.....+... ....+..+.+||.+||..+|.+||++
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 208 AERKPPLFNMNAMSALYHIAQNESPALQ--------------------------SGHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred HcCCCCCccccHHHHHHHHhhcCCCCcC--------------------------cccccHHHHHHHHHHhhCCcccCCCH
Confidence 9999999877655554444443322211 01234578999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 003375 807 GDLYEMFVARTSSS 820 (825)
Q Consensus 807 ~EIL~hL~~l~sss 820 (825)
.++++|.+......
T Consensus 262 ~~ll~~~~~~~~~~ 275 (308)
T cd06634 262 EVLLKHRFVLRERP 275 (308)
T ss_pred HHHhhCccccccCC
Confidence 99999987666543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.98 Aligned_cols=276 Identities=23% Similarity=0.282 Sum_probs=202.9
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.+.||+|+||.||+|.. .+..+++|+..... ... .+...+.+|+.+++.++||||+++++++.....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEE----GIPSTALREISLLKELKHPNIVKLLDVIHTERK-- 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccc----cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc--
Confidence 67788999999999999997 46889999875442 111 112234789999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.++||||++ ++|.+++... ...+++..++.++.|++.||.|||++||+||||+|+||+++.+
T Consensus 73 ------------~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 73 ------------LYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred ------------eEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 499999998 6999999861 1468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||++......... .....++..|+|||.+.+ ...++.++|||||||++|||++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLRT----------YTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCccc----------cCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 46999999998765432111 122346788999999875 23678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
.+||.+.+.......+...........+....... ...+.. .............+..+.++|.+||..||.+||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK-FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc-cCccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 99998877666555554432222222222211111 000000 000000111222366899999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
+++.|.
T Consensus 275 ~~l~~p 280 (282)
T cd07829 275 EALKHP 280 (282)
T ss_pred HHhhCc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=342.91 Aligned_cols=278 Identities=25% Similarity=0.322 Sum_probs=198.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
-+.+|+.++.||+||||.||+++. .+..||||-+.++. ..... .++.+|+..|.+|+|||||++|..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~----skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLY----SKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHH----HHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 467889999999999999999996 78999999876653 22222 3448999999999999999999877652
Q ss_pred CCCC---------------C----------------------------------C---------------------CC--
Q 003375 566 KWLP---------------S----------------------------------A---------------------DG-- 573 (825)
Q Consensus 566 ~~~~---------------~----------------------------------~---------------------~~-- 573 (825)
..-. . . ++
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 1100 0 0 00
Q ss_pred -------C-------------------C-------ccccceEEEEEcccCCCCHHHHHHHhhccCCCcc-CHHHHHHHHH
Q 003375 574 -------N-------------------P-------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQ 619 (825)
Q Consensus 574 -------~-------------------~-------~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~l-s~~~i~~Ia~ 619 (825)
. . ......+||-||||+..+|.+++.. +... .....|++++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFR 704 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHH
Confidence 0 0 0012478999999998777777765 2222 4788999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc------ccc--ccccccCCCCCCCcccC
Q 003375 620 DVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS------FLH--TCCIAHRGIPAPDVCVG 691 (825)
Q Consensus 620 QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~------~~~--~~~~s~~~~~~~~~~vG 691 (825)
+|+.||.|+|++|||||||||.|||++.++ .|||+|||+|..... ... ............+..+|
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~~-------~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG 777 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSRN-------SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG 777 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCCC-------CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence 999999999999999999999999999774 599999999987321 000 01111122223456789
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccc
Q 003375 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770 (825)
Q Consensus 692 T~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~ 770 (825)
|.-|+|||++.+... ..|+.|+||||||+||+||+. ||... ....++..+..+ .++.. ..
T Consensus 778 TalYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g---~iP~~-~~----------- 838 (1351)
T KOG1035|consen 778 TALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG---SIPEP-AD----------- 838 (1351)
T ss_pred eeeeecHHHhccccc-ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC---CCCCC-cc-----------
Confidence 999999999987433 479999999999999999983 56422 222333333333 33321 00
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 771 ~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
...+..+.-..+|..||+.||.+||||.|+|+.
T Consensus 839 ---------f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 839 ---------FFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ---------cccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 011122345789999999999999999999975
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.14 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=199.3
Q ss_pred eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
....+||+|+||.||++.. .+..+|+|...... ..... .+.+|+.+++.++||||+++++.+...+.
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 91 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRE----LLFNEVVIMRDYQHENVVEMYNSYLVGDE--- 91 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHH----HHHHHHHHHHhcCCcchhheeeEEEeCCE---
Confidence 3457899999999999987 56788888754221 12222 34899999999999999999999886553
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
.++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||+|.||+++.+
T Consensus 92 -----------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-- 152 (292)
T cd06657 92 -----------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-- 152 (292)
T ss_pred -----------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC--
Confidence 4999999999999998764 458899999999999999999999999999999999999876
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
+.++|+|||++......... .....|++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 153 -----~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 153 -----GRVKLSDFGFCAQVSKEVPR----------RKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred -----CCEEEcccccceeccccccc----------ccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhCC
Confidence 45999999988655331110 123458899999999865 55788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL 810 (825)
.||.+.........+.....+.+.. ....+..+.+++.+||..+|.+||++.+++
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCC-------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 9998777665555444332211110 011245689999999999999999999999
Q ss_pred HHHHhhcCCCCC
Q 003375 811 EMFVARTSSSIS 822 (825)
Q Consensus 811 ~hL~~l~sss~S 822 (825)
+|-.......++
T Consensus 269 ~~~~~~~~~~~~ 280 (292)
T cd06657 269 KHPFLAKAGPPS 280 (292)
T ss_pred cChHHhccCCCc
Confidence 986544444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=295.74 Aligned_cols=254 Identities=27% Similarity=0.334 Sum_probs=195.8
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||.|+||.||++.+. +..+++|+...... ..+.....+.+|+.++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999984 78899998643221 11222344589999999999999999999887554
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
..|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 35999999999999999986 2368999999999999999999999999999999999999887
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
..++|+|||++.......... ............++..|+|||.+.. ...+.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQIN--LNDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCcccc--cccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 459999999987553321100 0000111233468889999999876 4578899999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 003375 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 812 (825)
Q Consensus 736 ~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa---~EIL~h 812 (825)
.........+..+..+ .+.. ...+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIE-WPED-------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcC-CCcc-------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 8777766666543211 1100 0124578999999999999999999 777776
Q ss_pred HH
Q 003375 813 FV 814 (825)
Q Consensus 813 L~ 814 (825)
-+
T Consensus 258 ~~ 259 (265)
T cd05579 258 PF 259 (265)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.03 Aligned_cols=284 Identities=19% Similarity=0.230 Sum_probs=202.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|.+.+.||+|+||.||+|.. .+..||+|+.... .......+ .+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc--chhhHHHH----HHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 37899999999999999999986 5678888875422 11111222 3478999999999999999999886443
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......+++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 90 ~~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 154 (345)
T cd07877 90 SL--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154 (345)
T ss_pred cc--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc
Confidence 21 0112458899988 6899988864 4589999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 155 ~~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 155 ED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred CC-------CCEEEeccccccccccc-------------ccccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHH
Confidence 77 45999999998754321 122357899999999864 23578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||...+.......+........+..+..........+... .............++.+.+||.+||+.||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 999999987766655555444322222222211110000000000 00000011111245678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
|++.+++.|-...
T Consensus 292 ~t~~e~l~h~~f~ 304 (345)
T cd07877 292 ITAAQALAHAYFA 304 (345)
T ss_pred CCHHHHhcChhhh
Confidence 9999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.42 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=192.9
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
+|++.+.||.|+||.||+|.. .+..+|+|++........ ....+.+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----chHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 488999999999999999986 567899998653221111 11223348899999999 49999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DTK--------------LHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CCe--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 543 4999999999999999976 346889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++......... ......|+..|+|||.+... ...++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceeccccccc---------ccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHH
Confidence 9876 46999999998765332111 11234588999999998641 134678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|++|..||..... ..+...+.... +.++ ...+..+.+|+.+||..||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSE-PPYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccC-CCCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964322 22222222111 1111 1134578999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 003375 801 TERP-----TAGDLYEM 812 (825)
Q Consensus 801 ~eRP-----Sa~EIL~h 812 (825)
.+|| ++.+++.|
T Consensus 252 ~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 252 KKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHhcCCCCCCHHHHHcC
Confidence 9997 88999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.22 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=197.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
..+++|++.+.||+|+||.||+|.+. +..+|+|+..... . ...... +.+|+.++.++. ||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~-~~~~~~----~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--N-KEENKR----ILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--C-hHHHHH----HHHHHHHHHhccCCCchHhhheeee
Confidence 67889999999999999999999985 7889999865321 1 112222 366777777775 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSEN 642 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~N 642 (825)
.... .|+||||+. ++|.+++... ...+++..+..++.||+.||+|||+ .||+||||+|+|
T Consensus 85 ~~~~--------------~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 85 TDSD--------------VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred cCCe--------------EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 6654 499999996 6888887652 2468999999999999999999997 599999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|+++.+ ..+||+|||++..+..... .....++..|+|||++.+......++.++||||||++
T Consensus 146 ill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 146 ILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred EEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 999876 4699999999876543211 1122478899999998753222447889999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|+|++|+.||..... .+....+.....+.++. ....+..+.+|+.+||..||.
T Consensus 208 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~ 262 (296)
T cd06618 208 LVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-------------------------NEGFSPDFCSFVDLCLTKDHR 262 (296)
T ss_pred HHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHHccCChh
Confidence 9999999999975432 23333333322221110 001345789999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
+||++.+++.|.+-.
T Consensus 263 ~Rp~~~~il~~~~~~ 277 (296)
T cd06618 263 KRPKYRELLQHPFIR 277 (296)
T ss_pred hCCCHHHHhcChhhh
Confidence 999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.19 Aligned_cols=271 Identities=22% Similarity=0.328 Sum_probs=209.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHh--hCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk--~L~HPNIV~l~g~~~~ 564 (825)
..+...++.++||+|.||.||+|...++.||||++.. .+.+.| ..|-.|+. .++|+||++|+++-..
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-------~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-------QEKQSF----QNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCH-------HHHHHH----HhHHHHHhccCccchhHHHhhchhcc
Confidence 3466778899999999999999999999999999763 233344 66666544 5679999999987543
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC---------Cccc
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMH 635 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~---------gIVH 635 (825)
... ....++||++|.+.|+|.+||+. ..++|....+|+..|++||+|||.. .|+|
T Consensus 276 ~t~----------~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 276 GTA----------DRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred CCc----------cccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 221 13467999999999999999997 6799999999999999999999973 6999
Q ss_pred cCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCch
Q 003375 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLE 713 (825)
Q Consensus 636 rDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~--~~s~k 713 (825)
||||+.||||..+ .++.|+|||+|..+...... ......+||.+|||||++.+...-. ..-.+
T Consensus 340 RDlkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~--------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr 404 (534)
T KOG3653|consen 340 RDLKSKNVLVKND-------LTCCIADFGLALRLEPGKPQ--------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKR 404 (534)
T ss_pred ccccccceEEccC-------CcEEeeccceeEEecCCCCC--------cchhhhhhhhhhcCHHHHhhhcccccHHHHHH
Confidence 9999999999988 67999999999888643221 1123358999999999998743211 12257
Q ss_pred hhHHHHHHHHHHHHhCC------------CCCC-----CCCHHHHHHHHHc-CCCCCchhHHhhhccCccccccccCCCC
Q 003375 714 VDIWSYGCLLLELLTLQ------------VPYM-----GLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGF 775 (825)
Q Consensus 714 SDVWSLGvILyELLTG~------------~PF~-----~~~~~~i~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~ 775 (825)
.||||+|.+||||+++. .||. ..+..++...+.+ ..+|.+++.+...
T Consensus 405 ~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--------------- 469 (534)
T KOG3653|consen 405 IDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--------------- 469 (534)
T ss_pred HHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---------------
Confidence 99999999999999863 3332 1234455555444 4788888765332
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 776 ~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.....+.+.++.||..||+.|.|+.-+.+++..+.....
T Consensus 470 -------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 470 -------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred -------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 124578999999999999999999999999888876654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.95 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=195.9
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|...+.||+|+||.||+|+. .+..+++|+...... ........ +.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQD----IIKEVKFLQQLKHPNTIEYKGCYLKEHT-- 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHH----HHHHHHHHHhCCCCCCccEEEEEEeCCE--
Confidence 66778899999999999987 567888887643321 12222233 4889999999999999999999886653
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
.|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 96 ------------~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 96 ------------AWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred ------------EEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 499999996 688888764 23468899999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
+.++|+|||++..... .....|+..|+|||++.... ...++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhC
Confidence 4599999998854321 12346889999999985321 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 003375 730 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809 (825)
Q Consensus 730 ~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EI 809 (825)
..||...+.......+.....+.... ...+..+.+|+.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998776655555444332221110 1123468999999999999999999999
Q ss_pred HHHHHh
Q 003375 810 YEMFVA 815 (825)
Q Consensus 810 L~hL~~ 815 (825)
+.|...
T Consensus 271 l~~~~~ 276 (313)
T cd06633 271 LRHDFV 276 (313)
T ss_pred hcCccc
Confidence 988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.76 Aligned_cols=286 Identities=20% Similarity=0.221 Sum_probs=207.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|++.+.||.|+||.||+|.. .+..+++|..... .......+ .+.+|+.+++.++||||+++++++......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV--FDDLIDAK----RILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc--cccchhhh----hHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 589999999999999999997 4678898875432 11122222 348999999999999999999998755311
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 75 ---------DFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred ---------cccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 2234699999997 589998875 2478999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++......... ........+++.|+|||++.+. ..++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLSS---SRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeecccccc-------cccccccccccCcCCceeeecc---cCCCcchhHHHHHHHHHHHHc
Confidence 46999999999876543210 0011234688999999999861 267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|.+||.+.+..+....+.........+.+..........+... .............+..+.+||.+||+.+|.+||+
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 9999998887776666554322222221111000000000000 0000011112235678999999999999999999
Q ss_pred HHHHHHHHH
Q 003375 806 AGDLYEMFV 814 (825)
Q Consensus 806 a~EIL~hL~ 814 (825)
+.+++.|.+
T Consensus 283 ~~~ll~~~~ 291 (330)
T cd07834 283 ADEALAHPY 291 (330)
T ss_pred HHHHHhCcc
Confidence 999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.86 Aligned_cols=248 Identities=21% Similarity=0.247 Sum_probs=185.0
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 003375 497 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 574 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~ 574 (825)
.||+|+||.||+|.. .+..+|+|+...+........ ..+ ......+.+++...||||+++++++.....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~------- 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPDK------- 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCCE-------
Confidence 489999999999986 567899998754322211111 111 011222344555679999999998886553
Q ss_pred CccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCC
Q 003375 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 654 (825)
Q Consensus 575 ~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~ 654 (825)
.++||||+.|++|..++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.+
T Consensus 72 -------~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 72 -------LSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred -------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 4999999999999998875 3568999999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~ 734 (825)
..++|+|||++..+.... .....|+..|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 459999999987553211 122368999999999874 2357889999999999999999999997
Q ss_pred CCCH---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 003375 735 GLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 806 (825)
Q Consensus 735 ~~~~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-----Sa 806 (825)
.... ......+. ...+.++ ...+..+.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~~-~~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMTL-TMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHhh-ccCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 6532 22211111 1111111 11245799999999999999999 99
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.++++|.+.
T Consensus 250 ~~ll~~~~~ 258 (278)
T cd05606 250 QEVKEHPFF 258 (278)
T ss_pred HHHHhCccc
Confidence 999988543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.98 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=185.0
Q ss_pred CCCceeeeee--cccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 489 FPSLSSCDEA--GKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~L--G~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
.++|.+.+.+ |+|+||.||++.. .+..+++|+...... . ..|+.....+ +||||+++++.+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~-----------~~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--N-----------AIEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--c-----------hhhHHHHHHhhcCCCEEEEEEEEe
Confidence 3456666666 9999999999986 567788888653211 1 1122222222 6999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..+. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||
T Consensus 80 ~~~~--------------~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 140 (267)
T PHA03390 80 TLKG--------------HVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140 (267)
T ss_pred cCCe--------------eEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6653 4999999999999999986 23789999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
+++.++ ..++|+|||++...... ....++..|+|||++.+ ..++.++|||||||++
T Consensus 141 l~~~~~------~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il 196 (267)
T PHA03390 141 LYDRAK------DRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLT 196 (267)
T ss_pred EEeCCC------CeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHH
Confidence 998773 26999999998765321 12358899999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++|..||.......+. ..+........ ......++.+.+||.+||+.+|.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 197 YELLTGKHPFKEDEDEELDLESLLKRQQKKL-------------------------PFIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHCCCCCCCCCcchhhHHHHHHhhcccC-------------------------CcccccCHHHHHHHHHHhccChhh
Confidence 9999999999755433211 11111100000 001124567999999999999999
Q ss_pred CCC-HHHHHHHHH
Q 003375 803 RPT-AGDLYEMFV 814 (825)
Q Consensus 803 RPS-a~EIL~hL~ 814 (825)
||+ ++++++|-+
T Consensus 252 R~~~~~~~l~h~~ 264 (267)
T PHA03390 252 RLTNYNEIIKHPF 264 (267)
T ss_pred CCchHHHHhcCCc
Confidence 996 699998754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.32 Aligned_cols=276 Identities=24% Similarity=0.258 Sum_probs=197.6
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 568 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~ 568 (825)
|++.+.||+|+||.||+|.. .+..+++|....... .... . ...+|+..+++++ ||||+++++++.....
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~-~----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~- 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEE-C----MNLREVKSLRKLNEHPNIVKLKEVFRENDE- 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhH-H----HHHHHHHHHHhccCCCCchhHHHHhhcCCc-
Confidence 67889999999999999998 456788887543221 1111 1 1267999999999 9999999999876543
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 73 -------------~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 73 -------------LYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred -------------EEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 49999999 68999998761 12468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.++|+|||++........ .....++..|+|||++.. ...++.++||||||+++|||++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRPP-----------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCCC-----------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 4599999999876543211 122458899999998864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccc-cc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~-~~-~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|++||...........+.....+.....+......... .. ................+..+.+||.+||+.+|.+|||+
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 99999887665555444432211111111000000000 00 00000000011111224679999999999999999999
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.|++.|.
T Consensus 275 ~ei~~~~ 281 (283)
T cd07830 275 SQALQHP 281 (283)
T ss_pred HHHhhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=297.62 Aligned_cols=254 Identities=25% Similarity=0.260 Sum_probs=189.5
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
+|++.+.||+|+||.||++.. .+..+|+|+.+..... ........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999875 4567999986532111 1111223448899999999 49999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||.||+
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DTK--------------LHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CCE--------------EEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 543 4999999999999999875 246889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ ..++|+|||++..+...... ......|+..|+|||.+.+.. ...+.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGGS--GGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCCC--CCCcchhhhHHHHHHHH
Confidence 9876 45999999998765332111 112245889999999987521 23678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|++|..||..... ..+...+.... +..+ ...+..+.++|.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSK-PPFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccC-CCCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 99999999964322 12222221111 1111 1124578999999999999
Q ss_pred CCCCCHHHH---HHHH
Q 003375 801 TERPTAGDL---YEMF 813 (825)
Q Consensus 801 ~eRPSa~EI---L~hL 813 (825)
++|||+.++ ++|.
T Consensus 252 ~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 252 KKRLGANGADEIKNHP 267 (288)
T ss_pred hhccCcchHHHHhcCc
Confidence 999996544 5554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=295.13 Aligned_cols=258 Identities=23% Similarity=0.366 Sum_probs=207.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
.++++++++..||.|+.|.||++++.. .-.|||.. ... ...++.+++ ++.+.++..-. +|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M--~rt-~Nkee~kRI----LmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQM--RRT-GNKEENKRI----LMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEee--ccc-CCHHHHHHH----HHhhhHHhhccCCCeeeeeeeEEe
Confidence 567888899999999999999999865 55666654 332 233444444 88898877665 999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 642 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~N 642 (825)
.+..+ +|.||.+. .-++.+++. -.+++++..+-++...++.||.||-.+ ||||||+||+|
T Consensus 162 ~n~dV--------------~IcMelMs-~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 162 TNTDV--------------FICMELMS-TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred eCchH--------------HHHHHHHH-HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 87655 89999995 556666654 235699999999999999999999875 89999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||+|..+ .+||||||++-.+...... ....|-+.|||||.+.. .....|..++||||||++
T Consensus 223 ILlDe~G-------niKlCDFGIsGrlvdSkAh-----------trsAGC~~YMaPERidp-~~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 223 ILLDERG-------NIKLCDFGISGRLVDSKAH-----------TRSAGCAAYMAPERIDP-PDKPKYDIRADVWSLGIT 283 (391)
T ss_pred eEEccCC-------CEEeecccccceeeccccc-----------ccccCCccccCccccCC-CCCCccchhhhhhhhccc
Confidence 9999885 4999999999877543321 23368999999999975 234678999999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|+||.||+.||.+. ...+++..+.+...|.++... ..++.+++|+..||..|+.
T Consensus 284 lveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r 338 (391)
T KOG0983|consen 284 LVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHR 338 (391)
T ss_pred hhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCcc
Confidence 99999999999874 567788888876555555321 1367899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003375 802 ERPTAGDLYEMFV 814 (825)
Q Consensus 802 eRPSa~EIL~hL~ 814 (825)
+||...++|+|-.
T Consensus 339 ~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 339 KRPKYNKLLEHPF 351 (391)
T ss_pred cCcchHHHhcCcc
Confidence 9999999999843
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=303.12 Aligned_cols=276 Identities=20% Similarity=0.242 Sum_probs=197.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||.|+||.||+|.. .+..+|+|...... ......+. +.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKR----TYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHH----HHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 46799999999999999999986 56778888754321 11112223 378999999999999999999886433
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..++||||+. ++|..++.. ..++...+..++.||+.||.|||+.||+||||+|.|||++
T Consensus 83 ~-------------~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~ 142 (328)
T cd07856 83 E-------------DIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142 (328)
T ss_pred C-------------cEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence 2 3599999994 799988864 4578888999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.++|+|||++....... ....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 143 ~~-------~~~~l~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 143 EN-------CDLKICDFGLARIQDPQM-------------TGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred CC-------CCEEeCccccccccCCCc-------------CCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHH
Confidence 76 459999999987543211 12357889999998754 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccc-cccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~~--~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||...........+.........+............+ .... ............++.+.++|.+||+.+|.+|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 999999987766544433332211111111111000000000 0000 0000111112345789999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
|++.+++.|-
T Consensus 280 ~t~~ell~~~ 289 (328)
T cd07856 280 ISAAEALAHP 289 (328)
T ss_pred CCHHHHhcCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.65 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=207.3
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhh--CCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~--L~HPNIV~l~g~~~~~~~ 567 (825)
...++.+.||+|.||.||+|+|.|..||||||.-. +.+.+ .+|.+|++. |+|+||+.|++.-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-------dE~SW----frEtEIYqTvmLRHENILgFIaaD~~~~- 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-------DERSW----FRETEIYQTVMLRHENILGFIAADNKDN- 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc-------chhhh----hhHHHHHHHHHhccchhhhhhhccccCC-
Confidence 45689999999999999999999999999998532 12223 667766655 68999999998755333
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 639 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~--------gIVHrDLK 639 (825)
..-.++|||++|.+.|||.+||.. ..++.+..++++..+|.||+|||.. .|.|||||
T Consensus 279 ---------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 279 ---------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred ---------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 235689999999999999999986 6799999999999999999999974 49999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC--CchhhHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY--GLEVDIW 717 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~--s~kSDVW 717 (825)
+.||||..+ +++.|+|+|+|.........-. ...+..+||.+|||||++........+ -..+|||
T Consensus 344 SKNILVKkn-------~~C~IADLGLAv~h~~~t~~id------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 344 SKNILVKKN-------GTCCIADLGLAVRHDSDTDTID------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred cccEEEccC-------CcEEEeeceeeEEecccCCccc------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 999999987 5799999999987765433211 224556899999999999753322222 2579999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHHc-CCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 718 SYGCLLLELLTL----------QVPYMGL-----SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 718 SLGvILyELLTG----------~~PF~~~-----~~~~i~~~I~~-~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
|||.|+||++-+ ++||.+. +.+++.+.+.- ..+|.++..+ ..
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW----------------------~s 468 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW----------------------KS 468 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc----------------------cc
Confidence 999999999863 6888553 33344444432 3566655432 12
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
.+....+.+||+.||..||..|.||--|.+.|.++.+
T Consensus 469 ~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 469 DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2345678999999999999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=330.31 Aligned_cols=150 Identities=25% Similarity=0.274 Sum_probs=127.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|.+.++||.|+||.||+|.+. +..||+|++..... .... +...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~----~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKN----MVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHH----HHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3689999999999999999999985 78899999753321 1112 223458899999999999999999988765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .||||||+.|++|.+++.. ...+++..++.|+.||+.||.|||.+|||||||||+||||
T Consensus 77 ~~--------------~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 NN--------------VYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred CE--------------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 53 5999999999999999975 2458889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCccc
Q 003375 646 DLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
+.+ +.+||+|||+++.
T Consensus 138 ~~~-------g~vkL~DFGls~~ 153 (669)
T cd05610 138 SNE-------GHIKLTDFGLSKV 153 (669)
T ss_pred cCC-------CCEEEEeCCCCcc
Confidence 876 4699999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=287.29 Aligned_cols=243 Identities=30% Similarity=0.370 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||.|+||.||++.. .+..+++|+...... ........ +..|+.++++++||||+++++.+.....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEH----TLTERNILSRINHPFIVKLHYAFQTEEK-------- 67 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHH----HHHHHHHHHHcCCCcHHHHHHHeecCCe--------
Confidence 69999999999997 467899998653321 11222333 4889999999999999999998876554
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|.||+++.+
T Consensus 68 ------~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 68 ------LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred ------eEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 4999999999999999986 2468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003375 656 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 656 ~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~ 735 (825)
+.++|+|||++........ ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEGS----------RTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCCC----------cccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4599999999876543211 1123458899999999876 4578899999999999999999999987
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 003375 736 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 812 (825)
Q Consensus 736 ~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa---~EIL~h 812 (825)
.+.......+.... ..++. ..+..+.++|.+||..||.+||++ .++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFPE---------------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCCC---------------------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 77655555554421 11111 114578999999999999999999 787776
Q ss_pred H
Q 003375 813 F 813 (825)
Q Consensus 813 L 813 (825)
.
T Consensus 248 ~ 248 (250)
T cd05123 248 P 248 (250)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=297.37 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=208.9
Q ss_pred cee-eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 492 LSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 492 y~i-~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
|++ .+.||+|+|+.|--+.. ++..+||||+. .+.. .. +.++.+|++++.+.+ |+||++++++|+++..
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiid--Kq~g--Hs----R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIID--KQPG--HS----RSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhh--cCCc--hH----HHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 444 47789999999999875 88899999954 3321 11 234589999999997 9999999999998876
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+ |||||-+.||+|...|.+ ...|++.++.++.++|+.||.|||.+||.||||||+|||-..
T Consensus 151 F--------------YLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 151 F--------------YLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred E--------------EEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 5 999999999999999987 467999999999999999999999999999999999999875
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ .-.-||||||.++.-+...... +....+.-.+.+|+..|||||+..-.- ....|..+.|.||||||||-|
T Consensus 212 pn----~vsPvKiCDfDLgSg~k~~~~~---spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 212 PN----KVSPVKICDFDLGSGIKLNNDC---SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred CC----CcCceeeeccccccccccCCCC---CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 53 2345999999998765432221 122223334558999999999975321 224688999999999999999
Q ss_pred HhCCCCCCCCC---------------HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003375 727 LTLQVPYMGLS---------------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 727 LTG~~PF~~~~---------------~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
+.|.+||.|.- ...++..|+.+....-. ..+..++.+..+|
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd------------------------kdWahIS~eakdl 340 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD------------------------KDWAHISSEAKDL 340 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh------------------------hhhHHhhHHHHHH
Confidence 99999997642 23456667666543222 2234567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+..+|..|+..|.++.++++|.+.
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCccc
Confidence 999999999999999999997653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=323.17 Aligned_cols=290 Identities=22% Similarity=0.255 Sum_probs=205.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.-|...+.||+||||.||++++ .|..+|||.++... .....+.. .+|+++|++|+|||||+++++-.+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~----~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERW----CREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHH----HHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4567789999999999999996 67889999865322 12223333 899999999999999999988654431
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .......+|||||.||||..++.+ +.....+++.+++.++.+++.||.|||.+|||||||||.||++..
T Consensus 86 ~--------~~~~~~vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~ 155 (732)
T KOG4250|consen 86 G--------LVTRLPVLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI 155 (732)
T ss_pred C--------cccccceEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence 1 012345999999999999999986 333467999999999999999999999999999999999999976
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
.. ++.-..||+|||+|+.+..... -...+||+.|.+||++.. ...|+..+|.|||||++|+++
T Consensus 156 Ge---dgq~IyKLtDfG~Arel~d~s~-----------~~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 156 GE---DGQSIYKLTDFGAARELDDNSL-----------FTSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred cC---CCceEEeeecccccccCCCCCe-----------eeeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHHHh
Confidence 53 2567899999999998876442 255789999999999984 367899999999999999999
Q ss_pred hCCCCCCCCC-H---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 728 TLQVPYMGLS-E---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 728 TG~~PF~~~~-~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||..||.... + .++...+.......+--.... ....+......++. ...........+-..+..+|..+|.+|
T Consensus 219 TG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~--~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~ 295 (732)
T KOG4250|consen 219 TGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE--EENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKR 295 (732)
T ss_pred ccCCCCCcCCCccccchhhhhhhccCCCceeEeeec--ccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHh
Confidence 9999994332 2 223333333221111100000 00000000000111 111122334556778889999999999
Q ss_pred C--CHHHHHHHHHhh
Q 003375 804 P--TAGDLYEMFVAR 816 (825)
Q Consensus 804 P--Sa~EIL~hL~~l 816 (825)
. .+.+....+..+
T Consensus 296 ~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 296 GHEGFDRFFAEVDDI 310 (732)
T ss_pred CCCCcchHHHHHHHH
Confidence 8 666665555444
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.54 Aligned_cols=302 Identities=17% Similarity=0.227 Sum_probs=220.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.....|+-..+||+|.||.||+|+. .+..||+|++-+.. +.+.|-...++|+.+|..|+|+|++.+++.|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 3456788899999999999999986 45667777653321 222333444899999999999999999998875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .......+|+||.+|+ .+|..++.+ ...+++..++.+++.+++.||.|+|...|+|||+||.|+|
T Consensus 88 k~Tp------~~r~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvL 156 (376)
T KOG0669|consen 88 KATP------TNRDRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVL 156 (376)
T ss_pred ccCC------cccccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEE
Confidence 4421 1113346899999998 699999975 3467999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +++||+|||+++.+...... ..+..+..+-|..|.+||.+.| ...|+++.|||..||||.
T Consensus 157 It~d-------gilklADFGlar~fs~~~n~------~kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 157 ITKD-------GILKLADFGLARAFSTSKNV------VKPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMA 220 (376)
T ss_pred EcCC-------ceEEeeccccccceeccccc------CCCCcccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHH
Confidence 9987 67999999999876543221 1112344567999999999998 467899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccc------ccC-CCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA------QSG-SGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~------~~~-~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
||+|+.+.+++.+..+.+..|..-.....++.++.....+..... +.. ...+..-.+....+...+|++++|.
T Consensus 221 eMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~ 300 (376)
T KOG0669|consen 221 EMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLK 300 (376)
T ss_pred HHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhc
Confidence 999999999999888777766543222222222221111111000 000 0000000011123467899999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 798 ENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.||.+|++++++++|-.....+.+
T Consensus 301 ~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 301 LDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCcccCcchHhhhchhhhhcCCcc
Confidence 999999999999999887766654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=319.63 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=217.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
+-+.|++.+.||.|.+|.||+++. +++.+|+||..... .. .+++ .-|..+|+.+. |||++.+||+|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~---deEi----E~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DE---EEEI----ELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cc---cHHH----HHHHHHHHhccCCCCcceEEEEEEE
Confidence 345789999999999999999875 78899999965432 11 1222 56888888885 9999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+.. ...++|||||||.|||..++++... ..++.+..+..|++.++.||.+||++.++|||||-.|||
T Consensus 88 ~~~~---------~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 88 KDPG---------NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred ecCC---------CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 6532 4457999999999999999999854 577999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~-~~~s~kSDVWSLGvIL 723 (825)
++.++. |||+|||.+..++.... ..++++|||.|||||++...+.. ..|+.++|+||||++.
T Consensus 156 LT~e~~-------VKLvDFGvSaQldsT~g----------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa 218 (953)
T KOG0587|consen 156 LTENAE-------VKLVDFGVSAQLDSTVG----------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA 218 (953)
T ss_pred EeccCc-------EEEeeeeeeeeeecccc----------cccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence 999854 99999999987765332 35678999999999999865432 3578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
.||..|.+|+..+.+...+..|-....|.+.. +..-+..+.++|..||..|..+|
T Consensus 219 IEladG~PPl~DmHPmraLF~IpRNPPPkLkr-------------------------p~kWs~~FndFIs~cL~Kd~e~R 273 (953)
T KOG0587|consen 219 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR-------------------------PKKWSKKFNDFISTCLVKDYEQR 273 (953)
T ss_pred ehhcCCCCCccCcchhhhhccCCCCCCccccc-------------------------hhhHHHHHHHHHHHHHhhccccC
Confidence 99999999999998887776666665554432 12236789999999999999999
Q ss_pred CCHHHHHHHH
Q 003375 804 PTAGDLYEMF 813 (825)
Q Consensus 804 PSa~EIL~hL 813 (825)
|+..++++|.
T Consensus 274 P~~~~ll~hp 283 (953)
T KOG0587|consen 274 PSTEELLKHP 283 (953)
T ss_pred cchhhhccCC
Confidence 9999999884
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.30 Aligned_cols=262 Identities=24% Similarity=0.252 Sum_probs=207.3
Q ss_pred CCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 489 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 489 ~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
.++|.+. ++||-|-.|.|..+.. .+..+|+|+.. . .. ...+|+++--.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--D---s~--------KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--D---SP--------KARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--c---CH--------HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4566654 6789999999999987 67789999842 1 11 127888875444 59999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.-. ....+.||||.++||.|...|.. .+...|++.++-.|++||..|+.|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 432 24468999999999999999987 45677999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
..... .+..+||+|||+|+....... -.+..-||.|.|||++.. ..|+...|+||+||++|
T Consensus 194 yt~t~----~na~lKLtDfGFAK~t~~~~~-----------L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTTS----PNAPLKLTDFGFAKETQEPGD-----------LMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecCC----CCcceEecccccccccCCCcc-----------ccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 98764 457899999999987653221 123357999999999975 66899999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
-|+.|.+||....- ..+...|..+....- .+.+..+++..+++|+.+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP------------------------~pEWs~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP------------------------EPEWSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCccCC------------------------ChhHhHHHHHHHHHHHHHhcCCc
Confidence 99999999965432 234555555543221 12335568899999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003375 801 TERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ss 819 (825)
.+|.|+.++++|.+-....
T Consensus 311 teRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhheeHHHhhcCchhcccc
Confidence 9999999999998765443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.06 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=204.6
Q ss_pred eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
.+.||.|.||+||-|++ +++.||||++. ...........+ ..|++||+.+.||.||.+.-.|++.+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvId--KlrFp~kqesql----R~EVaILq~l~HPGiV~le~M~ET~erv---- 638 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVID--KLRFPTKQESQL----RNEVAILQNLHHPGIVNLECMFETPERV---- 638 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeee--cccCCCchHHHH----HHHHHHHHhcCCCCeeEEEEeecCCceE----
Confidence 47899999999999987 78899999954 333333333444 8999999999999999999999877654
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
++|||-+. |+..++|-. ....++++...+.++.||+.||.|||-++|+|+||||+|||+....
T Consensus 639 ----------FVVMEKl~-GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~--- 701 (888)
T KOG4236|consen 639 ----------FVVMEKLH-GDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS--- 701 (888)
T ss_pred ----------EEEehhhc-chHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC---
Confidence 99999997 566666654 2346799999999999999999999999999999999999998663
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
.-+++||||||+|+.+.+... ....+|||.|+|||+++. ..|+..-|+||.|||+|--++|..|
T Consensus 702 -~FPQvKlCDFGfARiIgEksF-----------RrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 702 -PFPQVKLCDFGFARIIGEKSF-----------RRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred -CCCceeeccccceeecchhhh-----------hhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEeccccc
Confidence 457899999999999876543 255789999999999997 7899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 733 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 733 F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
|... +++.++|++..... .+..+.++++..++||..+|+..-.+|.|.+..+.|
T Consensus 766 FNEd--EdIndQIQNAaFMy------------------------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FNED--EDINDQIQNAAFMY------------------------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCc--cchhHHhhcccccc------------------------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 9644 34455555442111 122234557789999999999999999999999888
Q ss_pred HH
Q 003375 813 FV 814 (825)
Q Consensus 813 L~ 814 (825)
.+
T Consensus 820 ~W 821 (888)
T KOG4236|consen 820 PW 821 (888)
T ss_pred hh
Confidence 65
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=271.09 Aligned_cols=282 Identities=20% Similarity=0.233 Sum_probs=213.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|...++||+|.||+||+|+. ..+-||+|.+++.....+-.. ..++|+-+|+.|+|.|||+++++...++.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps------salreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS------SALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH------HHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4677789999999999999996 556788888877654443332 23899999999999999999999876664
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+-+|+|||. .+|..|... -+..++.+.++.++.|+++||.|+|++++.||||||.|+||+.
T Consensus 76 --------------ltlvfe~cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ 136 (292)
T KOG0662|consen 76 --------------LTLVFEFCD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR 136 (292)
T ss_pred --------------eEEeHHHhh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence 489999997 699999876 3567899999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
++ .+||+|||+++.+.-.... ...-+-|..|.+|.++.+ ...|+...|+||.|||+.||.
T Consensus 137 ng-------elkladfglarafgipvrc----------ysaevvtlwyrppdvlfg---akly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 137 NG-------ELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred CC-------cEEecccchhhhcCCceEe----------eeceeeeeeccCcceeee---eehhccchHhhhcchHHHHHh
Confidence 84 5999999999987653321 122367899999999987 467899999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
. |++.|++.+..+....|.......-.+.++.+...+... +.-...........+.....-.+|+.++|.-+|.+|.+
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris 276 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS 276 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC
Confidence 6 888899988877777765543222233333322222110 11011111111122223334579999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+++.++|.-.-
T Consensus 277 aeaalqhpyf~ 287 (292)
T KOG0662|consen 277 AEAALQHPYFS 287 (292)
T ss_pred HHHHhcCcccc
Confidence 99999986443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=331.89 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=214.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|.+++.||+|+||.|.+++. .+..||+|+...-.... ..+. .-|..|-.+|..-..+-|+.++-.|.++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~t----A~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAET----ACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhH----HHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 35799999999999999999998 56678888753211110 1111 23478889999999999999999999888
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
++ |+||||++||+|..++.++ ..+++..++.++..|+.||.-||+.|+|||||||+||||+
T Consensus 149 ~L--------------YlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 149 YL--------------YLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD 209 (1317)
T ss_pred ce--------------EEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec
Confidence 65 9999999999999999872 3699999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~-~~~s~kSDVWSLGvILyE 725 (825)
.. +++||+|||.+-.+...... .....+|||.|.+||++..+... +.|++.+|.||+||++||
T Consensus 210 ~~-------GHikLADFGsClkm~~dG~V---------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YE 273 (1317)
T KOG0612|consen 210 KS-------GHIKLADFGSCLKMDADGTV---------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYE 273 (1317)
T ss_pred cc-------CcEeeccchhHHhcCCCCcE---------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHH
Confidence 88 56999999999877654332 23567899999999999987766 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+.|..||...+....+..|.... .-.+| ....+++...+||.+.+. +|..|.
T Consensus 274 MlyG~TPFYadslveTY~KIm~hk~~l~FP-------------------------~~~~VSeeakdLI~~ll~-~~e~RL 327 (1317)
T KOG0612|consen 274 MLYGETPFYADSLVETYGKIMNHKESLSFP-------------------------DETDVSEEAKDLIEALLC-DREVRL 327 (1317)
T ss_pred HHcCCCcchHHHHHHHHHHHhchhhhcCCC-------------------------cccccCHHHHHHHHHHhc-Chhhhc
Confidence 999999999988888888887652 11111 123367889999999885 899998
Q ss_pred C---HHHHHHHHHh
Q 003375 805 T---AGDLYEMFVA 815 (825)
Q Consensus 805 S---a~EIL~hL~~ 815 (825)
. +++|..|...
T Consensus 328 grngiedik~HpFF 341 (1317)
T KOG0612|consen 328 GRNGIEDIKNHPFF 341 (1317)
T ss_pred ccccHHHHHhCccc
Confidence 8 9999999654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.23 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=212.2
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
....+++|..+++||+|.||.|.+++- .+..+|+||.+.... ...+++..- +.|-++|+..+||.+..+--.|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHT----lTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHT----LTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhh----hhHHHHHHhccCcHHHHhhhhh
Confidence 335789999999999999999999986 678999999754433 233333333 7889999999999999888777
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.... ++|+||||+.||.|.-.|.. ...|++..++.+...|+.||.|||+++||.||||.+|
T Consensus 238 Qt~d--------------rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 238 QTQD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred ccCc--------------eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 7655 45999999999999988875 4679999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
+|++.+ +++||+|||+++.-.....+ ..+++|||.|+|||++.. ..|+.++|.|.+||+
T Consensus 299 LlLDkD-------GHIKitDFGLCKE~I~~g~t----------~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GVV 357 (516)
T KOG0690|consen 299 LLLDKD-------GHIKITDFGLCKEEIKYGDT----------TKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGVV 357 (516)
T ss_pred heeccC-------CceEeeecccchhcccccce----------eccccCChhhcCchhhcc----ccccceeehhhhhHH
Confidence 999998 45999999999864332221 356789999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||||++|+.||...+...++..|..... .+| ...+++...|+..+|..||.+
T Consensus 358 MYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFP---------------------------r~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 358 MYEMMCGRLPFYNKDHEKLFELILMEDL-KFP---------------------------RTLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred HHHHHhccCcccccchhHHHHHHHhhhc-cCC---------------------------ccCCHHHHHHHHHHhhcChHh
Confidence 9999999999999998888888876521 111 122557899999999999999
Q ss_pred CC-----CHHHHHHHH
Q 003375 803 RP-----TAGDLYEMF 813 (825)
Q Consensus 803 RP-----Sa~EIL~hL 813 (825)
|. .+.||.+|-
T Consensus 410 RLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 410 RLGGGPDDAKEIMRHR 425 (516)
T ss_pred hcCCCchhHHHHHhhh
Confidence 95 477887773
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=336.47 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=190.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..|...+.||+|+||.||+|.+ .+..||+|... ..... . ..|+.++++++|||||+++|++.....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~------~----~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSI------P----SSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc--CCccc------c----HHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3456678999999999999996 56778888643 21110 1 356889999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCEE
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH---SKHIMHRDIKSENIL 644 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH---s~gIVHrDLKP~NIL 644 (825)
. |+||||+++|+|.++++. +++..+..|+.||+.||+||| ..+|+||||||+||+
T Consensus 758 ~--------------~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 758 A--------------YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred C--------------EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 3 999999999999999963 788999999999999999999 669999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.++ ..++. ||....... .....+|+.|||||++.+ ..++.++|||||||++|
T Consensus 816 ~~~~~-------~~~~~-~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~ 869 (968)
T PLN00113 816 IDGKD-------EPHLR-LSLPGLLCT--------------DTKCFISSAYVAPETRET----KDITEKSDIYGFGLILI 869 (968)
T ss_pred ECCCC-------ceEEE-ecccccccc--------------CCCccccccccCcccccC----CCCCcccchhhHHHHHH
Confidence 98763 35554 555432211 112358899999999876 66899999999999999
Q ss_pred HHHhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~--~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||+||+.||..... ..+............ . ..+.+..... ...........+.+++.+||+.||.+
T Consensus 870 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCH---L--------DMWIDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred HHHhCCCCCCcccCCCCcHHHHHHHhcCccc---h--------hheeCccccC-CCCccHHHHHHHHHHHHhhCcCCchh
Confidence 99999999853211 111111111100000 0 0000110000 01112334567889999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCC
Q 003375 803 RPTAGDLYEMFVARTSSSISS 823 (825)
Q Consensus 803 RPSa~EIL~hL~~l~sss~S~ 823 (825)
|||+.||++.|+.+..+++++
T Consensus 938 RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 938 RPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred CcCHHHHHHHHHHhhcccccc
Confidence 999999999999998866654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=316.39 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=209.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV 556 (825)
.+-+++.+.+.||+|+||.|++|... ...||||. ++..... .+.+.+ ..|+.+|+.+. ||||+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~--~k~~~~~-~~~~~~----~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKM--LKENASS-SEKKDL----MSELNVLKELGKHPNIV 365 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEe--cccccCc-HHHHHH----HHHHHHHHHhcCCcchh
Confidence 33445567789999999999999842 44677776 4433333 444555 99999999996 99999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh---------ccCC--CccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---------~~~~--~~ls~~~i~~Ia~QIa~AL 625 (825)
.++|++.....+ ++|+||+..|+|.+|++... .... ..+.....+.++.||+.|+
T Consensus 366 ~llG~~t~~~~~--------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GM 431 (609)
T KOG0200|consen 366 NLLGACTQDGPL--------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGM 431 (609)
T ss_pred hheeeeccCCce--------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHH
Confidence 999999875543 99999999999999999743 0111 2388999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC--CCcccchhhhhc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRA 703 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vG--T~~YmAPEvl~~ 703 (825)
+||++.++|||||-..|||+..+ .++||+|||+|+.......... ....| ...|||||.+..
T Consensus 432 e~L~~~~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 432 EYLASVPCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred HHHhhCCccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc
Confidence 99999999999999999999977 5799999999986544332210 11122 245999999986
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
..|+.++||||||++||||+| |..||.+.. ..++...+..+.+...|..
T Consensus 496 ----~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~------------------------- 546 (609)
T KOG0200|consen 496 ----RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEH------------------------- 546 (609)
T ss_pred ----CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCC-------------------------
Confidence 789999999999999999998 899999865 6667777888776555532
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
+.+++.+++..||+.+|.+||++.++.+.|....
T Consensus 547 --c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 547 --CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3567899999999999999999999999998753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=305.50 Aligned_cols=258 Identities=26% Similarity=0.318 Sum_probs=218.5
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCee--EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
...+.+++++..||-|+||.|=++..+... +|+|+.+.+..... .+.+. +..|-.||..++.|.||++|-.|.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-kQqeH----v~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-KQQEH----VFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-hHHHH----HHhHHHHHHhcCchHHHHHHHHhc
Confidence 356788899999999999999999987666 78888543332222 23333 378999999999999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
++.++ |++||-|-||.|+..+++ +..|+..+++.++..+++|++|||++|||.|||||+|.
T Consensus 491 d~kyv--------------YmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 491 DSKYV--------------YMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred cchhh--------------hhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 88876 999999999999999987 57899999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||.|||+|+.+.....+ .+++|||.|.|||++.. .....++|.||||+++
T Consensus 552 lLd~~-------Gy~KLVDFGFAKki~~g~KT-----------wTFcGTpEYVAPEIILn----KGHD~avDyWaLGIli 609 (732)
T KOG0614|consen 552 LLDNR-------GYLKLVDFGFAKKIGSGRKT-----------WTFCGTPEYVAPEIILN----KGHDRAVDYWALGILI 609 (732)
T ss_pred eeccC-------CceEEeehhhHHHhccCCce-----------eeecCCcccccchhhhc----cCcchhhHHHHHHHHH
Confidence 99987 56999999999998765443 45789999999999987 6678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++|.+||.+.+++..+..|.++.. -.+| ..+.....+||+++...+|.+
T Consensus 610 ~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P---------------------------r~I~k~a~~Lik~LCr~~P~E 662 (732)
T KOG0614|consen 610 YELLTGSPPFSGVDPMKTYNLILKGIDKIEFP---------------------------RRITKTATDLIKKLCRDNPTE 662 (732)
T ss_pred HHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---------------------------cccchhHHHHHHHHHhcCcHh
Confidence 999999999999999999999988731 1111 223456789999999999999
Q ss_pred CCC-----HHHHHHHHHhh
Q 003375 803 RPT-----AGDLYEMFVAR 816 (825)
Q Consensus 803 RPS-----a~EIL~hL~~l 816 (825)
|.. +.+|-+|-+..
T Consensus 663 RLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 663 RLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred hhccccCChHHHHhhhhhh
Confidence 976 88999986643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=288.87 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=199.9
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHH-HhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~i-Lk~L~HPNIV~l~g~~~~~~ 566 (825)
.+++-+..||.|+||+|++..++ +...|||.++ .... ..+.+ +++.|... ++.-+.||||++||....++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr--~~n~-~keq~----rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIR--SNNI-EKEQK----RLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEee--eccc-hHHHH----HHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 45566788999999999999985 4555666544 3322 23333 44888876 45556999999999988776
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILL 645 (825)
. +||.||+|+ .||..+.+....-....+++..+-.|+...+.||.||-.. .||||||||+|||+
T Consensus 137 d--------------cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl 201 (361)
T KOG1006|consen 137 D--------------CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL 201 (361)
T ss_pred c--------------eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE
Confidence 4 499999997 7988877655555557799999999999999999999876 89999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+..| .+||||||++-.+..... .+.-+|-..|||||.+.... ..|..+|||||||++|||
T Consensus 202 dr~G-------~vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p~~--~gyDiRSDvWSLGITL~E 261 (361)
T KOG1006|consen 202 DRHG-------DVKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDPSD--KGYDIRSDVWSLGITLYE 261 (361)
T ss_pred ecCC-------CEeeecccchHhHHHHHH-----------hhhccCCccccChhccCCcc--CCcchhhhhhhhcceEee
Confidence 9885 499999999976654221 13346889999999997632 358899999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+.||..||.+.+ ..+.+..+..+..|.+... ....+.+..+..+|.-||.+|-..||
T Consensus 262 vAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~----------------------~~~~~~s~~~~~fintCl~Kd~~~Rp 319 (361)
T KOG1006|consen 262 VATGNFPYRKWDSVFEQLCQVVIGDPPILLFD----------------------KECVHYSFSMVRFINTCLIKDRSDRP 319 (361)
T ss_pred eecCCCCcchHHHHHHHHHHHHcCCCCeecCc----------------------ccccccCHHHHHHHHHHhhcccccCc
Confidence 999999998764 3444555555655544321 11223466799999999999999999
Q ss_pred CHHHHHHH
Q 003375 805 TAGDLYEM 812 (825)
Q Consensus 805 Sa~EIL~h 812 (825)
...+++++
T Consensus 320 ky~~Lk~~ 327 (361)
T KOG1006|consen 320 KYDDLKKF 327 (361)
T ss_pred chhhhhcC
Confidence 99998876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=293.71 Aligned_cols=283 Identities=19% Similarity=0.229 Sum_probs=207.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CC----cceee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SC----IVEMY 559 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PN----IV~l~ 559 (825)
.-++|.+...+|+|.||.|-.+.+ .+..+|+||++ .+..+.+..+-|+.+|++|.+ |+ +|++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 357899999999999999999987 45688999853 344555556889999999952 33 67888
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLK 639 (825)
+||...+. .|||+|.+ |-|+.+++.. ++..+++...++.|++||+.+++|||+.+++|-|||
T Consensus 158 ~wFdyrgh--------------iCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK 219 (415)
T KOG0671|consen 158 DWFDYRGH--------------ICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK 219 (415)
T ss_pred hhhhccCc--------------eEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence 88876554 49999999 4799999986 556789999999999999999999999999999999
Q ss_pred CCCEEEecCcc-------------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003375 640 SENILIDLERK-------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706 (825)
Q Consensus 640 P~NILLd~~~~-------------~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~ 706 (825)
|+|||+..... ....+..++|+|||.|....... ...+.|..|.|||++.+
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------------s~iVsTRHYRAPEViLg--- 283 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------------STIVSTRHYRAPEVILG--- 283 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------------ceeeeccccCCchheec---
Confidence 99999865421 12235679999999998654422 34578999999999998
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC------------
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG------------ 774 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~------------ 774 (825)
-.++.++||||+||||+||.||...|++-+..+-+..+..... ++|..+-.-.. ..+.+....+.
T Consensus 284 -LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~ 360 (415)
T KOG0671|consen 284 -LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKY 360 (415)
T ss_pred -cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhh-hHhhhhcccccCccccccccchh
Confidence 6789999999999999999999999987765553333333222 22322211100 00000000000
Q ss_pred -CC-------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 775 -FE-------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 775 -~~-------~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
++ ...........|.+||++||.+||.+|+|+.|+|.|....
T Consensus 361 v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~ 410 (415)
T KOG0671|consen 361 VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFA 410 (415)
T ss_pred hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhh
Confidence 00 0011123345699999999999999999999999997654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=307.46 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=210.3
Q ss_pred ceeeeeecccCceEEEEEEE--C----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--G----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
....++||+|+||+||+|.| . +.+||+|++.-. .......++ +.|+.+|.+|.||||++++|++..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~----LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIEL----LDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHH----HHHHHHHhcCCCchHHHHhhhcccc
Confidence 45678999999999999998 2 357888886422 222233334 9999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. +.||++|+++|+|.+|++. .+..+..+..+.|..||++||.|||.+++|||||-..|+||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 4 3799999999999999986 34678889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
... ..+||.|||+++.+........ .....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~ey~--------~~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKEYS--------APGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCccccccc--------ccccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 877 4599999999998866443311 122234577999999886 789999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+| |..||.+....++.+.+..+.+..-+ +.++-+++-++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqP---------------------------piCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQP---------------------------PICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCC---------------------------CCccHHHHHHHHHHhccCcccCc
Confidence 998 99999999999998888887553222 12355789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
+|+++...+..+...
T Consensus 946 ~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 946 TFKELAEEFSRMARD 960 (1177)
T ss_pred cHHHHHHHHHHHhcC
Confidence 999999998877544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.52 Aligned_cols=224 Identities=21% Similarity=0.148 Sum_probs=171.8
Q ss_pred cCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCccc
Q 003375 501 SVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 578 (825)
Q Consensus 501 G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~ 578 (825)
|.||.||++.+ ++..+|+|...... .+ .+|...+....||||+++++++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~----~~~~~~~~~~~~~~i~~~~~~~~~~~~----------- 59 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EY----SRERLTIIPHCVPNMVCLHKYIVSEDS----------- 59 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hh----hhHHHHHHhcCCCceeehhhheecCCe-----------
Confidence 89999999997 66789999864321 11 345555566679999999999876543
Q ss_pred cceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeE
Q 003375 579 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658 (825)
Q Consensus 579 ~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~v 658 (825)
.++||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+
T Consensus 60 ---~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 60 ---VFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred ---EEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 4999999999999999876 2458999999999999999999999999999999999999877 459
Q ss_pred EEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 003375 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 738 (825)
Q Consensus 659 KL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~ 738 (825)
+|+|||.+....... ....++..|+|||++.. ..++.++||||+||++|||++|..||.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999876553311 11235678999999865 5678899999999999999999988743211
Q ss_pred HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003375 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEM 812 (825)
Q Consensus 739 ~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa-----~EIL~h 812 (825)
. +.......+ +...++.+.+||.+||+.||.+||++ +++++|
T Consensus 188 ~-----~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 188 G-----INTHTTLNI---------------------------PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred h-----cccccccCC---------------------------cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 0 000000000 01134578999999999999999996 777766
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=302.38 Aligned_cols=243 Identities=25% Similarity=0.249 Sum_probs=195.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
..+.|.+...+|.|+|+.|-.+.. .+...++|++.... .. ..+|+.++... +||||+++.+.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--~~----------~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--DD----------NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--cc----------cccccchhhhhcCCCcceeecceecC
Confidence 467899999999999999999987 67788999865331 10 14577666666 59999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+|||++.|+-|.+.+.. .......+..|+.+|+.|+.|||.+|||||||||+|||
T Consensus 388 ~~~--------------~~~v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 388 GKE--------------IYLVMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred Cce--------------eeeeehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 654 4999999999888877765 22333778889999999999999999999999999999
Q ss_pred Ee-cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 645 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
++ .. ++++|+|||.++....... .-.-|..|.|||++.. ..|++++|+||||++|
T Consensus 448 ~~~~~-------g~lrltyFG~a~~~~~~~~-------------tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 448 LDGSA-------GHLRLTYFGFWSELERSCD-------------TPALTLQYVAPEVLAI----QEYTEACDWWSLGVLL 503 (612)
T ss_pred ecCCC-------CcEEEEEechhhhCchhhc-------------ccchhhcccChhhhcc----CCCCcchhhHHHHHHH
Confidence 95 44 5699999999987765311 1246789999999985 7799999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++|+.||...... ++...+..+.. . ..+++..++||.+||+.||.+
T Consensus 504 y~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 504 YEMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred HHHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhh
Confidence 9999999999765433 45555443321 1 234678999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
||++.++..|-+..
T Consensus 554 Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 554 RLGADEIGAHPWFL 567 (612)
T ss_pred CcChhhhccCcchh
Confidence 99999999998873
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=286.93 Aligned_cols=249 Identities=25% Similarity=0.310 Sum_probs=202.9
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeee
Q 003375 484 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 560 (825)
Q Consensus 484 ~d~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g 560 (825)
.+.+...+|.++.+||+|+||.|.+|..+ ...+||||.+..... ..++++-- +.|-++|.... -|.+++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii-QdDDvect----m~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII-QDDDVECT----MVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceee-ecCcccce----ehhhhheecCCCCchHHHHHH
Confidence 44577889999999999999999999874 457899986544322 22333322 56777777664 788999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
.|.+-+. +|+||||+.||+|--.|.+ -..+.+..+..++..|+-||-|||++|||.||||.
T Consensus 418 cFQTmDR--------------LyFVMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 418 CFQTMDR--------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred Hhhhhhh--------------eeeEEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 9887664 4999999999999999887 35688889999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +++||+|||+++.---... .+.++.|||.|+|||++.- .+|+..+|.||||
T Consensus 479 DNvmLd~e-------GHiKi~DFGmcKEni~~~~----------TTkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~G 537 (683)
T KOG0696|consen 479 DNVMLDSE-------GHIKIADFGMCKENIFDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFG 537 (683)
T ss_pred cceEeccC-------CceEeeecccccccccCCc----------ceeeecCCCcccccceEEe----cccccchhHHHHH
Confidence 99999988 5699999999975432221 2456789999999999986 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|+||||+.|++||.+.+..+++..|..... .++. ..+.+..++....|...|
T Consensus 538 VLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPK---------------------------slSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 538 VLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPK---------------------------SLSKEAVAICKGLLTKHP 589 (683)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcc---------------------------cccHHHHHHHHHHhhcCC
Confidence 999999999999999999999998876532 1121 125578889999999999
Q ss_pred CCCCC
Q 003375 801 TERPT 805 (825)
Q Consensus 801 ~eRPS 805 (825)
.+|..
T Consensus 590 ~kRLG 594 (683)
T KOG0696|consen 590 GKRLG 594 (683)
T ss_pred ccccC
Confidence 99953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=262.36 Aligned_cols=238 Identities=33% Similarity=0.436 Sum_probs=187.8
Q ss_pred CceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCcccc
Q 003375 502 VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579 (825)
Q Consensus 502 ~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~ 579 (825)
+||.||+|.+. +..+++|+........ ..+ .+.+|+..+++++|+||+++++.+....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRE----RILREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc---HHH----HHHHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 58999999984 5889999865432211 123 3489999999999999999999987554
Q ss_pred ceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEE
Q 003375 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659 (825)
Q Consensus 580 ~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vK 659 (825)
..+++|||+++++|.+++.. ...++...++.++.+++.+|.|||+.+|+|+||+|.||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKK-----RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 35999999998899999976 2238899999999999999999999999999999999999877 4599
Q ss_pred EeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 003375 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 738 (825)
Q Consensus 660 L~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~-~~~ 738 (825)
|+|||.+........ .....++..|++||.+.+ ..++.++||||||+++|+|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGGL-----------LTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeeccccc-----------cccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999987654321 123458889999999975 5678899999999999999999999977 445
Q ss_pred HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 739 ~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
..+...+.......... ....+..+.+++.+||..+|.+||++.+++++
T Consensus 193 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHhccCCCCccc-------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 44544444332211110 00024578999999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.37 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=202.8
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
.|...+.|..-++||+|+||.||-+.. ++..+|.|....+.. ..+.-+...+.|-.||.+++.+.||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-----Kkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-----KKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-----HHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456778899999999999999998875 677777775332211 1122223458899999999999999998888
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.+.+.+ ++||..|.||+|.-.|.+ .+...|++..++.++.+|+.||++||+++||.|||||+|
T Consensus 255 eTkd~L--------------ClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 255 ETKDAL--------------CLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred cCCCce--------------EEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 877654 999999999999999886 344679999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||+|.. +++.|+|+|+|..+...... ...+||.+|||||++.. ..|+...|.|||||+
T Consensus 318 ILLDd~-------GhvRISDLGLAvei~~g~~~-----------~~rvGT~GYMAPEvl~n----e~Y~~s~Dwf~lGCl 375 (591)
T KOG0986|consen 318 ILLDDH-------GHVRISDLGLAVEIPEGKPI-----------RGRVGTVGYMAPEVLQN----EVYDFSPDWFSLGCL 375 (591)
T ss_pred eeeccC-------CCeEeeccceEEecCCCCcc-----------ccccCcccccCHHHHcC----CcccCCccHHHHHhH
Confidence 999988 45999999999987653321 23489999999999987 669999999999999
Q ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 723 LLELLTLQVPYMGLSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~----~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
||||+.|+.||...... ++-..+... . .+.+...++++.+|.+.+|..
T Consensus 376 lYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~---------------------------~ey~~kFS~eakslc~~LL~K 427 (591)
T KOG0986|consen 376 LYEMIAGHSPFRQRKEKVKREEVDRRTLED-P---------------------------EEYSDKFSEEAKSLCEGLLTK 427 (591)
T ss_pred HHHHHcccCchhhhhhhhhHHHHHHHHhcc-h---------------------------hhcccccCHHHHHHHHHHHcc
Confidence 99999999999654322 222222211 1 111123467899999999999
Q ss_pred CCCCCC-----CHHHHHHHH
Q 003375 799 NPTERP-----TAGDLYEMF 813 (825)
Q Consensus 799 DP~eRP-----Sa~EIL~hL 813 (825)
||.+|. .++++.+|.
T Consensus 428 dp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 428 DPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred CHHHhccCCCcCcchhhhCc
Confidence 999996 466777774
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.52 Aligned_cols=273 Identities=21% Similarity=0.225 Sum_probs=213.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|-++.+||+|||+.||+|.+ ....|||||..+.... ..+..+++..-..+|..|-+.|.||.||++|++|..+.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 36799999999999999999986 6789999998776543 23344556666789999999999999999999998554
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~--gIVHrDLKP~NIL 644 (825)
. .+|-|+|||+|.+|+-||+. ...+++.+++.|+.||+.||.||... .|||-||||.|||
T Consensus 541 d-------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 541 D-------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL 602 (775)
T ss_pred c-------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence 3 35999999999999999987 46799999999999999999999986 6999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
+-... ..+.+||+|||+++.+...... ...+...+.-..||..|++||.+.-.......+.|+||||+|||+|
T Consensus 603 Lv~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 603 LVNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred EecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 96552 3567999999999998765432 1223333444579999999999875444567899999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHH--HHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 725 ELLTLQVPYMGLSE-LEIHDL--IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 725 ELLTG~~PF~~~~~-~~i~~~--I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
..+.|+.||..... .+++.. |.+.....++ ..+.++.+..++|++||.+.-+
T Consensus 676 QClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP-------------------------~KPvVsseAkaFIRRCLaYRKe 730 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDILQENTILKATEVQFP-------------------------PKPVVSSEAKAFIRRCLAYRKE 730 (775)
T ss_pred hhhccCCCCCCchhHHHHHhhhchhcceeccCC-------------------------CCCccCHHHHHHHHHHHHhhhh
Confidence 99999999965432 222211 1111100000 0122456789999999999999
Q ss_pred CCCCHHHHHHH
Q 003375 802 ERPTAGDLYEM 812 (825)
Q Consensus 802 eRPSa~EIL~h 812 (825)
.|....++..+
T Consensus 731 DR~DV~qLA~d 741 (775)
T KOG1151|consen 731 DRIDVQQLACD 741 (775)
T ss_pred hhhhHHHHccC
Confidence 99999998765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=300.94 Aligned_cols=289 Identities=15% Similarity=0.113 Sum_probs=175.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|... ... .. +.+ ..| .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~--~~~--~~--e~~----~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EYG--AV--EIW----MNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec--ccc--hh--HHH----HHH--HHHhhchhhHHHHHH
Confidence 46789999999999999999999973 5678888643 111 11 111 111 122223344444333
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc---------------CCCccCHHHHHHHHHHHHHHH
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------~~~~ls~~~i~~Ia~QIa~AL 625 (825)
.+..... .......+|||||+.+++|.+++...... .........+..++.||+.||
T Consensus 197 ~~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 197 GFLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 3221110 01223569999999999999998751100 001112345678999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||+++|+||||||+|||++.+. ..+||+|||+|+.+..... .......+|+.|||||.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccC
Confidence 999999999999999999998642 4699999999976543211 1123457899999999765321
Q ss_pred CC------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc
Q 003375 706 KP------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 767 (825)
Q Consensus 706 ~~------------------~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~ 767 (825)
.. ..++.++|||||||+||||+++..|+... .......+..... .+......... ..
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~-~~~~~~~~~~~---~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDY-DLVAWRKLVEP---RA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCC-cHHHHHHhhcc---cc
Confidence 10 12345679999999999999977664321 2222222222211 11111000000 00
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 768 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 768 ~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
.......+ ...........+||.+||++||.+|||+.++++|.+....
T Consensus 409 ~~~~~~~~---~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 409 SPDLRRGF---EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred chhhhhhh---hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 00000000 0001123356799999999999999999999999665443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=266.54 Aligned_cols=274 Identities=21% Similarity=0.280 Sum_probs=204.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
...++|++.+++|+|.|+.||.|.. ++..+++|+.+ + -..+. +.+|+.||..|. |||||+++++..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--P-----VkkkK----IkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--P-----VKKKK----IKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--h-----HHHHH----HHHHHHHHHhccCCCCeeehhhhhc
Confidence 4567999999999999999999984 78889999854 2 22233 389999999998 999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... ....||+||+++.+...+.. .++...+..++.+++.||.|+|+.||+|||+||.|+
T Consensus 104 Dp~S------------ktpaLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 104 DPES------------KTPSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred Cccc------------cCchhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 6542 24589999999888777654 377888999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
+|+... -.++|+|+|+|.+...... .+..+.+..|-.||.+-. -..|...-|+|||||+|
T Consensus 164 mIdh~~------rkLrlIDWGLAEFYHp~~e-----------YnVRVASRyfKGPELLVd---y~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 164 MIDHEL------RKLRLIDWGLAEFYHPGKE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 223 (338)
T ss_pred eechhh------ceeeeeecchHhhcCCCce-----------eeeeeehhhcCCchheee---chhccccHHHHHHHHHH
Confidence 999774 4699999999988765332 244567888999999986 35678899999999999
Q ss_pred HHHHhCCCCCC-CCCHHHHHHHHHcC-CCCC-----------chhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 724 LELLTLQVPYM-GLSELEIHDLIQMG-KRPR-----------LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 724 yELLTG~~PF~-~~~~~~i~~~I~~~-~~p~-----------l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
..|+..+.||. |.+..+.+-.|.+. .... ++..+..+..... ......+..++...-.+++..+
T Consensus 224 A~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~---rk~w~~Fi~~~n~hl~~peaiD 300 (338)
T KOG0668|consen 224 ASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHS---RKPWSRFINSENQHLVSPEAID 300 (338)
T ss_pred HHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccc---cccHHHhCCccccccCChHHHH
Confidence 99999999884 43333322232221 1111 2222221111111 1111122233333334578999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
|+.++|.+|..+|+||.|.+.|.-
T Consensus 301 lldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 301 LLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred HHHHHHhhccccccchHHHhcCch
Confidence 999999999999999999999843
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=257.93 Aligned_cols=226 Identities=25% Similarity=0.370 Sum_probs=183.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~ 565 (825)
-+.+..+..||+|+||.|-+.++ ++.-.|+|-++.... ....+ ++++|+.+..+. .+|.+|.|||.+..+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~----r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQK----RLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHH----HHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 34566788999999999887776 677777776544322 22333 348999886655 599999999988766
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NIL 644 (825)
..+ ||.||.++ .||..+-++..+.+ ..+++..+-+|+..|+.||.|||++ .+||||+||+|||
T Consensus 118 gdv--------------wIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiL 181 (282)
T KOG0984|consen 118 GDV--------------WICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNIL 181 (282)
T ss_pred ccE--------------EEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEE
Confidence 654 99999997 79998887765554 6799999999999999999999998 8999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ ++||+||||++-.+...... +...|-..|||||.+...-....|+.++||||||++++
T Consensus 182 In~~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmi 243 (282)
T KOG0984|consen 182 INYD-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMI 243 (282)
T ss_pred EccC-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhh
Confidence 9988 45999999999877543221 22358889999999987666668999999999999999
Q ss_pred HHHhCCCCCCCC-CHHHHHHHHHcCCCCCchh
Q 003375 725 ELLTLQVPYMGL-SELEIHDLIQMGKRPRLTD 755 (825)
Q Consensus 725 ELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~ 755 (825)
||.+++.||... ++.+.+.++.....|.++.
T Consensus 244 ElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 244 EMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 999999999754 7888888888887777663
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.71 Aligned_cols=284 Identities=19% Similarity=0.249 Sum_probs=205.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+.+--+.||.|+||.||.+++ .++.+++|.+. ........ .+++.+|+++|..++|.|++..+++......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s----~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLAS----CKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHH----HHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3455678999999999999997 45667766532 21111122 2455899999999999999999887654321
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.....+|+|+|++. .+|...|-. ...++...++-+++||++||.|||+.+|.||||||.|+|++.
T Consensus 127 ---------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 127 ---------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred ---------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 12345799999996 799998875 467999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +++||||||+++........ . .+.-+-|..|.|||+++| ...|+.+.||||.|||+.||+
T Consensus 192 N-------CvLKICDFGLARvee~d~~~-h--------MTqEVVTQYYRAPEiLMG---aRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 192 N-------CILKICDFGLARTWDQRDRL-N--------MTHEVVTQYYRAPELLMG---ARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred C-------ceEEecccccccccchhhhh-h--------hHHHHHHHHhccHHHhhc---chhhcCccceehhhHHHHHHH
Confidence 7 88999999999876442211 0 112256889999999998 467899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCC------CchhhhhhHHHHHHHHHHhcccCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFE------KPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
.++..|+..++.+..+.|..- ..|... .+..........+.+...+-. ..........+...++..+|.+||
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~E-aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~ 331 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQE-AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDP 331 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHH-HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCC
Confidence 999999999888877777654 333322 222111100011111111100 000111223456788999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003375 801 TERPTAGDLYEMFV 814 (825)
Q Consensus 801 ~eRPSa~EIL~hL~ 814 (825)
.+|.+..+.+.|+-
T Consensus 332 dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 332 DKRISVEEALQHRY 345 (449)
T ss_pred cccccHhhhccccc
Confidence 99999999988753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=274.78 Aligned_cols=286 Identities=22% Similarity=0.254 Sum_probs=203.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-----C---CCcceee
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 559 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-----H---PNIV~l~ 559 (825)
.+|.+.++||-|.|++||+|.+ ..+.||+||.+- .+.|.+..+.||++|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 6899999999999999999997 678899999752 2344555689999999984 2 4699999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 638 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDL 638 (825)
+.|...+. ...++++|+|++ |-+|..+|.. ...+.++...++.|++||+.||.|||.+ ||||-||
T Consensus 149 D~FkhsGp----------NG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSGP----------NGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecCC----------CCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 99987653 345889999999 6799999986 3345699999999999999999999987 9999999
Q ss_pred CCCCEEEecCcc--------------------------------------------------------------------
Q 003375 639 KSENILIDLERK-------------------------------------------------------------------- 650 (825)
Q Consensus 639 KP~NILLd~~~~-------------------------------------------------------------------- 650 (825)
||+|||+.....
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 999999954410
Q ss_pred ------------------------------------------C-------------------------------------
Q 003375 651 ------------------------------------------K------------------------------------- 651 (825)
Q Consensus 651 ------------------------------------------~------------------------------------- 651 (825)
.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 0
Q ss_pred ------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003375 652 ------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719 (825)
Q Consensus 652 ------------~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSL 719 (825)
......+||+|||.|.-.... .+.-+.|..|.|||++.+ ..|++.+||||+
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-------------FT~DIQTRQYRapEVllG----sgY~~~ADiWS~ 437 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-------------FTEDIQTRQYRAPEVLLG----SGYSTSADIWST 437 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhh-------------hchhhhhhhccCcceeec----CCCCCchhHHHH
Confidence 000123556666655433221 112257899999999998 789999999999
Q ss_pred HHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCCCchhHHhhhccCccccccccC----------CC------CCC
Q 003375 720 GCLLLELLTLQVPYMGL------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG----------SG------FEK 777 (825)
Q Consensus 720 GvILyELLTG~~PF~~~------~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~----------~~------~~~ 777 (825)
+|++|||+||...|... .+.+-+..|..-. -.+|..+..-... ...+.+.. +. .++
T Consensus 438 AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL-G~iPr~ia~~Gk~-SRdFFnr~G~LrhI~~LK~WpL~~VL~eK 515 (590)
T KOG1290|consen 438 ACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL-GKIPRKIALGGKY-SRDFFNRRGELRHIRRLKPWPLYEVLIEK 515 (590)
T ss_pred HHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH-hhccHHHHhcCcc-hHhhhccccceecccccCCCcHHHHHHHH
Confidence 99999999999998421 1222222222210 0112211111111 11111111 00 122
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 778 ~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.....+...++.+||.-||+.+|.+||||.++|+|.+-..
T Consensus 516 Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 516 YEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred hCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccC
Confidence 3344566788999999999999999999999999977553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=299.74 Aligned_cols=258 Identities=26% Similarity=0.334 Sum_probs=191.2
Q ss_pred ceeeeeecccCce-EEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSS-SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG-~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~~ 569 (825)
|.-.+.+|.|+.| .||+|.+.++.||||-+. .++.....+||..|+.-. |||||++|+.-.+...
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-- 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-- 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCce--
Confidence 3446778999998 589999999999999642 122223489999999986 9999999987665553
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCc
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 649 (825)
+||..|.|. .+|.+++... ............+.++.|++.||++||+.+||||||||.||||+...
T Consensus 578 ------------~YIalELC~-~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 578 ------------LYIALELCA-CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred ------------EEEEehHhh-hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 599999997 7999999862 11111111145678899999999999999999999999999998742
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 650 ~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
.++...++|+|||+++.+........ ......||-+|+|||++.. ..-+.++|||||||++|+.++|
T Consensus 644 --~~~~~ra~iSDfglsKkl~~~~sS~~-------r~s~~sGt~GW~APE~L~~----~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 644 --ADGTLRAKISDFGLSKKLAGGKSSFS-------RLSGGSGTSGWQAPEQLRE----DRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred --CCcceeEEecccccccccCCCcchhh-------cccCCCCcccccCHHHHhc----cccCcccchhhcCceEEEEecC
Confidence 33557899999999998865432211 1244579999999999987 3346699999999999999996
Q ss_pred -CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 730 -QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 730 -~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
.+||...-. ....|..+...-.. + ....+ .+..+||.+|+.++|..||+|.+
T Consensus 711 G~HpFGd~~~--R~~NIl~~~~~L~~-----L------------------~~~~d--~eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 711 GSHPFGDSLE--RQANILTGNYTLVH-----L------------------EPLPD--CEAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred CccCCCchHH--hhhhhhcCccceee-----e------------------ccCch--HHHHHHHHHhcCCCcccCCCHHH
Confidence 899964422 22334443211000 0 00001 16899999999999999999999
Q ss_pred HHHHHHhh
Q 003375 809 LYEMFVAR 816 (825)
Q Consensus 809 IL~hL~~l 816 (825)
||.|....
T Consensus 764 VL~HPlFW 771 (903)
T KOG1027|consen 764 VLNHPLFW 771 (903)
T ss_pred HhCCCccC
Confidence 99996544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=285.93 Aligned_cols=276 Identities=21% Similarity=0.276 Sum_probs=210.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC------CCCcceeeee
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 561 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~------HPNIV~l~g~ 561 (825)
.+|.+....|+|-|++|.+|.+ .+..|||||+.-.. .-.+.- ++|+.||++|+ --|+++++-.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtG----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTG----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhh----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 5788999999999999999997 56799999975322 111222 78999999995 3578999988
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
|...+ ++|||+|-+. .+|.++|+++.. ...|....+..++.|+..||..|-+.||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 87555 5699999996 899999998533 245788899999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||+++.. .++||||||.|........+. ..-+..|.|||++.| .+|....|+||+||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneitP------------YLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEITP------------YLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCccccccccccccH------------HHHHHhccCcceeec----CcccCCccceeece
Confidence 99998774 589999999998776543332 234678999999998 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccc--------------c-----ccCCC--------
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV--------------A-----QSGSG-------- 774 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~--------------~-----~~~~~-------- 774 (825)
+||||.||+..|+|.+..+++........+ ++..+-.-..+....| + .....
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk-~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~ 702 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGK-FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLG 702 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCC-CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHH
Confidence 999999999999999888877665543222 1111111000000000 0 00000
Q ss_pred ------CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 775 ------FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 775 ------~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
-..+.....+..+|.+||.+||..||++|.|..++|+|..
T Consensus 703 s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 703 SELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence 0134445566788999999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=284.55 Aligned_cols=293 Identities=16% Similarity=0.150 Sum_probs=186.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------------------CCeeEEEEEEecccCCCChHHH------HhhHHhHHH
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEI------RNFEYSCLG 542 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~------------------~~~~vAVKI~~lk~~~~~~~~~------~~~~~~~lr 542 (825)
...++|.+.++||+|+||.||+|.. .+..||||.+.........+.. ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577999999999999999999964 2356888886543221111000 001122356
Q ss_pred HHHHHhhCCCCCc-----ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc--------------
Q 003375 543 EVRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------- 603 (825)
Q Consensus 543 Ev~iLk~L~HPNI-----V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------- 603 (825)
|+.++.+++|.++ ++++++|..... +........+|||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~------~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~ 295 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTA------DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGK 295 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccc------cccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCC
Confidence 7788888876654 677777754211 011112346999999999999999874210
Q ss_pred -----cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccccccccccc
Q 003375 604 -----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678 (825)
Q Consensus 604 -----~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~ 678 (825)
.....+++..++.++.||+.||.|||+++|+||||||+|||++.+ ..+||+|||++.........
T Consensus 296 ~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~--- 365 (507)
T PLN03224 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF--- 365 (507)
T ss_pred chhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc---
Confidence 011234677889999999999999999999999999999999877 45999999999654321111
Q ss_pred ccCCCCCCCcccCCCcccchhhhhcccCCC------------------CCCchhhHHHHHHHHHHHHhCCC-CCCCCCHH
Q 003375 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN------------------LYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 739 (825)
Q Consensus 679 s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~------------------~~s~kSDVWSLGvILyELLTG~~-PF~~~~~~ 739 (825)
......+|+.|+|||.+....... ....+.||||+||+||+|+++.. ||.+....
T Consensus 366 ------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f 439 (507)
T PLN03224 366 ------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF 439 (507)
T ss_pred ------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh
Confidence 011224589999999986421100 01235799999999999999875 76543221
Q ss_pred HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhh
Q 003375 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMFVAR 816 (825)
Q Consensus 740 ~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP---~eRPSa~EIL~hL~~l 816 (825)
... +... ...+ ..+... ......+ ......++..++|+.+||..+| .+|+|++|+|+|.+..
T Consensus 440 ~~~--~~~~-~~~~-~~~r~~--------~~~~~~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 440 NTE--LRQY-DNDL-NRWRMY--------KGQKYDF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hhH--Hhhc-cchH-HHHHhh--------cccCCCc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 110 0000 0000 000000 0000001 0122346789999999999866 6899999999997654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=279.35 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=193.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
-|..++.||-|+||.|.+++- ....+|.|..+.+.. ..++-..-+..|-.||.....+-||++|-.|.+.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 377899999999999999985 455667776432211 1111112347788999999999999999999988765
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
|+||+|++||++-.+|-+ ...|.+..++.++..+..|+++.|+.|+|||||||+|||||.+
T Consensus 705 --------------YFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 705 --------------YFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD 765 (1034)
T ss_pred --------------EEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC
Confidence 999999999999999986 4679999999999999999999999999999999999999998
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccC--------------------------------CCCCCCcccCCCccc
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR--------------------------------GIPAPDVCVGTPRWM 696 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~--------------------------------~~~~~~~~vGT~~Ym 696 (825)
+++||+|||++.-+.......++... ........+||+.|+
T Consensus 766 -------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 766 -------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred -------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 46999999999755332222111100 001123458999999
Q ss_pred chhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCC
Q 003375 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGF 775 (825)
Q Consensus 697 APEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~ 775 (825)
|||++.. ..++.-+|.||.|||||||+.|++||...++.+....+.+. ....++
T Consensus 839 apevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~--------------------- 893 (1034)
T KOG0608|consen 839 APEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP--------------------- 893 (1034)
T ss_pred ChHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc---------------------
Confidence 9999986 67899999999999999999999999887766544443322 111111
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHH
Q 003375 776 EKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMF 813 (825)
Q Consensus 776 ~~~~~~~~~s~~L~dLI~~CL~~DP~eRP---Sa~EIL~hL 813 (825)
...+.+.+..+||.++. -+++.|. -+++|..|-
T Consensus 894 ----~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHp 929 (1034)
T KOG0608|consen 894 ----YQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHP 929 (1034)
T ss_pred ----cccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCc
Confidence 11223556777877654 3677775 355566663
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=263.60 Aligned_cols=279 Identities=19% Similarity=0.217 Sum_probs=203.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-.+|.-+..+|.|+- .|--|.+ .+..||+|....... .....+ +..+|..++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~ak----ra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAK----RAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccch----hhhhhhhhhhhhcccceeeeeeccCccc
Confidence 356777888899988 6666665 567777776533321 122222 3389999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......|+||||+. .+|...+.. .++-+++..|++|++.|+.|||+.||+||||||+||++.
T Consensus 89 ~l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 89 TL--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred cH--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence 32 23446799999997 799999873 477789999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +++||.|||+|+...... ..+..+.|..|.|||++.+ ..+.+.+||||+||++.||
T Consensus 153 ~~-------~~lKi~dfg~ar~e~~~~-----------~mtpyVvtRyyrapevil~----~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 153 SD-------CTLKILDFGLARTEDTDF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred ch-------hheeeccchhhcccCccc-----------ccCchhheeeccCchheec----cCCcccchhhhhhhHHHHH
Confidence 87 679999999998654431 1234578999999999998 4488999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccC------cccc---------ccccCCCCCCchhhhhhHHHHHHH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC------HEHE---------VAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
++|...|.|.+..+.+.++.......-+..+..+... ..++ +.+..... ..+...-....+.+|
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~-~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV-VLEGSKLDCSLARDL 289 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccc-cccCCccchHHHHHH
Confidence 9999999988766655555443222222222221110 0000 11111100 111112335678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 003375 792 FRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL 813 (825)
+.+||..||++|.+++++|.|.
T Consensus 290 l~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhccChhhcccHHHHhcCC
Confidence 9999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=287.22 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=211.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+-++|.+.+.+|.|+||.||+|++ .+..+|+|++++.... ....+ .+|+-+++..+|||||.++|.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~i----qqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGI----QQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----ccccc----ccceeeeecCCCcChHHHHhhhhhh
Confidence 456899999999999999999997 6788999998876543 23333 7899999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
..+ ||+||||.||+|.+.-.- ...+++.++..+.+..++||+|||+.|-+|||||-.|||+
T Consensus 85 dkl--------------wicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 85 DKL--------------WICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred cCc--------------EEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 644 999999999999997654 4789999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+..++ +||.|||.+..+..... ....+.||+.|||||+..- ...+.|+..+|||++|++..|
T Consensus 146 td~gD-------vklaDfgvsaqitati~----------KrksfiGtpywmapEvaav-erkggynqlcdiwa~gitAie 207 (829)
T KOG0576|consen 146 TDEGD-------VKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIWALGITAIE 207 (829)
T ss_pred cccCc-------eeecccCchhhhhhhhh----------hhhcccCCccccchhHHHH-Hhcccccccccccccccchhh
Confidence 98854 99999999877654322 2356789999999999753 234678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC--CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|-.-++|.....+++....+.+.. .|.+.+ ....++.+.+|++.+|..+|++|
T Consensus 208 l~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD-------------------------k~kws~~fh~fvK~altknpKkR 262 (829)
T KOG0576|consen 208 LGELQPPLFDLHPMRALFLMTKSGFQPPTLKD-------------------------KTKWSEFFHNFVKGALTKNPKKR 262 (829)
T ss_pred hhhcCCcccccchHHHHHHhhccCCCCCcccC-------------------------CccchHHHHHHHHHHhcCCCccC
Confidence 999999988888887776665542 222221 11225678999999999999999
Q ss_pred CCHHHHHHH
Q 003375 804 PTAGDLYEM 812 (825)
Q Consensus 804 PSa~EIL~h 812 (825)
|+++.+|.|
T Consensus 263 ptaeklL~h 271 (829)
T KOG0576|consen 263 PTAEKLLQH 271 (829)
T ss_pred CChhhheec
Confidence 999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=262.62 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=210.3
Q ss_pred CCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
.++++...+-+|.||.||+|.|.. +.|.+|. ++. ..+.-+... ++.|.-+|..+.|||+.++.++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKT--vk~-~AS~iQv~~----~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKT--VKQ-HASQIQVNL----LLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHH--HHh-cccHHHHHH----HHHHHHHHhcCcCCCccceeEEE
Confidence 457788889999999999997732 3344443 221 222333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh---ccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~---~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLK 639 (825)
.++... .++++.+..-|+|..|+.... ....+.++..+...++.|++.|++|||++||||.||-
T Consensus 357 ie~~~~-------------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiA 423 (563)
T KOG1024|consen 357 IEDYAT-------------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIA 423 (563)
T ss_pred eeccCc-------------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhh
Confidence 875543 489999998899999998432 2334567778889999999999999999999999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSL 719 (825)
..|.+|++. ..|||+|=.+++.+-.....+ ....+ .....||+||.+.. ..|+.++|||||
T Consensus 424 aRNCvIdd~-------LqVkltDsaLSRDLFP~DYhc-LGDnE-------nRPvkWMslEal~n----~~yssasDvWsf 484 (563)
T KOG1024|consen 424 ARNCVIDDQ-------LQVKLTDSALSRDLFPGDYHC-LGDNE-------NRPVKWMSLEALQN----SHYSSASDVWSF 484 (563)
T ss_pred hhcceehhh-------eeEEeccchhccccCcccccc-cCCCC-------CCcccccCHHHHhh----hhhcchhhhHHH
Confidence 999999876 679999999998775543332 22211 24578999999987 789999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 720 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 720 GvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
||+||||+| |+.||...++.++...+..+.+-.-| .++++++..++.-||..
T Consensus 485 GVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWal 537 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWAL 537 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhc
Confidence 999999998 89999999999999999988663322 34578999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003375 799 NPTERPTAGDLYEMFVART 817 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ 817 (825)
.|++||+++|+..-|.+..
T Consensus 538 lpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 538 LPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CcccCCCHHHHHHHHHHHH
Confidence 9999999999999987764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=260.23 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=195.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..+++|.++.+||+|+|+.|.+++. ..+-+|+|+++..... ..+++ ..+..|-.++.+. +||.+|-+..+|.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n-ddedi----dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN-DDEDI----DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC-Ccccc----hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 4678999999999999999999987 5667889986533222 22222 2346677777666 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
++..+ ++|.||++||+|.-.+.+ ...++++.++.+...|+.||.|||++|||.||||.+|+
T Consensus 322 tesrl--------------ffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 322 TESRL--------------FFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ccceE--------------EEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 87754 999999999999877765 36799999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.. +.+||+|+|+++.--....+ +.++.|||.|.|||++++ ..|+..+|.|+|||+|
T Consensus 383 lldae-------ghikltdygmcke~l~~gd~----------tstfcgtpnyiapeilrg----eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 383 LLDAE-------GHIKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLM 441 (593)
T ss_pred EEccC-------CceeecccchhhcCCCCCcc----------cccccCCCcccchhhhcc----cccCceehHHHHHHHH
Confidence 99988 46999999999764332222 356789999999999998 7899999999999999
Q ss_pred HHHHhCCCCCCC-------CCHHH-HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003375 724 LELLTLQVPYMG-------LSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795 (825)
Q Consensus 724 yELLTG~~PF~~-------~~~~~-i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~C 795 (825)
+||+.|+.||.- .+..+ +++.|... .-.++..+ +-....+++.-
T Consensus 442 femmagrspfdivgm~n~d~ntedylfqvilek-qiriprsl---------------------------svkas~vlkgf 493 (593)
T KOG0695|consen 442 FEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIPRSL---------------------------SVKASHVLKGF 493 (593)
T ss_pred HHHHcCCCCcceecCCCcccchhHHHHHHHhhh-ccccccee---------------------------ehhhHHHHHHh
Confidence 999999999952 12222 23333322 11222211 23456788999
Q ss_pred cccCCCCCCC------HHHHHHH
Q 003375 796 TEENPTERPT------AGDLYEM 812 (825)
Q Consensus 796 L~~DP~eRPS------a~EIL~h 812 (825)
|.+||.+|.. +.++..|
T Consensus 494 lnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 494 LNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred hcCCcHHhcCCCcccchhhhhcc
Confidence 9999999953 5555554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=232.83 Aligned_cols=212 Identities=34% Similarity=0.491 Sum_probs=175.5
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
||.|++|.||++... +..+++|++....... . ...+.+|+.+++.++|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---L----LEELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---H----HHHHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999986 7889999876432211 1 233489999999999999999999987653
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec-CccCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 654 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~~~~~~ 654 (825)
..+++|||+.+++|.+++... ...++...++.++.+++.+|.+||+.|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 359999999999999999861 136889999999999999999999999999999999999997 4
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003375 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734 (825)
Q Consensus 655 ~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~ 734 (825)
..++|+|||.+........ ......+...|++||.+... ...+.+.|+|+||+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 4599999999976644221 01223578899999998751 2678899999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 735 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 735 ~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
..+.+++.+|+..+|.+||++.+++++|
T Consensus 188 ---------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 0478899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=271.87 Aligned_cols=206 Identities=26% Similarity=0.371 Sum_probs=169.6
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCC----CChHHHHhhHHhHHHHHHHHhhCC---CCCc
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG----SSADEIRNFEYSCLGEVRMLGALR---HSCI 555 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~----~~~~~~~~~~~~~lrEv~iLk~L~---HPNI 555 (825)
.+..+.+|..++.||.|+||.|++|.++ ...|++|.+...... ......- .+-.|+.||..|+ |+||
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLG----tVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLG----TVPSEIQILATLNKHSHENI 631 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccC----ccchhHHHHHHhhhcCccch
Confidence 3467888999999999999999999984 456666664322111 0111111 2367999999998 9999
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEccc-CCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~-~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
++++++|++++++ ||+||-- +|.+|.++|.. ...+++.++..|++||+.|+++||.+|||
T Consensus 632 lKlLdfFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~iv 692 (772)
T KOG1152|consen 632 LKLLDFFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIV 692 (772)
T ss_pred hhhhheeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCce
Confidence 9999999988876 9999975 46799999986 46799999999999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
|||||-+|+.++.+ +.+||+|||.|...... ....++||..|.|||++.| ..+.+..-
T Consensus 693 hrdikdenvivd~~-------g~~klidfgsaa~~ksg------------pfd~f~gtv~~aapevl~g---~~y~gk~q 750 (772)
T KOG1152|consen 693 HRDIKDENVIVDSN-------GFVKLIDFGSAAYTKSG------------PFDVFVGTVDYAAPEVLGG---EKYLGKPQ 750 (772)
T ss_pred ecccccccEEEecC-------CeEEEeeccchhhhcCC------------CcceeeeeccccchhhhCC---CccCCCcc
Confidence 99999999999977 56999999998765442 2356789999999999987 45668899
Q ss_pred hHHHHHHHHHHHHhCCCCCCC
Q 003375 715 DIWSYGCLLLELLTLQVPYMG 735 (825)
Q Consensus 715 DVWSLGvILyELLTG~~PF~~ 735 (825)
|||++|++||.++....||.+
T Consensus 751 diwalgillytivykenpyyn 771 (772)
T KOG1152|consen 751 DIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhhhheeeEEEeccCCCcC
Confidence 999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=231.41 Aligned_cols=213 Identities=32% Similarity=0.441 Sum_probs=171.5
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|.+.+.||.|++|.||++... +..+++|+....... ... ..+.+|+..+++++|+||+++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-- 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQR----EEFLREIRILKKLKHPNIVKLYGVFEDPEP-- 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHH----HHHHHHHHHHHhCCCCChhhheeeeecCCc--
Confidence 567899999999999999984 578999987543221 122 344899999999999999999999876543
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCc-cCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~-ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.+++|||+++++|.+++... .. +++..+..++.+++.+|.|||+.+++|+||+|.||+++..
T Consensus 72 ------------~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 72 ------------LYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred ------------eEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 49999999989999999861 22 7899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|+|||.+......... ......++..|++||.+. ....++.++|||+||+++|+|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLAA---------LLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCcccc---------cccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 45999999998876543200 112345788999999984 23567779999999999999999
Q ss_pred CCCCCCC-C-CHHHHHHHHHcCC
Q 003375 729 LQVPYMG-L-SELEIHDLIQMGK 749 (825)
Q Consensus 729 G~~PF~~-~-~~~~i~~~I~~~~ 749 (825)
|+.||.. . +...+.+.+..+.
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCC
Confidence 9999977 3 3446667776664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=252.91 Aligned_cols=287 Identities=23% Similarity=0.312 Sum_probs=195.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g 560 (825)
...+.|.++++||.|.|++||++.. ....||+|-+... ... .++..|+++|..+. +.||+.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p--------~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSP--------SRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCc--------hHHHHHHHHHHHhccchhhhcchh
Confidence 3456789999999999999999985 4567888875432 111 13488999999997 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++...+. ..+||||++.....++... ++...+..+++.++.||.++|.+|||||||||
T Consensus 103 ~~rnnd~--------------v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKp 160 (418)
T KOG1167|consen 103 CFRNNDQ--------------VAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKP 160 (418)
T ss_pred hhccCCe--------------eEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCc
Confidence 9886664 4999999999999998875 77899999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccc-cccc---------------------------------cCCCCCC
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT-CCIA---------------------------------HRGIPAP 686 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~-~~~s---------------------------------~~~~~~~ 686 (825)
.|+|.+... ..-.|+|||+|......... .... .......
T Consensus 161 sNFL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 161 SNFLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 999998764 35789999999732111100 0000 0000011
Q ss_pred CcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHH-HHHHH--------H-----cCC--
Q 003375 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS-ELE-IHDLI--------Q-----MGK-- 749 (825)
Q Consensus 687 ~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~-~~~-i~~~I--------~-----~~~-- 749 (825)
-..+||++|.|||++... ...++++||||.|||+.-+++++.||.... +.. +.+.+ . .+.
T Consensus 235 anrAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~ 311 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL 311 (418)
T ss_pred cccCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee
Confidence 134799999999999863 445889999999999999999999995321 111 11110 0 011
Q ss_pred ------CCCchhHHhhhccCccccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 750 ------RPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 750 ------~p~l~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
.+.+++....+.+..-........ ...........+..+.+|+.+||..||.+|.|+++.|+|..
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 111121111111111000000000 01111112223447899999999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=236.04 Aligned_cols=254 Identities=19% Similarity=0.241 Sum_probs=185.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeE-ec
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK-IS 564 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~-~~ 564 (825)
.+.|.+.+.||+|.||.+.+|.+. ++.+++|.+... ....+.| .+|...--.|. |.||+..|++- .+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF----~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADF----VREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHH----HHHhccceeeccchhhhHHHHHHhhc
Confidence 357899999999999999999984 456777765321 2233444 88887766665 99999887654 33
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. .+++|||++.|+|.+-+.. ..+.+....+++.|+++||.|+|++++||||||.+|||
T Consensus 94 ~d~--------------YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiL 153 (378)
T KOG1345|consen 94 SDA--------------YVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENIL 153 (378)
T ss_pred Cce--------------EEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEE
Confidence 333 3899999999999988764 45788889999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~-~~~s~kSDVWSLGvIL 723 (825)
|...+ -..+||||||+.+..+..-.. .--+..|.+||.......+ -...+.+|||.||+++
T Consensus 154 if~~d-----f~rvKlcDFG~t~k~g~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 154 IFDAD-----FYRVKLCDFGLTRKVGTTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred EecCC-----ccEEEeeecccccccCceehh-------------hhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 97663 258999999998766542211 1245679999988654222 2357889999999999
Q ss_pred HHHHhCCCCCCCCCHH----HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 724 LELLTLQVPYMGLSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 724 yELLTG~~PF~~~~~~----~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|.++||.+||+..... .-+.++.....+.+|+.+ ...++.+..++++-|.++
T Consensus 216 f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F------------------------~~fs~~a~r~Fkk~lt~~ 271 (378)
T KOG1345|consen 216 FYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF------------------------NPFSEKALRLFKKSLTPR 271 (378)
T ss_pred eeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh------------------------cccCHHHHHHHHHhcCCc
Confidence 9999999999743211 123333444444444322 233567888999999999
Q ss_pred CCCC---CCHHHHHHHH
Q 003375 800 PTER---PTAGDLYEMF 813 (825)
Q Consensus 800 P~eR---PSa~EIL~hL 813 (825)
|++| .++......+
T Consensus 272 ~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 272 FKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ccccchhHHHHHHHHHH
Confidence 9999 4444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=276.94 Aligned_cols=224 Identities=13% Similarity=0.130 Sum_probs=149.2
Q ss_pred HhhCCC-CCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHH
Q 003375 547 LGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 547 Lk~L~H-PNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
.+.+.| +||.+++++|..... ++ .....++++|||+. ++|.++|.. ....+++..++.+++||+.||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al 93 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNL----DG---LDDDSIVRALECED-VSLRQWLDN----PDRSVDAFECFHVFRQIVEIV 93 (793)
T ss_pred cchhhHHHHHHHhhcccCCccc----cc---cccchhhhhhccCC-ccHHHHHhc----ccccccHHHHHHHHHHHHHHH
Confidence 345556 688888888743221 00 01123578889885 799999974 235689999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccC------------CCCCCeEEEeecCCcccccccccc---cccc-c--CCCCCCC
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIA-H--RGIPAPD 687 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~---~~~s-~--~~~~~~~ 687 (825)
.|||++||+||||||+||||+..+.. .+....+||+|||+++........ .... . .......
T Consensus 94 ~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 94 NAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 99999999999999999999653210 012345788888887653211000 0000 0 0000112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccc
Q 003375 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 767 (825)
Q Consensus 688 ~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~ 767 (825)
..+||+.|||||++.+ ..++.++|||||||+||||++|.+|+.... .....+.....+. .
T Consensus 174 ~~~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~---~----------- 233 (793)
T PLN00181 174 LAMEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP---Q----------- 233 (793)
T ss_pred ccCCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh---h-----------
Confidence 2468999999999986 668999999999999999999988875321 1222221111110 0
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 768 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 768 ~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.........+++.+||.++|.+||++.||++|.+-
T Consensus 234 -------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 234 -------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred -------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 00012345688899999999999999999998653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=217.86 Aligned_cols=170 Identities=24% Similarity=0.290 Sum_probs=128.1
Q ss_pred CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 592 GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++.....
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 689999975 1346999999999999999999999998 9999999877 45888 999876543
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC
Q 003375 672 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR 750 (825)
Q Consensus 672 ~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~-~~i~~~I~~~~~ 750 (825)
. ...||+.|||||++.+ ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1148899999999986 6688999999999999999999999976533 223333322211
Q ss_pred CCchhHHhhhccCccccccccCCCCCCchhhhhhHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 751 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS--FLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 751 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
+..+.. ......... .+.++|.+||..+|.+||++.++++|+..+....
T Consensus 123 ~~~~~~---------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 123 ADDPRD---------------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred cCCccc---------------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 111100 000111222 6899999999999999999999999998875443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-22 Score=221.36 Aligned_cols=272 Identities=21% Similarity=0.220 Sum_probs=195.5
Q ss_pred CceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC----CCcceeeeeEe
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 563 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H----PNIV~l~g~~~ 563 (825)
+|.+.+.||+|+||.||++.... ..+|+|+.......... . +..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~----~----l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS----V----LKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc----c----chhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999744 36899987543222111 1 2668888888863 68888888874
Q ss_pred -cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 564 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 564 -~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...+ .||||+.+ |.+|.++.... ....++..++..|+.|++.+|.+||+.|++||||||.|
T Consensus 91 ~~~~~--------------~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STEDF--------------NFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCce--------------eEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 3332 39999999 68999988652 24789999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCccccc--ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~--~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+++..... .....+.|.|||+++... ...... ..........+.||..|+++.+..+ ...+.+.|+||++
T Consensus 153 ~~~g~~~~--~~~~~~~llDfGlar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~ 224 (322)
T KOG1164|consen 153 FVVGQSSR--SEVRTLYLLDFGLARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLF 224 (322)
T ss_pred eeecCCCC--cccceEEEEecCCCccccccCCCCcc--cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHH
Confidence 99986531 112469999999998332 222110 0011111234569999999999887 6678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
.++.||+.|..||.+.........+........... .....+..+..++..+-..+.
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~ 281 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDY 281 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCC
Confidence 999999999999977654322222222111000000 001123466777777777999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003375 801 TERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ss 819 (825)
..+|....+...|+.....
T Consensus 282 ~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 282 EDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cCCCCHHHHHHHHHHHHHh
Confidence 9999999999988766544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-22 Score=204.13 Aligned_cols=269 Identities=32% Similarity=0.409 Sum_probs=197.2
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCC-CcceeeeeEecCCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 570 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HP-NIV~l~g~~~~~~~~~~ 570 (825)
|.+.+.||.|+||.||++.+. ..+++|+......... .....+.+|+.++..+.|+ +|+++++.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEGS--- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE---
Confidence 788999999999999999988 6788888654332221 1233458999999999988 79999999854332
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
.+++++|+.+++|.+++...... ..+.......++.|++.++.|+|..+++||||||+||+++..+
T Consensus 73 -----------~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~- 138 (384)
T COG0515 73 -----------LYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG- 138 (384)
T ss_pred -----------EEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC-
Confidence 59999999999999777651100 2688999999999999999999999999999999999998773
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
..++++|||.+............. .......||..|+|||.+.+.. ...+....|+||+|++++++++|.
T Consensus 139 -----~~~~l~dfg~~~~~~~~~~~~~~~----~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 139 -----RVVKLIDFGLAKLLPDPGSTSSIP----ALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred -----CeEEEeccCcceecCCCCcccccc----ccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCC
Confidence 159999999998554322110000 1134567999999999997511 035788999999999999999999
Q ss_pred CCCCCCCH----HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 731 VPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 731 ~PF~~~~~----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
.||..... ......+.....+...... ...........+.+++.+|+..+|..|.+.
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 209 PPFEGEKNSSATSQTLKIILELPTPSLASPL-------------------SPSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccc-------------------CccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 99876653 4444444443322000000 000001223568899999999999999999
Q ss_pred HHHHHH
Q 003375 807 GDLYEM 812 (825)
Q Consensus 807 ~EIL~h 812 (825)
.+...+
T Consensus 270 ~~~~~~ 275 (384)
T COG0515 270 SSDLSH 275 (384)
T ss_pred HHHhhc
Confidence 887775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=207.54 Aligned_cols=224 Identities=22% Similarity=0.262 Sum_probs=179.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
-..|.++++||+|+||.++.|+. ++..||+|....+. ..+. +..|.+..+.|. .++|..+|-+..+.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQ-------LrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQ-------LRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC---Ccch-------HHHHHHHHHHHcCCCCCCceeeecccc
Confidence 35799999999999999999985 89999999765442 2222 266888888886 79999988776554
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.+- .||||++ |.||++++.- ....|+.+++..++.|++.-++|+|.+.+|.|||||+|+||
T Consensus 97 ~~N--------------iLVidLL-GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLI 157 (449)
T KOG1165|consen 97 KYN--------------ILVIDLL-GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLI 157 (449)
T ss_pred chh--------------hhhhhhh-CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceee
Confidence 432 8999999 6899999875 56789999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
...+. .....+.|+|||+|+.+........ .+........||..||+--...+ ..-+.+-|+-|||-++..
T Consensus 158 Grp~~--k~~n~IhiiDFGmAK~YrDp~TkqH---IPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmY 228 (449)
T KOG1165|consen 158 GRPGT--KDANVIHIIDFGMAKEYRDPKTKQH---IPYREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMY 228 (449)
T ss_pred cCCCC--CCCceEEEEeccchhhhcCcccccc---CccccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhh
Confidence 87643 2345799999999998876554332 22233456679999999988877 556889999999999999
Q ss_pred HHhCCCCCCCCC---HHHHHHHHHcCCC
Q 003375 726 LLTLQVPYMGLS---ELEIHDLIQMGKR 750 (825)
Q Consensus 726 LLTG~~PF~~~~---~~~i~~~I~~~~~ 750 (825)
.|-|.+||++.. ..+.++.|....+
T Consensus 229 FLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 229 FLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hccCCCccccccCcchHHHHHHhccccc
Confidence 999999998864 4456666766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=198.95 Aligned_cols=222 Identities=18% Similarity=0.209 Sum_probs=173.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC-CCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H-PNIV~l~g~~~ 563 (825)
+..++|.++++||.|+||.+|+|.. .+..||+|+...+... + . +..|..+...|++ ..|..+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---p---q----L~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---P---Q----LLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---c---c----hhHHHHHHHHhccCCCCchhhhhcc
Confidence 5678999999999999999999986 7899999986533211 1 1 2679999999974 66666666665
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+..+- .+||+++ |.||.+++.- ....|+..+++-++-|++.-++|+|.+++|||||||+|+
T Consensus 82 e~~yn--------------vlVMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 82 EKDYN--------------VLVMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccccc--------------eeeeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 55433 8999999 6899999874 456799999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|..-+. ....+.|+|||+|+.+....... +.+........||..|.+--...+ ...+.+.|+-|+|.+|
T Consensus 143 LMGlgr----h~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 143 LMGLGR----HCNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVL 211 (341)
T ss_pred eecccc----ccceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhccee
Confidence 997653 23469999999999876543322 222223355679999999887776 3457789999999999
Q ss_pred HHHHhCCCCCCCCCHH---HHHHHHHcC
Q 003375 724 LELLTLQVPYMGLSEL---EIHDLIQMG 748 (825)
Q Consensus 724 yELLTG~~PF~~~~~~---~i~~~I~~~ 748 (825)
..+.-|..||++.... +.++.|...
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHh
Confidence 9999999999987554 344555544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=207.38 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++.++.+.-+|.+...|..|+|+|.+..+++||..+.. .+....+.| ..|.-.|+-+.||||+.++|.|...
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~--~t~risrdf----neefp~lrifshpnilpvlgacnsp- 259 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE--VTARISRDF----NEEFPALRIFSHPNILPVLGACNSP- 259 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh--cchhhcchh----hhhCcceeeecCCchhhhhhhccCC-
Confidence 677888899999999999999999999999999965443 333333334 8888889999999999999998744
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-Cc-cccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HI-MHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gI-VHrDLKP~NIL 644 (825)
+++.++..|++.|+|+..++. .....++..++.+++.+|++|++|||+. .+ .---|.+..++
T Consensus 260 -------------pnlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvm 323 (448)
T KOG0195|consen 260 -------------PNLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVM 323 (448)
T ss_pred -------------CCceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEE
Confidence 355999999999999999986 3445677889999999999999999997 33 34458889999
Q ss_pred EecCccCCCCCCeEEEe--ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLC--DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~--DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|+++ .+++|. |--++.. .....-.|.||+||.++..+. ..--.++|+|||+++
T Consensus 324 ided-------ltarismad~kfsfq-----------------e~gr~y~pawmspealqrkpe-d~n~raadmwsfail 378 (448)
T KOG0195|consen 324 IDED-------LTARISMADTKFSFQ-----------------EVGRAYSPAWMSPEALQRKPE-DLNIRAADMWSFAIL 378 (448)
T ss_pred ecch-------hhhheecccceeeee-----------------ccccccCcccCCHHHHhcCch-hcchhhhhHHHHHHH
Confidence 9987 344443 3222211 111245689999999986322 223468999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~-~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
||||.|...||...++++.-.+|. .+.++.++. ..+..+..|+.-|+..||.
T Consensus 379 lwel~trevpfadlspmecgmkialeglrv~ipp---------------------------gis~hm~klm~icmnedpg 431 (448)
T KOG0195|consen 379 LWELNTREVPFADLSPMECGMKIALEGLRVHIPP---------------------------GISRHMNKLMNICMNEDPG 431 (448)
T ss_pred HHHhhccccccccCCchhhhhhhhhccccccCCC---------------------------CccHHHHHHHHHHhcCCCC
Confidence 999999999999999988765554 445655552 2356789999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003375 802 ERPTAGDLYEMFVART 817 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ 817 (825)
+||.++.|+-.|+++.
T Consensus 432 krpkfdmivpilekm~ 447 (448)
T KOG0195|consen 432 KRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCcceehhhHHHhc
Confidence 9999999999988764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=215.17 Aligned_cols=174 Identities=20% Similarity=0.168 Sum_probs=125.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCC-CChHHHHhhHHhHHHHHHHHhhCCCCCcce-eeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~-~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~-l~g~ 561 (825)
...++|.+.+.||+|+||+||+|.+ .+..+|+|+....... ..... ...+.+|+.+|++|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~----~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLA----RHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHH----HHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 4467899999999999999999987 4566788875321110 11112 234599999999999999985 4432
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KS 640 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL-KP 640 (825)
+ ..||||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||
T Consensus 91 ----~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP 140 (365)
T PRK09188 91 ----G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKP 140 (365)
T ss_pred ----C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCc
Confidence 1 1399999999999962 211 11 1467899999999999999999999 99
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
+|||++.+ +.+||+|||+|+.+........+.. ...-....+++.|+|||++..
T Consensus 141 ~NILv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~~--~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 141 QNWLMGPD-------GEAAVIDFQLASVFRRRGALYRIAA--YEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceEEEcCC-------CCEEEEECccceecccCcchhhhhh--hhhhhhhhccCccCCcccCCh
Confidence 99999765 4599999999998755332111100 011135678899999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=238.20 Aligned_cols=268 Identities=18% Similarity=0.187 Sum_probs=190.6
Q ss_pred CCc-eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSL-SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y-~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..| .....+|.|++|.|+.+.. .....+.|.++++ .. .......+...+..|+-+-..|.||||+..+..+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 334 4678899999998877764 2333444443322 11 22333344444688888899999999988877766444
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. .-+||||++ +|..++.. ...+....+..++.|++.|++|||..||.||||||+|+++.
T Consensus 395 ~~--------------~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 395 GI--------------LQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred cc--------------hhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 32 334999998 99999986 24788999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.. +++||+|||.+..+....... .......+|+..|+|||++.+ ...-....||||.|+++..|
T Consensus 455 ~~-------g~lki~Dfg~~~vf~~~~e~~------~~~~~g~~gS~pY~apE~~~~---~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 455 EN-------GILKIIDFGAASVFRYPWEKN------IHESSGIVGSDPYLAPEVLTG---KEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred cC-------CceEEeecCcceeeccCcchh------hhhhcCcccCCcCcCcccccc---cccCcchhhhhhccceEEEE
Confidence 88 579999999987664433210 112345689999999999986 23445689999999999999
Q ss_pred HhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|+.||......+.. ........-.+. ..........+...+.+|.+||++||.+|.|
T Consensus 519 ~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 519 ILGRFPWKVAKKSDNSFKTNNYSDQRNIF--------------------EGPNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred ecCCCccccccccccchhhhccccccccc--------------------cChHHHHHhchhhHHHHHHHHccCChhheec
Confidence 9999999654332211 111111000000 0011223344667899999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+++|++.-|-
T Consensus 579 i~~i~~d~W~ 588 (601)
T KOG0590|consen 579 IEQILNDEWI 588 (601)
T ss_pred HHHHhhChHh
Confidence 9999986543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=206.58 Aligned_cols=218 Identities=22% Similarity=0.307 Sum_probs=154.1
Q ss_pred CCCCcceeeeeEecCCCC-C-------CC-----CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHH
Q 003375 551 RHSCIVEMYGHKISSKWL-P-------SA-----DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 617 (825)
Q Consensus 551 ~HPNIV~l~g~~~~~~~~-~-------~~-----~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~I 617 (825)
+|||||+++++|.++-.. | .. -.........+|+||.-++ .+|.+|+.. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 599999999998864211 1 00 0011223457999999997 699999986 45778888999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccc-cccccCCCCCCCcccCCCccc
Q 003375 618 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT-CCIAHRGIPAPDVCVGTPRWM 696 (825)
Q Consensus 618 a~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~-~~~s~~~~~~~~~~vGT~~Ym 696 (825)
+.|+++|+.|||++||.|||||++||||..++ +.-+.++|+|||++---...... .+.++ .-...|...-|
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy~S~-----~Vd~GGNa~lm 418 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPYESD-----EVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecC---CCCcEEEEcccceeeeccccccccccccc-----cccCCCcceec
Confidence 99999999999999999999999999998763 36678999999998543321111 11111 11224778899
Q ss_pred chhhhhcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCC
Q 003375 697 APEVLRAMHKPN--LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773 (825)
Q Consensus 697 APEvl~~~~~~~--~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~ 773 (825)
|||+....++.. ....|+|.|+.|.+.||+++...||.+...+.+- ...++...|.++
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp------------------- 479 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP------------------- 479 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc-------------------
Confidence 999998654332 1246999999999999999999999774332211 112222333333
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003375 774 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810 (825)
Q Consensus 774 ~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL 810 (825)
..+++.+.+|+..+|+.||++|++..=..
T Consensus 480 --------~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 480 --------SRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred --------ccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 23466789999999999999999865433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-21 Score=227.59 Aligned_cols=263 Identities=20% Similarity=0.199 Sum_probs=186.3
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+|...+.||.+.|=.|.+|++....++|||+..+..........+. +.|++ +..++|||.+.+.-+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr----L~~ik-~~l~~~pn~lPfqk~~~t~kA--- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR----LEEIK-FALMKAPNCLPFQKVLVTDKA--- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH----HHHHH-HHhhcCCcccchHHHHHhhHH---
Confidence 7888999999999999999997777999999655434444433333 55666 777789999998877665543
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
.|||-+|+. -+|++.|.. +.-+..-+.+-|+.||+.||..+|+.||+|||||.+||||+.-
T Consensus 96 -----------AylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 96 -----------AYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred -----------HHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 389999997 599999975 3557778888999999999999999999999999999999876
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-------CCCCCCchhhHHHHHHHH
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-------~~~~~s~kSDVWSLGvIL 723 (825)
.-+.|+||..-+..--+... .+.-. +..++...-..|.|||.+-... .....+++.||||+||++
T Consensus 157 -----NW~~LtDFAsFKPtYLPeDN--Padf~-fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYLPEDN--PADFT-FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred -----chhhhhcccccCCccCCCCC--cccce-EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 34899999865433211100 00000 0011112335799999986411 112267899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+||++ |++||. -.+++ ....+........++.+ ....+++||..|++.||.+
T Consensus 229 aELf~Eg~PlF~---LSQL~-aYr~~~~~~~e~~Le~I-----------------------ed~~~Rnlil~Mi~rdPs~ 281 (1431)
T KOG1240|consen 229 AELFLEGRPLFT---LSQLL-AYRSGNADDPEQLLEKI-----------------------EDVSLRNLILSMIQRDPSK 281 (1431)
T ss_pred HHHHhcCCCccc---HHHHH-hHhccCccCHHHHHHhC-----------------------cCccHHHHHHHHHccCchh
Confidence 99988 688883 22322 22222211112222221 1225899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003375 803 RPTAGDLYEMFVA 815 (825)
Q Consensus 803 RPSa~EIL~hL~~ 815 (825)
|.+|++.|+.-..
T Consensus 282 RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 282 RLSAEDYLQKYRG 294 (1431)
T ss_pred ccCHHHHHHhhhc
Confidence 9999999987544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=197.85 Aligned_cols=255 Identities=20% Similarity=0.213 Sum_probs=158.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC----------CCccee
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----------SCIVEM 558 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H----------PNIV~l 558 (825)
.+...+.||.|+++.||.+++ .++.+|+|++.... .......+.+ .+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 457789999999999999999 55999999997765 3344445554 555544443322 223333
Q ss_pred eeeEecCCCCCCCC---CCCccccceEEEEEcccCCCCHHHHHHHhhccCCC--ccCHHHHHHHHHHHHHHHHHHHhCCc
Q 003375 559 YGHKISSKWLPSAD---GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHI 633 (825)
Q Consensus 559 ~g~~~~~~~~~~~~---~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~--~ls~~~i~~Ia~QIa~AL~yLHs~gI 633 (825)
++.....+.-+... +...+.....+++|+-+. ++|.+++......... .+.......+..|+++.+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 33333221110000 011122335688999996 7999987654333222 33444556778999999999999999
Q ss_pred cccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc----CCCC
Q 003375 634 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNL 709 (825)
Q Consensus 634 VHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~----~~~~ 709 (825)
||+||||+|+|++.+ +.++|+||+.....+..... ...+..|.+||...... ....
T Consensus 167 VHgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EEST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred EecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccce
Confidence 999999999999988 45999999987765542211 13457899999875421 1235
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHH
Q 003375 710 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 789 (825)
Q Consensus 710 ~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 789 (825)
++.+.|.|+||+++|.|+++..||....+...... . ...+. +.++.++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------~-----------------f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------D-----------------FSRCR-DMPEPVQ 274 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------G-----------------GTTSS----HHHH
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------c-----------------chhcC-CcCHHHH
Confidence 78999999999999999999999975533211000 0 11222 4577899
Q ss_pred HHHHHhcccCCCCC
Q 003375 790 DVFRRCTEENPTER 803 (825)
Q Consensus 790 dLI~~CL~~DP~eR 803 (825)
.||..+|+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=184.10 Aligned_cols=146 Identities=14% Similarity=0.087 Sum_probs=108.1
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH--------H----------HHhhHHhHHHHHHHHhhCCCCCc
Q 003375 495 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------E----------IRNFEYSCLGEVRMLGALRHSCI 555 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~--------~----------~~~~~~~~lrEv~iLk~L~HPNI 555 (825)
...||+|+||.||+|.. .+..||+|+.+......... . .+.......+|+.+|.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999997 57899999976543211110 0 00111233569999999988877
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 634 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yL-Hs~gIV 634 (825)
.....+... ..+|||||++|++|...+.. ...++...+..++.||+.+|.|| |+.||+
T Consensus 82 ~~p~~~~~~----------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLK----------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEec----------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 443332211 12899999998777655332 24688999999999999999999 799999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
||||||+|||++.+ .++|+|||+|...
T Consensus 141 HrDlkP~NIli~~~--------~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYHDG--------KLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEECC--------cEEEEEccccccC
Confidence 99999999999832 4999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=187.00 Aligned_cols=184 Identities=13% Similarity=0.126 Sum_probs=132.9
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhh--HHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~--~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||.|+||.||++...+..+|+|++.-+... .......| -..+.+|+..+.++.||+|..+..++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 68999999999999999998887889999997533221 11111111 1124799999999999999999988764321
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .-......+|||||++|.+|.++.. ++. ....+|+.+|..||..|++||||||.||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 1 0001124599999999999988732 222 24569999999999999999999999999986
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ + ++|+|||.......... ...++.. ..++.++|||+||++|..+.
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~a----------------------~d~~vle----r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRKA----------------------KDRIDLE----RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-------C-EEEEECCCcccccchhh----------------------HHHHHHH----hHhcccccccceeEeehHHH
Confidence 5 3 99999998865432110 0112332 34567999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=178.18 Aligned_cols=147 Identities=14% Similarity=0.123 Sum_probs=110.1
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHhhHHhHHHHHHHHhhCCCCCc
Q 003375 495 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHSCI 555 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~------------------~~~~~~~~~~lrEv~iLk~L~HPNI 555 (825)
...||+|+||.||+|.. ++..||+|+.......... .........+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999997 4889999997754321110 0001112234689999999999988
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHH-HHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 633 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~-L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gI 633 (825)
.....+.... .+|||||++|+++... +.. ..++...+..++.|++.+|.+||. +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5544433211 2899999998755443 332 457888999999999999999999 999
Q ss_pred cccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 634 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 634 VHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
+||||||+|||++ + +.++|+|||++.....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~~ 169 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELDH 169 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecCC
Confidence 9999999999998 4 3599999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-18 Score=176.47 Aligned_cols=201 Identities=12% Similarity=0.028 Sum_probs=140.0
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~~~~ 571 (825)
.+...|++|+||+||++...+.+++.+-+........ .-+...+.+|+++|++|. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~----~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR----GVAWWLARREALALRQLDGLPRTPRLLHWD--------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhh----hHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------
Confidence 3567899999999999888887777665433222111 111124589999999996 58899998862
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCEEEecCcc
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERK 650 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL-KP~NILLd~~~~ 650 (825)
..+++|||+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||.|||++.+
T Consensus 72 ---------~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-- 128 (218)
T PRK12274 72 ---------GRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-- 128 (218)
T ss_pred ---------CEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--
Confidence 13999999999898754321 11347789999999999999999999 7999999866
Q ss_pred CCCCCCeEEEeecCCccccccccccccccc---CCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAH---RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~---~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+.++|+|||+|.............. -..........++.|+.|+...... ..--...+.++.|+-+|.++
T Consensus 129 -----g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 129 -----GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred -----CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHH
Confidence 3599999999986543221000000 0000001123678899998765421 12236778899999999999
Q ss_pred hCCCCCCCC
Q 003375 728 TLQVPYMGL 736 (825)
Q Consensus 728 TG~~PF~~~ 736 (825)
|+..|+.+.
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=206.41 Aligned_cols=226 Identities=25% Similarity=0.285 Sum_probs=177.4
Q ss_pred eecccCceEEEEEE-----ECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCC
Q 003375 497 EAGKSVSSSLFRCK-----FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~-----~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~~~ 570 (825)
.+|+|+||.|++++ +.+.-+|.|+.+.......... .. ..|..++...+ ||.+|++...+..+...
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t----~~er~il~~~~~~~f~v~lhyafqt~~kl-- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HT----KQERIILAFVHNTPFLVKLHYAFQTDGKL-- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--cc----ccHHHHHhhccCCCceeeeeeeeccccch--
Confidence 37999999999865 3567778887543332222222 22 56788888887 99999999998877654
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
+++++|..||.|...+.+ ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+
T Consensus 73 ------------~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 73 ------------YLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred ------------hHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 999999999999888875 4567788888889999999999999999999999999999988
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
+++++.|||+++..-.... ..||..|||||++.+ ...++|.||||++++||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~~--------------~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEKI--------------ACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhhh--------------cccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 4599999999987654221 158999999999984 467899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
.||.+ ++...|..... ..+ ......+.+++..++..+|..|.-.
T Consensus 189 ~pf~~----~~~~~Il~~~~-~~p---------------------------~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAEL-EMP---------------------------RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCCch----HHHHHHhhhcc-CCc---------------------------hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 99987 44444444321 122 2235578899999999999999644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-17 Score=170.28 Aligned_cols=143 Identities=20% Similarity=0.228 Sum_probs=112.5
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
+.||+|++|.||+|.+.+..+++|+...+..............++.+|+.++..+.|++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-------- 73 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--------
Confidence 579999999999999988999999864332222111112222356899999999999998777666654433
Q ss_pred ccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCC
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~ 655 (825)
.++||||++|++|.+++.. ... .+..++.+|+.+|.+||+.|++|||++|.|||++ +
T Consensus 74 ------~~lv~e~~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 74 ------FIIVMEYIEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred ------CEEEEEEeCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 3899999999999999865 112 7889999999999999999999999999999998 3
Q ss_pred CeEEEeecCCcccc
Q 003375 656 PVVKLCDFDRAVPL 669 (825)
Q Consensus 656 ~~vKL~DFGlA~~~ 669 (825)
..++|+|||++...
T Consensus 131 ~~~~liDf~~a~~~ 144 (211)
T PRK14879 131 GKIYLIDFGLAEFS 144 (211)
T ss_pred CCEEEEECCcccCC
Confidence 35999999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-18 Score=193.09 Aligned_cols=220 Identities=25% Similarity=0.344 Sum_probs=166.2
Q ss_pred HhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHH
Q 003375 547 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 626 (825)
Q Consensus 547 Lk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~ 626 (825)
|+.+.|.|+.+++|.+.... ..++|.+||..|+|.+.+.. ....+++.....++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 46788999999999998664 35999999999999999986 3466888889999999999999
Q ss_pred HHHhCCc-cccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 627 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 627 yLHs~gI-VHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
|||+..| .|+.|++.|.+++.. +.+||+|||+.......... . ......-..-|.|||.+.+..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~---~-----~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP---E-----AHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc---c-----ccchhHHHHhccCHHHhcccc
Confidence 9999876 999999999999976 88999999998766431100 0 011112346799999998742
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCc
Q 003375 706 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 778 (825)
Q Consensus 706 ~~~~---~s~kSDVWSLGvILyELLTG~~PF~~~----~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 778 (825)
.... .+.+.||||||++++|+++...||... .+.++...+..+..+.+...+..
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------- 188 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------------------- 188 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh-------------------
Confidence 2222 578899999999999999999999652 33456666655222111111100
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 779 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 779 ~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
..+..+.+..++.+||..+|.+||++++|-..++.+....
T Consensus 189 --~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 189 --LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred --hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 0023447899999999999999999999999988877653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=173.37 Aligned_cols=144 Identities=14% Similarity=0.123 Sum_probs=104.3
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-----CCCCcceeeeeEecCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 567 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-----~HPNIV~l~g~~~~~~~ 567 (825)
.-.+.||+|+||.||. .-.....++|+...... ...+ .+.+|+.+++.| .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~----~~~~----~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGD----GGDK----EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCeEEEEEecccc----chHH----HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 3457899999999996 22223346787654321 1222 349999999999 57999999999987531
Q ss_pred CCCCCCCCccccceEEEEEcc--cCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCEE
Q 003375 568 LPSADGNPEHHLLQSAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy--~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL-~yLHs~gIVHrDLKP~NIL 644 (825)
. .....+|||| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+|||
T Consensus 76 ~----------g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 76 T----------GYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred C----------eEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 1 1123488999 557999999975 235555 35678888888 9999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCc
Q 003375 645 IDLERKKADGKPVVKLCDFDRA 666 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA 666 (825)
++..+. +...++|+||+.+
T Consensus 138 l~~~~~---~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRISE---SEVIPVVCDNIGE 156 (210)
T ss_pred EeccCC---CCCcEEEEECCCC
Confidence 986432 3357999995443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=197.79 Aligned_cols=201 Identities=17% Similarity=0.210 Sum_probs=153.5
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEec
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKIS 564 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~ 564 (825)
-..|.|.+.||+|+||.||+|.. ++..+|+|+-+.... .+- .==.+++.+|+ -+.|+.+...+..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEf---------YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEF---------YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eee---------eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 45788999999999999999986 678899998643221 111 11123344444 3455555555443
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+ ..+||+||.+.|+|.+++.. .+.+++..+..+..|++.-+.+||..+||||||||+|+|
T Consensus 766 ~~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 766 QN--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFL 826 (974)
T ss_pred CC--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeE
Confidence 33 23899999999999999973 577999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|...-....+...++|+|||.+.-+.-.... .......+|-.+-.+|+..| ..++..+|.|.|+.+++
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~--------~~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDG--------TKFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCC--------cEEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHHH
Confidence 9876544445677999999998655321111 11234468888999999987 88999999999999999
Q ss_pred HHHhCCC
Q 003375 725 ELLTLQV 731 (825)
Q Consensus 725 ELLTG~~ 731 (825)
-||.|+.
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=6e-17 Score=164.59 Aligned_cols=139 Identities=21% Similarity=0.261 Sum_probs=105.8
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCc
Q 003375 497 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~ 576 (825)
.||+|+||.||++.+.+..+++|++..+...........-..++.+|+.++..+.|++|.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC---------
Confidence 48999999999999989999999865332222111111112455899999999998876554444443332
Q ss_pred cccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCC
Q 003375 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656 (825)
Q Consensus 577 ~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~ 656 (825)
.++||||++|++|.+++.. ... .++.+++.+|.+||+.|++|||++|.|||++ + .
T Consensus 72 -----~~lv~e~~~g~~l~~~~~~------~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 72 -----KTIVMEYIEGKPLKDVIEE------GND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred -----CEEEEEEECCccHHHHHhh------cHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 3899999999999998764 111 7899999999999999999999999999998 4 3
Q ss_pred eEEEeecCCcccc
Q 003375 657 VVKLCDFDRAVPL 669 (825)
Q Consensus 657 ~vKL~DFGlA~~~ 669 (825)
.++++|||++...
T Consensus 127 ~~~liDfg~a~~~ 139 (199)
T TIGR03724 127 KLYLIDFGLGKYS 139 (199)
T ss_pred cEEEEECCCCcCC
Confidence 5999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-18 Score=201.42 Aligned_cols=224 Identities=23% Similarity=0.297 Sum_probs=156.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-.+|..++.|..|+||.||+++++ .+.+|.|+-+-+ .|++ ||..+-+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------------------lilR-----nilt~a~n----- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------------------LILR-----NILTFAGN----- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------------------hhhh-----ccccccCC-----
Confidence 357889999999999999999875 677777652200 1121 23332221
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.++| |+-...++. -..++.. ++.+++|||+.||+|||+||+|.||+
T Consensus 132 ---------------pfvv------gDc~tllk~-----~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT 177 (1205)
T KOG0606|consen 132 ---------------PFVV------GDCATLLKN-----IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT 177 (1205)
T ss_pred ---------------ccee------chhhhhccc-----CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee
Confidence 1344 344444443 1233332 27899999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccc-----cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s-----~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
.- +.+|++|||+++.......++... ........-.+|||.|.|||++.. ..|+..+|.|++|+
T Consensus 178 ~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr----qgygkpvdwwamGi 246 (1205)
T KOG0606|consen 178 SM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGI 246 (1205)
T ss_pred ec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh----hccCCCccHHHHHH
Confidence 88 459999999987654322221110 001112334579999999999986 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|+||.+-|..||.+.++++++..+....... + +.....+++++++|.++|+.+|.
T Consensus 247 IlyeFLVgcvpffGdtpeelfg~visd~i~w-p------------------------E~dea~p~Ea~dli~~LL~qnp~ 301 (1205)
T KOG0606|consen 247 ILYEFLVGCVPFFGDTPEELFGQVISDDIEW-P------------------------EEDEALPPEAQDLIEQLLRQNPL 301 (1205)
T ss_pred HHHHHheeeeeccCCCHHHHHhhhhhhhccc-c------------------------ccCcCCCHHHHHHHHHHHHhChH
Confidence 9999999999999999999988876542211 1 11223356899999999999999
Q ss_pred CCC---CHHHHHHH
Q 003375 802 ERP---TAGDLYEM 812 (825)
Q Consensus 802 eRP---Sa~EIL~h 812 (825)
.|. .+-+|.+|
T Consensus 302 ~Rlgt~ga~evk~h 315 (1205)
T KOG0606|consen 302 CRLGTGGALEVKQH 315 (1205)
T ss_pred hhcccchhhhhhhc
Confidence 994 34444443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=187.53 Aligned_cols=146 Identities=20% Similarity=0.218 Sum_probs=113.3
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
...|...+.||+|+||.||++.+.+..+++|++..+..............++.+|+.+++.++|++|+..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 3445678999999999999999987777777654332221111111223456899999999999999887766654332
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||++|++|.+++. ....++.+|+.+|.|||+.||+||||||+|||++ +
T Consensus 411 -------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 411 -------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred -------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 389999999999999875 2367899999999999999999999999999994 3
Q ss_pred ccCCCCCCeEEEeecCCcccc
Q 003375 649 RKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~ 669 (825)
..++|+|||+++..
T Consensus 464 -------~~~~liDFGla~~~ 477 (535)
T PRK09605 464 -------DRLYLIDFGLGKYS 477 (535)
T ss_pred -------CcEEEEeCcccccC
Confidence 35999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=169.21 Aligned_cols=148 Identities=14% Similarity=0.163 Sum_probs=109.1
Q ss_pred CceeeeeecccCceEEEEEE---ECCeeEEEEEEecccCCCCh----------------HHHHhhHHhHHHHHHHHhhCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCK---FGSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR 551 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~---~~~~~vAVKI~~lk~~~~~~----------------~~~~~~~~~~lrEv~iLk~L~ 551 (825)
-|.+.+.||+|+||.||+|. .++..||+|+.......... ...+.....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999998 37889999997654321100 011112234578999999997
Q ss_pred CCC--cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH
Q 003375 552 HSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 629 (825)
Q Consensus 552 HPN--IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH 629 (825)
+.+ +.+++++ . ..+|||||++|.+|..+... ...+....+..++.||+.+|.+||
T Consensus 109 ~~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH 165 (237)
T smart00090 109 EAGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY 165 (237)
T ss_pred hcCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH
Confidence 532 3344432 1 12899999998888765432 234566677899999999999999
Q ss_pred hCC-ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 630 SKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 630 s~g-IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
.+| |+||||||+|||++ + ..++|+|||.+...
T Consensus 166 ~~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~~ 198 (237)
T smart00090 166 KEGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVEL 198 (237)
T ss_pred hcCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhcc
Confidence 999 99999999999998 4 35999999998654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=179.63 Aligned_cols=183 Identities=23% Similarity=0.336 Sum_probs=132.9
Q ss_pred ceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEE
Q 003375 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659 (825)
Q Consensus 580 ~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vK 659 (825)
..+||.|++|.-.+|.++|.. +......+....+.++.|++.|+.| ++.+|+|+||.||++..+ ..+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~r--r~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRR--RRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhC--CCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhhh
Confidence 357999999999999999974 2233456788899999999999999 999999999999999877 3599
Q ss_pred EeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 003375 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSE 738 (825)
Q Consensus 660 L~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~ 738 (825)
|+|||+........... .........+||..||+||.+.+ ..|+.++||||||+||+||++ =..+|. .
T Consensus 397 IgDFgl~ts~~~~~~~~----~~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~e---r 465 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVA----PAAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQFE---R 465 (516)
T ss_pred hhhhhheeecccCCccc----chhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHHH---H
Confidence 99999987665433110 01112244579999999999997 789999999999999999997 222221 1
Q ss_pred HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 739 ~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
......+..+..|+.. ....+.-..|+.+||.+.|.+||++.+..-|
T Consensus 466 ~~t~~d~r~g~ip~~~---------------------------~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEF---------------------------LQDYPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred HHhhhhhhcCCCChHH---------------------------hhcCcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 1222333333322110 0112234689999999999999966655444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=154.70 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=106.0
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH--------------HHHhhHHhHHHHHHHHhhCCCCC--
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 554 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~--------------~~~~~~~~~lrEv~iLk~L~HPN-- 554 (825)
|.+.+.||.|+||.||++.. .+..+|||++.......... ........+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999987 58899999976533111000 00011123578999999998874
Q ss_pred cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 555 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 555 IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
++.+++. . ..++||||++|++|..+... .....++.+|+.++.++|..||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 3444332 1 13899999999998765321 23567889999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
||||||.||+++.+ +.++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 469999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=152.24 Aligned_cols=147 Identities=16% Similarity=0.193 Sum_probs=105.7
Q ss_pred eeeec-ccCceEEEEEEECCeeEEEEEEecccC-----CCChHHHHhhHHhHHHHHHHHhhCCCCCc--ceeeeeEecCC
Q 003375 495 CDEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSK 566 (825)
Q Consensus 495 ~~~LG-~G~fG~Vy~a~~~~~~vAVKI~~lk~~-----~~~~~~~~~~~~~~lrEv~iLk~L~HPNI--V~l~g~~~~~~ 566 (825)
...|| .|+.|+||.+...+..+++|.+..... ............++.+|+.++.+|.|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35677 889999999998888999998753211 00000000112345899999999998875 67777654322
Q ss_pred CCCCCCCCCccccceEEEEEcccCC-CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ....+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||.+||+||||||.|||+
T Consensus 116 ~~----------~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 116 GL----------FYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred Cc----------ceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 11 1234699999997 699998864 234543 35789999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCccc
Q 003375 646 DLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
+.++ .++|+|||.+..
T Consensus 176 ~~~~-------~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDG-------KFWLIDFDRGEL 191 (239)
T ss_pred cCCC-------CEEEEECCCccc
Confidence 8763 599999998754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=141.81 Aligned_cols=141 Identities=16% Similarity=0.222 Sum_probs=95.7
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhh------------------HHhHHHHHHHHhhCCCCC-
Q 003375 495 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNF------------------EYSCLGEVRMLGALRHSC- 554 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~------------------~~~~lrEv~iLk~L~HPN- 554 (825)
.+.||+|+||.||+|... +..||+|+......... ....+ ......|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFK--KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchh--hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 568999999999999975 88999998754322111 11110 001135566666665332
Q ss_pred -cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHH-HHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-C
Q 003375 555 -IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 631 (825)
Q Consensus 555 -IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~-~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~ 631 (825)
+.++++.. ..++||||++++++.. .+.. .... ..+..++.+++.++.++|. .
T Consensus 80 ~~~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~------~~~~-~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 80 PVPKPIDLN------------------RHVLVMEFIGGDGIPAPRLKD------VRLL-EDPEELYDQILELMRKLYREA 134 (187)
T ss_pred CCCceEecC------------------CCEEEEEEeCCCCccChhhhh------hhhc-ccHHHHHHHHHHHHHHHhhcc
Confidence 34444321 2389999999854321 1221 0011 5678899999999999999 9
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
||+|+||||+||+++ + ..++|+|||.+....
T Consensus 135 ~ivH~Dl~p~Nili~-~-------~~~~liDfg~a~~~~ 165 (187)
T cd05119 135 GLVHGDLSEYNILVD-D-------GKVYIIDVPQAVEID 165 (187)
T ss_pred CcCcCCCChhhEEEE-C-------CcEEEEECccccccc
Confidence 999999999999998 4 359999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.4e-16 Score=182.18 Aligned_cols=267 Identities=22% Similarity=0.223 Sum_probs=190.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
+...|.+.+.||+|+|+.|-.+.. .....+++...+..........+ .+..|..+-+.+. |+|++.+++.....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~----~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSE----HIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhh----hcCccccccccccccccccccCCccCCC
Confidence 466788899999999999998875 33333444333433332222222 3366888888887 99999999987765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHH-HHhhccCCCccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENI 643 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L-~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH-s~gIVHrDLKP~NI 643 (825)
... +++++|..|+++.+.+ .. .....+...+..++.|+..+|.|+| ..++.|+||||+|.
T Consensus 94 ~~~--------------~~~~~~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~ 155 (601)
T KOG0590|consen 94 RSY--------------LLSLSYSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNS 155 (601)
T ss_pred ccc--------------ccccCcccccccccccccC----CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccc
Confidence 543 9999999999999888 32 2225677788899999999999999 99999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC-CCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vG-T~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
+++..+. .+++.|||+|..+....... .......| ++.|+|||.+.+ .....+..|+||.|++
T Consensus 156 ~l~~s~~------~l~~~df~~At~~~~~~g~~-------~~~~~~~g~s~~y~a~E~~~~---~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 156 LLDESGS------ALKIADFGLATAYRNKNGAE-------RSLKDRCGSSPPYGAPEHLSG---KAYRGPSVDVWSLGIV 219 (601)
T ss_pred hhccCCC------cccCCCchhhccccccCCcc-------eeeecccCCCCCCCCcccccc---hhhcCCCccccccccc
Confidence 9998741 59999999998775521111 11123357 999999999876 2456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~-~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+.-+++|..||......... ..+..... ...............+++.+++..+|.
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~k~l~~~~~ 275 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKG------------------------RFTQLPWNSISDQAHDLLHKILKENPS 275 (601)
T ss_pred ccccccCCCCccccccccccceeeccccc------------------------ccccCccccCChhhhhcccccccCCch
Confidence 99999999999655433210 00000000 000111223345678899999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
.|.+..++...-+..
T Consensus 276 ~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 276 NRLSIEELKLDNWLS 290 (601)
T ss_pred hcccccccccccccc
Confidence 999999887664443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.5e-14 Score=131.58 Aligned_cols=133 Identities=20% Similarity=0.213 Sum_probs=105.5
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PNIV~l~g~~~~~~~~~~~ 571 (825)
+.+.||.|.++.||++...+..+++|+..... . .. .+.+|+.++..++| .+++++++++...+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~--~----~~----~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSRE--K----GA----DREREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCC--c----hh----HHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 45789999999999999988889999854221 1 12 33889999999986 58888888765433
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEEecC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 648 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~---gIVHrDLKP~NILLd~~ 648 (825)
..+++|||++|+.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 24999999998766543 4456677899999999999985 79999999999999875
Q ss_pred ccCCCCCCeEEEeecCCcccc
Q 003375 649 RKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~ 669 (825)
..++++|||.+...
T Consensus 126 -------~~~~l~Df~~~~~~ 139 (155)
T cd05120 126 -------KILGIIDWEYAGYG 139 (155)
T ss_pred -------cEEEEEecccccCC
Confidence 45999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.5e-12 Score=143.89 Aligned_cols=252 Identities=23% Similarity=0.202 Sum_probs=178.6
Q ss_pred Cceeeeeecc--cCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 491 SLSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 491 ~y~i~~~LG~--G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
.+.+.+.+|. |.+|.||.+.. ....+|+|.-....... ...... ++|+...+.++ |+|.++.+..+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRK-----LREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccc-----cchhhcccccCccccccccCcccc
Confidence 4567888999 99999999875 45667777533222211 111111 57777777776 999999888777
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHH----HHHHHHhCCccccCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIK 639 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~----AL~yLHs~gIVHrDLK 639 (825)
..+.. |+-+|+|. .+|..+... ....++...++..+.+... ||.++|..+|+|-|+|
T Consensus 189 ~~~~l--------------fiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~k 249 (524)
T KOG0601|consen 189 GSGIL--------------FIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLK 249 (524)
T ss_pred cCCcc--------------eeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCcccccccc
Confidence 66644 99999996 788888875 2344788889999999999 9999999999999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSL 719 (825)
|.||++..+. ...+++|||+...+.......... ......|...|++||.+.+ .++.+.|||++
T Consensus 250 p~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~sl 313 (524)
T KOG0601|consen 250 PANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFSL 313 (524)
T ss_pred hhheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcch
Confidence 9999998772 458999999998876644221110 0111247788999999974 67899999999
Q ss_pred HHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 720 GCLLLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 720 GvILyELLTG~~PF~~~--~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
|.++.+..++..++... +.. ..+.+. .++..+ ...-+..+...+..|++
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W---~~~r~~---~ip~e~-----------------------~~~~s~~l~~~~~~~~d 364 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSW---SQLRQG---YIPLEF-----------------------CEGGSSSLRSVTSQMLD 364 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCc---cccccc---cCchhh-----------------------hcCcchhhhhHHHHhcC
Confidence 99999999987666332 110 001111 011111 11113345558999999
Q ss_pred cCCCCCCCHHHHHHH
Q 003375 798 ENPTERPTAGDLYEM 812 (825)
Q Consensus 798 ~DP~eRPSa~EIL~h 812 (825)
.+|..|++++.++++
T Consensus 365 ~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 365 EDPRLRLTAQILTAL 379 (524)
T ss_pred cchhhhhHHHHHhcc
Confidence 999999999988765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-11 Score=122.03 Aligned_cols=144 Identities=14% Similarity=0.103 Sum_probs=102.7
Q ss_pred eeeecccCceEEEEEEEC--------CeeEEEEEEecccCCCChH------------------HHHhhHHhHHHHHHHHh
Q 003375 495 CDEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLG 548 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~--------~~~vAVKI~~lk~~~~~~~------------------~~~~~~~~~lrEv~iLk 548 (825)
...||.|--+.||.|... +..+|||+++......... ....+.....+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999854 3689999988544322111 11122233458999999
Q ss_pred hCC--CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHH-HHHHHhhccCCCccCHHHHHHHHHHHHHHH
Q 003375 549 ALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK-NYIEKLSETGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 549 ~L~--HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~-~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
+|. .-++.+++++. . -+|||||+.+..+. ..+++ ..++......+..+++.+|
T Consensus 82 rl~~~Gv~vP~pi~~~--~----------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 82 RMQKAGIPCPEVVVLK--K----------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHHcCCCCCeEEEec--C----------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHH
Confidence 996 35666777541 1 28999999764442 22322 2355566778889999999
Q ss_pred HHH-HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 626 VEL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 626 ~yL-Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
..| |..|||||||++.|||+..+ .++|+|||.+....
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~~--------~v~iIDF~qav~~~ 175 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHDG--------KVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEECC--------cEEEEECCCceeCC
Confidence 999 89999999999999999743 49999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-11 Score=140.59 Aligned_cols=150 Identities=15% Similarity=0.149 Sum_probs=97.9
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCC--------------------------hHHHHhhHH------hHH
Q 003375 495 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS--------------------------ADEIRNFEY------SCL 541 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~--------------------------~~~~~~~~~------~~l 541 (825)
.+.||.|++|+||+|+. .+..||||+.+......- ..-.+++.. .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999997 688999999753211000 011122222 245
Q ss_pred HHHHHHhhCC----CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHH
Q 003375 542 GEVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 617 (825)
Q Consensus 542 rEv~iLk~L~----HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~I 617 (825)
+|+..+.+++ |.+-+.+-.++.+-. ...+|||||++|++|.++.... . ..+ ....+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-------------~~~vLvmE~i~G~~L~~~~~~~-~---~~~---~~~~i 261 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-------------SERVLTMEWIDGIPLSDIAALD-E---AGL---DRKAL 261 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-------------CCceEEEEeECCcccccHHHHH-h---cCC---CHHHH
Confidence 5666666553 322233222222110 1238999999999999887531 1 112 23456
Q ss_pred HHHHHH-HHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 618 AQDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 618 a~QIa~-AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
+.+++. .+..+|..|++|+|+||.||+++.+ +.++|+|||++..+..
T Consensus 262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 666666 4788999999999999999999876 4599999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-11 Score=144.62 Aligned_cols=168 Identities=14% Similarity=0.159 Sum_probs=99.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCC--------------------------CChHHHHhhHHhH
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 540 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~--------------------------~~~~~~~~~~~~~ 540 (825)
|..|.. +.||.|++|+||+|+.. ++.||||+.+..... ....-.++|...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 566776 79999999999999973 789999997633100 0112233444445
Q ss_pred HHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccC--CCccCHHHHHHHH
Q 003375 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIA 618 (825)
Q Consensus 541 lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~--~~~ls~~~i~~Ia 618 (825)
.+|+.++... .|+.++...|.....+.-..-.+ ......+|||||++|+.|.++..- .+.+ ...+....+..++
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~-d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYW-DYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeec-ccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHH
Confidence 5555554444 24444333332221110000000 001234799999999999875321 1111 1123333444444
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 619 ~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
.|| +..|++|+|+||.||+++.++. ..+.++++|||++..+..
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCH
Confidence 444 4589999999999999987742 234799999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.5e-11 Score=117.21 Aligned_cols=127 Identities=15% Similarity=0.181 Sum_probs=92.7
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcc-eeeeeEecCCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSADG 573 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV-~l~g~~~~~~~~~~~~~ 573 (825)
.+.|+.|.++.||+++..+..+++|+...... ... .+.+|+.+++.+.+.+++ +++.+...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-----~~~----~~~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-----LLI----NRENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-----ccc----CHHHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 46789999999999999999999998532211 011 226789999988755544 45544321
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCEEEecC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 648 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gI-----VHrDLKP~NILLd~~ 648 (825)
..++||||++|.++... . . ....++.+++.+|+.||..++ +|+|++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 12899999999877543 0 0 113456899999999999985 9999999999998 3
Q ss_pred ccCCCCCCeEEEeecCCcc
Q 003375 649 RKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~ 667 (825)
..++++|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 248999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-10 Score=116.75 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=103.3
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc--ceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI--V~l~g~~~~~~~~~~~~~ 573 (825)
..+++|+-+.||.+.+.+..+++|....|.-....-+.+--..+..+|+.++.+++--.| ..++++ +...
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~------ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDN------ 73 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCC------
Confidence 467899999999999988889999876554443333333334567899999999874444 344443 3322
Q ss_pred CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
..|+|||++|..|.+++.. . ...++..|-.-+.-||..||||+||.++||++...
T Consensus 74 --------~~I~me~I~G~~lkd~l~~------~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----- 128 (204)
T COG3642 74 --------GLIVMEYIEGELLKDALEE------A------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----- 128 (204)
T ss_pred --------CEEEEEEeCChhHHHHHHh------c------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----
Confidence 2799999999888889876 1 24566777777788999999999999999999865
Q ss_pred CCCeEEEeecCCccc
Q 003375 654 GKPVVKLCDFDRAVP 668 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~ 668 (825)
.+.++|||++..
T Consensus 129 ---~i~~IDfGLg~~ 140 (204)
T COG3642 129 ---RIYFIDFGLGEF 140 (204)
T ss_pred ---cEEEEECCcccc
Confidence 399999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=115.82 Aligned_cols=154 Identities=22% Similarity=0.221 Sum_probs=114.9
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~ 573 (825)
....|-+|+-+.|+++.+.++..+||-...+.-....-+.+-...+..+|+++|.++.--.|.-..=++.+...-
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~----- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG----- 85 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC-----
Confidence 467888999999999999999999998766655544444444556779999999998744443333233332222
Q ss_pred CCccccceEEEEEcccCC-CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 574 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
.|+|||++| .++.+++...-. ..........++.+|-+.+.-||..+|||+||..+||++..+++
T Consensus 86 ---------~i~ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~-- 151 (229)
T KOG3087|consen 86 ---------QIYMEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN-- 151 (229)
T ss_pred ---------eEEEEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC--
Confidence 899999985 488899876321 22233334788999999999999999999999999999988753
Q ss_pred CCCCeEEEeecCCccc
Q 003375 653 DGKPVVKLCDFDRAVP 668 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~ 668 (825)
...+.|+|||++..
T Consensus 152 --~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 --QITPILIDFGLSSV 165 (229)
T ss_pred --cCceEEEeecchhc
Confidence 45679999999853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=140.39 Aligned_cols=254 Identities=24% Similarity=0.172 Sum_probs=179.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCC-hHHHHhhHHhHHHHHHHHhhCC-CCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~-~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~ 561 (825)
....+|.++..||.|.|+.|+.... ++..+++|-. ...... ..++.. +.|+.+...+. |.+++.++..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~--~~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL--LNGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhh--hccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCC
Confidence 4567888999999999999999875 3455666653 222222 222222 67888888886 9999987766
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+.... +.||-.|||+++++...+.- ...+.+...+++..|++.++.++|+..++|+|+||+
T Consensus 335 W~~~r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ps 395 (524)
T KOG0601|consen 335 WSQLR--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPS 395 (524)
T ss_pred ccccc--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhccccccc
Confidence 65433 23789999999988776643 356888899999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCccc-chhhhhcccCCCCCCchhhHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~Ym-APEvl~~~~~~~~~s~kSDVWSLG 720 (825)
||++..++ +..++.|||++..+.-.. ......-.++ .+|++.. ...+..+.|+||||
T Consensus 396 ni~i~~~~------~~~~~~~~~~~t~~~~~~-------------~~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~ 453 (524)
T KOG0601|consen 396 NILISNDG------FFSKLGDFGCWTRLAFSS-------------GVFHHIDRLYPIAEILLE---DYPHLSKADIFSLG 453 (524)
T ss_pred ceeeccch------hhhhccccccccccceec-------------ccccccccccccchhhcc---cccccccccccccc
Confidence 99998752 458999999986532211 1112333444 2555543 25678899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
..+.+.+++...-..... ...+..+..+.++. ...++..+...+...++
T Consensus 454 ~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~----------------------------~~~~~q~~~kv~~~~~~ 502 (524)
T KOG0601|consen 454 LSVDEAITGSPLSESGVQ---SLTIRSGDTPNLPG----------------------------LKLQLQVLLKVMINPDR 502 (524)
T ss_pred ccccccccCcccCccccc---ceeeecccccCCCc----------------------------hHHhhhhhhhhhcCCcc
Confidence 999999998754322211 12233333333331 12467888999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 003375 801 TERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ss 819 (825)
..||.+.++..|.......
T Consensus 503 ~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 503 KRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred ccchhhhhhcccchhhhhc
Confidence 9999999998887765543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=148.53 Aligned_cols=261 Identities=23% Similarity=0.252 Sum_probs=176.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..++.+.+.+-+-.|+++.++.+.-. +...+.|+..+....... ..+.. ..+-.++-..++|-++...--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-~~~s~----r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-DYESI----RSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc-ccccc----CCccCccccCCCCceecccCCCCC
Confidence 57888999999999999999998742 223344433221111110 11111 223233333344555544332211
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
..-.+|||+|+.|++|...++. ....+.+.+...+..+..+++|||...++|+|++|.|+|
T Consensus 876 --------------rsP~~L~~~~~~~~~~~Skl~~-----~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 876 --------------RSPLPLVGHYLNGGDLPSKLHN-----SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL 936 (1205)
T ss_pred --------------CCCcchhhHHhccCCchhhhhc-----CCCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence 1235999999999999999986 234566677778888999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccc---------------------cccCCCCCCCcccCCCcccchhhhhc
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------------IAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~---------------------~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
+..+ +..++.|||......-...... ............+||+.|.+||.+.+
T Consensus 937 ~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 937 IAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred hccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9888 4589999984433221100000 00000112345679999999999987
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
...+..+|.|++|++++|.++|.+||....+.+++..+.....+.. .....
T Consensus 1010 ----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p-------------------------~g~~~ 1060 (1205)
T KOG0606|consen 1010 ----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWP-------------------------EGPEE 1060 (1205)
T ss_pred ----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCC-------------------------CCccc
Confidence 5667899999999999999999999999999998888776643211 11122
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHH
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
.+...++++.+.+..+|.+|..+.
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcc
Confidence 345688999999999999997765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-11 Score=127.98 Aligned_cols=213 Identities=22% Similarity=0.250 Sum_probs=142.2
Q ss_pred HHhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHH
Q 003375 546 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 546 iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
-|-++-|.|||+++.|+.+.+.- ..+...+++||+..|+|..+|++.... ...+......+|+.||+.||
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~---------e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal 189 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYE---------EKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSAL 189 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccc---------cccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhh
Confidence 35556799999999998766532 456779999999999999999975444 36788888999999999999
Q ss_pred HHHHhC--CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 626 VELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 626 ~yLHs~--gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
.|||+. .|+|+++..+-|++..+ +-+|++ -+.-.......... .. .......+-++|.+||.=..
T Consensus 190 ~yLhs~~PpiihgnlTc~tifiq~n-------gLIkig-~~ap~s~h~s~~~~----~~-~Ek~~~~~~~g~~a~~sg~~ 256 (458)
T KOG1266|consen 190 SYLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIG-SVAPDSTHPSVNST----RE-AEKSVNTSLPGFSAPESGTT 256 (458)
T ss_pred hhhhccCCccccCCcchhheeecCC-------ceEEec-ccCccccchhhhhh----hH-hhhhccccCCccccCCcCcc
Confidence 999997 69999999999999866 335543 22111111100000 00 00112236688999997433
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhh
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLTG~~PF-~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 782 (825)
...+.++|||+||....||..+..-- .+.+.......+.+... .+.
T Consensus 257 ----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-~le---------------------------- 303 (458)
T KOG1266|consen 257 ----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-GLE---------------------------- 303 (458)
T ss_pred ----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-ecc----------------------------
Confidence 34567999999999999998876432 22221111122211100 000
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 783 ~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
...-..++.+|++..|..||++.+++-|.-.+
T Consensus 304 --n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 304 --NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred --CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 01124578899999999999999999886544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.9e-09 Score=121.11 Aligned_cols=163 Identities=16% Similarity=0.215 Sum_probs=118.7
Q ss_pred CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCC
Q 003375 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 591 (825)
Q Consensus 512 ~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~g 591 (825)
.+.++.|.+...... .... .+.+-++.|+.|+||||++++..+..++. .|||+|-+.
T Consensus 36 ~~~~vsVF~~~~~~~----~~~~----~~~~A~k~lKtlRHP~Il~yL~t~e~~~~--------------~ylvTErV~- 92 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG----EVTE----LAKRAVKRLKTLRHPNILSYLDTTEEEGT--------------LYLVTERVR- 92 (690)
T ss_pred cCCceEEEEEeCCCc----hhhH----HHHHHHHHhhhccCchhhhhhhhhcccCc--------------eEEEeeccc-
Confidence 455666666543321 1111 23667888999999999999999887664 499999995
Q ss_pred CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 592 GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
.|..+++. +....+...+.||+.||.|||. .+++|++|.-+-|+|+..++ .||++|-++....
T Consensus 93 -Pl~~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-------WkLggle~v~~~~ 156 (690)
T KOG1243|consen 93 -PLETVLKE--------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE-------WKLGGLELVSKAS 156 (690)
T ss_pred -cHHHHHHH--------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc-------EEEeeeEEEeccc
Confidence 89999987 3366777788999999999985 58999999999999999854 9999999886543
Q ss_pred ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 671 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 671 ~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
..... .....--..|..|+.+.. -....|.|-|||++||++.|
T Consensus 157 ~~~~~----------~~~~~~~~s~~~P~~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 GFNAP----------AKSLYLIESFDDPEEIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCCcc----------cccchhhhcccChhhcCc------cccchhhhhHHHHHHHHhCc
Confidence 32110 011112234566766532 12467999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=8.8e-09 Score=105.41 Aligned_cols=144 Identities=19% Similarity=0.176 Sum_probs=97.1
Q ss_pred eeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PNIV~l~g~~~~~~~~~~~~ 572 (825)
+.|+.|.++.||++...+ ..+++|+....... ... ..+.+|+.+++.+.+ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~----~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~------ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSA----HDVAREYRVLRALAGTGVPVPKVLALCEDPS------ 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---ccc----ccHHHHHHHHHHhhCCCCCCCCEEEECCCCC------
Confidence 578999999999998865 78999985332211 011 233889999999975 44566776654321
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh----------------------
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 630 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs---------------------- 630 (825)
.....++||||++|.+|...+.. ..++......++.+++.+|.+||+
T Consensus 71 -----~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 71 -----VLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred -----ccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 01124899999999877665421 134555555666666666666663
Q ss_pred ----------------------------------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 631 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 631 ----------------------------------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
..++|+|++|.|||++.+. ...+.|+||+.+..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~~ 206 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEecccccc
Confidence 2469999999999998731 14589999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.1e-08 Score=104.54 Aligned_cols=152 Identities=16% Similarity=0.128 Sum_probs=99.5
Q ss_pred cCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhH------HhHHHHHHHHhhCCCCCc--ceeeeeEecCCCCCCCC
Q 003375 501 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE------YSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSAD 572 (825)
Q Consensus 501 G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~------~~~lrEv~iLk~L~HPNI--V~l~g~~~~~~~~~~~~ 572 (825)
.....|++..+.+..+.||...... .....+.+. ..+.+|...+.+|..-+| +++++++......
T Consensus 33 ~~~rrvvr~~~~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~---- 105 (268)
T PRK15123 33 LEGRRTLRFELAGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP---- 105 (268)
T ss_pred CCCceEEEEEECCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC----
Confidence 3334477888888899999653211 001111100 024789998888853333 3444454321110
Q ss_pred CCCccccceEEEEEcccCCC-CHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 573 GNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.....+||||++++. +|.+++.... ....+......++.+|+..+.-||..||+|+|+++.|||++.+...
T Consensus 106 -----~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 106 -----ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPG 177 (268)
T ss_pred -----ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccC
Confidence 112459999999975 8999986421 1345667788999999999999999999999999999999852000
Q ss_pred CCCCCeEEEeecCCcc
Q 003375 652 ADGKPVVKLCDFDRAV 667 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~ 667 (825)
..+...+.|+||+.+.
T Consensus 178 ~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 178 REEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCCceEEEEECCccc
Confidence 1134679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-08 Score=103.74 Aligned_cols=132 Identities=20% Similarity=0.239 Sum_probs=85.1
Q ss_pred EEEEEEE-CCeeEEEEEEecccCCCChH------------------HHHhhHHhHHHHHHHHhhCCCC--CcceeeeeEe
Q 003375 505 SLFRCKF-GSADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 563 (825)
Q Consensus 505 ~Vy~a~~-~~~~vAVKI~~lk~~~~~~~------------------~~~~~~~~~lrEv~iLk~L~HP--NIV~l~g~~~ 563 (825)
.||.|.. .+..+|+|+.+......... .......+..+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 67899999988654333221 1112234578999999999854 567777553
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccC--CCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHH-HHhCCccccCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 640 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~--gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~y-LHs~gIVHrDLKP 640 (825)
.+ +|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+
T Consensus 80 -~~----------------~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 80 -RN----------------VIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp -TT----------------EEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred -CC----------------EEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 11 89999998 6556554332 22244566778888886666 5799999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
.|||++.+ .+.|+|||.+...
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEET
T ss_pred hhEEeecc--------eEEEEecCcceec
Confidence 99999876 3999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.6e-07 Score=102.51 Aligned_cols=277 Identities=17% Similarity=0.127 Sum_probs=162.0
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
....||+|+.+.+|-.---+ ..+.||+.... . ... .+-+..|... .||-+-.-+.|-.. .
T Consensus 15 ~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pp-p--a~~--------aqk~a~la~~p~~p~~~~rvaWPqa-------~ 75 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR-DQVAKIYHAPP-P--AAQ--------AQKVAELAATPDAPLLNYRVAWPQA-------T 75 (637)
T ss_pred CCccccCCccceeeecchhh-chhheeecCCC-c--hHH--------HHHHHHhccCCCCcchhhhhcccHH-------H
Confidence 45789999999999754322 23456653221 1 111 1223344444 36655432222111 0
Q ss_pred CCCccccceEEEEEcccCCC-CHHHHHHH-hhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 573 GNPEHHLLQSAIFMEYVKGG-SVKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gG-SL~~~L~~-~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
-..........++|+.+.|. ....+... ..+..-....|...++.++.|+.+.+.||..|.+-+|+.++|||++.++
T Consensus 76 L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~- 154 (637)
T COG4248 76 LHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS- 154 (637)
T ss_pred hhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-
Confidence 01111222368999999864 22222221 1122234567899999999999999999999999999999999999884
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh-cccCCCCCCchhhHHHHHHHHHHHHhC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~-~~~~~~~~s~kSDVWSLGvILyELLTG 729 (825)
.|.|.|=..-........ ..--+|...|.+||.-. +......-+...|.|.||+++++|+.|
T Consensus 155 ------~V~LVdsDsfqi~~ng~~-----------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 155 ------KVVLVDSDSFQINANGTL-----------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ------eEEEEcccceeeccCCce-----------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 478877442221111110 11237899999999876 222223446789999999999999987
Q ss_pred -CCCCCCCCH-----HHHHHHHHcCCCCCchhHHhhhccCccccccccCC-CCCCchhhhhhHHHHHHHHHHhccc--CC
Q 003375 730 -QVPYMGLSE-----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEE--NP 800 (825)
Q Consensus 730 -~~PF~~~~~-----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~L~dLI~~CL~~--DP 800 (825)
++||.+... ...-..|..+....-++ ..... .........-.++.+..|+.+|+.. ++
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~-------------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~ 284 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYASD-------------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVA 284 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeechh-------------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCC
Confidence 999977521 11111232222111110 00000 0000011122356788999999875 35
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 003375 801 TERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss 820 (825)
.-|||++..+..|..+..+.
T Consensus 285 ~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 285 TPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred CCCCCHHHHHHHHHHHHHhh
Confidence 68999999988887766543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.8e-07 Score=100.63 Aligned_cols=220 Identities=16% Similarity=0.096 Sum_probs=144.9
Q ss_pred CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCcccc
Q 003375 502 VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579 (825)
Q Consensus 502 ~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~ 579 (825)
-..+.|++.. .|..|++|............. ..-+++++++.|+|||++.++|..... +.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~--------t~lve~wkkl~h~NvV~frevf~t~tF----------~D 349 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD--------TSLVEAWKKLCHTNVVPFREVFLTYTF----------GD 349 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccc--------hHHHHHHHHhccCceeehhhhhhhhcc----------Cc
Confidence 4467888886 455666665422211111111 345788999999999999999984432 23
Q ss_pred ceEEEEEcccCC-CCHHHHHHHhh----------ccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 580 LQSAIFMEYVKG-GSVKNYIEKLS----------ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 580 ~~~~LVmEy~~g-GSL~~~L~~~~----------~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..+++|++|+++ ++|.++--... ...+...++..+|.++.||..||.++|+.|+.-+-|.|.+||++.+
T Consensus 350 ~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 350 LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK 429 (655)
T ss_pred ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc
Confidence 457999999986 57777643211 1123457789999999999999999999999999999999999866
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++|...|+...+.... + |.+.+ -.+-|.-.||.+++.|.|
T Consensus 430 -------~RIriS~C~i~Dvl~~d~-----------------~-------~~le~-------~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 430 -------MRIRISGCGIMDVLQEDP-----------------T-------EPLES-------QQQNDLRDLGLLLLALAT 471 (655)
T ss_pred -------ceEEEecccceeeecCCC-----------------C-------cchhH-------HhhhhHHHHHHHHHHHhh
Confidence 458887777654432211 0 12222 246799999999999999
Q ss_pred CCCC-CCCCCHHHH-HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 729 LQVP-YMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 729 G~~P-F~~~~~~~i-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
|..- +......+. ...|. ...+.++.+++.-....++.+ -++
T Consensus 472 ~~~ns~~~d~~~~s~~~~I~-----------------------------------~~yS~D~rn~v~yl~s~~~~~-ksI 515 (655)
T KOG3741|consen 472 GTENSNRTDSTQSSHLTRIT-----------------------------------TTYSTDLRNVVEYLESLNFRE-KSI 515 (655)
T ss_pred cccccccccchHHHHHHHhh-----------------------------------hhhhHHHHHHHHHHHhcCccc-ccH
Confidence 9643 222222221 12221 112446777777777777776 667
Q ss_pred HHHHHHH
Q 003375 807 GDLYEMF 813 (825)
Q Consensus 807 ~EIL~hL 813 (825)
.+++.++
T Consensus 516 ~~llp~~ 522 (655)
T KOG3741|consen 516 QDLLPMI 522 (655)
T ss_pred HHHHHHH
Confidence 7776664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.7e-07 Score=95.50 Aligned_cols=111 Identities=23% Similarity=0.242 Sum_probs=85.5
Q ss_pred hHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCC-CHHHHHHHhhccCCCccCHHHHH
Q 003375 539 SCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLAL 615 (825)
Q Consensus 539 ~~lrEv~iLk~L~H--PNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~i~ 615 (825)
+..+|...+..|.. -.+.+.+++....... ....+||||++++. +|.+++... ..++.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------GYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------ceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 34788888888753 3345666665543321 13569999999974 899998751 226677788
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 616 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 616 ~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
.++.+++..+.-||..||+|+|+++.|||++.++ +...+.|+||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999999874 346799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=89.79 Aligned_cols=148 Identities=15% Similarity=0.108 Sum_probs=101.9
Q ss_pred cccCceEEEEEEECCeeEEEEEEecccCCC-C-hHHHHhhHHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCCCC
Q 003375 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGS-S-ADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSADGN 574 (825)
Q Consensus 499 G~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~-~-~~~~~~~~~~~lrEv~iLk~L~H--PNIV~l~g~~~~~~~~~~~~~~ 574 (825)
|+||.+.|++....+..+-+|--.-..... . +... ..|.+|+..|.+|.. -.+.++. ++.....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~----ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~------- 94 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGR----PTIVREVAVIKELERAGVIVPKIV-FGEAVKI------- 94 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCc----hHHHHHHHHHHHHHHcCCCCCccc-eeeeecc-------
Confidence 568999999988877766666532111100 0 1122 234899999998863 2244444 2221110
Q ss_pred CccccceEEEEEcccCC-CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCC
Q 003375 575 PEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653 (825)
Q Consensus 575 ~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~ 653 (825)
....+.+||+|-+.| .+|.+++.+ ....+.+......++.+|+..+.-||..|+.|+|+.+.|||++.++
T Consensus 95 --~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---- 165 (216)
T PRK09902 95 --EGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---- 165 (216)
T ss_pred --CCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----
Confidence 123467999998864 589998864 2223567778889999999999999999999999999999998653
Q ss_pred CCCeEEEeecCCccc
Q 003375 654 GKPVVKLCDFDRAVP 668 (825)
Q Consensus 654 ~~~~vKL~DFGlA~~ 668 (825)
...++++||.-++.
T Consensus 166 -~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 -KAEAGFLDLEKSRR 179 (216)
T ss_pred -CeeEEEEEhhccch
Confidence 25699999986654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.8e-07 Score=94.72 Aligned_cols=141 Identities=18% Similarity=0.189 Sum_probs=101.3
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHH-H-------------HhhHHhHHHHHHHHhhCCCC--Cc
Q 003375 493 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADE-I-------------RNFEYSCLGEVRMLGALRHS--CI 555 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~-~-------------~~~~~~~lrEv~iLk~L~HP--NI 555 (825)
.++.+||-|--+.||.|.. .+.++|+|+.+.-........ . ..-.....+|.++|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678999999999999998 589999998775433221110 0 00012357899999999744 66
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVH 635 (825)
.+.+++- ...+||||++|--|... ++..+..-.++..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 6666552 23899999998555432 2234555666777777777777899999
Q ss_pred cCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 636 rDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
+|+.+-|||++.++ .++++||--+..
T Consensus 226 GDlSefNIlV~~dg-------~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDG-------DIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCC-------CEEEEeCccccc
Confidence 99999999999984 499999976643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.9e-08 Score=113.36 Aligned_cols=156 Identities=19% Similarity=0.173 Sum_probs=105.2
Q ss_pred HHHHHHHHHHhC-CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccch
Q 003375 620 DVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698 (825)
Q Consensus 620 QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAP 698 (825)
+++.||.|+|+. ++||+.|.|++|.++.. +.+||+.|+.+..........+ .......+-...-...|.||
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~~p~-~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTEYPF-SEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCcccc-ccCCCCCChhhccCcccccc
Confidence 344999999987 89999999999999988 4599999999876654322211 11112223334566789999
Q ss_pred hhhhcccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCC
Q 003375 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777 (825)
Q Consensus 699 Evl~~~~~~~~~s~kSDVWSLGvILyELL-TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 777 (825)
|++.+ ...+.++|+||+||++|.+. .|+..+......... ....... ... .
T Consensus 179 E~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~-~~~----------------------~ 230 (700)
T KOG2137|consen 179 EYLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLL-NAG----------------------A 230 (700)
T ss_pred hhhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhccc-ccc----------------------c
Confidence 99987 56789999999999999998 555555433222111 1111100 000 0
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003375 778 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811 (825)
Q Consensus 778 ~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~ 811 (825)
.......+.++.+=|.+++..++..||++.+++.
T Consensus 231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 0111345678899999999999999997776654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.2e-06 Score=86.72 Aligned_cols=148 Identities=11% Similarity=0.115 Sum_probs=95.2
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhH--HhHHHHHHHHhhCC---CCCcceeeeeEec
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE--YSCLGEVRMLGALR---HSCIVEMYGHKIS 564 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~--~~~lrEv~iLk~L~---HPNIV~l~g~~~~ 564 (825)
.+|.+.+.+-......|.+....+..+++|..+-+... .......|. ....+++..+.+++ --.++.++-+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 56888899988889999999999999999986533211 111111110 01233444444443 3333333333322
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .....++||||++|..|.++.. +++ .++..|++++.-||..|++|+|..|.|++
T Consensus 110 k~~~---------~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 110 KIFR---------YTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred eecc---------ceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 2110 1234568999999988876542 222 24566788899999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCccc
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
++.+ .++++||+..+.
T Consensus 168 v~~~--------~i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNN--------GIRIIDTQGKRM 183 (229)
T ss_pred EECC--------cEEEEECccccc
Confidence 9865 399999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.1e-06 Score=85.74 Aligned_cols=147 Identities=18% Similarity=0.230 Sum_probs=101.6
Q ss_pred CCceeeeeecccCc-eEEEEEEECCeeEEEEEEec---ccCCCChHH----------HHhhHHhHHHHHHHHhhCC---C
Q 003375 490 PSLSSCDEAGKSVS-SSLFRCKFGSADAAAKVRTL---KVCGSSADE----------IRNFEYSCLGEVRMLGALR---H 552 (825)
Q Consensus 490 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~vAVKI~~l---k~~~~~~~~----------~~~~~~~~lrEv~iLk~L~---H 552 (825)
.+++.++.||.|.. |.||+++..+..+|+|+++. .......+. ...+..-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 99999999999999999432 111111001 1123345788999877775 5
Q ss_pred CCc--ceeeeeEecCC--CCCC--CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHH
Q 003375 553 SCI--VEMYGHKISSK--WLPS--ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 626 (825)
Q Consensus 553 PNI--V~l~g~~~~~~--~~~~--~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~ 626 (825)
.++ |+++||..-.. .... .++......+...||.||++... .+... -+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHHHHH
Confidence 667 99999986442 0000 01222334567799999997522 12222 3466777788
Q ss_pred HHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCc
Q 003375 627 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 666 (825)
Q Consensus 627 yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA 666 (825)
.+|..||+-+|+++.|..= -+|+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~~------------G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYRG------------GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCccccccC------------CEEEecccC
Confidence 9999999999999999872 489999965
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.6e-05 Score=84.20 Aligned_cols=144 Identities=14% Similarity=0.117 Sum_probs=100.7
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh----------------HHHHhhHHhHHHHHHHHhhCC--CCCc
Q 003375 495 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR--HSCI 555 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~----------------~~~~~~~~~~lrEv~iLk~L~--HPNI 555 (825)
...|..|--+.||+|.. .+..+|+|+++........ ...+.......+|+..|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 44778888899999986 5889999998865433222 011122234678888888885 5555
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCC-CHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 633 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gI 633 (825)
.+.+++.. -.|||||+... .-.-.|+ ...+....+..+..++++.+.-|-. .++
T Consensus 133 P~Pi~~~~------------------nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~L 188 (268)
T COG1718 133 PEPIAFRN------------------NVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAGL 188 (268)
T ss_pred CCceeecC------------------CeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence 66666542 27999999642 1111111 1234444788889999999999988 799
Q ss_pred cccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 634 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 634 VHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
||+||..=|||+..+ .+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~~~--------~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVHDG--------EPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEECC--------eEEEEECccccccC
Confidence 999999999999833 59999999887554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.7e-05 Score=91.08 Aligned_cols=148 Identities=17% Similarity=0.188 Sum_probs=92.0
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCC--------------------------CChHHHHhhHHh------HHH
Q 003375 496 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCG--------------------------SSADEIRNFEYS------CLG 542 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~--------------------------~~~~~~~~~~~~------~lr 542 (825)
..|+.++-|+||+|+.. |+.|||||.+..... ......++|.+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67889999999999985 899999996532211 011122333333 345
Q ss_pred HHHHHhhCC-----CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHH
Q 003375 543 EVRMLGALR-----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 617 (825)
Q Consensus 543 Ev~iLk~L~-----HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~I 617 (825)
|+..+.+++ .|+|. +=.++.+- ...-.|+|||++|..+.+..... ...++.+ .+
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~-------------t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k---~i 269 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEY-------------TTRRVLTMEWIDGIKISDIAALK----SAGIDRK---EL 269 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhc-------------cCCcEEEEEeeCCEecccHHHHH----hcCCCHH---HH
Confidence 555555553 23321 11122110 11238999999999998885431 1234432 23
Q ss_pred HHHHHHH-HHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 618 AQDVAAA-LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 618 a~QIa~A-L~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
+..++++ +..+-..|++|.|..|.||+++.+ +.+.+.|||+...+..
T Consensus 270 a~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~-------g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 270 AELLVRAFLRQLLRDGFFHADPHPGNILVRSD-------GRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHhcCccccCCCccceEEecC-------CcEEEEcCcceecCCH
Confidence 3333333 344445899999999999999988 4599999999987754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=76.75 Aligned_cols=72 Identities=8% Similarity=0.022 Sum_probs=47.9
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC--cceeeeeEecCCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADG 573 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN--IV~l~g~~~~~~~~~~~~~ 573 (825)
..||+|..+.||+.. +..+++|+.... ... . .+.+|.++++.+..-. +.+++++....+.
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~---~~~---~----~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~------ 68 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPG---FDK---E----TIKREFDASRKVFSLGIPTPHPFDLVEDGGR------ 68 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCC---CCH---H----HHHHHHHHHHHHHHcCCCCCceEEEEecCCe------
Confidence 578999999999843 446778875321 111 1 2378999998886433 4566766654443
Q ss_pred CCccccceEEEEEcccCCCC
Q 003375 574 NPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~~gGS 593 (825)
.++|||+++|.+
T Consensus 69 --------~glv~e~i~G~~ 80 (226)
T TIGR02172 69 --------LGLIYELIVGKR 80 (226)
T ss_pred --------eeeeeeecCCcc
Confidence 378999999853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=74.03 Aligned_cols=81 Identities=15% Similarity=0.188 Sum_probs=55.2
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCC--CcceeeeeEecCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HP--NIV~l~g~~~~~~~~~~~~ 572 (825)
++.|+.|..+.||+....+..+++|+.... .... .+.+|+.++..|... .+.+++........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~------~~~~----~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~----- 66 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP------DAAE----RLRREAAVLRQLAEHGIPVPRVLAFDTSDEF----- 66 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH------HHHH----HHHHHHHHHHHHHHTTSBS--EEEEEEETEE-----
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC------CCHH----HHHHHHHHHHHHHhcCCCCceEEeecccccc-----
Confidence 468999999999999998889999985311 1222 337888888888633 35566664432221
Q ss_pred CCCccccceEEEEEcccCCCCHHH
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKN 596 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~ 596 (825)
....+++|++++|..+..
T Consensus 67 ------~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 67 ------NGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp ------TSEEEEEEEEESSEEHHH
T ss_pred ------cccceEEEEEeccccccc
Confidence 123699999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=76.16 Aligned_cols=75 Identities=12% Similarity=0.032 Sum_probs=49.1
Q ss_pred ecccCc-eEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCCCCCCC
Q 003375 498 AGKSVS-SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 498 LG~G~f-G~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~~~~~~~~~ 575 (825)
|-.|.+ ..||+....+..+.+|+..... .. .+.+|+.+++.+. +--+.+++++....+
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-------~~----~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--------- 65 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-------TY----ELEREAERLRWLAGKLPVPEVIDYGSDDG--------- 65 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-------cc----chHHHHHHHHHHHhcCCCCeEEEEEecCC---------
Confidence 444555 7899998776788888753211 11 2267888888885 444557777665332
Q ss_pred ccccceEEEEEcccCCCCHHHH
Q 003375 576 EHHLLQSAIFMEYVKGGSVKNY 597 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~~ 597 (825)
..++|||+++|.+|...
T Consensus 66 -----~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 66 -----RAWLLTSAVPGVPAAAL 82 (244)
T ss_pred -----ccEEEEEeeCCccHhHh
Confidence 23899999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.4e-05 Score=74.72 Aligned_cols=129 Identities=25% Similarity=0.263 Sum_probs=90.8
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcc-eeeeeEecCCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPS 570 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV-~l~g~~~~~~~~~~ 570 (825)
.+..+.|++|.+|.||++.|.+..+|+|+.+-+ .....+ ..|+++|..+.-.++. ++|.+..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d------s~r~~l----~kEakiLeil~g~~~~p~vy~yg~------- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRD------SPRRNL----EKEAKILEILAGEGVTPEVYFYGE------- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCC------cchhhH----HHHHHHHHHhhhcCCCceEEEech-------
Confidence 356789999999999999999999999986532 222333 8899999999866664 4555432
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CC-CEEEecC
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK-SE-NILIDLE 648 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLK-P~-NILLd~~ 648 (825)
-++.|||+.|-.|.+.-.. ..... ...++..---|-..||-|+.|. |. ||++...
T Consensus 87 -----------~~i~me~i~G~~L~~~~~~--------~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 87 -----------DFIRMEYIDGRPLGKLEIG--------GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred -----------hhhhhhhhcCcchhhhhhc--------ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 1677999998788776542 12222 3345555444666799999997 43 5555442
Q ss_pred ccCCCCCCeEEEeecCCccc
Q 003375 649 RKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~ 668 (825)
.+.|+||..|+.
T Consensus 144 --------~~~iIDFd~At~ 155 (201)
T COG2112 144 --------DVYIIDFDSATF 155 (201)
T ss_pred --------cEEEEEccchhh
Confidence 399999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=3.6e-06 Score=97.74 Aligned_cols=186 Identities=21% Similarity=0.152 Sum_probs=131.1
Q ss_pred ceeeeeecccCceEEEEEEECCeeE-EEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC-cceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~~v-AVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN-IV~l~g~~~~~~~~~ 569 (825)
+...+.+++|+++.+++.+...+.. ..+++... ... .-++++|.+++||| .+..++-+..+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~------rl~~eLLdK~n~P~~~v~~~~d~~~E~--- 307 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSR------RLAIELLDKVNNPNPVVRYLEDYDGED--- 307 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhh------HHHHHHHHHccCCCCcccccccCCccc---
Confidence 5677889999999999988644322 23332211 111 45889999999999 555555544443
Q ss_pred CCCCCCccccceEEEEEcccCCC-CHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
..+|+|+++.++ +-...+.. ....+..-....+.+.-.++|++||+.--+|+| ||+..+.
T Consensus 308 -----------~~~i~~~i~s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~ 368 (829)
T KOG0576|consen 308 -----------YLWIPMRICSTGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE 368 (829)
T ss_pred -----------ccchhhhhhcCCccccccCCh----hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc
Confidence 349999999876 22211110 112334445556677778899999998889999 8888764
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
..++.||+....+.... .++...+|+.|+|||+... ..+..+-|+|++|+-..+|.-
T Consensus 369 --------~~~~~~~~v~~~L~~~~-----------~~~t~~~~~~~~~pev~~~----~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 369 --------EVKLLDFAVPPQLTRTM-----------KPRTAIGTPEPLAPEVIQE----NTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred --------ccccccccCCcccCccc-----------ccccCCCCCCCCCchhhcc----cccccCCCccCCCcchhhcCC
Confidence 48999999987765532 2356679999999998876 677889999999998888888
Q ss_pred CCCCCCC
Q 003375 729 LQVPYMG 735 (825)
Q Consensus 729 G~~PF~~ 735 (825)
|-+|-..
T Consensus 426 ~~pPr~~ 432 (829)
T KOG0576|consen 426 GLPPRSS 432 (829)
T ss_pred CCCCCCC
Confidence 8777543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0002 Score=88.94 Aligned_cols=81 Identities=17% Similarity=0.202 Sum_probs=53.1
Q ss_pred eeeecccCceEEEEEEECC----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCc--ceeeeeEecCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCI--VEMYGHKISSKW 567 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNI--V~l~g~~~~~~~ 567 (825)
.+.|+.|.+..+|+....+ ..+++|......... ... .+.+|+.+|+.|. |++| .+++.++.+...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~----~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAH----AVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHH----HHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 5778999999999988744 356666532211111 111 2378999999996 6665 777777654321
Q ss_pred CCCCCCCCccccceEEEEEcccCCCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
. ...|+||||++|..
T Consensus 116 ~-----------G~~flVME~v~G~~ 130 (822)
T PLN02876 116 I-----------GTAFYIMEYLEGRI 130 (822)
T ss_pred C-----------CCceEEEEecCCcc
Confidence 1 23489999999754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00012 Score=85.77 Aligned_cols=151 Identities=17% Similarity=0.225 Sum_probs=91.2
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHH-----------------------HHhhHHh------HHHHH
Q 003375 495 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADE-----------------------IRNFEYS------CLGEV 544 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~-----------------------~~~~~~~------~lrEv 544 (825)
.+.||.-+.|+||+|+. ++..|||||-+.........+ .+++... |.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46789999999999997 678899998653222111111 1122222 34444
Q ss_pred HHHhhC----CCCC------cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHH
Q 003375 545 RMLGAL----RHSC------IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 614 (825)
Q Consensus 545 ~iLk~L----~HPN------IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i 614 (825)
+...++ .|-+ |.++|-.+.. ...|+|||++|..+.+.-.- . ...++...+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----------------~RVLtME~~~G~~i~Dl~~i-~---~~gi~~~~i 305 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----------------KRVLTMEYVDGIKINDLDAI-D---KRGISPHDI 305 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----------------ceEEEEEecCCccCCCHHHH-H---HcCCCHHHH
Confidence 433332 3444 4444433221 34899999999766554321 1 134555543
Q ss_pred HHHHHHHHHH-HHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccc
Q 003375 615 LFIAQDVAAA-LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 671 (825)
Q Consensus 615 ~~Ia~QIa~A-L~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~ 671 (825)
. ..+.++ +.-|-..|++|+|=.|.||++..+. .+.+.+.+-|||+...+..
T Consensus 306 ~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~---~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 306 L---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNP---EGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred H---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCC---CCCccEEEEcccccccccH
Confidence 3 333333 2223456899999999999999653 2457899999999877654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00057 Score=70.75 Aligned_cols=140 Identities=18% Similarity=0.230 Sum_probs=93.9
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCC------------CChHHHHhhHHhHHHHHHHHhhCC------CCCcc
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG------------SSADEIRNFEYSCLGEVRMLGALR------HSCIV 556 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~------------~~~~~~~~~~~~~lrEv~iLk~L~------HPNIV 556 (825)
...||+|+.-.||.--. +....|||....... ....... +..+|+.....+. +.+|.
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYR----QNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhH----HHHHHHHHHHHHhhccCCcccccc
Confidence 45789999999998433 445788886544300 0000112 2366776666665 88999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCC------CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG------GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~g------GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
+++|+..++... .+|+|.+.. .+|.+++.. ..++. ... ..+-.-..||-.
T Consensus 81 r~~G~veT~~G~--------------Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~~---~~L~~f~~~l~~ 136 (199)
T PF10707_consen 81 RFYGFVETNLGL--------------GLVVELIRDADGNISPTLEDYLKE------GGLTE-ELR---QALDEFKRYLLD 136 (199)
T ss_pred cEeEEEecCCce--------------EEEEEEEECCCCCcCccHHHHHHc------CCccH-HHH---HHHHHHHHHHHH
Confidence 999999877644 889987643 378888864 34555 333 334444578888
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEee-cCCc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCD-FDRA 666 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~D-FGlA 666 (825)
.+|+.+||+|.||++..... +...+.|+| ||..
T Consensus 137 ~~Iv~~dl~~~NIv~~~~~~---~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 137 HHIVIRDLNPHNIVVQRRDS---GEFRLVLIDGLGEK 170 (199)
T ss_pred cCCeecCCCcccEEEEecCC---CceEEEEEeCCCCc
Confidence 99999999999999987743 334678887 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00081 Score=83.34 Aligned_cols=249 Identities=18% Similarity=0.183 Sum_probs=152.6
Q ss_pred eeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+...|..-.+|+++..+|.. ..+-++-..... .....++. ...-|...+.++.|+|++.++.|......
T Consensus 182 vy~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~-~~~k~~i~----~~E~e~~~l~k~~~~n~~~~~~~~le~~~ 256 (1351)
T KOG1035|consen 182 VYPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYEST-PCGKKEIQ----TTEIELESLSKIAHDNLGGYFVYGLERLF 256 (1351)
T ss_pred eeeeeccccCceEEEEehhhhHHhhcCcccccCcccCc-cchHHHHH----HHHHHHHHHHhhccccccceeEEeehhhc
Confidence 33337777888888888721 112222111110 01111122 22557777889999999999998876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. + -...+..++|..-++...+.. -..++..+.+.+..++..||.|+|+....|.-|..+-..
T Consensus 257 ~----g------~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~--- 318 (1351)
T KOG1035|consen 257 R----G------IVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK--- 318 (1351)
T ss_pred c----h------HHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc---
Confidence 2 0 133456688988889888876 467889999999999999999999995444433333111
Q ss_pred CccCCCCCCeEEEe--ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLC--DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 648 ~~~~~~~~~~vKL~--DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+...++.+++.++ ||+........... ....-+..|.+||.... .........|+|.+|..+..
T Consensus 319 -~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----------~~~~~~~~~~~~e~~~~--~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 319 -ESTVDGEGVVAISLSDFDSSKPLPDNEKS-----------FSDLLAEIRNADEDLKE--NTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred -ccccCccceeecchhhhcccccCCCcccc-----------hhhcCcccccccccccc--ccchhhhhhHHHHHHHHHhh
Confidence 1112233556666 88888766543221 11234556778887764 11223445799999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+..+..+-.... ....+... .....+.+++.+|+.-++++|++
T Consensus 385 ~~~~~~i~~~~~---~~~~~l~~----------------------------------~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVSLLDV----------------------------------LSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred hhhcCccccccc---chhhhhcc----------------------------------ccchhhhhhhhhhcchhhhhccc
Confidence 988765431110 00000000 00114677889999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+++.|....
T Consensus 428 ~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 428 ALELLTHPFLR 438 (1351)
T ss_pred hhhhhhchhcc
Confidence 99999986544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0019 Score=68.00 Aligned_cols=29 Identities=21% Similarity=0.284 Sum_probs=24.1
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
+++|+|+.|.|||++.+ ...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~-------~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-------RLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECC-------CEEEEEeCcccC
Confidence 58999999999999754 346799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00074 Score=69.29 Aligned_cols=100 Identities=20% Similarity=0.181 Sum_probs=79.7
Q ss_pred HHHHHHHhhCCC-CCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHH---HHHhhccCCCccCHHHHHH
Q 003375 541 LGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY---IEKLSETGEKHVSVKLALF 616 (825)
Q Consensus 541 lrEv~iLk~L~H-PNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~---L~~~~~~~~~~ls~~~i~~ 616 (825)
..|.-+|+.+++ +++++++|+|- .++|+||...+++... +.. -...+|..+.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------------------~~~v~E~~~~~~~~~~~~~l~~-----~~~~~w~~R~~ 63 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------------------RFYVVEYVGAGSLYGIYRPLSQ-----FLQSPWEQRAK 63 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------------------CEEEEEeecCcccccccccccc-----ccccCHHHHHH
Confidence 458889999985 79999999984 1789999987666421 111 12368999999
Q ss_pred HHHHHHHHHHHHHh---CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 617 IAQDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 617 Ia~QIa~AL~yLHs---~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
|+.++++.+.+|+. ..+.-.|++|+|+-++.+ +.+|++|...+....
T Consensus 64 iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-------~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 64 IALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-------GRLKLIDLDDVFVED 113 (188)
T ss_pred HHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-------CcEEEEechhcchhH
Confidence 99999999999998 358889999999999977 459999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00028 Score=77.19 Aligned_cols=141 Identities=16% Similarity=0.224 Sum_probs=96.9
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHh-h-------------HHhHHHHHHHHhhCC-C-CCc
Q 003375 493 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRN-F-------------EYSCLGEVRMLGALR-H-SCI 555 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~-~-------------~~~~lrEv~iLk~L~-H-PNI 555 (825)
.++++||-|--+.||.+.+ .++..++|+.++-...+..-...+ + +-...+|+..|+.|. | --|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 5788999999999999988 488999998776544332211111 0 113478999998885 2 224
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003375 556 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635 (825)
Q Consensus 556 V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVH 635 (825)
.+.+++. ..++|||++.|..|...-+- .+.. .+...++.-+.-|-++|+||
T Consensus 175 PkpiD~~------------------RH~Vvmelv~g~Pl~~v~~v--------~d~~---~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 175 PKPIDHN------------------RHCVVMELVDGYPLRQVRHV--------EDPP---TLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred CCccccc------------------ceeeHHHhhcccceeeeeec--------CChH---HHHHHHHHHHHHHHHcCcee
Confidence 4444432 34899999999888765422 2222 34444555566778899999
Q ss_pred cCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 636 rDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
+|..-=||+++.+ ..++++||--....
T Consensus 226 gDFNEFNimv~dd-------~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 226 GDFNEFNIMVKDD-------DKIVVIDFPQMVST 252 (465)
T ss_pred cccchheeEEecC-------CCEEEeechHhhcc
Confidence 9999999999977 45999999765443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0038 Score=65.20 Aligned_cols=73 Identities=14% Similarity=0.161 Sum_probs=46.3
Q ss_pred eeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC-cceeeeeEecCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLPS 570 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN-IV~l~g~~~~~~~~~~ 570 (825)
++.|..|-...+|++... +..+++|+...... ... ...+|+.+++.+...+ ..++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~-----d~~~E~~~~~~l~~~gl~P~v~~~~~--~---- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LII-----DRERELRIHKLLSKHGLAPKLYATFQ--N---- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----cee-----cHHHHHHHHHHHHhCCCCCeEEEEeC--C----
Confidence 457788888999999875 46788887542111 001 1156888888885333 344444321 1
Q ss_pred CCCCCccccceEEEEEcccCCCCH
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSV 594 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL 594 (825)
++||||++|.++
T Consensus 68 ------------~~l~e~i~G~~l 79 (235)
T cd05157 68 ------------GLIYEFIPGRTL 79 (235)
T ss_pred ------------cEEEEeeCCCcC
Confidence 589999998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0051 Score=67.49 Aligned_cols=81 Identities=15% Similarity=0.114 Sum_probs=55.7
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC---CCcceeeeeEecCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH---SCIVEMYGHKISSKWLP 569 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H---PNIV~l~g~~~~~~~~~ 569 (825)
.-.+.||.|..+.||+....+..+.+|+.+- .... . .+..|...|+.|.- ..+.++++++.....
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~---~~~~---~----~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-- 84 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARS---FSTP---G----VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-- 84 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecc---cccc---h----HHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--
Confidence 4467899999999999987666778887431 0011 1 23789999988853 467788887754321
Q ss_pred CCCCCCccccceEEEEEcccCCCCH
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSV 594 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL 594 (825)
....+||||+++|.++
T Consensus 85 ---------~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 ---------PGPDVLLLERLRGVSV 100 (297)
T ss_pred ---------CCCeEEEEeccCCEec
Confidence 1124999999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00018 Score=90.47 Aligned_cols=161 Identities=14% Similarity=-0.040 Sum_probs=115.0
Q ss_pred hHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHH
Q 003375 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618 (825)
Q Consensus 539 ~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia 618 (825)
....|...++...|+++...+.-..... ....|++++|+.+|.+.+.|.+-.+. ...+....+....
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~------------s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~ 1341 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSE------------STEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRH 1341 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCC------------ChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHH
Confidence 3466666677778999887665443222 22348999999999999999762221 1233344444444
Q ss_pred HHHHHHHHHHHhC-----CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCC
Q 003375 619 QDVAAALVELHSK-----HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 693 (825)
Q Consensus 619 ~QIa~AL~yLHs~-----gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~ 693 (825)
.+.+.+..-+|.+ --+|++||+-|.+|..+ ..+|++++|+.+....... ..+..++++
T Consensus 1342 kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-------y~v~~gk~gLdKIknp~~s----------f~Gl~l~sp 1404 (2724)
T KOG1826|consen 1342 KVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-------YNVKLGKGGLDKIKNPVLS----------FFGLELCSP 1404 (2724)
T ss_pred HHHHhccchhhhcccCCccchhhhhhhhccceecC-------CcccccccccccccCchHh----------hhhhhhCCH
Confidence 5557788888875 27899999999999877 4499999999983322111 124457888
Q ss_pred cccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003375 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733 (825)
Q Consensus 694 ~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF 733 (825)
.|+.|++... -.++.++|+|..|+-+|++.-|..+|
T Consensus 1405 ~~v~qli~N~----ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1405 IYVLQLIKNE----IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHH----HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999876 45677899999999999998888776
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0097 Score=67.98 Aligned_cols=79 Identities=14% Similarity=0.047 Sum_probs=50.4
Q ss_pred eeeecccCceEEEEEEECC--eeEEEEEEecccCCCC---hHHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEecCC
Q 003375 495 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSS---ADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSK 566 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~---~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~~~ 566 (825)
.+.||.|.+..||++...+ ..++||.-........ ....++ ...|.+.|..+. ..++.+++.+..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR----~~~Eae~L~~l~~~~p~~VPkV~~~D~~-- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDR----ARIEAEALKIQAKYVPDLVPKVYHYDEE-- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHH----HHHHHHHHHHHHhhCCCCCCeEEEECCC--
Confidence 4689999999999999854 3799997431111000 111222 366777777763 3567778876331
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCC
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
..++||||+++..
T Consensus 105 --------------~~~lVME~L~~~~ 117 (401)
T PRK09550 105 --------------LAVTVMEDLSDHK 117 (401)
T ss_pred --------------CCEEEEecCCCcc
Confidence 1389999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.011 Score=63.08 Aligned_cols=137 Identities=13% Similarity=0.149 Sum_probs=75.6
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc-ceeeeeEecCCCCCCCCCCC
Q 003375 497 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADGNP 575 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI-V~l~g~~~~~~~~~~~~~~~ 575 (825)
.+..|-...+|+....+..+++|+......... . ...+|..+++.+....+ .+++... .+
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~---~-----~r~~E~~~l~~l~~~g~~P~~i~~~--~~--------- 63 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG---V-----DRQREYQILQALSALGLAPKPILVN--EH--------- 63 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc---C-----cHHHHHHHHHHHHhcCCCCceEEEe--CC---------
Confidence 355688889999988887888886421111100 0 11678888888864333 3344332 11
Q ss_pred ccccceEEEEEcccCCCCHHH--------------HHHHhhcc--CCCccCHH-HHHHHHHHH---------HHHHHHHH
Q 003375 576 EHHLLQSAIFMEYVKGGSVKN--------------YIEKLSET--GEKHVSVK-LALFIAQDV---------AAALVELH 629 (825)
Q Consensus 576 ~~~~~~~~LVmEy~~gGSL~~--------------~L~~~~~~--~~~~ls~~-~i~~Ia~QI---------a~AL~yLH 629 (825)
++||||++|..+.. .+.+.... ....++.. .+..+..++ ...+..+-
T Consensus 64 -------~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 136 (256)
T TIGR02721 64 -------WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFR 136 (256)
T ss_pred -------EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHH
Confidence 78999999865431 11211111 11122221 111221111 11122221
Q ss_pred h--------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 630 S--------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 630 s--------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
. ..++|+|+.|.||+++.++ +.|+||..+.
T Consensus 137 ~~~~~~~~~~~l~H~Dl~~~Nil~~~~~--------~~lIDwE~a~ 174 (256)
T TIGR02721 137 SAPEPAPLPLAPLHMDVHAYNLVVTPQG--------LKLIDWEYAS 174 (256)
T ss_pred hccCCCCCCCeeecCCCCcCcEEEeCCC--------CEEEeccccC
Confidence 1 2589999999999998652 6899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.013 Score=64.29 Aligned_cols=152 Identities=16% Similarity=0.172 Sum_probs=81.1
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC--cceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN--IV~l~g~~~~~~~~ 568 (825)
....++.++.|....+|+....+..+++|+.... ..... +..|+.++..|.... +.+++..... ...
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~---~~~~~-------i~~e~~~l~~L~~~g~pvp~~i~t~~g-~~~ 91 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKR---VKAEE-------LPFFLALTTHLAARGLPVPKPVKSRDG-RQL 91 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCC---CCHHH-------HHHHHHHHHHHHHCCCCCCccccCCCC-Cee
Confidence 3445667788888899998876667888875321 11111 145667777764222 3444432110 000
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHH-----------HHHHHhh---c---cCC-C--ccC-HHHHH------------
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVK-----------NYIEKLS---E---TGE-K--HVS-VKLAL------------ 615 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~-----------~~L~~~~---~---~~~-~--~ls-~~~i~------------ 615 (825)
. ......++||+|++|..+. ..+.... . ... . .++ +....
T Consensus 92 -~------~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 92 -S------TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred -h------hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 0 0112458999999975321 1111110 0 000 0 001 10000
Q ss_pred HHHHHHHHHHHHHHh-------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 616 FIAQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 616 ~Ia~QIa~AL~yLHs-------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.....+...++++.. .+++|+|+.+.||+++.+ ..+.|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-------~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGD-------SVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECC-------ceEEEeeccccc
Confidence 011223345555543 589999999999999876 346899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.01 Score=66.20 Aligned_cols=149 Identities=13% Similarity=0.114 Sum_probs=101.4
Q ss_pred eeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHhhHHhHHHHHHHHhhCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHSC 554 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~------------------~~~~~~~~~~lrEv~iLk~L~HPN 554 (825)
+...|..|--+-||.|.- .|..+||||++-....+.. ...+...-...+|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445677899999999986 6777999998743322211 112333345678899899987555
Q ss_pred cceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCC-HHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-C
Q 003375 555 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-H 632 (825)
Q Consensus 555 IV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGS-L~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-g 632 (825)
|.-.--+... .-.|||+|+.+.. -.-.|+ ...++...+..+-.|++.-|.-|.+. +
T Consensus 228 IP~PePIlLk----------------~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c~ 285 (520)
T KOG2270|consen 228 IPCPEPILLK----------------NHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKCR 285 (520)
T ss_pred CCCCCceeee----------------cceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHhc
Confidence 4322111111 1279999995321 112222 35677788889999999999888765 8
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccccc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 672 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~ 672 (825)
+||.||.-=|+|+... .+.|+|-+-+.....+
T Consensus 286 LVHADLSEfN~LyhdG--------~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 286 LVHADLSEFNLLYHDG--------KLYIIDVSQSVEHDHP 317 (520)
T ss_pred eeccchhhhhheEECC--------EEEEEEccccccCCCh
Confidence 9999999999999754 6999999988765543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.062 Score=59.01 Aligned_cols=30 Identities=23% Similarity=0.442 Sum_probs=24.9
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.++||+|+.|.|||++.+ ...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-------~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-------RLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECC-------ceEEEEeccccc
Confidence 389999999999999854 245799999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.012 Score=68.20 Aligned_cols=85 Identities=20% Similarity=0.197 Sum_probs=56.9
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHH
Q 003375 712 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 712 ~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
+|+|||++|.++.|+.-|...|......+....+.+....+......... ..........+.++
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e----------------~~~~~~~d~~~~~~ 173 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME----------------HLIQLLADKKRLPL 173 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH----------------HHHHHhhhHhHHHH
Confidence 59999999999999999988887766666555555443222211110000 01223445678899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 003375 792 FRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~h 812 (825)
..+|+-..|..||...++.++
T Consensus 174 ~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 174 LKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred hccCCccccccccchhHHhcC
Confidence 999999999999977766543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.064 Score=58.12 Aligned_cols=147 Identities=14% Similarity=0.156 Sum_probs=80.8
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC--cceeeeeEecCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN--IV~l~g~~~~~~~~~~~~ 572 (825)
.+.|..|....+|+....+..+++|+... ... .. +..|+.++..|.+-+ +.+++.... ...+.
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~----~~~---~~----~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~~--- 83 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK----VSA---EE----LPFFLALLDHLAERGLPVPRPIADRD-GEYLS--- 83 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC----CCh---Hh----ccHHHHHHHHHHHCCCCCCccccCCC-CcEee---
Confidence 56778888899999987777899998542 111 12 266888887775322 444443211 00000
Q ss_pred CCCccccceEEEEEcccCCCCHHH-----------HHHHhh---cc-CC-----CccCHHHH----------HHHHHHHH
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKN-----------YIEKLS---ET-GE-----KHVSVKLA----------LFIAQDVA 622 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~-----------~L~~~~---~~-~~-----~~ls~~~i----------~~Ia~QIa 622 (825)
......++||+|++|..+.. .+.... .. .. ....+... ......+.
T Consensus 84 ----~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 84 ----ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred ----eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 00123589999999865421 111110 00 00 00011100 00111233
Q ss_pred HHHHHHHh-------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 623 AALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 623 ~AL~yLHs-------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.++.++.. .+++|+|+.|.|||++.+ ..+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~-------~~~~iIDfe~a~ 204 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGD-------ELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC-------ceEEEeehhhhc
Confidence 34455443 379999999999999875 346899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.041 Score=63.04 Aligned_cols=78 Identities=14% Similarity=0.041 Sum_probs=51.8
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCCh---HHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEecCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKW 567 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~---~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~~~~ 567 (825)
..+.||.|....||+....+..++||.-.......+. ....+- ..|+..|+.+. ..++.+++.++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~----~~Ea~aL~~~~~~~p~~VPkVy~~ded~~- 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERA----YFEATALREHGRLCPDHVPEVYHFDRTMA- 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHH----HHHHHHHHHhhhcCCCCCCeEEEECCCCC-
Confidence 4778999999999999887777999875422221111 111111 44666666654 357888888876332
Q ss_pred CCCCCCCCccccceEEEEEcccCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKG 591 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~g 591 (825)
+++|||+++
T Consensus 111 ---------------vlvME~L~~ 119 (418)
T PLN02756 111 ---------------LIGMRYLEP 119 (418)
T ss_pred ---------------EEEEeecCC
Confidence 789999976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.079 Score=57.71 Aligned_cols=33 Identities=27% Similarity=0.347 Sum_probs=24.9
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.++|+|+.|.|||++.+. .....+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~---~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPS---SETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCC---CCCCcEEEEeeCCCC
Confidence 689999999999998630 001248999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.059 Score=60.79 Aligned_cols=75 Identities=13% Similarity=-0.007 Sum_probs=45.3
Q ss_pred eecccCceEEEEEEECC--eeEEEEEEecccCCC---ChHHHHhhHHhHHHHHHHHhhCC--CC-CcceeeeeEecCCCC
Q 003375 497 EAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGS---SADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKWL 568 (825)
Q Consensus 497 ~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~---~~~~~~~~~~~~lrEv~iLk~L~--HP-NIV~l~g~~~~~~~~ 568 (825)
.||.|....||++...+ ..++||.-....... .+-... +..-|...|+... -| .+.++|.+-.+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~----R~~~E~~~L~~~~~~~P~~vP~vy~~D~e---- 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLD----RARIESSALIRQGEHVPHLVPRIFHFDTE---- 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCcc----HHHHHHHHHHHhhccCccccCeEEEEccc----
Confidence 57999999999998754 478888643222111 111222 2256777777664 34 45566654321
Q ss_pred CCCCCCCccccceEEEEEcccCC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKG 591 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~g 591 (825)
...+|||+++.
T Consensus 74 ------------~~~~vMEdL~~ 84 (370)
T TIGR01767 74 ------------MAVTVMEDLSH 84 (370)
T ss_pred ------------cceehHhhCcc
Confidence 12699999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.12 Score=59.11 Aligned_cols=77 Identities=14% Similarity=0.062 Sum_probs=47.8
Q ss_pred eeeecccCceEEEEEEEC--CeeEEEEEEecccC--CCChHHHHhhHHhHHHHHHHHhhCC--CC-CcceeeeeEecCCC
Q 003375 495 CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVC--GSSADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKW 567 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~--~~~~~~~~~~~~~~lrEv~iLk~L~--HP-NIV~l~g~~~~~~~ 567 (825)
.+.||.|.-..||++... +..++||.-..... ...+-..+ +..-|..+|+.+. -| .+.++|.+-.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~----R~~~E~~aL~~~~~~~P~~VP~vy~~D~e--- 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTN----RIRIESDVLQLEEELAPGLVPKVYLFDSV--- 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChH----HHHHHHHHHHHHHhhCCCcCCeEEEECcH---
Confidence 678899999999999974 56788886432111 11111222 2256777777764 34 46667655322
Q ss_pred CCCCCCCCccccceEEEEEcccCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKG 591 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~g 591 (825)
...+|||+++.
T Consensus 107 -------------~~~~vMEdL~~ 117 (409)
T PRK12396 107 -------------MNCCVMEDLSD 117 (409)
T ss_pred -------------HhhHHHHhCcc
Confidence 23789999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.2 Score=55.77 Aligned_cols=32 Identities=25% Similarity=0.378 Sum_probs=26.7
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
.++|+|+.+.||+|+..+. +=|.||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~~~~~-------~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP-------TGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCe-------eEEEeccccccCC
Confidence 5899999999999998742 8899999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.16 Score=55.15 Aligned_cols=30 Identities=33% Similarity=0.512 Sum_probs=24.3
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.++|+|+.|.|||++.++ ...-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~------~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA------RVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCC------CEEEEECcHhcc
Confidence 489999999999998632 246799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.37 Score=53.71 Aligned_cols=31 Identities=19% Similarity=0.349 Sum_probs=25.2
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
++|.|+.+.|||++.++ ..++++||..|..-
T Consensus 184 ~CHnDl~~~NiL~~~~~------~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE------GKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCC------CcEEEEcccccCCC
Confidence 78999999999997542 35999999987543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.32 Score=55.52 Aligned_cols=30 Identities=30% Similarity=0.151 Sum_probs=24.3
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
..++|.||-+.|||.+.+ .+.++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~~~--------~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--------GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCC--------CEEEEEeccccC
Confidence 357999999999998644 399999987753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.5 Score=53.02 Aligned_cols=31 Identities=29% Similarity=0.477 Sum_probs=25.7
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
.++|+|+++.|||++..+ ..+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~------~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEET------RAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCC------CcEEEEeehhccc
Confidence 589999999999998542 3599999998754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.83 E-value=1.6 Score=47.94 Aligned_cols=29 Identities=21% Similarity=0.336 Sum_probs=24.9
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
+++|+|+.++|||++.++ .+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-------~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-------GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-------CEEEEEhhhcc
Confidence 799999999999998763 48899998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.02 E-value=1 Score=49.53 Aligned_cols=75 Identities=15% Similarity=0.117 Sum_probs=45.7
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEecCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~~~~~~ 569 (825)
+-.+.++.|....+|+....+..+.||+..-. ... .|..|..-|+.|. --.+.+++++....+.
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~-------~~~----~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-- 86 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSES-------GRD----MFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-- 86 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGG-------GCC----HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChh-------hHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--
Confidence 45678888999999999988899999986511 112 2377888888874 4456788888765442
Q ss_pred CCCCCCccccceEEEEEcccCCC
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGG 592 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gG 592 (825)
.||||||++.+
T Consensus 87 ------------~fLlle~l~~~ 97 (288)
T PF03881_consen 87 ------------AFLLLEFLEMG 97 (288)
T ss_dssp ------------CEEEEE-----
T ss_pred ------------ceEEEEeecCC
Confidence 29999999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=90.57 E-value=0.032 Score=46.73 Aligned_cols=43 Identities=30% Similarity=0.759 Sum_probs=34.5
Q ss_pred eeeccccceeeeeeeccccCCCccccccccccc-----------CCCCCCcceEEe
Q 003375 388 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD-----------FQPHAWNTILVK 432 (825)
Q Consensus 388 ~~g~~~~rallfk~l~d~~~~~~p~rLVrG~~~-----------~~~~a~~~~lVr 432 (825)
..|.|.+.|.||..++-.++ ||||+|.|+.- ...|+|.++.+.
T Consensus 5 ~~G~C~~~a~l~~~llr~~G--Ipar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~ 58 (68)
T smart00460 5 KYGTCGEFAALFVALLRSLG--IPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE 58 (68)
T ss_pred cceeeHHHHHHHHHHHHHCC--CCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC
Confidence 46999999999999999999 99999999642 345666555554
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.52 E-value=0.32 Score=54.02 Aligned_cols=85 Identities=24% Similarity=0.259 Sum_probs=49.7
Q ss_pred EEEEcccCCCCHHHHHHH-hhccCCCccCHHHHHHHHHHHHHHHHHHHhC----CccccCCCCCCEEEecCccC------
Q 003375 583 AIFMEYVKGGSVKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHSK----HIMHRDIKSENILIDLERKK------ 651 (825)
Q Consensus 583 ~LVmEy~~gGSL~~~L~~-~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~----gIVHrDLKP~NILLd~~~~~------ 651 (825)
.||++++.+ +-...-.. ..+.+ -..-.+-++.++.||+.-.-.+... +++|-||||+||||-...+.
T Consensus 251 IIIfPLArc-Sadkv~~~~~~e~G-F~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~ 328 (444)
T PHA03111 251 IIIFPLARC-SADKVTEENAAELG-FKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK 328 (444)
T ss_pred EEEEehhhc-ccccCCHHHHHHcC-CccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence 788888753 32222111 11112 2223456677888887655445443 69999999999999776420
Q ss_pred -----CCCCCeEEEeecCCcccc
Q 003375 652 -----ADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 652 -----~~~~~~vKL~DFGlA~~~ 669 (825)
......++|.||.+++..
T Consensus 329 ~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 329 DATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred CeEEEeccchhhhhcccCHHHHc
Confidence 011234667777777543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.31 E-value=0.66 Score=52.34 Aligned_cols=70 Identities=26% Similarity=0.234 Sum_probs=55.0
Q ss_pred eEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEEecCccCCCCCCeEE
Q 003375 581 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVK 659 (825)
Q Consensus 581 ~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~~~~~~~~~vK 659 (825)
..|++|++- |++|... ..-..+++..|+.+.+.-|.-+..+ .+-|||+.-.||||+ +| .|.
T Consensus 300 y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-------nvt 361 (488)
T COG5072 300 YLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-------NVT 361 (488)
T ss_pred EEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-------ceE
Confidence 468889887 4566432 2245778889999888887777765 789999999999999 53 499
Q ss_pred EeecCCccc
Q 003375 660 LCDFDRAVP 668 (825)
Q Consensus 660 L~DFGlA~~ 668 (825)
|+||-+++.
T Consensus 362 LIDfklsRl 370 (488)
T COG5072 362 LIDFKLSRL 370 (488)
T ss_pred EEEeeeeec
Confidence 999999984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.16 E-value=2.6 Score=47.22 Aligned_cols=145 Identities=21% Similarity=0.285 Sum_probs=79.7
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc------ceeeeeEecCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI------VEMYGHKISSKWLP 569 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI------V~l~g~~~~~~~~~ 569 (825)
..|.. .-..||+....+..+++|+.... ....+ +..|+..|..|.-..| ...=|-....
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~---~~~~~-------i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~---- 96 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRYILKIYRPG---WTRAE-------IPFELALLQHLAERGIPVPAPLPSLDGELLEA---- 96 (331)
T ss_pred ccccc-ccCceEEEEecCCCeEEEEecCC---CCHHH-------HHHHHHHHHHHHHcCCCCCCCccCCCcchhhh----
Confidence 34444 55679999987777899986532 12221 2557778877742222 1111111100
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHH------------HHHHhh---------ccC-CCccCHHH-------------H
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKN------------YIEKLS---------ETG-EKHVSVKL-------------A 614 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~------------~L~~~~---------~~~-~~~ls~~~-------------i 614 (825)
..+ + +..+-|.+|++|..+.. ++-... ... .....+.. -
T Consensus 97 -~~~----~-~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~ 170 (331)
T COG2334 97 -LSG----G-PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEP 170 (331)
T ss_pred -ccC----C-ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCc
Confidence 000 1 46689999999877762 111100 000 01112210 0
Q ss_pred HHHHHHHHHHHHHHHhC--------C--ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 615 LFIAQDVAAALVELHSK--------H--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 615 ~~Ia~QIa~AL~yLHs~--------g--IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.....++...+..+... + +||+|+.|.|||++.+. ..+.++|||-+.
T Consensus 171 ~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~------~~~g~iDFdDa~ 227 (331)
T COG2334 171 EDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDT------DVSGFIDFDDAG 227 (331)
T ss_pred hhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCC------CeeeEEEccccc
Confidence 12334455555555542 3 99999999999998772 158899999764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.75 E-value=0.39 Score=53.68 Aligned_cols=86 Identities=21% Similarity=0.217 Sum_probs=49.2
Q ss_pred EEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh----CCccccCCCCCCEEEecCccC-------
Q 003375 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKK------- 651 (825)
Q Consensus 583 ~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs----~gIVHrDLKP~NILLd~~~~~------- 651 (825)
.||++++. ++-...-......-+-..-.+-++.++.|||.-.--+.. .+++|-||||+||||-...+.
T Consensus 247 IIIfPLA~-~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 247 IIIFPLAR-CSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred EEEEehhh-cchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 68898875 333332221111111222244566777787643322333 369999999999999776421
Q ss_pred ----CCCCCeEEEeecCCcccc
Q 003375 652 ----ADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 652 ----~~~~~~vKL~DFGlA~~~ 669 (825)
......++|.||.+++..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 112345788888887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.21 E-value=1.3 Score=50.84 Aligned_cols=62 Identities=23% Similarity=0.334 Sum_probs=46.4
Q ss_pred eEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCEEEecC
Q 003375 581 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 581 ~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yL-Hs~gIVHrDLKP~NILLd~~ 648 (825)
...||-+|..|-++..+++. ...+++...+++.-.+.||.-+ --.+++|.|+.|.||++...
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW------KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhc------ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 34677788999999999975 3445566667777667775443 44689999999999999755
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=87.54 E-value=1 Score=48.87 Aligned_cols=29 Identities=31% Similarity=0.440 Sum_probs=24.2
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.+++|+|+.+.||+++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~--------~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--------EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC--------cEEEEECcccc
Confidence 479999999999999863 27899999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.64 E-value=6.9 Score=45.63 Aligned_cols=29 Identities=24% Similarity=0.406 Sum_probs=23.7
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
.++|.|+-+.|||.+.+ .++|+||-.|..
T Consensus 285 VfCHNDl~~~NiL~~~~--------~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK--------CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC--------CEEEEeeccccc
Confidence 57999999999997543 399999987753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 825 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 619 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 735
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 736 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 795 CTEENPTERPT 805
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 660
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 721 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 777
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 778 PEAELETLSFLVDVFRRCTEENPTERPT 805
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 700 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 754
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 619 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 674
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 735 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 794 RCTEENPTERPT 805
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 619 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 676
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 677 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 736
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 737 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 796 TEENPTERPT 805
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 757
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 619 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 675
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 676 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 736 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 794 RCTEENPTERPT 805
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 66/276 (23%), Positives = 104/276 (37%), Gaps = 64/276 (23%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
C+ E+ +L L H +++ Y I ++ L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIE-----------DNELN---IVLELADAGDLSRMI 123
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 719 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 532 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 589
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 590 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 650 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 710 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 769
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 770 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 824
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 640
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 701 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 759
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 537 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 595
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 596 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 646
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 647 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 506 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 625
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 683
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 684 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 739
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 800 PTERPTAGDLYEMF 813
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 598
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 714
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 774
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 775 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 809
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 653
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 713
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 774 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 778
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 779 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 825
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 783 ETLS-FLVDVFRRCTEENPTERPTAGDL 809
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 539 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 598
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 659 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 717 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 654
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 713
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 714 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 771 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 723 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 825
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 539 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 718 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 816
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 49/288 (17%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 539 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 596
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 657 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-- 709
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 710 -----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 764
+ D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 765 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 811
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 652
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 711
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 712 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 754
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 539 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 596
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 657 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 704
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 764
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 765 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 811
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 540 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 599
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 718
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 719 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 760
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 663 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 716
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 508 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 565
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 617
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 618 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 677
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 678 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 737
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 793
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 794 RCTEENPTERPTAGDL 809
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 539 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 596
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 657 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 704
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 764
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 765 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 811
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 654
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 712
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 772
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 773 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 663 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 716
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 508 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 624
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 684
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 685 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 744
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 745 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 790
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 791 VFR----RCTEENPTERPTAGDL 809
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 654
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 710
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 711 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 754
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 781 ELETLS-FLVDVFRRCTEENPTERPTAGDL 809
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 781 ELETLS-FLVDVFRRCTEENPTERPTAGDL 809
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 573
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 633
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 634 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 693
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 812
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 813 FVARTSSSISS 823
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 581
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 582 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 700 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 653
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 710
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 711 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 751
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 812 M 812
Sbjct: 312 R 312
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 573
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 574 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 632
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 692
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 693 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 601 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 656
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 657 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 716 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 774
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 775 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 661 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 601 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 780 AELETLS-FLVDVFRRCTEENPTERPTAGDL 809
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 34/202 (16%), Positives = 67/202 (33%), Gaps = 44/202 (21%)
Query: 538 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK 595
Y + L ++ Y HL Q+ E G++
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFY----------------SAHLFQNGSVLVGELYSYGTLL 155
Query: 596 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKK 651
N I T EK + L + A + + ++H I+H DIK +N ++ + +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 652 ADGKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
D + L D +++ ++ F C T + E+L +K
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NK 260
Query: 707 PNLYGLEVDIWSYGCLLLELLT 728
P + ++D + + +L
Sbjct: 261 P--WNYQIDYFGVAATVYCMLF 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 543 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 659
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 716
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 717 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 776 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 48/210 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 661 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
DF +V T C GT ++ PE++ K + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIE--GKT--HDEKVDLWCA 198
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 543 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 656
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 657 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 716 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 775
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 776 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 817
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 818 SSS 820
+
Sbjct: 332 DAE 334
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 572
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 573 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 628
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 689 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 748
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 749 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 809 LYE 811
E
Sbjct: 350 AME 352
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 551 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 610
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 611 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 668
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 669 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 789 VDVFRRCTEENPTERPTAGDL 809
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 9e-28
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 644 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 601 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 660 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 776
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 45/212 (21%), Positives = 81/212 (38%), Gaps = 33/212 (15%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 663 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
+ + GT +++APE+L K Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLE--QKK--YTVTVDYWSFG 210
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 752
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 638
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 757
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 694
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 749
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 638
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 693
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 694 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 812 MF 813
Sbjct: 292 EL 293
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 661 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 718 SYGCLLLELLT 728
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 580 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 693
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 694 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 751
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 752 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 812 MF 813
Sbjct: 302 QL 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 52/283 (18%), Positives = 102/283 (36%), Gaps = 69/283 (24%)
Query: 543 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 600
E+++L H ++ Y + + ++L I +E ++++ +E
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFL--------------YIALELC-NLNLQDLVESK 102
Query: 601 -LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV-- 657
+S+ K + + + +A+ + LHS I+HRD+K +NIL+ + +
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 658 ----VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
+ + DF R+ L+ GT W APE+L +
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPS-------------GTSGWRAPELLEESNN 209
Query: 707 PNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
+DI+S GC+ +L+ G + I G L+ +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNIIRGIF-----SLDEMKCL 263
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806
H+ + EA D+ + + +P +RPTA
Sbjct: 264 HDRSLI--------AEAT--------DLISQMIDHDPLKRPTA 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 661 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 718 SYGCLLLELLT 728
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 584 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 639
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 758
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 575
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 576 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 625
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 685
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 686 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 744
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 745 IQMGKRPRLTDELEAL 760
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 661 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 718 SYGCLLLELLT 728
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 642
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 703 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 760
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 761 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 593
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 594 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 704
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 760
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 694
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 749
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 704
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 705 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 596
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 657 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 640 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 757
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 560
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 561 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 614
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 615 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 734
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 735 GLSELEIHDLIQMGK 749
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 584 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 642 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 699 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 752
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 753 LTDELEAL 760
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 644 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 702 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 757
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 811
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 576 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 690
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 691 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 543 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 720
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 781 ELETLSFLV-DVFRRCTEENPTERPTAGDL 809
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 693
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 752
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 753 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 813 F 813
F
Sbjct: 273 F 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 574
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 575 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 689
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 690 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 748 GK 749
G
Sbjct: 244 GN 245
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 693
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 753
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 811
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 698 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 753
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 706 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGK 749
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 637
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 693
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 694 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 751 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 811 EMF 813
E
Sbjct: 297 ERI 299
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 693
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 596
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 657 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 712 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 693
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 50/220 (22%)
Query: 543 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
D I + GTP + APE++R DI++ G
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVRTGPTV-----ATDIYTVG 263
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 760
L L G + + + D L
Sbjct: 264 RTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL 300
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 698
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 699 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 663 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 781 ELETLSFLV-DVFRRCTEENPTERPTA 806
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 740
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 801 TERPTAGDLYEMF 813
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 646 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 749
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 704 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 759
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 760 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 811
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 596
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 597 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 657 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 663 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 663 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGK 749
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGK 749
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 576 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 690
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 691 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 598
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 599 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 658 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 714
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 739
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 800 PTERPTAGDLYEMF 813
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 698
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 757
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 637
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 693
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 694 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 751 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 811 EMF 813
E
Sbjct: 338 ERI 340
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 697
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 699
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 700 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 756 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 809
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 599
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 660 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 575
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 576 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 632
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 690
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 691 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 748
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 749 K 749
+
Sbjct: 321 Q 321
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 698
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 699 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 757
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 758 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 739
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 800 PTERPTAGDLYEMF 813
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 599
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 660 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 713
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 714 VDIWSYGCLLLELLT 728
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 517 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 689
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 690 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 580 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 692
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 693 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 747
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 748 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 808 DLYEMFVARTSSSISSRS 825
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 646 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 59/243 (24%)
Query: 517 AAKV-----RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
AAK + G S +EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 628
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 686
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 746
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 747 MGK 749
Sbjct: 225 AVN 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 663 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 781 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 811
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 580 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 628
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 689 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 738
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 799 NPTERPTAGDLYEMF 813
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 693
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 752
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 753 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 813 F 813
F
Sbjct: 273 F 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 599
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 660 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 713
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 714 VDIWSYGCLLLELLT 728
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 740
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 801 TERPTAGDLYEMF 813
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 517 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 689
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 690 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 646 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 749
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 579 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 627
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 688 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 740
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 801 TERPTAGDLYEMF 813
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 580 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 620
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 681 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 733
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 794 RCTEENPTERPTAGDLYEMF 813
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 580 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 629
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 689
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 690 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 742
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 743 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 803 RPTAGDLYEMF 813
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 646 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 749
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 764
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 765 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 806
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 517 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 628
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 686
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 687 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 746
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 747 MGK 749
Sbjct: 232 AVS 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 579 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 627
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 688 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 740
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 801 TERPTAGDLYEMF 813
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-21
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 697
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 698 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 756
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 579 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 627
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 688 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 740
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 801 TERPTAGDLYEMF 813
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 543 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 599
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 600 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 657 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 714
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 715 DIWSYGCLLLELLTLQVP 732
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 740
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 801 TERPTAGDLYEMF 813
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 599
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 600 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 656
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 657 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 713
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSE 738
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 693
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 694 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 752
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 753 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 813 F 813
F
Sbjct: 271 F 271
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 692
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 693 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 663 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 517 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 574
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 575 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 629
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 687
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 748 GK 749
Sbjct: 248 VN 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 598
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 599 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 658 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 714
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 715 DIWSYGCLLLELLT 728
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 579 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 627
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 688 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 739
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 800 PTERPTAGDLYEMF 813
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 599
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 660 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 716
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 717 WSYGCLLLELLT 728
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 599
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 660 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 718 SYGCLLLELL 727
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 520 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 579 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 639 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 754
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 815 ARTSSSISSR 824
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 749
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 534 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 593
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 594 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 654 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 712 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 584 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 640 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 698
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 699 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 732
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 580 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 620
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 681 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 733
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 794 RCTEENPTERPTAGDLYEMF 813
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 644
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 645 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 580 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 628
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 689 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 738
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 799 NPTERPTAGDLYEM 812
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 704
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 747
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 579 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 625
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 685
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 686 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 738
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 739 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 798 ENPTERPTAGDLYEMF 813
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 701
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 743
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 579 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 629
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 689
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 690 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 741
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 742 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 802 ERPTAGDLYEMF 813
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-18
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 640 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 695
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 749
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 579 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 627
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 746
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 747 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 807 GDLYEMF 813
+
Sbjct: 289 AQILVSL 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 646 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 743
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 532 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 587
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 588 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 642
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 643 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 697
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 698 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 756
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 757 LE 758
L+
Sbjct: 254 LD 255
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGK 749
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 598
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 599 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 658 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 714
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 715 DIWSYGCLLLELLT 728
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGK 749
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 598
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 599 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 658 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 714
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 715 DIWSYGCLLLELLT 728
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 39/199 (19%), Positives = 69/199 (34%), Gaps = 59/199 (29%)
Query: 543 EVRMLGALRHSCIVEMY---GHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK-- 595
E+++L LRH ++++ ++ K ++ MEY G +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQK-----------------MYMVMEYCVCGMQEML 98
Query: 596 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 655
+ + + K V A + L LHS+ I+H+DIK N+L+
Sbjct: 99 DSVPE------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT----- 147
Query: 656 PVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
+K+ T G+P + PE+ + +
Sbjct: 148 --LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPPEIANGLD---TF 189
Query: 711 -GLEVDIWSYGCLLLELLT 728
G +VDIWS G L + T
Sbjct: 190 SGFKVDIWSAGVTLYNITT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 598
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 659 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 749
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 600
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 661 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 714
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 715 DIWSYGCLLLELLTLQVPYM-GLSELE 740
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 663 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 717
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 718 SYGCLLLELLTLQVPYMGLSELE 740
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 578
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 579 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 620
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 680
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 681 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 733
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 734 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 789
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 790 DVFRRCTEENPTERPTAGDLYEMF 813
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 543 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 661 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 714
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 715 DIWSYGCLLLELLTLQVPYM-GLSELE 740
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 54/206 (26%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E+ +L L+H IV ++ + H + E+ +K Y +
Sbjct: 51 EICLLKELKHKNIVRLH--------------DVLHS--DKKLTLVFEFCDQ-DLKKYFDS 93
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ + + VK F+ Q + L HS++++HRD+K +N+LI+ +G +KL
Sbjct: 94 CNGDLDPEI-VKS--FLFQ-LLKGLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKL 142
Query: 661 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 715
+F RA +P+R + V T W P+VL Y +D
Sbjct: 143 ANFGLARAFGIPVRCYSA--------------EVVT-LWYRPPDVLFGAKL---YSTSID 184
Query: 716 IWSYGCLLLELLTLQVPYM-GLSELE 740
+WS GC+ EL P G +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 663 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 717
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 718 SYGCLLLELLTLQ 730
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 663 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 773
+LLE++T E L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPAVD--EHREPQLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 774 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 701
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 533 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 592
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 593 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 653 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 704
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 705 HKPNLYGLEVDIWSYGCLLLELLTLQ 730
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 4e-15
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 663 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 717
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 718 SYGCLLLELLTLQVPYMGLSELE 740
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 600
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 661 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 715
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 716 IWSYGCLLLELLTLQVPYMGLSELE 740
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 679
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 680 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 734
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 735 GLSELE 740
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 44/164 (26%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 700
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 701 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 740
L L Y VD+WS GC+ E+ + P G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEAD 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 663 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 717
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 718 SYGCLLLELLTLQVPYMGLSELE 740
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 533 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 592
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 593 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 707
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 708 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 603 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 659 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 713
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELE 740
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 599
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 709
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 710 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 740
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 593 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 706
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 707 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 764
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 765 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 719 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 766
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 767 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 807
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 808 D 808
Sbjct: 405 Q 405
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 656
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 657 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 717 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 750
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 751 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 798 ENPTERPTAGD 808
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 541 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 658
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 659 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 713
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 774 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 806
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 543 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 721 CLLLELLTLQVPYMG 735
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 533 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 583
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 584 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 624
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 625 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 681
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 682 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 740
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 741 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 788
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 789 VDVFRRCTEENPTERPTA 806
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 688 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 743
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 744 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 794
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 795 CTEENPTERPTA 806
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 586 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 749
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 688 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 743
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 744 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGD 808
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 658
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 709
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 710 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 753
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 754 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 808
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 663 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 716
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 770
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 771 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 685
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 686 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 688 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 739
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 740 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 786
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 787 FLVDVFRRCTEENPTERPTA 806
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 664
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 665 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 725 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 772
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 773 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 808
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 617 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 664
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 665 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 725 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 772
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 773 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 808
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 688 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 744
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 745 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 791
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 792 FRRCTEENPTERPTAGD 808
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 688 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 743
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 744 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGD 808
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 688 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 745
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 746 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 793
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 794 RCTEENPTERPTAGD 808
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 688 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 745
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 746 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 793
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 794 RCTEENPTERPTAGD 808
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 685
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 686 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 685
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 686 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 731 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 770
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 771 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 806
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 688 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 610 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 669 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 729 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 765
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 766 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 688 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 739
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 740 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 790
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 791 VFRRCTEENPTERPTA 806
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 613 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 654
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 655 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 702
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 751
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 752 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 798 ENPTERPTAGDLYE 811
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 714
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 715 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 659 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 714
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 715 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 636
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 637 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 693
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 694 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 743
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 744 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 799 NPTERPTAGDLYEM 812
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 77 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 136
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 137 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 196
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 197 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 254
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 255 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 300
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 301 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 352
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 353 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 399
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 400 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 445
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 446 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 503
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 504 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 564 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 602
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 649
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 260 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 319
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 320 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 376
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 377 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 431
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 432 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 478
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 479 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 534
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 535 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 567
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 568 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 607
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 608 HVSVKLALF-----I----------------AQDVAAALV-------------------- 626
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 627 -----------ELHSKHIMHRDIKSENILIDLERKKADG 654
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 79/483 (16%), Positives = 142/483 (29%), Gaps = 145/483 (30%)
Query: 11 HTSSSISTVSSSNSRSLTARKSS-KQWKRHHLQQRARQERL------NNSRKWRG-EGHA 62
+ T S +S ++ R S + R L+ + + L N++ W
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 63 Q---TSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDD 119
+ T+ R+K D L++ T + I LD L E ++LL D
Sbjct: 267 KILLTT-----RFKQ-VTDFLSAATTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDC 313
Query: 120 KIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-C 178
+ + L E + LS + +D ++ +N K V C
Sbjct: 314 RPQD---LPREVLTTNPR-----------------RLSII-AESIRDGLATWDNWKHVNC 352
Query: 179 KTKRHS-DRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 237
+ L+ +P + R + + S+ P A P +
Sbjct: 353 DKLTTIIESSLNVLEPAEYR----------KMFDR---LSV---FPP---SA--HIPTIL 391
Query: 238 LTGY-EQTPHLDSREVI-------LVDRKSDEE--------LDAIALSAQALVLH---LK 278
L+ D V+ LV+++ E L+ LH +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 279 QLNGLTK----DGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPF 334
N D + +D + H + + R ++R F
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQY-----FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--F 502
Query: 335 VCT--CSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVC 392
+ + +A+ S IL+ ++ L+ K
Sbjct: 503 LEQKIRHDSTAWNASGS---ILNTLQQ----------LKFYK------------------ 531
Query: 393 RHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IR 451
Y+CD P LV LDF P ++ K +R+ + A + I
Sbjct: 532 -------PYICD--NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIF 580
Query: 452 EEA 454
EEA
Sbjct: 581 EEA 583
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 659 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 714
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 715 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 599 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 658
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 659 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 714
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 715 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 598 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 658 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 714
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 715 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 660
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 661 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 714
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 715 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 757
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 610 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 666
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 667 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 722
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 723 LLELLTLQVPYMGL 736
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.01 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.84 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.94 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.17 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.23 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=467.63 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=213.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
...+++|++++.||+|+||.||+|++ .+..||||++.... ......+. +.+|+.+|++|+|||||++++++.
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREE----SRREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT--SCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--CCHHHHHH----HHHHHHHHHHCCCCCCCcEEEEEE
Confidence 35688999999999999999999998 57889999975432 33333344 499999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+.+. +|||||||+||+|.++|.. .+...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 94 ~~~~--------------~yiVmEy~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 94 ENGS--------------LYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp ETTE--------------EEEEEECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred ECCE--------------EEEEEeCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 7664 4999999999999999975 2335689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++|||||||+|
T Consensus 157 Ll~~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GT~~YmAPE~l~~----~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 157 FLTKD-------GTVQLGDFGIARVLNSTVEL----------ARACIGTPYYLSPEICEN----KPYNNKSDIWALGCVL 215 (350)
T ss_dssp EECTT-------CCEEECSTTEESCCCHHHHH----------HHHHHSCCTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeecCCccc----------ccccCCCccccCHHHHCC----CCCCcHHHHHHHHHHH
Confidence 99877 45999999999877542211 123579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||+||++||.+.+..+++..+..+..+.++. ..++++.+||.+||+.||.+|
T Consensus 216 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 216 YELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---------------------------HYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhHC
Confidence 99999999999999999988888776544332 135679999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
||+.|+++|-+
T Consensus 269 ~s~~e~l~hp~ 279 (350)
T 4b9d_A 269 PSVNSILEKGF 279 (350)
T ss_dssp CCHHHHHTSHH
T ss_pred cCHHHHhcCHH
Confidence 99999999844
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=452.47 Aligned_cols=268 Identities=25% Similarity=0.374 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++.++|++.++||+|+||+||+|++.+ .||||+++ .........+.| .+|+.+|++|+|||||+++|++...
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~f----~~E~~il~~l~HpNIV~l~g~~~~~- 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILK--VVDPTPEQFQAF----RNEVAVLRKTRHVNILLFMGYMTKD- 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECC--CSSCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEE--ecCCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEECC-
Confidence 667889999999999999999999866 58999854 333444444444 9999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. +|||||||+||+|.++|.. ....+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 105 ~--------------~~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~ 166 (307)
T 3omv_A 105 N--------------LAIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 166 (307)
T ss_dssp S--------------CEEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE
T ss_pred e--------------EEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC
Confidence 2 3999999999999999975 235699999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+........ ......+||+.|||||++.+.. ...|+.++|||||||+||||
T Consensus 167 ~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 167 EG-------LTVKIGDFGLATVKSRWSGS--------QQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp TT-------EEEEECCCSSCBC--------------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccCceecccCCcc--------eeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHH
Confidence 77 56999999999876432211 1123457999999999997522 24689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLSELE-IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~~~~-i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+||+.||.+.+... +...+..+. .|.++. ....+++.+.+||.+||+.||.+||
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLSK------------------------LYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT------------------------SCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCccc------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 99999998876544 444444442 222221 1123466899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.||+++|+.+..+-
T Consensus 287 s~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 287 LFPQILSSIELLQHSL 302 (307)
T ss_dssp CHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhccC
Confidence 9999999999887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=453.97 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=220.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
++-++|.+.+.||+|+||.||+|++. +..||||+.+ . ......+. |.+|+.+|++|+|||||+++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~--~~~~~~~~----f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--D--ASDNARKD----FHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEEC--S--CCHHHHHH----HHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeC--C--CChHHHHH----HHHHHHHHHhCCCCCCccEE
Confidence 55678999999999999999999873 5678999854 2 22333344 49999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh--------ccCCCccCHHHHHHHHHHHHHHHHHHHhC
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS--------ETGEKHVSVKLALFIAQDVAAALVELHSK 631 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~--------~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~ 631 (825)
|++.+.+. +|||||||++|+|.++|.... ......+++..++.|+.||+.||+|||++
T Consensus 82 g~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 82 GVCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp EEECSSSS--------------EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeeCCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99987654 499999999999999998631 12235799999999999999999999999
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s 711 (825)
+||||||||+||||+.+ +++||+|||+|+.......... .....||+.|||||++.+ ..++
T Consensus 148 ~iiHRDlKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~~~--------~~~~~gt~~ymAPE~~~~----~~~~ 208 (299)
T 4asz_A 148 HFVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYRV--------GGHTMLPIRWMPPESIMY----RKFT 208 (299)
T ss_dssp TCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCEEE--------TTTEEECGGGCCHHHHHH----CCCC
T ss_pred CcccCccCHhhEEECCC-------CcEEECCcccceecCCCCceee--------cCceecChhhcCHHHHcC----CCCC
Confidence 99999999999999987 5699999999987644322110 123469999999999987 6799
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 712 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 712 ~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
.++|||||||+||||+| |+.||.+.+..++...+..+.++..+.. +++.+.+
T Consensus 209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~ 261 (299)
T 4asz_A 209 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT---------------------------CPQEVYE 261 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTT---------------------------CCHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------chHHHHH
Confidence 99999999999999999 8999999999999999888766554421 3557999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
||.+||+.||.+|||+.+|++.|+.+...++
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999998876544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=455.10 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=215.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
+...+|.+.++||+|+||.||+|++. +..||||++. . ......+. |.+|+.+|++|+|||||+++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~--~~~~~~~~----f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--E--ASESARQD----FQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEES--C--CSHHHHHH----HHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEEC--c--CCHHHHHH----HHHHHHHHHhCCCCCCCcEE
Confidence 45568899999999999999999873 5679999864 2 23333344 49999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc----------cCCCccCHHHHHHHHHHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------TGEKHVSVKLALFIAQDVAAALVELH 629 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~----------~~~~~ls~~~i~~Ia~QIa~AL~yLH 629 (825)
|++.+... +|||||||++|+|.+++..... .....+++..++.|+.||+.||+|||
T Consensus 110 g~~~~~~~--------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 110 GVCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp EEECSSSS--------------EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCE--------------EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 99986654 4999999999999999975321 11246899999999999999999999
Q ss_pred hCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003375 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709 (825)
Q Consensus 630 s~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~ 709 (825)
+++||||||||+||||+.+ +++||+|||+|+.+...... .......||+.|||||++.+ ..
T Consensus 176 ~~~iiHRDLKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~----~~ 236 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RK 236 (329)
T ss_dssp HTTCCCSCCCGGGEEEETT-------TEEEECCCC------------------------CCCCGGGCCHHHHTT----CC
T ss_pred cCCeecccccHhhEEECCC-------CcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcC----CC
Confidence 9999999999999999977 57999999999876432211 01233579999999999986 77
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 710 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 710 ~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
++.++|||||||+||||+| |+.||.+.+..++...+..+.++..+.. +++.+
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~~~~ 289 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA---------------------------CPPEV 289 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTT---------------------------CCHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCccc---------------------------ccHHH
Confidence 9999999999999999999 8999999999999888888766554421 35679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+||.+||+.||.+|||+.||+++|+.+...++
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 999999999999999999999999999877654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=451.72 Aligned_cols=266 Identities=20% Similarity=0.313 Sum_probs=219.6
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCccee
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l 558 (825)
.+++.++++.++||+|+||.||+|.+ .+..||||++. ... .....+ .|.+|+.+|++|+|||||++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~--~~~-~~~~~~----~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK--DKA-EGPLRE----EFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECC--C-C-CC-CHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEEC--ccc-ChHHHH----HHHHHHHHHHhCCCCCCCCc
Confidence 36678899999999999999999997 34678999853 221 112223 34999999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
+|++.....+ +||||||++|+|.++|...... ....+++..++.|+.||+.||+|
T Consensus 95 ~g~~~~~~~~--------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 160 (308)
T 4gt4_A 95 LGVVTKDQPL--------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 160 (308)
T ss_dssp EEEECSSSSC--------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEECCEE--------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 9999876654 9999999999999999752211 12458999999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||+++||||||||+||||+.+ +++||+|||+|+.+...... .......||+.|||||++.+
T Consensus 161 LH~~~iiHRDLK~~NILl~~~-------~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~---- 221 (308)
T 4gt4_A 161 LSSHHVVHKDLATRNVLVYDK-------LNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMY---- 221 (308)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHH----
T ss_pred HHhCCCCCCCccccceEECCC-------CCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhC----
Confidence 999999999999999999987 56999999999876543211 11234579999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 708 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
..++.++|||||||+||||+| |..||.+.+..++...+..+.+++.++ .+++
T Consensus 222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~ 274 (308)
T 4gt4_A 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD---------------------------DCPA 274 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCH
T ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cchH
Confidence 679999999999999999998 899999999999998888876554442 2355
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
.+.+|+.+||+.||.+|||+.||+++|+++..
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 79999999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=457.02 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=218.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-..|++.++||+|+||.||+|++ .+..||||++...... ..+ .+.+|+.+|++|+|||||+++++|.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGG----GGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 35699999999999999999998 5788999997654321 122 3489999999999999999999999776
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. +|||||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 145 ~--------------~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 204 (346)
T 4fih_A 145 E--------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 204 (346)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC
Confidence 4 4999999999999999976 4699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++|||||||+||||
T Consensus 205 ~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyem 263 (346)
T 4fih_A 205 HD-------GRVKLSDFGFCAQVSKEVPR----------RKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEM 263 (346)
T ss_dssp TT-------CCEEECCCTTCEECCSSSCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEecCcCceecCCCCCc----------ccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHH
Confidence 77 45999999999876542211 234689999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|++||.+.+..+++..+.....+.+.. ....++.+.+||.+||+.||.+|||+
T Consensus 264 l~G~~PF~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~dli~~~L~~dP~~R~ta 318 (346)
T 4fih_A 264 VDGEPPYFNEPPLKAMKMIRDNLPPRLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATA 318 (346)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSSCCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHcCCCCCCCc-------------------------cccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999988888887764433321 12346689999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 003375 807 GDLYEMFVARTSSS 820 (825)
Q Consensus 807 ~EIL~hL~~l~sss 820 (825)
.|+++|-+......
T Consensus 319 ~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 319 AELLKHPFLAKAGP 332 (346)
T ss_dssp HHHTTCGGGGGCCC
T ss_pred HHHhcCHhhcCCCC
Confidence 99999977655443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=451.49 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=210.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.++.|++.++||+|+||.||+|++ .+..||||++..+.. . .+|+.+|+.|+|||||++++++.+.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~----~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------R----VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------C----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------H----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 456799999999999999999998 478899999764321 1 5799999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. +|||||||+||+|.++|.. ...+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 123 ~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 123 PW--------------VNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp TE--------------EEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred CE--------------EEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 64 4999999999999999986 2569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++ ..+||+|||+|+.+....... .......++||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 184 ~~~g------~~vKl~DFGla~~~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 248 (336)
T 4g3f_A 184 SSDG------SRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCMMLH 248 (336)
T ss_dssp CTTS------CCEEECCCTTCEEC-----------------CCCCCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred eCCC------CEEEEeeCCCCeEccCCCccc-----ceecCCccccCccccCHHHHCC----CCCCcHHHHHHHHHHHHH
Confidence 8763 259999999998775432111 0111234579999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+||++||.+.+..++...+.....+ +. ..+..+++.+.+||.+||+.||.+|||
T Consensus 249 mltG~~Pf~~~~~~~~~~~i~~~~~~-~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s 303 (336)
T 4g3f_A 249 MLNGCHPWTQYFRGPLCLKIASEPPP-IR------------------------EIPPSCAPLTAQAIQEGLRKEPVHRAS 303 (336)
T ss_dssp HHHSSCSSTTTCCSCCHHHHHHSCCG-GG------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCcCCCCCCCHHHHHHHHHcCCCC-ch------------------------hcCccCCHHHHHHHHHHccCCHhHCcC
Confidence 99999999888777766666654321 11 011234668999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.||+++|....
T Consensus 304 a~el~~~l~~~l 315 (336)
T 4g3f_A 304 AMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=446.35 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=211.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++++.||+|+||+||+|++ .+..||+|++..... ......+.+.+|+.+|++|+|||||++++++.+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3456899999999999999999998 578899999753321 011122345999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. +|||||||+||+|.++|.+ ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 104 ~~~--------------~yivmEy~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNIL 164 (311)
T 4aw0_A 104 DEK--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 164 (311)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeE
Confidence 664 4999999999999999986 357999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 165 l~~~-------g~vKl~DFGla~~~~~~~~~--------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvily 225 (311)
T 4aw0_A 165 LNED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIY 225 (311)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTTTC--------CCBCCCCSCGGGCCHHHHHH----SCBCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEEcCCceecCCCCCc--------ccccCcccCcccCCHHHHcC----CCCCcHHHHHHHHHHHH
Confidence 9877 45999999999876532211 11245689999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||+||++||.+.+..+++..|..... .+++ ..++++.+||.+||+.||.+||
T Consensus 226 eml~G~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~lL~~dp~~R~ 277 (311)
T 4aw0_A 226 QLVAGLPPFRAGNEGLIFAKIIKLEY-DFPE---------------------------KFFPKARDLVEKLLVLDATKRL 277 (311)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCC-CCCT---------------------------TCCHHHHHHHHHHSCSSGGGST
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------ccCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999988888877632 1221 1245789999999999999999
Q ss_pred CHHHHH
Q 003375 805 TAGDLY 810 (825)
Q Consensus 805 Sa~EIL 810 (825)
|++|++
T Consensus 278 t~~e~~ 283 (311)
T 4aw0_A 278 GCEEME 283 (311)
T ss_dssp TSGGGT
T ss_pred ChHHHc
Confidence 998853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=436.11 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=198.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++....... . ....++.+|+.+|++|+|||||++++++.+
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-S----DMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-H----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4578999999999999999999997 57899999975432211 1 122345999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. +||||||| +|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 85 ~~~--------------~~ivmEy~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL 144 (275)
T 3hyh_A 85 KDE--------------IIMVIEYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL 144 (275)
T ss_dssp SSE--------------EEEEEECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred CCE--------------EEEEEeCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence 664 49999999 5899999986 357999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+|+....... ....+||+.|||||++.+ ...++.++|||||||+||
T Consensus 145 l~~~-------~~vkl~DFGla~~~~~~~~-----------~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily 203 (275)
T 3hyh_A 145 LDEH-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILY 203 (275)
T ss_dssp ECTT-------CCEEECCSSCC--------------------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecCCCeecCCCCc-----------cCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHH
Confidence 9877 4599999999986543221 234579999999999986 233578999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||+||+.||.+.+..++...+..+..+ ++. ..++.+.+||.+||+.||.+||
T Consensus 204 ~lltg~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 255 (275)
T 3hyh_A 204 VMLCRRLPFDDESIPVLFKNISNGVYT-LPK---------------------------FLSPGAAGLIKRMLIVNPLNRI 255 (275)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCC-CCT---------------------------TSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHccCChhHCc
Confidence 999999999998888888887765321 221 1255789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|++|+++|-+-.
T Consensus 256 s~~eil~hpw~k 267 (275)
T 3hyh_A 256 SIHEIMQDDWFK 267 (275)
T ss_dssp CHHHHHHCHHHH
T ss_pred CHHHHHcCcccc
Confidence 999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=459.09 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=217.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-..|++.++||+|+||.||+|++ .+..||||++.+... ...+ .+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGG----GHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHH----HHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 45799999999999999999998 578899999765422 1122 3489999999999999999999999766
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. +|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 222 ~--------------~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 222 E--------------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp E--------------EEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred E--------------EEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 4 4999999999999999976 4699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||||
T Consensus 282 ~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyem 340 (423)
T 4fie_A 282 HD-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEM 340 (423)
T ss_dssp TT-------CCEEECCCTTCEECCSSCC----------CBCCCEECTTTCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEecCccceECCCCCc----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHH
Confidence 77 4599999999987654221 1245689999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|++||.+.+..+++..+.....+.+.. ....++.+.+||.+||..||.+|||+
T Consensus 341 l~G~~PF~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~dli~~~L~~dP~~R~ta 395 (423)
T 4fie_A 341 VDGEPPYFNEPPLKAMKMIRDNLPPRLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATA 395 (423)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCSC-------------------------TTSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHcCCCCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999998888887764433221 11235689999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 003375 807 GDLYEMFVARTSS 819 (825)
Q Consensus 807 ~EIL~hL~~l~ss 819 (825)
.|+|+|-+.....
T Consensus 396 ~ell~Hp~~~~~~ 408 (423)
T 4fie_A 396 AELLKHPFLAKAG 408 (423)
T ss_dssp HHHTTCGGGGGCC
T ss_pred HHHhcCHHhcCCC
Confidence 9999997665443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=431.67 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=203.1
Q ss_pred CCc-eeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSL-SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y-~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++| ++.++||+|+||.||+|.+. +..||+|++... .......+. |.+|+.+|++|+|||||+++++|....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh--hCCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 344 78889999999999999984 567888876433 233333344 499999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NIL 644 (825)
. ....+|||||||+||+|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+|||
T Consensus 99 ~----------~~~~~~lvmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 99 K----------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp T----------TEEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEE
T ss_pred C----------CCcEEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhee
Confidence 1 12346999999999999999986 356999999999999999999999998 999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.. .+.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||+||
T Consensus 164 l~~~------~g~vKl~DFGla~~~~~~~------------~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvily 220 (290)
T 3fpq_A 164 ITGP------TGSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCML 220 (290)
T ss_dssp ESST------TSCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHH
T ss_pred EECC------CCCEEEEeCcCCEeCCCCc------------cCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHH
Confidence 9742 1469999999997543211 134579999999999864 4899999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+||++||.+.. ...+...+..+..|... +...++++.+||.+||+.||.+|
T Consensus 221 elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHC
Confidence 9999999997654 44555555554332111 11234578999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003375 804 PTAGDLYEMFVA 815 (825)
Q Consensus 804 PSa~EIL~hL~~ 815 (825)
||+.|+++|.+-
T Consensus 275 ~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 275 YSIKDLLNHAFF 286 (290)
T ss_dssp CCHHHHHTSGGG
T ss_pred cCHHHHhcCccc
Confidence 999999999664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=442.76 Aligned_cols=268 Identities=23% Similarity=0.349 Sum_probs=215.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC-CCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H-PNIV~l 558 (825)
++.++|++.+.||+|+||.||+|.+.+ +.||||+... . ......+. |.+|+.+|.++.| ||||++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~--~-~~~~~~~~----~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--G-ATHSEHRA----LMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT--T-CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc--c-cChHHHHH----HHHHHHHHHHcCCCCcEEEE
Confidence 456789999999999999999999743 4688887532 1 22333344 4999999999975 999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
+|+|...+. .+|||||||++|+|.++|+..... ....+++..++.|+.||+.||+|
T Consensus 134 ~g~~~~~~~-------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 134 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp EEEECCTTS-------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCC-------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 999875432 249999999999999999863221 13458999999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||+++||||||||+||||+.+ +++||+|||+|+.+....... ......||+.|||||++.+
T Consensus 201 LH~~~iiHRDLK~~NILl~~~-------~~vKi~DFGlar~~~~~~~~~--------~~~~~~gt~~ymAPE~l~~---- 261 (353)
T 4ase_A 201 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD---- 261 (353)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----
T ss_pred HhhCCeecCccCccceeeCCC-------CCEEECcchhhhhcccCCCce--------eeccccccccccCHHHHhc----
Confidence 999999999999999999987 469999999998764432110 1234569999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 003375 708 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 785 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 785 (825)
..|+.++|||||||+||||+| |+.||.+.+. ..+...+..+.++.+++. .+
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~ 314 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------------------------TT 314 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT---------------------------CC
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCcc---------------------------CC
Confidence 779999999999999999998 8999988754 455666666665554422 24
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 786 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 786 ~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
+++.+||.+||+.||.+|||+.||++||+.+..+.
T Consensus 315 ~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 315 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 57999999999999999999999999999886543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=441.99 Aligned_cols=252 Identities=24% Similarity=0.270 Sum_probs=204.7
Q ss_pred CCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
.++|++++.||+|+||.||+|+. .+..||+|++...... ..... ++.+|+.+|++|+|||||++++++.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~----~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRV----RTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC----------CCCCCCCCTTEECEEEEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHH----HHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 36899999999999999999987 3567999997533211 11112 3488999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+.+. +|||||||+||+|.+++.+ ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 97 ~~~~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 157 (304)
T 3ubd_A 97 TEGK--------------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157 (304)
T ss_dssp ETTE--------------EEEEECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred ECCE--------------EEEEEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence 7664 4999999999999999986 35699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||+|+....... .....+||+.|||||++.+ ..|+.++|||||||+|
T Consensus 158 Ll~~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvil 216 (304)
T 3ubd_A 158 LLDEE-------GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLM 216 (304)
T ss_dssp EECTT-------SCEEEESSEEEEC-----C----------CCCSCCCCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEecccccceeccCCCc----------cccccccCcccCCHHHhcc----CCCCCCCcccchHHHH
Confidence 99887 4599999999986543211 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||+||++||.+.+..++...+.+...+ ++. ..++++.+||.+||+.||.+|
T Consensus 217 yemltG~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 217 FEMLTGTLPFQGKDRKETMTMILKAKLG-MPQ---------------------------FLSPEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------------------cCCHHHHHHHHHHcccCHHHC
Confidence 9999999999999999988888765321 221 135679999999999999999
Q ss_pred CC-----HHHHHHHHH
Q 003375 804 PT-----AGDLYEMFV 814 (825)
Q Consensus 804 PS-----a~EIL~hL~ 814 (825)
|| ++|+++|.+
T Consensus 269 ~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 269 LGAGPDGVEEIKRHSF 284 (304)
T ss_dssp TTCSTTTHHHHHTSGG
T ss_pred CCCCcCCHHHHHcCcc
Confidence 98 589998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=424.55 Aligned_cols=269 Identities=25% Similarity=0.288 Sum_probs=203.3
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
+|.+.++||+|+||.||+|+++++.||||++... ..+.+ ....|+..+.+++|||||+++|++...+.
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--- 71 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG--- 71 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS---
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhhH--HHHHHHHHHhcCCCCCCCcEEEEEEecCC---
Confidence 5889999999999999999999999999986422 11222 12456777788999999999999986542
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCC
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSEN 642 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~--------gIVHrDLKP~N 642 (825)
....+|||||||++|+|.++++. ..+++..+..|+.|++.||+|||++ +||||||||+|
T Consensus 72 -------~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 72 -------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp -------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred -------CceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 12357999999999999999986 4689999999999999999999987 99999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYG 720 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~--~~~~s~kSDVWSLG 720 (825)
|||+.+ +++||+|||+|+.......... ......+||+.|||||++.+... ...++.++||||||
T Consensus 139 ILl~~~-------~~~Ki~DFGla~~~~~~~~~~~------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 139 ILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp EEECTT-------SCEEECCCTTCEEEETTTTEES------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEEeCCCCccccCCCCcee------eecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 999877 5699999999987654332211 11234579999999999975211 11367899999999
Q ss_pred HHHHHHHhCCCCCCCCC---------------HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 721 CLLLELLTLQVPYMGLS---------------ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 721 vILyELLTG~~PF~~~~---------------~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
|+||||+||.+||.... ...+...+... .+|.++... ...+.
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~----------------------~~~~~ 263 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QSCEA 263 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GSSHH
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc----------------------cchHH
Confidence 99999999977663221 12233333222 334333211 12234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
++.+.+|+.+||+.||.+||||.||++.|+.+...
T Consensus 264 ~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 66899999999999999999999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=434.44 Aligned_cols=291 Identities=16% Similarity=0.200 Sum_probs=215.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++++.||+|+||+||+|++ .+..||||++.. ........+ ++.+|+.+|+.|+|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~--~~~~~~~~~----~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN--AFDVVTNAK----RTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETT--TTSSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECc--cccchHHHH----HHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 5799999999999999999998 578899998642 223333333 34899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+ .....+|||||||+ |+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.
T Consensus 128 ~--------~~~~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 128 Y--------GEFKSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp T--------TTCCCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred c--------ccCCEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence 2 11235799999996 689999975 467999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+|+.+...... ........+||+.|||||++.+ ...++.++||||+|||||||+
T Consensus 194 ~-------~~~Ki~DFGla~~~~~~~~~------~~~~~~~~~GT~~Y~APEv~~~---~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 194 N-------CELKIGDFGMARGLCTSPAE------HQYFMTEYVATRWYRAPELMLS---LHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp T-------CCEEECCCTTCBCC-------------CCCCCSSCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecceeeecccCccc------cccccccceeChHhcCHHHhcC---CCCCCChhheehhHHHHHHHH
Confidence 7 45999999999876432211 1112345689999999999886 245799999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++||.+.+..+.+..|...........+..........+...... ..........++++.+||.+||.+||.+||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 99999999998888887765422221111111100000000000000 001111233467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.|+|+|.+..
T Consensus 338 ta~e~L~Hp~f~ 349 (398)
T 4b99_A 338 SAAAALRHPFLA 349 (398)
T ss_dssp CHHHHTTSGGGT
T ss_pred CHHHHhcCHhhC
Confidence 999999996643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=419.19 Aligned_cols=275 Identities=24% Similarity=0.288 Sum_probs=191.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.+|++++.||+|+||.||+|++ .+..||||++.... ..... +.+.+|+.+|++|+|||||++++++...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~----~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAR----EKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHH----HHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHH----HHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 35799999999999999999998 47889999875432 22222 34599999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..... ........+|||||||+||+|.+++... ......+...++.|+.||+.||+|||++|||||||||+||||+
T Consensus 77 ~~~~~--~~~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 77 TTEKL--QPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp ------------CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ccccc--cccCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 21000 0011223579999999999999999851 1112345677899999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccc--cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s--~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
.+ +.+||+|||+|+.+.......... ..........+||+.|||||++.+ ..|+.++|||||||+||
T Consensus 153 ~~-------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvily 221 (299)
T 4g31_A 153 MD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----NSYSHKVDIFSLGLILF 221 (299)
T ss_dssp TT-------CCEEECCCCCC--------------------------CCCTTSCHHHHTT----CCCCTHHHHHHHHHHHH
T ss_pred CC-------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC----CCCCCHHHHHHHHHHHH
Confidence 77 459999999998875432211100 001112234579999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++ ||.+... ......+.....|. .....++.+.+||.+||+.||.+|
T Consensus 222 ell~---Pf~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 222 ELLY---PFSTQMERVRTLTDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp HHHS---CCSSHHHHHHHHHHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred HHcc---CCCCccHHHHHHHHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHC
Confidence 9996 7754321 22233333332221 112234567889999999999999
Q ss_pred CCHHHHHHHHHh
Q 003375 804 PTAGDLYEMFVA 815 (825)
Q Consensus 804 PSa~EIL~hL~~ 815 (825)
||+.||++|-+.
T Consensus 272 ps~~eil~h~~~ 283 (299)
T 4g31_A 272 PEAINIIENAVF 283 (299)
T ss_dssp CCHHHHHTSGGG
T ss_pred cCHHHHhcCHhh
Confidence 999999998543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=434.60 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=216.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++++.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.+|+.|+|||||+++++|.+.
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~----~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE----TVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHH----HHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 467999999999999999999998 5788999986532 122223 348999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. +|||||||+||+|.++|.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 227 ~~--------------~~iv~E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill 288 (573)
T 3uto_A 227 NE--------------MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288 (573)
T ss_dssp SE--------------EEEEEECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEeecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccc
Confidence 64 5999999999999999864 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+. .+.+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 289 ~~~~-----~~~vKl~DFG~a~~~~~~~~~-----------~~~~GT~~y~APEv~~~----~~y~~~~DiWSlGvilye 348 (573)
T 3uto_A 289 TTKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYI 348 (573)
T ss_dssp SSSS-----CCCEEECCCSSCEECCTTSEE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred cCCC-----CCCEEEeeccceeEccCCCce-----------eeeEECccccCHHHhCC----CCCCcHHHHHHHHHHHHH
Confidence 8652 257999999999887543221 23479999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|.+||.+.+..+++..+......... ......++.+.+||.+||+.||.+|||
T Consensus 349 ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 349 LLSGLSPFGGENDDETLRNVKSCDWNMDD------------------------SAFSGISEDGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCS------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHCCCCCCCcCHHHHHHHHHhCCCCCCc------------------------ccccCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999999888888766332111 111234568999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.|+|+|-+..
T Consensus 405 ~~e~l~Hpw~~ 415 (573)
T 3uto_A 405 IHQALEHPWLT 415 (573)
T ss_dssp HHHHHHSTTTS
T ss_pred HHHHhcCcCcC
Confidence 99999996644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=411.77 Aligned_cols=285 Identities=20% Similarity=0.169 Sum_probs=199.6
Q ss_pred CCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
++|++.++||+|+||+||+|++ .+..||+|++... . .. .++.+|+.+|+.+ +|||||++++++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~----~~----~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--S----HP----IRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--S----CH----HHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--c----CH----HHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 5799999999999999999986 2567899875321 1 11 2348899999998 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+.+. +|||||||+||+|.+++. .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 91 ~~~~--------------~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 91 KNDH--------------VVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp ETTE--------------EEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECCE--------------EEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 7664 499999999999999984 389999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCccccccccccccc------------------ccCCCCCCCcccCCCcccchhhhhccc
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI------------------AHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~------------------s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
|++.+. +.+||+|||+|+........... ...........+||+.|||||++.+
T Consensus 149 Ll~~~~------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 220 (361)
T 4f9c_A 149 LYNRRL------KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-- 220 (361)
T ss_dssp EEETTT------TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--
T ss_pred EEeCCC------CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--
Confidence 998652 46999999999866432211000 0000111234579999999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC-----------------------CCchhHHhhhc
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKR-----------------------PRLTDELEALG 761 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLTG~~PF~~-~~~~~i~~~I~~~~~-----------------------p~l~~~l~~~~ 761 (825)
...++.++||||+|||||||+||+.||.. .+..+.+..|..... ...........
T Consensus 221 -~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 221 -CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp -CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred -CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 24589999999999999999999999954 444444444432100 00000000000
Q ss_pred cCc--cccc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 762 SCH--EHEV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 762 ~~~--~~~~-~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
... .+.. ................++++.+||.+||++||.+|||++|+|+|.+.
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 000 0000 00000001112233456789999999999999999999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=434.67 Aligned_cols=258 Identities=20% Similarity=0.235 Sum_probs=205.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++++.||+|+||.||+|+. .+..||+|++......... ..........++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 6789999999999999999999998 5788999997533211100 01111111345677888899999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +|||||||+||+|..+|.. ...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 264 ~~~--------------lylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL 324 (689)
T 3v5w_A 264 PDK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324 (689)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE
Confidence 764 4999999999999999986 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+|+.+.... ....+||+.|||||++.. +..|+.++|||||||+||
T Consensus 325 ld~~-------G~vKL~DFGlA~~~~~~~------------~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvilY 382 (689)
T 3v5w_A 325 LDEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLF 382 (689)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHH
T ss_pred EeCC-------CCEEecccceeeecCCCC------------CCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHHH
Confidence 9987 459999999998764321 234589999999999964 256899999999999999
Q ss_pred HHHhCCCCCCCCC---HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 725 ELLTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 725 ELLTG~~PF~~~~---~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
||++|++||.+.+ ..++...+..... .++ ...++++.+||.+||+.||.
T Consensus 383 EmLtG~~PF~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~S~~a~dLI~~lL~~dP~ 434 (689)
T 3v5w_A 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELP---------------------------DSFSPELRSLLEGLLQRDVN 434 (689)
T ss_dssp HHHHSSCTTCGGGCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSCGG
T ss_pred HHHhCCCCCCCCChHHHHHHHHhhcCCCC-CCC---------------------------ccCCHHHHHHHHHHccCCHh
Confidence 9999999997642 3334444433321 111 12356799999999999999
Q ss_pred CCCC-----HHHHHHHHHh
Q 003375 802 ERPT-----AGDLYEMFVA 815 (825)
Q Consensus 802 eRPS-----a~EIL~hL~~ 815 (825)
+|++ ++||++|.+.
T Consensus 435 ~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 435 RRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp GCTTCSSSTHHHHTTSGGG
T ss_pred HCCCCCCCCHHHHhcCccc
Confidence 9998 7999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.61 Aligned_cols=267 Identities=28% Similarity=0.458 Sum_probs=209.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.+.+|++.+.||+|+||.||+|++.+..||+|++... .......+.+ .+|+.+|++++||||+++++++....
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ--DFHAERVNEF----LREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC--CCSHHHHHHH----HHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC--CCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 56789999999999999999999999999999996432 3333444444 89999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NIL 644 (825)
.. ++||||+++++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 108 ~~--------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIl 171 (309)
T 3p86_A 108 NL--------------SIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171 (309)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEE
T ss_pred ce--------------EEEEecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEE
Confidence 44 9999999999999999751 11124899999999999999999999999 999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 172 l~~~-------~~~kL~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 172 VDKK-------YTVKVCDFGLSRLKASTFLS----------SKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILW 230 (309)
T ss_dssp ECTT-------CCEEECCCC---------------------------CCTTSCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EeCC-------CcEEECCCCCCccccccccc----------cccCCCCccccChhhhcC----CCCCchhhHHHHHHHHH
Confidence 9877 46999999999754332111 233469999999999986 66789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++|+.||.+.+..+....+... ....++ ...++.+.+||.+||+.||.+|
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---------------------------RNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 999999999998888777666433 222222 1234579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCCCC
Q 003375 804 PTAGDLYEMFVARTSSSISS 823 (825)
Q Consensus 804 PSa~EIL~hL~~l~sss~S~ 823 (825)
||+.+|++.|+.+..+..++
T Consensus 284 ps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 284 PSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CCHHHHHHHHHHHHC-----
T ss_pred cCHHHHHHHHHHHHHhCCCC
Confidence 99999999999998775544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=384.41 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=212.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.... ......+. +.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQK----LFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4578999999999999999999997 67889999975432 23333333 4899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 86 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 86 EKT--------------LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCE--------------EEEEEECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 553 5999999999999999976 256899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||+||
T Consensus 147 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 147 LDAD-------MNIKIADFGFSNEFTVGGK-----------LDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILY 205 (328)
T ss_dssp ECTT-------SCEEECSTTCCGGGSSSCG-----------GGTTSSSGGGCCHHHHHT---CCCCSHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCceecCCCCc-----------cccccCCcceeCcccccC---CCcCCchhhhhhhHHHHH
Confidence 9877 4599999999976543221 133469999999999986 233458999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||.+.+..++...+..+... ++. ..++.+.+||.+||..||.+||
T Consensus 206 ell~g~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKELRERVLRGKYR-IPF---------------------------YMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHCCCChhHCc
Confidence 999999999999988888777765321 111 1245789999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.|+++|.+-
T Consensus 258 t~~eil~h~~~ 268 (328)
T 3fe3_A 258 TLEQIMKDRWI 268 (328)
T ss_dssp CHHHHTTCTTT
T ss_pred CHHHHhcCHhh
Confidence 99999999654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=376.81 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=213.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|++....... .+ .+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KE----LIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----HH----HHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----HH----HHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 457899999999999999999986 67789999876543211 12 348899999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 149 (297)
T 3fxz_A 90 DE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (297)
T ss_dssp TE--------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CE--------------EEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 53 4999999999999999986 468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 150 ~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 208 (297)
T 3fxz_A 150 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 208 (297)
T ss_dssp CTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCGGGCCHHHHHC----SCBCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCceecCCcccc----------cCCccCCcCccChhhhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 45999999999766432211 233579999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.+.......+.....+.+. .....++.+.+||.+||+.||.+|||
T Consensus 209 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps 263 (297)
T 3fxz_A 209 MIEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRGS 263 (297)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHHCSCCCS-------------------------CGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhHCcC
Confidence 99999999988877666555544332221 01223567999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 003375 806 AGDLYEMFVARTSSS 820 (825)
Q Consensus 806 a~EIL~hL~~l~sss 820 (825)
+.|+++|.+......
T Consensus 264 ~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 264 AKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHTTCGGGGGCCC
T ss_pred HHHHhhChhhcccCc
Confidence 999999977655443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=365.29 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+++|++.+.||+|+||.||+|.+.+..+|+|+........... ..+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQ----TIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHH----HHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 567899999999999999999999999999999965432222122 2234589999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH---IMHRDIKSENI 643 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g---IVHrDLKP~NI 643 (825)
.. ++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 80 ~~--------------~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Ni 139 (271)
T 3dtc_A 80 NL--------------CLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139 (271)
T ss_dssp -C--------------EEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGE
T ss_pred ce--------------EEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHE
Confidence 43 999999999999999853 57999999999999999999999999 89999999999
Q ss_pred EEecCccC-CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~-~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|++...+. ....+.+||+|||++........ ....||+.|+|||++.+ ..++.++||||||++
T Consensus 140 l~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 203 (271)
T 3dtc_A 140 LILQKVENGDLSNKILKITDFGLAREWHRTTK------------MSAAGAYAWMAPEVIRA----SMFSKGSDVWSYGVL 203 (271)
T ss_dssp EESSCCSSSCCSSCCEEECCCCC-------------------------CCGGGSCHHHHHH----CCCSHHHHHHHHHHH
T ss_pred EEecccccccccCcceEEccCCcccccccccc------------cCCCCccceeCHHHhcc----CCCCchhhHHHHHHH
Confidence 99864221 11246799999999976543221 22368999999999987 668999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|+|++|+.||.+.+.......+..... ..++ ...++.+.+||.+||+.||.
T Consensus 204 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 256 (271)
T 3dtc_A 204 LWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---------------------------STCPEPFAKLMEDCWNPDPH 256 (271)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC---------------------------cccCHHHHHHHHHHhcCCcc
Confidence 9999999999998887776665554421 1111 12345799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
+|||+.+++++|+.+
T Consensus 257 ~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 257 SRPSFTNILDQLTTI 271 (271)
T ss_dssp GSCCHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHhcC
Confidence 999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.32 Aligned_cols=268 Identities=20% Similarity=0.314 Sum_probs=215.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|.+. +..||||++... ......+. +.+|+.+|++++||||++++++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRD----FLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEE
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHH----HHHHHHHHHhCCCCCCCcEEEE
Confidence 55678999999999999999999983 345899986422 22333333 4999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... ||||||+++++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 119 ~~~~~~~--------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 180 (325)
T 3kul_A 119 VTRGRLA--------------MIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR 180 (325)
T ss_dssp ECGGGCC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEeCCcc--------------EEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 9765543 999999999999999975 2356999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 181 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~ 242 (325)
T 3kul_A 181 NVLVDSN-------LVCKVSDFGLSRVLEDDPDAAY-------TTTGGKIPIRWTAPEAIAF----RTFSSASDVWSFGV 242 (325)
T ss_dssp GEEECTT-------CCEEECCCSSCEECC----CCE-------ECC---CCGGGSCHHHHHH----CEECHHHHHHHHHH
T ss_pred eEEECCC-------CCEEECCCCcccccccCcccee-------eccCCCCcccccCHhHhcC----CCCCcHHHHHHHHH
Confidence 9999876 4699999999987654321111 0122346789999999986 56899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||++ |..||.+....++...+..+..+..+. ..++.+.+||.+||..||
T Consensus 243 il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 243 VMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM---------------------------GCPHALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC---------------------------CcCHHHHHHHHHHccCCh
Confidence 9999999 999999998888888877664433221 235579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSISSR 824 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~S~~ 824 (825)
.+|||+.+|++.|+.+.....+.+
T Consensus 296 ~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 296 AQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp GGSCCHHHHHHHHHHHHHSCC---
T ss_pred hhCcCHHHHHHHHHHHHhCccccc
Confidence 999999999999999987766543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=382.92 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=214.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
...++|++.+.||+|+||.||+|.+. +..||+|+.... ......+. +.+|+.+|+.+ +||||+
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHH----HHHHHHHHHHSCCCTTBC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHH----HHHHHHHHHHhcCCCCEe
Confidence 34578999999999999999999862 245888885322 22233333 49999999999 899999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++.....+ |+||||+++|+|.+++..... .....+++..++.++.||+.||
T Consensus 151 ~~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 216 (370)
T 2psq_A 151 NLLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216 (370)
T ss_dssp CEEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEccCCCE--------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 999999866544 999999999999999986321 1124588999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+||||+.+ +.+||+|||+++.+...... .......+|+.|+|||++.+
T Consensus 217 ~~LH~~~ivHrDlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~-- 279 (370)
T 2psq_A 217 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFD-- 279 (370)
T ss_dssp HHHHHTTEECSCCCGGGEEECTT-------CCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHT--
T ss_pred HHHHhCCeeccccchhhEEECCC-------CCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcC--
Confidence 99999999999999999999877 46999999999866432211 01123357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||+||||+| |..||.+....++...+..+.++.++. ..
T Consensus 280 --~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 330 (370)
T 2psq_A 280 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NC 330 (370)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TS
T ss_pred --CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CC
Confidence 678999999999999999999 999999988888777777665443331 23
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+..+.+||.+||+.||.+|||+.||+++|+.+..
T Consensus 331 ~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 4579999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=384.60 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=214.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-+.|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.+|+.++||||+++++++....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 35699999999999999999998 47889999976543222111 011223489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~--------------~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 149 (361)
T 2yab_A 89 D--------------VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (361)
T ss_dssp E--------------EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred E--------------EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 3 5999999999999999965 35799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++. ....+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 ~~~~---~~~~vkl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 150 DKNI---PIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp CTTS---SSCCEEECCCSSCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred CCCC---CccCEEEEecCCceEcCCCCc-----------cccCCCCccEECchHHcC----CCCCccccHHHHHHHHHHH
Confidence 6631 123699999999987643211 133469999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.+..++...+........... ....++.+.+||.+||..||.+|||+
T Consensus 212 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~t~ 267 (361)
T 2yab_A 212 LSGASPFLGDTKQETLANITAVSYDFDEEF------------------------FSQTSELAKDFIRKLLVKETRKRLTI 267 (361)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCchh------------------------ccCCCHHHHHHHHHHCCCChhHCcCH
Confidence 999999999988888888776643221111 12235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.|+++|.+-
T Consensus 268 ~e~l~hp~~ 276 (361)
T 2yab_A 268 QEALRHPWI 276 (361)
T ss_dssp HHHHTSTTT
T ss_pred HHHhcCcCc
Confidence 999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.26 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=213.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..+|+|++... ...... +.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVL----VKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHH----HHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHH----HHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 57899999999999999999998 4678999986532 122233 489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~--------------~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 75 E--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp E--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred E--------------EEEEEEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 3 5999999999999999864 234689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+. .+.+||+|||++..+...... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 137 ~~~-----~~~~kl~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 196 (321)
T 1tki_A 137 TRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred cCC-----CCCEEEEECCCCeECCCCCcc-----------ccccCChhhcCcHHhcC----CCCCchhhHHHHHHHHHHH
Confidence 642 257999999999876432211 23469999999999986 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.+..++...+........... ....+..+.+||.+||..||.+|||+
T Consensus 197 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~ 252 (321)
T 1tki_A 197 LSGINPFLAETNQQIIENIMNAEYTFDEEA------------------------FKEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCcCCCHHHHHHHHHcCCCCCChhh------------------------hccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999988888888776643322211 12335679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 003375 807 GDLYEMFVART 817 (825)
Q Consensus 807 ~EIL~hL~~l~ 817 (825)
.|+++|.+-..
T Consensus 253 ~e~l~hp~~~~ 263 (321)
T 1tki_A 253 SEALQHPWLKQ 263 (321)
T ss_dssp HHHHHSHHHHS
T ss_pred HHHhcChhhcc
Confidence 99999977543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=367.58 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=212.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-++|++.+.||+|+||.||+|.+ .+..+|+|++..... ......+ .+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLK----RFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHH----HHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHH----HHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 346899999999999999999997 577899998754322 2233333 449999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. .|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~--------------~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 84 DC--------------YYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144 (294)
T ss_dssp SE--------------EEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred Ce--------------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 53 5999999999999999986 2468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 145 ~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 204 (294)
T 4eqm_A 145 DSN-------KTLKIFDFGIAKALSETSLT---------QTNHVLGTVQYFSPEQAKG----EATDECTDIYSIGIVLYE 204 (294)
T ss_dssp CTT-------SCEEECCCSSSTTC----------------------CCSSCCHHHHHT----CCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEEeCCCcccccccccc---------ccCccccCccccCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 877 45999999999876432211 1233469999999999986 667899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP- 804 (825)
|++|+.||.+.+.............+.....+ ....++.+.++|.+||..||.+||
T Consensus 205 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 205 MLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV-----------------------RKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS-----------------------CTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred HHhCCCCCCCCChHHHHHHHhhccCCCcchhc-----------------------ccCCCHHHHHHHHHHhcCCHhHccc
Confidence 99999999988877766555555444332211 122356799999999999999998
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003375 805 TAGDLYEMFVARTSSSI 821 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss~ 821 (825)
+++++.+.|..+.....
T Consensus 262 ~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 262 TIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SHHHHHHHHHTSSSSSS
T ss_pred cHHHHHHHHHHHHhhcc
Confidence 89999999998876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=362.74 Aligned_cols=259 Identities=21% Similarity=0.334 Sum_probs=215.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+ .+..+|+|++.... .. .+. +.+|+.++++++||||+++++++...
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BC---HHH----HHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cC---HHH----HHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4457899999999999999999998 67789999865322 11 123 48999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 139 (269)
T 4hcu_A 78 AP--------------ICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139 (269)
T ss_dssp SS--------------EEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred Cc--------------eEEEEEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE
Confidence 54 4999999999999999975 23568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 140 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 140 GEN-------QVIKVSDFGMTRFVLDDQYTS---------STGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp CGG-------GCEEECCTTGGGGBCCHHHHS---------TTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEecccccccccccccccc---------ccCcccccccCCHHHhcC----CCCCchhhhHHHHHHHHH
Confidence 877 459999999998664422111 123357889999999986 668999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||.+....++...+.....+..+. ..++.+.+|+.+||+.||.+||
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcCccCCCCC---------------------------cCCHHHHHHHHHHccCCcccCc
Confidence 999 999999998888887777664333221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
|+.+++++|+.+..+
T Consensus 253 s~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 253 AFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHc
Confidence 999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=380.84 Aligned_cols=259 Identities=25% Similarity=0.311 Sum_probs=213.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+. +.+|+.+++.|+||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc--CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 35799999999999999999998 47789999975432 23333344 489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 102 F--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162 (362)
T ss_dssp E--------------EEEEECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred E--------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 3 4999999999999999875 35689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+++ ...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 163 ~~~~----~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 223 (362)
T 2bdw_A 163 SKAK----GAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 223 (362)
T ss_dssp CSST----TCCEEECCCTTCBCCTTCCS-----------CCCSCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCCC----CCCEEEeecCcceEecCCcc-----------cccCCCCccccCHHHHcc----CCCCchhhHHHHHHHHHHH
Confidence 6532 25699999999976643211 123569999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.+...+...+..+....... .....++.+.+||.+||..||.+|||+
T Consensus 224 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (362)
T 2bdw_A 224 LVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------------------EWDTVTPEAKSLIDSMLTVNPKKRITA 279 (362)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCcc------------------------cccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999988888887777663321111 112345679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.++++|.+-
T Consensus 280 ~e~l~hp~~ 288 (362)
T 2bdw_A 280 DQALKVPWI 288 (362)
T ss_dssp HHHTTSHHH
T ss_pred HHHhcCccc
Confidence 999999653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.28 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=211.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+++|++.+.||+|+||.||+|.+.+..+|+|++... .......+.+ .+|+.++++++||||+++++++....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRDF----NEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT--TCCHHHHHHH----HHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc--ccCHHHHHHH----HHHHHHHHhcCCCchhheEEEEccCC
Confidence 67889999999999999999999999999999997543 2333333444 99999999999999999999987652
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NIL 644 (825)
. ...++||||+++|+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 81 ~------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil 145 (271)
T 3kmu_A 81 A------------PHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145 (271)
T ss_dssp S------------SSCEEEEECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEE
T ss_pred C------------CCeEeeecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEE
Confidence 1 135999999999999999985 22235899999999999999999999999 999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.++|+|||++..... ....||+.|+|||++.+.. ...++.++|||||||++|
T Consensus 146 ~~~~-------~~~~l~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 202 (271)
T 3kmu_A 146 IDED-------MTARISMADVKFSFQS---------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLLW 202 (271)
T ss_dssp ECTT-------SCEEEEGGGSCCTTSC---------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHHH
T ss_pred EcCC-------cceeEEeccceeeecc---------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHHH
Confidence 9877 4588988887654322 2236899999999998621 123345899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++|+.||.+.+.......+... ..+.++. ..++.+.+||.+||+.||.+|
T Consensus 203 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~R 255 (271)
T 3kmu_A 203 ELVTREVPFADLSNMEIGMKVALEGLRPTIPP---------------------------GISPHVSKLMKICMNEDPAKR 255 (271)
T ss_dssp HHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCccccChHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhC
Confidence 999999999988877766555443 3333221 235579999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003375 804 PTAGDLYEMFVARTS 818 (825)
Q Consensus 804 PSa~EIL~hL~~l~s 818 (825)
||+.++++.|+.+..
T Consensus 256 ps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 256 PKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHHCC
T ss_pred cCHHHHHHHHHHhhc
Confidence 999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=372.15 Aligned_cols=268 Identities=23% Similarity=0.356 Sum_probs=216.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
...++|++.+.||+|+||.||+|++.+ ..||+|+.... ......+ .+.+|+.++++++||||++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQA----DFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHH----HHHHHHHHHHhCCCCCEEEEE
Confidence 456789999999999999999999854 78999985422 1223333 449999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-------------------CCCccCHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQD 620 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-------------------~~~~ls~~~i~~Ia~Q 620 (825)
+++...... |+||||+++++|.+++...... ....+++..++.++.|
T Consensus 117 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 182 (343)
T 1luf_A 117 GVCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182 (343)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred EEEccCCce--------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence 999866544 9999999999999999863211 1256899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003375 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700 (825)
Q Consensus 621 Ia~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEv 700 (825)
|+.||.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||+
T Consensus 183 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~ 247 (343)
T 1luf_A 183 VAAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYYK--------ADGNDAIPIRWMPPES 247 (343)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHH
T ss_pred HHHHHHHHHhCCeecCCCCcceEEECCC-------CeEEEeecCCCcccccCcccc--------ccCCCcccceecChhh
Confidence 9999999999999999999999999877 459999999998664322110 1123468899999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCch
Q 003375 701 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779 (825)
Q Consensus 701 l~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 779 (825)
+.+ ..++.++|||||||++|||++ |..||.+....++...+..+..+.++.
T Consensus 248 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------ 299 (343)
T 1luf_A 248 IFY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------------------------ 299 (343)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT------------------------
T ss_pred hcc----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCC------------------------
Confidence 986 568999999999999999999 999999998888887777665433331
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 780 ~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
..+..+.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus 300 ---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 300 ---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 124579999999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=362.83 Aligned_cols=283 Identities=19% Similarity=0.239 Sum_probs=209.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|.+ .+..||+|++..... ...... .+.+|+.++++++||||+++++++....
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHH----HHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcch----HHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 46899999999999999999998 567899999765432 222223 3489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .+|||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 75 K--------------LTLVFEFCD-QDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 4 499999998 577777664 235699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 195 (292)
T 3o0g_A 136 RN-------GELKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------SCEEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCCcccc----------ccCCccccCCcChHHHcC---CCCcCchHHHHHHHHHHHHH
Confidence 77 45999999999876432111 233468999999999975 23479999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~P-F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|..| |.+.+..+....+...........+........ ...................++.+.+||.+||+.||.+||
T Consensus 196 ~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 988777 566666666555544321111111111110000 000000011111222334567899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|++|+++|.+..
T Consensus 276 t~~e~l~hp~f~ 287 (292)
T 3o0g_A 276 SAEEALQHPYFS 287 (292)
T ss_dssp CHHHHHTSGGGT
T ss_pred CHHHHhcCcccc
Confidence 999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=380.52 Aligned_cols=270 Identities=21% Similarity=0.326 Sum_probs=218.2
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcce
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE 557 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~ 557 (825)
.....++|++.+.||+|+||.||+|.+. +..||||++. . ......... +.+|+.++++++||||++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~--~-~~~~~~~~~----~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--E-VCSEQDELD----FLMEALIISKFNHQNIVR 138 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC--S-SCCHHHHHH----HHHHHHHHHHCCCTTBCC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc--c-ccChhhHHH----HHHHHHHHHhCCCCCCCe
Confidence 3456789999999999999999999953 4578999853 2 122333333 489999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc--CCCccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMH 635 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVH 635 (825)
+++++...... +|||||+++|+|.+++...... ....+++..++.++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 204 (367)
T 3l9p_A 139 CIGVSLQSLPR--------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH 204 (367)
T ss_dssp EEEEECSSSSC--------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEecCCCC--------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99999866544 9999999999999999874321 1245899999999999999999999999999
Q ss_pred cCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhh
Q 003375 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 715 (825)
Q Consensus 636 rDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSD 715 (825)
|||||+||||+.++. ...+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|
T Consensus 205 rDlkp~NIll~~~~~----~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~D 268 (367)
T 3l9p_A 205 RDIAARNCLLTCPGP----GRVAKIGDFGMARDIYRAGYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKTD 268 (367)
T ss_dssp SCCCGGGEEESCSST----TCCEEECCCHHHHHHHHHSSC--------TTCCGGGSCGGGCCHHHHHH----CCCCHHHH
T ss_pred CCCChhhEEEecCCC----CceEEECCCcccccccccccc--------ccCCCcCCcccEECHHHhcC----CCCCcHHH
Confidence 999999999986532 256999999999765432211 11233468999999999987 67899999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 716 IWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 716 VWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
||||||+||||++ |..||.+....++...+..+..+..+. ..+..+.+||.+
T Consensus 269 vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~ 321 (367)
T 3l9p_A 269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQ 321 (367)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHH
Confidence 9999999999998 999999999888888887765433321 124578999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 003375 795 CTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 795 CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
||+.||.+|||+.+|+++|+.+..
T Consensus 322 ~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 322 CWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999988764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=371.40 Aligned_cols=286 Identities=21% Similarity=0.251 Sum_probs=208.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
....+|++.+.||+|+||.||+|++.+..||||++.... .... ...+|+.+|++++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-----KQSW----QNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-----HHHH----HHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-----hHHH----HHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 456789999999999999999999999999999975321 2222 2367999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC----------Ccccc
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHR 636 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~----------gIVHr 636 (825)
.. ...+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||
T Consensus 92 ~~----------~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~ 155 (322)
T 3soc_A 92 SV----------DVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155 (322)
T ss_dssp SS----------SEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred CC----------CceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence 21 2357999999999999999986 4599999999999999999999999 99999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhh
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVD 715 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~-~~~~s~kSD 715 (825)
||||+|||++.+ +.+||+|||+++.+...... .......||+.|+|||++.+... ...++.++|
T Consensus 156 Dlkp~Nill~~~-------~~~kL~DFg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 220 (322)
T 3soc_A 156 DIKSKNVLLKNN-------LTACIADFGLALKFEAGKSA--------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220 (322)
T ss_dssp CCSGGGEEECTT-------CCEEECCCTTCEEECTTSCC--------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred CCChHhEEECCC-------CeEEEccCCcccccccccCc--------cccccCccCccccCHhhcccccccCcCCCccch
Confidence 999999999877 46999999999876542211 11233579999999999975211 123567899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 716 IWSYGCLLLELLTLQVPYMGLSELEIHD-LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 716 VWSLGvILyELLTG~~PF~~~~~~~i~~-~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
||||||+||||+||+.||.+........ .......+............ ...............++.+.+||.+
T Consensus 221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~ 294 (322)
T 3soc_A 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK------KKRPVLRDYWQKHAGMAMLCETIEE 294 (322)
T ss_dssp HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc------cCCCCccccccccchHHHHHHHHHH
Confidence 9999999999999999997643211000 00001111111110000000 0000000111122346679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 003375 795 CTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 795 CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
||+.||.+|||+.+|++.|+.+..
T Consensus 295 cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 295 CWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=387.89 Aligned_cols=260 Identities=25% Similarity=0.299 Sum_probs=212.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..+|+|++..+. ......+ .+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQ----KLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHH----HHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHH----HHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 36799999999999999999987 67889999875432 2222333 3489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 84 ~--------------~~lv~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 84 H--------------HYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144 (444)
T ss_dssp E--------------EEEEECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred E--------------EEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 4 4999999999999999986 35699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+. ....+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||+||+|
T Consensus 145 ~~~----~~~~vkL~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGvilyel 206 (444)
T 3soa_A 145 SKL----KGAAVKLADFGLAIEVEGEQQA----------WFGFAGTPGYLSPEVLRK----DPYGKPVDLWACGVILYIL 206 (444)
T ss_dssp BSS----TTCCEEECCCSSCBCCCTTCCB----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred ccC----CCCcEEEccCceeEEecCCCce----------eecccCCcccCCHHHhcC----CCCCCccccHHHHHHHHHH
Confidence 542 1256999999999766542211 123579999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|.+||.+.+...+...+..+....... .....++.+.+||.+||+.||.+|||+
T Consensus 207 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta 262 (444)
T 3soa_A 207 LVGYPPFWDEDQHRLYQQIKAGAYDFPSP------------------------EWDTVTPEAKDLINKMLTINPSKRITA 262 (444)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCccHHHHHHHHHhCCCCCCcc------------------------ccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999998888888887764321111 011235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.|+++|.+-
T Consensus 263 ~e~L~hp~~ 271 (444)
T 3soa_A 263 AEALKHPWI 271 (444)
T ss_dssp HHHHHSCTT
T ss_pred HHHhcCccc
Confidence 999998543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.17 Aligned_cols=264 Identities=26% Similarity=0.306 Sum_probs=209.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++|++.+.||+|+||.||+|.+ .+..||+|++........ .... +.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST----EDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCH----HHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchH----HHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5799999999999999999997 578899999764321111 0112 23489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .||||||++|++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~--------------~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 100 M--------------LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp E--------------EEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 3 5999999999999998875322 234689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+++ ...+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||+||+|
T Consensus 165 ~~~~----~~~vkl~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 165 SKEN----SAPVKLGGFGVAIQLGESGLV----------AGGRVGTPHFMAPEVVKR----EPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp SSST----TCCEEECCCTTCEECCTTSCB----------CCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCCC----CCcEEEecCcceeEecCCCee----------ecCCcCCcCccCHHHHcC----CCCCchHhhHHHHHHHHHH
Confidence 6532 356999999999876542211 133469999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+. ...+...+..+.....+.. ....++.+.+||.+||..||.+|||+
T Consensus 227 l~g~~pf~~~-~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 227 LSGCLPFYGT-KERLFEGIIKGKYKMNPRQ------------------------WSHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHSSCSSCSS-HHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCc-HHHHHHHHHcCCCCCCccc------------------------cccCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999875 3445555555433222211 12235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.++++|.+.
T Consensus 282 ~e~l~hp~~ 290 (351)
T 3c0i_A 282 YEALNHPWL 290 (351)
T ss_dssp HHHHTSHHH
T ss_pred HHHhcChhh
Confidence 999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.78 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=212.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.|.+.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 5699999999999999999998 47889999976543322111 0011234899999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 89 --------------VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp --------------EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred --------------EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 5999999999999999964 356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
++. ....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 150 ~~~---~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 150 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp SSS---SSCCEEECCCTTCEECCTTSC-----------CCCCCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CCCCEEEEECCCCeECCCCCc-----------cccccCCcCcCCceeecC----CCCCcHHHHHHHHHHHHHHH
Confidence 641 223699999999987643211 123469999999999976 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||.+....+....+.......... .....+..+.+||.+||..||.+|||+.
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 267 (326)
T 2y0a_A 212 SGASPFLGDTKQETLANVSAVNYEFEDE------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQ 267 (326)
T ss_dssp HSCCSSCCSSHHHHHHHHHHTCCCCCHH------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCcCCCCCCCHHHHHHHHHhcCCCcCcc------------------------ccccCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999999888877777766543322111 1122356789999999999999999999
Q ss_pred HHHHHHHhh
Q 003375 808 DLYEMFVAR 816 (825)
Q Consensus 808 EIL~hL~~l 816 (825)
++++|.+..
T Consensus 268 e~l~hp~~~ 276 (326)
T 2y0a_A 268 DSLQHPWIK 276 (326)
T ss_dssp HHHHSTTTS
T ss_pred HHhcCCCcc
Confidence 999986543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.43 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=214.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
....+|.+.+.||+|+||.||+|.+ .+..||+|+.... ......+. +.+|+.+++.++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRD----LLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHH----HHHHHHHHhhCCCCceeeEE
Confidence 3467899999999999999999986 2367899985421 23333344 48999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-------------------CCCccCHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQD 620 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-------------------~~~~ls~~~i~~Ia~Q 620 (825)
+++...... ++||||+++++|.+++...... ....+++..++.++.|
T Consensus 93 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 93 GACSQDGPL--------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred EEEecCCce--------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 999866544 9999999999999999863221 1234899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003375 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700 (825)
Q Consensus 621 Ia~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEv 700 (825)
|+.||.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||+
T Consensus 159 i~~~l~~lH~~~ivH~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 159 ISQGMQYLAEMKLVHRDLAARNILVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIES 223 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETT-------TEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHCCCcccccchheEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcccccChhh
Confidence 9999999999999999999999999977 469999999998764422111 1123357889999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCch
Q 003375 701 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779 (825)
Q Consensus 701 l~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 779 (825)
+.+ ..++.++|||||||++|||++ |..||.+.....+...+.....+..+.
T Consensus 224 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------ 275 (314)
T 2ivs_A 224 LFD----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD------------------------ 275 (314)
T ss_dssp HHH----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT------------------------
T ss_pred hcC----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCc------------------------
Confidence 987 568899999999999999999 999999888877777776654433221
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 780 ~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
..++.+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus 276 ---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 276 ---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 235579999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=369.32 Aligned_cols=283 Identities=19% Similarity=0.234 Sum_probs=209.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-+++|++.+.||+|+||.||+|.+ .+..||+|++..... .. .....+.+|+.++++++||||+++++++...
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DE----GIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 5678999999999999999999998 677899998754321 11 1223448999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 92 RC--------------LTLVFEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp SC--------------EEEEEECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 54 499999998 589888875 23568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++........ .....||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 153 NSD-------GALKLADFGLARAFGIPVRS----------YTHEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp CTT-------CCEEECCCTTCEETTSCCC-------------CCCCCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCcCceecCCCccc----------ccCCcccCCcCCHHHhcC---CCCCCchHHhHHHHHHHHH
Confidence 877 45999999999876432211 123468999999999975 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCC----CCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS----GFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|++|+.||.+....+....+........+..+...... ..+..... ...........++++.+||.+||+.||.
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 290 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL--PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS--HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTT
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc--chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChh
Confidence 99999999887666555554432111111111111000 00000000 0001112233456889999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
+|||+.|+++|.+..
T Consensus 291 ~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 291 KRISARDAMNHPYFK 305 (311)
T ss_dssp TSCCHHHHHTSGGGT
T ss_pred HCCCHHHHhcCcccc
Confidence 999999999986654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=357.33 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=212.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|++.... .. .+. +.+|+.++++++||||+++++++...
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MS---EDE----FFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--Cc---HHH----HHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34578999999999999999999985 4579999865322 11 122 38999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~ 137 (268)
T 3sxs_A 76 YP--------------IYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137 (268)
T ss_dssp SS--------------EEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE
T ss_pred Cc--------------eEEEEEccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE
Confidence 53 49999999999999999862 2458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 138 ~~~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 197 (268)
T 3sxs_A 138 DRD-------LCVKVSDFGMTRYVLDDQYVS---------SVGTKFPVKWSAPEVFHY----FKYSSKSDVWAFGILMWE 197 (268)
T ss_dssp CTT-------CCEEECCTTCEEECCTTCEEE---------CCSCCCCGGGCCHHHHHH----SEEETTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCccceecchhhhhc---------ccCCCcCcccCCHHHHhc----cCCchhhhhHHHHHHHHH
Confidence 877 459999999998765432211 122346788999999986 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||...........+........+. ..++.+.+||.+||+.||.+||
T Consensus 198 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 250 (268)
T 3sxs_A 198 VFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH---------------------------LASDTIYQIMYSCWHELPEKRP 250 (268)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHTTCSSGGGSC
T ss_pred HHcCCCCCccccChHHHHHHHHcCCCCCCCC---------------------------cChHHHHHHHHHHcCCChhhCc
Confidence 999 999999888888777776654333221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.+++++|+.+..
T Consensus 251 s~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 251 TFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHHHHHHHGGGCC
T ss_pred CHHHHHHHHHHhhh
Confidence 99999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=363.73 Aligned_cols=281 Identities=19% Similarity=0.235 Sum_probs=206.0
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+++|++.+.||+|+||.||+|.+ .+..+|+|++...... . .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--E----GIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--G----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc--c----ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 46899999999999999999998 4778999987543211 1 112334899999999999999999999986654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 --------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 75 --------------LVLVFEHLD-QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp --------------EEEEEECCS-EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------EEEEEEecC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 499999998 599999875 2356899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 136 E-------GELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeECccccccCccccc----------cccccccccccCchheeC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 45999999999765432111 123468999999999975 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+|+.||.+.+..+....+...........+....... .+.+. ..............++.+.+||.+||+.||.+|||
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT-VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC-CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc-cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 9999999888776665554321111111110000000 00000 00000011112235678999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.|+++|.+.
T Consensus 275 ~~e~l~hp~f 284 (288)
T 1ob3_A 275 AKQALEHAYF 284 (288)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcCcch
Confidence 9999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.73 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=210.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+. +..||+|++.... .. .+. +.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MS---EDE----FIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BC---HHH----HHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CC---HHH----HHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 55679999999999999999999984 4579999865321 11 122 48999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili 153 (283)
T 3gen_A 92 RP--------------IFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153 (283)
T ss_dssp SS--------------EEEEECCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred CC--------------eEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence 54 49999999999999999752 2468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 154 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~ 213 (283)
T 3gen_A 154 NDQ-------GVVKVSDFGLSRYVLDDEYTS---------SVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWE 213 (283)
T ss_dssp CTT-------SCEEECSTTGGGGBCCHHHHS---------TTSTTSCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEcccccccccccccccc---------ccCCccCcccCCHHHhcc----CCCCchhhHHHHHHHHHH
Confidence 877 459999999998664432111 122357889999999986 568999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |+.||...+.......+........+. ..++.+.+||.+||+.||.+||
T Consensus 214 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 214 IYSLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSC
T ss_pred HHhCCCCCccccChhHHHHHHhcccCCCCCC---------------------------cCCHHHHHHHHHHccCChhHCc
Confidence 998 999999988888887777664433221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.+++++|+.+..
T Consensus 267 s~~~ll~~L~~~~~ 280 (283)
T 3gen_A 267 TFKILLSNILDVMD 280 (283)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.04 Aligned_cols=263 Identities=25% Similarity=0.301 Sum_probs=214.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+. +.+|+.++++++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 357899999999999999999998 47789999976443 23333344 48999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~--------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 138 (284)
T 3kk8_A 78 SF--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 138 (284)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE
Confidence 53 4999999999999999876 2568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++. ...+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 139 ~~~~~----~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 139 ASKAK----GAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYI 199 (284)
T ss_dssp SSSST----TCCEEECCCTTCEECCSSCB-----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred ecCCC----CCcEEEeeceeeEEcccCcc-----------ccCCCCCcCCcCchhhcC----CCCCcccchHHHHHHHHH
Confidence 86632 35699999999976643221 123469999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.........+..+....... .....++.+.+||.+||+.||.+|||
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps 255 (284)
T 3kk8_A 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------------------EWDTVTPEAKSLIDSMLTVNPKKRIT 255 (284)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHCCCCCCCCchhHHHHHHHhccccCCch------------------------hhcccCHHHHHHHHHHcccChhhCCC
Confidence 999999999988888877776653221110 01123567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.|+++|.+-...
T Consensus 256 ~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 256 ADQALKVPWICNR 268 (284)
T ss_dssp HHHHTTSHHHHSC
T ss_pred HHHHhcCccccCC
Confidence 9999999765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=377.11 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=210.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|+. .+..||+|++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 3567999999999999999999998 578899999753211 011112344899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 137 (337)
T 1o6l_A 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence 653 5999999999999999976 256899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 138 l~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 196 (337)
T 1o6l_A 138 LDKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeeccchhhcccCCC----------cccccccChhhCChhhhcC----CCCCchhhcccchhHHH
Confidence 9877 4599999999975432111 1234579999999999976 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|+.||.+.+...+...+..... .++. ..++.+.+||.+||+.||.+||
T Consensus 197 ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 197 EMMCGRLPFYNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHhc
Confidence 99999999998888887777765422 1111 1245789999999999999999
Q ss_pred -----CHHHHHHHHHh
Q 003375 805 -----TAGDLYEMFVA 815 (825)
Q Consensus 805 -----Sa~EIL~hL~~ 815 (825)
++.+|++|.+.
T Consensus 249 g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 249 GGGPSDAKEVMEHRFF 264 (337)
T ss_dssp TCSTTTHHHHHTSGGG
T ss_pred CCCCCCHHHHHcCCCc
Confidence 99999998543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.98 Aligned_cols=257 Identities=25% Similarity=0.274 Sum_probs=202.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|+. .+..+|+|++............. .+.+|+.+|+.++||||++++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA----HTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHH----HHHHHHHHHHhCCCCCccceeEE
Confidence 5678999999999999999999987 57789999975432211122222 34889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+..... .||||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 ~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 150 (327)
T 3a62_A 90 FQTGGK--------------LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPE 150 (327)
T ss_dssp EECSSC--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred EEcCCE--------------EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHH
Confidence 986654 4999999999999999986 246899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 151 Nill~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 209 (327)
T 3a62_A 151 NIMLNHQ-------GHVKLTDFGLCKESIHDGT----------VTHTFCGTIEYMAPEILMR----SGHNRAVDWWSLGA 209 (327)
T ss_dssp TEEECTT-------SCEEECCCSCC--------------------CTTSSCCTTSCHHHHTT----SCCCTHHHHHHHHH
T ss_pred HeEECCC-------CcEEEEeCCcccccccCCc----------cccccCCCcCccCHhhCcC----CCCCCcccchhHHH
Confidence 9999877 4599999999875432211 1233469999999999976 56799999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|||++|+.||.+.+.......+..... .++ ...+..+.+||.+||..||.
T Consensus 210 il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dp~ 261 (327)
T 3a62_A 210 LMYDMLTGAPPFTGENRKKTIDKILKCKL-NLP---------------------------PYLTQEARDLLKKLLKRNAA 261 (327)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCC---------------------------TTSCHHHHHHHHHHSCSCGG
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------CCCCHHHHHHHHHHHhcCHh
Confidence 99999999999999888877777765432 111 11245789999999999999
Q ss_pred CCC-----CHHHHHHHHHh
Q 003375 802 ERP-----TAGDLYEMFVA 815 (825)
Q Consensus 802 eRP-----Sa~EIL~hL~~ 815 (825)
+|| ++.++++|.+.
T Consensus 262 ~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 262 SRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp GSTTSSTTTHHHHHHSGGG
T ss_pred hccCCCCCCHHHHHcCCcc
Confidence 999 89999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=380.81 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=213.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|.+.+.||+|+||.||+|.+ .+..||+|+.... ......+.+ .+|+.+|++++||||+++++++..
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~----~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKF----LQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTT----THHHHHHTTCCCTTBCCEEEEECS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEec
Confidence 4457899999999999999999998 4778999985421 223333344 899999999999999999999976
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ||||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 184 ~~~~--------------~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 245 (377)
T 3cbl_A 184 KQPI--------------YIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245 (377)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCc--------------EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence 6544 9999999999999999862 245899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||+||
T Consensus 246 ~~~~-------~~~kl~DfG~s~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 246 VTEK-------NVLKISDFGMSREEADGVYAA--------SGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLW 306 (377)
T ss_dssp ECTT-------CCEEECCGGGCEECTTSEEEC--------CSSCCEEEGGGSCHHHHHH----CEEEHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEECcCCCceecCCCceee--------cCCCCCCCcCcCCHhHhcc----CCCCchhhHHHHHHHHH
Confidence 9877 469999999998654321110 0112235778999999986 56889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+| |..||.+....++...+..+.+...+. ..++.+.+||.+||+.||.+|
T Consensus 307 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPE---------------------------LCPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp HHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchhC
Confidence 9998 999999998888877777665433332 124578999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003375 804 PTAGDLYEMFVART 817 (825)
Q Consensus 804 PSa~EIL~hL~~l~ 817 (825)
||+.+|++.|+.+.
T Consensus 360 ps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 360 PSFSTIYQELQSIR 373 (377)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999998874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=372.36 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=209.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|++.+.||+|+||.||+|.+ .+..||||++... ......+. +.+|+.++.++ +||||+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHH----HHHHHHHHHhhcCCcceeee
Confidence 4567899999999999999999985 2367999986422 22333333 49999999999 69999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----------------------------------
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 604 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------------------------------- 604 (825)
++++..... ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~-------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 92 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp EEEECSTTS-------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred eeeeecCCC-------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 999876443 249999999999999999863210
Q ss_pred ---------------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCe
Q 003375 605 ---------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 657 (825)
Q Consensus 605 ---------------------------~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~ 657 (825)
....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~ 231 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-------NV 231 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-------GC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-------Cc
Confidence 01228999999999999999999999999999999999999877 45
Q ss_pred EEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003375 658 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGL 736 (825)
Q Consensus 658 vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~ 736 (825)
+||+|||++..+....... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.
T Consensus 232 ~kl~Dfg~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 232 VKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp EEECCCGGGSCTTSCTTCE--------EC--CEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred EEEEeccceeeecccccch--------hccccCCCceeEChhhhcC----CCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 9999999998664322111 1233468999999999986 678999999999999999998 99999877
Q ss_pred CHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 737 SEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 737 ~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
... .+...+.....+..+. ..++.+.+||.+||+.||.+|||+.+|++||+.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 300 KIDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCSHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 543 3444444443332221 124579999999999999999999999999998
Q ss_pred hcC
Q 003375 816 RTS 818 (825)
Q Consensus 816 l~s 818 (825)
+..
T Consensus 353 ~~~ 355 (359)
T 3vhe_A 353 LLQ 355 (359)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=381.26 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=206.5
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeE
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~ 562 (825)
...+++|++.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 36689999999999999999999998 467899999753211 1111223448899999998 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... +||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 94 QTPDR--------------LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp ECSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 86654 5999999999999999986 2569999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 155 ILl~~~-------g~ikL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 213 (353)
T 3txo_A 155 VLLDHE-------GHCKLADFGMCKEGICNGV----------TTATFCGTPDYIAPEILQE----MLYGPAVDWWAMGVL 213 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCSCC-------------------CCGGGCCHHHHHH----HHCTTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEccccceeecccCCc----------cccccCCCcCeEChhhcCC----CCcCCccCCCcchHH
Confidence 999877 4599999999975432111 1234579999999999987 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||||++|+.||.+.+..++...+...... ++. ..++.+.+||.+||..||.+
T Consensus 214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDLFEAILNDEVV-YPT---------------------------WLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhhCHHH
Confidence 99999999999999998888888765321 111 12457899999999999999
Q ss_pred CCCH------HHHHHHHHh
Q 003375 803 RPTA------GDLYEMFVA 815 (825)
Q Consensus 803 RPSa------~EIL~hL~~ 815 (825)
||++ .+|++|.+.
T Consensus 266 R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp STTSGGGTCTHHHHTSGGG
T ss_pred ccCCcccCCHHHHhhCCcc
Confidence 9998 899988553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=360.89 Aligned_cols=266 Identities=21% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcce
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE 557 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~ 557 (825)
+..++|++.+.||+|+||.||+|.+.. ..+|+|+..... ....+.+.+|+.++++++||||++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCEeE
Confidence 456789999999999999999998743 468999864221 122234589999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
+++++...... ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|||
T Consensus 77 ~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D 138 (289)
T 4fvq_A 77 NYGVCVCGDEN--------------ILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGN 138 (289)
T ss_dssp EEEEECCTTCC--------------EEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEEEEEeCCCC--------------EEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCC
Confidence 99999866544 999999999999999986 223489999999999999999999999999999
Q ss_pred CCCCCEEEecCccC-CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 638 IKSENILIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 638 LKP~NILLd~~~~~-~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
|||+|||++.++.. ......+||+|||++...... ....||+.|+|||++.+ ...++.++||
T Consensus 139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di 201 (289)
T 4fvq_A 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------DILQERIPWVPPECIEN---PKNLNLATDK 201 (289)
T ss_dssp CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--------------HHHHHTTTTSCHHHHHC---GGGCCHHHHH
T ss_pred cCcceEEEecCCcccccccceeeeccCcccccccCc--------------cccCCcCcccCHHHhCC---CCCCCchhHH
Confidence 99999999887421 112234999999998765332 12357899999999975 2457899999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003375 717 WSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795 (825)
Q Consensus 717 WSLGvILyELLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~C 795 (825)
|||||++|||++| .+||................ .++. ..++.+.+||.+|
T Consensus 202 wslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~l~~li~~~ 252 (289)
T 4fvq_A 202 WSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH--QLPA---------------------------PKAAELANLINNC 252 (289)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCC---------------------------CSSCTTHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCccccchHHHHHHhhccC--CCCC---------------------------CCCHHHHHHHHHH
Confidence 9999999999995 55665555554443333221 1110 0123578999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCCCCCCC
Q 003375 796 TEENPTERPTAGDLYEMFVARTSSSISSR 824 (825)
Q Consensus 796 L~~DP~eRPSa~EIL~hL~~l~sss~S~~ 824 (825)
|+.||.+|||+.+++++|+.+.++..+.+
T Consensus 253 l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 253 MDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp SCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred cCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998766543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.56 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=217.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
...++|.+.+.||+|+||.||+|.+.+ ..||+|+.... ........ +.+|+.+++++ +||||+
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHH----HHHHHHHHHHhcCCchhh
Confidence 456789999999999999999999632 46999986432 22333334 48999999999 899999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++...... ++||||+++|+|.+++...... ....+++..++.|+.||+.||
T Consensus 139 ~~~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 204 (382)
T 3tt0_A 139 NLLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204 (382)
T ss_dssp CEEEEECSSSSC--------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred hheeeeccCCce--------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 999999876644 9999999999999999873211 124589999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+||||+.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 205 ~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~-- 267 (382)
T 3tt0_A 205 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD-- 267 (382)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTT-------CCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHS--
T ss_pred HHHHhCCEecCCCCcceEEEcCC-------CcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcC--
Confidence 99999999999999999999877 45999999999866432211 11223357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||++|||++ |..||.+....++...+..+..+..+. ..
T Consensus 268 --~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 318 (382)
T 3tt0_A 268 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NC 318 (382)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SC
T ss_pred --CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cC
Confidence 678999999999999999999 999999998888888877765443321 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
++.+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 319 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 45799999999999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.44 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=214.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+ .+..+|+|++.... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~---~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MS---EE----DFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BC---HH----HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CC---HH----HHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3457899999999999999999998 66789999865322 11 12 348999999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~~--------------~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili 137 (267)
T 3t9t_A 76 API--------------CLVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137 (267)
T ss_dssp SSC--------------EEEECCCTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred CCe--------------EEEEeCCCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 544 999999999999999986 23468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 138 GEN-------QVIKVSDFGMTRFVLDDQYTS---------STGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp CGG-------GCEEECCTTGGGGBCCHHHHS---------TTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEcccccccccccccccc---------cccccccccccChhhhcC----CCccchhchhhhHHHHHH
Confidence 877 459999999998664322110 122357889999999986 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||......+....+..+..+..+. ..+..+.+|+.+||+.||.+||
T Consensus 198 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhccCCCCCCCCCHHHHHHHHhcCCcCCCCc---------------------------cCcHHHHHHHHHHccCChhhCc
Confidence 999 899999888888777776654332221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
|+.+++++|+.+..+
T Consensus 251 s~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 251 AFSRLLRQLAEIAES 265 (267)
T ss_dssp CHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=365.78 Aligned_cols=266 Identities=24% Similarity=0.266 Sum_probs=203.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChH------------------HHHhhHHhHHHHHHH
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRM 546 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~------------------~~~~~~~~~lrEv~i 546 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.......... ......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 5678999999999999999999987 57889999976443211100 001112345899999
Q ss_pred HhhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHH
Q 003375 547 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 626 (825)
Q Consensus 547 Lk~L~HPNIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~ 626 (825)
|++++||||+++++++..... ...|+||||+++++|.+++. ...+++..++.++.||+.||.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~------------~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~ 151 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNE------------DHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIE 151 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSS------------SEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCCC------------CEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHH
Confidence 999999999999999875321 24699999999999987653 257999999999999999999
Q ss_pred HHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003375 627 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706 (825)
Q Consensus 627 yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~ 706 (825)
|||++||+||||||+|||++.+ +.+||+|||++......... .....||+.|+|||++.+..
T Consensus 152 ~lH~~~ivH~Dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~- 213 (298)
T 2zv2_A 152 YLHYQKIIHRDIKPSNLLVGED-------GHIKIADFGVSNEFKGSDAL----------LSNTVGTPAFMAPESLSETR- 213 (298)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-------SCEEECCCTTCEECSSSSCE----------ECCCCSCGGGCCGGGCCTTC-
T ss_pred HHHHCCeeccCCCHHHEEECCC-------CCEEEecCCCcccccccccc----------ccCCcCCccccChhhhccCC-
Confidence 9999999999999999999877 45999999999876532211 12346999999999987511
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
...++.++|||||||++|+|++|+.||.+.....+...+...... ++. ....++
T Consensus 214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~ 267 (298)
T 2zv2_A 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE-FPD-------------------------QPDIAE 267 (298)
T ss_dssp CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCS-------------------------SSCCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCC-CCC-------------------------ccccCH
Confidence 012478999999999999999999999988777766666544211 110 012356
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
.+.+||.+||+.||.+|||+.||++|.+
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 7999999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.81 Aligned_cols=291 Identities=21% Similarity=0.213 Sum_probs=210.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|++ .+..||+|++.......... .....+.+|+.+++.++ ||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 3457899999999999999999996 67889999976543221111 11112367777776664 9999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... .....++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 ~~~~~~~---------~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 83 CATSRTD---------REIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp EEECCSS---------SEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred eeccCCC---------CceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 9865421 2335799999997 699999986 22334999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 150 Nil~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 207 (308)
T 3g33_A 150 NILVTSG-------GTVKLADFGLARIYSYQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGC 207 (308)
T ss_dssp TEEECTT-------SCEEECSCSCTTTSTTCCC-----------SGGGGCCCSSCCHHHHHT----SCCCSTHHHHHHHH
T ss_pred HEEEcCC-------CCEEEeeCccccccCCCcc-----------cCCccccccccCchHHcC----CCCCchHHHHHHHH
Confidence 9999877 4599999999976543211 133579999999999986 66899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|+|++|++||.+.+..+....+...........+..........+. ..............++.+.+||.+||+.||.
T Consensus 208 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (308)
T 3g33_A 208 IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286 (308)
T ss_dssp HHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSC-CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccC-CCCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence 999999999999998887776666543211111111111000000000 0000111122234567899999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
+|||+.|+++|.+-.
T Consensus 287 ~R~t~~e~l~h~~~~ 301 (308)
T 3g33_A 287 KRISAFRALQHSYLH 301 (308)
T ss_dssp TSCCHHHHHTSTTC-
T ss_pred cCCCHHHHhcCcccc
Confidence 999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.98 Aligned_cols=291 Identities=21% Similarity=0.242 Sum_probs=211.3
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+. +..||+|++...... ...+ .+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVD----VQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHH----HHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 467999999999999999999984 788999997532211 1122 3389999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ...+|||||+++++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 81 ~------------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 146 (319)
T 4euu_A 81 T------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (319)
T ss_dssp T------------CCEEEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred C------------ceEEEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEe
Confidence 2 14699999999999999998621 223489999999999999999999999999999999999983
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc----CCCCCCchhhHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~----~~~~~s~kSDVWSLGvI 722 (825)
... +....+||+|||+++....... .....||+.|+|||++.... ....++.++|||||||+
T Consensus 147 ~~~---~~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 147 IGE---DGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp ECT---TSCEEEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred ccC---CCCceEEEccCCCceecCCCCc-----------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 221 1236799999999987654221 12346999999999986321 12567899999999999
Q ss_pred HHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 723 LLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 723 LyELLTG~~PF~~~~----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
+|||++|+.||.... ..++...+..+..+.....+.... ...+................+..+.+||.+||+.
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECST---TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhccc---CCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 999999999996432 234444444433222111111000 0000000000011223456678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003375 799 NPTERPTAGDLYEMFVART 817 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ 817 (825)
||.+|||++|+++|.....
T Consensus 290 dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 290 DQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTTSCCHHHHHHHHHHHT
T ss_pred ChhhhccHHHhhhccHHHh
Confidence 9999999999999988653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.43 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=212.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|...+.||+|+||.||+|+. .+..||||++..... ...+ .+.+|+.++++++||||+++++++.....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRE----LLFNEVVIMRDYQHFNVVEMYKSYLVGEE- 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHH----HHHHHHHHHTTCCCTTBCCEEEEEEETTE-
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHH----HHHHHHHHHHhCCCCCcceEEEEEEECCE-
Confidence 477888999999999999998 578999999754321 1222 34899999999999999999999986553
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 117 -------------~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 117 -------------LWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp -------------EEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred -------------EEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 5999999999999999864 468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 178 -------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~ 236 (321)
T 2c30_A 178 -------GRVKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----SLYATEVDIWSLGIMVIEMVD 236 (321)
T ss_dssp -------CCEEECCCTTCEECCSSSCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CcEEEeeeeeeeecccCccc----------cccccCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 45999999999876432211 133469999999999976 668899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|+.||.+.+..+....+.....+.+.. ....++.+.+||.+||+.||.+|||+.+
T Consensus 237 g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 237 GEPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------SHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp SSCTTTTSCHHHHHHHHHHSSCCCCTT-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCcCc-------------------------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999888877777766654433221 1123567999999999999999999999
Q ss_pred HHHHHHhhcCCCC
Q 003375 809 LYEMFVARTSSSI 821 (825)
Q Consensus 809 IL~hL~~l~sss~ 821 (825)
+++|.+......+
T Consensus 292 ll~hp~~~~~~~~ 304 (321)
T 2c30_A 292 LLDHPFLLQTGLP 304 (321)
T ss_dssp HHTSGGGGGCCCG
T ss_pred HhcChhhccCCCc
Confidence 9999877655443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.42 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhh--CCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~--L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|++.+..||||++... ....+ .+|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKSW----FRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHHH----HHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchhh----HHHHHHHHHhhccCcCeeeEEEeecc
Confidence 44578999999999999999999999999999997432 12222 556666665 789999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH--------hCCcccc
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHR 636 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH--------s~gIVHr 636 (825)
... .....++||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+||
T Consensus 74 ~~~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 74 SRH----------SSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp EET----------TEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred ccC----------CCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 321 12357999999999999999964 56999999999999999999999 9999999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCchh
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEV 714 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~--~~s~kS 714 (825)
||||+|||++.+ +.+||+|||+++.......... .......||+.|+|||++.+..... .++.++
T Consensus 138 Dlkp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 204 (301)
T 3q4u_A 138 DLKSKNILVKKN-------GQCCIADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204 (301)
T ss_dssp CCCGGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred CCChHhEEEcCC-------CCEEEeeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchh
Confidence 999999999877 4699999999976654322211 0112346999999999998621111 345799
Q ss_pred hHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCc
Q 003375 715 DIWSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKP 778 (825)
Q Consensus 715 DVWSLGvILyELLTG----------~~PF~~~~-----~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 778 (825)
|||||||++|||+|| ..||.... ...+...+... ..+.++. .
T Consensus 205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~ 262 (301)
T 3q4u_A 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN----------------------R 262 (301)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----------------------G
T ss_pred hHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh----------------------h
Confidence 999999999999999 88885432 12222222211 2222221 1
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 779 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 779 ~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
......++.+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 263 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 12234567899999999999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.27 Aligned_cols=273 Identities=19% Similarity=0.301 Sum_probs=201.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe-----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|.+... .||+|++... .......+. +.+|+.++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD--IIASSDIEE----FLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHH----HHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc--ccCHHHHHH----HHHHHHHHHHCCCCceehhhce
Confidence 4567899999999999999999987432 6899985432 222233344 4899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
+...... ......++||||+++++|.+++..... .....+++..++.|+.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~--------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp 165 (323)
T 3qup_A 94 SLRSRAK--------GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165 (323)
T ss_dssp EECC---------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred eeccccc--------cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCc
Confidence 8865422 112245999999999999999976322 1123589999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 166 ~NIli~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 226 (323)
T 3qup_A 166 RNCMLAED-------MTVCVADFGLSRKIYSGDYYR--------QGCASKLPVKWLALESLAD----NLYTVHSDVWAFG 226 (323)
T ss_dssp GGEEECTT-------SCEEECCCCC-------------------------CCGGGCCHHHHHH----CCCCHHHHHHHHH
T ss_pred ceEEEcCC-------CCEEEeecccccccccccccc--------ccccccCcccccCchhhcC----CCCCCccchhhHH
Confidence 99999877 469999999998764422110 1122357889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+....++...+.....+..+. ..++.+.+||.+||+.|
T Consensus 227 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 279 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP---------------------------ECMEEVYDLMYQCWSAD 279 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSS
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC---------------------------ccCHHHHHHHHHHccCC
Confidence 99999999 999999888887777776654332221 23457999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+|||+.++++.|+.+...
T Consensus 280 p~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 280 PKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHHH
Confidence 99999999999998887644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.19 Aligned_cols=279 Identities=22% Similarity=0.303 Sum_probs=203.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..-++|++.+.||+|+||.||+|++ .+..||+|++... .....+. +.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRD----FEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHH----HHHHHHHHHhCCCCCEeeEEE
Confidence 4567899999999999999999985 5778999986421 2333334 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 142 (295)
T 3ugc_A 79 VCYSAGR------------RNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142 (295)
T ss_dssp EECHHHH------------TSCEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEecCCC------------CceEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 9864321 135999999999999999986 224589999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 143 ~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (295)
T 3ugc_A 143 RNILVENE-------NRVKIGDFGLTKVLPQDKEFF-------KVKEPGESPIFWYAPESLTE----SKFSVASDVWSFG 204 (295)
T ss_dssp GGEEEEET-------TEEEECCCCSCC--------------------CTTCGGGGCCHHHHHH----CCCCHHHHHHHHH
T ss_pred hhEEEcCC-------CeEEEccCcccccccCCccee-------eeccCCCCccceeCcHHhcC----CCCChHHHHHHHH
Confidence 99999977 469999999998765432110 01122357788999999987 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCch-hHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||+||..||..... .....+......... ..+... ..... ........++.+.+||.+||+.|
T Consensus 205 ~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPA-EFMRMIGNDKQGQMIVFHLIEL--------LKNNG---RLPRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp HHHHHHHHTTCTTCSHHH-HHHHHHCTTCCTHHHHHHHHHH--------HHTTC---CCCCCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhcccccCCChH-HHHhhhcCccccchhHHHHHHH--------HhccC---cCCCCcCcCHHHHHHHHHHcCCC
Confidence 999999999999864322 211111111100000 000000 00000 00111234678999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+|||+.+|++.|+.+...
T Consensus 273 p~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 273 VNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999988654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.46 Aligned_cols=283 Identities=23% Similarity=0.276 Sum_probs=207.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|.+. +..+|+|++... ....... ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIK----KIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC--CC-HHHH----HHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc--ccchHHH----HHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 578999999999999999999984 778999986432 2222222 33489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 76 ~--------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 76 R--------------LHLVFEYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred e--------------EEEEEEeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 3 5999999999999998864 35689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 196 (311)
T 4agu_A 137 KH-------SVIKLCDFGFARLLTGPSDY----------YDDEVATRWYRSPELLVG---DTQYGPPVDVWAIGCVFAEL 196 (311)
T ss_dssp TT-------SCEEECCCTTCEECC----------------------GGGCCHHHHHT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCchhccCcccc----------cCCCcCCccccChHHHhc---CCCCCcchhhHHHHHHHHHH
Confidence 77 46999999999876532211 123468999999999975 35678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc---ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|..||.+....+....+........+.....+..... ...................+..+.+||.+||+.||.+|
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 999999999887776666554422222221111100000 00000000000011123456779999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
||+.|+++|.+..
T Consensus 277 pt~~ell~hp~f~ 289 (311)
T 4agu_A 277 LTCEQLLHHPYFE 289 (311)
T ss_dssp CCHHHHHTSGGGT
T ss_pred CCHHHHhcChHHH
Confidence 9999999985543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=385.36 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=214.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+..++|++.+.||+|+||.||+|.+.+..||||+.+... ..+ .+.+|+.+|++++||||+++++++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSH----HHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred cChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHH----HHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 567889999999999999999999999999999964321 222 3489999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..||||||+++|+|.+++... +...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 260 ~-------------~~~iv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 323 (450)
T 1k9a_A 260 G-------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323 (450)
T ss_dssp S-------------CEEEEEECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred C-------------ceEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC
Confidence 1 259999999999999999862 334579999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||+||||
T Consensus 324 ~~-------~~~kl~DfG~a~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 324 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp TT-------SCEEECCCTTCEECC-------------------CCCTTTSCHHHHHS----SCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCcccccccc-------------cCCCCCcceeCHHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 469999999997543211 11247889999999986 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+| |+.||.+.+..++...+..+.++..+. .+++.+.+||.+||+.||.+|||
T Consensus 380 ~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~Rpt 432 (450)
T 1k9a_A 380 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYDVMKNCWHLDAATRPT 432 (450)
T ss_dssp HTTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHCcC
Confidence 98 999999888777777777665443331 23567999999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 003375 806 AGDLYEMFVARTSSS 820 (825)
Q Consensus 806 a~EIL~hL~~l~sss 820 (825)
+.+|++.|+.+....
T Consensus 433 ~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 433 FLQLREQLEHIRTHE 447 (450)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhh
Confidence 999999999886543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.82 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=199.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|+.. .. ...... +.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NC-TSDSVR----EKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT--TT-TSHHHH----HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecc--cc-CCHHHH----HHHHHHHHHHHhCCCCccceEEEE
Confidence 45678999999999999999999973 2347777643 21 222223 344899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+... . .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 ~~~~-~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 145 (281)
T 1mp8_A 85 ITEN-P--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 145 (281)
T ss_dssp ECSS-S--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EccC-c--------------cEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH
Confidence 7432 2 3999999999999999986 2346899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 146 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 146 NVLVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGV 205 (281)
T ss_dssp GEEEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHH
T ss_pred HEEECCC-------CCEEECccccccccCccccc---------ccccCCCcccccChhhccc----CCCCCccCchHHHH
Confidence 9999977 46999999999876442211 1122357789999999986 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
++|||++ |..||.+....++...+.....+.++. ..++.+.+||.+||..||
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCh
Confidence 9999997 999999888777777776654333221 235679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003375 801 TERPTAGDLYEMFVARTS 818 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~s 818 (825)
.+|||+.+++++|+.+..
T Consensus 259 ~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 259 SRRPRFTELKAQLSTILE 276 (281)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.33 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=199.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.-++|++.+.||+|+||.||+|.+.+ .+|+|++... .......+.+ .+|+.++++++||||++++++....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~- 92 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP- 92 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS--SCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc--CCCHHHHHHH----HHHHHHHHhCCCCcEEEEEeeccCC-
Confidence 566789999999999999999999866 4999986543 3334444444 8999999999999999999975432
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 --------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~ 154 (289)
T 3og7_A 93 --------------QLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154 (289)
T ss_dssp --------------SCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --------------ccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 24999999999999999864 235689999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++......... .......||+.|+|||++... ....++.++|||||||++|+|
T Consensus 155 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el 218 (289)
T 3og7_A 155 ED-------NTVKIGDFGLATEKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYEL 218 (289)
T ss_dssp TT-------TEEEECCCC--------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceecccccccccc--------ccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHH
Confidence 77 46999999999765432111 112334699999999999632 125678999999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|+.||.+... ..+...+.....+.... ......++.+.+||.+||+.||.+|||
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps 275 (289)
T 3og7_A 219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLS-----------------------KVRSNCPKRMKRLMAECLKKKRDERPS 275 (289)
T ss_dssp HHSSCTTSSCCCHHHHHHHHHHTSCCCCTT-----------------------SSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCccccchHHHHHHHhcccccCcchh-----------------------hccccCCHHHHHHHHHHccCChhhCCC
Confidence 999999987654 44444444442211110 011223568999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.+|++.|+.+..
T Consensus 276 ~~ell~~L~~l~~ 288 (289)
T 3og7_A 276 FPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=363.30 Aligned_cols=286 Identities=21% Similarity=0.305 Sum_probs=196.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|++...... ...+ .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPS----TAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCH----HHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHH----HHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 356899999999999999999987 4778999987644321 1112 338899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+ ..+|||||++ ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 76 ~--------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 140 (317)
T 2pmi_A 76 N--------------KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140 (317)
T ss_dssp T--------------EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred C--------------eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeE
Confidence 5 3599999998 699999986322 12245899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 141 INKR-------GQLKLGDFGLARAFGIPVNT----------FSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp ECTT-------CCEEECCCSSCEETTSCCCC----------CCCCCSCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcCccceecCCCccc----------CCCCcccccccCchHhhC---CCCCCcHHHHHHHHHHHH
Confidence 9877 45999999999876432111 123468999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCC---CchhHHhhhccCccccccccCC-CC---CCchhhhhhHHHHHHHHHHhcc
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRP---RLTDELEALGSCHEHEVAQSGS-GF---EKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p---~l~~~l~~~~~~~~~~~~~~~~-~~---~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
||++|+.||.+.+..+....+...... .............. .+..... .. ..+......+..+.+||.+||+
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 999999999998887766666442111 11111111000000 0000000 00 0000111345689999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 003375 798 ENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~l 816 (825)
.||.+|||+.|+++|.+..
T Consensus 280 ~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 280 LNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp SSGGGSCCHHHHTTSGGGG
T ss_pred CCcccCCCHHHHhCChhhh
Confidence 9999999999999985543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=370.09 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=205.7
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeee
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 561 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~ 561 (825)
++..+++|++.+.||+|+||.||+|++ .+..+|+|++..... ......+. +.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~----~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDW----VQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHH----HHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHH----HHHHHHHHHhcCCCCccCeEEEE
Confidence 346788999999999999999999998 478899999764332 22233333 48899999988 79999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+..... .|+||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 ~~~~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 79 FQTESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp EECSSE--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 986653 5999999999999999986 246999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 140 NIll~~~-------g~~kL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 198 (345)
T 3a8x_A 140 NVLLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGV 198 (345)
T ss_dssp GEEECTT-------SCEEECCGGGCBCSCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHH
T ss_pred HEEECCC-------CCEEEEeccccccccCCCC----------cccccCCCccccCccccCC----CCCChHHhHHHHHH
Confidence 9999877 4599999999975432111 1234579999999999986 66899999999999
Q ss_pred HHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003375 722 LLLELLTLQVPYMGL---------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 792 (825)
Q Consensus 722 ILyELLTG~~PF~~~---------~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 792 (825)
+||||++|+.||... ....+...+..... .++ ...+..+.+||
T Consensus 199 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li 250 (345)
T 3a8x_A 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVL 250 (345)
T ss_dssp HHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHH
T ss_pred HHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHH
Confidence 999999999999652 22223333333211 111 12355789999
Q ss_pred HHhcccCCCCCCCH------HHHHHHHHh
Q 003375 793 RRCTEENPTERPTA------GDLYEMFVA 815 (825)
Q Consensus 793 ~~CL~~DP~eRPSa------~EIL~hL~~ 815 (825)
.+||+.||.+||++ .+|++|.+.
T Consensus 251 ~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 251 KSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp HHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred HHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 99999999999995 899998553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.57 Aligned_cols=257 Identities=24% Similarity=0.276 Sum_probs=209.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... .........+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 5678999999999999999999998 45579999875321 1122233456899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~--------------~~lv~e~~~~~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 81 ATR--------------VYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 553 5999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 142 i~~~-------~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 198 (279)
T 3fdn_A 142 LGSA-------GELKIADFGWSVHAPSSR------------RTDLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCY 198 (279)
T ss_dssp ECTT-------SCEEECSCCEESCC--------------------CCCCTTCCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeccccccCCccc------------ccccCCCCCccCHhHhcc----CCCCccchhHhHHHHHH
Confidence 9877 459999999986543321 123468999999999986 66789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||...+.......+...... ++ ...++.+.+||.+||+.||.+||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 199 EFLVGKPPFEANTYQETYKRISRVEFT-FP---------------------------DFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCC-CC---------------------------TTSCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHCCCCCCCCcHHHHHHHHHhCCCC-CC---------------------------CcCCHHHHHHHHHHhccChhhCC
Confidence 999999999988887777666554221 11 11245789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.||++|.+-...
T Consensus 251 s~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 251 MLREVLEHPWITAN 264 (279)
T ss_dssp CHHHHHHCHHHHHH
T ss_pred CHHHHhhCccccCC
Confidence 99999999775543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=384.84 Aligned_cols=283 Identities=17% Similarity=0.221 Sum_probs=208.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|++... .......+ ++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHH----HHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 357899999999999999999987 5788999986532 12223333 448999999999999999999999765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ......||||||++ ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 134 ~~~--------~~~~~~~lv~E~~~-~~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll 197 (464)
T 3ttj_A 134 KTL--------EEFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197 (464)
T ss_dssp CST--------TTCCEEEEEEECCS-EEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred Ccc--------ccCCeEEEEEeCCC-CCHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE
Confidence 432 12345799999998 46777764 248999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 198 ~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 255 (464)
T 3ttj_A 198 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 255 (464)
T ss_dssp CTT-------SCEEECCCCCC-----CCC-----------C----CCCTTCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEEEEeeeecCCCcc-----------cCCCcccccccCHHHHcC----CCCCHHHHHHHHHHHHHH
Confidence 877 4599999999986543211 233579999999999987 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC---------------CCCchhhhhhHHHHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---------------FEKPEAELETLSFLVD 790 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~L~d 790 (825)
|++|++||.+.+..+....+........+..+...... ...+...... ..........++.+.+
T Consensus 256 ll~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH-HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh-hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 99999999999888777776654333333322221100 0000000000 0011122233678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
||.+||..||.+|||++|+++|.+.
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHcCCChhhCCCHHHHhcChhh
Confidence 9999999999999999999999654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.57 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=210.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|+. .+..+|+|+...... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 4578999999999999999999998 578899999753211 001112344889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 78 AQQ--------------IFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 653 5999999999999999986 356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~-------g~~kL~Dfg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 194 (318)
T 1fot_A 139 LDKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIY 194 (318)
T ss_dssp ECTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeecCcceecCCcc-------------ccccCCccccCHhHhcC----CCCCcccchhhhHHHHH
Confidence 9877 459999999998654311 23469999999999986 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|..||.+.+.......+..... .++. ..++.+.+||.+||..||.+||
T Consensus 195 ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 195 EMLAGYTPFYDSNTMKTYEKILNAEL-RFPP---------------------------FFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------CCCHHHHHHHHHHhccCHHHcC
Confidence 99999999998888887777766532 1111 1245789999999999999999
Q ss_pred -----CHHHHHHHHHh
Q 003375 805 -----TAGDLYEMFVA 815 (825)
Q Consensus 805 -----Sa~EIL~hL~~ 815 (825)
++++|++|.+.
T Consensus 247 ~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWF 262 (318)
T ss_dssp TSSTTTTHHHHTSGGG
T ss_pred CCcCCCHHHHhcCccc
Confidence 99999998554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=363.44 Aligned_cols=268 Identities=23% Similarity=0.263 Sum_probs=203.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... ..... ...+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSF----YLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHH----HHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHH----HHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 3467899999999999999999997 678899999754321 12222 2345899999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ....||||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 84 ~~~~----------~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 84 ETPA----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp EETT----------EEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cCCC----------CcccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 5421 2245999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++..+...... ........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 149 ~~~~-------~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~ 210 (311)
T 3ork_A 149 ISAT-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLY 210 (311)
T ss_dssp EETT-------SCEEECCCSCC-------------------------CCTTCCHHHHHT----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCcccccccccc-------cccccccCcCcccCCHHHhcC----CCCCchHhHHHHHHHHH
Confidence 9877 45999999999876442211 011233469999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|+.||.+.........+.......... .....+..+.+||.+||+.||.+||
T Consensus 211 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R~ 266 (311)
T 3ork_A 211 EVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRY 266 (311)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH------------------------HSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCCCccc------------------------ccCCCCHHHHHHHHHHHhcCHhhCh
Confidence 9999999999988877665555443211110 0112356799999999999999999
Q ss_pred CHHHHHHH-HHhh
Q 003375 805 TAGDLYEM-FVAR 816 (825)
Q Consensus 805 Sa~EIL~h-L~~l 816 (825)
++.+++.+ |...
T Consensus 267 ~~~~~l~~~l~~~ 279 (311)
T 3ork_A 267 QTAAEMRADLVRV 279 (311)
T ss_dssp SSHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHH
Confidence 77766655 4443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.07 Aligned_cols=271 Identities=25% Similarity=0.350 Sum_probs=207.8
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
|...+.||+|+||.||+|.+.+..+|+|++............+ .+.+|+.++++++||||+++++++......
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--- 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ----QFDQEIKVMAKCQHENLVELLGFSSDGDDL--- 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHH----HHHHHHHHHHHCCCTTBCCEEEEECSSSSC---
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHH----HHHHHHHHHHhcCCCCeEEEEEEEecCCce---
Confidence 4567899999999999999999999999975433222222333 348999999999999999999999866544
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
++||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 106 -----------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~--- 169 (307)
T 2nru_A 106 -----------CLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA--- 169 (307)
T ss_dssp -----------EEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---
T ss_pred -----------EEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---
Confidence 9999999999999999752 223568999999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 731 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~ 731 (825)
+.+||+|||++.......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 170 ----~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 170 ----FTAKISDFGLARASEKFAQTV--------MTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ----CCEEECCCTTCEECCSCSSCE--------ECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ----CcEEEeecccccccccccccc--------cccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCC
Confidence 469999999998664322110 1123469999999999874 36889999999999999999999
Q ss_pred CCCCCCHHH----HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 732 PYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 732 PF~~~~~~~----i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
||......+ +...+... ...+...+. . .........+..+.+|+.+||+.||.+|||+.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDE-EKTIEDYID------------K----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTT-SCCHHHHSC------------S----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcccCcchHHHHHHHHHhhhh-hhhhhhhcc------------c----cccccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 997654332 22222211 111111110 0 01122345577899999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003375 808 DLYEMFVARTSS 819 (825)
Q Consensus 808 EIL~hL~~l~ss 819 (825)
+|+++|+.+.++
T Consensus 296 ~l~~~L~~l~~s 307 (307)
T 2nru_A 296 KVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHHHHHC--
T ss_pred HHHHHHHHHhcC
Confidence 999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.87 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=213.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+ .+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQ----MLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT--CCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc--CCHHHHH----HHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 4567999999999999999999998 57789999875432 2333333 34899999999999999999998864
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIK 639 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g-----IVHrDLK 639 (825)
.. ....++||||+++++|.+++..... ....+++..++.++.||+.||.|||++| |+|||||
T Consensus 77 ~~------------~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 77 RT------------NTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp GG------------GTEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CC------------CceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 32 1246999999999999999986322 2345899999999999999999999999 9999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSL 719 (825)
|+|||++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||
T Consensus 144 p~NIl~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~sl 202 (279)
T 2w5a_A 144 PANVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSL 202 (279)
T ss_dssp GGGEEECSS-------SCEEECCCCHHHHC---CHH----------HHHHHSCCTTCCHHHHHC----C-CCHHHHHHHH
T ss_pred hhhEEEcCC-------CCEEEecCchheeecccccc----------ccccCCCccccChHHhcc----CCCCchhhHHHH
Confidence 999999877 45999999999766432211 012358999999999986 568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 720 GvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|+++|+|++|..||...+..++...+..+..+.++. ..+..+.+||.+||+.|
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 255 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLK 255 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc---------------------------ccCHHHHHHHHHHcCCC
Confidence 999999999999999988888877777765443331 12457999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003375 800 PTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~s 818 (825)
|.+|||+.+|+++++....
T Consensus 256 p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 256 DYHRPSVEEILENPLILEH 274 (279)
T ss_dssp GGGSCCHHHHHTSTTCCGG
T ss_pred cccCCCHHHHHhChhhhhh
Confidence 9999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=383.40 Aligned_cols=261 Identities=21% Similarity=0.347 Sum_probs=215.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.+.||+|+||.||+|.+. +..||||+..... ...+. +.+|+.+|++|+||||+++++++..
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~----~~~E~~~l~~l~h~~iv~l~~~~~~- 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEA----FLAEANVMKTLQHDKLVKLHAVVTK- 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHH----HHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHH----HHHHHHHHhhCCCCCEeeEEEEEeC-
Confidence 45678999999999999999999984 6789999865321 12233 4899999999999999999999862
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .||||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 255 ~~--------------~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill 317 (454)
T 1qcf_A 255 EP--------------IYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 317 (454)
T ss_dssp SS--------------CEEEECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred Cc--------------cEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 22 399999999999999997521 2357889999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++......... .....+|+.|+|||++.. ..++.++|||||||+|||
T Consensus 318 ~~~-------~~~kl~DFG~a~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~e 377 (454)
T 1qcf_A 318 SAS-------LVCKIADFGLARVIEDNEYTA---------REGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLME 377 (454)
T ss_dssp CTT-------CCEEECSTTGGGGBCCHHHHT---------TCSSSSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEeeCCCceEcCCCceec---------cCCCcccccccCHHHhcc----CCCCcHHHHHhHHHHHHH
Confidence 877 469999999998764322110 122347889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+| |+.||.+.+..++...+..+.+...+. ..++.+.+||.+||..||.+||
T Consensus 378 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 378 IVTYGRIPYPGMSNPEVIRALERGYRMPRPE---------------------------NCPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhHCc
Confidence 999 999999999888888877664433221 2356799999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003375 805 TAGDLYEMFVARTSSSI 821 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss~ 821 (825)
|+.+|++.|+.+.....
T Consensus 431 t~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 431 TFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CHHHHHHHHHTSSSSSC
T ss_pred CHHHHHHHHHHHHhccc
Confidence 99999999999877544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.75 Aligned_cols=288 Identities=21% Similarity=0.247 Sum_probs=205.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
...+++|++.+.||+|+||.||+|.+ .+..||+|++.... ......+. +.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGT----AIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchh----HHHHHHHHHHcCCCCcceEEEEEe
Confidence 36788999999999999999999987 67889999864332 22222233 389999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .+|||||++ ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 104 ~~~~--------------~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 104 HNHR--------------LHLIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ETTE--------------EEEEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCCE--------------EEEEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 7654 499999998 599999986 35689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++. .....+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++
T Consensus 164 ll~~~~~--~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 164 LLSVSDA--SETPVLKIGDFGLARAFGIPIRQ----------FTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228 (329)
T ss_dssp EEEC-------CCEEEECCTTHHHHHC---------------------CCTTCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEecCCC--CccceEEECcCCCccccCCcccc----------cCCCcCCccccCHHHhcC---CCCCCcHHHHHHHHHHH
Confidence 9975531 23467999999999866432111 123468999999999975 24579999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhcccC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|||++|..||.+.+..+....+...........+...... ..+........ ........++.+.+||.+||+.|
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL--PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh--hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 9999999999988877766665443111111111110000 00000000000 01111224578999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003375 800 PTERPTAGDLYEMFVAR 816 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l 816 (825)
|.+|||+.|+++|.+..
T Consensus 307 P~~R~t~~e~l~hp~f~ 323 (329)
T 3gbz_A 307 PVKRISAKNALEHPYFS 323 (329)
T ss_dssp GGGSCCHHHHHTSGGGS
T ss_pred hhhCCCHHHHhCCcccC
Confidence 99999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.63 Aligned_cols=260 Identities=19% Similarity=0.304 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--Cee----EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~----vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|.+. +.. +|+|..... ..... ...+.+|+.++++++||||+++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKA----NKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------C----HHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHH----HHHHHHHHHHHHhCCCCCEeEEEE
Confidence 45578999999999999999999973 333 455553211 11112 234589999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.... .++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~---------------~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 85 ICLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEESSS---------------EEEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC---------------eEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 998543 3899999999999999986 235689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 146 ~NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG 206 (327)
T 3poz_A 146 RNVLVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYG 206 (327)
T ss_dssp GGEEEEET-------TEEEECCTTHHHHHTTTCC---------------CCCGGGSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CCEEEccCcceeEccCCcccc--------cccCCCccccccChHHhcc----CCCCchhhhhhhH
Confidence 99999887 469999999998765432211 1123357889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||+| |..||.+.....+...+..+.....+. ..+..+.+|+.+||+.|
T Consensus 207 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~ 259 (327)
T 3poz_A 207 VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMID 259 (327)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSC
T ss_pred HHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999888877777776654332221 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003375 800 PTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~s 818 (825)
|.+|||+.+++++|+.+..
T Consensus 260 p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 260 ADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGGSCCHHHHHHHHHHHHT
T ss_pred hhhCCCHHHHHHHHHHHHh
Confidence 9999999999999988754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=353.97 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=208.5
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 485 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 485 d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
+....++|++.+.||+|+||.||+|.+ .+..||+|++............ ...+.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI-EKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHH-CCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHH-HHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 335668999999999999999999998 5788999986544333222221 1124458999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 640 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP 640 (825)
.... ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||
T Consensus 93 ~~~~----------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp 152 (287)
T 4f0f_A 93 HNPP----------------RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS 152 (287)
T ss_dssp TTTT----------------EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred cCCC----------------eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence 6432 799999999999999875 2357999999999999999999999999 99999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.++. .....+||+|||+++...... ....||+.|+|||++.+. ...++.++||||||
T Consensus 153 ~Nil~~~~~~--~~~~~~kl~Dfg~~~~~~~~~-------------~~~~g~~~y~aPE~~~~~--~~~~~~~~Di~slG 215 (287)
T 4f0f_A 153 PNIFLQSLDE--NAPVCAKVADFGLSQQSVHSV-------------SGLLGNFQWMAPETIGAE--EESYTEKADTYSFA 215 (287)
T ss_dssp GGEEESCCCT--TCSCCEEECCCTTCBCCSSCE-------------ECCCCCCTTSCGGGSSCS--SCEECHHHHHHHHH
T ss_pred ceEEEeccCC--CCceeEEeCCCCccccccccc-------------cccCCCccccCchhhccC--CCCcCchhhHHHHH
Confidence 9999987632 233459999999997543311 224699999999998531 24578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHH--HHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 721 CLLLELLTLQVPYMGLSELEI--HDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i--~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
|++|+|++|+.||........ ...+... ..+.++ ...++.+.+||.+||+
T Consensus 216 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~ 268 (287)
T 4f0f_A 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---------------------------EDCPPRLRNVIELCWS 268 (287)
T ss_dssp HHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHhc
Confidence 999999999999976654332 3333322 222222 1235679999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 003375 798 ENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~l 816 (825)
.||.+|||+.+|++.|+.+
T Consensus 269 ~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 269 GDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SSGGGSCCHHHHHHHHHTC
T ss_pred CChhhCcCHHHHHHHHHhC
Confidence 9999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.15 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=207.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--Cee----EEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~----vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|.+. +.. +++|+..... .......+ .+|+.++++++||||+++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~----~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAV----TDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSC----CHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHH----HHHHHHHhcCCCCCcCeEEE
Confidence 45678999999999999999999973 333 6666643221 11122233 78999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++... ..++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 83 ~~~~~---------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 83 LCPGS---------------SLQLVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp EECBS---------------SEEEEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred EEcCC---------------ccEEEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 88532 24899999999999999975 234688999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 144 ~Nil~~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 204 (325)
T 3kex_A 144 RNVLLKSP-------SQVQVADFGVADLLPPDDKQ--------LLYSEAKTPIKWMALESIHF----GKYTHQSDVWSYG 204 (325)
T ss_dssp TTEEESSS-------SCEEECSCSGGGGSCCCTTC--------CC-----CCTTTSCHHHHHH----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CeEEECCCCcccccCccccc--------ccccCCCCcccccChHHhcc----CCCChhhHhHHhH
Confidence 99999877 45999999999876543211 11233468889999999987 6689999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|+|+| |..||.+....++...+.....+..+.. .+..+.+||.+||..|
T Consensus 205 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 205 VTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI---------------------------CTIDVYMVMVKCWMID 257 (325)
T ss_dssp HHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT---------------------------BCTTTTHHHHHHTCSC
T ss_pred HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc---------------------------CcHHHHHHHHHHcCCC
Confidence 99999999 9999998888777777776644333321 1335788999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003375 800 PTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~s 818 (825)
|.+|||+.+++++|+.+..
T Consensus 258 p~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 258 ENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTSCCHHHHHHHHHHHTT
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=368.68 Aligned_cols=260 Identities=24% Similarity=0.283 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..+... ... +.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCP----ENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chH----HHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3578999999999999999999998 5788999997644321 111 234899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 137 (323)
T 3tki_A 77 GNI--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (323)
T ss_dssp SSE--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCe--------------EEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence 653 4999999999999998864 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++..+....... ......||+.|+|||++.+ ...++.++|||||||+||
T Consensus 138 l~~~-------~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 199 (323)
T 3tki_A 138 LDER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLT 199 (323)
T ss_dssp ECTT-------CCEEECCCTTCEECEETTEEC--------CBCSCCSCGGGSCHHHHHC---SSBCHHHHHHHHHHHHHH
T ss_pred EeCC-------CCEEEEEeeccceeccCCccc--------ccCCCccCcCccCcHHhcc---CCCCCCcccHHHHHHHHH
Confidence 9877 459999999998664322110 1133579999999999986 233478999999999999
Q ss_pred HHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
+|++|+.||.+.... .....+..... ... .....+..+.+||.+||..||.+|
T Consensus 200 ~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 200 AMLAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHHHSSCSCSSSCTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHhCCCCCCCCchHHHHHHHHhcccc-cCC-------------------------ccccCCHHHHHHHHHHccCChhhC
Confidence 999999999776543 22222222211 000 112235678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 003375 804 PTAGDLYEMFVAR 816 (825)
Q Consensus 804 PSa~EIL~hL~~l 816 (825)
||+.|+++|.+..
T Consensus 254 ~t~~eil~h~~~~ 266 (323)
T 3tki_A 254 ITIPDIKKDRWYN 266 (323)
T ss_dssp CCHHHHTTCTTTT
T ss_pred cCHHHHhhChhhc
Confidence 9999999997654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=360.12 Aligned_cols=255 Identities=25% Similarity=0.458 Sum_probs=200.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.+++|++.+.||+|+||.||+|.+.+..+|+|++.. ....+. +.+|+.++++++||||+++++++.+.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~------~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~- 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES------ESERKA----FIVELRQLSRVNHPNIVKLYGACLNP- 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS------TTHHHH----HHHHHHHHHHCCCTTBCCEEEBCTTT-
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC------hhHHHH----HHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence 5678999999999999999999999999999998531 122333 48999999999999999999987522
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCCE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---KHIMHRDIKSENI 643 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs---~gIVHrDLKP~NI 643 (825)
.++||||+++++|.+++... .....++...++.++.||+.||.|||+ +||+||||||+||
T Consensus 74 ---------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI 136 (307)
T 2eva_A 74 ---------------VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136 (307)
T ss_dssp ---------------TEEEEECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred ---------------cEEEEEcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence 39999999999999999751 112347889999999999999999999 8999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++ ..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 137 ll~~~~------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 193 (307)
T 2eva_A 137 LLVAGG------TVLKICDFGTACDIQTHM-------------TNNKGSAAWMAPEVFEG----SNYSEKCDVFSWGIIL 193 (307)
T ss_dssp EEETTT------TEEEECCCCC-------------------------CCTTSSCHHHHTC----CCCCTHHHHHHHHHHH
T ss_pred EEeCCC------CEEEEccccccccccccc-------------ccCCCCCceEChhhhCC----CCCCcHHHHHHHHHHH
Confidence 998763 358999999997653311 12358999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 724 LELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 724 yELLTG~~PF~~~~--~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|||++|+.||.... ...+...+..+..+.+. ...+..+.+||.+||+.||.
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~dp~ 246 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI---------------------------KNLPKPIESLMTRCWSKDPS 246 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB---------------------------TTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc---------------------------cccCHHHHHHHHHHhcCChh
Confidence 99999999997543 33333344443333222 12345789999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003375 802 ERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ss 819 (825)
+|||+.+|+++|+.+...
T Consensus 247 ~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 247 QRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp GSCCHHHHHHHHHHHGGG
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=352.08 Aligned_cols=258 Identities=23% Similarity=0.270 Sum_probs=208.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+. +..+|+|++...... ..+ .+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVD----RFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHH----HHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHH----HHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 357999999999999999999984 457888876533211 122 3489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 80 ~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 140 (277)
T 3f3z_A 80 D--------------IYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140 (277)
T ss_dssp E--------------EEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred e--------------EEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEe
Confidence 3 5999999999999999876 25689999999999999999999999999999999999994
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++ ....+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|
T Consensus 141 ~~~----~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l 200 (277)
T 3f3z_A 141 TDS----PDSPLKLIDFGLAARFKPGKM-----------MRTKVGTPYYVSPQVLEG-----LYGPECDEWSAGVMMYVL 200 (277)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTTHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEEecccceeccCccc-----------hhccCCCCCccChHHhcc-----cCCchhhehhHHHHHHHH
Confidence 321 225699999999976643221 123469999999999874 478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|+.||......+....+..+........+ ...++.+.+||.+||+.||.+|||+
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~R~s~ 256 (277)
T 3f3z_A 201 LCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------LNVSPQAESLIRRLLTKSPKQRITS 256 (277)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------------------hcCCHHHHHHHHHHccCChhhCcCH
Confidence 9999999998888887777766433222111 1235679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 003375 807 GDLYEMFVART 817 (825)
Q Consensus 807 ~EIL~hL~~l~ 817 (825)
.++++|.+...
T Consensus 257 ~~~l~h~~~~~ 267 (277)
T 3f3z_A 257 LQALEHEWFEK 267 (277)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHhcCHHHhc
Confidence 99999865443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.37 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=206.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|.+.+.||+|+||.||+|.+.. ..||+|+.... ......+ .+.+|+.+++.++||||++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD---CTLDNKE----KFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT---SCHHHHH----HHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc---cCchHHH----HHHHHHHHHHhCCCCCcceEEEE
Confidence 456889999999999999999998632 24888875322 1223333 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+.... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 142 (281)
T 3cc6_A 82 IEEEP---------------TWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR 142 (281)
T ss_dssp ECSSS---------------CEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred EcCCC---------------CEEEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence 76432 38999999999999999762 245899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 143 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 202 (281)
T 3cc6_A 143 NILVASP-------ECVKLGDFGLSRYIEDEDYY---------KASVTRLPIKWMSPESINF----RRFTTASDVWMFAV 202 (281)
T ss_dssp GEEEEET-------TEEEECCCCGGGCC------------------CCCCCGGGCCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CcEEeCccCCCccccccccc---------ccccCCCCcceeCchhhcc----CCCCchhccHHHHH
Confidence 9999877 46999999999866442211 1123357889999999986 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
++|+|++ |+.||...........+.....+..+. ..++.+.+||.+||..||
T Consensus 203 il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD---------------------------LCPPVLYTLMTRCWDYDP 255 (281)
T ss_dssp HHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCc
Confidence 9999998 999998877777666666554332221 124579999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003375 801 TERPTAGDLYEMFVART 817 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ 817 (825)
.+|||+.+++++|+.+.
T Consensus 256 ~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 256 SDRPRFTELVCSLSDVY 272 (281)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999998875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.04 Aligned_cols=264 Identities=22% Similarity=0.253 Sum_probs=212.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45799999999999999999998 47789999976543322111 011223489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~ 149 (321)
T 2a2a_A 89 D--------------VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (321)
T ss_dssp E--------------EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred E--------------EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence 3 5999999999999999975 35689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++. ....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 ~~~~---~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 150 DKNI---PIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp CTTS---SSCCEEECCCTTCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCCC---CcCCEEEccCccceecCcccc-----------ccccCCCCCccCcccccC----CCCCCccccHHHHHHHHHH
Confidence 7631 122699999999986643211 123469999999999976 6689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+....+....+........+. .....+..+.+||.+||..||.+|||+
T Consensus 212 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~ 267 (321)
T 2a2a_A 212 LSGASPFLGDTKQETLANITSVSYDFDEE------------------------FFSHTSELAKDFIRKLLVKETRKRLTI 267 (321)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHhcccccChh------------------------hhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999988887777776553321111 112235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.++++|.+-
T Consensus 268 ~e~l~hp~~ 276 (321)
T 2a2a_A 268 QEALRHPWI 276 (321)
T ss_dssp HHHHHSTTT
T ss_pred HHHhcCccc
Confidence 999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.27 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..+|+|+... ......+. +.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRT----FLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHH----HHHHHHHHHhCCCcCcccEEEEEecC
Confidence 457899999999999999999998 477889887531 23333344 49999999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 80 KR--------------LNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp TE--------------EEEEEECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred Ce--------------eEEEEEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 53 4999999999999999986 23568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCccccccccccccc----ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~----s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
+.+ +.+||+|||++............ ............||+.|+|||++.+ ..++.++|||||||
T Consensus 142 ~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~ 210 (310)
T 3s95_A 142 REN-------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGI 210 (310)
T ss_dssp CTT-------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred CCC-------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----CCCCcHHHHHHHHH
Confidence 877 45999999999876543221100 0000011124579999999999986 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|||++|..||......... ............ .....++.+.+||.+||+.||.
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~ 265 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDRY-------------------CPPNCPPSFFPITVRCCDLDPE 265 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTT------SSBCHHHHHHHT-------------------CCTTCCTTHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCcchhhhHHH------Hhhhhhcccccc-------------------CCCCCCHHHHHHHHHHccCChh
Confidence 999999999998654221100 000000000000 0012244689999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 003375 802 ERPTAGDLYEMFVARTS 818 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~s 818 (825)
+|||+.+|++.|+.+..
T Consensus 266 ~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 266 KRPSFVKLEHWLETLRM 282 (310)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHH
Confidence 99999999999987753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.10 Aligned_cols=267 Identities=25% Similarity=0.335 Sum_probs=206.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
.+.++|++.+.||+|+||.||+|.+ .+..||+|++.... ..... ..+.+|+.+++++ +||||+++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSER----EALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------C----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHH----HHHHHHHHHHHhhcCCCCeeeE
Confidence 4567899999999999999999997 34579999875321 11222 3448999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc------------------CCCccCHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQD 620 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~------------------~~~~ls~~~i~~Ia~Q 620 (825)
++++...... ++||||+++|+|.+++...... ....+++..++.++.|
T Consensus 115 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 180 (344)
T 1rjb_A 115 LGACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180 (344)
T ss_dssp EEEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred EEEEeeCCcc--------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHH
Confidence 9999866544 9999999999999999862110 0134789999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhh
Q 003375 621 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700 (825)
Q Consensus 621 Ia~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEv 700 (825)
|+.||.|||++||+||||||+|||++.+ +.+||+|||++.......... ......||+.|+|||+
T Consensus 181 i~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 181 VAKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPES 245 (344)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHH
T ss_pred HHHHHHHHHhCCcccCCCChhhEEEcCC-------CcEEeCCCccCcccccCccce--------eccCccCccCccCHHH
Confidence 9999999999999999999999999877 569999999998664422110 0123457889999999
Q ss_pred hhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCc
Q 003375 701 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 778 (825)
Q Consensus 701 l~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 778 (825)
+.+ ..++.++|||||||+||+|+| |..||.+...... ...+..+..+..+
T Consensus 246 ~~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------ 297 (344)
T 1rjb_A 246 LFE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP------------------------ 297 (344)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC------------------------
T ss_pred hcc----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC------------------------
Confidence 986 678999999999999999998 9999987764443 3333333322222
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 779 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 779 ~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
...++.+.+||.+||..||.+|||+.+|+++|+.+....
T Consensus 298 ---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 298 ---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 112457999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.06 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=205.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|.+.+.||+|+||.||+|.+ .+..+|+|+........ ..+ .+.+|+.+|++++||||+++++++...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PME----QIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS---CHH----HHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch---hHH----HHHHHHHHHHhCCCchHHhHHHheecC
Confidence 347899999999999999999998 46789999876543221 122 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~--------------~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~ 157 (285)
T 3is5_A 93 HN--------------MYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF 157 (285)
T ss_dssp SE--------------EEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred Ce--------------EEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE
Confidence 53 59999999999999999753322 3569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+... ..+.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+
T Consensus 158 ~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~il~~ 217 (285)
T 3is5_A 158 QDTS----PHSPIKIIDFGLAELFKSDEH-----------STNAAGTALYMAPEVFK-----RDVTFKCDIWSAGVVMYF 217 (285)
T ss_dssp SSSS----TTCCEEECCCCCCCC---------------------CTTGGGCCHHHHT-----TCCCHHHHHHHHHHHHHH
T ss_pred ecCC----CCCCEEEEeeecceecCCccc-----------CcCcccccCcCChHHhc-----cCCCcccCeehHHHHHHH
Confidence 6532 235699999999976543211 12346999999999986 357899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||.+.....+...+.......... ....++.+.+||.+||+.||.+|||
T Consensus 218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps 272 (285)
T 3is5_A 218 LLTGCLPFTGTSLEEVQQKATYKEPNYAVE-------------------------CRPLTPQAVDLLKQMLTKDPERRPS 272 (285)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCC---------------------------CCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhCCCCCCCCCHHHHHhhhccCCcccccc-------------------------cCcCCHHHHHHHHHHccCChhhCcC
Confidence 999999999888777766655442211110 0112457899999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.||++|.+.
T Consensus 273 ~~e~l~hp~f 282 (285)
T 3is5_A 273 AAQVLHHEWF 282 (285)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcCHHh
Confidence 9999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=373.01 Aligned_cols=293 Identities=19% Similarity=0.239 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++. ........... +.+|+.+|+.+. ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~----~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQR----TFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEEC--C--CCHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEec--ccccChHHHHH----HHHHHHHHHhccCCCCCCeeeeEEe
Confidence 3467899999999999999999987 57789999863 22223333333 389999999998 999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..+. ..+||||||++ ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 140 (388)
T 3oz6_A 80 ADND------------RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140 (388)
T ss_dssp CTTS------------SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCC------------CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHe
Confidence 5432 24699999998 699999986 4689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCccccccccccccc-----------ccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----------s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
|++.+ +.+||+|||+++.+......... ...........+||+.|+|||++.+ ...++.
T Consensus 141 ll~~~-------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~ 210 (388)
T 3oz6_A 141 LLNAE-------CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG---STKYTK 210 (388)
T ss_dssp EECTT-------CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT---CCCCCT
T ss_pred EEcCC-------CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC---CCCCCC
Confidence 99877 46999999999876432111000 0001112234579999999999975 356899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc--------cCCCCCCc------
Q 003375 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ--------SGSGFEKP------ 778 (825)
Q Consensus 713 kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~--------~~~~~~~~------ 778 (825)
++|||||||+||||++|++||.+.+.......+......+..+.+..........+.. ........
T Consensus 211 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (388)
T 3oz6_A 211 GIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290 (388)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhh
Confidence 9999999999999999999999998887777665432222222221110000000000 00000000
Q ss_pred -----hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 779 -----EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 779 -----~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
......++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 291 ~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp HHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred hcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence 000134568999999999999999999999999954
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=359.18 Aligned_cols=265 Identities=21% Similarity=0.321 Sum_probs=213.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
...++|++.+.||+|+||.||+|.+. +..||+|++... ....... .+.+|+.+++.++||||++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERI----EFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHH----HHHHHHHHGGGCCCTTBCCEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHH----HHHHHHHHHHhcCCCCEeeeE
Confidence 34578999999999999999999864 467888875321 2222333 348999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----cCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
+++...... ++||||+++++|.+++..... .....+++..++.++.||+.||.|||++||+
T Consensus 95 ~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 160 (322)
T 1p4o_A 95 GVVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160 (322)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred EEEccCCcc--------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999766544 999999999999999986321 1124578999999999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+|||++.+ +.+||+|||++........... .....+|+.|+|||++.+ ..++.++
T Consensus 161 H~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~----~~~~~~~ 221 (322)
T 1p4o_A 161 HRDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYS 221 (322)
T ss_dssp CSCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHH
T ss_pred cCCCccceEEEcCC-------CeEEECcCcccccccccccccc--------ccCCCCCCCccChhhhcc----CCCCchh
Confidence 99999999999877 4599999999986644321110 122357899999999986 6689999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 715 DVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
|||||||++|+|++ |..||.+.+..++...+.....+..+. ..+..+.+||.
T Consensus 222 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~ 274 (322)
T 1p4o_A 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMR 274 (322)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999999 899999988888777776654332221 23457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 794 RCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+||..||.+|||+.+++++|+.+..
T Consensus 275 ~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 275 MCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCCcccCcCHHHHHHHHHHhhc
Confidence 9999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.51 Aligned_cols=290 Identities=21% Similarity=0.230 Sum_probs=207.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+...+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 3467899999999999999999997 46789999865432211 111222345899999999999999999999976
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ++||||+++ +|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 84 ~~~~--------------~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 144 (346)
T 1ua2_A 84 KSNI--------------SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 144 (346)
T ss_dssp TTCC--------------EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCce--------------EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEE
Confidence 6544 999999984 99988864 2356889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++.+...... .....||+.|+|||++.+ ...++.++|||||||++|
T Consensus 145 ~~~~-------~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 204 (346)
T 1ua2_A 145 LDEN-------GVLKLADFGLAKSFGSPNRA----------YTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILA 204 (346)
T ss_dssp ECTT-------CCEEECCCGGGSTTTSCCCC----------CCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecccceeccCCccc----------CCcccccccccCchHhhC---CCCCCchhhhHhHHHHHH
Confidence 9877 45999999999876432211 233468999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|.+||.+.+..+....+...........+...........................++.+.+||.+||..||.+||
T Consensus 205 ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 99999999999888777666654321111111111111000000000000111112234567899999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.|+++|.+....
T Consensus 285 t~~ell~h~~f~~~ 298 (346)
T 1ua2_A 285 TATQALKMKYFSNR 298 (346)
T ss_dssp CHHHHHTSGGGTSS
T ss_pred CHHHHhcChhhhcC
Confidence 99999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=372.52 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 5688999999999999999999998 578899999753211 011112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 113 NSN--------------LYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 553 5999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 174 l~~~-------g~~kL~DFg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 229 (350)
T 1rdq_E 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEcccccceeccCCc-------------ccccCCccccCHHHhcC----CCCCCcCCEecccHhHh
Confidence 9877 469999999998664321 23469999999999986 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|..||.+.+..++...+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 230 ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 230 EMAAGYPPFFADQPIQIYEKIVSGKV-RFPS---------------------------HFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHhcc
Confidence 99999999999988888888776532 1111 1245789999999999999999
Q ss_pred C-----HHHHHHHHHh
Q 003375 805 T-----AGDLYEMFVA 815 (825)
Q Consensus 805 S-----a~EIL~hL~~ 815 (825)
+ +.+|++|.+.
T Consensus 282 ~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWF 297 (350)
T ss_dssp TSSTTTTHHHHTSGGG
T ss_pred CCccCCHHHHHhCcCc
Confidence 8 9999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=354.13 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=213.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
....+|++.+.||+|+||.||+|.+. +..+|+|++... ....+.+ .+|+.++++++||||+++++++..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHH----HHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHH----HHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45678999999999999999999985 678899986422 1223334 899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~--------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 143 (288)
T 3kfa_A 81 EPP--------------FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143 (288)
T ss_dssp SSS--------------EEEEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred CCC--------------EEEEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence 553 4999999999999999976 33456899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|
T Consensus 144 ~~~~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (288)
T 3kfa_A 144 VGEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 203 (288)
T ss_dssp ECGG-------GCEEECCCCGGGTSCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccCccceeccCCcccc---------ccCCccccCcCChhhhcc----CCCCchhhHHHHHHHHH
Confidence 9877 459999999998765432211 122357889999999987 66899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
+|++ |..||.+.+...+...+.....+..+. ..++.+.+||.+||..||.+|
T Consensus 204 ~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~R 256 (288)
T 3kfa_A 204 EIATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDR 256 (288)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHhCCChhhC
Confidence 9999 999999888777777766654332221 234579999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003375 804 PTAGDLYEMFVARTS 818 (825)
Q Consensus 804 PSa~EIL~hL~~l~s 818 (825)
||+.++++.|+.+..
T Consensus 257 ps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 257 PSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=359.20 Aligned_cols=272 Identities=23% Similarity=0.346 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|.+.+.||+|+||.||+|.+. +..||+|++... .......+.+ .+|+.++++++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD--NSSQREIEEF----LSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHHH----HHHHHHHHTCCCTTBCCCCEE
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc--ccchhHHHHH----HHHHHHHhcCCCCCeeeeeEE
Confidence 34578999999999999999999863 236889885432 2333444444 899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
+...... .....++||||+++++|.+++..... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 105 ~~~~~~~---------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp 175 (313)
T 3brb_A 105 CIEMSSQ---------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175 (313)
T ss_dssp EEC----------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSG
T ss_pred Eeecccc---------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 8865422 22356999999999999999964221 2345699999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 236 (313)
T 3brb_A 176 RNCMLRDD-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFG 236 (313)
T ss_dssp GGEEECTT-------SCEEECSCSCC------------------------CCGGGSCHHHHHS----SCCCHHHHHHHHH
T ss_pred ceEEEcCC-------CcEEEeecCcceeccccccc--------CcccccCCCccccCchhhcC----CCccchhhhHHHH
Confidence 99999877 45999999999876432211 01123457889999999986 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|+|++ |..||.+.....+...+..+..+..+. ..++.+.+||.+||..|
T Consensus 237 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 289 (313)
T 3brb_A 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE---------------------------DCLDELYEIMYSCWRTD 289 (313)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHTTCSS
T ss_pred HHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCC
Confidence 99999999 999999888877777776664433331 23457999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+|||+.+|+++|+.+...
T Consensus 290 p~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 290 PLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999988654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=362.90 Aligned_cols=269 Identities=25% Similarity=0.392 Sum_probs=211.5
Q ss_pred CCCCCCCCCCceeeeeecccCceEEEEEEE--CCeeE--EEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 482 SGLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADA--AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 482 ~~~d~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~v--AVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
..++...+++|++.+.||+|+||.||+|++ .+..+ ++|++. .. ......+ .+.+|+.+++++ +||||+
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~--~~-~~~~~~~----~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EY-ASKDDHR----DFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEE--CC-------C----HHHHHHHHHTTCCCCTTBC
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeec--cc-cchHHHH----HHHHHHHHHHhccCCCchh
Confidence 345557889999999999999999999987 45544 666653 21 1122223 348999999999 899999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh-----------ccCCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-----------~~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++..... .|+||||+++++|.+++.... ......+++..++.++.||+.||
T Consensus 90 ~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 155 (327)
T 1fvr_A 90 NLLGACEHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155 (327)
T ss_dssp CEEEEEEETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHH
T ss_pred hhceeeeeCCc--------------eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 99999986653 599999999999999997521 01124689999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.+
T Consensus 156 ~~LH~~~ivH~dlkp~NIl~~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-- 215 (327)
T 1fvr_A 156 DYLSQKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY-- 215 (327)
T ss_dssp HHHHHTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH--
T ss_pred HHHHhCCccCCCCccceEEEcCC-------CeEEEcccCcCcccccccc-----------ccCCCCCccccChhhhcc--
Confidence 99999999999999999999877 4599999999874332111 122357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||++|||++ |..||.+.+..++...+..+..+..+ ...
T Consensus 216 --~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 266 (327)
T 1fvr_A 216 --SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNC 266 (327)
T ss_dssp --CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC---------------------------TTB
T ss_pred --ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC---------------------------CCC
Confidence 567899999999999999998 99999998888777766555332222 123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
++.+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 267 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 457999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=375.86 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=211.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
..++|++.+.||+|+||.||+|.+ .+..+|+|+.... ...... .+.+|+.+|+.++||||+++++++...
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~----~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----TVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHH----HHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 457899999999999999999998 5678999986532 122222 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||++||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 121 ~~--------------~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 182 (387)
T 1kob_A 121 YE--------------MVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182 (387)
T ss_dssp SE--------------EEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence 53 5999999999999999864 23468999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++ .+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 183 ~~~~-----~~~vkL~DFG~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 242 (387)
T 1kob_A 183 ETKK-----ASSVKIIDFGLATKLNPDEIV-----------KVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYV 242 (387)
T ss_dssp SSTT-----CCCEEECCCTTCEECCTTSCE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred ecCC-----CCceEEEecccceecCCCcce-----------eeeccCCCccCchhccC----CCCCCcccEeeHhHHHHH
Confidence 7542 256999999999876432211 22369999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.+..+....+......... ......++.+.+||.+||..||.+|||
T Consensus 243 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt 298 (387)
T 1kob_A 243 LLSGLSPFAGEDDLETLQNVKRCDWEFDE------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLT 298 (387)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------------------STTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------------------cccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999999998887777777654321111 011223567999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.++++|.+-.
T Consensus 299 ~~ell~hp~~~ 309 (387)
T 1kob_A 299 VHDALEHPWLK 309 (387)
T ss_dssp HHHHHTSTTTS
T ss_pred HHHHhhCcccc
Confidence 99999996543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.59 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=212.3
Q ss_pred CCCCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 488 SFPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 488 ~~~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
..++|.+.+ .||+|+||.||+|.+ .+..||+|+.... ......+. +.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEE----MMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHH----HHHHHHHHHhCCCCCEeEEEEEe
Confidence 346777877 999999999999986 4667999986532 22333333 48999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 80 ~~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 140 (287)
T 1u59_A 80 QAE---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140 (287)
T ss_dssp ESS---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCC---------------CcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence 432 24999999999999999864 23568999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 141 ili~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 202 (287)
T 1u59_A 141 VLLVNR-------HYAKISDFGLSKALGADDSYYT-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVT 202 (287)
T ss_dssp EEEEET-------TEEEECCCTTCEECTTCSCEEC-------CCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcccceeeeccCcceee-------ccccccccccccCHHHhcc----CCCCchhhHHHHHHH
Confidence 999977 4699999999987654222110 1122357899999999986 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|||++ |+.||.+....++...+..+..+.++. ..++.+.+||.+||..||.
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 203 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWE 255 (287)
T ss_dssp HHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---------------------------CcCHHHHHHHHHHcCCChh
Confidence 999998 999999888888777777665443331 2356799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003375 802 ERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ss 819 (825)
+||++.+++++|+.+..+
T Consensus 256 ~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 256 DRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=357.82 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=210.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... ......+ .+.+|+.+++++ +||||+++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTERE----ALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHHHCCCTTBCCE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHH----HHHHHHHHHhhcccCCCeeeE
Confidence 4457899999999999999999986 3468999986422 2222333 348999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-------------cCCCccCHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++...... ++||||+++|+|.+++..... .....+++..++.++.||+.||
T Consensus 93 ~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 158 (313)
T 1t46_A 93 LGACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (313)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCc--------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 9999866544 999999999999999986321 0123589999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 159 ~~lH~~~i~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 221 (313)
T 1t46_A 159 AFLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN-- 221 (313)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH--
T ss_pred HHHHHCCeecCCCccceEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcceeeChHHhcC--
Confidence 99999999999999999999877 569999999998765432110 1123457889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
..++.++|||||||+||+|+| |..||.+...... ...+.....+..+ ..
T Consensus 222 --~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 272 (313)
T 1t46_A 222 --CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------EH 272 (313)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TT
T ss_pred --CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc---------------------------cc
Confidence 678999999999999999999 9999987754433 3333333222111 12
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+..+.+||.+||..||.+|||+.+|+++|+.+.....
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 34579999999999999999999999999998876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=374.11 Aligned_cols=262 Identities=21% Similarity=0.345 Sum_probs=201.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
....+|.+.+.||+|+||.||+|++. +..||+|+.... ......+. +.+|+.+|++++||||++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRD----FLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHH----HHHHHHHHHhCCCCCCCeEEEE
Confidence 44568999999999999999999863 567999985432 22333333 4999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... +|||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 115 ~~~~~~~--------------~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 176 (373)
T 2qol_A 115 VTKSKPV--------------MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176 (373)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EeeCCce--------------EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 9866544 999999999999999975 2346899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||
T Consensus 177 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 177 NILINSN-------LVCKVSDFGLGRVLEDDPEAAY-------TTRGGKIPIRWTSPEAIAY----RKFTSASDVWSYGI 238 (373)
T ss_dssp GEEECTT-------CCEEECCC-----------------------------CTTSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEECcCccccccccCCccce-------eccCCCcCCCccChhhhcc----CCcCchhcHHHHHH
Confidence 9999877 4699999999987654221100 0112246788999999987 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||++ |+.||.+.+..++...+..+.....+ ...+..+.+||.+||+.||
T Consensus 239 il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 239 VLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---------------------------MDCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp HHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---------------------------TTCBHHHHHHHHHHTCSSG
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------ccccHHHHHHHHHHhCcCh
Confidence 9999998 99999998888877777655322211 1234579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003375 801 TERPTAGDLYEMFVARTS 818 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~s 818 (825)
.+||++.+|++.|+.+..
T Consensus 292 ~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 292 NNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999988754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=365.84 Aligned_cols=272 Identities=23% Similarity=0.248 Sum_probs=207.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCC-CChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~-~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++|++.+.||+|+||.||+|.+ .+..+|+|++...... ......+ .+.+|+.++++++||||+++++++....
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE----RIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHH----HHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 6799999999999999999998 5668899987543211 1112223 4489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------------------------------cCCCccCH
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------------------------TGEKHVSV 611 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------------------------------~~~~~ls~ 611 (825)
. .+|||||++||+|.+++..... .....+++
T Consensus 102 ~--------------~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 102 Y--------------ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp E--------------EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred e--------------EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 3 5999999999999999852111 01223467
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC
Q 003375 612 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691 (825)
Q Consensus 612 ~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vG 691 (825)
..++.|+.||+.||.|||++||+||||||+|||++.++ ...+||+|||++..+....... ........|
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~g 236 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-----SFEIKLVDFGLSKEFYKLNNGE------YYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS-----SCCEEECCCTTCEEGGGTTCC--------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCC-----CceEEEeeccccccccccCccc------cccccccCC
Confidence 88899999999999999999999999999999998663 2579999999998664322110 011234469
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc
Q 003375 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 771 (825)
Q Consensus 692 T~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~ 771 (825)
|+.|+|||++.+. ...++.++|||||||+||||++|+.||.+.+..+....+.........
T Consensus 237 t~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 297 (345)
T 3hko_A 237 TPYFVAPEVLNTT--NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN----------------- 297 (345)
T ss_dssp CGGGCCHHHHTCS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-----------------
T ss_pred CccccCchhhccC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-----------------
Confidence 9999999999742 256789999999999999999999999998888777776655322111
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 772 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 772 ~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
......++.+.+||.+||..||.+|||+.++++|.+-.
T Consensus 298 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 298 -------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp -------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred -------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence 11122356899999999999999999999999996543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=371.63 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=208.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..+++|++.+.||+|+||.||+|++ .+..||+|++...... .......+..|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-----hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 5688999999999999999999998 4788999987532110 011122347899999877 8999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... .|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 89 TKEN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149 (345)
T ss_dssp CSSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred eCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence 6653 5999999999999999986 25689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 150 LLDKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLL 208 (345)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeEChhhhhcccCCC----------cccCCCCCcccCChhhhcC----CCCCChhhhHHHHHHH
Confidence 99877 4599999999975432111 1234579999999999986 6689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|..||.+.+..++...+..... .++. ..++.+.+||.+||..||.+|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 209 YEMLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------ccCHHHHHHHHHHhcCCHhHc
Confidence 999999999999988888877765532 1221 124578999999999999999
Q ss_pred CCHH-HHHHHHH
Q 003375 804 PTAG-DLYEMFV 814 (825)
Q Consensus 804 PSa~-EIL~hL~ 814 (825)
|++. +|++|.+
T Consensus 261 ~~~~~~i~~hp~ 272 (345)
T 1xjd_A 261 LGVRGDIRQHPL 272 (345)
T ss_dssp BTTBSCGGGSGG
T ss_pred CCChHHHHcCcc
Confidence 9998 8887754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.28 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=217.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~ 566 (825)
++|++.+.||+|+||.||+|.+ .+..||||+...............+.+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999998 478999999876654455556666667789999999999 7999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 174 --------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 174 --------------FMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 35999999999999999986 25689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~--~~~~s~kSDVWSLGvILy 724 (825)
.+ +.+||+|||++..+..... .....||+.|+|||++.+... ...++.++|||||||+||
T Consensus 235 ~~-------~~ikl~DfG~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 235 DN-------MQIRLSDFGFSCHLEPGEK-----------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp TT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcccccCCCcc-----------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 77 4599999999987653221 123469999999999975321 135788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||.+.........+..+........ ....+..+.+||.+||..||.+||
T Consensus 297 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rp 352 (365)
T 2y7j_A 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE------------------------WDDRSSTVKDLISRLLQVDPEARL 352 (365)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH------------------------HSSSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc------------------------cccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999998888777777766533221111 112345799999999999999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
|+.++++|.+
T Consensus 353 s~~ell~hp~ 362 (365)
T 2y7j_A 353 TAEQALQHPF 362 (365)
T ss_dssp CHHHHHHSGG
T ss_pred CHHHHhcCcc
Confidence 9999999865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.09 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=208.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..+|+|++.......... ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFENKT- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecCCC-
Confidence 4689999999999999999998 47899999976543322111 011223489999999999999999999998654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 82 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 82 -------------DVVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------eEEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 35999999999999999976 246899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
++. ....+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 144 ~~~---~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 144 KNV---PNPRIKLIDFGIAHKIEAGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp SSS---SSCCEEECCCTTCEECC-------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CCC---CCCceEEEecccceeccCCCc-----------ccccCCCcCccCcceecC----CCCCcchhhhhHHHHHHHHH
Confidence 642 234699999999986643221 123468999999999976 66889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|..||.+....+....+.......... .....+..+.+||.+||..||.+|||+.
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEE------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcch------------------------hcccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 9999999888877777666543221111 1122356799999999999999999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
++++|.+
T Consensus 262 ~~l~h~~ 268 (283)
T 3bhy_A 262 QSLEHSW 268 (283)
T ss_dssp HHHHCHH
T ss_pred HHHhCHH
Confidence 9999843
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=364.10 Aligned_cols=283 Identities=20% Similarity=0.257 Sum_probs=210.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-----CCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----HSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-----HPNIV~l~g 560 (825)
.-++|++.+.||+|+||.||+|.+ .+..||+|++.. ...... .+..|+.+++.+. ||||+++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~----~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTR----SAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHH----HHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhh----hhHHHHHHHHHhcccCCCCCCeecccc
Confidence 347899999999999999999998 677899998642 122222 3378999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .+|||||+ +++|.+++.. .....+++..++.++.||+.||.|||++||+||||||
T Consensus 104 ~~~~~~~--------------~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 165 (360)
T 3llt_A 104 KFMYYDH--------------MCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165 (360)
T ss_dssp EEEETTE--------------EEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeeECCe--------------eEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCc
Confidence 9986653 59999999 8999999986 2234589999999999999999999999999999999
Q ss_pred CCEEEecCccC------------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh
Q 003375 641 ENILIDLERKK------------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702 (825)
Q Consensus 641 ~NILLd~~~~~------------------~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~ 702 (825)
+|||++..... ......+||+|||++...... .....||+.|+|||++.
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------HGSIINTRQYRAPEVIL 232 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------CCSCCSCGGGCCHHHHT
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-------------CcCccCcccccCcHHHc
Confidence 99999752100 001357999999999764331 12346999999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC-CC--C----
Q 003375 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SG--F---- 775 (825)
Q Consensus 703 ~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~-~~--~---- 775 (825)
+ ..++.++|||||||+||+|++|+.||.+.+..+....+.....+.....+..........+.... .. +
T Consensus 233 ~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 233 N----LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp T----CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred C----CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 6 67899999999999999999999999998887777766654433322222211111100000000 00 0
Q ss_pred -----------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 776 -----------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 776 -----------~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
..+.......+.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 011111222367889999999999999999999998854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.33 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+++|++.+.||+|+||.||+|.+.+..+|+|+.... ...+ .+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--H----HHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch------hHHH----HHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 56789999999999999999999999999999986421 1223 3489999999999999999999876433
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~-------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (278)
T 1byg_A 88 G-------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151 (278)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------ceEEEEecCCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe
Confidence 1 249999999999999999862 113478999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 152 ~~-------~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 152 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccccccccccc-------------cCCCccccccCHHHhCC----CCCCchhcHHHHHHHHHHH
Confidence 77 459999999987654321 12257889999999986 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++ |..||......++...+..+..+..+ ...++.+.+||.+||+.||.+|||
T Consensus 208 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rps 260 (278)
T 1byg_A 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPAVYEVMKNCWHLDAAMRPS 260 (278)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------ccCCHHHHHHHHHHhcCChhhCCC
Confidence 98 99999888777766666554332222 123567999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.++++.|+.+..
T Consensus 261 ~~~l~~~L~~i~~ 273 (278)
T 1byg_A 261 FLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=376.91 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=203.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..+++|++.+.||+|+||.||+|++ .+..+|+|++...... .....+ .+.+|..+|.++ +||||+++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~----~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CC----HHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHH----HHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 5678999999999999999999998 4678999997643322 122222 348899999887 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... +||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 124 ~~~~--------------~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 184 (396)
T 4dc2_A 124 TESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184 (396)
T ss_dssp CSSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred ECCE--------------EEEEEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 6654 5999999999999999986 25699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 185 Ll~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~gt~~Y~aPE~l~~----~~~~~~~DiwslGvll 243 (396)
T 4dc2_A 185 LLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLM 243 (396)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCBCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecceeeecccCCC----------ccccccCCcccCCchhhcC----CCCChHHHHHHHHHHH
Confidence 99877 4599999999975322111 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCC---------HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 724 LELLTLQVPYMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 724 yELLTG~~PF~~~~---------~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
|||++|+.||.... ...+...+.... ..++ ...+..+.+||.+
T Consensus 244 yell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p---------------------------~~~s~~~~~li~~ 295 (396)
T 4dc2_A 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIP---------------------------RSLSVKAASVLKS 295 (396)
T ss_dssp HHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-CCCC---------------------------TTSCHHHHHHHHH
T ss_pred HHHHhCCCCCcccccccccchhhHHHHHHHHhccc-cCCC---------------------------CcCCHHHHHHHHH
Confidence 99999999996432 122333333321 1111 1235578999999
Q ss_pred hcccCCCCCCCH------HHHHHHHHh
Q 003375 795 CTEENPTERPTA------GDLYEMFVA 815 (825)
Q Consensus 795 CL~~DP~eRPSa------~EIL~hL~~ 815 (825)
||+.||.+||++ .||++|.+.
T Consensus 296 lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 296 FLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp HTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred HhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 999999999984 799998553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=374.12 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|.+.+.||+|+||.||+|.+ .+..||+|++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-----cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 5688999999999999999999998 678899999753211 111222345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~--------------~~lv~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 140 (336)
T 3h4j_B 81 PTD--------------IVMVIEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140 (336)
T ss_dssp SSE--------------EEEEECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred CCE--------------EEEEEECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence 653 59999999 6899999876 256999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||++|
T Consensus 141 l~~~-------~~~kl~DFG~s~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 199 (336)
T 3h4j_B 141 LDDN-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVING---KLYAGPEVDVWSCGIVLY 199 (336)
T ss_dssp ECTT-------CCEEECCSSCTBTTTTSBT-----------TCCCTTSTTTSCGGGSCC---SGGGCHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEEeccceeccCCcc-----------cccccCCcCcCCHHHHcC---CCCCCCccchhHHHHHHH
Confidence 9877 4599999999976543221 123469999999999976 122378999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||.+.....+...+.... ...+...++.+.+||.+||..||.+||
T Consensus 200 ~ll~g~~Pf~~~~~~~~~~~i~~~~----------------------------~~~p~~~s~~~~~li~~~L~~dP~~Rp 251 (336)
T 3h4j_B 200 VMLVGRLPFDDEFIPNLFKKVNSCV----------------------------YVMPDFLSPGAQSLIRRMIVADPMQRI 251 (336)
T ss_dssp HHHHSSCSSBCSSSTTCBCCCCSSC----------------------------CCCCTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCC----------------------------CCCcccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999997654322111111000 001112356789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.||++|.+...
T Consensus 252 t~~eil~hp~~~~ 264 (336)
T 3h4j_B 252 TIQEIRRDPWFNV 264 (336)
T ss_dssp CHHHHTTCHHHHT
T ss_pred CHHHHHhChhhcc
Confidence 9999999977543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=372.18 Aligned_cols=293 Identities=19% Similarity=0.210 Sum_probs=208.3
Q ss_pred CCCCCceeeeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 487 GSFPSLSSCDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G--~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
...++|++.+.||+| +||.||+|++ .+..||+|++.... ......+ .+.+|+.+++.++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVT----FLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHH----HHHHHHHHHHhCCCCCCCcEeEEE
Confidence 456789999999999 9999999998 47889999976543 2233333 348999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...+. .||||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~--------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 96 IADNE--------------LWVVTSFMAYGSAKDLICT---HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp EETTE--------------EEEEEECCTTCBHHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EECCE--------------EEEEEEccCCCCHHHHHhh---hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 87654 5999999999999999986 223568999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+.+ +.+||+|||++............ .........||+.|+|||++.+. ...++.++|||||||+
T Consensus 159 Ill~~~-------~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 159 ILISVD-------GKVYLSGLRSNLSMISHGQRQRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGIT 226 (389)
T ss_dssp EEECTT-------CCEEECCGGGCEECEETTEECSC---BCCCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEcccccceeeccccccccc---cccccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHH
Confidence 999877 46999999998765432211110 11112344799999999999751 1457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh----ccCccc-----cc---------cccCCCCCCchhhhhh
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL----GSCHEH-----EV---------AQSGSGFEKPEAELET 784 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~----~~~~~~-----~~---------~~~~~~~~~~~~~~~~ 784 (825)
+|||++|+.||.+.+..+....+..+..+.+....... ...... .. ................
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999887655544443333222111000000 000000 00 0000000011123345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 678999999999999999999999999844
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.02 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=209.8
Q ss_pred CCCCCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
....+|.+.+ .||+|+||.||+|.+ .+..+|+|++.... ...... +.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALK----DELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHH----HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHH----HHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456799988 999999999999965 35679999865321 122222 345999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+.. . ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 87 ~~~-~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~ 146 (291)
T 1xbb_A 87 CEA-E--------------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 146 (291)
T ss_dssp EES-S--------------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ECC-C--------------CcEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcc
Confidence 842 2 24999999999999999986 356899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+
T Consensus 147 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 208 (291)
T 1xbb_A 147 NVLLVTQ-------HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGV 208 (291)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred eEEEeCC-------CcEEEccCCcceeeccCCCccc-------ccccCCCCceeeChHHhcc----CCCChhhhHHHHHH
Confidence 9999977 4699999999987654322110 0122346789999999986 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
++|+|++ |+.||.+.+..++...+..+..+.++. ..++.+.+||.+||+.||
T Consensus 209 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 209 LMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSST
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCh
Confidence 9999999 999999998888887777665443331 235579999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 003375 801 TERPTAGDLYEMFVARTS 818 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~s 818 (825)
.+||++.+|++.|+.+..
T Consensus 262 ~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 262 ENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.38 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=201.1
Q ss_pred eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~ 570 (825)
...+.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.+|++|+||||+++++++.....
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--- 160 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKE----EVKNEISVMNQLDHANLIQLYDAFESKND--- 160 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSSE---
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHH----HHHHHHHHHHhCCCCCCCeEEEEEEECCE---
Confidence 4467899999999999997 5778999987532 122333 34899999999999999999999986553
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
.+|||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+..+.
T Consensus 161 -----------~~lv~E~~~~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~- 224 (373)
T 2x4f_A 161 -----------IVLVMEYVDGGELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD- 224 (373)
T ss_dssp -----------EEEEEECCTTCEEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-
T ss_pred -----------EEEEEeCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-
Confidence 5999999999999999875 234689999999999999999999999999999999999996442
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
.+.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|.
T Consensus 225 ----~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 225 ----AKQIKIIDFGLARRYKPREK-----------LKVNFGTPEFLAPEVVNY----DFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp ----TTEEEECCCSSCEECCTTCB-----------CCCCCSSCTTCCHHHHTT----CBCCHHHHHHHHHHHHHHHHHSS
T ss_pred ----CCcEEEEeCCCceecCCccc-----------cccccCCCcEeChhhccC----CCCCcHHhHHHHHHHHHHHHhCC
Confidence 26799999999987643221 123469999999999976 67899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL 810 (825)
.||.+.+..+....+.......... .....++.+.+||.+||+.||.+|||+.|++
T Consensus 286 ~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 286 SPFLGDNDAETLNNILACRWDLEDE------------------------EFQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCSCSG------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHhccCCCChh------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999988887777776553221111 1122356899999999999999999999999
Q ss_pred HHHHh
Q 003375 811 EMFVA 815 (825)
Q Consensus 811 ~hL~~ 815 (825)
+|.+.
T Consensus 342 ~hp~~ 346 (373)
T 2x4f_A 342 KHPWL 346 (373)
T ss_dssp HSHHH
T ss_pred cCcCc
Confidence 98653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=368.06 Aligned_cols=257 Identities=24% Similarity=0.261 Sum_probs=206.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
..++|++.+.||+|+||.||+|.+ .+..+|+|++..... .. .+|+.++.++ +||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~----~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DP----TEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CC----HHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------Ch----HHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 346799999999999999999998 477899999753221 12 5688888888 69999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl 148 (342)
T 2qr7_A 88 GKY--------------VYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL 148 (342)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEE
Confidence 553 5999999999999999975 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
+..... ....+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 149 ~~~~~~---~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 211 (342)
T 2qr7_A 149 YVDESG---NPESIRICDFGFAKQLRAENGL----------LMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLY 211 (342)
T ss_dssp ESSSSC---SGGGEEECCCTTCEECBCTTCC----------BCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHH
T ss_pred EecCCC---CcCeEEEEECCCcccCcCCCCc----------eeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHH
Confidence 865421 2246999999999876432211 123468999999999986 45788999999999999
Q ss_pred HHHhCCCCCCC---CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 725 ELLTLQVPYMG---LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 725 ELLTG~~PF~~---~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
||++|..||.+ .+..++...+..+....... .....++.+.+||.+||..||.
T Consensus 212 ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 212 TMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG------------------------YWNSVSDTAKDLVSKMLHVDPH 267 (342)
T ss_dssp HHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST------------------------TTTTSCHHHHHHHHHHTCSSTT
T ss_pred HHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc------------------------ccccCCHHHHHHHHHHCCCChh
Confidence 99999999975 35566666666653321110 1122456899999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 003375 802 ERPTAGDLYEMFVAR 816 (825)
Q Consensus 802 eRPSa~EIL~hL~~l 816 (825)
+|||+.++++|.+..
T Consensus 268 ~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 268 QRLTAALVLRHPWIV 282 (342)
T ss_dssp TSCCHHHHTTSHHHH
T ss_pred HCcCHHHHhcCCeec
Confidence 999999999997753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=360.16 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
+...+|.+.+.||+|+||.||+|.+.. ..||+|+.... ....... .+.+|+.++++++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRV----DFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHH----HHHHHHHHHHhCCCCCCCcEEE
Confidence 456789999999999999999998732 34888886422 1223333 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .+|||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 114 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCCC--------------cEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 9876553 4999999999999999976 235689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 237 (333)
T 1mqb_A 176 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 237 (333)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CcEEECCCCcchhhccccccc-------cccCCCCccccccCchhccc----CCCCchhhhHHHH
Confidence 99999876 469999999998765422110 01122346889999999986 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+....++...+..+..+..+. ..+..+.+||.+||+.|
T Consensus 238 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999888888877776654332221 13457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+||++.+|+++|+.+...
T Consensus 291 p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 291 RARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TTTSCCHHHHHHHHHHHHHS
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.48 Aligned_cols=277 Identities=24% Similarity=0.283 Sum_probs=199.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|++ .+..||+|++.... .....+ .+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELARE----KVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHH----HHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHH----HHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 56899999999999999999998 57889999976432 122223 3499999999999999999999987543
Q ss_pred CCC-------------------------------------------CCCCCCccccceEEEEEcccCCCCHHHHHHHhhc
Q 003375 567 WLP-------------------------------------------SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE 603 (825)
Q Consensus 567 ~~~-------------------------------------------~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~ 603 (825)
... .............++||||+++++|.+++...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-- 155 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-- 155 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--
Confidence 200 00000001223479999999999999999862
Q ss_pred cCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccc--cC
Q 003375 604 TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HR 681 (825)
Q Consensus 604 ~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s--~~ 681 (825)
......++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++............ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-------CCEEECCCTTCEECSCC-----------
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-------CCEEEeecCcccccccchhhcccccccc
Confidence 222345677899999999999999999999999999999999877 469999999998775432111000 00
Q ss_pred CCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc
Q 003375 682 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 761 (825)
Q Consensus 682 ~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~ 761 (825)
.........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.. .......+.....+
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~---------- 292 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHG----NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP---------- 292 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHC----CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC----------
T ss_pred ccccccccCCCcCccChHHhcC----CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC----------
Confidence 0111234579999999999986 6789999999999999999998776521 12222223222221
Q ss_pred cCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 762 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
......++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 293 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 293 -----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp -----------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred -----------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 112233457899999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.66 Aligned_cols=260 Identities=19% Similarity=0.318 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeE----EEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~v----AVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|.+ .+..+ ++|..... ......+ .+.+|+.++++++||||+++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~---~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANK----EILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC---SSCCCHH----HHHHHHHHHTTCCBTTBCCCCE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc---cCHHHHH----HHHHHHHHHHhCCCCCeeEEEE
Confidence 4567899999999999999999997 34444 55543211 1112223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.... .++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~---------------~~~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 145 (327)
T 3lzb_A 85 ICLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEESSS---------------EEEEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC---------------ceEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence 987543 4899999999999999986 235689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||+++......... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 146 ~NIl~~~~-------~~~kL~DfG~a~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG 206 (327)
T 3lzb_A 146 RNVLVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYG 206 (327)
T ss_dssp GGEEEEET-------TEEEECCTTC------------------------CCCGGGSCHHHHHH----CCCCHHHHHHHHH
T ss_pred HHEEEcCC-------CCEEEccCcceeEccCccccc--------cccCCCccccccCHHHHcC----CCCChHHHHHHHH
Confidence 99999877 469999999998764422111 1122357889999999987 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||++ |..||.+....++...+........+. ..+..+.+||.+||..|
T Consensus 207 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~d 259 (327)
T 3lzb_A 207 VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMRKCWMID 259 (327)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999988887777776654333221 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003375 800 PTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~s 818 (825)
|.+|||+.+|++.|+.+..
T Consensus 260 p~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 260 ADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGGSCCHHHHHHHHHHHHT
T ss_pred hhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=377.44 Aligned_cols=297 Identities=18% Similarity=0.177 Sum_probs=194.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+ .+..||+|++. .........+. +.+|+.+|+.|+|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~----~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKR----ILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEEC--STTSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEec--hhhcCHHHHHH----HHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 47899999999999999999987 56789999863 22233333344 489999999999999999999986543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ....+||||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+
T Consensus 126 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 126 VE---------KFDELYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp TT---------TCCCEEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred cc---------cCceEEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 21 2235799999995 799999975 35699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCccccccccccccc-----------------ccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~-----------------s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~ 709 (825)
.+ +.+||+|||+++........... ...........+||+.|+|||++.. ...
T Consensus 191 ~~-------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~ 260 (458)
T 3rp9_A 191 QD-------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QEN 260 (458)
T ss_dssp TT-------CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT---CCC
T ss_pred CC-------CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCC
Confidence 77 46999999999876532211000 0000011234578999999998753 256
Q ss_pred CCchhhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHcCCCCCchhHHh
Q 003375 710 YGLEVDIWSYGCLLLELLT-----------LQVPYMGLSE--------------------LEIHDLIQMGKRPRLTDELE 758 (825)
Q Consensus 710 ~s~kSDVWSLGvILyELLT-----------G~~PF~~~~~--------------------~~i~~~I~~~~~p~l~~~l~ 758 (825)
++.++||||||||||||++ |+++|.+.+. ...+..+.........+.+.
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 8999999999999999999 7777766542 11222222211111111111
Q ss_pred hhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 759 ALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 759 ~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
.........+... .............++.+.+||.+||..||.+|||++|+|+|.+..
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 1100000000000 011111222334567899999999999999999999999996543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.64 Aligned_cols=283 Identities=19% Similarity=0.208 Sum_probs=206.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+ .+..||+|++. ......... .++.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHH----HHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeC--ccccCHHHH----HHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 46899999999999999999998 57789999853 222222223 34589999999999999999999987653
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ......|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 98 TL--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp ST--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred cc--------ccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 22 1123469999999 7899999986 4689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 163 ~~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 163 ED-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp TT-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeeecccccccc-------------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHH
Confidence 77 45999999999865431 123468999999999875 24688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||.+.+..+....+.........+.+..+.......+.... ............++.+.+||.+||..||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 9999999998887777666554222222222111000000000000 0001111223446789999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003375 804 PTAGDLYEMFVA 815 (825)
Q Consensus 804 PSa~EIL~hL~~ 815 (825)
||+.++++|...
T Consensus 300 ~t~~e~l~hp~f 311 (367)
T 1cm8_A 300 VTAGEALAHPYF 311 (367)
T ss_dssp CCHHHHHHSGGG
T ss_pred CCHHHHhcChHH
Confidence 999999999654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=385.03 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=215.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
+...+|++.+.||+|+||.||+|.+. +..||||++... .. ..+. +.+|+.+|++++||||+++++++..
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~---~~~~----~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--cc---chHH----HHHHHHHHHhcCCCCEeeEEEEEec
Confidence 44567999999999999999999985 678999985422 11 2233 4899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
...+ ||||||+++|+|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 288 ~~~~--------------~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 350 (495)
T 1opk_A 288 EPPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350 (495)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCcE--------------EEEEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 6544 999999999999999986 23356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++........ ......+++.|+|||++.+ ..++.++|||||||+||
T Consensus 351 l~~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlG~~l~ 410 (495)
T 1opk_A 351 VGEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 410 (495)
T ss_dssp ECGG-------GCEEECCTTCEECCTTCCEE---------CCTTCCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEEeecccceeccCCcee---------ecCCCcCCcceeCHhHHhc----CCCCcHHhHHhHHHHHH
Confidence 9877 46999999999876432211 0122346789999999986 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+| |..||.+.+..++...+....+...+. ..++.+.+||.+||+.||.+|
T Consensus 411 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~R 463 (495)
T 1opk_A 411 EIATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDR 463 (495)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCcChhHC
Confidence 9999 999999988887777776654433221 235679999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 003375 804 PTAGDLYEMFVARTSSS 820 (825)
Q Consensus 804 PSa~EIL~hL~~l~sss 820 (825)
||+.+|++.|+.+....
T Consensus 464 Ps~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 464 PSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCHHHHHHHHHTSCSSS
T ss_pred cCHHHHHHHHHHHHhcc
Confidence 99999999999886543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=382.75 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=206.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|++ .+..+|+|++....... .... .+.+|+.+|+.++||||+++++++.....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNS----KLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTH----HHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHH----HHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4699999999999999999998 56789999975432211 1122 34899999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+|||||++|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 111 --------------~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 111 --------------YYLVMECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp --------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred --------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 5999999999999999876 256899999999999999999999999999999999999976
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
.+ ....+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 172 ~~----~~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~-----~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 172 KE----KDALIKIVDFGLSAVFENQKK-----------MKERLGTAYYIAPEVLRK-----KYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp SS----TTCCEEECCCTTCEECBTTBC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEECCCCeECCCCcc-----------ccccCCCcCeeCHHHHcc-----cCCCchhHHHHHHHHHHHH
Confidence 53 235699999999987653221 123469999999999863 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|.+||.+.+..++...+..+........ ....++.+.+||.+||+.||.+|||+.
T Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPE------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCSGG------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCchh------------------------cccCCHHHHHHHHHHCCCChhhCccHH
Confidence 99999999999888888877643221111 122356799999999999999999999
Q ss_pred HHHHHHHh
Q 003375 808 DLYEMFVA 815 (825)
Q Consensus 808 EIL~hL~~ 815 (825)
++++|.+-
T Consensus 288 e~l~hp~~ 295 (494)
T 3lij_A 288 QALEHPWI 295 (494)
T ss_dssp HHHTCHHH
T ss_pred HHhcCccc
Confidence 99998553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.84 Aligned_cols=256 Identities=25% Similarity=0.283 Sum_probs=193.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|++ .+..||+|++..... . .+ .+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~---~~----~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--I---DE----NVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--S---CH----HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--c---cH----HHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 4568999999999999999999998 577899998753211 1 12 23899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .+|||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 88 PTH--------------LAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp SSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred CCE--------------EEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 653 5999999999999999976 246999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC-CchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~-s~kSDVWSLGvIL 723 (825)
++.++. ..+||+|||+++....... .....||+.|+|||++.+ ..+ +.++|||||||++
T Consensus 149 l~~~~~-----~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il 208 (361)
T 3uc3_A 149 LDGSPA-----PRLKICDFGYSKSSVLHSQ-----------PKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTL 208 (361)
T ss_dssp ECSSSS-----CCEEECCCCCC--------------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHH
T ss_pred EcCCCC-----ceEEEeecCccccccccCC-----------CCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHH
Confidence 986632 5699999999874322111 133469999999999986 344 4459999999999
Q ss_pred HHHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 724 LELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 724 yELLTG~~PF~~~~~----~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|+|++|+.||.+... ......+..... .++. ....++.+.+||.+||..|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIPD-------------------------DIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHSSCSCC----CCCHHHHHHHHHTTCC-CCCT-------------------------TSCCCHHHHHHHHHHSCSC
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-CCCC-------------------------cCCCCHHHHHHHHHHccCC
Confidence 999999999976543 223333332211 1110 0123567899999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003375 800 PTERPTAGDLYEMFVAR 816 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l 816 (825)
|.+|||+.||++|.+..
T Consensus 263 P~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 263 PATRISIPEIKTHSWFL 279 (361)
T ss_dssp TTTSCCHHHHHTSHHHH
T ss_pred hhHCcCHHHHHhCcchh
Confidence 99999999999997653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=366.52 Aligned_cols=283 Identities=19% Similarity=0.221 Sum_probs=205.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|.+ .+..||+|++..... ...... +.+|+.+|+.++||||+++++++....
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCT----AIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCC----CCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchh----HHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 57899999999999999999998 477899998753321 111112 267999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .+|||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 74 ~--------------~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 74 S--------------LTLVFEYLD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp C--------------EEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred E--------------EEEEecccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 4 499999998 699999886 235689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 135 ~~-------~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 135 ER-------GELKLADFGLARAKSIPTKT----------YDNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp TT-------CCEEECSSSEEECC----------------------CGGGCCHHHHTT---CCCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCcccccccCCccc----------cccccCcccccChhhhcC---CCCCCcHHHHHHHHHHHHHH
Confidence 77 45999999999765432111 123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc-C-CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-G-SGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~-~-~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|+.||.+.+..+....+...........+.............. . ............++.+.+||.+||+.||.+||
T Consensus 195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 999999999888777766655322221211111110000000000 0 00001112234467889999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.|+++|.+...
T Consensus 275 t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 275 SAEDAMKHPFFLS 287 (324)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhhh
Confidence 9999999966543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=358.77 Aligned_cols=267 Identities=21% Similarity=0.215 Sum_probs=206.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~ 565 (825)
-++|++.+.||+|+||.||+|.+ .+..||+|+...... .+ .+.+|+.++++| +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~----~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------AP----QLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SC----CHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hH----HHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 36899999999999999999996 678999998754321 11 238899999999 899999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~--------------~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 78 KY--------------NAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp TE--------------EEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred Cc--------------cEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 53 49999999 89999999862 3579999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++. .....+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 139 ~~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 209 (330)
T 2izr_A 139 GRPGN--KTQQVIHIIDFALAKEYIDPETKKH---IPYREHKSLTGTARYMSINTHLG----KEQSRRDDLEALGHMFMY 209 (330)
T ss_dssp CCGGG--TCTTSEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ccCCC--CCCceEEEEEcccceeeecCCCCcc---ccccccCCcCCCccccChHHHcC----CCCCchhHHHHHHHHHHH
Confidence 87742 1223499999999987654322110 01111245679999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 726 LLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 726 LLTG~~PF~~~~~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|++|+.||.+.+. .+.+..+.....+.....+ ....+ .+.+||.+||..||.+
T Consensus 210 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~-----------------------~~~~p-~~~~li~~~l~~~p~~ 265 (330)
T 2izr_A 210 FLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL-----------------------CENFP-EMATYLRYVRRLDFFE 265 (330)
T ss_dssp HHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH-----------------------TTTCH-HHHHHHHHHHHCCTTC
T ss_pred HhcCCCCccccccccHHHHHHHHHhhhccCCHHHH-----------------------hccCh-HHHHHHHHHHhCCCCC
Confidence 9999999987543 3334444322111111100 01123 7999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
||++.+|++.|+.+.
T Consensus 266 RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 266 KPDYDYLRKLFTDLF 280 (330)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999998664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=371.64 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=208.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..+++|++.+.||+|+||.||+|++. +..||+|+....... .....+.+.+|..+|..+ +||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 56889999999999999999999985 467999987532110 111123348899999988 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... +||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 152 (353)
T 2i0e_A 92 TMDR--------------LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152 (353)
T ss_dssp CSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred cCCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 6653 5999999999999999986 24699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 153 ll~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 211 (353)
T 2i0e_A 153 MLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLL 211 (353)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBSTHHHHHHHHHHH
T ss_pred EEcCC-------CcEEEEeCCcccccccCCc----------ccccccCCccccChhhhcC----CCcCCcccccchHHHH
Confidence 99877 4599999999975432111 1234579999999999986 6689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|+.||.+.+..++...+..... .++. ..+..+.+||.+||..||.+|
T Consensus 212 ~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 212 YEMLAGQAPFEGEDEDELFQSIMEHNV-AYPK---------------------------SMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCTTSC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHc
Confidence 999999999999988888887776532 1111 134578999999999999999
Q ss_pred CC-----HHHHHHHHH
Q 003375 804 PT-----AGDLYEMFV 814 (825)
Q Consensus 804 PS-----a~EIL~hL~ 814 (825)
|+ +.+|++|.+
T Consensus 264 ~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 264 LGCGPEGERDIKEHAF 279 (353)
T ss_dssp TTCSTTHHHHHHTSGG
T ss_pred CCCCCCCHHHHhcCcc
Confidence 94 699999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=381.95 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=211.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-----hHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~-----~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..++|.+.+.||+|+||.||+|.+ .+..+|+|++........ ....+...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 357899999999999999999998 467899999764322111 1111233455699999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~~~~~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp 174 (504)
T 3q5i_A 114 VFEDKKY--------------FYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174 (504)
T ss_dssp EEECSSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEcCCE--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcH
Confidence 9986553 5999999999999999976 25699999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.++. ...+||+|||++........ .....||+.|+|||++.+ .++.++||||||
T Consensus 175 ~Nil~~~~~~----~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG 234 (504)
T 3q5i_A 175 ENILLENKNS----LLNIKIVDFGLSSFFSKDYK-----------LRDRLGTAYYIAPEVLKK-----KYNEKCDVWSCG 234 (504)
T ss_dssp GGEEESSTTC----CSSEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHH
T ss_pred HHEEEecCCC----CccEEEEECCCCEEcCCCCc-----------cccccCCcCCCCHHHhcc-----CCCchHHHHHHH
Confidence 9999987631 24699999999987644221 123469999999999863 578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|++|+|++|.+||.+.+..++...+..+........ ....++.+.+||.+||.+||
T Consensus 235 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp 290 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND------------------------WKNISDEAKELIKLMLTYDY 290 (504)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH------------------------HTTSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc------------------------cCCCCHHHHHHHHHHcCCCh
Confidence 999999999999999999888888877643222111 12235679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003375 801 TERPTAGDLYEMFVAR 816 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l 816 (825)
.+|||+.|+++|.+-.
T Consensus 291 ~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 291 NKRCTAEEALNSRWIK 306 (504)
T ss_dssp TTSCCHHHHHTSHHHH
T ss_pred hHCCCHHHHhcCHhhh
Confidence 9999999999997654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.12 Aligned_cols=265 Identities=22% Similarity=0.357 Sum_probs=213.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
...++|++.+.||+|+||.||+|.+. +..||+|+.... ......+. +.+|+.+++++ +||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHHH----HHHHHHHHHHHCCCTTBC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHHH----HHHHHHHHHHhhcCCCEe
Confidence 44578999999999999999999863 456899985422 22333333 48999999999 899999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++...... ++||||+++++|.+++...... ....+++..++.++.||+.||
T Consensus 105 ~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 105 NLLGACTQDGPL--------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp CEEEEECSSSCC--------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEccCCce--------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 999999866544 9999999999999999862211 123489999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
.|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 171 ~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 233 (334)
T 2pvf_A 171 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFD-- 233 (334)
T ss_dssp HHHHHTTEECSCCSGGGEEECTT-------CCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHH--
T ss_pred HHHHhCCeeCCCCccceEEEcCC-------CCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcC--
Confidence 99999999999999999999877 459999999998765422110 0122357889999999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||++|||++ |..||.+....++...+..+..+..+. ..
T Consensus 234 --~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 284 (334)
T 2pvf_A 234 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NC 284 (334)
T ss_dssp --CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TC
T ss_pred --CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc---------------------------cC
Confidence 568899999999999999999 999999988888877776664433221 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus 285 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=382.36 Aligned_cols=261 Identities=26% Similarity=0.311 Sum_probs=212.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..||+|++....... ... ..+.+|+.+|++++||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDT----STILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCH----HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHH----HHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 46899999999999999999998 57889999975332111 112 23489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 95 ~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~ 155 (486)
T 3mwu_A 95 S--------------FYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (486)
T ss_dssp E--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred E--------------EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 3 5999999999999999876 25689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
..+ ..+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 156 ~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l 215 (486)
T 3mwu_A 156 SKE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYIL 215 (486)
T ss_dssp SSS----TTCCEEECSCSCTTTBCCC---------------CCTTGGGGCCGGGGGS-----CCCHHHHHHHHHHHHHHH
T ss_pred cCC----CCCCEEEEECCcCeECCCCCc-----------cCCCcCCCCCCCHHHhCC-----CCCchhhHHHHHHHHHHH
Confidence 542 235799999999976543211 123469999999999974 489999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|.+||.+.+..++...+..+..+.... .....++.+.+||.+||..||.+|||+
T Consensus 216 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~ 271 (486)
T 3mwu_A 216 LSGTPPFYGKNEYDILKRVETGKYAFDLP------------------------QWRTISDDAKDLIRKMLTFHPSLRITA 271 (486)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCSCSG------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCc------------------------ccCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999888888887764321111 112345689999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 003375 807 GDLYEMFVARTS 818 (825)
Q Consensus 807 ~EIL~hL~~l~s 818 (825)
.++++|.+-...
T Consensus 272 ~~~l~hp~~~~~ 283 (486)
T 3mwu_A 272 TQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHCHHHHHT
T ss_pred HHHhcCHhhccC
Confidence 999999765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=364.97 Aligned_cols=288 Identities=22% Similarity=0.272 Sum_probs=211.6
Q ss_pred CCCCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 483 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 483 ~~d~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
.+....+++|++.+.||+|+||.||+|.+. +..||+|++... .......+ .+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 91 (331)
T 4aaa_A 18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKK----IAMREIKLLKQLRHENLVNLLE 91 (331)
T ss_dssp -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHHH----HHHHHHHHHhhCCCCCEeeEEE
Confidence 355578899999999999999999999984 778999986432 22222223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~~--------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 152 (331)
T 4aaa_A 92 VCKKKKR--------------WYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152 (331)
T ss_dssp EEEETTE--------------EEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EeecCCE--------------EEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcCh
Confidence 9986653 4999999999888887664 35699999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++..+...... .....||+.|+|||++.+ ...++.++||||||
T Consensus 153 ~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG 212 (331)
T 4aaa_A 153 ENILVSQS-------GVVKLCDFGFARTLAAPGEV----------YDDEVATRWYRAPELLVG---DVKYGKAVDVWAIG 212 (331)
T ss_dssp GGEEECTT-------SCEEECCCTTC----------------------CCCCCTTCCHHHHTT---CTTCCTHHHHHHHH
T ss_pred heEEEcCC-------CcEEEEeCCCceeecCCccc----------cCCCcCCccccCcccccC---CCCcchHHHHHHHH
Confidence 99999877 46999999999765432211 123468999999999975 23678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccC---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
|++|+|++|+.||.+.+..+....+........+.....+... .....................++.+.+||.+||+
T Consensus 213 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 292 (331)
T 4aaa_A 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292 (331)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhc
Confidence 9999999999999988877766555443222222211111000 0000000000011111223456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 003375 798 ENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~ 815 (825)
.||.+|||+.|+++|.+.
T Consensus 293 ~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 293 IDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp SSGGGSCCGGGGGGSHHH
T ss_pred cCcccCCCHHHHhcCchh
Confidence 999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.18 Aligned_cols=274 Identities=23% Similarity=0.311 Sum_probs=201.5
Q ss_pred CCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
...|++.+.||+|+||.||+|++ .+..||+|++..... ....+ .+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIA----DLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHH----HHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHH----HHHHHHHHHHhCCCCCeeeeeeEE
Confidence 35599999999999999999985 678899999753321 11222 348999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... ...++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 93 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 156 (302)
T 4e5w_A 93 TEDGG------------NGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 156 (302)
T ss_dssp EC---------------CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence 86531 1359999999999999999652 3468999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++........... ......||..|+|||++.+ ..++.++|||||||+
T Consensus 157 il~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 157 VLVESE-------HQVKIGDFGLTKAIETDKEYYT-------VKDDRDSPVFWYAPECLMQ----SKFYIASDVWSFGVT 218 (302)
T ss_dssp EEEEET-------TEEEECCCTTCEECCTTCCEEE-------CCCCTTCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcccccccccCCCccee-------ccCCCCCCccccCCeeecC----CCCCcchhHHHHHHH
Confidence 999877 4699999999987654322110 1123468889999999987 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCch--hHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|+|++|..|+... ................ ....... ... ........++.+.+||.+||+.||
T Consensus 219 l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~~l~~li~~~l~~dp 284 (302)
T 4e5w_A 219 LHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLVNTLK---------EGK---RLPCPPNCPDEVYQLMRKCWEFQP 284 (302)
T ss_dssp HHHHHTTTCGGGSH--HHHHHHHHCSCCGGGHHHHHHHHHH---------TTC---CCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred HHHHHHccCCCcch--hhHHhhccCCcccccCHHHHHHHHh---------ccC---CCCCCCCCCHHHHHHHHHHcCCCC
Confidence 99999999986422 1111111111000000 0000000 000 001112346689999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003375 801 TERPTAGDLYEMFVART 817 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ 817 (825)
.+|||+.++++.|+.+.
T Consensus 285 ~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 285 SNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHh
Confidence 99999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.57 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=207.4
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---Ce--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~---~~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
...+|++.+.||+|+||.||+|.+. +. .+|+|+.. . .......+. +.+|+.++++++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~--~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--R-ITDIGEVSQ----FLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEET--T-CCSHHHHHH----HHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecc--c-CCCHHHHHH----HHHHHHHHHhCCCCCEeeeeeEE
Confidence 3457999999999999999999863 22 35666543 2 222333344 48999999999999999999986
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~-------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 96 LRSEG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp CCSSS-------------CCEEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EcCCC-------------ceEEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 54332 24999999999999999974 23568999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++.......... ........+|+.|+|||++.+ ..++.++|||||||+
T Consensus 159 il~~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 221 (298)
T 3f66_A 159 CMLDEK-------FTVKVADFGLARDMYDKEYYS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVL 221 (298)
T ss_dssp EEECTT-------CCEEECSCGGGCCCSCGGGCB------C-----CCBCGGGSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECcccccccccccchhc------cccccCCCCCccccChHHhcC----CCCChHHHHHHHHHH
Confidence 999876 469999999998765432211 111233468899999999987 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|+|++ +.+||.+.+..+....+..+..+..+. ..++.+.+||.+||+.||.
T Consensus 222 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 274 (298)
T 3f66_A 222 LWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAE 274 (298)
T ss_dssp HHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChh
Confidence 999999 677887777666666666554332221 1245799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCC
Q 003375 802 ERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~sss~ 821 (825)
+|||+.++++.|+.+...-.
T Consensus 275 ~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 275 MRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp GSCCHHHHHHHHHHHHHTSC
T ss_pred hCcCHHHHHHHHHHHHHhhc
Confidence 99999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.12 Aligned_cols=271 Identities=25% Similarity=0.410 Sum_probs=203.0
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
...+++|++.+.||+|+||.||+|.+ .+..+|+|++..... ....... .+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARA----DCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 35678999999999999999999997 578899998754221 2233333 3489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 103 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 103 EDNE--------------LNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167 (310)
T ss_dssp ETTE--------------EEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred cCCc--------------EEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence 6653 4999999999999999976432 235689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 168 l~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il 226 (310)
T 2wqm_A 168 FITAT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLL 226 (310)
T ss_dssp EECTT-------SCEEECCC----------------------------CCSSCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccceeeecCCCcc----------ccccCCCeeEeChHHhCC----CCCCchhhHHHHHHHH
Confidence 99876 45999999998765432211 123468999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCC--CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 724 LELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 724 yELLTG~~PF~~~--~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|+|++|..||.+. ....+...+.....+.+. ....++.+.+||.+||..||.
T Consensus 227 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~ 280 (310)
T 2wqm_A 227 YEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPE 280 (310)
T ss_dssp HHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC--------------------------TTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHhCCCCCcccchhHHHHHHHhhcccCCCCc--------------------------ccccCHHHHHHHHHHcCCChh
Confidence 9999999999754 333444555444332211 012355799999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCCCC
Q 003375 802 ERPTAGDLYEMFVARTSSSISS 823 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~sss~S~ 823 (825)
+|||+.+|+++|+.+.....++
T Consensus 281 ~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 281 KRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp GSCCHHHHHHHHHHHHHHHC--
T ss_pred hCCCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999886654433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=381.18 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=203.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++...... ...... .+.+|+.+|+.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHH----HHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 4578899999999999999999997 5778999997543211 112222 33889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NI 643 (825)
... +||||||+++|+|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+||
T Consensus 220 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 220 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp TTE--------------EEEEECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred CCE--------------EEEEEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 654 4999999999999999976 2568999999999999999999998 9999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 281 ll~~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 281 MLDKD-------GHIKITDFGLCKEGIKDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp EECSS-------SCEEECCCCCCCTTCC---------------CCSSSCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEccCCCceeccCCCcc----------cccccCCccccCHhhcCC----CCCCCccchhhhHHHH
Confidence 99877 45999999999754322111 234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|+.||.+.+...+...+...... ++. ..++.+.+||.+||+.||.+|
T Consensus 340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 340 YEMMCGRLPFYNQDHEKLFELILMEEIR-FPR---------------------------TLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCc---------------------------cCCHHHHHHHHHHcccCHHHh
Confidence 9999999999998888887777654321 111 124578999999999999999
Q ss_pred C-----CHHHHHHHHHh
Q 003375 804 P-----TAGDLYEMFVA 815 (825)
Q Consensus 804 P-----Sa~EIL~hL~~ 815 (825)
| ++.|+++|.+.
T Consensus 392 ~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp TTCSTTTHHHHHTSGGG
T ss_pred CCCCCCCHHHHHhCccc
Confidence 9 99999998553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.41 Aligned_cols=270 Identities=16% Similarity=0.168 Sum_probs=210.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..-++|++.+.||+|+||.||+|.+ .+..||+|+..... ..+ .+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~----~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAP----QLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSC----CHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccH----HHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 3456799999999999999999996 78899999864321 112 238899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 77 EGLH--------------NVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp ETTE--------------EEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CCce--------------eEEEEEec-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 6553 49999999 8999999986 234699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++. .....+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||+|
T Consensus 138 l~~~~~~--~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 208 (298)
T 1csn_A 138 LIGRPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVF 208 (298)
T ss_dssp EECCSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EeccCCC--CCCCeEEEEECcccccccccccccc---ccccCccCCCCCcccCCchhhcC----CCCChHHHHHHHHHHH
Confidence 9987632 2335699999999987754322111 01112344579999999999986 6689999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 724 LELLTLQVPYMGLS---ELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 724 yELLTG~~PF~~~~---~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|||++|+.||.+.. .......+.... .+..+. .....++.+.+||.+||+.|
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCC
T ss_pred HHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH------------------------HHhhCcHHHHHHHHHHhcCC
Confidence 99999999998743 334443333221 111111 11123568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 003375 800 PTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~s 818 (825)
|.+|||+.+|++.|+.+..
T Consensus 265 p~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 265 FDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp TTCCCCHHHHHHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHHHH
Confidence 9999999999999988764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.68 Aligned_cols=271 Identities=21% Similarity=0.335 Sum_probs=213.4
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcc
Q 003375 484 LDPGSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 556 (825)
Q Consensus 484 ~d~~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV 556 (825)
+.....++|++.+.||+|+||.||+|.+ .+..||+|++. . ......... +.+|+.++++++||||+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~-~~~~~~~~~----~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--E-VCSEQDELD----FLMEALIISKFNHQNIV 96 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC--S-SCCHHHHHH----HHHHHHHHHHCCCTTBC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec--c-ccchhhHHH----HHHHHHHHhhCCCCCCC
Confidence 3346678999999999999999999984 34579999853 1 122333333 48999999999999999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc--CCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~--~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
++++++...... ||||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+
T Consensus 97 ~~~~~~~~~~~~--------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 162 (327)
T 2yfx_A 97 RCIGVSLQSLPR--------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI 162 (327)
T ss_dssp CEEEEECSSSSC--------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eEEEEEcCCCCc--------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee
Confidence 999999866544 9999999999999999873211 114588999999999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+|||++.++. ...+||+|||++......... .......||+.|+|||++.+ ..++.++
T Consensus 163 H~dlkp~NIli~~~~~----~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 226 (327)
T 2yfx_A 163 HRDIAARNCLLTCPGP----GRVAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKT 226 (327)
T ss_dssp CSCCCGGGEEESCSST----TCCEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH----CCCCHHH
T ss_pred cCcCCHhHEEEecCCC----cceEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcC----CCCCchh
Confidence 9999999999985531 256999999999765432211 01233468999999999986 6689999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 715 DVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
|||||||++|+|+| |..||.......+...+..+..+..+. ..+..+.+||.
T Consensus 227 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~ 279 (327)
T 2yfx_A 227 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMT 279 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 999999888888777777664433221 12457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 794 RCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+||+.||.+|||+.+|+++|+.+..
T Consensus 280 ~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 280 QCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=377.85 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=209.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.+.||+|+||.||+|.+.+ ..||||+.... ... .+. +.+|+.+|++|+||||+++++++..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC--CCC---HHH----HHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 455789999999999999999999954 67999985432 211 223 4899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .+|||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 251 ~~--------------~~iv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 313 (452)
T 1fmk_A 251 EP--------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313 (452)
T ss_dssp SS--------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred Cc--------------eEEEehhhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 22 39999999999999999752 12458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||+|||
T Consensus 314 ~~~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~e 373 (452)
T 1fmk_A 314 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 373 (452)
T ss_dssp CGG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEECCCccceecCCCcee---------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHH
Confidence 877 45999999999876432111 0122357889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |+.||.+....++...+..+.+...+. ..++.+.+||.+||+.||.+||
T Consensus 374 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 374 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCc
Confidence 999 999999998888888877765433321 2355789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.+|++.|+.+..+.
T Consensus 427 t~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 427 TFEYLQAFLEDYFTST 442 (452)
T ss_dssp CHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHHhccC
Confidence 9999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=363.97 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=208.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..|++.+.||+|+||.||+|.+ .+..||+|++..... ...... ..+.+|+.+|++++||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKW----QDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHH----HHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence 4589999999999999999996 678899998754321 112222 344899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.+|||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 129 --------------~~lv~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 129 --------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp --------------EEEEEECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred --------------EEEEEecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 599999998 6898888641 356899999999999999999999999999999999999997
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++...... ....||+.|+|||++.+.. ...++.++|||||||+||||+
T Consensus 190 ~-------~~~kL~DfG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 190 P-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp T-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHHTTS-SCCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeccCceecCCC--------------CcccCCcceeCHhhhcccc-CCCCCcHHHHHHHHHHHHHHH
Confidence 7 56999999999765321 2246999999999996422 256789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|+.||.+.+.......+.....+.+.. ...++.+.+||.+||+.||.+|||+.
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ 301 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 301 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999999888777666665553332210 11245789999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 003375 808 DLYEMFVARTSS 819 (825)
Q Consensus 808 EIL~hL~~l~ss 819 (825)
++++|.+.....
T Consensus 302 ~ll~h~~~~~~~ 313 (348)
T 1u5q_A 302 VLLKHRFVLRER 313 (348)
T ss_dssp HHTTCHHHHSCC
T ss_pred HHhhChhhhccC
Confidence 999998766544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.94 Aligned_cols=301 Identities=17% Similarity=0.190 Sum_probs=214.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|++ .+..||+|++...... .... ..+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFP----ITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSC----HHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccch----HHHHHHHHHHHhccCCCcccHhheeec
Confidence 4578999999999999999999998 5778999986443221 1111 234889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ........||||||++ ++|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 88 KASP------YNRCKGSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp C--------------CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cccc------cccCCceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 5321 0011235799999998 588888864 2356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++.+...... .........||+.|+|||++.+ ...++.++|||||||++|
T Consensus 157 ~~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 157 ITRD-------GVLKLADFGLARAFSLAKNS------QPNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp ECTT-------SCEEECCCTTCEECCCCSSS------SCCCCCSSCSCGGGCCHHHHTT---CCSCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccchhcccccccccc------cccccCCcccccCccCchhhcC---CCCCCcHhHHHHHHHHHH
Confidence 9877 45999999999876532211 1111234578999999999975 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchh-----hhhhHHHHHHHHHHhcccC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~L~dLI~~CL~~D 799 (825)
+|++|.+||.+.+.......+........+..+.............. ........ ....++.+.+||.+||+.|
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 299 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCC
Confidence 99999999999888777666654321111111111100000000000 00000000 0112456899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCCC
Q 003375 800 PTERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~sss~ 821 (825)
|.+|||+.|+++|.+......+
T Consensus 300 P~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 300 PAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp GGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhCCCHHHHhCCCCcCCCCCc
Confidence 9999999999999877654443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.65 Aligned_cols=257 Identities=24% Similarity=0.276 Sum_probs=193.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+. +..||+|++.... ..+. +.+|+.+|++++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKI----VRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHH----HHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 356999999999999999999984 5679999875321 1222 378999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 122 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~ 182 (349)
T 2w4o_A 122 --------------EISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182 (349)
T ss_dssp --------------EEEEEECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred --------------eEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence 35999999999999999875 35689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
... ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 183 ~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 243 (349)
T 2w4o_A 183 TPA----PDAPLKIADFGLSKIVEHQVL-----------MKTVCGTPGYCAPEILRG----CAYGPEVDMWSVGIITYIL 243 (349)
T ss_dssp SSS----TTCCEEECCCC---------------------------CGGGSCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCCEEEccCccccccCcccc-----------cccccCCCCccCHHHhcC----CCCCcccchHHHHHHHHHH
Confidence 521 135799999999986543211 123469999999999986 6689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~-i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|..||......+ +...+.......... .....+..+.+||.+||..||.+|||
T Consensus 244 l~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (349)
T 2w4o_A 244 LCGFEPFYDERGDQFMFRRILNCEYYFISP------------------------WWDEVSLNAKDLVRKLIVLDPKKRLT 299 (349)
T ss_dssp HHSSCTTCCTTCHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HhCCCCCCCCcccHHHHHHHHhCCCccCCc------------------------hhhhCCHHHHHHHHHHccCChhhCcC
Confidence 99999997765443 455555443221110 11223567999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 003375 806 AGDLYEMFVART 817 (825)
Q Consensus 806 a~EIL~hL~~l~ 817 (825)
+.++++|.+-..
T Consensus 300 ~~e~l~hp~~~~ 311 (349)
T 2w4o_A 300 TFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHSTTTTS
T ss_pred HHHHhcCcccCC
Confidence 999999966543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.62 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=188.2
Q ss_pred CCceee---eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 490 PSLSSC---DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~---~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
.+|++. +.||+|+||.||+|.+ .+..||+|++... ... .+.+|+.+++.+. ||||+++++++.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~----~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEA----NTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHH----HHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhh----hHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 456654 7899999999999998 4778999986421 112 3378999999997 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... .||||||++||+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 77 DQLH--------------TFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp CSSE--------------EEEEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCE--------------EEEEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 6653 4999999999999999986 35799999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++ ....+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 138 ll~~~~----~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (325)
T 3kn6_A 138 LFTDEN----DNLEIKIIDFGFARLKPPDNQP----------LKTPCFTLHYAAPELLNQ----NGYDESCDLWSLGVIL 199 (325)
T ss_dssp EEEC--------CEEEECCCTTCEECCC------------------------------------CCCCHHHHHHHHHHHH
T ss_pred EEecCC----CcccEEEeccccceecCCCCCc----------ccccCCCcCccCHHHhcC----CCCCCccchHHHHHHH
Confidence 998653 2347999999999765432211 123468999999999976 6789999999999999
Q ss_pred HHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 724 LELLTLQVPYMGLSE-------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 724 yELLTG~~PF~~~~~-------~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|+|++|+.||.+.+. .++...+..+..+.. .......++.+.+||.+||
T Consensus 200 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L 255 (325)
T 3kn6_A 200 YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE------------------------GEAWKNVSQEAKDLIQGLL 255 (325)
T ss_dssp HHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC------------------------SHHHHTSCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC------------------------cccccCCCHHHHHHHHHHC
Confidence 999999999976432 344444444432211 1122334678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 797 EENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
..||.+|||+.++++|.+-.....
T Consensus 256 ~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 256 TVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp CCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCChhHCCCHHHHhcChhhccCcc
Confidence 999999999999999977655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=378.76 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=211.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|++ .+..+|+|+...... ........+.+|+.+++.++||||+++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4567899999999999999999998 467899998753210 001111234889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +||||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 141 ~~~--------------~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL 200 (410)
T 3v8s_A 141 DRY--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200 (410)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHee
Confidence 654 5999999999999999976 45899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++........ .....+||+.|+|||++.+......++.++|||||||+||
T Consensus 201 l~~~-------g~ikL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvily 264 (410)
T 3v8s_A 201 LDKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264 (410)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSEE---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeccceeEeeccCCcc---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHH
Confidence 9877 45999999999876543211 1234579999999999986322223789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e- 802 (825)
||++|+.||.+.+.......+.... ...++. ....++.+.+||.+||..+|.+
T Consensus 265 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~lL~~~~~rl 319 (410)
T 3v8s_A 265 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRL 319 (410)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-------------------------TCCCCHHHHHHHHHHSSCGGGCT
T ss_pred HHHhCCCCCCCCChhhHHHHHHhccccccCCC-------------------------cccccHHHHHHHHHHccChhhhC
Confidence 9999999999998888887776531 111110 0123567999999999999988
Q ss_pred -CCCHHHHHHHHHhh
Q 003375 803 -RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 -RPSa~EIL~hL~~l 816 (825)
||+++||++|.+..
T Consensus 320 gR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 320 GRNGVEEIKRHLFFK 334 (410)
T ss_dssp TSSCHHHHHTSGGGC
T ss_pred CCCCHHHHhcCcccc
Confidence 99999999997654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.04 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=212.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+....+|.+.+.||+|+||.||+|.+. +..+|+|+...... ......+ .+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQRE----KMSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHH----HHHHHHHHHHhCCCCCEeeeeeeec
Confidence 356788999999999999999999984 67899998754322 2223333 3489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..+. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 86 DNDF--------------VFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp CSSE--------------EEEEEECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 6553 5999999999999999876 24689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++
T Consensus 147 l~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 205 (294)
T 2rku_A 147 FLNED-------LEVKIGDFGLATKVEYDGER----------KKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 205 (294)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCCSSCCHHHHTT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEeccCceecccCccc----------cccccCCCCcCCcchhcc----CCCCchhhHHHHHHHH
Confidence 99877 45999999999876432111 123469999999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|+.||......+....+..... .++ ...+..+.+||.+||+.||.+|
T Consensus 206 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 206 YTLLVGKPPFETSCLKETYLRIKKNEY-SIP---------------------------KHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCC-CCC---------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhhccC-CCc---------------------------cccCHHHHHHHHHHcccChhhC
Confidence 999999999998877766665554321 111 1124578999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 003375 804 PTAGDLYEMFVARTSS 819 (825)
Q Consensus 804 PSa~EIL~hL~~l~ss 819 (825)
||+.++++|.......
T Consensus 258 ps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 258 PTINELLNDEFFTSGY 273 (294)
T ss_dssp CCGGGGGGSHHHHTSC
T ss_pred cCHHHHhhChheecCC
Confidence 9999999997665443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.78 Aligned_cols=262 Identities=21% Similarity=0.236 Sum_probs=202.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|+..... ........ +.+|+.++..+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQN----ALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC--TTSHHHHH----HHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc--cccHHHHH----HHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 346899999999999999999998 57899999865332 22223333 48999999999 89999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~--------------~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 147 (289)
T 1x8b_A 83 DDH--------------MLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147 (289)
T ss_dssp TTE--------------EEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCe--------------EEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence 653 59999999999999999863322 256899999999999999999999999999999999999
Q ss_pred EecCccC------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 645 IDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 645 Ld~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
++.++.. ......+||+|||++...... ....||+.|+|||++.+ ...++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~---~~~~~~ 210 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQE---NYTHLP 210 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTT---CCTTHH
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccCCc--------------cccCCCccccChhHhcC---CCCCCc
Confidence 9865310 012357999999999766432 12358999999999975 235678
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003375 713 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 792 (825)
Q Consensus 713 kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 792 (825)
++|||||||++|+|++|.+|+.... ....+..+..+.++. ..++.+.+||
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------------------~~~~~~~~li 260 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQ---------------------------VLSQEFTELL 260 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSS---------------------------CCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCc---------------------------ccCHHHHHHH
Confidence 9999999999999999998875442 233444443333321 1245799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 793 RRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 793 ~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.+||+.||.+|||+.++++|.+-..
T Consensus 261 ~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 261 KVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHhCCCcccCCCHHHHhhChHhhh
Confidence 9999999999999999999976543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=362.26 Aligned_cols=283 Identities=17% Similarity=0.211 Sum_probs=206.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||+|+||.||+|.+ .+..||+|++... .......+. +.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT--TSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc--cCChHHHHH----HHHHHHHHHhcCCCCccceEEeeccc
Confidence 357899999999999999999987 5788999986532 222333333 48999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ......||||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 97 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~ 160 (371)
T 2xrw_A 97 KSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160 (371)
T ss_dssp CST--------TTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccc--------ccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence 422 12235799999998 589888853 48899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 161 ~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 161 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp CTT-------SCEEECCCCC---------------------------CTTCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEEeecccccccccc-----------cCCceecCCccCHHHhcC----CCCCchHhHHHHHHHHHH
Confidence 877 4599999999976543211 123469999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC---------------CCCchhhhhhHHHHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---------------FEKPEAELETLSFLVD 790 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~L~d 790 (825)
|++|+.||.+.+..+....+........+..+..+.... ..+...... ..........+..+.+
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH-HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH-HHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 999999999998888777777654443333322211000 000000000 0011122334678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
||.+||..||.+|||+.|+++|.+-
T Consensus 298 li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 298 LLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHCcCChhhCCCHHHHhCCcch
Confidence 9999999999999999999999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.98 Aligned_cols=285 Identities=14% Similarity=0.129 Sum_probs=207.4
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhh----HHhHHHHHHHHhhCCCCCcc
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIV 556 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~----~~~~lrEv~iLk~L~HPNIV 556 (825)
.-++|++.+.||+|+||.||+|.+. +..||+|+....... ...+.+.+ ...+.+|+..+..++||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4458999999999999999999983 367999997533210 00111111 12345677788899999999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHr 636 (825)
++++++..... .....||||||+ |++|.+++.. ....+++..++.|+.||+.||.|||++||+||
T Consensus 112 ~~~~~~~~~~~----------~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr 176 (364)
T 3op5_A 112 KYWGSGLHDKN----------GKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHG 176 (364)
T ss_dssp CEEEEEEEEET----------TEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred eEEeeeeeccC----------CcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe
Confidence 99999875421 123569999999 8999999986 23569999999999999999999999999999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
||||+||||+.+. .+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++||
T Consensus 177 Dlkp~Nill~~~~-----~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 244 (364)
T 3op5_A 177 DIKASNLLLNYKN-----PDQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNG----VAPSRRGDL 244 (364)
T ss_dssp CCCGGGEEEESSC-----TTCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTT----CCCCHHHHH
T ss_pred cCCHHHEEEecCC-----CCeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCC----CCCCchhhH
Confidence 9999999998432 25799999999987754322111 01111234569999999999986 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003375 717 WSYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795 (825)
Q Consensus 717 WSLGvILyELLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~C 795 (825)
|||||+||||+||+.||.+.. .............+.+...+...+. ....++.+.+||..|
T Consensus 245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~li~~c 306 (364)
T 3op5_A 245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP------------------AANAPGEIAKYMETV 306 (364)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC------------------TTCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc------------------cccCHHHHHHHHHHH
Confidence 999999999999999998543 2222222222222222322221110 012356899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 003375 796 TEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 796 L~~DP~eRPSa~EIL~hL~~l~s 818 (825)
|..||.+||++.+|++.|+.+..
T Consensus 307 l~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 307 KLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCHHHHHHHHHHHHH
Confidence 99999999999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=364.15 Aligned_cols=276 Identities=22% Similarity=0.283 Sum_probs=208.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... .....+. +.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEE----FETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHH----HHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHH----HHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3567899999999999999999997 4678999975422 1222333 48999999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+.. ++||||+++++|.+++... ......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 108 ~~~--------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~ 172 (321)
T 2qkw_B 108 NEM--------------ILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL 172 (321)
T ss_dssp TCC--------------EEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE
T ss_pred CeE--------------EEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE
Confidence 543 9999999999999998641 1122458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 173 ~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 173 DEN-------FVPKITDFGISKKGTELDQT--------HLSTVVKGTLGYIDPEYFIK----GRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp CTT-------CCEEECCCTTCEECSSSSCC--------CCBCCCEEETTTCCHHHHHH----CBCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeccccccccccccc--------ccccccCCCccccCHHHhcC----CCCCcccchHhHHHHHHH
Confidence 876 46999999999765432111 11123468999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHH----cCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQ----MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~----~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
|++|+.||.+..+......+. ......+.. .... ..........+..+.+|+.+||+.||.
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~ 298 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ------------IVDP---NLADKIRPESLRKFGDTAVKCLALSSE 298 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS------------SSSS---SCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHH------------hcCh---hhccccCHHHHHHHHHHHHHHcCCCcc
Confidence 999999997654322111000 000000000 0000 001122345678899999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 003375 802 ERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ss 819 (825)
+|||+.+++++|+.+...
T Consensus 299 ~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 299 DRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp GSCCHHHHHHHHHHHHHS
T ss_pred cCcCHHHHHHHHHHHhhc
Confidence 999999999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=377.50 Aligned_cols=267 Identities=20% Similarity=0.277 Sum_probs=201.2
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|.+.+.||+|+||.||+|.+ .+..||+|++..+...............+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 47899999999999999999998 567899999865543322221122223458999999999999999999997533
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 213 --------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 213 --------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273 (419)
T ss_dssp --------------EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred --------------ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 24999999999999988764 35799999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
..+. ...+||+|||+++....... .....||+.|+|||++.+.. ...++.++|||||||+||+|
T Consensus 274 ~~~~----~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 274 SQEE----DCLIKITDFGHSKILGETSL-----------MRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp SSSS----SCCEEECCSSTTTSCC----------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHH
T ss_pred cCCC----cceEEEeecccceecCCCcc-----------ccccCCCCCccCceeeecCC-CCCCCchhhhHhHHHHHHHH
Confidence 6532 35699999999987643221 13356999999999986421 24678899999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|..||.+... ..+...+..+.....+.. ....++.+.+||.+||+.||.+|||
T Consensus 338 ltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps 393 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEV------------------------WAEVSEKALDLVKKLLVVDPKARFT 393 (419)
T ss_dssp HHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHCCCCCCCCcchHHHHHHHhcCCCCCCchh------------------------hcccCHHHHHHHHHHccCChhHCcC
Confidence 999999976533 334445554443333322 1234567999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.|+++|.+.
T Consensus 394 ~~e~l~hp~~ 403 (419)
T 3i6u_A 394 TEEALRHPWL 403 (419)
T ss_dssp HHHHHHSGGG
T ss_pred HHHHhCCccc
Confidence 9999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=348.54 Aligned_cols=269 Identities=25% Similarity=0.357 Sum_probs=216.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCC-CChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeE
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~-~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~ 562 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++...... ......+...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4578999999999999999999998 5688999997654321 223344455566799999999996 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 94 ETNT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 7654 35999999999999999986 2568999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYG 720 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~--~~~~~s~kSDVWSLG 720 (825)
||++.+ +.+||+|||++........ .....||+.|+|||++.+.. ....++.++||||||
T Consensus 155 il~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 155 ILLDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp EEECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred EEEcCC-------CcEEEecccchhhcCCCcc-----------cccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 999877 4599999999977643221 12346899999999986321 124578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+++|+|++|..||.+.+.......+......... ......+..+.+||.+||..||
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS------------------------PEWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------------------TTGGGSCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc------------------------ccccccCHHHHHHHHHHccCCc
Confidence 9999999999999988887777766655322111 0112345679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 003375 801 TERPTAGDLYEMFVAR 816 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l 816 (825)
.+|||+.++++|....
T Consensus 273 ~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 273 QKRYTAEEALAHPFFQ 288 (298)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred ccCCCHHHHHhChHhh
Confidence 9999999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.84 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=210.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|+..... .. .+ .+.+|+.++++++||||+++++++...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~---~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MS---PD----AFLAEANLMKQLQHQRLVRLYAVVTQE 80 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SC---HH----HHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--cc---HH----HHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence 34578999999999999999999984 4579999864321 11 22 348999999999999999999987633
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. .++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 81 ~---------------~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~ 142 (279)
T 1qpc_A 81 P---------------IYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (279)
T ss_dssp S---------------CEEEEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C---------------cEEEEecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE
Confidence 2 39999999999999998642 11358999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 143 ~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~e 202 (279)
T 1qpc_A 143 SDT-------LSCKIADFGLARLIEDNEYTA---------REGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 202 (279)
T ss_dssp CTT-------SCEEECCCTTCEECSSSCEEC---------CTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECCCcccccccCccccc---------ccCCCCccCccChhhhcc----CCCCchhhhHHHHHHHHH
Confidence 876 459999999998765432110 122357889999999986 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |..||.+.+..++...+..+..+..+. ..+..+.+||.+||..||.+||
T Consensus 203 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 203 IVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCcccCHHHHHHHHhcccCCCCcc---------------------------cccHHHHHHHHHHhccChhhCC
Confidence 999 999999988888777776654322221 2345799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
|+.+|++.|+.+...
T Consensus 256 s~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 256 TFDYLRSVLEDFFTA 270 (279)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHh
Confidence 999999999887543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.28 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=208.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|+.... ......+. +.+|+.+++++ +||||+++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHH----HHHHHHHHHhcccCCCeeeE
Confidence 3457899999999999999999985 3478999986422 22333333 48999999999 69999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
++++...+. ..++||||+++++|.+++...... ....+++..++.++.||+.||.|
T Consensus 97 ~~~~~~~~~-------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 97 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp EEEECCTTS-------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCC-------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 999875432 249999999999999999862110 01238899999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||++||+||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 164 lH~~~i~H~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~---- 224 (316)
T 2xir_A 164 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD---- 224 (316)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----
T ss_pred HHhCCcccccCccceEEECCC-------CCEEECCCccccccccCccce--------eccCCCcceeecCchhhcc----
Confidence 999999999999999999877 459999999998664322110 0123457899999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 003375 708 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 785 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 785 (825)
..++.++|||||||++|+|+| |..||.+... ..+...+..+..+..+. ..+
T Consensus 225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 277 (316)
T 2xir_A 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTT 277 (316)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCC
T ss_pred ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC---------------------------CCC
Confidence 678999999999999999998 9999987653 33444444443322221 124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 786 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 786 ~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
+.+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 278 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 5789999999999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=372.94 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=205.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..... ........+.+|+.+|+.++|||||++++++.+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 6688999999999999999999998 467799998753211 011112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+.||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~--------------~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 147 (384)
T 4fr4_A 87 EED--------------MFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147 (384)
T ss_dssp SSE--------------EEEEECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 654 4999999999999999975 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||++..+..... .....||+.|+|||++.... ...++.++|||||||+||
T Consensus 148 l~~~-------g~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~DiwSlG~il~ 208 (384)
T 4fr4_A 148 LDEH-------GHVHITDFNIAAMLPRETQ-----------ITTMAGTKPYMAPEMFSSRK-GAGYSFAVDWWSLGVTAY 208 (384)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCGGGTCCCS-SCCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeccceeeeccCCCc-----------eeccCCCccccCCeeeccCC-CCCCCccceeechHHHHH
Confidence 9877 4699999999987643221 13457999999999997421 245789999999999999
Q ss_pred HHHhCCCCCCCCC---HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 725 ELLTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 725 ELLTG~~PF~~~~---~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
||++|+.||.... ...+...+..... .++ ...+..+.+||.+||+.||.
T Consensus 209 elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~p---------------------------~~~s~~~~~li~~lL~~dP~ 260 (384)
T 4fr4_A 209 ELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYP---------------------------SAWSQEMVSLLKKLLEPNPD 260 (384)
T ss_dssp HHHHSSCSSCCCTTSCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhhccc-CCC---------------------------CcCCHHHHHHHHHHhcCCHh
Confidence 9999999997543 3333333333211 111 11345799999999999999
Q ss_pred CCCC-HHHHHHHHH
Q 003375 802 ERPT-AGDLYEMFV 814 (825)
Q Consensus 802 eRPS-a~EIL~hL~ 814 (825)
+||+ +++|++|.+
T Consensus 261 ~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 261 QRFSQLSDVQNFPY 274 (384)
T ss_dssp GSCCSHHHHHTSGG
T ss_pred HhcccHHHHHcChh
Confidence 9998 888888744
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.25 Aligned_cols=296 Identities=20% Similarity=0.215 Sum_probs=201.2
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+++|++.+.||+|+||.||+|++.+..||+|++.... ...+ ....|+..+..++||||+++++.+...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNF--INEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhhH--HHHHHHHHHHhccCcchhhheeccccc
Confidence 3678999999999999999999999999999999975321 1222 113344445568999999999876543
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC---------Ccccc
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHR 636 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~---------gIVHr 636 (825)
... .....+|||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||
T Consensus 80 ~~~---------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~ 144 (336)
T 3g2f_A 80 TAD---------GRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144 (336)
T ss_dssp CTT---------SCEEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS
T ss_pred ccC---------CCceEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeec
Confidence 211 22356999999999999999976 4468899999999999999999999 99999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC---CCCCch
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLE 713 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~---~~~s~k 713 (825)
||||+||||+.+ +.+||+|||+++.+........ ...........||+.|+|||++.+.... ..++.+
T Consensus 145 Dikp~Nill~~~-------~~~kL~DFG~a~~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 145 DLNSRNVLVKND-------GTCVISDFGLSMRLTGNRLVRP--GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp SCSGGGEEECTT-------SCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ccccceEEEcCC-------CcEEEeeccceeecccccccCc--cccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 999999999876 4699999999987654321110 0011112344699999999999752110 235678
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC-CHHHH--HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 714 VDIWSYGCLLLELLTLQVPYMGL-SELEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 714 SDVWSLGvILyELLTG~~PF~~~-~~~~i--~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
+|||||||+||||++|..||... ..... .........+.... +....... . ...... .........++.+.+
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~--~~~~~~-~~~~~~~~~~~~l~~ 290 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED-MQVLVSRE-K--QRPKFP-EAWKENSLAVRSLKE 290 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH-HHHHHTTS-C--CCCCCC-TTCCCCSHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH-HHhhhccc-c--cCCCCC-cccccccchHHHHHH
Confidence 99999999999999997766322 11100 00000111111111 00000000 0 000000 000112235678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
||.+||+.||.+|||+.|+++.|+.+...
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 99999999999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=353.98 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=212.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..-..|++.+.||+|+||.||+|.+ .+..||+|++...... ...+ .+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIE----DIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHH----HHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3446799999999999999999987 5778999997644321 2223 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 151 (303)
T 3a7i_A 92 DTK--------------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL 151 (303)
T ss_dssp TTE--------------EEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCe--------------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEE
Confidence 553 5999999999999999864 56899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 152 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 210 (303)
T 3a7i_A 152 LSEH-------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAI 210 (303)
T ss_dssp ECTT-------SCEEECCCTTCEECBTTBCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccceecCccccc----------cCccCCCcCccCHHHHhc----CCCCchhhhHHHHHHHH
Confidence 9877 45999999999776432211 133469999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||...........+.....+.++. ..+..+.+||.+||..||.+||
T Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~Rp 263 (303)
T 3a7i_A 211 ELARGEPPHSELHPMKVLFLIPKNNPPTLEG---------------------------NYSKPLKEFVEACLNKEPSFRP 263 (303)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS---------------------------SCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHccCCCCCCCcCHHHHHHHhhcCCCCCCcc---------------------------ccCHHHHHHHHHHcCCChhhCc
Confidence 9999999999888877776666554333221 1245789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.+|++|.+....
T Consensus 264 s~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 264 TAKELLKHKFILRN 277 (303)
T ss_dssp CHHHHTTCHHHHHH
T ss_pred CHHHHhhChhhhcC
Confidence 99999999765443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.33 Aligned_cols=274 Identities=21% Similarity=0.259 Sum_probs=205.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|++...... ... ..+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGE----LQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CC----CHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHH----HHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 457899999999999999999987 5788999986432211 111 13489999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENI 643 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~---gIVHrDLKP~NI 643 (825)
.. ++||||+++|+|.+++.... .....+++..++.|+.||+.||.|||++ ||+||||||+||
T Consensus 101 ~~--------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 101 ER--------------LLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CC--------------EEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred ce--------------EEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 44 99999999999999998621 1234589999999999999999999999 999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++.......... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (326)
T 3uim_A 166 LLDEE-------FEAVVGDFGLAKLMDYKDTHV---------TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225 (326)
T ss_dssp EECTT-------CCEEECCCSSCEECCSSSSCE---------ECCCCSCGGGCCHHHHHH----SEECHHHHHHHHHHHH
T ss_pred EECCC-------CCEEeccCccccccCcccccc---------cccccCCcCccCHHHhcc----CCCCccccchhHHHHH
Confidence 99877 469999999998764322111 123459999999999986 5679999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 724 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 724 yELLTG~~PF~~~-----~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
|+|++|+.||... ........+......... ..... ...........+..+.+|+.+||+.
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~ 291 (326)
T 3uim_A 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-----------EALVD---VDLQGNYKDEEVEQLIQVALLCTQS 291 (326)
T ss_dssp HHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS-----------TTSSC---TTCTTSCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhCCCcccccccccccchhHHHHHHHHhhchhh-----------hhhcC---hhhccccCHHHHHHHHHHHHHHhCc
Confidence 9999999999521 111111111111100000 00000 0011223345678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 003375 799 NPTERPTAGDLYEMFVART 817 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ 817 (825)
||.+|||+.+|+++|+...
T Consensus 292 dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 292 SPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CGGGSCCHHHHHHHHHTSS
T ss_pred CCccCCCHHHHHHHhcCcc
Confidence 9999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=380.61 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=213.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+ .+.+|+.+|++++||||+++++++...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKE----SLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHH----HHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHH----HHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 346799999999999999999998 57889999975432221 12223 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 99 GY--------------FYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 53 5999999999999999975 3569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+... ..+.+||+|||++..+...... ....||+.|+|||++.+ .++.++|||||||++|+
T Consensus 160 ~~~~----~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ 219 (484)
T 3nyv_A 160 ESKS----KDANIRIIDFGLSTHFEASKKM-----------KDKIGTAYYIAPEVLHG-----TYDEKCDVWSTGVILYI 219 (484)
T ss_dssp SSSS----TTCCEEECCTTHHHHBCCCCSH-----------HHHTTGGGTCCHHHHHT-----CCCTHHHHHHHHHHHHH
T ss_pred ecCC----CCCcEEEEeeeeeEEccccccc-----------ccCCCCccccCceeecC-----CCCCcceeHHHHHHHHH
Confidence 6432 2357999999999866432211 23469999999999974 57899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|.+||.+.+..++...+..+...... ......++.+.+||.+||+.||.+|||
T Consensus 220 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s 275 (484)
T 3nyv_A 220 LLSGCPPFNGANEYDILKKVEKGKYTFEL------------------------PQWKKVSESAKDLIRKMLTYVPSMRIS 275 (484)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCS------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCCCCC------------------------cccccCCHHHHHHHHHHCCCChhHCcC
Confidence 99999999999988888888776432111 111234568999999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.++++|.+-.
T Consensus 276 ~~e~l~h~~~~ 286 (484)
T 3nyv_A 276 ARDALDHEWIQ 286 (484)
T ss_dssp HHHHHTSHHHH
T ss_pred HHHHhhChhhc
Confidence 99999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.79 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=209.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..+|+|+..... .........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 5678999999999999999999998 46779999875321 1111223455899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 86 RK--------------RIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 55 35999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 147 ~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T 2vgo_A 147 MGYK-------GELKIADFGWSVHAPSLR------------RRTMCGTLDYLPPEMIEG----KTHDEKVDLWCAGVLCY 203 (284)
T ss_dssp ECTT-------CCEEECCCTTCEECSSSC------------BCCCCSCGGGCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEecccccccCcccc------------cccccCCCCcCCHHHhcc----CCCCcccchhhHHHHHH
Confidence 9877 459999999986554311 123468999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||...........+..... .++ ...+..+.+||.+||..||.+||
T Consensus 204 ~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 204 EFLVGMPPFDSPSHTETHRRIVNVDL-KFP---------------------------PFLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCC-CCC---------------------------TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHhHHHHHHhcccc-CCC---------------------------CcCCHHHHHHHHHHhhcCHhhCC
Confidence 99999999998877776666554321 111 11245789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.++++|.+...
T Consensus 256 s~~~ll~h~~~~~ 268 (284)
T 2vgo_A 256 PLKGVMEHPWVKA 268 (284)
T ss_dssp CHHHHHTCHHHHH
T ss_pred CHHHHhhCHHHHh
Confidence 9999999866543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.53 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
...++|++.+.||+|+||.||+|.+.+ ..+|+|+.... ......+. +.+|+.+++++ +||||+++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEA----LMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHH----HHHHHHHHHhhcCCCCeeeE
Confidence 456789999999999999999999733 36899986422 12233333 48999999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc---------CCCccCHHHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------GEKHVSVKLALFIAQDVAAALVELH 629 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---------~~~~ls~~~i~~Ia~QIa~AL~yLH 629 (825)
++++...... ++||||+++|+|.+++...... ....+++..++.++.||+.||.|||
T Consensus 116 ~~~~~~~~~~--------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 181 (333)
T 2i1m_A 116 LGACTHGGPV--------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181 (333)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCce--------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 9999866544 9999999999999999863211 1245799999999999999999999
Q ss_pred hCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 003375 630 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 709 (825)
Q Consensus 630 s~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~ 709 (825)
++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+ ..
T Consensus 182 ~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 242 (333)
T 2i1m_A 182 SKNCIHRDVAARNVLLTNG-------HVAKIGDFGLARDIMNDSNYI--------VKGNARLPVKWMAPESIFD----CV 242 (333)
T ss_dssp HTTEECSCCSGGGCEEEGG-------GEEEBCCCGGGCCGGGCTTSE--------ECSSCEECGGGSCHHHHHH----CC
T ss_pred cCCcccCCcccceEEECCC-------CeEEECcccccccccccccee--------ecCCCCCCccccCHHHhcc----CC
Confidence 9999999999999999877 469999999998664322110 1123457889999999986 66
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 710 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHD-LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 710 ~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~-~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
++.++|||||||++|||+| |..||.+........ .+.....+..+ ...++.
T Consensus 243 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 295 (333)
T 2i1m_A 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP---------------------------AFAPKN 295 (333)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTCCHH
T ss_pred CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------CCCCHH
Confidence 8999999999999999999 999998765444333 33333222111 112457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus 296 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 899999999999999999999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.32 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=194.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++... .......+ .+.++...++.++||||+++++++..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKR----LLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc--cCcHHHHH----HHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4567899999999999999999998 7788999986432 11112111 22455566888899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NI 643 (825)
... .++||||++ |+|.+++...... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 78 ~~~--------------~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Ni 141 (290)
T 3fme_A 78 EGD--------------VWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNV 141 (290)
T ss_dssp SSS--------------EEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGC
T ss_pred cCC--------------EEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 654 499999998 5998888754333 36799999999999999999999998 999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 142 LINAL-------GQVKMCDFGISGYLVDDVA-----------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp EECTT-------CCEEBCCC--------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecCCccccccccc-----------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 99876 4599999999976644221 12236999999999985322346789999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++|+.||... ..............+..+. ...++.+.+||.+||+.||.+
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~ 257 (290)
T 3fme_A 204 IELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--------------------------DKFSAEFVDFTSQCLKKNSKE 257 (290)
T ss_dssp HHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--------------------------TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCccccCchHHHHHHHhccCCCCccc--------------------------ccCCHHHHHHHHHHhhcChhh
Confidence 9999999999763 3434333333332222110 123557999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.++++|.+..
T Consensus 258 Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 258 RPTYPELMQHPFFT 271 (290)
T ss_dssp SCCHHHHTTSHHHH
T ss_pred CcCHHHHHhCcccc
Confidence 99999999986543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=352.56 Aligned_cols=266 Identities=25% Similarity=0.375 Sum_probs=199.9
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC--CCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L--~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|++.+..||+|++... ....+ .+|.+++..+ +||||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-------EEASW----FRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-------GHHHH----HHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-------ccchh----hhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 468999999999999999999999999999997422 11122 4555665554 8999999999988653
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--------CccccCC
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDI 638 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~--------gIVHrDL 638 (825)
. .....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||
T Consensus 105 ~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 105 G----------SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp G----------GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred C----------CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence 1 12357999999999999999976 4699999999999999999999999 9999999
Q ss_pred CCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc------
Q 003375 639 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL------ 712 (825)
Q Consensus 639 KP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~------ 712 (825)
||+|||++.+ +.+||+|||++..+........ .......||+.|+|||++.+ .....
T Consensus 169 kp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~~~ 231 (337)
T 3mdy_A 169 KSKNILVKKN-------GTCCIADLGLAVKFISDTNEVD------IPPNTRVGTKRYMPPEVLDE----SLNRNHFQSYI 231 (337)
T ss_dssp CGGGEEECTT-------SCEEECCCTTCEECC---------------CCSSCSCGGGCCHHHHTT----CCCTTCTHHHH
T ss_pred chHHEEECCC-------CCEEEEeCCCceeecccccccc------CCCCCCccCcceeChhhccc----ccCCccccCcc
Confidence 9999999877 4699999999977654322110 11234579999999999986 22233
Q ss_pred hhhHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCC
Q 003375 713 EVDIWSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFE 776 (825)
Q Consensus 713 kSDVWSLGvILyELLTG----------~~PF~~~~-----~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 776 (825)
++|||||||++|||+|| +.||.... .......+... ..+.++.
T Consensus 232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 290 (337)
T 3mdy_A 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN--------------------- 290 (337)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG---------------------
T ss_pred ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccc---------------------
Confidence 49999999999999999 67775432 11222222111 2222221
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 777 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 777 ~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
......+++.+.+||.+||+.||.+|||+.+|+++|+.+..+.
T Consensus 291 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 291 -RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp -GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1112346778999999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.21 Aligned_cols=281 Identities=23% Similarity=0.319 Sum_probs=206.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
..-++|++.+.||+|+||.||+|++ .+..||+|++... .....+. +.+|+.++++++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRD----FQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHH----HHHHHHHHHhcCCCceeEEEE
Confidence 4457899999999999999999985 5678999986422 2333333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... ...++||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 92 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 155 (327)
T 3lxl_A 92 VSYGPGR------------QSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155 (327)
T ss_dssp EEECSSS------------CEEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEecCCC------------ceEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence 9874332 2469999999999999999862 23589999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++........... ......||+.|+|||++.+ ..++.++||||||
T Consensus 156 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 217 (327)
T 3lxl_A 156 RNILVESE-------AHVKIADFGLAKLLPLDKDYYV-------VREPGQSPIFWYAPESLSD----NIFSRQSDVWSFG 217 (327)
T ss_dssp GGEEEEET-------TEEEECCGGGCEECCTTCSEEE-------CSSCCCSCGGGSCHHHHHH----CEEEHHHHHHHHH
T ss_pred hhEEECCC-------CCEEEcccccceecccCCccce-------eeccCCccccccCHHHhcc----CCCChHHhHHHHH
Confidence 99999877 4699999999987654322111 1123458899999999987 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
|++|+|++|..||.................+........... .. ........++.+.+||.+||+.||
T Consensus 218 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 218 VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE---------GQ---RLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT---------TC---CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc---------cc---CCCCCCcccHHHHHHHHHHcCCCh
Confidence 999999999999865432211110000011111111100000 00 001122346789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+|||+.+|+++|+.+.....
T Consensus 286 ~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 286 QDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp GGSCCHHHHHHHHHHC-----
T ss_pred hhCcCHHHHHHHHHHHHhhhc
Confidence 999999999999998866543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=357.99 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=212.0
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+....+|.+.+.||+|+||.||++.+ .+..+|+|++..... ......+ .+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQRE----KMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45667899999999999999999998 467899998754322 2223333 3489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~--------------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 112 DNDF--------------VFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp CSSE--------------EEEEECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cCCe--------------EEEEEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 6553 5999999999999999876 25689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 173 l~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 231 (335)
T 2owb_A 173 FLNED-------LEVKIGDFGLATKVEYDGER----------KKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCIM 231 (335)
T ss_dssp EECTT-------CCEEECCCTTCEECCSTTCC----------BCCCCSCCSSCCHHHHHT----SCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeccCceecccCccc----------ccccCCCccccCHHHhcc----CCCCchhhHHHHHHHH
Confidence 99877 45999999999876432111 123469999999999986 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|+.||......+....+..... .++. ..+..+.+||.+||+.||.+|
T Consensus 232 ~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 232 YTLLVGKPPFETSCLKETYLRIKKNEY-SIPK---------------------------HINPVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCcCCCCCCCHHHHHHHHhcCCC-CCCc---------------------------cCCHHHHHHHHHHccCChhHC
Confidence 999999999988877766666554421 1111 124578999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 003375 804 PTAGDLYEMFVARTS 818 (825)
Q Consensus 804 PSa~EIL~hL~~l~s 818 (825)
||+.++++|.+....
T Consensus 284 ps~~ell~~~~~~~~ 298 (335)
T 2owb_A 284 PTINELLNDEFFTSG 298 (335)
T ss_dssp CCGGGGGGSHHHHTS
T ss_pred cCHHHHhcCccccCC
Confidence 999999998765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=365.94 Aligned_cols=293 Identities=18% Similarity=0.184 Sum_probs=208.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
...+|++.+.||+|+||.||+|.+ .+..||+|++..... .. .+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~----~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YK----NRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SC----CHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hH----HHHHHHHHHcCCCCccchhheeeec
Confidence 456899999999999999999997 678899998643211 11 5799999999999999999998754
Q ss_pred CCCCCCC-----------C-------------CCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHH
Q 003375 566 KWLPSAD-----------G-------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 621 (825)
Q Consensus 566 ~~~~~~~-----------~-------------~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QI 621 (825)
....... + .........++||||++ ++|.+++...... ...+++..++.++.||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQL 150 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHH
Confidence 3200000 0 00012335799999998 6999888754333 3679999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003375 622 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701 (825)
Q Consensus 622 a~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl 701 (825)
+.||.|||++||+||||||+|||++..+ +.+||+|||+++.+..... .....||+.|+|||++
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKD------NTLKLCDFGSAKKLIPSEP-----------SVAYICSRFYRAPELM 213 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTT------TEEEECCCTTCEECCTTSC-----------CCCCCCCSSCCCHHHH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCC------CcEEEEECCCCcccCCCCC-----------CcCcccCCCccCHHHh
Confidence 9999999999999999999999998431 5799999999986643221 1234689999999998
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc-CccccccccCCCCCCchh
Q 003375 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEA 780 (825)
Q Consensus 702 ~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~ 780 (825)
.+ ...++.++|||||||++|||++|+.||.+.+..+....+.........+.+..... .....+.......-....
T Consensus 214 ~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (383)
T 3eb0_A 214 LG---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290 (383)
T ss_dssp TT---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred cC---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence 75 24589999999999999999999999999888777666655422222222222110 000000000000000001
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 781 ~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
....++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 1234667999999999999999999999998844
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=368.31 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=201.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHH-HhhCCCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~i-Lk~L~HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|++ .+..+|+|++....... ...... +.+|..+ ++.++||||+++++++.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~----~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKH----IMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHH----HHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 5678999999999999999999998 46789999976443221 122222 3667776 57789999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... +|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 110 ~~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 110 TADK--------------LYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp CSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eCCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 7654 5999999999999999986 25689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 171 ll~~~-------g~ikL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 229 (373)
T 2r5t_A 171 LLDSQ-------GHIVLTDFGLCKENIEHNS----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVL 229 (373)
T ss_dssp EECTT-------SCEEECCCCBCGGGBCCCC----------CCCSBSCCCCCCCHHHHTT----CCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeeCccccccccCCC----------ccccccCCccccCHHHhCC----CCCCchhhhHHHHHHH
Confidence 99877 4599999999975432111 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|..||.+.+..++...+...... ++ ...+..+.+||.+||+.||.+|
T Consensus 230 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 230 YEMLYGLPPFYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp HHHHHSSCTTCCSBHHHHHHHHHHSCCC-CC---------------------------SSSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcccC-CC---------------------------CCCCHHHHHHHHHHcccCHHhC
Confidence 9999999999998888888777665221 11 1124578999999999999999
Q ss_pred CCH----HHHHHHHH
Q 003375 804 PTA----GDLYEMFV 814 (825)
Q Consensus 804 PSa----~EIL~hL~ 814 (825)
|++ .+|++|..
T Consensus 282 ~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 282 LGAKDDFMEIKSHVF 296 (373)
T ss_dssp TTTTTTHHHHHTSGG
T ss_pred CCCCCCHHHHhCCcc
Confidence 986 57777743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=367.41 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=198.4
Q ss_pred CCceeeeeecccCceEEEEEEE---CCe--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF---GSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~---~~~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..|.+.+.||+|+||.||+|.+ .+. .+|+|+. +.. ......+.+ .+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~--~~~-~~~~~~~~~----~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEEC--CSC-SCSHHHHHH----HHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEc--CCC-CCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEEc
Confidence 4578899999999999999986 222 4566653 322 222333444 899999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 162 ~~~-------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 162 SEG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp CSS-------------CCEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCC-------------CeEEEEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 321 24999999999999999975 2356889999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++.+....... ........+|+.|+|||++.+ ..++.++|||||||+||
T Consensus 225 l~~~-------~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 225 LDEK-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp ECTT-------CCEEECCC---------------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccccccccc------ccccCCCCCcccccChHHhcC----CCCCcHHHHHHHHHHHH
Confidence 9876 469999999998664322110 011123457889999999987 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+| |.+||.+.+..++...+..+.++..+. ..+..+.+||.+||..||.+|
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~R 340 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMR 340 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhC
Confidence 9999 788888777666666666554332221 124579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 003375 804 PTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 804 PSa~EIL~hL~~l~sss~ 821 (825)
||+.+|+++|+.+.....
T Consensus 341 Ps~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 341 PSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCHHHHHHHHHHHHHTCC
T ss_pred cCHHHHHHHHHHHHHhcc
Confidence 999999999999876544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.20 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=207.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
-+++|++.+.||+|+||.||+|.+ .+..+|+|++........... ...+.+|+.++++++||||+++++++...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNG----EANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchh----HHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 357899999999999999999998 567899999754321111112 23459999999999999999999998643
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ...++||||++++ |.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~------------~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~ 142 (305)
T 2wtk_C 79 EK------------QKMYMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL 142 (305)
T ss_dssp ---------------CEEEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC------------CeEEEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence 21 2469999999865 8888875 234579999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++.......... ......||+.|+|||++.+. ...++.++|||||||++|+
T Consensus 143 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 143 TTG-------GTLKISALGVAEALHPFAADD--------TCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp CTT-------CCEEECCCTTCEECCTTCSSC--------EECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeeccccccccCcccccc--------ccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHH
Confidence 877 459999999998764321110 01234699999999999752 1234789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.+..++...+.....+ ++ ...++.+.+||.+||..||.+|||
T Consensus 206 l~~g~~p~~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~l~~li~~~l~~dp~~Rps 257 (305)
T 2wtk_C 206 ITTGLYPFEGDNIYKLFENIGKGSYA-IP---------------------------GDCGPPLSDLLKGMLEYEPAKRFS 257 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCC-CC---------------------------SSSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhCCCCCCCchHHHHHHHHhcCCCC-CC---------------------------CccCHHHHHHHHHHccCChhhCCC
Confidence 99999999988887777776655321 11 112457899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.++++|.+....
T Consensus 258 ~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 258 IRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHSHHHHSC
T ss_pred HHHHhcCcccccC
Confidence 9999999765543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=360.11 Aligned_cols=287 Identities=18% Similarity=0.212 Sum_probs=212.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..||+|++.. ....... ..+.+|+.+|++++||||+++++++.....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYC----QRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---TTCHHHH----HHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc---ccCcHHH----HHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 5899999999999999999997 567899998642 1122222 344899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .....|+||||+. ++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 100 ~---------~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 100 E---------QMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp T---------TCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 1 2235799999997 699999976 46999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++.......... .......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 164 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCcceEecCCCCCcc-------ccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHH
Confidence 7 459999999998765432111 11233479999999999764 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+..+....+.........+.+..........+... .............+..+.+||.+||+.||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 99999998887776666654322222222211100000000000 000111112233467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.|+++|.+..
T Consensus 307 t~~e~l~hp~~~ 318 (364)
T 3qyz_A 307 EVEQALAHPYLE 318 (364)
T ss_dssp CHHHHHTSGGGT
T ss_pred CHHHHhcCcchh
Confidence 999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=378.96 Aligned_cols=257 Identities=23% Similarity=0.276 Sum_probs=211.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|.+.+.||+|+||.||+|.+ .+..||+|++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 5678999999999999999999998 578999999753211 111123355899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl 148 (476)
T 2y94_A 88 PSD--------------IFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148 (476)
T ss_dssp SSE--------------EEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence 553 5999999999999999864 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++|||||||++|
T Consensus 149 l~~~-------~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 149 LDAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISG---RLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp ECTT-------CCEEECCCSSCEECCTTCC-----------BCCCCSCSTTCCHHHHTT---CCBCSHHHHHHHHHHHHH
T ss_pred EecC-------CCeEEEeccchhhcccccc-----------ccccCCCcCeEChhhccC---CCCCCCcceehhhHHHHH
Confidence 9877 4599999999987643211 123469999999999986 223478999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||.+.+...+...+..+... .+ ...++.+.+||.+||..||.+||
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~Li~~~L~~dP~~Rp 259 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDGIFY-TP---------------------------QYLNPSVISLLKHMLQVDPMKRA 259 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTTCCC-CC---------------------------TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcCCcC-CC---------------------------ccCCHHHHHHHHHHcCCCchhCc
Confidence 999999999988877777777655321 11 01245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.+|++|.+..
T Consensus 260 t~~eil~hp~~~ 271 (476)
T 2y94_A 260 TIKDIREHEWFK 271 (476)
T ss_dssp CHHHHHTCHHHH
T ss_pred CHHHHHhCHHhh
Confidence 999999986643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.87 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=198.0
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PNIV~l~g~~~~~ 565 (825)
-.+|++.+.||+|+||.||+|.+ .+..||+|++.... ......+.+ .+|+.+|++++| |||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHH----HHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 45799999999999999999987 56779999975432 233333444 899999999986 9999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .|||||+. +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 82 ~~--------------~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll 141 (343)
T 3dbq_A 82 QY--------------IYMVMECG-NIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 141 (343)
T ss_dssp SE--------------EEEEECCC-SEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEeCC-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence 53 59999955 6899999986 3568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-------CCCCCCchhhHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWS 718 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-------~~~~~s~kSDVWS 718 (825)
+. +.+||+|||+++.+...... .......||+.|+|||++.+.. ....++.++||||
T Consensus 142 ~~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws 205 (343)
T 3dbq_A 142 VD--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205 (343)
T ss_dssp ET--------TEEEECCCSSSCCC--------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH
T ss_pred EC--------CcEEEeecccccccCccccc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH
Confidence 63 35999999999876432211 0123447999999999997421 1146789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 719 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 719 LGvILyELLTG~~PF~~~~~-~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|||+||||++|+.||..... ......+... ....++ ...+..+.+||.+||
T Consensus 206 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L 258 (343)
T 3dbq_A 206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCL 258 (343)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc---------------------------ccCCHHHHHHHHHHc
Confidence 99999999999999976532 2333333222 111111 011347899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 003375 797 EENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+.||.+|||+.++++|.+....
T Consensus 259 ~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 259 KRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCChhHCCCHHHHHhCcccccc
Confidence 9999999999999999776543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=378.27 Aligned_cols=266 Identities=23% Similarity=0.269 Sum_probs=211.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|++ .+..+|+|++..... ........+.+|+.++..++||||+++++++.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-----hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3457899999999999999999998 467899998753210 011111235889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +||||||++||+|.+++.. ....+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 146 ~~~--------------~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 146 DNN--------------LYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207 (437)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence 654 5999999999999999975 2356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvIL 723 (825)
|+.+ +.+||+|||+++........ .....+||+.|+|||++.... ....++.++|||||||+|
T Consensus 208 l~~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil 271 (437)
T 4aw2_A 208 MDMN-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271 (437)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSCE---------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEcchhhhhhcccCCCc---------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHH
Confidence 9877 46999999999766432211 123357999999999997321 124678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||++|+.||.+.+..+....+.... ...++. .....++.+.+||.+||..+|.+
T Consensus 272 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 272 YEMLYGETPFYAESLVETYGKIMNHKERFQFPT------------------------QVTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS------------------------SCCCSCHHHHHHHHTTSSCGGGC
T ss_pred HHHHhCCCCCCCCChhHHHHhhhhccccccCCc------------------------ccccCCHHHHHHHHHHhcccccc
Confidence 99999999999998888877775421 111111 01123567999999999988888
Q ss_pred --CCCHHHHHHHHHh
Q 003375 803 --RPTAGDLYEMFVA 815 (825)
Q Consensus 803 --RPSa~EIL~hL~~ 815 (825)
||+++||++|.+.
T Consensus 328 ~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 328 LGQNGIEDFKKHPFF 342 (437)
T ss_dssp TTTTTTHHHHTSGGG
T ss_pred cCCCCHHHHhCCCcc
Confidence 9999999999665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.77 Aligned_cols=262 Identities=22% Similarity=0.343 Sum_probs=207.2
Q ss_pred CceeeeeecccCceEEEEEEE--CC---eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~---~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.|.+.+.||+|+||.||+|.+ .+ ..+|+|+... .......+.+ .+|+.++++++||||+++++++...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT---CCSHHHHHHH----HHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc---cccHHHHHHH----HHHHHHHHhCCCCCeeeEEEEEecC
Confidence 466779999999999999986 22 2578887532 2223333444 8999999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... .++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~-------------~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 95 EGL-------------PHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp SSC-------------CEEEECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCC-------------cEEEEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 432 3899999999999999975 23568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||++..+....... ........+|+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 158 ~~~-------~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 158 DES-------FTVKVADFGLARDILDREYYS------VQQHRHARLPVKWTALESLQT----YRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp CTT-------CCEEECCTTSSCTTTTGGGGC------SCCSSCTTCGGGGSCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeCcCCCcccccCCcccc------cccCcCCCCCccccChhhhcc----CCCChhhchhhHHHHHHH
Confidence 877 469999999998664422111 111233468899999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ +.+||...+...+...+........+. ..++.+.+||.+||+.||.+||
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE---------------------------YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCCc---------------------------cchHHHHHHHHHHccCChhhCc
Confidence 999 556667677777776666654332221 1245799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.++++.|+.+....
T Consensus 274 s~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 274 TFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHHH
Confidence 9999999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=354.44 Aligned_cols=266 Identities=23% Similarity=0.248 Sum_probs=200.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++..... .. ..+...+.+|+.++++++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SD----PVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cC----HHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 6689999999999999999999997 577899998643221 11 2223445899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 106 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl 166 (309)
T 2h34_A 106 DGQ--------------LYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166 (309)
T ss_dssp TTE--------------EEEEEECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCe--------------EEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE
Confidence 653 4999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 226 (309)
T 2h34_A 167 VSAD-------DFAYLVDFGIASATTDEKLT---------QLGNTVGTLYYMAPERFSE----SHATYRADIYALTCVLY 226 (309)
T ss_dssp ECTT-------SCEEECSCCC-------------------------CCGGGCCGGGTCC--------CCCHHHHHHHHHH
T ss_pred EcCC-------CCEEEecCccCccccccccc---------cccccCCCcCccCHHHHcC----CCCCchHhHHHHHHHHH
Confidence 9877 45999999999765432211 1123468999999999976 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||.+.....+...+..... .... .....+..+.+||.+||..||.+||
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 227 ECLTGSPPYQGDQLSVMGAHINQAIP-RPST------------------------VRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp HHHHSSCSSCSCHHHHHHHHHHSCCC-CGGG------------------------TSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCCCCCCCchHHHHHHHhccCCC-Cccc------------------------cCCCCCHHHHHHHHHhccCCHHHHH
Confidence 99999999988766544444433221 1110 0112345789999999999999999
Q ss_pred -CHHHHHHHHHhhcCCCC
Q 003375 805 -TAGDLYEMFVARTSSSI 821 (825)
Q Consensus 805 -Sa~EIL~hL~~l~sss~ 821 (825)
+++++++.|+.......
T Consensus 282 ~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 282 VTCGDLSAAAHAALATAD 299 (309)
T ss_dssp SSHHHHHHHHHHTCC---
T ss_pred HhHHHHHHHHHHHHHhhc
Confidence 99999999998876654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.43 Aligned_cols=265 Identities=21% Similarity=0.283 Sum_probs=201.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..||+|++..................+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999998 4678999997543221111111111234589999999999999999999986432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 --------------YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp --------------EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred --------------eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 4999999999999999864 357899999999999999999999999999999999999986
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
++. ...+||+|||++......... ....||+.|+|||++.+.. ...++.++|||||||++|+|+
T Consensus 150 ~~~----~~~~kl~Dfg~~~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 150 QEE----DCLIKITDFGHSKILGETSLM-----------RTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SSS----SCCEEECCCTTCEECCCCHHH-----------HHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHH
T ss_pred CCC----CCeEEEccCccceeccccccc-----------ccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHH
Confidence 632 356999999999876432211 1235899999999985321 256789999999999999999
Q ss_pred hCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|..||...... .+...+..+.....+.. ....+..+.+||.+||..||.+|||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEV------------------------WAEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCcccchHHHHHHHHHhCccccCchh------------------------hhhcCHHHHHHHHHHcccCHhhCCCH
Confidence 999999765432 34444444433322221 12235679999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.++++|.+
T Consensus 270 ~~~l~h~~ 277 (322)
T 2ycf_A 270 EEALRHPW 277 (322)
T ss_dssp HHHHTSGG
T ss_pred HHHhhCcC
Confidence 99998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=369.63 Aligned_cols=296 Identities=19% Similarity=0.217 Sum_probs=202.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+ .+..||+|++. .........+. +.+|+.+|+.++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCKR----ILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC--STTTSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeC--chhcChHHHHH----HHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 47899999999999999999998 56789999864 22233333333 499999999999999999999987553
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. .....||||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 99 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 99 LL---------KFDELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp TT---------TCCCEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CC---------cCCeEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 21 2235799999997 699999975 35699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccc------------cCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s------------~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
.+ +.+||+|||+++............ ..........+||+.|+|||++.. ...++.++
T Consensus 164 ~~-------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~~ 233 (432)
T 3n9x_A 164 QD-------CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKSI 233 (432)
T ss_dssp TT-------CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT---CSCCCTHH
T ss_pred CC-------CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCccc
Confidence 77 469999999998765432110000 000011245679999999999754 25689999
Q ss_pred hHHHHHHHHHHHHhC-----------CCCCCCCCH-----------------HHHHHHHHcC-CCCCchhHHhhhccCcc
Q 003375 715 DIWSYGCLLLELLTL-----------QVPYMGLSE-----------------LEIHDLIQMG-KRPRLTDELEALGSCHE 765 (825)
Q Consensus 715 DVWSLGvILyELLTG-----------~~PF~~~~~-----------------~~i~~~I~~~-~~p~l~~~l~~~~~~~~ 765 (825)
|||||||+||||++| .++|.+.+. .+....+... ..|. .+.+........
T Consensus 234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~-~~~~~~~~~~~~ 312 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT-EDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC-HHHHHTCCCHHH
T ss_pred ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC-HHHHHhccCHHH
Confidence 999999999999984 444444321 1222222221 1111 111111100000
Q ss_pred cccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 766 HEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 766 ~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
..+... .............++.+.+||.+||..||.+|||+.|+++|....
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 000000 000111112234577899999999999999999999999996543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.14 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=201.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-..|.+.+.||+|+||.||+|.+ .+..||+|++... .......+. +.+|+.++++++||||+++++++....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch--hhCHHHHHH----HHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34589999999999999999998 4556777776433 223333344 489999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NIL 644 (825)
. .....++||||+++++|.+++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||
T Consensus 99 ~----------~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 99 K----------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp S----------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred C----------CCceEEEEEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence 1 12357999999999999999986 256899999999999999999999999 999999999999
Q ss_pred Ee-cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 645 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
++ .+ +.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++
T Consensus 164 ~~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l 219 (290)
T 1t4h_A 164 ITGPT-------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCM 219 (290)
T ss_dssp ESSTT-------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeeCCCcccccccc------------cccccCCcCcCCHHHHhc-----cCCCcchHHHHHHHH
Confidence 97 34 469999999996543321 123469999999999864 478999999999999
Q ss_pred HHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++|+.||.... .......+..+..+.. .....++.+.+||.+||+.||.+
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCCCCcCcHHHHHHHHhccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998754 4444444444322111 11122457999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003375 803 RPTAGDLYEMFVA 815 (825)
Q Consensus 803 RPSa~EIL~hL~~ 815 (825)
|||+.++++|.+.
T Consensus 274 Rps~~ell~h~~f 286 (290)
T 1t4h_A 274 RYSIKDLLNHAFF 286 (290)
T ss_dssp SCCHHHHHTSGGG
T ss_pred CCCHHHHhhCccc
Confidence 9999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=346.47 Aligned_cols=300 Identities=21% Similarity=0.240 Sum_probs=208.6
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+. +..||+|++... .....+. +.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKH----ALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHH----HHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 468999999999999999999984 788999986532 2333333 489999999999999999999986543
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
................|+||||++ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 210000011112346799999998 699999864 5689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++ ..+||+|||++......... ........+|+.|+|||++.+ ...++.++|||||||++|||
T Consensus 155 ~~~------~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 155 TED------LVLKIGDFGLARIMDPHYSH-------KGHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp TTT------TEEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHH
T ss_pred CCC------CeEEEccCccccccCCCccc-------ccccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHH
Confidence 542 57999999999876432111 011233468999999999874 25688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|+.||.+.+..+....+.......................... .............+..+.+||.+||+.||.+||
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (320)
T 2i6l_A 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence 999999999887777666655432222222111110000000000 000001111233567899999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
|+.++++|.+...-+
T Consensus 299 t~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 299 TAEEALSHPYMSIYS 313 (320)
T ss_dssp CHHHHHTSHHHHTTC
T ss_pred CHHHHhCCccccccc
Confidence 999999997655443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=370.18 Aligned_cols=281 Identities=22% Similarity=0.229 Sum_probs=207.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+|++.+.||+|+||.||+|++ .+..||||++.... ..+ .+|+.+|+.|+|||||++++++....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~----~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFK----NRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSC----CHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhH----HHHHHHHHHcCCCCccceeeEEeccC
Confidence 34799999999999999999998 57889999864321 111 57999999999999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. .....+++||||++ ++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 121 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~ 190 (420)
T 1j1b_A 121 EK--------KDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD 190 (420)
T ss_dssp TT--------TTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE
T ss_pred CC--------CcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe
Confidence 11 12234689999998 588887765322 236799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++ ..+||+|||+++.+..... .....||+.|+|||++.+ ...++.++|||||||+||||
T Consensus 191 ~~~------~~~kl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 191 PDT------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp TTT------TEEEECCCTTCEECCTTCC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred CCC------CeEEeccchhhhhcccCCC-----------ceeeeeCCCcCCHHHHcC---CCCCCchhhhHHHHHHHHHH
Confidence 652 4689999999986543211 123468999999999975 24689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCC-CCCc----hhhhhhHHHHHHHHHHhcccCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG-FEKP----EAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~----~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|+.||.+.+..+.+..+.........+.+..... .+...... .... ......++.+.+||.+||..||.
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS----CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh----hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence 999999999887666655554322222222222110 00000000 0000 01123467899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.|+++|.+.
T Consensus 327 ~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 327 ARLTPLEACAHSFF 340 (420)
T ss_dssp GSCCHHHHHTSGGG
T ss_pred HCCCHHHHhCCHhh
Confidence 99999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=343.71 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=202.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... .........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 5678999999999999999999998 47889999975321 1111223455899999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 83 PT--------------DFFMVMEYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp SS--------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred CC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 55 35999999999999999986 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ....+.++||||||+++|
T Consensus 144 ~~~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~ 202 (276)
T 2h6d_A 144 LDAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISG---RLYAGPEVDIWSCGVILY 202 (276)
T ss_dssp ECTT-------SCEEECCCCGGGCCCC------------------------CCTGGGTT---SCCCHHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccccccCCCcc-----------eecccCCccccCHHHHcC---CCCCCccchHHHHHHHHH
Confidence 9877 4599999999976643211 123368999999999976 123468999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||.......+...+...... ++. ..+..+.+||.+||+.||.+||
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 254 (276)
T 2h6d_A 203 ALLCGTLPFDDEHVPTLFKKIRGGVFY-IPE---------------------------YLNRSVATLLMHMLQVDPLKRA 254 (276)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCCCCcHHHHHHHhhcCccc-Cch---------------------------hcCHHHHHHHHHHccCChhhCC
Confidence 999999999888877777666554221 111 1245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.+|++|.+..
T Consensus 255 s~~~~l~h~~~~ 266 (276)
T 2h6d_A 255 TIKDIREHEWFK 266 (276)
T ss_dssp CHHHHHHSHHHH
T ss_pred CHHHHHhChhhc
Confidence 999999996643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.13 Aligned_cols=260 Identities=21% Similarity=0.325 Sum_probs=185.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.... .........+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 3567899999999999999999997 67889999975321 1111223455899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 144 (278)
T 3cok_A 83 SNY--------------VYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL 144 (278)
T ss_dssp SSE--------------EEEEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEE
T ss_pred CCe--------------EEEEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 553 5999999999999999975 2356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 145 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (278)
T 3cok_A 145 LTRN-------MNIKIADFGLATQLKMPHEK----------HYTLCGTPNYISPEIATR----SAHGLESDVWSLGCMFY 203 (278)
T ss_dssp ECTT-------CCEEECCCTTCEECC------------------------------------------CTHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeecceeeccCCCCc----------ceeccCCCCcCCcchhcC----CCCCchhhHHHHHHHHH
Confidence 9877 45999999999876432111 123468999999999976 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|+.||...........+..... . .+...+..+.+||.+||+.||.+||
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp 255 (278)
T 3cok_A 204 TLLIGRPPFDTDTVKNTLNKVVLADY-E---------------------------MPSFLSIEAKDLIHQLLRRNPADRL 255 (278)
T ss_dssp HHHHSSCSSCCCSCC-----CCSSCC-C---------------------------CCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHhCCCCCCChhHHHHHHHHhhccc-C---------------------------CccccCHHHHHHHHHHcccCHhhCC
Confidence 99999999976654332222111100 0 0112355789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 003375 805 TAGDLYEMFVARTS 818 (825)
Q Consensus 805 Sa~EIL~hL~~l~s 818 (825)
|+.++++|.+....
T Consensus 256 s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 256 SLSSVLDHPFMSRN 269 (278)
T ss_dssp CHHHHTTSTTTC--
T ss_pred CHHHHhcCccccCC
Confidence 99999998665443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=350.37 Aligned_cols=258 Identities=24% Similarity=0.238 Sum_probs=207.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|.+.+.||+|+||.||+|++ .+..+|+|++..... ...+ .+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDS----SLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchH----HHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 35799999999999999999998 578899999763321 1112 3489999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 80 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~ 140 (304)
T 2jam_A 80 --------------HYYLVMQLVSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140 (304)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred --------------EEEEEEEcCCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 35999999999999999976 24689999999999999999999999999999999999994
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
..+ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (304)
T 2jam_A 141 TPE----ENSKIMITDFGLSKMEQNGI------------MSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVITYIL 200 (304)
T ss_dssp SSS----TTCCEEBCSCSTTCCCCCBT------------THHHHSCCCBCCTTTBSS----CSCCHHHHHHHHHHHHHHH
T ss_pred cCC----CCCCEEEccCCcceecCCCc------------cccccCCCCccChHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 321 22569999999987543211 122368999999999976 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.....+...+..+..+... ......++.+.+||.+||..||.+|||+
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (304)
T 2jam_A 201 LCGYPPFYEETESKLFEKIKEGYYEFES------------------------PFWDDISESAKDFICHLLEKDPNERYTC 256 (304)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHCCCCCCT------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHcCCCCCCc------------------------cccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999988888877777665322111 0112235679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 003375 807 GDLYEMFVART 817 (825)
Q Consensus 807 ~EIL~hL~~l~ 817 (825)
.++++|.+-..
T Consensus 257 ~~~l~h~~~~~ 267 (304)
T 2jam_A 257 EKALSHPWIDG 267 (304)
T ss_dssp HHHHTSHHHHS
T ss_pred HHHhcCccccC
Confidence 99999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.75 Aligned_cols=272 Identities=26% Similarity=0.329 Sum_probs=199.8
Q ss_pred CCCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeE
Q 003375 487 GSFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~ 562 (825)
..-+.|++. +.||+|+||.||+|.+ .+..||+|++.... ..... .+.+|+.++.++ +||||+++++++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~----~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRS----RVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHH----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHH----HHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344678885 7899999999999986 57889999975331 11122 348999999995 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...+. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 141 (316)
T 2ac3_A 81 EEEDR--------------FYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141 (316)
T ss_dssp EETTE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eeCCE--------------EEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHH
Confidence 86653 5999999999999999986 2468999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 721 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~-~~~~s~kSDVWSLGv 721 (825)
||++.++. ...+||+|||++........... ..........||+.|+|||++.+... ...++.++|||||||
T Consensus 142 il~~~~~~----~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 142 ILCEHPNQ----VSPVKICDFDLGSGIKLNGDCSP---ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214 (316)
T ss_dssp EEESCSSS----SCSEEECCTTCCC----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred EEEccCCC----cCceEEEEccCccccccCCcccc---ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence 99987632 24599999999976643211100 00111123469999999999874110 023678999999999
Q ss_pred HHHHHHhCCCCCCCCCH---------------HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHH
Q 003375 722 LLLELLTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 786 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~---------------~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 786 (825)
++|||++|+.||.+... ..+...+...... ++. ......+.
T Consensus 215 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~-----------------------~~~~~~~~ 270 (316)
T 2ac3_A 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPD-----------------------KDWAHISC 270 (316)
T ss_dssp HHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCH-----------------------HHHTTSCH
T ss_pred HHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCc-----------------------hhcccCCH
Confidence 99999999999976542 2233344333221 111 01122456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 787 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 787 ~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
.+.+||.+||..||.+|||+.|+++|.+-.
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 799999999999999999999999996654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=353.50 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=202.4
Q ss_pred CCc-eeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 490 PSL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 490 ~~y-~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
++| ++.+.||+|+||.||++.+ .+..||+|++... ......+. +.+|+.+|++++||||+++++++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSG----WKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHH----HHHHHHHHHhCCCcchhhEEEEE
Confidence 445 9999999999999999875 5778999997532 22233333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...+. ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 103 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~N 164 (318)
T 3lxp_A 103 EDAGA------------ASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARN 164 (318)
T ss_dssp EETTT------------TEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 86432 246999999999999999975 458999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 165 il~~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 165 VLLDND-------RLVKIGDFGLAKAVPEGHEYYR-------VREDGDSPVFWYAPECLKE----YKFYYASDVWSFGVT 226 (318)
T ss_dssp EEECTT-------CCEEECCGGGCEECCTTCSEEE-------C---CCCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECCccccccccccccccc-------cccCCCCCceeeChHHhcC----CCCCcHHHHHHHHHH
Confidence 999877 4599999999987654321110 1123358889999999987 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHH---------------HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHH
Q 003375 723 LLELLTLQVPYMGLSELE---------------IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 787 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~---------------i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 787 (825)
+|+|++|..||....... +...+...... ......++.
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 279 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL---------------------------PRPDKCPAE 279 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC---------------------------CCCTTCCHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC---------------------------CCCccccHH
Confidence 999999999996532211 11111111111 111234568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 788 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 788 L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999988754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=381.99 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=214.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
+..++|++.+.||+|+||.||+|.+.+ ..||||++.... .. .+. +.+|+.+|++|+||||+++++++..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CC---HHH----HHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 456789999999999999999999854 679999865322 11 223 4899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .||||||+++|+|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 334 ~~--------------~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 396 (535)
T 2h8h_A 334 EP--------------IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396 (535)
T ss_dssp SS--------------CEEEECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cc--------------ceEeeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 22 399999999999999997521 2458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++.+....... .....++..|+|||++.. ..++.++|||||||+|||
T Consensus 397 ~~~-------~~~kl~DFG~a~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~e 456 (535)
T 2h8h_A 397 GEN-------LVCKVADFGLARLIEDNEYTA---------RQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 456 (535)
T ss_dssp CGG-------GCEEECCTTSTTTCCCHHHHT---------TCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEcccccceecCCCceec---------ccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHH
Confidence 877 459999999998764322110 122347889999999986 678999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|++ |+.||.+....++...+..+.+...+. .++..+.+||.+||+.||.+||
T Consensus 457 l~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 457 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp HTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhHCc
Confidence 999 999999998888888877665433221 2355789999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.+|++.|+.+..+.
T Consensus 510 t~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 510 TFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHHHHHHHTSSCCC
T ss_pred CHHHHHHHHHHHhhcc
Confidence 9999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.26 Aligned_cols=298 Identities=19% Similarity=0.214 Sum_probs=209.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+. +..||+|++... ....... .+.+|+.++++++||||+++++++..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFAL----RTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHH----HHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 34578999999999999999999984 788999986421 1222223 34899999999999999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~~---------~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil 144 (353)
T 2b9h_A 81 DSFE---------NFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144 (353)
T ss_dssp SCST---------TCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cccC---------ccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 4211 1235799999997 699999986 46899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........................||+.|+|||++.+ ...++.++|||||||++|
T Consensus 145 ~~~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 145 INSN-------CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp ECTT-------CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHH
Confidence 9877 459999999998765432211100000111223478999999999864 356899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+|++|+.||.+.+.......+... ..+................+..... ...........++.+.+||.+||..||
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 999999999988776655444332 1111110000000000000000000 000011123456789999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 003375 801 TERPTAGDLYEMFVART 817 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~ 817 (825)
.+|||+.++++|.+-..
T Consensus 295 ~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 295 AKRITAKEALEHPYLQT 311 (353)
T ss_dssp GGSCCHHHHHTSGGGTT
T ss_pred ccCCCHHHHhcCccccc
Confidence 99999999999966543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.92 Aligned_cols=283 Identities=19% Similarity=0.231 Sum_probs=195.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..||+|++. .........+ ++.+|+.+|+.++||||+++++++.....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECS--STTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeC--ccccCHHHHH----HHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 6899999999999999999987 57789999853 2222333333 34899999999999999999999875422
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ......|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 103 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp G--------GGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c--------ccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC
Confidence 1 1123469999999 5899999875 46999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++..... ....+||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 168 ~-------~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 168 D-------CELKILDFGLARHTADE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp T-------CCEEECC----------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecccccccccc-------------CCCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHHH
Confidence 7 46999999999765431 123469999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+..+....+.........+.+..........+.... ............++.+.+||.+||..||.+||
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 999999998887777666554222222222111100000000000 01111122234467899999999999999999
Q ss_pred CHHHHHHHHHhh
Q 003375 805 TAGDLYEMFVAR 816 (825)
Q Consensus 805 Sa~EIL~hL~~l 816 (825)
|+.++++|....
T Consensus 305 t~~e~L~hp~~~ 316 (367)
T 2fst_X 305 TAAQALAHAYFA 316 (367)
T ss_dssp CHHHHHTSGGGT
T ss_pred CHHHHhcChhhh
Confidence 999999996543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.93 Aligned_cols=270 Identities=21% Similarity=0.308 Sum_probs=209.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+.+++|++.+.||+|+||.||+|.+.+ .+|+|++.... ......+.+ .+|+.++++++||||+++++++....
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~--~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIER--DNEDQLKAF----KREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCS--CCCCCCCCC----CTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCC--CCHHHHHHH----HHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 678999999999999999999999976 58999865432 222222334 78999999999999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~--------------~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~ 164 (319)
T 2y4i_B 103 H--------------LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164 (319)
T ss_dssp C--------------EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC
T ss_pred c--------------eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe
Confidence 3 4999999999999999864 234689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----CCCCCCchhhHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-----KPNLYGLEVDIWSYGC 721 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-----~~~~~s~kSDVWSLGv 721 (825)
+ +.+||+|||++......... ..........||+.|+|||++.+.. ....++.++|||||||
T Consensus 165 -~-------~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 165 -N-------GKVVITDFGLFSISGVLQAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp ----------CCEECCCSCCC---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred -C-------CCEEEeecCCcccccccccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 3 35999999998765322111 0111123346899999999997532 1245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|||++|+.||.......+...+..+..+.+.. ...+..+.+||.+||..||.
T Consensus 232 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------------------------IGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--------------------------SSCCTTHHHHHHHHHCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--------------------------CCCCHHHHHHHHHHhcCChh
Confidence 9999999999999988888777776664443221 01234689999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 003375 802 ERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~sss 820 (825)
+|||+.+|++.|+.+....
T Consensus 286 ~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 286 ERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TSCCHHHHHHHHTTC----
T ss_pred hCcCHHHHHHHHHHHHHhh
Confidence 9999999999999887653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=343.67 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=203.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
..+|++.+.||+|+||.||+|.+. +..+|+|+..... +.+ .+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKA----EREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGG----HHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHH----HHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 367999999999999999999984 7889999875331 223 78999999999999999999886422
Q ss_pred CCCCC--CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 567 WLPSA--DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~--~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
..+.. ...........++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 11000 000011234579999999999999999862 2246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 155 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 212 (284)
T 2a19_B 155 LVDT-------KQVKIGDFGLVTSLKNDGK-----------RTRSKGTLRYMSPEQISS----QDYGKEVDLYALGLILA 212 (284)
T ss_dssp EEET-------TEEEECCCTTCEESSCCSC-----------CCCCCSCCTTSCHHHHHC----SCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcchhheecccccc-----------ccccCCcccccChhhhcc----CCCcchhhhHHHHHHHH
Confidence 9977 4699999999987644221 123469999999999986 66899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||... ......+.....+ ...+..+.+||.+||..||.+||
T Consensus 213 ~l~~~~~~~~~~--~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 213 ELLHVCDTAFET--SKFFTDLRDGIIS------------------------------DIFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp HHHSCCSSHHHH--HHHHHHHHTTCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcCCcchhH--HHHHHHhhccccc------------------------------ccCCHHHHHHHHHHccCChhhCc
Confidence 999999887421 2222222222110 11245689999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 003375 805 TAGDLYEMFVARTSSSI 821 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss~ 821 (825)
|+.+++++|+.+..+..
T Consensus 261 s~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 261 NTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CHHHHHHHHHHHTC---
T ss_pred CHHHHHHHHHHHhhCCC
Confidence 99999999999877643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=363.31 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=203.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g 560 (825)
..+++|++.+.||+|+||.||+|+. .+..||+|++............+.+ .+|+.+|+.+ +||||+++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGC----CCHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHH----HHHHHHHHHccCCCceeEEEE
Confidence 5678999999999999999999998 6789999997533211111122223 7899999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .+|||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 127 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 187 (355)
T 1vzo_A 127 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 187 (355)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EEeeCce--------------EEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 9986653 4999999999999999986 24689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+||||+.+ +.+||+|||+++.+....... .....||+.|+|||++.+. ...++.++||||||
T Consensus 188 ~NIll~~~-------~~~kl~DfG~a~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG 249 (355)
T 1vzo_A 188 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 249 (355)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred HHEEECCC-------CcEEEeeCCCCeecccCCCCc---------ccCcccCcCccChhhhcCC--CCCCCchhhHHHHH
Confidence 99999877 459999999998664322111 1234699999999999751 23478899999999
Q ss_pred HHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 721 CLLLELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 721 vILyELLTG~~PF~~~~----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|+||||++|+.||.... ...+...+.... +.++ ...+..+.+||.+||
T Consensus 250 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~L 301 (355)
T 1vzo_A 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYP---------------------------QEMSALAKDLIQRLL 301 (355)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-CCCC---------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCccCCccchHHHHHHHHhccC-CCCC---------------------------cccCHHHHHHHHHHh
Confidence 99999999999996532 233333333221 1111 123457899999999
Q ss_pred ccCCCCCC-----CHHHHHHHHHhh
Q 003375 797 EENPTERP-----TAGDLYEMFVAR 816 (825)
Q Consensus 797 ~~DP~eRP-----Sa~EIL~hL~~l 816 (825)
..||.+|| ++.++++|+...
T Consensus 302 ~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 302 MKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp CSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred hhCHHHhcCCCCCCHHHHHcCcchh
Confidence 99999999 999999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.67 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=201.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---Ce--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
...++|++.+.||+|+||.||+|.+. +. .||+|+....... .....+ .+.+|+.++++++||||++++++
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMD----DFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHH----HHHHHHHHHHhCCCCCcccEEEE
Confidence 34568999999999999999999862 22 4788875432211 122233 44899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+.... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 ~~~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 150 (291)
T 1u46_A 90 VLTPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 150 (291)
T ss_dssp ECSSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EccCC---------------ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence 87543 38999999999999999862 245899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++........... ......+|+.|+|||++.+ ..++.++||||||+
T Consensus 151 Nili~~~-------~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 212 (291)
T 1u46_A 151 NLLLATR-------DLVKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGV 212 (291)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred eEEEcCC-------CCEEEccccccccccccccchh-------hhccCCCCceeeCchhhcC----CCCCchhhHHHHHH
Confidence 9999877 4699999999987654322110 1123357889999999986 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
++|+|++ |+.||.+.+..++...+..... +..+ ...+..+.+||.+||..|
T Consensus 213 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~ 265 (291)
T 1u46_A 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP---------------------------EDCPQDIYNVMVQCWAHK 265 (291)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC---------------------------cCcCHHHHHHHHHHccCC
Confidence 9999999 9999999888877777655421 1111 123567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 003375 800 PTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~sss 820 (825)
|.+|||+.+++++|+.+....
T Consensus 266 p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 266 PEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp GGGSCCHHHHHHHHHHHC---
T ss_pred cccCcCHHHHHHHHHHhCccc
Confidence 999999999999999887654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.62 Aligned_cols=292 Identities=19% Similarity=0.178 Sum_probs=201.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++....... ....+|+..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 5678999999999999999999998 47789999864322111 122678888899999999999999975
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSEN 642 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH--s~gIVHrDLKP~N 642 (825)
.... .......++||||++ ++|...+..... ....+++..++.++.||+.||.||| ++||+||||||+|
T Consensus 91 ~~~~-------~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 91 LGER-------DRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ECSS-------CTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred cccc-------cccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 4321 112234699999998 577766654322 2467899999999999999999999 9999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+... +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||+
T Consensus 162 Ill~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~i 221 (360)
T 3e3p_A 162 VLVNEAD------GTLKLCDFGSAKKLSPSEP-----------NVAYICSRYYRAPELIFG---NQHYTTAVDIWSVGCI 221 (360)
T ss_dssp EEEETTT------TEEEECCCTTCBCCCTTSC-----------CCSTTSCGGGCCHHHHTT---CSSCCTHHHHHHHHHH
T ss_pred EEEeCCC------CcEEEeeCCCceecCCCCC-----------cccccCCcceeCHHHHcC---CCCCCcHHHHHHHHHH
Confidence 9998621 5799999999987643221 123468999999999965 2457999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC----CchhhhhhHHHHHHHHHHhccc
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
+|+|++|+.||.+.+.......+...........+................... ........++.+.+||.+||+.
T Consensus 222 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 301 (360)
T 3e3p_A 222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301 (360)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCS
T ss_pred HHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhcc
Confidence 999999999999988877776666542222222222211100000000000000 0111122567899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 003375 799 NPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l 816 (825)
||.+|||+.|+++|.+..
T Consensus 302 dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 302 LPEERMKPYEALCHPYFD 319 (360)
T ss_dssp SGGGSCCHHHHTTSGGGG
T ss_pred CccccCCHHHHhcCcccc
Confidence 999999999999996543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=358.18 Aligned_cols=277 Identities=23% Similarity=0.288 Sum_probs=206.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|+.... ......+ .+.+|+.+++.++||||+++++++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRN----QIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHH----HHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 45678999999999999999999984 788999987543 1223333 44999999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NI 643 (825)
... .+|||||+++++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||
T Consensus 103 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 103 DGE--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp TTE--------------EEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CCE--------------EEEEEECCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 653 5999999999999999986 24689999999999999999999996 999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 164 l~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 164 LVNSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSL 220 (360)
T ss_dssp EECTT-------CCEEECCCCCCHHHHHHC----------------CCCCTTCCHHHHTT----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCCccccccc------------ccCCCCCCCeECHHHHcC----CCCCchhhHHHHHHHH
Confidence 99877 459999999997653321 123469999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc--c-----------------ccccccCCCCCCchhhhhh
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--E-----------------HEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~--~-----------------~~~~~~~~~~~~~~~~~~~ 784 (825)
|+|++|+.||...+..++...+................... . ........ ........
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP---PKLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC---CCCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC---CCCCcccc
Confidence 99999999998877666544332110000000000000000 0 00000000 00011224
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 6689999999999999999999999999664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=360.16 Aligned_cols=285 Identities=13% Similarity=0.085 Sum_probs=203.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhh----HHhHHHHHHHHhhCCCCCcce
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNF----EYSCLGEVRMLGALRHSCIVE 557 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~----~~~~lrEv~iLk~L~HPNIV~ 557 (825)
..-++|++.+.||+|+||.||+|.+ .+..+|+|+....... ...+...+ ...+.+|+.+++.++||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH-HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc-hHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3457899999999999999999998 4578999987533210 01111111 123578999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 637 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrD 637 (825)
+++++..... .....||||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+|||
T Consensus 113 ~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 176 (345)
T 2v62_A 113 FYGSGLTEFK----------GRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176 (345)
T ss_dssp EEEEEEEESS----------SCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eecccccccC----------CCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999886321 123569999999 8999999875 23799999999999999999999999999999
Q ss_pred CCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 003375 638 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 717 (825)
Q Consensus 638 LKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVW 717 (825)
|||+|||++.++. ..+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||
T Consensus 177 lkp~NIll~~~~~-----~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~ 244 (345)
T 2v62_A 177 IKAANLLLGYKNP-----DQVYLADYGLSYRYCPNGNHKQ---YQENPRKGHNGTIEFTSLDAHKG----VALSRRSDVE 244 (345)
T ss_dssp CSGGGEEEESSST-----TSEEECCCTTCEESSGGGCCCC---CCCCGGGCSCSCTTTCCHHHHHT----CCCCHHHHHH
T ss_pred cCHHHEEEccCCC-----CcEEEEeCCCceeccccccccc---chhccccccCCCccccCHHHhcC----CCCCchhhHH
Confidence 9999999987742 3699999999987754321100 00111134579999999999986 5789999999
Q ss_pred HHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 003375 718 SYGCLLLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 795 (825)
Q Consensus 718 SLGvILyELLTG~~PF~~~--~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~C 795 (825)
||||+||||++|+.||.+. ..... ........+.++..+..... ....++.+.+||.+|
T Consensus 245 slG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~~ 305 (345)
T 2v62_A 245 ILGYCMLRWLCGKLPWEQNLKDPVAV-QTAKTNLLDELPQSVLKWAP------------------SGSSCCEIAQFLVCA 305 (345)
T ss_dssp HHHHHHHHHHHSSCTTGGGTTCHHHH-HHHHHHHHHTTTHHHHHHSC------------------TTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccccccHHH-HHHHHhhcccccHHHHhhcc------------------ccccHHHHHHHHHHH
Confidence 9999999999999999653 22222 22222211222222211100 012356899999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCC
Q 003375 796 TEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 796 L~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
|..||.+|||+.+|++.|+.+...
T Consensus 306 l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 306 HSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred hhcCcccCCCHHHHHHHHhccCCc
Confidence 999999999999999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=368.51 Aligned_cols=263 Identities=24% Similarity=0.257 Sum_probs=196.4
Q ss_pred CCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHh-hCCCCCcceeeeeEe
Q 003375 488 SFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKI 563 (825)
Q Consensus 488 ~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk-~L~HPNIV~l~g~~~ 563 (825)
.+++|.+. +.||+|+||.||+|.+ .+..||+|++... . .+.+|+.++. .++||||+++++++.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~----~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------P----KARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------H----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------h----hHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 46778887 7899999999999998 4678999986411 1 2277888874 457999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... ....+||||||++||+|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 126 ~~~~----------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni 192 (400)
T 1nxk_A 126 NLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192 (400)
T ss_dssp EEET----------TEEEEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eccc----------CCcEEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceE
Confidence 4110 12356999999999999999975 2234699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++..+ ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+|
T Consensus 193 ll~~~~----~~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 253 (400)
T 1nxk_A 193 LYTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIM 253 (400)
T ss_dssp EESSSS----TTCCEEECCCTTCEECC----------------------CTTCCGGGSCC----CCSSSHHHHHHHHHHH
T ss_pred EEecCC----CCccEEEEecccccccCCCCc-----------cccCCCCCCccCHhhcCC----CCCCCcccHHHHHHHH
Confidence 998742 136799999999986543211 123468999999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHH----HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 724 LELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~----i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|||++|..||.+..... +...+..+... ++ .......+..+.+||.+||..|
T Consensus 254 ~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~-----------------------~~~~~~~s~~~~~li~~~L~~d 309 (400)
T 1nxk_A 254 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FP-----------------------NPEWSEVSEEVKMLIRNLLKTE 309 (400)
T ss_dssp HHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CC-----------------------TTTTTTSCHHHHHHHHTTSCSS
T ss_pred HHHHhCCCCCCCCccccccHHHHHHHHcCccc-CC-----------------------CcccccCCHHHHHHHHHHCCCC
Confidence 99999999997654321 22333332111 00 0011234568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+|||+.+|++|.+.....
T Consensus 310 P~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 310 PTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp GGGSCCHHHHHHSHHHHTTT
T ss_pred hhHCcCHHHHhcCccccCCC
Confidence 99999999999998766543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=362.95 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=197.8
Q ss_pred CCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--CCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--HPNIV~l~g~~~~~~ 566 (825)
.+|++.+.||+|+||.||+|.+ .+..||||++.... ......+. +.+|+.+|++|+ ||||+++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHH----HHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 4599999999999999999987 46789999976442 23333344 499999999997 599999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|||||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 130 ~--------------~~lv~E~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 130 Y--------------IYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189 (390)
T ss_dssp E--------------EEEEEEC-CSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred E--------------EEEEEec-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence 3 5999995 56899999986 35789999999999999999999999999999999999995
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-------CCCCCchhhHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-------PNLYGLEVDIWSY 719 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~-------~~~~s~kSDVWSL 719 (825)
. +.+||+|||+++.+...... ......+||+.|+|||++.+... ...++.++|||||
T Consensus 190 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 190 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp S--------SCEEECCCSSSCCC-----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred C--------CeEEEEecCccccccCCCcc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 3 35999999999876432211 01233479999999999975211 1358899999999
Q ss_pred HHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 720 GCLLLELLTLQVPYMGLS-ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 720 GvILyELLTG~~PF~~~~-~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
||+||||++|+.||.... .......+... ....++. ..+..+.+||.+||.
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD---------------------------IPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC---------------------------CSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc---------------------------cchHHHHHHHHHHcc
Confidence 999999999999997653 33333333332 1111110 113478999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhc
Q 003375 798 ENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 798 ~DP~eRPSa~EIL~hL~~l~ 817 (825)
.||.+|||+.||++|.+...
T Consensus 307 ~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHS
T ss_pred cChhhCCCHHHHhhCcCccc
Confidence 99999999999999976543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.43 Aligned_cols=269 Identities=17% Similarity=0.158 Sum_probs=200.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-++|++.+.||+|+||.||+|.+ .+..||+|+....... . .+.+|+.+++.++|++++..++.+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------C----CHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------h----HHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 347899999999999999999996 6788999986543211 1 238899999999999988887776543
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~-------------~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~ 138 (296)
T 4hgt_A 77 GD-------------YNVMVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138 (296)
T ss_dssp TT-------------EEEEEEECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC-------------ceEEEEEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeee
Confidence 32 359999999 8999999985 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+. ..+.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 139 ~~~~----~~~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 139 GLGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCGGGCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred eccC----CCCeEEEecCccceeccCcccCcc---CCCCcccccCCCccccchHHhcC----CCCCchhHHHHHHHHHHH
Confidence 3221 125699999999987654322110 01112234579999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHH---HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 726 LLTLQVPYMGLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 726 LLTG~~PF~~~~~~---~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|++|+.||.+.... .....+.....+... .......++.+.+||.+||+.||.+
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HhcCCCCCcccchhhhhhhhhhhhcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCCCC
Confidence 99999999765332 122222111000000 0011123567999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003375 803 RPTAGDLYEMFVARTS 818 (825)
Q Consensus 803 RPSa~EIL~hL~~l~s 818 (825)
|||+.+|++.|+.+..
T Consensus 265 Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 265 KPDYSYLRQLFRNLFH 280 (296)
T ss_dssp CCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHH
Confidence 9999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.76 Aligned_cols=268 Identities=26% Similarity=0.365 Sum_probs=207.0
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhh--CCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~--L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+.+..||+|++... .... +.+|+.++.. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~----~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERS----WFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHHH----HHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHHH----HHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 68999999999999999999999999999996421 1222 3788888887 789999999999886541
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH--------hCCccccCCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDIK 639 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH--------s~gIVHrDLK 639 (825)
.....++||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+|||||
T Consensus 111 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 111 ----------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp ----------SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred ----------ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 11246999999999999999976 46899999999999999999999 8999999999
Q ss_pred CCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCchhhHH
Q 003375 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDIW 717 (825)
Q Consensus 640 P~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~--~~s~kSDVW 717 (825)
|+||||+.+ +.+||+|||++............ ......||+.|+|||++.+..... .++.++|||
T Consensus 175 p~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~ 241 (342)
T 1b6c_B 175 SKNILVKKN-------GTCCIADLGLAVRHDSATDTIDI------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241 (342)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEEEETTTTEEEE------CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHH
T ss_pred HHHEEECCC-------CCEEEEECCCceecccccccccc------ccccCCcCcccCCHhhhcccccccccccCCcccHH
Confidence 999999877 45999999999876543221100 123346999999999998621111 233789999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhh
Q 003375 718 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781 (825)
Q Consensus 718 SLGvILyELLTG----------~~PF~~~~-----~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 781 (825)
||||+||||+|| ..||.... ...+...+... ..+.++..+ ..
T Consensus 242 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 299 (342)
T 1b6c_B 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QS 299 (342)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GT
T ss_pred HHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----------------------cc
Confidence 999999999999 78886542 23333333322 233333211 12
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
...++.+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 24567899999999999999999999999999988654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=349.03 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=205.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+. +..+|+|++.... ....+ .+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELE----DYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHH----HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHH----HHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 44578999999999999999999984 7789999865321 11223 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~--------------~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 149 (302)
T 2j7t_A 88 DGK--------------LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149 (302)
T ss_dssp C-C--------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CCe--------------EEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEE
Confidence 553 49999999999999998752 356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvIL 723 (825)
++.+ +.+||+|||++......... .....||+.|+|||++.... ....++.++|||||||++
T Consensus 150 ~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 150 MTLE-------GDIRLADFGVSAKNLKTLQK----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212 (302)
T ss_dssp ECTT-------SCEEECCCHHHHHHHHHHHC---------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEEECCCCccccccccc----------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHH
Confidence 9877 45999999987643321111 12346999999999985211 125678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|..||...+.......+.....+.+. .....+..+.+||.+||..||.+|
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~R 267 (302)
T 2j7t_A 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-------------------------TPSKWSVEFRDFLKIALDKNPETR 267 (302)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------------------------SGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHhcCCCCCccCCHHHHHHHHhccCCcccC-------------------------CccccCHHHHHHHHHHcccChhhC
Confidence 9999999999988877776666655433221 011235579999999999999999
Q ss_pred CCHHHHHHHHHh
Q 003375 804 PTAGDLYEMFVA 815 (825)
Q Consensus 804 PSa~EIL~hL~~ 815 (825)
||+.++++|.+-
T Consensus 268 ps~~~ll~h~~~ 279 (302)
T 2j7t_A 268 PSAAQLLEHPFV 279 (302)
T ss_dssp CCHHHHTTSTTT
T ss_pred CCHHHHhcChHH
Confidence 999999998543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.98 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=203.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+. +..||+|++.... ..+ .+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQ----EIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCH----HHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHH----HHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45678999999999999999999984 7889999875421 122 34889999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||
T Consensus 96 ~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 96 NTD--------------LWIVMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TTE--------------EEEEEECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEeecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 553 5999999999999999974 1356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 158 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 216 (314)
T 3com_A 158 LNTE-------GHAKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIQE----IGYNCVADIWSLGITAI 216 (314)
T ss_dssp ECTT-------CCEEECCCTTCEECBTTBSC----------BCCCCSCGGGCCHHHHSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccchhhhhhccc----------cCccCCCCCccChhhcCC----CCCCccccHHHHHHHHH
Confidence 9877 45999999999766432211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++|..||...........+.....+.+.. ....+..+.+||.+||..||.+||
T Consensus 217 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-------------------------PELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCcccCC-------------------------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999998887766655554443222210 112356799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 003375 805 TAGDLYEMFVART 817 (825)
Q Consensus 805 Sa~EIL~hL~~l~ 817 (825)
|+.++++|.+-..
T Consensus 272 t~~~ll~~~~~~~ 284 (314)
T 3com_A 272 TATQLLQHPFVRS 284 (314)
T ss_dssp CHHHHTTSHHHHT
T ss_pred CHHHHHhCHHHhc
Confidence 9999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=371.95 Aligned_cols=265 Identities=24% Similarity=0.267 Sum_probs=210.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|+. .+..||+|++.... .........+.+|+.++..++||||+++++++.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3467899999999999999999998 57889999975321 0111112345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +||||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 133 ~~~--------------~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 133 ENY--------------LYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194 (412)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCE--------------EEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee
Confidence 654 59999999999999999862 246899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCchhhHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGC 721 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~---~~~~~s~kSDVWSLGv 721 (825)
|+.+ +.+||+|||+++........ .....+||+.|+|||++.... ....++.++|||||||
T Consensus 195 ld~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGv 258 (412)
T 2vd5_A 195 LDRC-------GHIRLADFGSCLKLRADGTV---------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258 (412)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTSCE---------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHH
T ss_pred ecCC-------CCEEEeechhheeccCCCcc---------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhH
Confidence 9877 45999999999876442211 113357999999999997321 1245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
+||||++|+.||.+.+..+++..+.... ...++ ......++.+.+||.+||. +|
T Consensus 259 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~dli~~lL~-~p 313 (412)
T 2vd5_A 259 FAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP------------------------LVDEGVPEEARDFIQRLLC-PP 313 (412)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----------------------------CCCHHHHHHHHTTSS-CG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC------------------------ccccCCCHHHHHHHHHHcC-Ch
Confidence 9999999999999998888777776421 11111 0011235689999999999 99
Q ss_pred CCC---CCHHHHHHHHHh
Q 003375 801 TER---PTAGDLYEMFVA 815 (825)
Q Consensus 801 ~eR---PSa~EIL~hL~~ 815 (825)
.+| |+++||++|-+.
T Consensus 314 ~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 314 ETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp GGCTTTTTHHHHHTSGGG
T ss_pred hhcCCCCCHHHHhcCCCc
Confidence 998 599999999654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.19 Aligned_cols=249 Identities=24% Similarity=0.253 Sum_probs=192.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~ 566 (825)
++|++.++||+|+||+||+|.+ .+..||||+.... .........+ ..|+..+.++ +||||+++++++....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~----~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS--CCSHHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc--ccChHHHHHH----HHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 6799999999999999999998 4788999985422 2222322222 5666666555 8999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 131 ~--------------~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 131 I--------------LYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp E--------------EEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 3 59999999 57999998762 35699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 192 PR-------GRCKLGDFGLLVELGTAGA-----------GEVQEGDPRYMAPELLQG-----SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp GG-------GCEEECCCTTCEECC-----------------CCCCCGGGCCGGGGGT-----CCSTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceeeeecccCCC-----------CcccCCCccccCHhHhcC-----CCCchhhHHHHHHHHHHH
Confidence 77 4599999999876643221 123469999999999874 578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+... ...+..... +. ......++.+.+||.+||+.||.+|||+
T Consensus 249 ~~g~~~~~~~~~---~~~~~~~~~---~~-----------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 249 ACNMELPHGGEG---WQQLRQGYL---PP-----------------------EFTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp HHTCCCCSSHHH---HHHHTTTCC---CH-----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCccH---HHHHhccCC---Cc-----------------------ccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999777654322 222222211 11 1122345689999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.|+++|.+-
T Consensus 300 ~ell~hp~~ 308 (311)
T 3p1a_A 300 EALLALPVL 308 (311)
T ss_dssp HHHHTSGGG
T ss_pred HHHHhCccc
Confidence 999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=355.23 Aligned_cols=291 Identities=16% Similarity=0.163 Sum_probs=206.8
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh---HHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~---~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.++|++.+.||+|+||.||+|.+ .+..||+|++......... .....+.+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 46899999999999999999986 5778999987543322111 1112223456999999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... .....|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~---------~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 101 FEEP---------AMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCTT---------TCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ccCC---------CcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 4321 2335799999998 699998874 2356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 167 LADN-------NDITICDFNLAREDTADAN-----------KTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp ECTT-------CCEEECCTTC--------------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecCcccccccccc-----------cceecccceecCcHHhcC---CCCCCcHhHHHhHHHHHH
Confidence 9877 4599999999975433211 123468999999999875 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCcccccc----ccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVA----QSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
+|++|+.||.+.+.......+... ..+...... .........+. ...............++.+.+||.+||+.|
T Consensus 226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV-MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH-HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh-hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 999999999998877776666543 222222111 10000000000 000000111222344678999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 003375 800 PTERPTAGDLYEMFVA 815 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~ 815 (825)
|.+|||+.|+++|.+.
T Consensus 305 P~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 305 PQRRISTEQALRHPYF 320 (362)
T ss_dssp GGGSCCHHHHHTSGGG
T ss_pred hhhCCCHHHHHcCchh
Confidence 9999999999999654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.94 Aligned_cols=284 Identities=22% Similarity=0.238 Sum_probs=204.8
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
..+|++.+.||+|+||.||+|++ .+..+|+|.+..... .. .+|+.+|+.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--------~~----~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FK----NRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--------SC----CHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--------hH----HHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 45799999999999999999998 445577776532211 11 469999999999999999999975442
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe-
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID- 646 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd- 646 (825)
. .....+++||||+++ +|...+..... ....+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 107 ~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 176 (394)
T 4e7w_A 107 K--------KDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176 (394)
T ss_dssp S--------SSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred C--------CCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC
Confidence 1 122346899999985 66555543222 236799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||+||||
T Consensus 177 ~~-------~~~kL~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 177 PS-------GVLKLIDFGSAKILIAGEP-----------NVSYICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp TT-------TEEEECCCTTCEECCTTCC-----------CCSSCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeCCCcccccCCCC-----------CcccccCcCccCHHHHcC---CCCCCcHHHHHHHHHHHHHH
Confidence 44 5799999999987643221 123468999999999975 24589999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc-CccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|+.||.+.+..+....+.........+.+..... .....+................++.+.+||.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 999999999887776666555422222222221110 0000000000000000011225678999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.|+++|.+.
T Consensus 316 ~~e~l~hp~f 325 (394)
T 4e7w_A 316 AIEALCHPFF 325 (394)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcChhh
Confidence 9999999543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.30 Aligned_cols=275 Identities=24% Similarity=0.342 Sum_probs=194.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... .... ..+.+|+.++++++||||+++++++..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSM----DELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEES
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhH----HHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 5578999999999999999999986 677899997543221 1122 234899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc---CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~---~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
... .++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 ~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ 150 (303)
T 2vwi_A 85 KDE--------------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAG 150 (303)
T ss_dssp SSC--------------EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred cCC--------------cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChh
Confidence 654 49999999999999999753322 2356899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++.......... .........||+.|+|||++.+. ..++.++|||||||
T Consensus 151 Nil~~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~ 215 (303)
T 2vwi_A 151 NILLGED-------GSVQIADFGVSAFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGI 215 (303)
T ss_dssp GEEECTT-------CCEEECCCHHHHHCC--------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHH
T ss_pred hEEEcCC-------CCEEEEeccchheeccCCCcc-----chhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHH
Confidence 9999877 459999999987664322110 00112334699999999998741 34789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|+|++|+.||.................+.+..... ........+..+.+||.+||+.||.
T Consensus 216 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~dp~ 277 (303)
T 2vwi_A 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ------------------DKEMLKKYGKSFRKMISLCLQKDPE 277 (303)
T ss_dssp HHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc------------------cchhhhhhhHHHHHHHHHHccCChh
Confidence 9999999999998877666555544443333221110 0011122356799999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.++++|.+.
T Consensus 278 ~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 278 KRPTAAELLRHKFF 291 (303)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred hCcCHHHHhhChhh
Confidence 99999999998543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.90 Aligned_cols=258 Identities=26% Similarity=0.316 Sum_probs=209.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|.+ .+..||+|++...... ....+ .+.+|+.++++++||||+++++++....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTS----TILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHH----HHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHH----HHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 46899999999999999999998 5788999997643322 11223 3489999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 95 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 95 S--------------FYIVGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp E--------------EEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred e--------------EEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 3 5999999999999999876 24689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.++ ....+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|
T Consensus 156 ~~~----~~~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l 215 (287)
T 2wei_A 156 SKE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYIL 215 (287)
T ss_dssp CSS----TTCCEEECSTTGGGTBCCCSS-----------CSCHHHHHTTCCHHHHTT-----CCCTHHHHHHHHHHHHHH
T ss_pred cCC----CcccEEEeccCcceeecCCCc-----------cccccCcccccChHHhcC-----CCCCchhhHhHHHHHHHH
Confidence 653 135799999999876543211 123358899999999874 478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
++|..||.+.+..++...+..+..+.... .....++.+.+||.+||..||.+|||+
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~ 271 (287)
T 2wei_A 216 LSGTPPFYGKNEYDILKRVETGKYAFDLP------------------------QWRTISDDAKDLIRKMLTFHPSLRITA 271 (287)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCSG------------------------GGTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCch------------------------hhhhcCHHHHHHHHHHcccChhhCcCH
Confidence 99999999988888777776653221110 111235679999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.++++|.+.
T Consensus 272 ~ell~hp~~ 280 (287)
T 2wei_A 272 TQCLEHPWI 280 (287)
T ss_dssp HHHHHSHHH
T ss_pred HHHhcCHHH
Confidence 999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.04 Aligned_cols=286 Identities=22% Similarity=0.236 Sum_probs=208.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGH 561 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~ 561 (825)
..++|++.+.||+|+||.||+|.+ .+..||+|++........ ... .+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBC----THHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCc----hhhHHHHHHHhhhccCCCCeEeeeee
Confidence 347899999999999999999997 467899998765432211 111 226777777666 89999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+...... .....++||||++ |+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 ~~~~~~~---------~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 83 CTVSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp EEEEECS---------SEEEEEEEEECCS-CBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeecccC---------CCceEEEEEecCC-CCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 8732110 1235799999998 699999986 22345899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||
T Consensus 150 Nili~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 207 (326)
T 1blx_A 150 NILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGC 207 (326)
T ss_dssp GEEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHH
T ss_pred HeEEcCC-------CCEEEecCcccccccCCCC-----------ccccccccceeCHHHHhc----CCCCcchhHHHHHH
Confidence 9999877 4599999999976643221 123468999999999986 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|+|++|+.||.+.........+...........+..........+. ..............+..+.+||.+||..||.
T Consensus 208 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 208 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC-CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc-ccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 999999999999988877766665543111111111100000000000 0000011112234567899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.++++|.+.
T Consensus 287 ~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 287 KRISAYSALSHPYF 300 (326)
T ss_dssp TSCCHHHHHTSGGG
T ss_pred cCCCHHHHhcCccc
Confidence 99999999988543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.54 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++..... ..+ .+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEE----EIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTH----HHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHH----HHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3567899999999999999999998 678899999754321 122 338899999999 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..... ......++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 92 KKNPP--------GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 160 (326)
T ss_dssp ECC----------CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred eccCc--------cccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHE
Confidence 64311 0123579999999999999999862 224689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvI 722 (825)
|++.+ +.+||+|||++......... .....||+.|+|||++.... ....++.++|||||||+
T Consensus 161 l~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 161 LLTEN-------AEVKLVDFGVSAQLDRTVGR----------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp EECTT-------CCEEECCCTTTC-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeCcCceecCcCccc----------cccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 99876 45999999999765432111 12346999999999997321 12567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|+|++|..||.+.........+.....+.+. ....+..+.+||.+||..||.+
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~ 277 (326)
T 2x7f_A 224 AIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQ 277 (326)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--------------------------CSCSCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhCCCCCCCCcHHHHHHHhhcCccccCC--------------------------ccccCHHHHHHHHHHhccChhh
Confidence 99999999999888777666555544332211 0112457999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.++++|....
T Consensus 278 Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 278 RPATEQLMKHPFIR 291 (326)
T ss_dssp SCCHHHHHTSHHHH
T ss_pred CCCHHHHhhChHHh
Confidence 99999999986544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.86 Aligned_cols=270 Identities=17% Similarity=0.159 Sum_probs=204.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.-++|++.+.||+|+||.||+|++ .+..||+|+...... .+ .+.+|+.+++.++|++++..+.++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HP----QLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CC----HHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hh----HHHHHHHHHHHhhcCCCCCccccccCC
Confidence 457899999999999999999996 688999998754321 11 238899999999999988777766543
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. ..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~-------------~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 138 (296)
T 3uzp_A 77 GD-------------YNVMVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138 (296)
T ss_dssp TT-------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CC-------------ceEEEEEec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEE
Confidence 32 459999999 8999999975 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+. ..+.+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 139 ~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 139 GLGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ecCC----CCCeEEEeeCCCcccccccccccc---cccccccccccccccCChhhhcC----CCCCcchhhHHHHHHHHH
Confidence 5221 125699999999987654322110 01111244579999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 726 LLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 726 LLTG~~PF~~~~~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|++|+.||.+... .+....+.......... ......++.+.+||.+||+.||.+
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~ 264 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----------------------VLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----------------------HHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----------------------HHHhhCCHHHHHHHHHHHhcCcCc
Confidence 9999999976432 22222222211000000 011223567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003375 803 RPTAGDLYEMFVARTSS 819 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ss 819 (825)
|||+.+|++.|+.+...
T Consensus 265 Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 265 KPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHh
Confidence 99999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=356.85 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=204.5
Q ss_pred CCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 490 PSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 490 ~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
++|.+. +.||+|+||.||+|.+ .+..||+|++..... ...... .+.+|+.+++.+. ||||+++++++...
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRA----EILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHH----HHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHH----HHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 346666 8999999999999998 478999998764322 112222 3489999999996 79999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++||||+++|+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~--------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~ 164 (327)
T 3lm5_A 102 SE--------------IILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164 (327)
T ss_dssp SE--------------EEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred Ce--------------EEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEE
Confidence 53 5999999999999998853 223568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+... ..+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 165 ~~~~----~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ 225 (327)
T 3lm5_A 165 SSIY----PLGDIKIVDFGMSRKIGHACE-----------LREIMGTPEYLAPEILNY----DPITTATDMWNIGIIAYM 225 (327)
T ss_dssp SCBT----TBCCEEECCGGGCEEC--------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred ecCC----CCCcEEEeeCccccccCCccc-----------cccccCCcCccCCeeecC----CCCCchhhHHHHHHHHHH
Confidence 8731 125699999999987643221 123469999999999976 678899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||.+.+..+....+.......... .....++.+.+||.+||+.||.+|||
T Consensus 226 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (327)
T 3lm5_A 226 LLTHTSPFVGEDNQETYLNISQVNVDYSEE------------------------TFSSVSQLATDFIQSLLVKNPEKRPT 281 (327)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCCCCCCCchHHHHHHHhcccccCch------------------------hhcccCHHHHHHHHHHcCCChhhCcC
Confidence 999999999988877776666543221111 11223567999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.++++|.+.
T Consensus 282 ~~~ll~h~~~ 291 (327)
T 3lm5_A 282 AEICLSHSWL 291 (327)
T ss_dssp HHHHTTCGGG
T ss_pred HHHHhCCHhh
Confidence 9999999654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.07 Aligned_cols=293 Identities=20% Similarity=0.233 Sum_probs=212.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++.+.||+|+||.||+|.+. +..||+|++...... ... ..+.+|+.+|++++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPV----DVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCH----HHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chH----HHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 467999999999999999999984 788999997532211 112 23488999999999999999999987544
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. ...++||||+++|+|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 81 ~------------~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 146 (396)
T 4eut_A 81 T------------RHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (396)
T ss_dssp T------------CCEEEEECCCTTEEHHHHTTSG--GGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred C------------CeeEEEEecCCCCCHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEe
Confidence 2 1459999999999999999752 1123489999999999999999999999999999999999983
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC----CCCCchhhHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP----NLYGLEVDIWSYGCL 722 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~----~~~s~kSDVWSLGvI 722 (825)
... ++...+||+|||+++....... .....||+.|+|||++.+.... ..++.++|||||||+
T Consensus 147 ~~~---~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 147 IGE---DGQSVYKLTDFGAARELEDDEQ-----------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp ECT---TSCEEEEECCGGGCEECCCGGG-----------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred ecC---CCceeEEEecCCCceEccCCCc-----------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 221 1236799999999987654221 1234699999999998642100 246789999999999
Q ss_pred HHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 723 LLELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 723 LyELLTG~~PF~~~----~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
+|||++|+.||... ...++...+..+..+.....+... ....+................+..+.+||.+||+.
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA---ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECS---TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheec---cCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 99999999999642 234455555554332222111100 00000000000011123355678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 003375 799 NPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l~ss 819 (825)
||.+||++.++++++..+...
T Consensus 290 dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 290 DQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTTSCCHHHHHHHHHHHHTC
T ss_pred ChhhhccHHHHHHHHHHHhhc
Confidence 999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=382.12 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=204.9
Q ss_pred CCceeee-eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 490 PSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 490 ~~y~i~~-~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.++.+.+ .||+|+||.||+|.+ .+..||||+++.. . .....+. +.+|+.+|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~-~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--T-EKADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--C-SSTTHHH----HHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--C-ChHHHHH----HHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4555665 899999999999987 3456888885422 1 1122333 4899999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.. .+|||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 408 ~~---------------~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 EA---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp SS---------------EEEEEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CC---------------eEEEEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 32 4999999999999999964 2356899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||+||
T Consensus 469 l~~~-------~~vkL~DFGla~~~~~~~~~~-------~~~~~~~~~~~y~APE~~~~----~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 469 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp EEET-------TEEEECCCSTTTTCC---------------------CCTTSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEeeccCcccccCCCcee-------eeccCCCCccceeCHhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9977 569999999998764322110 00112246789999999986 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++ |+.||.+.+..++...+..+.++..+. .+++.+.+||.+||..||.+|
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 9998 999999998888888888775544332 235679999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003375 804 PTAGDLYEMFVART 817 (825)
Q Consensus 804 PSa~EIL~hL~~l~ 817 (825)
|++.+|++.|+.+.
T Consensus 584 Ps~~~l~~~L~~~~ 597 (613)
T 2ozo_A 584 PDFLTVEQRMRACY 597 (613)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999988764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.31 Aligned_cols=276 Identities=20% Similarity=0.244 Sum_probs=203.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++... ..+ .+.+|+.++++++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chH----HHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3457899999999999999999987 6788999986421 122 3489999999997 999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
.... ...++||||+++++|.+++.. +++..++.++.||+.||.|||++||+||||||+||
T Consensus 102 ~~~~------------~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 161 (330)
T 3nsz_A 102 DPVS------------RTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 161 (330)
T ss_dssp CTTT------------CCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCC------------CceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6321 246999999999999998743 88999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++ ..+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||+|
T Consensus 162 l~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 162 MIDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 221 (330)
T ss_dssp EEETTT------TEEEECCCTTCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CEEEEEeCCCceEcCCCCc-----------cccccccccccChhhhcC---CCcCCchhhHHHHHHHH
Confidence 998663 3699999999986543221 133468999999999875 35688999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcC-CCCC-----------chhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 724 LELLTLQVPYMGL-SELEIHDLIQMG-KRPR-----------LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 724 yELLTG~~PF~~~-~~~~i~~~I~~~-~~p~-----------l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
|+|++|+.||... ...+....+... ..+. +...+......... ...............++.+.+
T Consensus 222 ~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 298 (330)
T 3nsz_A 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR---KRWERFVHSENQHLVSPEALD 298 (330)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCC---CCGGGGCCTTTGGGCCHHHHH
T ss_pred HHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccc---cchhhhccccccccCCHHHHH
Confidence 9999999999543 333322222211 1000 11111110000000 000001111222335778999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
||.+||+.||.+|||+.|+++|.+..
T Consensus 299 li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 299 FLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHhcCCcccCCCHHHHhcCccHh
Confidence 99999999999999999999986543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.99 Aligned_cols=258 Identities=24% Similarity=0.295 Sum_probs=202.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|.+ .+..||+|+....... ...+ .+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPE----NIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHH----HHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhH----HHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 46899999999999999999998 4788999997644321 1223 3489999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 139 (276)
T 2yex_A 79 I--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (276)
T ss_dssp E--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence 3 4999999999999998864 35689999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||++.......... ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 140 ~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 140 ER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp TT-------CCEEECCCTTCEECEETTEEC--------CBCCCCSCGGGCCGGGGTC---SSBCHHHHHHHHHHHHHHHH
T ss_pred cC-------CCEEEeeCCCccccCCCcchh--------cccCCccccCccChHHHhc---CCCCCCcchHHHHHHHHHHH
Confidence 77 459999999998664322110 1123468999999999975 12347899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
++|..||...... .....+..... ... .....++.+.+||.+||..||.+|||
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 255 (276)
T 2yex_A 202 LAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSARIT 255 (276)
T ss_dssp HHSSCCCSCSCTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCchHHHHHHHhhhccc-ccC-------------------------chhhcCHHHHHHHHHHCCCCchhCCC
Confidence 9999999776543 22222222111 000 01223567899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
+.+|++|.+..
T Consensus 256 ~~~il~~~~~~ 266 (276)
T 2yex_A 256 IPDIKKDRWYN 266 (276)
T ss_dssp HHHHTTCTTTT
T ss_pred HHHHhcCcccc
Confidence 99999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=358.33 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=198.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCCh----HHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA----DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~----~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
.++|++.+.||+|+||.||+|.+ .+..||+|++......... .....+ .+|+.+|++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~----~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV----TLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEE----EHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHH----HHHHHHHHhCCCCCEeeEEEEE
Confidence 46799999999999999999987 6788999997654322110 122233 7899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCC-CHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gG-SL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
..... .++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 99 ~~~~~--------------~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 159 (335)
T 3dls_A 99 ENQGF--------------FQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE 159 (335)
T ss_dssp ECSSE--------------EEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeCCE--------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHH
Confidence 86653 49999999766 99999975 356999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||
T Consensus 160 NIll~~~-------~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~ 218 (335)
T 3dls_A 160 NIVIAED-------FTIKLIDFGSAAYLERGKL-----------FYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGV 218 (335)
T ss_dssp GEEECTT-------SCEEECCCTTCEECCTTCC-----------BCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHH
T ss_pred HEEEcCC-------CcEEEeecccceECCCCCc-----------eeccCCCccccChhhhcC---CCCCCCcccchhHHH
Confidence 9999877 4699999999987644221 123469999999999986 223488999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|+|++|..||...... .... .. .....++.+.+||.+||+.||.
T Consensus 219 il~el~~g~~pf~~~~~~------~~~~-~~---------------------------~~~~~~~~l~~li~~~L~~dP~ 264 (335)
T 3dls_A 219 TLYTLVFEENPFCELEET------VEAA-IH---------------------------PPYLVSKELMSLVSGLLQPVPE 264 (335)
T ss_dssp HHHHHHHSSCSCSSGGGG------TTTC-CC---------------------------CSSCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHhCCCchhhHHHH------Hhhc-cC---------------------------CCcccCHHHHHHHHHHccCChh
Confidence 999999999999653210 0000 00 0011356799999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.++++|.+.
T Consensus 265 ~Rps~~ell~hp~~ 278 (335)
T 3dls_A 265 RRTTLEKLVTDPWV 278 (335)
T ss_dssp GSCCHHHHHHCTTT
T ss_pred hCcCHHHHhcCccc
Confidence 99999999999654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=383.62 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=203.7
Q ss_pred eeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
+.||+|+||.||+|.+ .+..||||+++... ...... +.+.+|+.+|++|+|||||++++++....
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 443 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALK----DELLAEANVMQQLDNPYIVRMIGICEAES----- 443 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGH----HHHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHH----HHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence 4899999999999976 34679999865332 122222 34599999999999999999999986432
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.+|||||+++|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 444 ----------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--- 505 (635)
T 4fl3_A 444 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 505 (635)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---
T ss_pred ----------EEEEEEccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---
Confidence 4899999999999999976 3568999999999999999999999999999999999999977
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 730 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~ 730 (825)
+.+||+|||+++.+....... .......+|+.|+|||++.+ ..++.++|||||||+||||++ |+
T Consensus 506 ----~~~kL~DFGla~~~~~~~~~~-------~~~~~~~~t~~y~APE~~~~----~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 506 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ----TEEEECCTTHHHHTTC--------------------CGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----CCEEEEEcCCccccccCcccc-------ccccCCCCceeeeChhhhcC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 469999999998765422110 01122347889999999986 678999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL 810 (825)
.||.+.+..++...+..+.++..+. .+++.+.+||.+||+.||.+||++.+|+
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999999988888888776544432 1356799999999999999999999999
Q ss_pred HHHHhhc
Q 003375 811 EMFVART 817 (825)
Q Consensus 811 ~hL~~l~ 817 (825)
+.|+.+.
T Consensus 624 ~~L~~~~ 630 (635)
T 4fl3_A 624 LRLRNYY 630 (635)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.51 Aligned_cols=282 Identities=17% Similarity=0.164 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..-++|++.+.||+|+||.||+|.. .+..||+|++... .....+. +.+|+.+++.++||||+++++++..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREE----AQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHH----HHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHH----HHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 3456899999999999999999997 6788999986432 2233333 4899999999999999999999874
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .....++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl 166 (317)
T 2buj_A 98 ERG----------AKHEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166 (317)
T ss_dssp EET----------TEEEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ccC----------CCceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 321 12356999999999999999986433 2367999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||++.............. .........||+.|+|||++.+.. ...++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 167 LGDE-------GQPVLMDLGSMNQACIHVEGSRQAL-TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp ECTT-------SCEEECCCSSCEESCEEEESHHHHH-HHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecCcchhcccccccccccc-cccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHH
Confidence 9877 4599999999876542111000000 000001235799999999987511 123688999999999999
Q ss_pred HHHhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~--~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|++|+.||.... ...+...+...... + .....+..+.+||.+||+.||.+
T Consensus 238 el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~-------------------------~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSI--P-------------------------QSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp HHHHSSCTTHHHHHTTSCHHHHHHCC--C--C-------------------------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCChhhhhcccchhhHHhhccCCC--C-------------------------ccccCCHHHHHHHHHHhhcChhh
Confidence 9999999994311 00111111111100 0 01123567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCC
Q 003375 803 RPTAGDLYEMFVARTSSSISS 823 (825)
Q Consensus 803 RPSa~EIL~hL~~l~sss~S~ 823 (825)
|||+.+|+++|+.+..+.+..
T Consensus 291 Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 291 RPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp SCCHHHHHHHHHHTCCCCCC-
T ss_pred CCCHHHHHHHhhhcCCCCCCC
Confidence 999999999999998776653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=364.37 Aligned_cols=280 Identities=20% Similarity=0.228 Sum_probs=206.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC------CCCCcceeee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL------RHSCIVEMYG 560 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L------~HPNIV~l~g 560 (825)
..+|++.+.||+|+||.||+|.+ .+..||||++... .... ..+.+|+.+++.+ .|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~----~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFH----RQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHH----HHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchH----HHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 46799999999999999999998 4688999986421 2222 2347788888777 5789999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .++||||+. ++|.+++.. .....+++..++.|+.||+.||.|||++||+||||||
T Consensus 167 ~~~~~~~--------------~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp 228 (429)
T 3kvw_A 167 NFTFRNH--------------ICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228 (429)
T ss_dssp EEEETTE--------------EEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSG
T ss_pred ecccCCe--------------EEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9986653 599999996 699999986 2234589999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+||||+.++. ..+||+|||++...... .....||+.|+|||++.+ ..++.++||||||
T Consensus 229 ~NILl~~~~~-----~~vkL~DFG~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG 286 (429)
T 3kvw_A 229 ENILLKQQGR-----SGIKVIDFGSSCYEHQR-------------VYTYIQSRFYRAPEVILG----ARYGMPIDMWSLG 286 (429)
T ss_dssp GGEEESSTTS-----CCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHHT----BCCCTHHHHHHHH
T ss_pred HHeEEccCCC-----cceEEeecccceecCCc-------------ccccCCCCCccChHHHhC----CCCCchHHHHhHH
Confidence 9999987732 44999999999654321 123469999999999987 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccC----ccccccc-------------------cCCCC--
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC----HEHEVAQ-------------------SGSGF-- 775 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~----~~~~~~~-------------------~~~~~-- 775 (825)
|+||||++|.+||.+.+..+....+...........+...... ....+.. .....
T Consensus 287 ~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (429)
T 3kvw_A 287 CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366 (429)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEEC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccC
Confidence 9999999999999998887776666543222222211110000 0000000 00000
Q ss_pred -CCc-----hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 776 -EKP-----EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 776 -~~~-----~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
... ......++.+.+||.+||++||.+|||+.|+++|.+-..
T Consensus 367 ~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp STTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred CccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence 000 001122567899999999999999999999999976544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=344.13 Aligned_cols=281 Identities=20% Similarity=0.216 Sum_probs=206.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCC------Cccee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS------CIVEM 558 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HP------NIV~l 558 (825)
.-++|++.+.||+|+||.||+|.+ .+..||+|++.. ..... ..+.+|+.+++.++|+ +|+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~----~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYC----EAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHH----HHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchh----HHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 357899999999999999999987 578899998642 12222 3348899999988765 49999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL 638 (825)
++++..... .+|||||+ +++|.+++.. .....+++..++.++.||+.||.|||++||+||||
T Consensus 83 ~~~~~~~~~--------------~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 144 (339)
T 1z57_A 83 LEWFEHHGH--------------ICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDL 144 (339)
T ss_dssp EEEEEETTE--------------EEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ecccccCCc--------------EEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 999886653 59999999 7899999986 23346899999999999999999999999999999
Q ss_pred CCCCEEEecCccC------------CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003375 639 KSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706 (825)
Q Consensus 639 KP~NILLd~~~~~------------~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~ 706 (825)
||+|||++..+.. ....+.+||+|||++...... .....||+.|+|||++.+
T Consensus 145 kp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~--- 208 (339)
T 1z57_A 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILA--- 208 (339)
T ss_dssp CGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTT---
T ss_pred CHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhC---
Confidence 9999999864210 000356999999999764321 123469999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCC-----------
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF----------- 775 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~----------- 775 (825)
..++.++|||||||++|||++|..||...+..+....+.....+.....+...... ..+......+
T Consensus 209 -~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (339)
T 1z57_A 209 -LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVS 285 (339)
T ss_dssp -SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCG--GGEETTEECCCTTSHHHHHHH
T ss_pred -CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccch--hHHhhccccccccccccchhh
Confidence 66899999999999999999999999988877665555443222111111110000 0000000000
Q ss_pred -------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 776 -------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 776 -------~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
.........++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 286 RACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred hcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 000112234678999999999999999999999999844
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=388.72 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=209.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
..+.+|++++.||+|+||.||+|++ .+..||+|++...... .....+.+..|..+|..+ +||||+++++++.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-----HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 5688999999999999999999998 4567999997532110 111123348899999988 6999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... +||||||++||+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 413 ~~~~--------------~~lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NI 473 (674)
T 3pfq_A 413 TMDR--------------LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473 (674)
T ss_dssp CSSE--------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTE
T ss_pred eCCE--------------EEEEEeCcCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhE
Confidence 6553 5999999999999999986 24699999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 474 Ll~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DvwSlGvil 532 (674)
T 3pfq_A 474 MLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLL 532 (674)
T ss_dssp EECSS-------SCEEECCCTTCEECCCTTC----------CBCCCCSCSSSCCHHHHTC----CCBSTHHHHHHHHHHH
T ss_pred EEcCC-------CcEEEeecceeeccccCCc----------ccccccCCCcccCHhhhcC----CCCCccceEechHHHH
Confidence 99887 4699999999985432211 1234579999999999986 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|||++|+.||.+.+..+++..|..... .++. ..++.+.+||.+||+.||.+|
T Consensus 533 yelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dP~~R 584 (674)
T 3pfq_A 533 YEMLAGQAPFEGEDEDELFQSIMEHNV-AYPK---------------------------SMSKEAVAICKGLMTKHPGKR 584 (674)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCT---------------------------TSCHHHHHHHHHHSCSSSTTC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHHHC
Confidence 999999999999999888888876532 1121 135679999999999999999
Q ss_pred CCH-----HHHHHHHH
Q 003375 804 PTA-----GDLYEMFV 814 (825)
Q Consensus 804 PSa-----~EIL~hL~ 814 (825)
|++ .||++|.+
T Consensus 585 ~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 585 LGCGPEGERDIKEHAF 600 (674)
T ss_dssp TTCSTTHHHHHHSSGG
T ss_pred CCCCCCcHHHHhcCcc
Confidence 997 89998854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=354.83 Aligned_cols=281 Identities=19% Similarity=0.194 Sum_probs=206.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|+||.||+|.+ .+..||+|++... ....... ..+.+|+.+++.++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFA----KRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TSSHHHH----HHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchhHH----HHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 6899999999999999999997 5788999986432 2222223 344899999999999999999999986543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ......|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 116 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 116 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp S--------TTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 2 11224599999997 68988774 34899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 180 ~-------~~~kL~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 180 D-------CELKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp T-------CCEEECSTTCC---------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecCcccccccCc-------------CCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHH
Confidence 7 459999999997654321 23468999999999975 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+..+....+...........+..+.......+... .............++.+.+||.+||+.||.+||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 99999999887777666654322222221111100000000000 000001112234467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.|+++|.+.
T Consensus 317 t~~ell~hp~f 327 (371)
T 4exu_A 317 TAAQALTHPFF 327 (371)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCccc
Confidence 99999999664
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.59 Aligned_cols=275 Identities=20% Similarity=0.283 Sum_probs=186.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~ 566 (825)
.+|++.+.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.+++++. ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~----~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNR----AIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHH----HHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHH----HHHHHHHHHHHhccCCChhhccccccccc
Confidence 4799999999999999999998 6788999986422 223333 3489999999996 999999999986433
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 644 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NIL 644 (825)
.. ........++||||+. |+|.+++..... ...+++..++.|+.||+.||.|||++| |+||||||+|||
T Consensus 100 ~~------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 100 EE------SDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp TT------STTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred cc------cccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 21 0112345799999997 799999976322 346999999999999999999999999 999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCccccccccccccccc--CCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~--~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|+.+ +.+||+|||++.............. ..........||+.|+|||++... ....++.++|||||||+
T Consensus 171 ~~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 171 LSNQ-------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCI 242 (337)
T ss_dssp ECTT-------SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHH
T ss_pred ECCC-------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHH
Confidence 9877 4599999999987654322110000 000111234699999999998421 12567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|+|++|+.||.......+..... .... ....+..+.+||.+||+.||.+
T Consensus 243 l~el~~g~~p~~~~~~~~~~~~~~---~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVNGKY---SIPP---------------------------HDTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp HHHHHHSSCCC------------C---CCCT---------------------------TCCSSGGGHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCCcchhHHHhhcCcc---cCCc---------------------------ccccchHHHHHHHHHccCChhh
Confidence 999999999997654432221110 0000 0111235789999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 003375 803 RPTAGDLYEMFVARTSS 819 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ss 819 (825)
|||+.+++++|+.+...
T Consensus 293 Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.44 Aligned_cols=268 Identities=14% Similarity=0.092 Sum_probs=202.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC----------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCccee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG----------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~----------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l 558 (825)
-++|++.+.||+|+||.||+|.+. +..||+|+.... + .+.+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~----~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------G----RLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------S----THHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------c----hHHHHHHHHHHhcccchhhh
Confidence 478999999999999999999974 578999986522 1 23889999999999999984
Q ss_pred ---------------eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHH
Q 003375 559 ---------------YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA 623 (825)
Q Consensus 559 ---------------~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~ 623 (825)
++++... ....||||||+ +++|.+++... ....+++..++.++.||+.
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~ 170 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQ-------------DKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLD 170 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEET-------------TTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHH
T ss_pred hhhhccCCccCccchhhccccC-------------CcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHH
Confidence 4444432 12469999999 89999999862 1256999999999999999
Q ss_pred HHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 624 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 624 AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
||.|||++||+||||||+|||++.++. ..+||+|||+++.+........ ..........||+.|+|||++.+
T Consensus 171 ~L~~LH~~~ivH~Dikp~NIl~~~~~~-----~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-----SQVTLAGYGFAFRYCPSGKHVA---YVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHTTCBCSCCCGGGEEEETTEE-----EEEEECCGGGCBCSSGGGCCCC---CCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHhCCccCCCCCHHHEEEcCCCC-----ceEEEecCcceeeccCCCcccc---ccccccccccCCccccCHHHHcc
Confidence 999999999999999999999997731 3699999999987654322110 01111233479999999999986
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--CCCCchhHHhhhccCccccccccCCCCCCch
Q 003375 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS--ELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779 (825)
Q Consensus 704 ~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~--~~~i~~~I~~~--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 779 (825)
..++.++|||||||+||||++|+.||.+.. ...+....... ..+.+... ..
T Consensus 243 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~ 297 (352)
T 2jii_A 243 ----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP---------------------CG 297 (352)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECT---------------------TS
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhh---------------------cc
Confidence 578999999999999999999999997653 33333222211 11111100 00
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 780 ~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
.....++.+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus 298 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 298 HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 0112356899999999999999999999999999887643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=339.34 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=199.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|.....||+|+||.||+|.+ .+..||+|+..... ....+ .+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQ----PLHEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---H----HHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHH----HHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence 3455666677999999999999998 56788999865321 12222 34899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~~--------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 154 (295)
T 2clq_A 91 NGF--------------IKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154 (295)
T ss_dssp TTE--------------EEEEEECCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCc--------------EEEEEEeCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEE
Confidence 553 49999999999999999862 22345678999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++... +.+||+|||++......... .....||+.|+|||++.+.. ..++.++||||||+++|
T Consensus 155 ~~~~~------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 155 INTYS------GVLKISDFGTSKRLAGINPC----------TETFTGTLQYMAPEIIDKGP--RGYGKAADIWSLGCTII 216 (295)
T ss_dssp EETTT------CCEEECCTTTCEESCC---------------CCCCCCGGGCCHHHHHHGG--GGCSHHHHHHHHHHHHH
T ss_pred EECCC------CCEEEeecccccccCCCCCc----------ccccCCCccccChhhhcCCC--CCCCcHHHHHHHHHHHH
Confidence 98721 46999999999866432111 12346899999999997521 23789999999999999
Q ss_pred HHHhCCCCCCCCCHHH--HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 725 ELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~--i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|++|+.||....... ..........+.++ ...++.+.+||.+||+.||.+
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIP---------------------------ESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC---------------------------TTSCHHHHHHHHHTTCSSTTT
T ss_pred HHHHCCCCccCCCchhHHHHhhcccccccccc---------------------------ccCCHHHHHHHHHHccCChhh
Confidence 9999999997543322 11111112222221 123557899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|||+.++++|-....
T Consensus 270 Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 270 RACANDLLVDEFLKV 284 (295)
T ss_dssp SCCHHHHHTSGGGCC
T ss_pred CCCHHHHhcChhhhh
Confidence 999999999865543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=365.89 Aligned_cols=268 Identities=13% Similarity=0.121 Sum_probs=189.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHH---HHHhhCCCCCcceee---
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEV---RMLGALRHSCIVEMY--- 559 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv---~iLk~L~HPNIV~l~--- 559 (825)
..++|++.+.||+|+||.||+|.+ .+..||||++...... .....+. +.+|+ .+|++++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~----~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHH----HHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHH----HHHHHHHHHhccccCCHHHHHHHhhh
Confidence 356899999999999999999996 5789999997643222 2223333 48999 455566799999998
Q ss_pred ----eeEecCCCCC---CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccC--CCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 560 ----GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 560 ----g~~~~~~~~~---~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~--~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
+++...+... .............||||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 4444332100 00011111122479999999 589999998632211 1334468888999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----- 705 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~----- 705 (825)
+||+||||||+||||+.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 225 ~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~ 283 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYH 283 (377)
T ss_dssp TTEECSCCCGGGEEECTT-------CCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHH
T ss_pred CCeecCCCCHHHEEEcCC-------CCEEEEechhheecCCcc-------------cCCCC-cCccChhhhccccccccc
Confidence 999999999999999977 459999999998643311 22357 9999999998720
Q ss_pred --CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 706 --KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 706 --~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
....++.++|||||||+||||++|+.||.+.........+... ...
T Consensus 284 ~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------------------------~~~ 331 (377)
T 3byv_A 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--------------------------------CKN 331 (377)
T ss_dssp HCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--------------------------------CCC
T ss_pred ccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--------------------------------ccC
Confidence 0016899999999999999999999999665432211111000 012
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
.++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 3567999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=352.19 Aligned_cols=287 Identities=23% Similarity=0.231 Sum_probs=203.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--------CCCcce
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--------HSCIVE 557 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--------HPNIV~ 557 (825)
..++|++.+.||+|+||.||+|++ .+..||+|++.. ..... ..+.+|+.+|+.++ ||||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYT----ETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHH----HHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcch----HHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 347899999999999999999987 578899998642 12222 34489999999985 788999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHR 636 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHr 636 (825)
+++++..... .....+|||||+ +++|.+++.. .....+++..++.|+.||+.||.|||++ ||+||
T Consensus 106 ~~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 106 LLDDFKISGV----------NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp EEEEEEEEET----------TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred eecceeecCC----------CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 9999874321 123579999999 5788777765 2235699999999999999999999999 99999
Q ss_pred CCCCCCEEEecCcc------------------------------------------CCCCCCeEEEeecCCccccccccc
Q 003375 637 DIKSENILIDLERK------------------------------------------KADGKPVVKLCDFDRAVPLRSFLH 674 (825)
Q Consensus 637 DLKP~NILLd~~~~------------------------------------------~~~~~~~vKL~DFGlA~~~~~~~~ 674 (825)
||||+||||+.++. .......+||+|||++.......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~- 250 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF- 250 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-
Confidence 99999999986630 00011369999999998664321
Q ss_pred ccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcC
Q 003375 675 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLIQMG 748 (825)
Q Consensus 675 ~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~------~~~i~~~I~~~ 748 (825)
....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+ .......+...
T Consensus 251 ------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 314 (397)
T 1wak_A 251 ------------TEDIQTRQYRSLEVLIG----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314 (397)
T ss_dssp ------------CSCCSCGGGCCHHHHHT----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHH
T ss_pred ------------ccCCCCCcccCChhhcC----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHh
Confidence 22369999999999986 568999999999999999999999997654 22222222221
Q ss_pred CCCCchhHHhhhccCcccccccc-----CCCC----------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003375 749 KRPRLTDELEALGSCHEHEVAQS-----GSGF----------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813 (825)
Q Consensus 749 ~~p~l~~~l~~~~~~~~~~~~~~-----~~~~----------~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL 813 (825)
... .+..+..........+... .... .........+..+.+||.+||+.||.+|||+.||++|.
T Consensus 315 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 315 LGK-VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp HCS-CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cCC-CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 111 1111100000000000000 0000 00112345677899999999999999999999999986
Q ss_pred Hh
Q 003375 814 VA 815 (825)
Q Consensus 814 ~~ 815 (825)
+.
T Consensus 394 ~~ 395 (397)
T 1wak_A 394 WL 395 (397)
T ss_dssp GG
T ss_pred cc
Confidence 53
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=345.78 Aligned_cols=277 Identities=22% Similarity=0.292 Sum_probs=203.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
....+|++.+.||+|+||.||+|++ .+..||+|++... .....+. +.+|+.++++++||||+++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRD----FEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCCeeeEEE
Confidence 3456799999999999999999985 5778999986432 2233333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||
T Consensus 110 ~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp 173 (326)
T 2w1i_A 110 VCYSAGR------------RNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173 (326)
T ss_dssp EECC----------------CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEecCC------------CceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCc
Confidence 9875431 135999999999999999986 234689999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++||||||
T Consensus 174 ~NIli~~~-------~~~kL~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 235 (326)
T 2w1i_A 174 RNILVENE-------NRVKIGDFGLTKVLPQDKEYYK-------VKEPGESPIFWYAPESLTE----SKFSVASDVWSFG 235 (326)
T ss_dssp GGEEEEET-------TEEEECCCTTCEECCSSCSEEE-------CSSCCSCCGGGCCHHHHHH----CEEEHHHHHHHHH
T ss_pred ceEEEcCC-------CcEEEecCcchhhccccccccc-------cccCCCCceeEECchhhcC----CCCCchhhHHHHH
Confidence 99999877 4699999999987654322110 0122357888999999986 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCch-hHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|++|||+||..||.... ......+......... ..+.... ..... .......++.+.+||.+||..|
T Consensus 236 ~il~el~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~l~~li~~cl~~d 303 (326)
T 2w1i_A 236 VVLYELFTYIEKSKSPP-AEFMRMIGNDKQGQMIVFHLIELL--------KNNGR---LPRPDGCPDEIYMIMTECWNNN 303 (326)
T ss_dssp HHHHHHHHTTCGGGSHH-HHHHHHHCTTCCTHHHHHHHHHHH--------HTTCC---CCCCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhcCCCCCCCH-HHHHHhhccccchhhhHHHHHHHh--------hcCCC---CCCCCcccHHHHHHHHHHcCCC
Confidence 99999999999985331 1111111111000000 0000000 00000 0011234568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 003375 800 PTERPTAGDLYEMFVART 817 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ 817 (825)
|.+|||+.+|++.|+.+.
T Consensus 304 P~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 304 VNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=377.18 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=206.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|++.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|+.++||||+++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 5567899999999999999999998 578899999753311 111112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +||||||++||+|.+++.. .+...+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 256 ~~~--------------l~lVmEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 256 KDA--------------LCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp SSE--------------EEEEECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 653 5999999999999999975 22345999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 319 ld~~-------g~vKL~DFGla~~~~~~~~-----------~~~~~GT~~Y~APEvl~~----~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 319 LDDH-------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLY 376 (576)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCC-----------EECCCSCGGGCCHHHHTT----CEESSHHHHHHHHHHHH
T ss_pred EeCC-------CCeEEEecccceecccCcc-----------ccccCCCccccCHHHHcC----CCCCccchHHHHHHHHH
Confidence 9877 4699999999987643221 122479999999999986 56899999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||++|+.||.+.. ...+...+..... .++ ...++.+.+||.+||+.||
T Consensus 377 eLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~s~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPE-EYS---------------------------ERFSPQARSLCSQLLCKDP 428 (576)
T ss_dssp HHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCcccccchhHHHHHHHhhcccc-cCC---------------------------ccCCHHHHHHHHHhccCCH
Confidence 9999999997653 3344444433211 111 1235679999999999999
Q ss_pred CCCC-----CHHHHHHHHHh
Q 003375 801 TERP-----TAGDLYEMFVA 815 (825)
Q Consensus 801 ~eRP-----Sa~EIL~hL~~ 815 (825)
.+|| ++.||++|.+.
T Consensus 429 ~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGG
T ss_pred HHcCCCCCCCHHHHHhChhh
Confidence 9999 89999998554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=359.00 Aligned_cols=292 Identities=20% Similarity=0.243 Sum_probs=188.5
Q ss_pred Ccee-eeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 491 SLSS-CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 491 ~y~i-~~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.|.+ .++||+|+||.||+|++. +..||+|++. ..... ..+.+|+.+|++|+||||+++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGIS--------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECS--SSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3555 568999999999999964 5689999853 22111 1238899999999999999999999653
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc----CCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~----~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
.. ...||||||+. ++|.+++...... ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 91 ~~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~ 157 (405)
T 3rgf_A 91 AD------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 157 (405)
T ss_dssp TT------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CC------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHH
Confidence 21 24699999997 6999888753221 1235899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
||||...+. ..+.+||+|||+++.+...... ........||+.|+|||++.+ ...++.++|||||||
T Consensus 158 NIll~~~~~---~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~ 224 (405)
T 3rgf_A 158 NILVMGEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGC 224 (405)
T ss_dssp GEEECCSST---TTTCEEECCTTCCC-----------------------CCCTTCCHHHHTT---CCSCCHHHHHHHHHH
T ss_pred HeEEecCCC---CCCcEEEEECCCceecCCCCcc-------cccCCCceecCcccCchhhcC---CCcccchhhhHHHHH
Confidence 999954311 2367999999999876532111 011234579999999999975 245899999999999
Q ss_pred HHHHHHhCCCCCCCCCHH---------HHHHHHHcC-CCCCchhHHhhhccCcccc-----ccccCC-CCCC----chhh
Q 003375 722 LLLELLTLQVPYMGLSEL---------EIHDLIQMG-KRPRLTDELEALGSCHEHE-----VAQSGS-GFEK----PEAE 781 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~---------~i~~~I~~~-~~p~l~~~l~~~~~~~~~~-----~~~~~~-~~~~----~~~~ 781 (825)
+||||++|++||.+.... +.+..+... ..+. ...+.......... +..... .... ....
T Consensus 225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (405)
T 3rgf_A 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA-DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303 (405)
T ss_dssp HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCC-TTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTT
T ss_pred HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCC-hhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcC
Confidence 999999999999765431 223333221 1111 11111110000000 000000 0000 0000
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 782 ~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
...++.+.+||.+||..||.+|||+.|+|+|.+.....
T Consensus 304 ~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 01145789999999999999999999999998876544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=372.59 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=207.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
...++|.+.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|++++||||+++++++..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 5578899999999999999999998 578899999753221 111112345899999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +|+||||++||+|..++.... .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 257 ~~~--------------l~lVmE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 257 KTD--------------LCLVMTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321 (543)
T ss_dssp SSE--------------EEEEECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE
Confidence 653 599999999999999997521 11346999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++.+...... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 322 l~~~-------g~vkL~DFGla~~~~~~~~~----------~~~~~GT~~Y~APE~l~~----~~~~~~~DiwSlGvily 380 (543)
T 3c4z_A 322 LDDD-------GNVRISDLGLAVELKAGQTK----------TKGYAGTPGFMAPELLLG----EEYDFSVDYFALGVTLY 380 (543)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCCC----------BCCCCSCTTTSCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred EeCC-------CCEEEeecceeeeccCCCcc----------cccccCCccccChhhhcC----CCCChHHhcCcchHHHH
Confidence 9877 45999999999876432211 123479999999999986 67899999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~----~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||++|+.||.+.. ...+...+..... .++ ...+..+.+||.+||+.||
T Consensus 381 elltG~~PF~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~~lL~~dP 432 (543)
T 3c4z_A 381 EMIAARGPFRARGEKVENKELKQRVLEQAV-TYP---------------------------DKFSPASKDFCEALLQKDP 432 (543)
T ss_dssp HHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCccchhHHHHHHHHhhccc-CCC---------------------------cccCHHHHHHHHHhccCCH
Confidence 9999999997652 3445555443321 111 1235678999999999999
Q ss_pred CCCCC-----HHHHHHHHHh
Q 003375 801 TERPT-----AGDLYEMFVA 815 (825)
Q Consensus 801 ~eRPS-----a~EIL~hL~~ 815 (825)
.+||+ +.+|++|.+.
T Consensus 433 ~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 433 EKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp GGSCCCBTTBSHHHHTSGGG
T ss_pred hHCCCCcccCHHHHHcCccc
Confidence 99996 5889987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.52 Aligned_cols=275 Identities=20% Similarity=0.288 Sum_probs=196.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .+..||+|++... ....+ .+.+|+.++++++||||+++++++.....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLS----TILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHH----HHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 5799999999999999999997 5788999987432 22233 34899999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+... -.........|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~-~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKP-MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC-------CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhhh-hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 2000 0011123467999999999999999985 2356888999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccc----cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s----~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
+ +.+||+|||++............. ...........||+.|+|||++.+ ...++.++|||||||++
T Consensus 152 ~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 152 S-------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp T-------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS---CSCCCTHHHHHHHHHHH
T ss_pred C-------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC---CCCCcchhhHHHHHHHH
Confidence 7 459999999998764321100000 000111234569999999999975 24678999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|++ ||... ........+..... .++. ......+..+.+||.+||+.||.+
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~-~~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSI-EFPP-----------------------DFDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTC-CCCT-----------------------TCCTTTSHHHHHHHHHHTCSSGGG
T ss_pred HHHHh---ccCCchhHHHHHHhcccccc-ccCc-----------------------cccccchHHHHHHHHHHHhcCccc
Confidence 99998 55432 23334444433211 1111 111223557899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 003375 803 RPTAGDLYEMFVA 815 (825)
Q Consensus 803 RPSa~EIL~hL~~ 815 (825)
|||+.++++|.+.
T Consensus 275 Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 275 RPGARTLLNSGWL 287 (303)
T ss_dssp SCCHHHHHHSSCS
T ss_pred CcCHHHHhCCCCc
Confidence 9999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.98 Aligned_cols=281 Identities=19% Similarity=0.185 Sum_probs=205.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|.+.+.||+|+||.||+|.+ .+..||+|++... ....... ..+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFA----KRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST--TSSHHHH----HHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchHHH----HHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 6899999999999999999997 5788999986432 2222223 344899999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ......|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 98 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp G--------GGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT
T ss_pred c--------ccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC
Confidence 2 11234599999998 68887764 34899999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 162 ~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 162 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp T-------CCEEECSTTCTTC---------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeecccccCCCCC-------------ccccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHH
Confidence 7 45999999999765331 123468999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+..+....+...........+..+.......+.. ..............++.+.+||.+||..||.+||
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 298 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence 9999999888777666654431111111111100000000000 0000001112234567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.++++|.+.
T Consensus 299 t~~e~l~hp~f 309 (353)
T 3coi_A 299 TAAQALTHPFF 309 (353)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCcch
Confidence 99999999654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.62 Aligned_cols=261 Identities=15% Similarity=0.157 Sum_probs=198.7
Q ss_pred CCCceeeeeecccCceEEEEEE-------ECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCccee
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCK-------FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEM 558 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~-------~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l 558 (825)
-.+|.+.+.||+|+||.||+|. ..+..||+|+.... ....+ .+|+.++..++ |+||+++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~----~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEF----YIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHH----HHHHHHHHHSCGGGGGGBCCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHH----HHHHHHHHHhhhhhhhhhhhh
Confidence 4679999999999999999993 36788999986421 11223 77888888887 9999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL 638 (825)
++++...+. .||||||+++|+|.+++..........+++..++.|+.||+.||+|||++|||||||
T Consensus 133 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDi 198 (365)
T 3e7e_A 133 YSAHLFQNG--------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198 (365)
T ss_dssp EEEEECSSC--------------EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred heeeecCCC--------------cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 999987654 499999999999999998654444567999999999999999999999999999999
Q ss_pred CCCCEEEecCcc----CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 639 KSENILIDLERK----KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 639 KP~NILLd~~~~----~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||+||||+.... .....+.+||+|||+|+.+....... ......||+.|||||++.+ ..++.++
T Consensus 199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 266 (365)
T 3e7e_A 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--------IFTAKCETSGFQCVEMLSN----KPWNYQI 266 (365)
T ss_dssp SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE--------EECCSSCTTSCCCHHHHTT----CCBSTHH
T ss_pred CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc--------eeeeecCCCCCCChHHhcC----CCCCccc
Confidence 999999987100 01123679999999997654221110 0133469999999999986 5689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 715 DVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
|||||||+||||+||+.||....... ......+. .....+.+.+++..
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~------~~~~~~~~--------------------------~~~~~~~~~~~~~~ 314 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGE------CKPEGLFR--------------------------RLPHLDMWNEFFHV 314 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTE------EEECSCCT--------------------------TCSSHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCc------eeechhcc--------------------------ccCcHHHHHHHHHH
Confidence 99999999999999999995432110 00000000 00125678899999
Q ss_pred hcccCCCCC-CCHHHHHHHHHhhcC
Q 003375 795 CTEENPTER-PTAGDLYEMFVARTS 818 (825)
Q Consensus 795 CL~~DP~eR-PSa~EIL~hL~~l~s 818 (825)
||+.+|.+| |++.++.+.|+.+..
T Consensus 315 ~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 315 MLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCcchHHHHHHHHHHHHHH
Confidence 999999999 678888887776654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.93 Aligned_cols=281 Identities=19% Similarity=0.226 Sum_probs=210.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHH---------HHhhHHhHHHHHHHHhhCCCCCcce
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE---------IRNFEYSCLGEVRMLGALRHSCIVE 557 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~---------~~~~~~~~lrEv~iLk~L~HPNIV~ 557 (825)
..+++|++.+.||+|+||.||+|.+.+..||+|++........... .......+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4578999999999999999999999999999999864432211100 0000134589999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHH------HHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-
Q 003375 558 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY------IEKLSETGEKHVSVKLALFIAQDVAAALVELHS- 630 (825)
Q Consensus 558 l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~------L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs- 630 (825)
+++++...+ ..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+
T Consensus 108 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 170 (348)
T 2pml_X 108 CEGIITNYD--------------EVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNE 170 (348)
T ss_dssp CSEEEESSS--------------EEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeeCC--------------eEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 999998655 35999999999999998 432 224679999999999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~ 710 (825)
+||+||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++.+ ...+
T Consensus 171 ~~i~H~dl~p~Nil~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~ 228 (348)
T 2pml_X 171 KNICHRDVKPSNILMDKN-------GRVKLSDFGESEYMVDKK------------IKGSRGTYEFMPPEFFSN---ESSY 228 (348)
T ss_dssp SCEECCCCCGGGEEECTT-------SCEEECCCTTCEECBTTE------------ECSSCSCGGGCCGGGGSS---CCCE
T ss_pred CCEeecCCChHhEEEcCC-------CcEEEecccccccccccc------------ccCCCCCcCccCchhhcC---CCCC
Confidence 999999999999999877 459999999998764321 123469999999999986 1245
Q ss_pred Cc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 711 GL-EVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 711 s~-kSDVWSLGvILyELLTG~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
+. ++|||||||++|||++|..||..... .++...+..... .++..... +................+..+
T Consensus 229 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l 299 (348)
T 2pml_X 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRNH--------FLYPLTNKKSTCSNNFLSNED 299 (348)
T ss_dssp EHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSSS--------STTTTCC--------CCCHHH
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc-CCccchhh--------hhccccccccccchhhcCHHH
Confidence 55 99999999999999999999988766 666666655422 11210000 000000000111123456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.+||.+||+.||.+|||+.++++|.+.
T Consensus 300 ~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 300 IDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHccCChhhCCCHHHHhcCccc
Confidence 999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=340.48 Aligned_cols=282 Identities=18% Similarity=0.187 Sum_probs=204.2
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC------ccee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC------IVEM 558 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN------IV~l 558 (825)
.-++|++.+.||+|+||.||+|.+. +..||+|++.. ..... ..+.+|+.+++.++|++ |+.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~----~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYR----EAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHH----HHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccch----hHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 3578999999999999999999973 36899999642 12222 33488999999997665 8899
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 638 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDL 638 (825)
++++.... ..+|||||+ +++|.+++.. .....+++..++.++.||+.||.|||++||+||||
T Consensus 88 ~~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dl 149 (355)
T 2eu9_A 88 SDWFNFHG--------------HMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDL 149 (355)
T ss_dssp EEEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred eeeeeeCC--------------eEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 99887655 359999999 5788888775 22346899999999999999999999999999999
Q ss_pred CCCCEEEecCcc------------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC
Q 003375 639 KSENILIDLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706 (825)
Q Consensus 639 KP~NILLd~~~~------------~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~ 706 (825)
||+|||++..+. .......+||+|||++...... .....||+.|+|||++.+
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~--- 213 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------------HTTIVATRHYRPPEVILE--- 213 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------------CCSSCSCGGGCCHHHHTT---
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-------------ccCCcCCCcccCCeeeec---
Confidence 999999953210 0012367999999999764321 123469999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCC----------
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---------- 776 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~---------- 776 (825)
..++.++|||||||+||||++|..||.+.+..+....+.....+ ++..+....... ..+......+.
T Consensus 214 -~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 214 -LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP-IPSHMIHRTRKQ-KYFYKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp -CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCHHHHHHCSCG-GGEETTEECCCTTSHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CcHHHhhhccch-hhhcccccccccccchhcccc
Confidence 67899999999999999999999999988777665555443222 121111100000 00000000000
Q ss_pred --------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 777 --------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 777 --------~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
........+..+.+||.+||+.||.+|||+.|+++|.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 291 ENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337 (355)
T ss_dssp HHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGG
T ss_pred ccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 001112335689999999999999999999999998553
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=347.39 Aligned_cols=280 Identities=20% Similarity=0.239 Sum_probs=206.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CC-----Cccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HS-----CIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HP-----NIV~l 558 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++... .... ..+.+|+.+++.++ |+ +|+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~----~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFL----NQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHH----HHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHH----HHHHHHHHHHHHHHhcccccceeEEEe
Confidence 4468999999999999999999998 4678999986421 1222 33478888888885 55 49999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH--hCCcccc
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHR 636 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH--s~gIVHr 636 (825)
++++..... .+|||||+. ++|.+++.. .....+++..++.++.||+.||.||| ..||+||
T Consensus 122 ~~~~~~~~~--------------~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr 183 (382)
T 2vx3_A 122 KRHFMFRNH--------------LCLVFEMLS-YNLYDLLRN---TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC 183 (382)
T ss_dssp EEEEEETTE--------------EEEEEECCC-CBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC
T ss_pred eeeeccCCc--------------eEEEEecCC-CCHHHHHhh---cCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC
Confidence 999886553 599999997 699999986 22245899999999999999999999 4699999
Q ss_pred CCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 003375 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 716 (825)
Q Consensus 637 DLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDV 716 (825)
||||+||||+.+. .+.+||+|||+++..... .....||+.|+|||++.+ ..++.++||
T Consensus 184 Dlkp~NIll~~~~-----~~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di 241 (382)
T 2vx3_A 184 DLKPENILLCNPK-----RSAIKIVDFGSSCQLGQR-------------IYQYIQSRFYRSPEVLLG----MPYDLAIDM 241 (382)
T ss_dssp CCSGGGEEESSTT-----SCCEEECCCTTCEETTCC-------------CCSSCSCGGGCCHHHHTT----CCCCTHHHH
T ss_pred CCCcccEEEecCC-----CCcEEEEeccCceecccc-------------cccccCCccccChHHHcC----CCCCcHHHH
Confidence 9999999996542 267999999999876432 123469999999999986 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh-------ccCcccccc-----ccCCCCC--------
Q 003375 717 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-------GSCHEHEVA-----QSGSGFE-------- 776 (825)
Q Consensus 717 WSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~-------~~~~~~~~~-----~~~~~~~-------- 776 (825)
|||||+||||+||+.||.+.+..+....+...........+... .......+. .......
T Consensus 242 wSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (382)
T 2vx3_A 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLH 321 (382)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHH
Confidence 99999999999999999998887777666654222211111100 000000000 0000000
Q ss_pred ----------------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 777 ----------------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 777 ----------------~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.........+.+.+||.+||+.||.+|||+.|+|+|.+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 322 NILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence 000112234679999999999999999999999998664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=345.18 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=182.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHH-HHhhCCCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~-iLk~L~HPNIV~l~g~~~ 563 (825)
...++|++.+.||+|+||.||+|.+. +..||+|++.... .......+ .+|+. +++.++||||+++++++.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~----~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQL----LMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHH----HHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHH----HHHHHHHHHcCCCCcEeeeeeEEE
Confidence 45689999999999999999999984 7889999875321 22222222 56665 677889999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSEN 642 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~N 642 (825)
..+. .+|||||++ ++|.+++..........+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 92 ~~~~--------------~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N 156 (327)
T 3aln_A 92 REGD--------------CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156 (327)
T ss_dssp CSSE--------------EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGG
T ss_pred eCCc--------------eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHH
Confidence 6553 599999998 5999988754444456799999999999999999999999 99999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||+
T Consensus 157 Ill~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 157 ILLDRS-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp EEEETT-------TEEEECCCSSSCC-----------------------------------------CCSHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCCCceecccccc-----------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 999877 5699999999976643211 1223699999999998532223568899999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~-~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|+|++|+.||.+.... +....+..+..+.++ .......++.+.+||.+||..||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS-----------------------NSEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCC-----------------------CCSSCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC-----------------------CcccccCCHHHHHHHHHHhhCChh
Confidence 99999999999765321 111111111111111 001122356899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.+|++|.+.
T Consensus 276 ~Rps~~ell~hp~~ 289 (327)
T 3aln_A 276 KRPKYKELLKHPFI 289 (327)
T ss_dssp GSCCHHHHTTSHHH
T ss_pred hCcCHHHHHhChHH
Confidence 99999999998554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=373.59 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=206.6
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeE
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~ 562 (825)
..++|++.+.||+|+||.||+|.+. +..+|+|+. +.. ......+ .+.+|+.+|++++||||+++++++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~--~~~-~~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEEC--SST-TCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEe--ccc-CCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3467999999999999999999973 234666663 221 2222223 449999999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.. +. .|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 461 ~~-~~--------------~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~N 521 (656)
T 2j0j_A 461 TE-NP--------------VWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521 (656)
T ss_dssp CS-SS--------------CEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ec-Cc--------------eEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHh
Confidence 43 22 3999999999999999985 23468999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 522 ILl~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 522 VLVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVC 581 (656)
T ss_dssp EEEEET-------TEEEECCCCCCCSCCC-------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEeCC-------CCEEEEecCCCeecCCCcce---------eccCCCCCcceeCHHHhcC----CCCCchhhHHHHHHH
Confidence 999977 46999999999876432211 1122357889999999986 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
||||++ |..||.+....++...+..+..+.++. ..++.+.+||.+||..||.
T Consensus 582 l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~ 634 (656)
T 2j0j_A 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPS 634 (656)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChh
Confidence 999997 999999998888888877765443331 1345789999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 003375 802 ERPTAGDLYEMFVART 817 (825)
Q Consensus 802 eRPSa~EIL~hL~~l~ 817 (825)
+|||+.+|++.|+.+.
T Consensus 635 ~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 635 RRPRFTELKAQLSTIL 650 (656)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999998874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.01 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=197.0
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--CCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--HPNIV~l~g~~~~~ 565 (825)
-.+|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+.+ .+|+.++++++ ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~----~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHH----HHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHH----HHHHHHHHhccccCCceEEEEEEeecC
Confidence 45699999999999999999987 46779999975432 233333444 89999999997 59999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. .++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~--------------~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 160 (313)
T 3cek_A 101 QY--------------IYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 160 (313)
T ss_dssp SE--------------EEEEECC-CSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEec-CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE
Confidence 53 5999995 46899999986 3578999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-------CCCCCchhhHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-------PNLYGLEVDIWS 718 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~-------~~~~s~kSDVWS 718 (825)
+. +.+||+|||++......... .......||+.|+|||++.+... ...++.++||||
T Consensus 161 ~~--------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~s 224 (313)
T 3cek_A 161 VD--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224 (313)
T ss_dssp ET--------TEEEECCCSSSCC----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHH
T ss_pred EC--------CeEEEeeccccccccCcccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHH
Confidence 63 36999999999876432211 01123469999999999975211 136789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 003375 719 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 796 (825)
Q Consensus 719 LGvILyELLTG~~PF~~~~~-~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL 796 (825)
|||++|+|++|..||..... ......+... ....++ ...+..+.+||.+||
T Consensus 225 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l 277 (313)
T 3cek_A 225 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCL 277 (313)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc---------------------------ccchHHHHHHHHHHc
Confidence 99999999999999976532 2222222222 111111 011457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 003375 797 EENPTERPTAGDLYEMFVARTSSS 820 (825)
Q Consensus 797 ~~DP~eRPSa~EIL~hL~~l~sss 820 (825)
..||.+|||+.++++|.+......
T Consensus 278 ~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 278 KRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cCCcccCcCHHHHhcCccccCCCC
Confidence 999999999999999987655443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.69 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=186.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++.+.||+|+||.||+|.+ .+..||+|++.... ....... .+..+..+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKR---ILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHH---HHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHH---HHHHHHHHHHhcCCCceeeEEEEEec
Confidence 4578999999999999999999998 47889999875331 1122111 22455567888899999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 643 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NI 643 (825)
.. ..++||||+ ++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 96 ~~--------------~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 96 NT--------------DVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp SS--------------EEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred CC--------------cEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 55 359999999 46676666531 35689999999999999999999995 999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvI 722 (825)
|++.+ +.+||+|||++........ .....||+.|+|||++.... ....++.++|||||||+
T Consensus 157 l~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 157 LLDER-------GQIKLCDFGISGRLVDDKA-----------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp EECTT-------SCEEECCCTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCchhccCCcc-----------ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 99877 4599999999976543211 12346899999999995321 12467899999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 723 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 723 LyELLTG~~PF~~~-~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+|+|++|+.||... ...+....+.....+.++.. ...+..+.+||.+||..||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------------------------MGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------------------------SCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc-------------------------CCCCHHHHHHHHHHccCChh
Confidence 99999999999764 45555555555543332210 11345799999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003375 802 ERPTAGDLYEMFV 814 (825)
Q Consensus 802 eRPSa~EIL~hL~ 814 (825)
+|||+.+|++|..
T Consensus 274 ~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 274 KRPKYNKLLEHSF 286 (318)
T ss_dssp TSCCHHHHTTSHH
T ss_pred HCcCHHHHhhCHH
Confidence 9999999999854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.15 Aligned_cols=275 Identities=14% Similarity=0.081 Sum_probs=181.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC--CCCCcceee-----
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMY----- 559 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L--~HPNIV~l~----- 559 (825)
...|++.+.||+|+||.||+|.+ .+..||+|++..... ......+ .+.+|+.+++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELE----RLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHH----HHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHH----HHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 34599999999999999999997 578899999764321 1122222 347785544444 699988855
Q ss_pred --eeEecCCCCC---CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHH------HHHHHHHHHHHHHH
Q 003375 560 --GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA------LFIAQDVAAALVEL 628 (825)
Q Consensus 560 --g~~~~~~~~~---~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i------~~Ia~QIa~AL~yL 628 (825)
+++...+... .............||||||++ |+|.+++.... ..+....+ +.++.||+.||+||
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 3443322100 000001111245799999998 89999998631 22344445 67789999999999
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~ 708 (825)
|++||+||||||+||||+.+ +.+||+|||+++....... ...+|+.|+|||++.+ ...
T Consensus 211 H~~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~--~~~ 268 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPD-------GRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNA--STA 268 (371)
T ss_dssp HHTTEEETTCSGGGEEECTT-------SCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTC--SEE
T ss_pred HHCCCccCcCCHHHEEECCC-------CCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccC--CCC
Confidence 99999999999999999877 4599999999986643211 2357799999999964 114
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHH
Q 003375 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 788 (825)
Q Consensus 709 ~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 788 (825)
.++.++|||||||+||||++|+.||.+....... ........ ........ .......++.+
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~------------~~~~~~~~---~~~~~~~~~~~ 329 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG----SWKRPSLR------------VPGTDSLA---FGSCTPLPDFV 329 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT----CCCBCCTT------------SCCCCSCC---CTTSSCCCHHH
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCccccc----chhhhhhh------------hccccccc---hhhccCCCHHH
Confidence 5799999999999999999999999766432100 00000000 00000000 01112446789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 003375 789 VDVFRRCTEENPTERPTAGDLYEMFV 814 (825)
Q Consensus 789 ~dLI~~CL~~DP~eRPSa~EIL~hL~ 814 (825)
.+||.+||+.||.+|||+.++++|.+
T Consensus 330 ~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 330 KTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999999999999999999998854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=360.11 Aligned_cols=269 Identities=19% Similarity=0.215 Sum_probs=202.7
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcc-eeeeeE
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHK 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV-~l~g~~ 562 (825)
+...++|++.+.||+|+||.||+|.+ .+..||||+....... . .+.+|+.+++.|+|++++ .+..++
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~----~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------P----QLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------C----CHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------H----HHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 34567899999999999999999997 4789999986644321 1 238899999999975554 444444
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
.... ..+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|
T Consensus 73 ~~~~--------------~~~lvme~~-g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 133 (483)
T 3sv0_A 73 VEGD--------------YNVLVMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (483)
T ss_dssp EETT--------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eeCC--------------EEEEEEECC-CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence 4333 359999999 8999999985 23569999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
|||+... ..+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+
T Consensus 134 ILl~~~~----~~~~vkL~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 134 FLMGLGR----RANQVYIIDFGLAKKYRDTSTHQH---IPYRENKNLTGTARYASVNTHLG----IEQSRRDDLESLGYV 202 (483)
T ss_dssp EEECCGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred EEEecCC----CCCeEEEEeCCcceeccCCccccc---cccccccccCCCccccCHHHhcC----CCCChHHHHHHHHHH
Confidence 9995221 125799999999987754332111 11112235679999999999987 678999999999999
Q ss_pred HHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 723 LLELLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 723 LyELLTG~~PF~~~~~---~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
||||++|+.||.+... .+.+..+........... .....+..+.+||.+||..|
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-----------------------LCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-----------------------HHTTSCHHHHHHHHHHHTCC
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-----------------------HhcCCcHHHHHHHHHHhcCC
Confidence 9999999999987543 333333322211111110 11223568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 003375 800 PTERPTAGDLYEMFVART 817 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ 817 (825)
|.+||++.+|++.|+.+.
T Consensus 260 P~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 260 FDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp TTCCCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998773
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=343.28 Aligned_cols=289 Identities=19% Similarity=0.231 Sum_probs=205.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-----------CC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HS 553 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-----------HP 553 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++.. .....+ .+.+|+.+++++. ||
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTE----AAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHH----HHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----Cccchh----hhhHHHHHHHHhhcccccchhccccc
Confidence 4567899999999999999999997 678899998642 122222 3488999998886 89
Q ss_pred CcceeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC-C
Q 003375 554 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-H 632 (825)
Q Consensus 554 NIV~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-g 632 (825)
||+++++++..... .....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ |
T Consensus 87 ~i~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ 152 (373)
T 1q8y_A 87 HILKLLDHFNHKGP----------NGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG 152 (373)
T ss_dssp TBCCCCEEEEEEET----------TEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHhhccCC----------CCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999875431 123579999999 79999999862 234589999999999999999999998 9
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 712 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~ 712 (825)
|+||||||+||||+.++. ......+||+|||++....... ....||+.|+|||++.+ ..++.
T Consensus 153 ivH~Dikp~NIll~~~~~-~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~----~~~~~ 214 (373)
T 1q8y_A 153 IIHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGC 214 (373)
T ss_dssp EECSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCT
T ss_pred EEecCCChHHeEEeccCC-CcCcceEEEcccccccccCCCC-------------CCCCCCccccCcHHHhC----CCCCc
Confidence 999999999999975431 1123579999999997664321 22368999999999986 66899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCCCchhHHhhhccCcc-----ccccccCCCC------
Q 003375 713 EVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLIQMGKRPRLTDELEALGSCHE-----HEVAQSGSGF------ 775 (825)
Q Consensus 713 kSDVWSLGvILyELLTG~~PF~~~~------~~~i~~~I~~~~~p~l~~~l~~~~~~~~-----~~~~~~~~~~------ 775 (825)
++|||||||+||||++|+.||.+.. .......+..... .++..+........ ..........
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC-CCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence 9999999999999999999997654 2222222222111 11111110000000 0000000000
Q ss_pred ----CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 776 ----EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 776 ----~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.........+..+.+||.+||+.||.+|||+.||++|.+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence 001122456788999999999999999999999999976554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.01 Aligned_cols=265 Identities=24% Similarity=0.261 Sum_probs=178.0
Q ss_pred CCCCCceeee-eecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHH-HHHhhCCCCCcceeeeeE
Q 003375 487 GSFPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv-~iLk~L~HPNIV~l~g~~ 562 (825)
...++|.+.+ .||+|+||.||+|.+. +..||+|++... ... .+|+ ..++.++||||+++++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~--------~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA--------RQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH--------HHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH--------HHHHHHHHHhcCCCChHHHHHHH
Confidence 3457899965 6999999999999984 789999986421 111 2333 346677899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... .....+|||||++||+|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~~~----------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 92 ENMHH----------GKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp EEEET----------TEEEEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred hhccC----------CCceEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 75321 12346999999999999999985 233469999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.++ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 Ill~~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 218 (336)
T 3fhr_A 159 LLYTSKE----KDAVLKLTDFGFAKETTQNA------------LQTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVI 218 (336)
T ss_dssp EEESCSS----TTCCEEECCCTTCEEC--------------------------------------CHHHHHHHHHHHHHH
T ss_pred EEEEecC----CCceEEEeccccceeccccc------------cccCCCCcCccChhhhCC----CCCCchhhHHHHHHH
Confidence 9998653 23569999999997654321 123468999999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|+|++|..||.+.........+......... .. ........++.+.+||.+||+.||.+
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 278 (336)
T 3fhr_A 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-------------------GF-PNPEWSEVSEDAKQLIRLLLKTDPTE 278 (336)
T ss_dssp HHHHHHSSCCC----------------------------------------CC-CTTTSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHCCCCCCCccchhhhhhHHHhhhcccc-------------------cc-CchhhccCCHHHHHHHHHHCCCChhH
Confidence 99999999999766544332111111000000 00 00111234668999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|||+.++++|.+...
T Consensus 279 Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 279 RLTITQFMNHPWINQ 293 (336)
T ss_dssp SCCHHHHHHSHHHHT
T ss_pred CcCHHHHhcCccccc
Confidence 999999999977654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.53 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=190.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC----CCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL----RHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L----~HPNIV~l~g 560 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++......... ...-...+.+|+.++.++ +||||+++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS--PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc--cchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3457899999999999999999987 5678999986433221110 001112337899999998 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcc-cCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy-~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLK 639 (825)
++...+.. ++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 106 ~~~~~~~~--------------~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 166 (312)
T 2iwi_A 106 WFETQEGF--------------MLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK 166 (312)
T ss_dssp EC-----C--------------EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCS
T ss_pred EEecCCeE--------------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 98766544 999999 788999999986 2468999999999999999999999999999999
Q ss_pred CCCEEEe-cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 003375 640 SENILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 718 (825)
Q Consensus 640 P~NILLd-~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWS 718 (825)
|+|||++ .+ +.+||+|||++....... .....||+.|+|||++.+ ....+.++||||
T Consensus 167 p~Nil~~~~~-------~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s 224 (312)
T 2iwi_A 167 DENILIDLRR-------GCAKLIDFGSGALLHDEP------------YTDFDGTRVYSPPEWISR---HQYHALPATVWS 224 (312)
T ss_dssp GGGEEEETTT-------TEEEECCCSSCEECCSSC------------BCCCCSCTTTSCHHHHHH---SCBCHHHHHHHH
T ss_pred hhhEEEeCCC-------CeEEEEEcchhhhcccCc------------ccccCCcccccCceeeec---CCCCCccchHHH
Confidence 9999998 44 469999999998765321 123458999999999976 123356999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 003375 719 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798 (825)
Q Consensus 719 LGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~ 798 (825)
|||++|+|++|+.||.... . +.... ..++ ...+..+.+||.+||+.
T Consensus 225 lG~il~~l~~g~~pf~~~~--~----~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 225 LGILLYDMVCGDIPFERDQ--E----ILEAE-LHFP---------------------------AHVSPDCCALIRRCLAP 270 (312)
T ss_dssp HHHHHHHHHHSSCSCCSHH--H----HHHTC-CCCC---------------------------TTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHCCCCCCChH--H----Hhhhc-cCCc---------------------------ccCCHHHHHHHHHHccC
Confidence 9999999999999996432 1 11111 0111 11345789999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 003375 799 NPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 799 DP~eRPSa~EIL~hL~~l 816 (825)
||.+|||+.++++|.+..
T Consensus 271 ~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 271 KPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp STTTSCCHHHHHHSTTTC
T ss_pred ChhhCcCHHHHhcChhhc
Confidence 999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.99 Aligned_cols=253 Identities=22% Similarity=0.242 Sum_probs=197.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--CCCcceeeeeE
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--HPNIV~l~g~~ 562 (825)
...++|++.+.||+|+||.||+|.+ .+..||+|++.......... . .....+.+|+.++++++ ||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~-~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-L-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-C-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-h-hhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3467899999999999999999987 67889999976543221100 0 00122378999999996 59999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCC-CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
..... .++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 118 ~~~~~--------------~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 178 (320)
T 3a99_A 118 ERPDS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178 (320)
T ss_dssp ECSSE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ecCCc--------------EEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH
Confidence 86553 4999999986 899999986 256899999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
|||++.+. +.+||+|||++....... .....||+.|+|||++.+ ...++.++|||||||
T Consensus 179 NIll~~~~------~~~kL~Dfg~~~~~~~~~------------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 237 (320)
T 3a99_A 179 NILIDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGI 237 (320)
T ss_dssp GEEEETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHH
T ss_pred HEEEeCCC------CCEEEeeCcccccccccc------------ccCCCCCccCCChHHhcc---CCCCCccchHHhHHH
Confidence 99998331 469999999998765321 122469999999999976 233478999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
++|||++|+.||..... +..... .++ ...++.+.+||.+||..||.
T Consensus 238 il~el~~g~~pf~~~~~------~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 238 LLYDMVCGDIPFEHDEE------IIRGQV-FFR---------------------------QRVSSECQHLIRWCLALRPS 283 (320)
T ss_dssp HHHHHHHSSCSCCSHHH------HHHCCC-CCS---------------------------SCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHCCCCCCChhh------hhcccc-ccc---------------------------ccCCHHHHHHHHHHccCChh
Confidence 99999999999965321 111110 000 11245789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 003375 802 ERPTAGDLYEMFVA 815 (825)
Q Consensus 802 eRPSa~EIL~hL~~ 815 (825)
+|||+.+|++|.+.
T Consensus 284 ~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 284 DRPTFEEIQNHPWM 297 (320)
T ss_dssp GSCCHHHHHTSGGG
T ss_pred hCcCHHHHhcCHhh
Confidence 99999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.94 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=189.7
Q ss_pred CceeeeeecccCceE-EEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~-Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~ 568 (825)
+|.+.+.||+|+||+ ||++...+..||||++.... ...+ .+|+.+|+.+ +|||||++++++.....
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~----~~E~~~l~~l~~HpnIv~l~~~~~~~~~- 92 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFA----DREVQLLRESDEHPNVIRYFCTEKDRQF- 92 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEEC----HHHHHHHHHSCCCTTBCCEEEEEEETTE-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHH----HHHHHHHHhccCCCCcCeEEEEEecCCE-
Confidence 589999999999998 55566688999999864211 1122 7899999999 79999999999886653
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.||||||+. |+|.+++.. ....+....++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 93 -------------~~lv~E~~~-g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 93 -------------QYIAIELCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp -------------EEEEEECCS-EEHHHHHHS----SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred -------------EEEEEECCC-CCHHHHHHh----cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 499999997 699999975 22334555678999999999999999999999999999999654
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ ..+...+||+|||+++......... .......||+.|+|||++.+.. ...++.++|||||||+||||++
T Consensus 155 ~--~~~~~~~kL~DFG~a~~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 155 N--AHGKIKAMISDFGLCKKLAVGRHSF-------SRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp B--TTTBCCEEECCTTEEECC-------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred C--CCCceeEEEecccceeeccCCCcce-------eeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHc
Confidence 2 1234679999999998765322110 1123356999999999997421 2456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|..||...........+.......+ ......+..+.+||.+||+.||.+|||+.
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCL-------------------------HPEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTS-------------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcchhhHHHHHHHhccCCcccc-------------------------CccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 9999966544433322211111100 01122355688999999999999999999
Q ss_pred HHHHHHH
Q 003375 808 DLYEMFV 814 (825)
Q Consensus 808 EIL~hL~ 814 (825)
+|++|.+
T Consensus 280 evl~hp~ 286 (432)
T 3p23_A 280 HVLKHPF 286 (432)
T ss_dssp HHHTSTT
T ss_pred HHHhCcc
Confidence 9998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=342.62 Aligned_cols=273 Identities=22% Similarity=0.294 Sum_probs=189.4
Q ss_pred CCCCc-eeeeeecccCceEEEEE-EECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 003375 488 SFPSL-SSCDEAGKSVSSSLFRC-KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y-~i~~~LG~G~fG~Vy~a-~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~ 564 (825)
.+.++ .+.+.||+|+||+||.+ ...+..||||+.... ..+ .+.+|+.+|+++ +|||||++++++..
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~----~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCD----IALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHH----HHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHH----HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 34444 56788999999999754 457889999987532 112 337899999886 79999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCC--CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~--~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
... .||||||+. |+|.+++........ ...++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~--------------~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~N 145 (434)
T 2rio_A 81 DRF--------------LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN 145 (434)
T ss_dssp SSE--------------EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCe--------------EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 553 599999996 699999985211110 011233467899999999999999999999999999
Q ss_pred EEEecCcc------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCch
Q 003375 643 ILIDLERK------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLE 713 (825)
Q Consensus 643 ILLd~~~~------~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~---~~~~~s~k 713 (825)
||++.++. .......+||+|||+++.......... .......||+.|+|||++.+.. ....++.+
T Consensus 146 ILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp EEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred EEEecCcccccccccCCCceEEEEcccccceecCCCCccce------eeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 99986530 112346899999999987654221100 0112346999999999997521 12468899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHH
Q 003375 714 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 792 (825)
Q Consensus 714 SDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI 792 (825)
+|||||||++|||+| |..||....... ..+..+... ++. . ........++.+.+||
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~-~~~----------~----------~~~~~~~~~~~~~~li 276 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFS-LDE----------M----------KCLHDRSLIAEATDLI 276 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCC-CCC----------C----------TTCCCHHHHHHHHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCC-ccc----------c----------cccccccchHHHHHHH
Confidence 999999999999999 999997654333 122222110 000 0 0001234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHh
Q 003375 793 RRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 793 ~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
.+||+.||.+|||+.+|++|.+.
T Consensus 277 ~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 277 SQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhhCChhhCCCHHHHHhCCcc
Confidence 99999999999999999988543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.49 Aligned_cols=246 Identities=22% Similarity=0.212 Sum_probs=183.1
Q ss_pred CCCCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHH-hhCCCCCcceeeeeE
Q 003375 487 GSFPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHK 562 (825)
Q Consensus 487 ~~~~~y~i~-~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iL-k~L~HPNIV~l~g~~ 562 (825)
..+++|.+. +.||+|+||.||+|.+ .+..||+|++... .. +.+|+.++ +.++||||+++++++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~----~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HH----HHHHHHHHHHhccCCCchhHHhhh
Confidence 456889888 7899999999999998 5778999986421 12 27788887 556899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
..... .....+|||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~~----------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 81 ENLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp EEEET----------TEEEEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred hhhcC----------CCceEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 75110 12246999999999999999986 233469999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++..+ ..+.+||+|||++..... ..++.++|||||||+
T Consensus 148 il~~~~~----~~~~~kl~Dfg~a~~~~~------------------------------------~~~~~~~DiwslG~i 187 (299)
T 3m2w_A 148 LLYTSKR----PNAILKLTDFGFAKETTG------------------------------------EKYDKSCDMWSLGVI 187 (299)
T ss_dssp EEESSSS----TTCCEEECCCTTCEECTT------------------------------------CGGGGHHHHHHHHHH
T ss_pred EEEecCC----CCCcEEEecccccccccc------------------------------------ccCCchhhHHHHHHH
Confidence 9998742 125799999999854321 234679999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+|||++|..||.+.........+...... .... .........++.+.+||.+||+.||.+
T Consensus 188 l~el~tg~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 188 MYILLCGYPPFYSNHGLAISPGMKTRIRM-------------------GQYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp HHHHHHSSCSCCC-------CCSCCSSCT-------------------TCCS-SCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHCCCCCCCCcchhhhHHHHHHHhh-------------------cccc-CCchhcccCCHHHHHHHHHHcccChhh
Confidence 99999999999766543321111110000 0000 011112345678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 003375 803 RPTAGDLYEMFVARTS 818 (825)
Q Consensus 803 RPSa~EIL~hL~~l~s 818 (825)
|||+.|+++|.+-...
T Consensus 248 Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 248 RMTITEFMNHPWIMQS 263 (299)
T ss_dssp SCCHHHHHTSHHHHTG
T ss_pred CCCHHHHhcChhhccc
Confidence 9999999999776544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.99 Aligned_cols=273 Identities=16% Similarity=0.100 Sum_probs=189.0
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---------CCCccee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---------HSCIVEM 558 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---------HPNIV~l 558 (825)
..++|++.+.||+|+||.||+|++++..||+|++..................+.+|+.+|+.|+ |||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3578999999999999999999999999999998755322100001111123488888888885 6666666
Q ss_pred eeeEecCC-----------------CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHH
Q 003375 559 YGHKISSK-----------------WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 621 (825)
Q Consensus 559 ~g~~~~~~-----------------~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QI 621 (825)
++++.... .. ......-......||||||+++|+|.+.+.. ..+++..++.|+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~-~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGS-ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCC-SSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccc-cccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHH
Confidence 66543210 00 0000000013357999999999976666532 468999999999999
Q ss_pred HHHHHHHH-hCCccccCCCCCCEEEecCccC-------------CCCCCeEEEeecCCcccccccccccccccCCCCCCC
Q 003375 622 AAALVELH-SKHIMHRDIKSENILIDLERKK-------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 687 (825)
Q Consensus 622 a~AL~yLH-s~gIVHrDLKP~NILLd~~~~~-------------~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~ 687 (825)
+.||.||| ++||+||||||+||||+.++.. ......+||+|||+|+.... .
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------------~ 235 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------------G 235 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------------T
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------------C
Confidence 99999999 9999999999999999977310 00113799999999987643 1
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCchhHHhhhccCc
Q 003375 688 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL-LLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGSCH 764 (825)
Q Consensus 688 ~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI-LyELLTG~~PF~~~~~-~~i~~~I~~~-~~p~l~~~l~~~~~~~ 764 (825)
..+||+.|||||++.+ .. +.++||||||++ .+++++|..||.+... ..+...+... ....
T Consensus 236 ~~~gt~~y~aPE~~~g----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 298 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTG----DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------ 298 (336)
T ss_dssp EEECCCCTTCSGGGCC----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------------
T ss_pred cEEEeecccChhhhcC----CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------------
Confidence 2369999999999986 33 789999998777 7888889999843211 1122222211 1100
Q ss_pred cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH-HHHH
Q 003375 765 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY-EMFV 814 (825)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL-~hL~ 814 (825)
..........++.+.+||.+||+.| |+.|++ +|.+
T Consensus 299 ----------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 299 ----------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp ----------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred ----------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 0012234456889999999999977 999999 8754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.55 Aligned_cols=235 Identities=14% Similarity=0.075 Sum_probs=179.4
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+. +..||+|++.... .......+ .+.+|+.++.+++||||+++++++...+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~----~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQ----ETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHH----HHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 67999999999999999999984 7899999864322 12223333 34899999999999999999999986653
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.||||||++|++|.+++.. . .....+..|+.||+.||.|||++||+||||||+||||+.
T Consensus 106 --------------~~lv~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 106 --------------GLVVAEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp --------------EEEEEECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred --------------EEEEEEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 5999999999999999853 2 355678899999999999999999999999999999997
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+++| |++| ++.++|||||||+||||+
T Consensus 165 ~-------g~~kl~~~~------------------------------~~~~-----------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 165 D-------GDVVLAYPA------------------------------TMPD-----------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp T-------SCEEECSCC------------------------------CCTT-----------CCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecc------------------------------ccCC-----------CCchhHHHHHHHHHHHHH
Confidence 7 458887443 2222 478999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
||+.||.+.+................. .........++.+.+||.+||+.||.+| |+.
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPI---------------------EPADIDRDIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBC---------------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCC---------------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHH
Confidence 999999876532211000000000000 0001123346789999999999999999 999
Q ss_pred HHHHHHHhhcCCC
Q 003375 808 DLYEMFVARTSSS 820 (825)
Q Consensus 808 EIL~hL~~l~sss 820 (825)
++++.|+.+....
T Consensus 255 el~~~L~~~~~~~ 267 (286)
T 3uqc_A 255 TLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHhccC
Confidence 9999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=357.86 Aligned_cols=287 Identities=20% Similarity=0.196 Sum_probs=196.5
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
...+++|++.+.||+|+||.||+|.+ .+..||+|++... ......+. +.+|+.++++++||||+++++++.
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~----~~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRER----WCLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHH----HHHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHH----HHHHHHHHHhCCCCCCCceeeeec
Confidence 35678999999999999999999997 5788999985422 23333333 489999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..... ......++||||++||+|.+++... .....+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 83 ~~~~~--------~~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NI 152 (676)
T 3qa8_A 83 GLQKL--------APNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152 (676)
T ss_dssp TTCCC--------CTTSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTE
T ss_pred ccccc--------cCCCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 42211 0123459999999999999999852 2223588999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.++. ...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 153 Ll~~~g~----~~~vKL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 153 VLQPGPQ----RLIHKIIDLGYAKELDQGEL-----------CTEFVGTLQYLAPELLEQ----KKYTVTVDYWSFGTLA 213 (676)
T ss_dssp EEECCSS----SCEEEECSCCCCCBTTSCCC-----------CCCCCSCCTTCSSCSSCC----SCCSTTHHHHHHHHHH
T ss_pred EeecCCC----ceeEEEcccccccccccccc-----------cccccCCcccCChHHhcc----CCCCchhHHHHHHHHH
Confidence 9987632 35699999999987643221 133469999999999976 6789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+|++|..||.+....... ................... ...................++.+.+||.+||..||.+|
T Consensus 214 yeLltG~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~l~-g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kR 289 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQW---HGKVREKSNEHIVVYDDLT-GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHS---STTCC------CCSCCCCS-SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--
T ss_pred HHHHHCCCCCCcccchhhh---hhhhhcccchhhhhhhhhc-cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhC
Confidence 9999999999765332110 0000000000000000000 00000000000112334567899999999999999999
Q ss_pred CCHHHHHHH
Q 003375 804 PTAGDLYEM 812 (825)
Q Consensus 804 PSa~EIL~h 812 (825)
||+.++++|
T Consensus 290 PTa~elL~h 298 (676)
T 3qa8_A 290 GTDPQNPNV 298 (676)
T ss_dssp -CCTTCCCC
T ss_pred cCHHHHhcC
Confidence 999885433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=350.35 Aligned_cols=244 Identities=23% Similarity=0.258 Sum_probs=188.4
Q ss_pred CCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~---~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.++|++.+.||+|+||.||+|.+ .+..||||++.. . ....... .+.+|+.+|++++||||+++++++...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~--~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH--S-GDAEAQA----MAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS--S-CCHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc--c-CCHHHHH----HHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 47899999999999999999997 468899997532 1 2223333 348999999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
... ..+..||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 152 ~~~---------~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll 215 (681)
T 2pzi_A 152 DRH---------GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215 (681)
T ss_dssp CTT---------SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCC---------CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE
Confidence 431 22346999999999999987652 68999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ .+||+|||+++..... ....||+.|+|||++.+ . ++.++|||||||+||+
T Consensus 216 ~~~--------~~kl~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~----~-~~~~sDi~slG~~l~~ 268 (681)
T 2pzi_A 216 TEE--------QLKLIDLGAVSRINSF--------------GYLYGTPGFQAPEIVRT----G-PTVATDIYTVGRTLAA 268 (681)
T ss_dssp CSS--------CEEECCCTTCEETTCC--------------SCCCCCTTTSCTTHHHH----C-SCHHHHHHHHHHHHHH
T ss_pred eCC--------cEEEEecccchhcccC--------------CccCCCccccCHHHHcC----C-CCCceehhhhHHHHHH
Confidence 764 4999999999765432 23469999999999976 2 3889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|.+||.+.... .++. .......++.+.+||.+||+.||.+||+
T Consensus 269 l~~g~~~~~~~~~~------------~~~~----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~ 314 (681)
T 2pzi_A 269 LTLDLPTRNGRYVD------------GLPE----------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFT 314 (681)
T ss_dssp HHSCCCEETTEECS------------SCCT----------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHhCCCCCcccccc------------cccc----------------------cccccccCHHHHHHHhhhccCChhhCCC
Confidence 99999988642110 0000 0011123457899999999999999995
Q ss_pred -HHHHHHHHHhh
Q 003375 806 -AGDLYEMFVAR 816 (825)
Q Consensus 806 -a~EIL~hL~~l 816 (825)
++++.+.|..+
T Consensus 315 ~~~~l~~~l~~~ 326 (681)
T 2pzi_A 315 TAEEMSAQLTGV 326 (681)
T ss_dssp SHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 55555555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.89 Aligned_cols=266 Identities=14% Similarity=0.132 Sum_probs=185.1
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC-CCccee------
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEM------ 558 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H-PNIV~l------ 558 (825)
....|.+.+.||+|+||.||+|.+. +..||||++..... ......+ .+.+|+.+++.++| +|+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~----~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIK----QMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCH----HHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHH----HHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3456889999999999999999984 88999998753322 1112223 34899999999987 332211
Q ss_pred ---eeeEecCCCC---CCCCCCCccccceEEEEEcccCCCCHHHHHHHhh--ccCCCccCHHHHHHHHHHHHHHHHHHHh
Q 003375 559 ---YGHKISSKWL---PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS--ETGEKHVSVKLALFIAQDVAAALVELHS 630 (825)
Q Consensus 559 ---~g~~~~~~~~---~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~--~~~~~~ls~~~i~~Ia~QIa~AL~yLHs 630 (825)
+......+.. ..............+++|+++. ++|.+++.... ......+++..++.|+.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111111100 0000111112345688888875 89999996432 1223567888999999999999999999
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-----
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----- 705 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~----- 705 (825)
+|||||||||+||||+.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 230 ~~iiHrDiKp~NILl~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~ 288 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGASA-------------VSPIG-RGFAPPETTAERMLPFGQ 288 (413)
T ss_dssp TTEECSCCCGGGEEECTT-------CCEEECCGGGCEETTEEE-------------CCCCC-TTTCCHHHHHHHTSTTGG
T ss_pred CCcccCCcccceEEEecC-------CeEEEEeccceeecCCcc-------------ccCCC-CceeCchhhhcccccccc
Confidence 999999999999999987 459999999987654321 22357 9999999995321
Q ss_pred -CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 -KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 -~~~~~s~kSDVWSLGvILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
....++.++|||||||+||||++|+.||.+.+.......+... . ...
T Consensus 289 ~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~---------~~~ 336 (413)
T 3dzo_A 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-----------------------C---------KNI 336 (413)
T ss_dssp GCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS-----------------------C---------CCC
T ss_pred ccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh-----------------------c---------ccC
Confidence 2355788999999999999999999999766433211111000 0 012
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEM 812 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~h 812 (825)
++.+.+||.+||+.||.+||++.++++|
T Consensus 337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 337 PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4679999999999999999998888766
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=297.32 Aligned_cols=193 Identities=15% Similarity=0.120 Sum_probs=129.7
Q ss_pred eeecccCceEEEEEE--ECCeeEEEEEEecccCCC--ChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCC
Q 003375 496 DEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~--~~~~~vAVKI~~lk~~~~--~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~~~~~~~~ 570 (825)
..++.|++|.+..++ +-+..+++|++....... .....+.-.++|.+|+++|+++ .|+||+++++++.++..
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~--- 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS--- 316 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE---
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE---
Confidence 356667777666654 367889999986543222 2233333345679999999999 59999999999987764
Q ss_pred CCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCcc
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~ 650 (825)
+||||||++|++|.++|.. ...++.. .|+.||+.||+|||++|||||||||+||||+.+
T Consensus 317 -----------~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-- 375 (569)
T 4azs_A 317 -----------GWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-- 375 (569)
T ss_dssp -----------EEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT--
T ss_pred -----------EEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC--
Confidence 4999999999999999986 3456654 588999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 651 ~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
+.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 376 -----g~vKL~DFGlAr~~~~~~~----------~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 376 -----QHARLIDFGSIVTTPQDCS----------WPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -----SCEEECCCTTEESCC---C----------CSHHHHHHHHHHHHHHC----------------------CCCCTTH
T ss_pred -----CCEEEeecccCeeCCCCCc----------cccCceechhhccHHHhCC-----CCCCcccccccccchhhhcccc
Confidence 4599999999987654221 1244679999999999975 3567899999999988876654
Q ss_pred CC
Q 003375 731 VP 732 (825)
Q Consensus 731 ~P 732 (825)
.+
T Consensus 436 ~~ 437 (569)
T 4azs_A 436 SN 437 (569)
T ss_dssp HH
T ss_pred ch
Confidence 33
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=267.33 Aligned_cols=201 Identities=19% Similarity=0.176 Sum_probs=146.7
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~~ 572 (825)
...+.||+|+||.||+|.+.+..+++|....+.............+++.+|+.+|++++||||+++..++......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~---- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK---- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT----
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc----
Confidence 4467899999999999998899999998755433222222223345679999999999999999555555544433
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccCC
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 652 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~~ 652 (825)
||||||++|++|.+++.. ++.++.||+.||.|||++||+||||||+|||++.
T Consensus 415 ----------~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----- 466 (540)
T 3en9_A 415 ----------RIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----- 466 (540)
T ss_dssp ----------EEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----
T ss_pred ----------EEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----
Confidence 999999999999999863 5689999999999999999999999999999986
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 003375 653 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 732 (825)
Q Consensus 653 ~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~P 732 (825)
.+||+|||+++............ ........||+.|||||++.... ..|+..+|+|+..+-..+.+.++.+
T Consensus 467 ----~~kL~DFGla~~~~~~~~~~~~~---~~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 467 ----DLYIIDFGLGKISNLDEDKAVDL---IVFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ----SEEECCCTTCEECCCHHHHHHHH---HHHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ----eEEEEECccCEECCCccccccch---hhhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhccc
Confidence 39999999998875432110000 00012357999999999997522 2467788999999999998888877
Q ss_pred CC
Q 003375 733 YM 734 (825)
Q Consensus 733 F~ 734 (825)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 74
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.5e-21 Score=205.19 Aligned_cols=151 Identities=16% Similarity=0.142 Sum_probs=112.6
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH----------HHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD----------EIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~----------~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
|.+.+.||+|+||.||+|.+ .+..+|+|+........... ........+.+|+.+|++++ | +++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 45669999999999999998 57899999975432211100 00011234589999999999 4 56666
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.. + ..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||
T Consensus 169 ~~~~-~--------------~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp 221 (282)
T 1zar_A 169 VYAW-E--------------GNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQ 221 (282)
T ss_dssp EEEE-E--------------TTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred EEec-c--------------ceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCH
Confidence 5432 2 2399999999999987 421 23457999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~ 703 (825)
+|||++ + +.+||+|||+|+. +..|+|||++..
T Consensus 222 ~NILl~-~-------~~vkl~DFG~a~~-----------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 222 YNVLVS-E-------EGIWIIDFPQSVE-----------------------VGEEGWREILER 253 (282)
T ss_dssp TSEEEE-T-------TEEEECCCTTCEE-----------------------TTSTTHHHHHHH
T ss_pred HHEEEE-C-------CcEEEEECCCCeE-----------------------CCCCCHHHHHHH
Confidence 999999 6 4699999999853 345789999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=185.88 Aligned_cols=143 Identities=15% Similarity=0.131 Sum_probs=105.2
Q ss_pred ceeeeeecccCceEEEEEEE--CCee--EEEEEEecccCCCChH----------------HHHhhHHhHHHHHHHHhhCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF--GSAD--AAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR 551 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~--~~~~--vAVKI~~lk~~~~~~~----------------~~~~~~~~~lrEv~iLk~L~ 551 (825)
|.+.+.||+|+||.||+|.+ .+.. ||||+++......... ........+.+|+.+|.+|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999998 7888 9999965432111100 00111235689999999999
Q ss_pred CCCc--ceeeeeEecCCCCCCCCCCCccccceEEEEEcccCC-C----CHHHHHHHhhccCCCccCHHHHHHHHHHHHHH
Q 003375 552 HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-G----SVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 624 (825)
Q Consensus 552 HPNI--V~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~g-G----SL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~A 624 (825)
|++| ..+++. . ..+|||||+.+ | +|.+++.. .++..+..++.||+.|
T Consensus 129 ~~~i~~p~~~~~--~----------------~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----------------KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HTTCCCCCEEEE--E----------------TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc--C----------------CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHH
Confidence 8864 334432 1 12899999942 3 77766432 2345678899999999
Q ss_pred HHHHH-hCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 625 LVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 625 L~yLH-s~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
|.||| +.||+||||||.|||++. .++|+|||+|...
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~---------~~~liDFG~a~~~ 219 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID---------KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS---------SEEECCCTTCEET
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC---------cEEEEECcccccC
Confidence 99999 999999999999999975 3999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.9e-16 Score=173.47 Aligned_cols=150 Identities=17% Similarity=0.179 Sum_probs=102.8
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh--------------HHHHhhHHhHHHHHHHHhhCCCCCcc
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHSCIV 556 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~--------------~~~~~~~~~~lrEv~iLk~L~HPNIV 556 (825)
|++...||.|+||.||+|.. .+..||||+.+........ ...........+|...|.+|.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 79999999999999999997 6789999997653322110 00011111224566667776544432
Q ss_pred --eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 557 --EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 557 --~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
..++.. ..+|||||++|++|..+.. ......++.||+.+|.|||+.|||
T Consensus 177 vp~p~~~~------------------~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 177 VPEPIAQS------------------RHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp CCCEEEEE------------------TTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCeeeecc------------------CceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHCCCc
Confidence 222211 1279999999888754321 123457889999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCC---CeEEEeecCCccccc
Q 003375 635 HRDIKSENILIDLERKKADGK---PVVKLCDFDRAVPLR 670 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~---~~vKL~DFGlA~~~~ 670 (825)
||||||.||||+.+++..+.. ..+.|+||+-+....
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999999999886432222 248999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.6e-11 Score=125.29 Aligned_cols=140 Identities=14% Similarity=0.108 Sum_probs=107.5
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
++.|++...++.|+++.||++...+..+++|+........ .. .+.+|+.+|+.|. +..+.++++++...+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~----~~----~~~~E~~~l~~l~~~~~vP~v~~~~~~~~- 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----TY----DVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS----TT----CHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC----HH----HHHHHHHHHHHHhcCCCCCeEEEEEecCC-
Confidence 4678999999999999999999888899999865321111 11 2388999999985 677888998876543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-----------------
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 630 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs----------------- 630 (825)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 -------------~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 84 -------------WSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred -------------ceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 3499999999999876531 112234788999999999998
Q ss_pred ------------------------------------------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 631 ------------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 631 ------------------------------------------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
..++|+|++|.|||++.+ ..+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-------KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-------cEEEEEEchhcc
Confidence 348999999999999754 346799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.1e-09 Score=112.54 Aligned_cols=135 Identities=14% Similarity=0.111 Sum_probs=93.6
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC--cceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN--IV~l~g~~~~ 564 (825)
.+..|.+....+.|..+.||++... +..+++|+.... ... .+.+|+.+++.+.+.+ +.+++++...
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~----~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALN----ELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cch----hhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 3556676655556777999999764 567999985421 111 2378999999986444 4568887664
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC------------
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH------------ 632 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g------------ 632 (825)
.+ ..++||||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 87 ~~--------------~~~~v~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~ 139 (264)
T 1nd4_A 87 AG--------------RDWLLLGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKH 139 (264)
T ss_dssp SS--------------CEEEEEECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHH
T ss_pred CC--------------CCEEEEEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 33 249999999998874 11 011 1245667777777777643
Q ss_pred ----------------------------------------------ccccCCCCCCEEEecCccCCCCCCeEEEeecCCc
Q 003375 633 ----------------------------------------------IMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 666 (825)
Q Consensus 633 ----------------------------------------------IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA 666 (825)
++|+|++|.|||++.+ ..+.|+|||.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~liD~~~a 212 (264)
T 1nd4_A 140 RIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-------RFSGFIDCGRL 212 (264)
T ss_dssp HHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-------EEEEECCCTTC
T ss_pred HHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-------cEEEEEcchhc
Confidence 9999999999999754 34679999987
Q ss_pred c
Q 003375 667 V 667 (825)
Q Consensus 667 ~ 667 (825)
.
T Consensus 213 ~ 213 (264)
T 1nd4_A 213 G 213 (264)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2e-09 Score=117.76 Aligned_cols=148 Identities=15% Similarity=0.164 Sum_probs=105.6
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--CCCcceeeeeEecCCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--HPNIV~l~g~~~~~~~~~~~ 571 (825)
..+.|+.|.++.||++...+..+++|+....... ..... ..+.+|+.+++.|. +..+.+++.++.+....
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~-~~~~~----~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~--- 113 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSK-LLPSA----HAIEREYRVMDALAGTDVPVAKMYALCEDESVI--- 113 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT---
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCC-CCCcH----HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc---
Confidence 4678899999999999987788888864300110 00111 23488999999997 45678888887654321
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh---------------------
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 630 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs--------------------- 630 (825)
...|+||||++|..|.+.. ...++......++.+++..|..||+
T Consensus 114 --------g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3dxp_A 114 --------GRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQ 178 (359)
T ss_dssp --------SSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHH
T ss_pred --------CCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHH
Confidence 2349999999987764311 1246788888999999999999997
Q ss_pred -------------------------------------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 631 -------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 631 -------------------------------------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
..++|+|++|.|||++.++. ..+.|+||+.+..-
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~g 249 (359)
T 3dxp_A 179 IERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECccccccC
Confidence 35899999999999986631 35799999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=5.4e-09 Score=111.76 Aligned_cols=196 Identities=18% Similarity=0.210 Sum_probs=119.6
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCC--cceeeeeEecCCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSC--IVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPN--IV~l~g~~~~~~~~~~~~ 572 (825)
+.++.|.+..||++. ..+++|+... .... ..+.+|+.+|+.+. +.. +.+++.......
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~------~~~~----~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~------ 86 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH------SRGS----TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE------ 86 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS------HHHH----HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS------
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC------cchH----HHHHHHHHHHHHHHhcCCCCCCceEeecCCCC------
Confidence 458999999999974 5688887431 1222 23488999998884 333 344444432221
Q ss_pred CCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh----------------------
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 630 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs---------------------- 630 (825)
.....|+||++++|.+|...... .++......++.+++..|..||+
T Consensus 87 -----~~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 87 -----TYQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp -----SCSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred -----CCCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 11234899999999888654322 36677777888888888888885
Q ss_pred ------------------------------------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccccccc
Q 003375 631 ------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 674 (825)
Q Consensus 631 ------------------------------------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~ 674 (825)
..++|+|++|.|||++.+. ...+.|+||+.+..-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-----~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-----NTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-----TEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-----CCEEEEEeCCCCccCChHHH
Confidence 1379999999999998741 14588999999865432111
Q ss_pred ccccccC-CCCCC---CcccCCCcccc-hhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003375 675 TCCIAHR-GIPAP---DVCVGTPRWMA-PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733 (825)
Q Consensus 675 ~~~~s~~-~~~~~---~~~vGT~~YmA-PEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~PF 733 (825)
....... ..... ..+.....+.. |+.... .....+.|+++.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r------~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK------YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH------HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH------HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1000000 00000 00000001122 333321 123478999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-05 Score=86.33 Aligned_cols=139 Identities=16% Similarity=0.143 Sum_probs=87.6
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCC---CcceeeeeEecCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS---CIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HP---NIV~l~g~~~~~~~~~~~ 571 (825)
.+.++.|....||+. +..+++|+-. ..... ..+.+|+.+|+.|.+. .|.+++.+.....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~----~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----- 85 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK------SQQGA----DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----- 85 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES------SHHHH----HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC------CchHH----HHHHHHHHHHHHHHhcCCCCCCCeEeecccCC-----
Confidence 456788999999998 5778888732 11222 2348999999999742 2556666654211
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh---------------------
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 630 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs--------------------- 630 (825)
...|+||||++|.+|....- ..++......++.++...|..||+
T Consensus 86 --------g~~~~v~e~i~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 86 --------GNPFVGYRKVQGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp --------SCEEEEEECCCSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred --------CceEEEEeccCCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 12489999999988765321 112333334444444444444443
Q ss_pred ---------------------------------------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 631 ---------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 631 ---------------------------------------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
..++|+|++|.|||++.+.. ....+.|+||+.+..-
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~---~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR---QTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS---SCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC---CCceEEEEehhhcCCC
Confidence 24699999999999986210 1134689999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=2.6e-05 Score=81.03 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=88.9
Q ss_pred CCceeeeeecccCce-EEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 003375 490 PSLSSCDEAGKSVSS-SLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 565 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG-~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~ 565 (825)
..|+.. .+..|..| .||+... .+..+++|+.... .... +.+|..+|+.|. +--+.++++++.+.
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~----~~~E~~~l~~l~~~vPVP~v~~~~~~~ 92 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VAND----VTDEMVRLNWLTAFMPLPTIKHFIRTP 92 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHH----HHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhH----HHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence 334433 34445555 7998775 4567899986421 2222 378999998885 33366788877654
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhC--------------
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------------- 631 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~-------------- 631 (825)
+ ..|+|||+++|.++.+..... ......+..+++..|..||..
T Consensus 93 ~--------------~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~ 149 (272)
T 4gkh_A 93 D--------------DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFR 149 (272)
T ss_dssp T--------------EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHH
T ss_pred C--------------eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccc
Confidence 4 349999999998887765430 112233455555555555531
Q ss_pred --------------------------------------------CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 --------------------------------------------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 --------------------------------------------gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
.++|+|+.+.|||++.. ..+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-------~~~~viDwe~a~ 222 (272)
T 4gkh_A 150 LAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-------KLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred hhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-------eEEEEEECcccc
Confidence 26899999999999865 346799999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=3.3e-05 Score=83.87 Aligned_cols=84 Identities=12% Similarity=0.033 Sum_probs=53.6
Q ss_pred eeeeee-cccCceEEEEEEEC--------CeeEEEEEEecccC--CCChHHHHhhHHhHHHHHHHHhhCC-C--CCccee
Q 003375 493 SSCDEA-GKSVSSSLFRCKFG--------SADAAAKVRTLKVC--GSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEM 558 (825)
Q Consensus 493 ~i~~~L-G~G~fG~Vy~a~~~--------~~~vAVKI~~lk~~--~~~~~~~~~~~~~~lrEv~iLk~L~-H--PNIV~l 558 (825)
...+.| +.|....+|+.... +..+++|+...... ... . ..+.+|+.+|+.|. + ..+.++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~----~~~~~E~~~l~~L~~~~~vpvP~v 95 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---T----YRLDHQFEVIRLVGELTDVPVPRV 95 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---C----CCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---h----hHHHHHHHHHHHHhhcCCCCCCcE
Confidence 345778 88999999998764 66788887432110 000 0 12377888888885 3 346778
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 594 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL 594 (825)
+.+....... ...|+||||++|.+|
T Consensus 96 ~~~~~~~~~~-----------g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 96 RWIETTGDVL-----------GTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEEECSSTTT-----------SSCEEEEECCCCBCC
T ss_pred EEEccCCCcc-----------CCceEEEEecCCCCh
Confidence 8776543211 134899999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=9.7e-05 Score=81.63 Aligned_cols=82 Identities=11% Similarity=-0.029 Sum_probs=46.9
Q ss_pred eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CC-cceeeeeEecCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SC-IVEMYGHKISSKWL 568 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PN-IV~l~g~~~~~~~~ 568 (825)
-.+.||.|.++.||++.. .+..+++|........... .......++..|+.+|+.+.. |. +.+++.+. ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCc-
Confidence 356899999999999954 5578999975422110000 000011233778888887742 33 34555432 221
Q ss_pred CCCCCCCccccceEEEEEcccCCC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGG 592 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gG 592 (825)
.++||||++|.
T Consensus 110 -------------~~lvmE~l~g~ 120 (397)
T 2olc_A 110 -------------AVTVMEDLSHL 120 (397)
T ss_dssp -------------TEEEECCCTTS
T ss_pred -------------cEEEEEeCCCc
Confidence 28999999863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00062 Score=72.53 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=25.6
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
..++|+|+++.|||++.+ ..+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-------CcEEEEehhhcc
Confidence 579999999999999765 349999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0013 Score=69.88 Aligned_cols=71 Identities=13% Similarity=0.111 Sum_probs=43.4
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc-ceeeeeEecCCCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADG 573 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI-V~l~g~~~~~~~~~~~~~ 573 (825)
.+.|+.|....+|++ ..+++|+...... ..-. ..+|+.+++.+...++ .+++++..+.+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~-----~~~~----r~~E~~~l~~l~~~g~~P~~~~~~~~~~------- 82 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE-----EYIN----RANEAVAAREAAKAGVSPEVLHVDPATG------- 82 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC---------CCC----HHHHHHHHHHHHHTTSSCCEEEECTTTC-------
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc-----ceeC----HHHHHHHHHHHHHcCCCCceEEEECCCC-------
Confidence 778999999999999 6688998643211 1111 1567777777652222 45555432211
Q ss_pred CCccccceEEEEEccc-CCCCH
Q 003375 574 NPEHHLLQSAIFMEYV-KGGSV 594 (825)
Q Consensus 574 ~~~~~~~~~~LVmEy~-~gGSL 594 (825)
++|+||+ +|.+|
T Consensus 83 ---------~~v~e~i~~g~~l 95 (301)
T 3dxq_A 83 ---------VMVTRYIAGAQTM 95 (301)
T ss_dssp ---------CEEEECCTTCEEC
T ss_pred ---------EEEEeecCCCccC
Confidence 7899999 66444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0014 Score=73.10 Aligned_cols=81 Identities=7% Similarity=0.026 Sum_probs=47.9
Q ss_pred HhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCccc--CCCcccchhhhhcccC
Q 003375 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV--GTPRWMAPEVLRAMHK 706 (825)
Q Consensus 629 Hs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~v--GT~~YmAPEvl~~~~~ 706 (825)
+...++|+|++|.|||++.+ . ++|+||+.+..-........ .. -...|++|+......
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-------~-~~lID~e~a~~G~p~~Dla~-----------~l~~~~~~~~~~~~~~~~~- 289 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-------S-TQVIDPEFSFYGPMGFDIGA-----------YLGNLILAFFAQDGHATQE- 289 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-------C-EEECCCTTCEEECHHHHHHH-----------HHHHHHHHHHHGGGGCCSS-
T ss_pred CCCeEEecCCCCCcEEEeCC-------C-CEEEeCcccccCchHHHHHH-----------HHHHHHHHHHhcccccccc-
Confidence 45689999999999999765 2 89999998865432111000 00 012456665543100
Q ss_pred CCCCCchhhHHHHHHHHHHHHhC
Q 003375 707 PNLYGLEVDIWSYGCLLLELLTL 729 (825)
Q Consensus 707 ~~~~s~kSDVWSLGvILyELLTG 729 (825)
........++..+...+|+.+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~y~~ 312 (420)
T 2pyw_A 290 NDRKEYKQWILRTIEQTWNLFNK 312 (420)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHH
Confidence 01112345666888888887764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.003 Score=68.23 Aligned_cols=76 Identities=12% Similarity=0.044 Sum_probs=56.3
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC---CCCcceeeeeEecCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLPS 570 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~---HPNIV~l~g~~~~~~~~~~ 570 (825)
-.+.|+.|.+..+|+....+..+++|+.... ... .+.+|+..|+.|. ...+.+++.+....+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~~----~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YRS----MFRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GHH----HHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cHH----HHHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 4677899999999999887888999986421 122 3478988888884 356778888765432
Q ss_pred CCCCCccccceEEEEEcccCCCCH
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSV 594 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL 594 (825)
..|+||||++|..+
T Consensus 105 ----------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 ----------HSFLLLEALNKSKN 118 (312)
T ss_dssp ----------EEEEEEECCCCCCC
T ss_pred ----------ceEEEEEeccCCCC
Confidence 35999999998653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=67.95 Aligned_cols=36 Identities=33% Similarity=0.400 Sum_probs=27.1
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 669 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~ 669 (825)
..++|||+.+.|||++.+.. +...+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~---~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPERE---GLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSC---GGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcC---CCCCeEEEeCCCcCcC
Confidence 47999999999999976310 0135899999988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0067 Score=64.44 Aligned_cols=150 Identities=15% Similarity=0.114 Sum_probs=77.2
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC--cceeeeeEecCCCCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPS 570 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN--IV~l~g~~~~~~~~~~ 570 (825)
.-.+.|+.|....+|+....+..+++|+.... .. .. .+..|+.++..|...+ +.+++... ....+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~---~~---~~----~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~-- 91 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKR---VE---KN----DLPFFLGLMQHLAAKGLSCPLPLPRK-DGELL-- 91 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC---------CC----HHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSC--
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCC---CC---HH----HHHHHHHHHHHHHHCCCCCCcccCCC-CCCEE--
Confidence 44677888999999999887668999986421 01 11 2256777777764212 23333211 00000
Q ss_pred CCCCCccccceEEEEEcccCCCCHH-----------HHH---HHhhcc-CCC---ccC---HHHHHH------------H
Q 003375 571 ADGNPEHHLLQSAIFMEYVKGGSVK-----------NYI---EKLSET-GEK---HVS---VKLALF------------I 617 (825)
Q Consensus 571 ~~~~~~~~~~~~~LVmEy~~gGSL~-----------~~L---~~~~~~-~~~---~ls---~~~i~~------------I 617 (825)
.......++||+|++|..+. ..+ +..... ... ... +...+. +
T Consensus 92 -----~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 92 -----GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp -----EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred -----EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 00012358999999975421 111 111000 000 011 111000 0
Q ss_pred HHHHHHHHHHHHh-------CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 618 AQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 618 a~QIa~AL~yLHs-------~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
...+...+.+++. .+++|+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-------ELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-------ceEEEecchhcc
Confidence 0123444555552 369999999999999865 235799999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.022 Score=59.80 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=50.8
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC---CCcceeeeeEecCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH---SCIVEMYGHKISSKW 567 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H---PNIV~l~g~~~~~~~ 567 (825)
..-.+.+|.|..+.||+.+. .++.+++|+..-.. .. .. ..+..|+..|+.|.- --+.+++++. .
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~--~~----~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~-- 84 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PA--LD----GLFRAEALGLDWLGRSFGSPVPQVAGWD--D-- 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CC--CT----THHHHHHHHHHHHTCSTTCCSCCEEEEE--T--
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cc--hh----hHHHHHHHHHHHHHhhCCCCcceEEecc--C--
Confidence 45578899999999999997 56789999743221 11 11 123789999988852 2345555542 1
Q ss_pred CCCCCCCCccccceEEEEEcccCCCC
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
.++||||++++.
T Consensus 85 --------------~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 --------------RTLAMEWVDERP 96 (288)
T ss_dssp --------------TEEEEECCCCCC
T ss_pred --------------ceEEEEeecccC
Confidence 189999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.26 E-value=0.037 Score=56.82 Aligned_cols=100 Identities=15% Similarity=0.100 Sum_probs=63.5
Q ss_pred CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 592 GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLH-s~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
-||.+.|..+ +.+++++++|.++.|.+.+|.-+- .+.-..+=+.|..|+|..+|. |.+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-------V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-------VTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-------EEECC-C------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-------eeccc-cccc---
Confidence 3899999873 478999999999999999988762 112123334468888888743 54442 1110
Q ss_pred ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 003375 671 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 730 (825)
Q Consensus 671 ~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~ 730 (825)
.....+.|||... ...+.+.=|||||++||.-+--.
T Consensus 98 -------------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -------------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -------------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcC
Confidence 1223466888763 24578999999999999988633
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.011 Score=64.57 Aligned_cols=72 Identities=10% Similarity=0.180 Sum_probs=42.3
Q ss_pred eeeecccCceEEEEEEECC----------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCC-cceeeeeEe
Q 003375 495 CDEAGKSVSSSLFRCKFGS----------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKI 563 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~----------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPN-IV~l~g~~~ 563 (825)
.+.|+.|....+|++...+ ..+++|+.... ..... ....|..+++.|...+ +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~----~~~~E~~~l~~L~~~g~~P~~~~~~- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-----VDELY----NTISEFEVYKTMSKYKIAPQLLNTF- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-----GGGTS----CHHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-----cccee----cHHHHHHHHHHHHhcCCCCceEEec-
Confidence 5677888889999998754 57888874321 11111 1156888888775333 44666543
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
.+ ++||||++|.+
T Consensus 108 -~~----------------~~v~e~i~G~~ 120 (369)
T 3c5i_A 108 -NG----------------GRIEEWLYGDP 120 (369)
T ss_dssp -TT----------------EEEEECCCSEE
T ss_pred -CC----------------cEEEEEecCCc
Confidence 11 78999998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.046 Score=62.08 Aligned_cols=72 Identities=17% Similarity=0.125 Sum_probs=46.7
Q ss_pred eeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc-ceeeeeEecCCCCCCC
Q 003375 495 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSA 571 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~~--~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI-V~l~g~~~~~~~~~~~ 571 (825)
.+.|+.|-...+|++...+ ..+++|+..... . ..+. . .+|..+++.|...+| .++++.+. +
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~---~~id-R----~~E~~vl~~L~~~gl~P~ll~~~~--~----- 176 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D---EIIN-R----EREKKISCILYNKNIAKKIYVFFT--N----- 176 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C---SCSC-H----HHHHHHHHHHTTSSSBCCEEEEET--T-----
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h---hhcC-H----HHHHHHHHHHHhcCCCCCEEEEeC--C-----
Confidence 5678889999999999876 788999863211 0 0000 0 578899998875444 46676652 1
Q ss_pred CCCCccccceEEEEEcccCCCC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGS 593 (825)
++||||++|.+
T Consensus 177 -----------G~v~e~I~G~~ 187 (458)
T 2qg7_A 177 -----------GRIEEFMDGYA 187 (458)
T ss_dssp -----------EEEEECCCSEE
T ss_pred -----------eEEEEeeCCcc
Confidence 56999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.033 Score=62.49 Aligned_cols=71 Identities=15% Similarity=0.258 Sum_probs=46.6
Q ss_pred eeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCc-ceeeeeEe
Q 003375 494 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKI 563 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNI-V~l~g~~~ 563 (825)
-.+.|+.|-...||++... +..+++|+.... .. ...+ .+|+.+++.|...+| .++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~l----i~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHL----VAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHH----HHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHH----HHHHHHHHHHHhCCCCCcEEEEeC
Confidence 3567888999999999874 367888886311 11 0222 568888888853333 56666542
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGG 592 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gG 592 (825)
+ ++||||++|.
T Consensus 147 --~----------------g~v~e~l~G~ 157 (429)
T 1nw1_A 147 --G----------------GRLEEYIPSR 157 (429)
T ss_dssp --T----------------EEEECCCCEE
T ss_pred --C----------------CEEEEEeCCc
Confidence 1 5899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.57 E-value=0.029 Score=62.11 Aligned_cols=144 Identities=18% Similarity=0.225 Sum_probs=78.4
Q ss_pred eeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 495 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
.+.|..|-...+|++... +..+++++.. .... .... +.+|..+++.|. +.-..++++.+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g--~~~~---~~~~----~~rE~~vl~~L~~~gv~P~ll~~~~- 124 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG--AILQ---GVDS----LVLESVMFAILAERSLGPQLYGVFP- 124 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHHH----HHHHHHHHHHHHHTTSSCCEEEEET-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC--Cccc---hHHH----HHHHHHHHHHHHhcCCCCeEEEEcC-
Confidence 356777888899998873 3578888731 1111 1122 268988888885 322356666542
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHH--------------HHHHHhhccC---CCccC--HHHHHHHHHHHHH--
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSETG---EKHVS--VKLALFIAQDVAA-- 623 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~--------------~~L~~~~~~~---~~~ls--~~~i~~Ia~QIa~-- 623 (825)
+ .+||||++|.+|. +.|.+.-... ..... +..+.++..++..
T Consensus 125 -~----------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~ 187 (379)
T 3feg_A 125 -E----------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLP 187 (379)
T ss_dssp -T----------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCC
T ss_pred -C----------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhcc
Confidence 1 4899999975432 1122111110 11122 3555556554422
Q ss_pred -----------------HHHHHH----h----CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 624 -----------------ALVELH----S----KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 624 -----------------AL~yLH----s----~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
.+..|. . ..++|+|+.+.|||++.+.. ....+.|+||..+..
T Consensus 188 ~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~---~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 188 PTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPE---NADSLMLVDFEYSSY 254 (379)
T ss_dssp CCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC------CCEEECCCTTCEE
T ss_pred CcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCC---ccCcEEEEecccCCc
Confidence 233332 2 25899999999999986511 113589999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.058 Score=57.23 Aligned_cols=29 Identities=28% Similarity=0.287 Sum_probs=24.3
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--------~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--------GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--------SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--------CCEEEECCCCCc
Confidence 4689999999999997 3 289999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.52 E-value=0.14 Score=55.43 Aligned_cols=33 Identities=24% Similarity=0.414 Sum_probs=26.9
Q ss_pred CCccccCCCCCCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 631 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 631 ~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
..++|+|+.+.|||++.++ .+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-------~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-------SIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-------CEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCC-------eEEEEECCCCeeCC
Confidence 3699999999999998653 48999998876543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.17 E-value=0.57 Score=52.56 Aligned_cols=73 Identities=10% Similarity=0.088 Sum_probs=46.3
Q ss_pred eeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 003375 494 SCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 563 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~ 563 (825)
-.+.|..|-...+|+.... +..+++++..... ...+ ...+|..+++.|. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~i-----dR~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFY-----DSKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCC-----CHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhc-----CHHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 3566778888999999886 5778888743211 1101 1157888888875 322345565331
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCC
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
+ ++||||++|.+
T Consensus 145 --~----------------~~I~efI~G~~ 156 (424)
T 3mes_A 145 --E----------------GRIEEFIDGEP 156 (424)
T ss_dssp --T----------------EEEEECCCSEE
T ss_pred --C----------------CEEEEEeCCcc
Confidence 1 78999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.23 E-value=1.9 Score=47.51 Aligned_cols=35 Identities=29% Similarity=0.357 Sum_probs=25.9
Q ss_pred ccccCCCCCCEEEecCccCCCCCCeEEEeecCCccc
Q 003375 633 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 668 (825)
Q Consensus 633 IVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~ 668 (825)
++|+|+.+.|||+..+.. ......+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcc-cCcCCeEEEechHhccC
Confidence 679999999999965321 11235699999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 825 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-42
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 738
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 798
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 799 NPTERPTAGDLYEMF 813
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 737
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 798 ENPTERPTAGDLYE 811
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 634
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 745
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 746 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 798
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 799 NPTERPTAGDL 809
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-37
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 619 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 673
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 674 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 733
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 734 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 794 RCTEENPTERPTAGDLYE 811
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 67/317 (21%), Positives = 116/317 (36%), Gaps = 73/317 (23%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 619 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 675
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 676 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 735
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 736 L-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 794
+ +I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 795 CTEENPTERPTAGDLYE 811
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 723 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 782 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 4e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 574
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 575 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 634
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 695 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 752
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 753 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 819
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-35
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 756
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 783 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 811
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 783 ETLS-FLVDVFRRCTEENPTERPTAGDL 809
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 527 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 586
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 707 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 765
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 766 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 7e-34
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 783 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 824
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 1e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 512 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 631
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 691
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 692 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 750
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 751 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 811 EMF--VARTSSSISS 823
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 758
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-33
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 527 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 586
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 707 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 766
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 583 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 700
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 701 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 758
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 761
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 762 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 737
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 798 ENPTERPTAGDLYEMF 813
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 737
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 798 ENPTERPTAGDLYEMF 813
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 5e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 528 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 587
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 588 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 628
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 629 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 688
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 689 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 747
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 748 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 808 DLYEMF 813
++ +
Sbjct: 291 SIHRIL 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 7e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 761
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 762 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-32
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 809
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 546 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 605
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 606 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 665
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 666 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 785
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 786 SF-LVDVFRRCTEENPTERPTAGDL 809
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 783 ETLSF---LVDVFRRCTEENPTERPTAGDL 809
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-31
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 738
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 739 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 797
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 798 ENPTERPTAGDLYE 811
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 2e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 531 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 590
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 591 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 711 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 770
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 771 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 809
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 88/348 (25%)
Query: 486 PGSFPSLSSCD-----EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEY 538
P +P L D G+ + + + A ++ +K +S D+ R+F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDF-- 57
Query: 539 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597
GE+ +L L H I+ + G +L + +EY G++ ++
Sbjct: 58 --AGELEVLCKLGHHPNIINLLGACEHRGYL--------------YLAIEYAPHGNLLDF 101
Query: 598 IEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
+ K ++ + +S + L A DVA + L K +HRD+ + NIL+
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
V K+ DF + ++ RWMA E L
Sbjct: 162 -------ENYVAKIADFGLSRGQEVYVKKTM-----------GRLPVRWMAIESLNYSV- 202
Query: 707 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 765
Y D+WSYG LL E+++L PY G++ E+++ + G R +
Sbjct: 203 ---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD------- 252
Query: 766 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+ D+ R+C E P ERP+ +
Sbjct: 253 --------------------DEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 528 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 587
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 588 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 708 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 767
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 768 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 809
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 516 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 575
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 754
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 755 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 8e-30
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 763 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 814
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 528 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 587
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 588 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 708 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 766
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 824
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 543 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 599
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 600 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 650
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 651 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 710
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 711 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 769
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 770 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 818
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 639
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 640 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 699
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 700 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 758
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 759 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-29
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 576
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 577 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 636
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 637 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 696
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 697 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 756
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 757 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 811
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 1e-28
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 783 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 527 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 586
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 587 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 706
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 707 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 765
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 766 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 543 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 600
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 601 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 761
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 762 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 783 ETLSFLVDVFRRCTEENPTERPTA 806
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 723 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 782 LETLSFLVDVFRRCTEENPTERPTAGDL 809
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (281), Expect = 6e-28
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 584 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 703
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 704 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 763
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 764 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 9e-28
Identities = 54/300 (18%), Positives = 104/300 (34%), Gaps = 71/300 (23%)
Query: 520 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 579
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 580 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 634
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 694
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 695 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 753
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 754 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
D P+ L ++ R C + NP RP+ ++
Sbjct: 257 PDNC--------------------PDM-------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 5e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 534 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 593
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 594 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 654 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 713
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 714 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 773
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 774 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 809
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 723 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 781
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 782 LETLSFLVDVFRRCTEENPTERPTAGDL 809
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 543 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 600
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 601 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 709 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 766
Y E D+WSYG L EL +L ++ + +I+ G R
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--------------- 267
Query: 767 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 813
PE + D+ + C + +P +RPT + ++
Sbjct: 268 ---------LSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 9e-26
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 759
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 760 L 760
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 532 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 591
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 592 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 712 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 771
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 772 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 809
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 3e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 783 ETLSFLVDVFRRCTEENPTERPTAG 807
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 781
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 782 -LETLS-FLVDVFRRCTEENPTERPTAGDL 809
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-25
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 543 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 599
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 600 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 659
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 720 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 811
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 762
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 763 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 783 ETLSF---LVDVFRRCTEENPTERPTAGDL 809
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 499 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 558
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 618
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 619 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 678
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 679 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 737
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 738 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 796
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 797 EENPTERPTAGDL 809
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (253), Expect = 5e-24
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 543 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 601
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 602 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 661
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 662 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 722 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 780 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 809
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 7e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 517 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 575
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 576 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 635
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 636 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 695
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 696 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 755
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 756 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 8e-23
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 600
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 601 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 712 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 769
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 770 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 812
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 9e-22
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 543 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 602
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 603 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 662
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 663 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 782
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 783 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 809
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.7 bits (232), Expect = 3e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 523 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 582
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 583 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 702
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 703 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 751
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 3e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 543 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 600
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 601 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 659
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 660 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 719
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 720 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 760
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 761 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 809
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.1 bits (137), Expect = 8e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 534 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 593
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 594 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 653
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 654 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 708
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 709 LYGLEVDIWSYGCLLLE 725
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.9 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=433.58 Aligned_cols=268 Identities=24% Similarity=0.377 Sum_probs=210.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
++.++|++.+.||+|+||.||+|++++ .||||+++.. .......+.| .+|+.+|++++|||||++++++...
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~--~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~- 76 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP- 76 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCS--SCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcc--cCCHHHHHHH----HHHHHHHHhCCCCCEeeeeEEEecc-
Confidence 456789999999999999999999765 5999985433 3333444455 9999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.++||||||+||+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 77 --------------~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~ 138 (276)
T d1uwha_ 77 --------------QLAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138 (276)
T ss_dssp --------------SCEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --------------EEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc
Confidence 24999999999999999975 235699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+........ .......||+.|||||++.+.. ...++.++|||||||+||||
T Consensus 139 ~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 139 ED-------LTVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp TT-------SSEEECCCCCSCC--------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccccceeeccccCCc--------ccccccccCcccCCHHHHhccc-CCCCCchhhhhhhHHHHHHH
Confidence 77 46999999999876432211 1123457999999999997522 24589999999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHcCCCC-CchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPYMGLSEL-EIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF~~~~~~-~i~~~I~~~~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+||+.||.+.+.. .+...+..+..+ .+.. ....+++.+.+||.+||+.||.+||
T Consensus 203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSK------------------------VRSNCPKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG------------------------SCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCcchh------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 9999999887654 444555554322 2111 1122456899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 003375 805 TAGDLYEMFVARTSSS 820 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss 820 (825)
|+.+|+++|+.+..+.
T Consensus 259 t~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 259 LFPQILASIELLARSL 274 (276)
T ss_dssp CHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHHHHHcC
Confidence 9999999999887643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=429.25 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=213.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.+++|++.+.||+|+||.||+|++ ++..||+|++.... .........+.+|+.+|++++|||||++++++.+.
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 467899999999999999999998 46789999875321 11122334568999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. .|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 79 ~~--------------~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 TR--------------VYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEeecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 54 4999999999999999986 2569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+...... .....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 140 ~~~-------~~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSA-------GELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTT-------SCEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEeecccceeeecCCCc------------ccccCCCCcccCHHHHcC----CCCCchhhhhhHhHHHHH
Confidence 877 459999999997654321 123469999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||.+.+..++...+.+... .+++ ..++.+.+||.+||+.||.+|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEF-TFPD---------------------------FVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHhHCcC
Confidence 9999999999988888887766532 1221 13557899999999999999999
Q ss_pred HHHHHHHHHhh
Q 003375 806 AGDLYEMFVAR 816 (825)
Q Consensus 806 a~EIL~hL~~l 816 (825)
++|+++|.+-.
T Consensus 249 ~~eil~hp~~~ 259 (263)
T d2j4za1 249 LREVLEHPWIT 259 (263)
T ss_dssp HHHHHTCHHHH
T ss_pred HHHHHcCcCcC
Confidence 99999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=432.25 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=204.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|++ ++..||+|++... .......+. +.+|+.+|++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT--TSCHHHHHH----HHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChh--hCCHHHHHH----HHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 36899999999999999999998 4678999986543 333344444 499999999999999999999987533
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCC
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 641 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g-----IVHrDLKP~ 641 (825)
. ..+|||||||+||+|.+++...... ...+++..++.++.||+.||.|||++| ||||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 2 1369999999999999999764333 357999999999999999999999976 999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
||||+.+ +.+||+|||+|+.+...... .....||+.|||||++.+ ..++.++|||||||
T Consensus 144 NIll~~~-------~~vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTT-------SCEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred hcCcCCC-------CcEEEeeccceeecccCCCc----------cccCCCCcccCCHHHHcC----CCCChHHHHHhhCH
Confidence 9999877 45999999999876542211 234579999999999976 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 003375 722 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 801 (825)
Q Consensus 722 ILyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~ 801 (825)
+||||+||+.||.+.+..++...+..+..+.++. ..++.+.+||.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCChh
Confidence 9999999999999999988888887775544432 1245799999999999999
Q ss_pred CCCCHHHHHHHH
Q 003375 802 ERPTAGDLYEMF 813 (825)
Q Consensus 802 eRPSa~EIL~hL 813 (825)
+|||++||++|.
T Consensus 256 ~Rps~~ell~hp 267 (269)
T d2java1 256 HRPSVEEILENP 267 (269)
T ss_dssp GSCCHHHHHTST
T ss_pred HCcCHHHHHhCC
Confidence 999999999884
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=431.09 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=212.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+|++.+.||+|+||.||+|.+ .+..||+|++...... ..+ .+.+|+.+|++++|||||++++++.+.+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKE----LIINEILVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHH----HHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHH----HHHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence 5799999999999999999997 5789999997654321 122 34899999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 92 --------------~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 92 --------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp --------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 4999999999999998875 46999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+|+.+...... ....+||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 152 ~-------~~vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyeml 210 (293)
T d1yhwa1 152 D-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMI 210 (293)
T ss_dssp T-------CCEEECCCTTCEECCSTTCC----------BCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEeeccchhheeecccccc----------ccccccCCCccChhhhcC----CCCCchhceehHhHHHHHHh
Confidence 7 45999999999876432211 234579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
||+.||.+.+..+....+.....+.+. .+...++.+.+||.+||+.||.+|||+.
T Consensus 211 tG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 211 EGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp HSSCTTTTSCHHHHHHHHHHHCSCCCS-------------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------CcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999988877776666554333222 1122456899999999999999999999
Q ss_pred HHHHHHHhhcC
Q 003375 808 DLYEMFVARTS 818 (825)
Q Consensus 808 EIL~hL~~l~s 818 (825)
|+++|-+....
T Consensus 266 eil~Hp~~~~~ 276 (293)
T d1yhwa1 266 ELLQHQFLKIA 276 (293)
T ss_dssp HHTTCGGGGGC
T ss_pred HHhcCHhhCCC
Confidence 99999765443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-50 Score=428.99 Aligned_cols=270 Identities=20% Similarity=0.328 Sum_probs=207.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
+...+|++.+.||+|+||.||+|.+. +..++|+++.+... ......+.| .+|+.+|++|+|||||+++|++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCCccEEEEEe
Confidence 44678999999999999999999973 22333443334322 233334444 99999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
..+.+ +||||||++|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 98 ~~~~~--------------~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 98 KSTPV--------------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159 (299)
T ss_dssp SSSSC--------------EEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eCCEE--------------EEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceE
Confidence 76644 999999999999999875 235689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +++||+|||+|+.+........ ........||+.|||||++.+ ..++.++|||||||+|
T Consensus 160 Ll~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 160 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVM 223 (299)
T ss_dssp EECTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CcEEECCcccceEccCCCCcce-----eeecccccCCccccCHHHHhc----CCCCcccccccchHHH
Confidence 99877 5699999999987654322111 011122458999999999986 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||+| |++||.+.+..++...+..+.++..+. ..++.+.+||.+||+.||.+
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM---------------------------DCPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhH
Confidence 99998 899999999988888888775544331 23567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCC
Q 003375 803 RPTAGDLYEMFVARTSSSIS 822 (825)
Q Consensus 803 RPSa~EIL~hL~~l~sss~S 822 (825)
|||+.||+++|+.+...+.+
T Consensus 277 RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 277 RPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp SCCHHHHHHHHHHHHHSGGG
T ss_pred CcCHHHHHHHHHHHhcChhh
Confidence 99999999999988765443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=419.71 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=205.0
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
-.+|++.+.||+|+||.||+|++ ++..||||++. ..... .+. +.+|+.++++++|||||+++|++...+.
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~--~~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECC--SSSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEEC--CCcCc---HHH----HHHHHHHHHhcCCCCcccccceeccCCc
Confidence 35799999999999999999998 46679999853 22222 223 4899999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+ +|||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+++|+||||||+||||+.
T Consensus 75 ~--------------~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 75 I--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp C--------------EEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred e--------------EEEEEecCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC
Confidence 4 999999999999999875 2356889999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++........ ......||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 137 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 137 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp G-------GCEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCeEecccchheeccCCCce---------eecceecCcccCChHHhcC----CCCCchhhhcchHHHHHHHH
Confidence 7 45999999999876543221 1123468999999999986 67899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 T-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
| |.+||...+..++...+..+.++..+.. .++.+.+||.+||+.||.+|||+
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~Rps~ 249 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTGFRLYKPRL---------------------------ASTHVYQIMNHCWKERPEDRPAF 249 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHhcCCCCCccc---------------------------cCHHHHHHHHHHccCCHhHCcCH
Confidence 9 5777888888888888887755444321 24578999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 003375 807 GDLYEMFVARTS 818 (825)
Q Consensus 807 ~EIL~hL~~l~s 818 (825)
+||+++|+.+..
T Consensus 250 ~~il~~L~~i~e 261 (263)
T d1sm2a_ 250 SRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=427.91 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=213.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.|++++.||+|+||.||+|++ ++..||+|++... .....+.+ .+|+.+|++|+|||||++++++.+.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHH----HHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 4689999999999999999998 5678999986532 22334444 899999999999999999999987664
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
.|||||||+||+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 84 --------------~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 84 --------------LWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp --------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 49999999999999998752 356999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~-~~~~~s~kSDVWSLGvILyEL 726 (825)
+ +.+||+|||+|+........ .....||+.|||||++.... ....++.++|||||||+||||
T Consensus 146 ~-------~~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 146 D-------GDIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp T-------SCEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEechhhhccCCCccc----------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 7 45999999999766432211 12346999999999996432 235688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+||++||.+.+..++...+.....+.+.. ....++.+.+||.+||+.||.+|||+
T Consensus 209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------------------cccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999998888888877765443321 12245689999999999999999999
Q ss_pred HHHHHHHHh
Q 003375 807 GDLYEMFVA 815 (825)
Q Consensus 807 ~EIL~hL~~ 815 (825)
.|+++|.+-
T Consensus 264 ~ell~hp~~ 272 (288)
T d2jfla1 264 SQLLQHPFV 272 (288)
T ss_dssp HHHTTSGGG
T ss_pred HHHhcCccc
Confidence 999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=427.23 Aligned_cols=257 Identities=25% Similarity=0.290 Sum_probs=203.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++.+.||+|+||.||+|++ ++..||+|++..+.. .... +.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~----~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCP----ENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHH----HHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 57899999999999999999998 477899999764321 1122 24489999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 77 ~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 77 I--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp E--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred e--------------eEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 4 4999999999999999864 45799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+.+....... .....+||+.|||||++.+ ...++.++|||||||+||||
T Consensus 138 ~~-------~~~KL~DFG~a~~~~~~~~~~--------~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilyem 199 (271)
T d1nvra_ 138 ER-------DNLKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 199 (271)
T ss_dssp TT-------CCEEECCCTTCEECEETTEEC--------CBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccchhheeeccCCccc--------cccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHHH
Confidence 77 459999999998765432111 1234579999999999986 22346889999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LTG~~PF~~~~~~~-i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+||++||....... ....+..... .. ......++.+.+||.+||+.||.+|||
T Consensus 200 l~G~~pf~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 200 LAGELPWDQPSDSCQEYSDWKEKKT-YL-------------------------NPWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp HHSSCSCSSSSTTSHHHHHHHTTCT-TS-------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCC-CC-------------------------CccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999997654332 2222222211 10 011234567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
++|+++|.+.
T Consensus 254 ~~eil~hpwf 263 (271)
T d1nvra_ 254 IPDIKKDRWY 263 (271)
T ss_dssp HHHHTTCTTT
T ss_pred HHHHhcCHhh
Confidence 9999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=422.51 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=215.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++++.||+|+||.||+|++ .+..||||++.......... ....+.+.+|+.+|++|+|||||++++++.+...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4699999999999999999998 47789999976443222111 1122345899999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 --------------~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 88 --------------VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp --------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred --------------EEEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 4999999999999999986 256999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
++. ....+||+|||+|........ .....||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 149 ~~~---~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SSS---SSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CCC---cccceEecchhhhhhcCCCcc-----------ccccCCCCcccCHHHHcC----CCCCCcccchhhhHHHHHHH
Confidence 642 234699999999987654221 133469999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|+.||.+.+..+....+.......... .....++.+.+||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDE------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHH------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCch------------------------hcCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999999888888887764322111 1123456799999999999999999999
Q ss_pred HHHHHHHh
Q 003375 808 DLYEMFVA 815 (825)
Q Consensus 808 EIL~hL~~ 815 (825)
|+++|-+-
T Consensus 267 eil~hp~~ 274 (293)
T d1jksa_ 267 DSLQHPWI 274 (293)
T ss_dssp HHHHSTTT
T ss_pred HHhcCccc
Confidence 99998543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-49 Score=422.32 Aligned_cols=260 Identities=21% Similarity=0.373 Sum_probs=214.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
++.++|++.+.||+|+||.||+|.+ .+..||||++. .... ..+. +.+|+.+|++++|||||++++++.+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~--~~~~---~~~~----~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECC--TTCS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEEC--Cccc---hHHH----HHHHHHHHHhCCCCCEecCCccEee
Confidence 4557899999999999999999998 46789999853 2211 2233 4899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+.+ |||||||++|+|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 85 ~~~~--------------~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL 147 (287)
T d1opja_ 85 EPPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147 (287)
T ss_dssp SSSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CCee--------------EEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence 6654 999999999999999976 33467899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+|+......... .....||+.|||||++.+ ..++.++|||||||+||
T Consensus 148 l~~~-------~~~Kl~DFG~a~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~ 207 (287)
T d1opja_ 148 VGEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 207 (287)
T ss_dssp ECGG-------GCEEECCCCCTTTCCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEEccccceeecCCCCcee---------eccccccccccChHHHcC----CCCCchhhhhhHHHHHH
Confidence 9987 469999999998765432221 123358999999999987 67899999999999999
Q ss_pred HHHhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLTG~~P-F~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||++|..| |.+.+..++...+..+.++.++. ..++.+.+||.+||+.||.+|
T Consensus 208 ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~R 260 (287)
T d1opja_ 208 EIATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDR 260 (287)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHC
Confidence 99996555 56667777777776665544432 124579999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 003375 804 PTAGDLYEMFVARTSS 819 (825)
Q Consensus 804 PSa~EIL~hL~~l~ss 819 (825)
||+.+|++.|+.+...
T Consensus 261 ps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 261 PSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCHHHHHHHHHHTTSS
T ss_pred cCHHHHHHHHHHHHHh
Confidence 9999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-49 Score=426.14 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=210.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
.|++++.||+|+||.||+|++ ++..||||++..... ...... +.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~- 89 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKW----QDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHH----HHHHHHHHHHTTCCCTTBCCEEEEEEETTE-
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHH----HHHHHHHHHHHHCCCCCEeeEEEEEEECCE-
Confidence 489999999999999999997 577899998653321 122222 345999999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
.|||||||.+|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+
T Consensus 90 -------------~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 90 -------------AWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp -------------EEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred -------------EEEEEEecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC
Confidence 4999999999999877665 3579999999999999999999999999999999999999977
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||+|...... ....||+.|||||++.+.. ...|+.++|||||||+||||++
T Consensus 152 -------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 152 -------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp -------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEeecccccccCCC--------------CccccCccccCHHHHhccC-CCCcCchhhhhhHHHHHHHHHH
Confidence 56999999999765431 2346999999999997532 2468899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 808 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~E 808 (825)
|..||.+.+..+....+.....+.+.. ...++.+.+||.+||+.||.+|||++|
T Consensus 210 g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 210 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCC--------------------------CCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999999988888777777665443321 113567999999999999999999999
Q ss_pred HHHHHHhhc
Q 003375 809 LYEMFVART 817 (825)
Q Consensus 809 IL~hL~~l~ 817 (825)
+++|.+-..
T Consensus 264 ll~Hp~~~~ 272 (309)
T d1u5ra_ 264 LLKHRFVLR 272 (309)
T ss_dssp HTTCHHHHS
T ss_pred HHhCHHhcC
Confidence 999865443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=417.96 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=211.7
Q ss_pred CCceeeee-ecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 490 PSLSSCDE-AGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 490 ~~y~i~~~-LG~G~fG~Vy~a~~----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
++|.+.+. ||+|+||.||+|.+ ++..||||++... ......+.| .+|+.+|++++|||||+++|++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~----~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHH----HHHHHHHHhCCCCCEeeEeeeecc
Confidence 46778884 99999999999986 2446888885422 233334444 999999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+. +|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 81 ~~---------------~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 EA---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp SS---------------EEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred Ce---------------EEEEEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 32 4999999999999999864 2356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+++.+........ ......||+.|||||++.+ ..++.++|||||||+||
T Consensus 142 l~~~-------~~~Kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 142 LVNR-------HYAKISDFGLSKALGADDSYYT-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEEC-------CCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred eccC-------Cceeeccchhhhcccccccccc-------cccccccCccccChHHHhC----CCCCccchhhcchHHHH
Confidence 9987 5699999999987754332211 1233468999999999987 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 725 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 725 ELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
||+| |+.||.+.+..++...+..+.++.++.. .++.+.+||.+||+.||.+|
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---------------------------CPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc---------------------------CCHHHHHHHHHHcCCCHhHC
Confidence 9998 8999999988888888888766554421 35579999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 003375 804 PTAGDLYEMFVART 817 (825)
Q Consensus 804 PSa~EIL~hL~~l~ 817 (825)
||+.+|++.|+...
T Consensus 257 Ps~~~i~~~L~~~~ 270 (285)
T d1u59a_ 257 PDFLTVEQRMRACY 270 (285)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999998887543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=416.66 Aligned_cols=250 Identities=21% Similarity=0.327 Sum_probs=204.1
Q ss_pred eeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 496 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 496 ~~LG~G~fG~Vy~a~~~----~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
++||+|+||.||+|.+. +..||||+++.. .......+ .+.+|+.+|++++|||||+++|++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~----~~~~E~~il~~l~HpnIv~~~g~~~~~~----- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAES----- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEESSS-----
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh--hCCHHHHH----HHHHHHHHHHhCCCCCCceEEEEeccCC-----
Confidence 47999999999999863 356899986432 22222233 4599999999999999999999986432
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
.+|||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 82 ----------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--- 143 (277)
T d1xbba_ 82 ----------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 143 (277)
T ss_dssp ----------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---
T ss_pred ----------EEEEEEcCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---
Confidence 4899999999999999986 4569999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 730 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT-G~ 730 (825)
+.+||+|||+++.+........ ......||+.|||||++.+ ..++.++|||||||++|||+| |+
T Consensus 144 ----~~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 144 ----HYAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ----TEEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ----Ccccccchhhhhhccccccccc-------cccccCCCceecCchhhcC----CCCCchhhhccchhhhhHHhhCCC
Confidence 5699999999987654322211 1123468999999999987 668999999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003375 731 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 810 (825)
Q Consensus 731 ~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL 810 (825)
+||.+.+..++...+..+.++.++.. .++.+.+||.+||+.||.+|||+++|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPAG---------------------------CPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------cCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 99999999888888888766554421 245799999999999999999999998
Q ss_pred HHHHhh
Q 003375 811 EMFVAR 816 (825)
Q Consensus 811 ~hL~~l 816 (825)
+.|+..
T Consensus 262 ~~L~~~ 267 (277)
T d1xbba_ 262 LRLRNY 267 (277)
T ss_dssp HHHHHH
T ss_pred HHhhCH
Confidence 877654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-48 Score=429.57 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=214.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
-+++|++++.||+|+||.||+|++ .+..||||++... .....+ .+.+|+.+|++|+|||||++++++.+.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE----TVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHH----HHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHH----HHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 367999999999999999999998 5789999986432 222333 348999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. +|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 96 ~~--------------~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll 157 (350)
T d1koaa2 96 NE--------------MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157 (350)
T ss_dssp TE--------------EEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeee
Confidence 64 4999999999999999864 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+. .+.+||+|||+|+.+...... ....||+.|||||++.+ ..++.++|||||||++||
T Consensus 158 ~~~~-----~~~vkL~DFG~a~~~~~~~~~-----------~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilye 217 (350)
T d1koaa2 158 TTKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYI 217 (350)
T ss_dssp SSTT-----SCCEEECCCTTCEECCTTSCE-----------EEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHH
T ss_pred ccCC-----CCeEEEeecchheeccccccc-----------ceecCcccccCHHHHcC----CCCChhHhhhhhhHHHHH
Confidence 7542 257999999999876543221 23579999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|+.||.+.+..+++..+......... ......++.+.+||.+||+.||.+|||
T Consensus 218 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 218 LLSGLSPFGGENDDETLRNVKSCDWNMDD------------------------SAFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCC------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------------------ccccCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999988888888765332111 111234568999999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
++|+++|-+-
T Consensus 274 ~~eil~hp~~ 283 (350)
T d1koaa2 274 IHQALEHPWL 283 (350)
T ss_dssp HHHHHHSTTT
T ss_pred HHHHhcCccc
Confidence 9999999543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=410.21 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=213.7
Q ss_pred CCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
++|++.++||+|+||.||+|+++ +..||||+.+... .. .+. +.+|+.++++++|||||+++|++.+.+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~---~~~----~~~Ev~~~~~l~HpnIv~~~g~~~~~~~- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MS---EDE----FIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SC---HHH----HHHHHHHHHTCCCTTBCCEEEEECCSSS-
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CC---HHH----HHHHHHHHHhcCCCceeeEEEEEeeCCc-
Confidence 57899999999999999999994 5689999865332 22 223 4899999999999999999999986654
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
+++||||+++|+|..++.. ....+++..++.|+.||++||+|||++||+||||||+|||++.+
T Consensus 74 -------------~~iv~Ey~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~ 136 (258)
T d1k2pa_ 74 -------------IFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 136 (258)
T ss_dssp -------------EEEEEECCTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT
T ss_pred -------------eEEEEEccCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC
Confidence 4999999999999999875 23568899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 137 -------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 137 -------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp -------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHHT
T ss_pred -------CcEEECcchhheeccCCCce---------eecccCCCCCcCCcHHhcC----CCCCcceeecccchhhHhHHh
Confidence 56999999999876543221 1223469999999999987 678999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 -G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|+.||.+.+..++...+..+.++..+.. .++.+.+||.+||+.||.+|||++
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQGLRLYRPHL---------------------------ASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhCCCCCCccc---------------------------ccHHHHHHHHHHccCCHhHCcCHH
Confidence 8999999999999888887765544421 245799999999999999999999
Q ss_pred HHHHHHHhh
Q 003375 808 DLYEMFVAR 816 (825)
Q Consensus 808 EIL~hL~~l 816 (825)
+|++||..+
T Consensus 250 eil~~L~di 258 (258)
T d1k2pa_ 250 ILLSNILDV 258 (258)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHhhCC
Confidence 999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=418.31 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=212.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
++.++|++.+.||+|+||.||+|.++ +..||||++... .. ..+. +.+|+.+|++++|||||+++|++...
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~---~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~ 80 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SM---SPDA----FLAEANLMKQLQHQRLVRLYAVVTQE 80 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cC---CHHH----HHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 45678999999999999999999985 578999986422 11 1223 49999999999999999999987543
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. .+|||||+++|+|.+++... ....+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 81 ~---------------~~iv~Ey~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll 142 (272)
T d1qpca_ 81 P---------------IYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (272)
T ss_dssp S---------------CEEEEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C---------------eEEEEEeCCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee
Confidence 2 38999999999999987642 12358999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+.+...... ......||+.|||||++.+ ..++.++|||||||+|||
T Consensus 143 ~~~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~e 202 (272)
T d1qpca_ 143 SDT-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 202 (272)
T ss_dssp CTT-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHH
T ss_pred ecc-------cceeeccccceEEccCCccc---------cccccCCcccccChHHHhC----CCCCchhhhhhhHHHHHH
Confidence 877 56999999999877543211 1233468999999999986 668999999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+|| .+||...+..++...+..+.++..+. ..++.+.+||.+||+.||.+||
T Consensus 203 llt~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 203 IVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------cChHHHHHHHHHHcCCCHhHCc
Confidence 9995 56667777888888887776554442 1245799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 003375 805 TAGDLYEMFVARTSS 819 (825)
Q Consensus 805 Sa~EIL~hL~~l~ss 819 (825)
|+++|++.|+.+.++
T Consensus 256 t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 256 TFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhhhhc
Confidence 999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-49 Score=424.21 Aligned_cols=258 Identities=22% Similarity=0.205 Sum_probs=199.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+.|++.+.||+|+||.||+|++ .+..||||++...... ... ..+.+|+.+|++++|||||++++++.+.+.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKE----GSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4599999999999999999998 4778999997543221 111 234899999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
+|||||||+||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||+..
T Consensus 82 --------------~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 82 --------------LYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp --------------EEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred --------------EEEEEeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 4999999999999999975 457999999999999999999999999999999999999975
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
.. ..+.+||+|||+|+....... ....+||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 143 ~~----~~~~vkl~DFG~a~~~~~~~~-----------~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 143 LD----EDSKIMISDFGLSKMEDPGSV-----------LSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp SS----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred cC----CCceEEEeccceeEEccCCCe-----------eeeeeeCccccCcHHHcC----CCCCcHHHhhhhhHHHHHHH
Confidence 32 236799999999986543221 133579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
+|++||.+.+..++...+.....+... ......++.+.+||.+||++||.+|||+.
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDS------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCT------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCC------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999888888888766432111 01123456899999999999999999999
Q ss_pred HHHHHHHhh
Q 003375 808 DLYEMFVAR 816 (825)
Q Consensus 808 EIL~hL~~l 816 (825)
|+++|.+-.
T Consensus 260 eil~hp~~~ 268 (307)
T d1a06a_ 260 QALQHPWIA 268 (307)
T ss_dssp HHHHSTTTT
T ss_pred HHhcCHhhC
Confidence 999995543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=422.58 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=207.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
.++|++.+.||+|+||.||+|++ .+..||||++..... ..+...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 36799999999999999999998 477899999753211 11112234599999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 82 ~--------------~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 K--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEEccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 4 4999999999999999886 35799999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..++.++|||||||+||||
T Consensus 143 ~~-------~~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 ED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TT-------SCEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------ceEEecccccceecccCCcc--------cccccccCCccccCceeecc----CCCCcccceehhhHHHHHH
Confidence 77 45999999999876532211 11234579999999999987 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+||+.||.+.+..++...+.+... .++. ..++.+.+||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEY-DFPE---------------------------KFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCC-CCCT---------------------------TCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred hhCCCCCCCcCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHHccCCHhHCcCH
Confidence 999999999998888888776532 1221 124578999999999999999999
Q ss_pred HHHHHH
Q 003375 807 GDLYEM 812 (825)
Q Consensus 807 ~EIL~h 812 (825)
+|++++
T Consensus 256 ~e~~~~ 261 (288)
T d1uu3a_ 256 EEMEGY 261 (288)
T ss_dssp GGGTCH
T ss_pred HHHcCC
Confidence 986443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=411.76 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=201.6
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 492 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
|++.++||+|+||+||+|.+. +..||+|++.... ......+. +.+|+++|++++|||||++++++.....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHH----HHHHHHHHHhCCCCCeeeEEEEEeeccc--
Confidence 378889999999999999984 5678888765432 23333344 4999999999999999999999875321
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEEEec
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 647 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~ 647 (825)
....+||||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------cCCEEEEEEeCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 12357999999999999999986 256899999999999999999999998 999999999999964
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+. +.+||+|||+|+...... ....+||+.|||||++.+ .++.++|||||||+||||+
T Consensus 150 ~~------~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 PT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp TT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC------CCEEEeecCcceeccCCc------------cCCcccCccccCHHHhCC-----CCCCcCchhhHHHHHHHHH
Confidence 31 469999999997543321 123579999999999864 4899999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~-~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|+.||.+.. ..++...+..+..+... ....++++.+||.+||++||++|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCcccHHHHHHHHHcCCCCccc--------------------------CccCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999997654 45555666554332111 11234578999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
+|+++|.+
T Consensus 261 ~ell~Hp~ 268 (270)
T d1t4ha_ 261 KDLLNHAF 268 (270)
T ss_dssp HHHHTSGG
T ss_pred HHHhCCcc
Confidence 99999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=425.59 Aligned_cols=278 Identities=23% Similarity=0.304 Sum_probs=202.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
-++|++++.||+|+||+||+|++ ++..||+|++.... ..... .++.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHH----HHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46899999999999999999998 57889999876432 12222 34489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEE
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 645 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILL 645 (825)
. .||||||++||+|.+++.+ ...+++..++.++.||+.||.|||+ +||+||||||+||||
T Consensus 78 ~--------------~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl 138 (322)
T d1s9ja_ 78 E--------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138 (322)
T ss_dssp E--------------EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred E--------------EEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence 4 5999999999999999986 2569999999999999999999997 599999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 139 ~~~-------~~vkl~DFGla~~~~~~~------------~~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 139 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp CTT-------CCEEECCCCCCHHHHHHT------------C---CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCccccCCCc------------cccccCCccccCchHHcC----CCCCcHHHHHHHHHHHHH
Confidence 877 459999999998764321 134579999999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHc---CCCCCchhHHhhhccCccccccccCC-------------CCCCchhhhhhHHHHH
Q 003375 726 LLTLQVPYMGLSELEIHDLIQM---GKRPRLTDELEALGSCHEHEVAQSGS-------------GFEKPEAELETLSFLV 789 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~---~~~p~l~~~l~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~s~~L~ 789 (825)
|++|+.||.+.+.......... +.....+................... ...........+.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 9999999987654332111110 00000000000000000000000000 0000000112356899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 790 DVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 790 dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
+||.+||+.||.+|||++|+++|.+-
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 99999999999999999999998543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=410.84 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=206.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
+....|++.++||+|+||.||+|.+.. ..||||++... ........ |.+|+.+|++++|||||+++|
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~----~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVD----FLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHH----HHHHHHHHHhcCCCCEeeeeE
Confidence 344679999999999999999998733 35888875422 22333333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++..... .++||||+.+++|.+++.. ....+++..++.++.||+.||+|||+++|+||||||
T Consensus 77 ~~~~~~~--------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp 138 (283)
T d1mqba_ 77 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 138 (283)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCCc--------------eEEEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccccccCcccc
Confidence 9986654 4999999999999998875 235699999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+||||+.+ +.+||+|||+++.+....... .......||+.|||||++.+ ..++.++||||||
T Consensus 139 ~NILl~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~G 200 (283)
T d1mqba_ 139 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 200 (283)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred ceEEECCC-------CeEEEcccchhhcccCCCccc-------eEeccCCCCccccCHHHHcc----CCCCCcccccccH
Confidence 99999877 569999999998765422111 11223468999999999986 6789999999999
Q ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 721 CLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 721 vILyELLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
|+||||+++ .+||.+.+..++...+..+.++..+. ..+..+.+||.+||+.|
T Consensus 201 vil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 201 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQE 253 (283)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch---------------------------hhHHHHHHHHHHHCcCC
Confidence 999999995 55566677888888887776554442 12457899999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 003375 800 PTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l~ss 819 (825)
|.+|||+.||++.|+.+..+
T Consensus 254 p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 254 RARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTSCCHHHHHHHHHHHHHS
T ss_pred HhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=408.77 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=203.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
++.++|++.+.||+|+||.||+|.+. +..++|+++.++.. ......+ .+.+|+.+|++++|||||+++|++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44578999999999999999999973 23345555444432 2233333 3499999999999999999999985
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+ +. .||||||+++|+|.+++.. ....+++..++.++.||+.||.|||++|||||||||+||
T Consensus 79 ~-~~--------------~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 E-NP--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp S-SS--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred c-Ce--------------EEEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 3 22 3999999999999998875 235689999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++.+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 140 ll~~~-------~~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 140 LVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 199 (273)
T ss_dssp EEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred eecCC-------CcEEEccchhheeccCCcce---------eccceecCcccchhhHhcc----CCCCCccccccchHHH
Confidence 99987 56999999999876432211 1233468999999999987 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||+| |.+||.+.+..++...+..+.++.++. ..++.+.+||.+||..||.+
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhH
Confidence 99998 899999999988888888776554432 23567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|||+.||+++|+.+.
T Consensus 253 Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 253 RPRFTELKAQLSTIL 267 (273)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-48 Score=426.86 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=213.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
.++.|++++.||+|+||.||+|.+ .+..||+|++... .....+ .+.+|+.+|++|+|||||++++++.+.
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----TVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHH----HHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 457899999999999999999998 5788999986532 122222 348999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. +|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||
T Consensus 99 ~~--------------~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl 160 (352)
T d1koba_ 99 YE--------------MVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160 (352)
T ss_dssp SE--------------EEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccc
Confidence 54 4999999999999988754 23569999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+... .+.+||+|||+|+.+..... .....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 161 ~~~~-----~~~vkL~DFGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 220 (352)
T d1koba_ 161 ETKK-----ASSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYV 220 (352)
T ss_dssp SSTT-----CCCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHH
T ss_pred cccC-----CCeEEEeecccceecCCCCc-----------eeeccCcccccCHHHHcC----CCCCCccchHHHHHHHHH
Confidence 8542 25799999999987754321 123469999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+||+.||.+.+..++...+.....+... ......++.+.+||.+||+.||.+|||
T Consensus 221 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDE------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------------------STTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------------------ccccCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999988888888766432111 011224568999999999999999999
Q ss_pred HHHHHHHHH
Q 003375 806 AGDLYEMFV 814 (825)
Q Consensus 806 a~EIL~hL~ 814 (825)
+.|+++|-+
T Consensus 277 ~~eil~Hp~ 285 (352)
T d1koba_ 277 VHDALEHPW 285 (352)
T ss_dssp HHHHHTSTT
T ss_pred HHHHhcCHh
Confidence 999999843
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=422.04 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=204.6
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 559 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~ 559 (825)
+.++|++.+.||+|+||.||+|++.+ ..||+|+..... ..... ..+.+|+.+|.++ +|||||+++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSER----EALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------C----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHH----HHHHHHHHHHHHhcCCCcEeEEE
Confidence 44689999999999999999999732 247777653221 11222 2448999999998 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc------------------cCCCccCHHHHHHHHHHH
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------TGEKHVSVKLALFIAQDV 621 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~------------------~~~~~ls~~~i~~Ia~QI 621 (825)
+++.+.+.+ |||||||++|+|.++|..... .....+++..++.|+.||
T Consensus 108 ~~~~~~~~~--------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 108 GACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred EEEeeCCeE--------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 999877654 999999999999999975211 012358899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003375 622 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701 (825)
Q Consensus 622 a~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl 701 (825)
+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.......... .....||+.|||||++
T Consensus 174 ~~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~~--------~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 174 AKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYVV--------RGNARLPVKWMAPESL 238 (325)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSEE--------ETTEEECGGGCCHHHH
T ss_pred HHHHHHHHhCCeeeccCchhccccccC-------CeEEEeeccccccccCCCceee--------eccccCCCccCChHHH
Confidence 999999999999999999999999977 5699999999987654322110 1234689999999999
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHcCCCCCchhHHhhhccCccccccccCCCCCCch
Q 003375 702 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHD-LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 779 (825)
Q Consensus 702 ~~~~~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~-~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 779 (825)
.+ ..++.++|||||||+||||+| |++||.+.+..+.+. .+..+.++..+.
T Consensus 239 ~~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~------------------------ 290 (325)
T d1rjba_ 239 FE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF------------------------ 290 (325)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT------------------------
T ss_pred cC----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC------------------------
Confidence 87 678999999999999999998 899998876554444 444444433331
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 003375 780 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 780 ~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
..++.+.+||.+||+.||.+|||++||++||..
T Consensus 291 ---~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 291 ---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 235679999999999999999999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-47 Score=407.91 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=220.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~-~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
.++|++.+.||+|+||+||+|++ ++..+|||++....... .....+...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57899999999999999999998 67899999976554332 33444556667899999999997 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.+. .|||||||+||+|.++|.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~~--------------~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTF--------------FFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ccc--------------eEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 664 4999999999999999976 256999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~--~~~~~s~kSDVWSLGvI 722 (825)
++.+ +.+||+|||+++.+..... .....||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred EcCC-------CCeEEccchheeEccCCCc-----------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 9877 4699999999987654221 13346999999999997532 22457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||||++|+.||.+.+...+...+..+...... ......++++.+||.+||++||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS------------------------PEWDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------------------TTGGGSCHHHHHHHHHHCCSSGGG
T ss_pred hhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC------------------------cccccCCHHHHHHHHHHccCChhH
Confidence 99999999999999988888877766322111 111234678999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003375 803 RPTAGDLYEMFV 814 (825)
Q Consensus 803 RPSa~EIL~hL~ 814 (825)
|||++||++|-+
T Consensus 261 R~s~~eil~h~~ 272 (277)
T d1phka_ 261 RYTAEEALAHPF 272 (277)
T ss_dssp SCCHHHHTTSGG
T ss_pred CcCHHHHHcCHH
Confidence 999999999854
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=415.11 Aligned_cols=283 Identities=22% Similarity=0.222 Sum_probs=206.4
Q ss_pred eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 003375 494 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 571 (825)
Q Consensus 494 i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~~~ 571 (825)
.+++||+|+||+||+|++ .++.||||++....... ..+.+...+.+|+.+|++++|||||++++++...+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~--- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC---
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce---
Confidence 568999999999999997 57789999865433221 1122334569999999999999999999999877654
Q ss_pred CCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecCccC
Q 003375 572 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 651 (825)
Q Consensus 572 ~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~~~ 651 (825)
||||||+.++++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 -----------~ivmE~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~--- 136 (299)
T d1ua2a_ 76 -----------SLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--- 136 (299)
T ss_dssp -----------EEEEECCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred -----------eehhhhhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---
Confidence 99999999776665543 24678999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 003375 652 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 731 (825)
Q Consensus 652 ~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLTG~~ 731 (825)
+.+||+|||+|+........ ....+||+.|||||++.. ...++.++|||||||+||||+||.+
T Consensus 137 ----~~~KL~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 137 ----GVLKLADFGLAKSFGSPNRA----------YTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ----CCEEECCCGGGSTTTSCCCC----------CCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ----CccccccCccccccCCCccc----------ccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcC
Confidence 45999999999766542211 234579999999999875 2467999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003375 732 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 811 (825)
Q Consensus 732 PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~ 811 (825)
||.+.+..+....+...........+...........................++.+.+||.+||+.||.+|||++|+|+
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 99999888877776553211111111111100000000000111111122344678999999999999999999999999
Q ss_pred HHHhhcC
Q 003375 812 MFVARTS 818 (825)
Q Consensus 812 hL~~l~s 818 (825)
|-+....
T Consensus 280 Hp~f~~~ 286 (299)
T d1ua2a_ 280 MKYFSNR 286 (299)
T ss_dssp SGGGTSS
T ss_pred CHhhCCC
Confidence 9655433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=416.03 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=214.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
-+++|++++.||+|+||+||+|.+ ++..||+|++..+. .... .+.+|+.+|+.++|||||++++++.+.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQV----LVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHH----HHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHH----HHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 478999999999999999999998 57789999975431 2222 348999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. +|||||||+||+|.++|.. ....+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 74 ~~--------------~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll 135 (321)
T d1tkia_ 74 EE--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp TE--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee
Confidence 64 4999999999999999974 23469999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.++ ...+||+|||+++........ ....||+.|+|||.+.+ ..++.++|||||||+||+
T Consensus 136 ~~~~-----~~~ikl~DFG~~~~~~~~~~~-----------~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~ 195 (321)
T d1tkia_ 136 QTRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp SSSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHH
T ss_pred cCCC-----ceEEEEcccchhhccccCCcc-----------cccccccccccchhccC----CCCCchhhcccHHHHHHH
Confidence 8653 367999999999876442211 23468999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|++|..||.+.+..++...+........... ....++.+.+||.+||..||.+|||
T Consensus 196 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEA------------------------FKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------------------------HTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCChhh------------------------ccCCCHHHHHHHHHHccCChhHCcC
Confidence 9999999999999888888877643221111 1223567899999999999999999
Q ss_pred HHHHHHHHHh
Q 003375 806 AGDLYEMFVA 815 (825)
Q Consensus 806 a~EIL~hL~~ 815 (825)
+.|+++|-+-
T Consensus 252 ~~eil~hp~~ 261 (321)
T d1tkia_ 252 ASEALQHPWL 261 (321)
T ss_dssp HHHHHHSHHH
T ss_pred HHHHhcCHhh
Confidence 9999998543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=422.11 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=213.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
+.+++|++++.||+|+||.||+|++ .+..||+|++...... .......+.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 4678999999999999999999997 5789999997532111 11122345899999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... +|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 77 ~~~--------------~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred ccc--------------cccceeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 764 4999999999999999986 357899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+|+........ ....+||+.|||||++.+ ..++.++|||||||+||
T Consensus 138 l~~~-------g~vkl~DFG~a~~~~~~~~~----------~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKD-------GHIKITDFGLCKEGISDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTCC----------BCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ecCC-------CCEEEeecccccccccCCcc----------cccceeCHHHhhhhhccC----CCCChhhcccchhhHHH
Confidence 9887 45999999999865432211 234579999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||++|++||.+.+..++...+..... .++. ..++.+.+||.+||++||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCcCHHHHHHHHhcCCC-CCCc---------------------------cCCHHHHHHHHhhccCCchhhc
Confidence 99999999999999888888776532 2221 1355789999999999999999
Q ss_pred C-----HHHHHHHHH
Q 003375 805 T-----AGDLYEMFV 814 (825)
Q Consensus 805 S-----a~EIL~hL~ 814 (825)
+ ++||++|.+
T Consensus 249 ~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRF 263 (337)
T ss_dssp TCSTTTHHHHHTSGG
T ss_pred ccccccHHHHHcCcc
Confidence 4 999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=407.90 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=210.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++++|++.+.||+|+||.||+|+++++.||||+++ .. ...+. +.+|+.+|++++|||||+++|++.+..
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~--~~----~~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--ND----ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC--CC----C--HH----HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEEC--cH----HHHHH----HHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 567899999999999999999999999999999853 21 12233 489999999999999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .+||||||+++|+|.+++... ....+++..++.|+.||+.||.|||+++|+||||||+|||++
T Consensus 74 ~-------------~~~lv~ey~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~ 137 (262)
T d1byga_ 74 G-------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 137 (262)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------cEEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec
Confidence 1 249999999999999999752 123589999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 138 ~~-------~~~kl~dfg~s~~~~~~~-------------~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 138 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp TT-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEeecccccceecCCCC-------------ccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHH
Confidence 87 569999999998654322 22358899999999987 6789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 727 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 727 LT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
+| |++||...+..++...+..+.++.++.. .++.+.+||.+||..||.+|||
T Consensus 194 ~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~~~li~~cl~~dP~~Rps 246 (262)
T d1byga_ 194 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG---------------------------CPPAVYEVMKNCWHLDAAMRPS 246 (262)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc---------------------------CCHHHHHHHHHHcccCHhHCcC
Confidence 98 7999999888888888887766655532 2457899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 003375 806 AGDLYEMFVARTS 818 (825)
Q Consensus 806 a~EIL~hL~~l~s 818 (825)
+.+|+++|+.+.+
T Consensus 247 ~~~l~~~L~~i~~ 259 (262)
T d1byga_ 247 FLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-47 Score=402.82 Aligned_cols=266 Identities=24% Similarity=0.280 Sum_probs=208.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|.+ .++.||+|++..... ...... ..+.+|+.+|+.++|||||++++++.....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~----~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHH----HHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 5699999999999999999997 588999999653321 222223 345999999999999999999999986543
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ...+||||||++|++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 82 ~----------~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 82 A----------GPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp S----------SEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred C----------CceEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence 1 2346999999999999999876 356999999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ ..++|+|||.+......... .......+||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 147 ~-------~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 147 T-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp T-------SCEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred c-------ccceeehhhhhhhhcccccc-------ccccccccCcccccCHHHHcC----CCCCcceecccchHHHHHHH
Confidence 7 45999999998765432211 111244579999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP-Sa 806 (825)
||++||.+.+..++...+.......... .....++.+.+||.+||++||.+|| |+
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGG------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCch------------------------hccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 9999999998888776665543211110 1112356899999999999999999 89
Q ss_pred HHHHHHHHhhc
Q 003375 807 GDLYEMFVART 817 (825)
Q Consensus 807 ~EIL~hL~~l~ 817 (825)
+++++.|.++.
T Consensus 265 ~~l~~~l~r~~ 275 (277)
T d1o6ya_ 265 AEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-47 Score=412.89 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=211.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
++++|++++.||+|+||.||+|++ .+..||||++..... ......+.+.+|+.+|+.++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 467899999999999999999997 478899999753221 1111223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
.. +|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 77 ~~--------------~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 QQ--------------IFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred Ce--------------eeeEeeecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 64 5999999999999999986 4668899999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+...... ....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 138 ~~~-------g~vkL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEecCccceEecccc-------------ccccCcccccCHHHHcC----CCCCchhhccccchhHHH
Confidence 877 459999999998764321 23479999999999986 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 804 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP- 804 (825)
|+||+.||.+.+..++...+..+..+ ++. ..++.+.++|.+||..||.+||
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELR-FPP---------------------------FFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhhCHHhccc
Confidence 99999999999998888888765321 111 1245789999999999999996
Q ss_pred ----CHHHHHHHHH
Q 003375 805 ----TAGDLYEMFV 814 (825)
Q Consensus 805 ----Sa~EIL~hL~ 814 (825)
|+++|++|.+
T Consensus 246 ~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 246 NLQNGTEDVKNHPW 259 (316)
T ss_dssp SSTTTTHHHHTSGG
T ss_pred cchhhHHHHHcCcc
Confidence 9999999843
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=411.53 Aligned_cols=256 Identities=19% Similarity=0.319 Sum_probs=207.7
Q ss_pred CCceeeeeecccCceEEEEEEECC--e----eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEe
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 563 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~--~----~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~ 563 (825)
.+|++++.||+|+||+||+|.+.. . .||+|.+... ......+ .+.+|+.+|++++|||||+++|++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANK----EILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHH----HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 579999999999999999999732 2 4677764311 1112223 4499999999999999999999997
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+.. .+++|||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 82 ~~~---------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SSS---------------EEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC---------------eeEEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 543 3889999999999998876 346789999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
||+.+ +.+||+|||+|+......... ......||+.|||||++.+ ..++.++|||||||+|
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred eeCCC-------CCeEeeccccceecccccccc--------cccccccCccccChHHHhc----CCCChhhhhhhHHHHH
Confidence 99987 569999999998765422211 1123468999999999987 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|||+| |.+||.+.+..++...+..+.++..+. ..++.+.+||.+||+.||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHhCCCChhh
Confidence 99998 899999988888888888776554442 12457899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
|||+.||+++|+.+.
T Consensus 257 RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 257 RPKFRELIIEFSKMA 271 (317)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=410.71 Aligned_cols=266 Identities=25% Similarity=0.418 Sum_probs=214.4
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeE
Q 003375 486 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 562 (825)
Q Consensus 486 ~~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~ 562 (825)
.+++++|++.+.||+|+||.||+|++ .+..++||++.++.... ....+. +.+|+.+|.++ +|||||+++|++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRD----FAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CH----HHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHH----HHHHHHHHHhccCCCCEeeEEEEE
Confidence 47889999999999999999999997 44555555544433222 222333 49999999999 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhh-----------ccCCCccCHHHHHHHHHHHHHHHHHHHhC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELHSK 631 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~-----------~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~ 631 (825)
...+. +||||||+++|+|.++|.... ......+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~--------------~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~ 146 (309)
T d1fvra_ 81 EHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146 (309)
T ss_dssp EETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCe--------------eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC
Confidence 87654 499999999999999997421 12236789999999999999999999999
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 711 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s 711 (825)
||+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||.+.+ ..++
T Consensus 147 ~iiHrDlkp~NIL~~~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~----~~~~ 204 (309)
T d1fvra_ 147 QFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYT 204 (309)
T ss_dssp TEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH----CEEC
T ss_pred CccccccccceEEEcCC-------CceEEcccccccccccccc-----------ccceecCCcccchHHhcc----CCCC
Confidence 99999999999999987 4599999999976543221 123458999999999987 6789
Q ss_pred chhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHH
Q 003375 712 LEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 790 (825)
Q Consensus 712 ~kSDVWSLGvILyELLTG~-~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 790 (825)
.++|||||||++|||++|. +||.+.+..++...+..+.++.++. ..++.+.+
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~ 257 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCDDEVYD 257 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBCHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------cCCHHHHH
Confidence 9999999999999999965 6788889999888887776554442 13557999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 791 VFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 791 LI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
||.+||+.||++|||+.||+++|+.+...
T Consensus 258 li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 258 LMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999987744
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-47 Score=406.31 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=215.1
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
+-++|++.+.||+|+||.||+|++.+ ..||||++... ......+ ++.+|+.+|++++||||+++++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~----~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQA----DFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHH----HHHHHHHHHHhcCCCCccccee
Confidence 45689999999999999999999743 57899985321 2223333 4499999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-------------------cCCCccCHHHHHHHHHHH
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDV 621 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------------~~~~~ls~~~i~~Ia~QI 621 (825)
++...... ++||||+++|+|.+++..... .....+++..++.|+.||
T Consensus 84 ~~~~~~~~--------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 84 VCAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred eeccCCce--------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 99876654 999999999999999975211 112458899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhh
Q 003375 622 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 701 (825)
Q Consensus 622 a~AL~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl 701 (825)
+.||+|||+++||||||||+||||+.+ +.+||+|||+|+.+....... ......||+.|||||++
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~-------~~~Kl~DFGls~~~~~~~~~~--------~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYYK--------ADGNDAIPIRWMPPESI 214 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHHH
T ss_pred HHHhhhcccCCeEeeEEcccceEECCC-------CcEEEccchhheeccCCcccc--------ccCCCCcCcCcCCHHHH
Confidence 999999999999999999999999987 569999999998664432211 12334689999999999
Q ss_pred hcccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchh
Q 003375 702 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 780 (825)
Q Consensus 702 ~~~~~~~~~s~kSDVWSLGvILyELLTG~-~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 780 (825)
.+ ..++.++|||||||+||||++|. +||.+.+..++...+..+.++.++..
T Consensus 215 ~~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~------------------------ 266 (301)
T d1lufa_ 215 FY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN------------------------ 266 (301)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT------------------------
T ss_pred cc----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCcc------------------------
Confidence 87 67899999999999999999985 78999999999888888766554421
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 003375 781 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 817 (825)
Q Consensus 781 ~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ 817 (825)
.++.+.+||.+||+.||.+||||.||++.|+.+.
T Consensus 267 ---~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 267 ---CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2457899999999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=404.91 Aligned_cols=262 Identities=25% Similarity=0.347 Sum_probs=209.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
++.++|++.+.||+|+||.||+|++. +..||||++... ... .+. |.+|+.+|++++|||||+++|++.+.
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~---~~~----~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCC---HHH----HHHHHHHHHhcccCCEeEEEEEEecC
Confidence 56789999999999999999999984 457999985422 221 233 48999999999999999999998543
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
. .++||||+++|+|..++... ....+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 85 ~---------------~~lv~Ey~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 P---------------IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp S---------------CEEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C---------------eEEEEEecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE
Confidence 2 39999999999999998752 12458999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +++||+|||+++........ ......||+.|+|||++.. ..++.++|||||||+|||
T Consensus 147 ~~~-------~~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~e 206 (285)
T d1fmka3 147 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 206 (285)
T ss_dssp CGG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEcccchhhhccCCCce---------eeccccccccccChHHHhC----CCCCcHHhhhcchHHHHH
Confidence 877 46999999999876432211 1233468999999999987 678999999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 726 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 726 LLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
|+|| .+||.+....++...+..+.++.++. .+++.+.+||.+||+.||++||
T Consensus 207 l~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 207 LTTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------ccCHHHHHHHHHHcccCHhHCc
Confidence 9995 55567777888888887765544432 2355799999999999999999
Q ss_pred CHHHHHHHHHhhcCCCCC
Q 003375 805 TAGDLYEMFVARTSSSIS 822 (825)
Q Consensus 805 Sa~EIL~hL~~l~sss~S 822 (825)
|+++|++.|+...++..+
T Consensus 260 s~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 260 TFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CHHHHHHHHHTTTSCSCC
T ss_pred CHHHHHHHHhhhhcCCCC
Confidence 999999999987766543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-47 Score=416.62 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=212.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
..+++|++++.||+|+||.||+|++ ++..||||++..... ......+.+.+|+.+|+.++|||||++++++..
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 4578999999999999999999998 478999998753211 111112345899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... .++||||+.||+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 113 ~~~--------------~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 113 NSN--------------LYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccc--------------cccccccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence 654 4999999999999999986 246999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.+ +.+||+|||+|+.+.... ....||+.|||||++.+ ..++.++|||||||+||
T Consensus 174 l~~~-------g~ikL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvily 229 (350)
T d1rdqe_ 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred cCCC-------CCEEeeeceeeeeccccc-------------ccccCccccCCHHHHcC----CCCCccccccchhHHHH
Confidence 9877 469999999998765321 23469999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||+||+.||.+.+...+...+..+... ++ ...++.+.+||.+||..||.+|+
T Consensus 230 emltG~~Pf~~~~~~~~~~~i~~~~~~-~p---------------------------~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 230 EMAAGYPPFFADQPIQIYEKIVSGKVR-FP---------------------------SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CC---------------------------TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHhCCCCCCCcCHHHHHHHHhcCCCC-CC---------------------------ccCCHHHHHHHHHHhhhCHHhcc
Confidence 999999999999988888888766322 11 11355799999999999999994
Q ss_pred -----CHHHHHHHHH
Q 003375 805 -----TAGDLYEMFV 814 (825)
Q Consensus 805 -----Sa~EIL~hL~ 814 (825)
|+++|++|-+
T Consensus 282 ~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKW 296 (350)
T ss_dssp TSSTTTTHHHHTSGG
T ss_pred ccccccHHHHHcCcc
Confidence 9999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=402.49 Aligned_cols=280 Identities=20% Similarity=0.252 Sum_probs=207.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++++.||+|+||.||+|.+ .++.||+|++..... .. ...+.+.+|+.+|++++|||||++++++.+..
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TE----GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--Ch----HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 47899999999999999999998 478899999754321 11 12234589999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .||||||+. +++..++.. .....+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 75 ~--------------~~iv~e~~~-~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 K--------------LYLVFEFLH-QDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp E--------------EEEEEECCS-EEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred c--------------eeEEEeecC-Cchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 4 599999997 566666554 2345699999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||+|+........ .....||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TE-------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TT-------SCEEECSTTHHHHHCCCSBC----------TTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred cc-------CcceeccCCcceeccCCccc----------ceeecccceeeehhhhcc---ccCCCccccccccchhhhHH
Confidence 77 45999999999876442221 234479999999999875 24568999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
++|+.||.+.+..+....+...........+....... ......... .........++.+.+||.+||++||.+|
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc--ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 99999999888777666654431111111111100000 000000000 0111223446789999999999999999
Q ss_pred CCHHHHHHHHH
Q 003375 804 PTAGDLYEMFV 814 (825)
Q Consensus 804 PSa~EIL~hL~ 814 (825)
||++||++|-+
T Consensus 275 ~t~~ell~H~f 285 (298)
T d1gz8a_ 275 ISAKAALAHPF 285 (298)
T ss_dssp CCHHHHHTSGG
T ss_pred cCHHHHhCCHh
Confidence 99999999933
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-47 Score=418.25 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=202.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 565 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~ 565 (825)
++++|++.+.||+|+||.||+|++ .+..||+|++...... ............+|+.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc--hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 578999999999999999999998 5788999997532210 011111111124457778888999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. +|||||||+||+|.++|.. ...+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 80 ~~--------------~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 DK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CE--------------EEEEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 54 4999999999999999986 3568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+|+.+.... .....||+.|||||++.. ...++.++|||||||+|||
T Consensus 141 ~~~-------g~iKl~DFGla~~~~~~~------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSS-------SCEEECCCTTCEECSSSC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeeeceeeecCCCc------------ccccccccccchhHHhhc---CCCCCcccchhHHHHHHHH
Confidence 877 459999999998764321 233479999999999964 2568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC--CCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGK--RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 803 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~--~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eR 803 (825)
|+||+.||.+.+............ .+.++ ...++.+.+||.+||+.||.+|
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC---------------------------SSSCHHHHHHHHHHTCSSTTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCCCCC---------------------------CCCCHHHHHHHHHHcccCHHHh
Confidence 999999998765433332222221 11111 1235679999999999999999
Q ss_pred CC-----HHHHHHHHHh
Q 003375 804 PT-----AGDLYEMFVA 815 (825)
Q Consensus 804 PS-----a~EIL~hL~~ 815 (825)
|| ++||++|-+.
T Consensus 252 ~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 252 LGCLGRGAQEVKESPFF 268 (364)
T ss_dssp TTTSSSTHHHHHTSGGG
T ss_pred CCCcccCHHHHHcCccc
Confidence 99 7999998543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=400.71 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=202.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---C--eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG---S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 561 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~--~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~ 561 (825)
+...+|++.+.||+|+||.||+|++. + ..||||++..... ......+ .|.+|+.+|++++|||||+++|+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~----~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMD----DFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHH----HHHHHHHHHHhCCCCCEEEEEEE
Confidence 34567999999999999999999862 2 3577776532221 1222233 45999999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 003375 562 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 641 (825)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 641 (825)
+.+. . .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~-~--------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~ 140 (273)
T d1u46a_ 80 VLTP-P--------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140 (273)
T ss_dssp ECSS-S--------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred Eeec-c--------------hheeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHH
Confidence 9643 2 38999999999999988752 246999999999999999999999999999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 721 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGv 721 (825)
||||+.+ +.+||+|||+++.+........ ......||..|+|||++.+ ..++.++|||||||
T Consensus 141 NIll~~~-------~~vkl~DfGl~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 141 NLLLATR-------DLVKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGV 202 (273)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred Hhccccc-------cceeeccchhhhhcccCCCcce-------ecCccccCcccCCHHHHhC----CCCCcchhhhhhHH
Confidence 9999987 5699999999987754332211 1233468889999999987 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 003375 722 LLLELLT-LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 799 (825)
Q Consensus 722 ILyELLT-G~~PF~~~~~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~D 799 (825)
++|||+| |.+||.+.+..++...+... .++..+. ..+..+.+||.+||+.|
T Consensus 203 il~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE---------------------------DCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc---------------------------cccHHHHHHHHHHcCCC
Confidence 9999998 89999999999888887655 3332221 23457999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 003375 800 PTERPTAGDLYEMFVAR 816 (825)
Q Consensus 800 P~eRPSa~EIL~hL~~l 816 (825)
|.+|||+.+|++.|++.
T Consensus 256 p~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHhc
Confidence 99999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=401.58 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=201.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
++.++|++.++||+|+||.||+|.+. ++.||||++. .. ......+. +.+|+.++.++ +|+||+.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~~-~~~~~~~~----~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EG-ATHSEHRA----LMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEc--cc-cCcHHHHH----HHHHHHHHHhhcCCCeEEEe
Confidence 44578999999999999999999972 2468888743 21 22233333 37888888877 58999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhcc-----------CCCccCHHHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 627 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~-----------~~~~ls~~~i~~Ia~QIa~AL~y 627 (825)
++++...+. .+++|||||++|+|.+++...... ....+++..++.++.||+.||.|
T Consensus 83 ~~~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 83 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp EEEECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred eeeeccCCC-------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence 998875442 259999999999999999863211 12458999999999999999999
Q ss_pred HHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 003375 628 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 707 (825)
Q Consensus 628 LHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~ 707 (825)
||++|||||||||+||||+.+ +.+||+|||+|+........ .......||+.|||||++.+
T Consensus 150 lH~~~ivHrDlKp~NILl~~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~---- 210 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD---- 210 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGG-------GCEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----
T ss_pred HHhCCCcCCcCCccceeECCC-------CcEEEccCcchhhccccccc--------cccCceeeCccccchhHhhc----
Confidence 999999999999999999877 46999999999866432211 11234579999999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhH
Q 003375 708 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 785 (825)
Q Consensus 708 ~~~s~kSDVWSLGvILyELLTG-~~PF~~~~~-~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s 785 (825)
..++.++|||||||++|||+|| .+||.+... ..+...+..+.++.+++. .+
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 263 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------------------------TT 263 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT---------------------------CC
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---------------------------CC
Confidence 6789999999999999999986 568877654 444555566655444321 24
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 786 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 786 ~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
+.+.+||.+||+.||.+|||+.||++||+.+..
T Consensus 264 ~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=410.54 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=207.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHh-hCCCCCcceeeeeEecC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 565 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk-~L~HPNIV~l~g~~~~~ 565 (825)
+++|++++.||+|+||+||+|++ .+..||||++...... .+...+.+.+|+.++. .++|||||++++++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-----ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 47899999999999999999998 6788999997532110 1111123367777665 68999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 645 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 645 (825)
+. +||||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~--------------~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 EN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred Cc--------------eeEEEeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 64 4999999999999999986 3568999999999999999999999999999999999999
Q ss_pred ecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 003375 646 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 725 (825)
Q Consensus 646 d~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyE 725 (825)
+.+ +.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 137 ~~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKD-------GHIKIADFGMCKENMLGDAK----------TNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTT-------SCEEECCCTTCBCCCCTTCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred cCC-------Cceeccccchhhhccccccc----------ccccCCCCCcCCHHHHcC----CCCCchhhhhhhhHHHHH
Confidence 977 45999999999865432211 233579999999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 003375 726 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 805 (825)
Q Consensus 726 LLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPS 805 (825)
|+||+.||.+.+..++...+..+.. .++. ..++.+.+||.+||..||.+|||
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHhcccCCCCCcC
Confidence 9999999999999988888876532 2221 13557999999999999999999
Q ss_pred HH-HHHHHH
Q 003375 806 AG-DLYEMF 813 (825)
Q Consensus 806 a~-EIL~hL 813 (825)
+. +|++|.
T Consensus 248 ~~~~l~~hp 256 (320)
T d1xjda_ 248 VRGDIRQHP 256 (320)
T ss_dssp TBSCGGGSG
T ss_pred HHHHHHhCc
Confidence 95 788763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=400.33 Aligned_cols=265 Identities=24% Similarity=0.377 Sum_probs=212.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcc
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 556 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV 556 (825)
++.++|++++.||+|+||.||+|+..+ ..||||+... .........+ .+|+..+.++ +|||||
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~----~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDL----ISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT---TCCHHHHHHH----HHHHHHHHHHCCCTTBC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc---ccChHHHHHH----HHHHHHHHHhcCCCeEE
Confidence 456899999999999999999998622 3578887432 2223333344 8899999888 799999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----------cCCCccCHHHHHHHHHHHHHHH
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++++.++..+ ++||||+++|+|.++|..... .....+++..++.++.||+.||
T Consensus 83 ~~~~~~~~~~~~--------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 83 NLLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp CEEEEECSSSSC--------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHH
T ss_pred ecccccccCCeE--------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 999999876644 999999999999999975321 1235689999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
+|||+++||||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||.+.+
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~-- 211 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD-- 211 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTT-------CCEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH--
T ss_pred HHhhhCCEEeeeecccceeecCC-------CCeEeccchhhccccccccc--------cccccCCCChhhhhhhHhcC--
Confidence 99999999999999999999987 45999999999877543221 11234568999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 784 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (825)
..++.++|||||||+||||++ |.+||.+.+..++...+..+.++..+. ..
T Consensus 212 --~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~ 262 (299)
T d1fgka_ 212 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NC 262 (299)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SC
T ss_pred --CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cc
Confidence 679999999999999999998 799999999888888888776655442 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 785 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 785 s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
++.+.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 263 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 4579999999999999999999999999998865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=400.70 Aligned_cols=284 Identities=21% Similarity=0.197 Sum_probs=208.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC---CCCCcceeeeeE
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 562 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L---~HPNIV~l~g~~ 562 (825)
-++|++++.||+|+||+||+|++. +..||||++........ ... .+.+|+.+|+.| +||||+++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~----~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBC----THHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHH----HHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 368999999999999999999983 56789999765432211 111 226787777666 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 003375 563 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 642 (825)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 642 (825)
...... .....+++|||+.++.+...... ....+++..++.++.||+.||+|||++|||||||||+|
T Consensus 80 ~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRTD---------RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEECS---------SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cccccc---------cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 753311 23467999999997665544332 34668999999999999999999999999999999999
Q ss_pred EEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 003375 643 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 722 (825)
Q Consensus 643 ILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvI 722 (825)
||++.. +.+||+|||+++....... .....||+.|||||++.+ ..++.++|||||||+
T Consensus 147 ILi~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 147 ILVTSS-------GQIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 204 (305)
T ss_dssp EEECTT-------CCEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCeeecchhhhhhhccccc-----------CCCcccChhhcCcchhcC----CCCChhehhhchHHH
Confidence 999877 4599999999876543221 134579999999999986 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 723 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 723 LyELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
||||+||++||.+.+..+....+...........+..........+ ...............++.+.+||.+||++||.+
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 9999999999999988887776654322111111111100000000 000111111222345678999999999999999
Q ss_pred CCCHHHHHHHHH
Q 003375 803 RPTAGDLYEMFV 814 (825)
Q Consensus 803 RPSa~EIL~hL~ 814 (825)
|||+.|+++|.+
T Consensus 284 R~sa~e~L~Hpf 295 (305)
T d1blxa_ 284 RISAYSALSHPY 295 (305)
T ss_dssp SCCHHHHHTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999999954
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-46 Score=396.45 Aligned_cols=281 Identities=19% Similarity=0.211 Sum_probs=207.6
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
+++|+++++||+|+||+||+|++ .+..||||++..... .. ...+++.+|+.+|++++|||||++++++...+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DE----GIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GG----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--Ch----HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 57899999999999999999998 468899999754321 11 122345899999999999999999999987765
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. +++|||+.++.+..+... ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 75 ~--------------~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 L--------------VLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp E--------------EEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred e--------------eEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 4 999999986655555443 467999999999999999999999999999999999999988
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||++......... .....|++.|+|||.+.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~----------~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 E-------GELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEecccccceecccCccc----------cceecccchhhhHHHHhC---CCCCCcceeehhcCcHHHHHH
Confidence 7 45999999999876542211 233468999999999975 356789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
+|+.||.+.+..+....+...........+......... ..................++.+.+||.+||++||++|||+
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 999999988877766665443111111111111110000 0000001111122223446789999999999999999999
Q ss_pred HHHHHHHH
Q 003375 807 GDLYEMFV 814 (825)
Q Consensus 807 ~EIL~hL~ 814 (825)
.|+++|.+
T Consensus 276 ~ell~Hp~ 283 (286)
T d1ob3a_ 276 KQALEHAY 283 (286)
T ss_dssp HHHHTSGG
T ss_pred HHHhcCcc
Confidence 99999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=410.14 Aligned_cols=263 Identities=23% Similarity=0.237 Sum_probs=202.6
Q ss_pred CCCCceeee-eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 003375 488 SFPSLSSCD-EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 563 (825)
Q Consensus 488 ~~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l~g~~~ 563 (825)
-+++|.+.. .||+|+||+||+|++ .+..||||++... . .+.+|+.++.++ +|||||+++++|.
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~----~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------P----KARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------H----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------H----HHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 468999875 599999999999997 5678999986411 1 237899987655 7999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 003375 564 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 643 (825)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 643 (825)
+... ....+|||||||+||+|.++|.. .+...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NI 142 (335)
T d2ozaa1 76 NLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142 (335)
T ss_dssp EEET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eccc----------CCCEEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccc
Confidence 5211 12357999999999999999975 2335799999999999999999999999999999999999
Q ss_pred EEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 003375 644 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 723 (825)
Q Consensus 644 LLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvIL 723 (825)
|++..+ ..+.+||+|||+|+....... .....||+.|||||++.+ ..++.++|||||||+|
T Consensus 143 ll~~~~----~~~~~Kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 143 LYTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIM 203 (335)
T ss_dssp EESCSS----TTCCEEECCCTTCEECCCCCC-----------CCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHHH
T ss_pred cccccc----ccccccccccceeeeccCCCc-----------cccccCCcccCCcHHHcC----CCCCHHHHHHhhchhH
Confidence 998653 236799999999987654221 233579999999999986 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 724 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 724 yELLTG~~PF~~~~~~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
|+|+||++||.+.+.......+..... ... .+ ........++.+.+||.+||+.||.+
T Consensus 204 y~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~--------------------~~-~~~~~~~~s~~~~~li~~~L~~dP~~ 262 (335)
T d2ozaa1 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQY--------------------EF-PNPEWSEVSEEVKMLIRNLLKTEPTQ 262 (335)
T ss_dssp HHHTTSSCSCEETTCC--------CCCSCSS--------------------SC-CTTHHHHSCHHHHHHHHHHSCSSTTT
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC--------------------CC-CCcccccCCHHHHHHHHHHccCChhH
Confidence 999999999987665444333322210 000 00 11123345778999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 003375 803 RPTAGDLYEMFVAR 816 (825)
Q Consensus 803 RPSa~EIL~hL~~l 816 (825)
|||+.|+++|-+-.
T Consensus 263 R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 263 RMTITEFMNHPWIM 276 (335)
T ss_dssp SCCHHHHHHSHHHH
T ss_pred CcCHHHHHcCHHhh
Confidence 99999999996543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=397.54 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=219.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 559 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~ 559 (825)
++.++|++.+.||+|+||.||+|.+. +..||||++. .. ....... .+.+|+.++++++|||||+++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~--~~-~~~~~~~----~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EA-ASMRERI----EFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC--TT-SCHHHHH----HHHHHHHHGGGCCCTTBCCEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEEC--cc-cChHHHH----HHHHHHHHHHHcCCCCEeeee
Confidence 55689999999999999999999874 3678999753 22 2333333 349999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-----cCCCccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 003375 560 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIM 634 (825)
Q Consensus 560 g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-----~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIV 634 (825)
|++...... ++||||+++|+|.+++..... .....+++..+..++.||++||.|||+++|+
T Consensus 90 ~~~~~~~~~--------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 90 GVVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp EEECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred eEEecCCce--------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 999866544 999999999999999875321 1224578899999999999999999999999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+||||+.+ +++||+|||+|+.+........ .....||+.|+|||.+.+ ..++.++
T Consensus 156 HrDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~~--------~~~~~~t~~y~aPe~l~~----~~~~~~~ 216 (308)
T d1p4oa_ 156 HRDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYS 216 (308)
T ss_dssp CSCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHH
T ss_pred eceEcCCceeecCC-------ceEEEeecccceeccCCcceee--------ccceecccccCCHHHHcc----CCCCccc
Confidence 99999999999877 5699999999987654332211 122368999999999987 6789999
Q ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHH
Q 003375 715 DIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 793 (825)
Q Consensus 715 DVWSLGvILyELLTG-~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~ 793 (825)
|||||||+||||+|| .+||.+.+..++...+..+.++..+.. .++.+.+||.
T Consensus 217 Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~ 269 (308)
T d1p4oa_ 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN---------------------------CPDMLFELMR 269 (308)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHH
T ss_pred ccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCccc---------------------------chHHHHHHHH
Confidence 999999999999998 588999999999888887766554421 2457999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 794 RCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 794 ~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
+||+.||.+|||+.+|+++|+....+
T Consensus 270 ~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 99999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=393.94 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=204.4
Q ss_pred eeeeeecccCceEEEEEEECC---e--eEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 493 SSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 493 ~i~~~LG~G~fG~Vy~a~~~~---~--~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
.+.++||+|+||+||+|++.. + .||||.+ +. .......+.| .+|+.+|++++|||||+++|++.....
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~--~~-~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEE--CC-CCCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEE--Cc-ccCHHHHHHH----HHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 346789999999999999732 2 4666664 32 2234444444 999999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
..++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+||||+.
T Consensus 103 -------------~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 103 -------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp -------------EEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------ceEEEEEEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC
Confidence 35999999999999999875 3356778899999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++......... ........||+.|+|||.+.. ..++.++||||||++||||+
T Consensus 166 ~-------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 166 K-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELM 228 (311)
T ss_dssp T-------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecccchhhcccccccc------ceecccccccccccChHHHhc----CCCCChhHhhhhHHHHHHHH
Confidence 6 569999999998765432211 111233579999999999987 67899999999999999999
Q ss_pred hCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 003375 728 TLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 806 (825)
Q Consensus 728 TG~~PF~~-~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa 806 (825)
||..||.. .+..++...+..+.++..+. ..++.+.+||.+||+.||.+|||+
T Consensus 229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~ 281 (311)
T d1r0pa_ 229 TRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPSF 281 (311)
T ss_dssp TTSCCSCC------CHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cCcHHHHHHHHHHcCCCHhHCcCH
Confidence 97776644 45555666666666554432 124579999999999999999999
Q ss_pred HHHHHHHHhhcCCCCC
Q 003375 807 GDLYEMFVARTSSSIS 822 (825)
Q Consensus 807 ~EIL~hL~~l~sss~S 822 (825)
.||+++|+.+.++-..
T Consensus 282 ~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 282 SELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHHHHHHHHHHTCCS
T ss_pred HHHHHHHHHHHHhhhh
Confidence 9999999998776443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=393.25 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=211.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhC-CCCCccee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 558 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-------~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L-~HPNIV~l 558 (825)
++.++|++.+.||+|+||.||+|++ .+..||||++... ........ +.+|+.+++++ +|||||++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~----~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA----LMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc---cCHHHHHH----HHHHHHHHHhccCCCCEEEE
Confidence 4557999999999999999999986 2357899886422 22233333 48999999999 59999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhc-------------cCCCccCHHHHHHHHHHHHHHH
Q 003375 559 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAAL 625 (825)
Q Consensus 559 ~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~-------------~~~~~ls~~~i~~Ia~QIa~AL 625 (825)
++++...... +||||||++|+|.+++..... .....+++..++.++.||+.||
T Consensus 93 ~g~~~~~~~~--------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 158 (311)
T d1t46a_ 93 LGACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (311)
T ss_dssp EEEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEeeCCEE--------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 9999876544 999999999999999986321 1234689999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 003375 626 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 705 (825)
Q Consensus 626 ~yLHs~gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~ 705 (825)
+|||++|||||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 159 ~~LH~~~ivHrDLKp~NIl~~~~-------~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-- 221 (311)
T d1t46a_ 159 AFLASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN-- 221 (311)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH--
T ss_pred HHHHhCCeeeccccccccccccc-------CcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcC--
Confidence 99999999999999999999877 569999999998765432211 1234579999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 706 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 706 ~~~~~s~kSDVWSLGvILyELLT-G~~PF~~~~~~~i-~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
..++.++|||||||+||||+| |.+||.+.+.... ...+..+.++..+. .
T Consensus 222 --~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~ 272 (311)
T d1t46a_ 222 --CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE---------------------------H 272 (311)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------T
T ss_pred --CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------c
Confidence 678999999999999999999 6677766665444 44445554443332 1
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 819 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~ss 819 (825)
.++.+.+||.+||+.||.+|||+.+|++.|+++.+.
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 245799999999999999999999999999986554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=391.15 Aligned_cols=302 Identities=17% Similarity=0.191 Sum_probs=210.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEec
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 564 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~ 564 (825)
.++++|+++++||+|+||+||+|++ .+..||||++...... . ....++.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~----~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--E----GFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--T----SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--h----HHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 3578999999999999999999998 5788999986543221 1 122344899999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
.... ........|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 ~~~~------~~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NIL 149 (318)
T d3blha1 81 KASP------YNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 149 (318)
T ss_dssp ----------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cccc------ccccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchhee
Confidence 4321 0011235799999998655544332 2467899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+ +.+||+|||+++.+....... .......+||+.|+|||++.+ ...++.++|||||||++|
T Consensus 150 l~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 150 ITRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp ECTT-------SCEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHH
T ss_pred ecCC-------CcEEeeecceeeecccccccc------cccccceecCHHHhhHHHHcC---CCCCCcHHHcccCCceee
Confidence 9987 469999999998765432211 111234579999999999976 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCc----hhhhhhHHHHHHHHHHhcccCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP----EAELETLSFLVDVFRRCTEENP 800 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~L~dLI~~CL~~DP 800 (825)
||++|+.||.+.+.......+........++....................... ......++.+++||.+||++||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 999999999988877766665543211111111110000000000000000000 0112234577899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 003375 801 TERPTAGDLYEMFVARTSSSI 821 (825)
Q Consensus 801 ~eRPSa~EIL~hL~~l~sss~ 821 (825)
.+|||++|+++|-+....+.+
T Consensus 294 ~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 294 AQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp TTSCCHHHHHHSGGGSSSSCC
T ss_pred hHCcCHHHHHcChhhccCCCC
Confidence 999999999999887655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=389.80 Aligned_cols=269 Identities=25% Similarity=0.276 Sum_probs=201.7
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 569 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~~ 569 (825)
.+|.+.+.||+|+||.||+|++++..||||++... ..+.+ ....|+..+..++|||||++++++.....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhHH--HHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence 36889999999999999999999999999986432 11222 11345566678899999999999986542
Q ss_pred CCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCC
Q 003375 570 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 641 (825)
Q Consensus 570 ~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs--------~gIVHrDLKP~ 641 (825)
....+||||||+++|+|.+++++ ..+++..++.++.|++.||.|||+ +|||||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------cceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 23357999999999999999986 468999999999999999999996 59999999999
Q ss_pred CEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC--CCCCchhhHHHH
Q 003375 642 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLEVDIWSY 719 (825)
Q Consensus 642 NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~--~~~s~kSDVWSL 719 (825)
||||+.+ +.+||+|||+++.......... .......||+.|||||++.+.... ..++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEEC------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ceEEcCC-------CCeEEEecCccccccCCCccee------ccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 9999877 5699999999987755332211 112345799999999998752211 125779999999
Q ss_pred HHHHHHHHhCCCCCCCCC---------------HHHHHHHHHcC-CCCCchhHHhhhccCccccccccCCCCCCchhhhh
Q 003375 720 GCLLLELLTLQVPYMGLS---------------ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 783 (825)
Q Consensus 720 GvILyELLTG~~PF~~~~---------------~~~i~~~I~~~-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 783 (825)
||+||||+||..||.... ...+...+... .+|.++. ......
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----------------------~~~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN----------------------RWQSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----------------------GGGGCH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc----------------------ccCChH
Confidence 999999999988874322 11122222111 2222221 111233
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 003375 784 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 818 (825)
Q Consensus 784 ~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l~s 818 (825)
....+.+|+.+||+.||.+|||+.||+++|+.+..
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 45679999999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=390.52 Aligned_cols=250 Identities=22% Similarity=0.247 Sum_probs=197.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC--CCCcceeeeeEecC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 565 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~--HPNIV~l~g~~~~~ 565 (825)
++|++.+.||+|+||.||+|++ ++..||||++.......... .. ...++.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~~-~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LP-NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-CT-TCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh-hh-HHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4799999999999999999998 57889999876443221111 00 0112378999999997 99999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEcccCC-CCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 566 KWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~LVmEy~~g-GSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
+. .|+||||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~--------------~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 82 DS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp SE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Ce--------------EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceE
Confidence 64 4999999976 688888876 356999999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
++.+. +.+||+|||+|+...... .....||+.|||||++.+ ...++.++|||||||+||
T Consensus 143 l~~~~------~~vkl~DFG~a~~~~~~~------------~~~~~GT~~y~aPE~~~~---~~~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 143 IDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGILLY 201 (273)
T ss_dssp EETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHHHH
T ss_pred EecCC------CeEEECccccceeccccc------------ccccccCCCcCCHHHHcC---CCCCCcccccccceeeeh
Confidence 98652 469999999997654321 123479999999999986 234567899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 725 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 725 ELLTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
||+||+.||.+.+ .+..... .++ ...++++.+||.+||+.||.+||
T Consensus 202 ell~g~~Pf~~~~------~i~~~~~-~~~---------------------------~~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 202 DMVCGDIPFEHDE------EIIRGQV-FFR---------------------------QRVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHSSCSCCSHH------HHHHCCC-CCS---------------------------SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhhCCCCCCCch------HHhhccc-CCC---------------------------CCCCHHHHHHHHHHccCCHhHCc
Confidence 9999999997532 1222211 011 11356799999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|++|+++|.+-
T Consensus 248 s~~eil~hp~~ 258 (273)
T d1xwsa_ 248 TFEEIQNHPWM 258 (273)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCHhh
Confidence 99999998543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=394.83 Aligned_cols=281 Identities=19% Similarity=0.227 Sum_probs=205.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|+++++||+|+||+||+|.+ ++..||||++. .........+ .+.+|+.+|++++|||||+++++|...+.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~----~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEc--hhhcChHHHH----HHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 5899999999999999999998 47889999854 2223333333 44999999999999999999999986553
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. ....++||||||+ +.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 92 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 92 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------cccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 2 1233569999999 5788888875 56999999999999999999999999999999999999988
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+|+...... ....||+.|+|||++.+ ...++.++|||||||+||||+
T Consensus 157 ~-------~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 157 D-------CELKILDFGLARQADSEM-------------TGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSC-------------CSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cccccccccceeccCCcc-------------ccccccccccCHHHHcC---CCCCCccchhhcchHHHHHHH
Confidence 7 459999999998764321 33479999999999975 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++||.+.+.......+...........+.............. .............++.+.+||.+||..||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 99999999887776665554322221211111100000000000 000111122234467889999999999999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
|+.|||+|-+
T Consensus 294 ta~eiL~Hp~ 303 (346)
T d1cm8a_ 294 TAGEALAHPY 303 (346)
T ss_dssp CHHHHHHSGG
T ss_pred CHHHHhcChh
Confidence 9999999944
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=394.89 Aligned_cols=281 Identities=22% Similarity=0.227 Sum_probs=205.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 003375 491 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 568 (825)
Q Consensus 491 ~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~~ 568 (825)
+|+..++||+|+||+||+|++ .+..||||++..... .+ .+|+.+|++|+|||||++++++......
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HH----HHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 699999999999999999998 577899998753321 11 5799999999999999999998754321
Q ss_pred CCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecC
Q 003375 569 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 648 (825)
Q Consensus 569 ~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 648 (825)
....++|||||||++ ++...+.... .....+++..++.|+.||+.||+|||++||+||||||+||||+.+
T Consensus 89 --------~~~~~~~lv~Ey~~~-~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 89 --------KDEVYLNLVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --------CSCCEEEEEEECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred --------CCceEEEEEEeccCC-ccHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 123457999999985 4544444322 234679999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 003375 649 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 728 (825)
Q Consensus 649 ~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELLT 728 (825)
+ ..+||+|||+++.+..... .....||+.|+|||.+.+ ...++.++|||||||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTSC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CceeEecccchhhccCCcc-----------cccccccccccChHHhhc---ccCCCcceeecccceEEEehhh
Confidence 3 3699999999987643221 133479999999999875 3568999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 729 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 729 G~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
|++||.+.+..+.+..+.........+.+....... ...+................++.+.+||.+||.+||.+|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999888777766665432222222222211100 0000000000000011223467899999999999999999999
Q ss_pred HHHHHH
Q 003375 808 DLYEMF 813 (825)
Q Consensus 808 EIL~hL 813 (825)
|+++|-
T Consensus 299 e~L~Hp 304 (350)
T d1q5ka_ 299 EACAHS 304 (350)
T ss_dssp HHHTSG
T ss_pred HHhcCH
Confidence 999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=379.02 Aligned_cols=282 Identities=19% Similarity=0.216 Sum_probs=210.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|++++.||+|+||+||+|++ ++..||||+++... ....... ++.+|+.+|+.++|||||++++++....
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~----~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHH----HHHHHHHHHHhcCcCCEEeecccccccc
Confidence 47899999999999999999998 56789999976543 2222333 3489999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++|||++.+++|..++.. ...+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 75 ~--------------~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 K--------------LTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred c--------------eeEEeeecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 4 4999999999888887764 46789999999999999999999999999999999999998
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ ..+||+|||.++........ .....+++.|+|||++.+ ...++.++|||||||++|||
T Consensus 136 ~~-------~~~kl~DFG~a~~~~~~~~~----------~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RN-------GELKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------CCEEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred cC-------CceeeeecchhhcccCCCcc----------ceeeccccchhhhhHhcc---CCCCCchhhccccchHHHHH
Confidence 77 45999999999876543221 233467899999999876 24578999999999999999
Q ss_pred HhCCCCC-CCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 727 LTLQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 727 LTG~~PF-~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
++|+.|| .+.+..+....+.....+.....+........ ...................++.+.+||.+||++||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 9999886 45555555555544322211111111111000 000001111112223344567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
||+|||+|-+.
T Consensus 276 sa~e~L~Hp~f 286 (292)
T d1unla_ 276 SAEEALQHPYF 286 (292)
T ss_dssp CHHHHTTSGGG
T ss_pred CHHHHhcChhh
Confidence 99999998543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=385.56 Aligned_cols=285 Identities=18% Similarity=0.222 Sum_probs=203.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|+++++||+|+||+||+|.+ +++.||||++... ......+ ++++|+.+|++|+||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~----~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHHH----HHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 4699999999999999999997 5888999986421 1222333 44899999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .... +++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 81 ~---------~~~~-~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 81 E---------QMKD-VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp T---------TCCC-EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccce-EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 2 1112 444555668999999976 46999999999999999999999999999999999999987
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+||+|||+++......... ......+||+.|+|||++.. ...++.++||||+||++|||+
T Consensus 145 ~-------~~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 145 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEcccCceeeccCCCccc-------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHh
Confidence 7 459999999998765432221 11234579999999999864 256789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccc-ccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~-~~~--~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|+.||.+.+..+............................ ... .............+..+++||.+||+.||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 99999998877665555443211111111100000000000 000 000001112233456799999999999999999
Q ss_pred CHHHHHHHHH
Q 003375 805 TAGDLYEMFV 814 (825)
Q Consensus 805 Sa~EIL~hL~ 814 (825)
|+.|+|+|-+
T Consensus 288 ta~e~L~hpf 297 (345)
T d1pmea_ 288 EVEQALAHPY 297 (345)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcCHh
Confidence 9999999843
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=387.12 Aligned_cols=282 Identities=17% Similarity=0.216 Sum_probs=204.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 566 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~ 566 (825)
+++|+++++||+|+||+||+|.+ .+..||||++.... ........ +.+|+.+|++++|||||+++++|....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~----~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHH----HHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 47899999999999999999998 48899999975332 23333333 489999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
.. ....++|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~--------~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 90 TL--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp ST--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 32 123478999999975 5555543 3589999999999999999999999999999999999999
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.+ +.+|++|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||
T Consensus 154 ~~-------~~~kl~df~~~~~~~~~~~-----------~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 154 SD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 211 (355)
T ss_dssp TT-------CCEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred cc-------cceeeechhhhhccccccc-----------cccccccccccChhhhcC----CCCCCCcccccccchHHHH
Confidence 87 4599999999876543221 234469999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCcc-----------c----cccccCCCCCCchhhhhhHHHHHHH
Q 003375 727 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-----------H----EVAQSGSGFEKPEAELETLSFLVDV 791 (825)
Q Consensus 727 LTG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~-----------~----~~~~~~~~~~~~~~~~~~s~~L~dL 791 (825)
++|++||.+.+.......+........++.+........ . .+.... ...........++.+.+|
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL-FPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc-ccccccccccCCHHHHHH
Confidence 999999998887777666654433333332221111000 0 000000 011223344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 003375 792 FRRCTEENPTERPTAGDLYEMFVA 815 (825)
Q Consensus 792 I~~CL~~DP~eRPSa~EIL~hL~~ 815 (825)
|.+||.+||++||||+|||+|.+-
T Consensus 291 l~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHCcCChhHCcCHHHHhcCccc
Confidence 999999999999999999999543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=386.26 Aligned_cols=282 Identities=20% Similarity=0.240 Sum_probs=206.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++++.||+|+||+||+|++ .+..||||++. .........+. +.+|+.+|++|+|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECS--CTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEC--chhcChHHHHH----HHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 5799999999999999999997 57899999854 22333333333 4899999999999999999999875443
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
. .....++||+|+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~---------~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---------EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---------TTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c---------ccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 2 11123566677778999999864 46999999999999999999999999999999999999998
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
+ +.+|++|||++....... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp T-------CCEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred c-------ccccccccchhcccCccc-------------ccccccccccCchhhcC---CccCCcccchhhhhHHHHHHH
Confidence 7 459999999997654322 23469999999999875 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 804 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRP 804 (825)
+|++||.+.+.......+.........+................. ............++.+.+||.+||..||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 999999999888777776554222222111110000000000000 00111112234567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 003375 805 TAGDLYEMFVA 815 (825)
Q Consensus 805 Sa~EIL~hL~~ 815 (825)
|+.|+|+|-+.
T Consensus 294 ta~elL~Hp~f 304 (348)
T d2gfsa1 294 TAAQALAHAYF 304 (348)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcCHhh
Confidence 99999998554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-43 Score=373.81 Aligned_cols=268 Identities=16% Similarity=0.157 Sum_probs=196.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 567 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g~~~~~~~ 567 (825)
++|++.+.||+|+||.||+|++ .+..||||+...+.. .. .+.+|+++++.++|+|+|..++.+.....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HP----QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SC----CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CH----HHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 4799999999999999999998 478999998764321 11 23789999999998776666555543322
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 647 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 647 (825)
..++||||+. ++|...+.. ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 77 -------------~~~ivme~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 77 -------------YNVMVMELLG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp -------------EEEEEEECCC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred -------------EEEEEEEEcC-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence 3599999995 688777764 2457999999999999999999999999999999999999975
Q ss_pred CccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 003375 648 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 727 (825)
Q Consensus 648 ~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyELL 727 (825)
.+ ....+||+|||+|+.+........ ..........||+.|||||++.+ ..++.++|||||||++|||+
T Consensus 139 ~~----~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 139 GK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp GG----GTTCEEECCCSSCEECBCTTTCCB---CCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHHH
T ss_pred cC----CCceeeeeccCcceeccccccccc---eeccccCCcCCCccccCHHHHhC----CCCCChhhEEecCHHHHHHH
Confidence 53 236799999999998754332211 11122345679999999999986 66899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 003375 728 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 807 (825)
Q Consensus 728 TG~~PF~~~~~~~i~~~I~~~~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~ 807 (825)
||+.||...........+........... .+......++++.+||.+||+.||.+||++.
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTP--------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSC--------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred hCCCcccccchHHHHHHHHHhhcccCCCC--------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999987665543333221100000000 0011123456899999999999999999999
Q ss_pred HHHHHHHhh
Q 003375 808 DLYEMFVAR 816 (825)
Q Consensus 808 EIL~hL~~l 816 (825)
+|.+.|+.+
T Consensus 268 ~i~~~l~~~ 276 (299)
T d1ckia_ 268 YLRQLFRNL 276 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 887766654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-43 Score=380.63 Aligned_cols=278 Identities=19% Similarity=0.215 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
..++|+++++||+|+||+||+|++ .+..||+|+++.. ..+ ++.+|+.+|++++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~----~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHH----HHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 456899999999999999999998 5789999986421 122 3489999999996 9999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 644 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 644 (825)
... ..+++|||||.+++|..+. ..+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 102 ~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 102 PVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp TTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCC------------CceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 432 1469999999999987653 35899999999999999999999999999999999999
Q ss_pred EecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 003375 645 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 724 (825)
Q Consensus 645 Ld~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILy 724 (825)
|+.++ ..+||+|||+|+....... .....||+.|+|||.+.+ ...++.++|||||||++|
T Consensus 162 i~~~~------~~vkl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 162 IDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp EETTT------TEEEECCGGGCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCCC------CeeeecccccceeccCCCc-----------ccccccCccccCcccccC---CCCCCcccchhhhhhhhH
Confidence 98663 3699999999987654221 234579999999999876 245789999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCch-hHHhhhccCcccccccc--------CCCCCCchhhhhhHHHHHHHHHH
Q 003375 725 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQS--------GSGFEKPEAELETLSFLVDVFRR 794 (825)
Q Consensus 725 ELLTG~~PF~~~~-~~~i~~~I~~~~~p~l~-~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~s~~L~dLI~~ 794 (825)
||++|+.||.... ..+....+......... .............+... .............++++.+||.+
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 9999999996553 33222222211100000 00000000000000000 00011122234456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 003375 795 CTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 795 CL~~DP~eRPSa~EIL~hL~~l 816 (825)
||++||.+|||++|+|+|-+..
T Consensus 302 mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 302 LLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGT
T ss_pred HccCChhHCcCHHHHhcCcccC
Confidence 9999999999999999997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=386.70 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC-CCcceeee
Q 003375 487 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 560 (825)
Q Consensus 487 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H-PNIV~l~g 560 (825)
..+++|++++.||+|+||+||+|.. .++.||+|++............+. +.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~----~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGG----CCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHH----HHHHHHHHHhccCCCeEEEeee
Confidence 4578999999999999999999986 367899999754332211122233 3889999999976 89999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
++.+... .++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||
T Consensus 97 ~~~~~~~--------------~~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeccCCc--------------eeeeeecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence 9987664 4999999999999999986 35678999999999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 720 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLG 720 (825)
+|||++.+ +.+||+|||+++.+....... .....||+.|+|||.+.+. ...++.++||||||
T Consensus 158 ~Nill~~~-------~~vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred cceeecCC-------CCEEEeeccchhhhccccccc---------ccccccccccchhHHhhcC--CcCCCchhhhHHHH
Confidence 99999987 459999999998765433221 1334699999999999752 24578899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 003375 721 CLLLELLTLQVPYMGLSELEIHDLIQMG---KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 797 (825)
Q Consensus 721 vILyELLTG~~PF~~~~~~~i~~~I~~~---~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~ 797 (825)
|+||||+||+.||.+.+..+....+... ..+.++ ...++.+.+||.+||+
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---------------------------QEMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---------------------------ccCCHHHHHHHHHHcc
Confidence 9999999999999876544333333221 111111 1235689999999999
Q ss_pred cCCCCCC-----CHHHHHHHHH
Q 003375 798 ENPTERP-----TAGDLYEMFV 814 (825)
Q Consensus 798 ~DP~eRP-----Sa~EIL~hL~ 814 (825)
+||.+|| |++|+++|.+
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGG
T ss_pred cCHHHcCCCCcccHHHHHcCHh
Confidence 9999999 5899999744
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-41 Score=360.45 Aligned_cols=266 Identities=17% Similarity=0.176 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC-CCcceeeeeEecCC
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSK 566 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H-PNIV~l~g~~~~~~ 566 (825)
++|++++.||+|+||+||+|++ ++..||||+...... .. .+.+|+++++.|.| +||+.+++++....
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cH----HHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 5799999999999999999997 578899998643211 11 23789999999975 89999999987655
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 646 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd 646 (825)
. .++||||+ +++|.+++.. ....++...+..++.|++.||.|||++|||||||||+||||+
T Consensus 75 ~--------------~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 H--------------NVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp E--------------EEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred c--------------cEEEEEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 3 49999999 5899999875 235689999999999999999999999999999999999997
Q ss_pred cCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 003375 647 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 726 (825)
Q Consensus 647 ~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kSDVWSLGvILyEL 726 (825)
.... ...+.+||+|||+|+.+........ ..........||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~~~--~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPNS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSSS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred Cccc--ccCCceEEcccceeEEcccCccccc---eeecccCceEEchhhcCHHHhcC----CCCChHHHHHHhhHHHHHH
Confidence 6421 1235699999999988754322211 11122345679999999999986 6789999999999999999
Q ss_pred HhCCCCCCCCCH---HHHHHHHHcCCC-CCchhHHhhhccCccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 003375 727 LTLQVPYMGLSE---LEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 802 (825)
Q Consensus 727 LTG~~PF~~~~~---~~i~~~I~~~~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLI~~CL~~DP~e 802 (825)
+||..||.+... ......+..... +...+ .....++++.+|+..|+..+|.+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~ 262 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDA 262 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHH------------------------hcCCCCHHHHHHHHHHhcCCccc
Confidence 999999976533 333333332211 11111 11223567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 003375 803 RPTAGDLYEMFVART 817 (825)
Q Consensus 803 RPSa~EIL~hL~~l~ 817 (825)
||+++.+.+.|+.+.
T Consensus 263 rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 263 TPDYDYLQGLFSKVL 277 (293)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999888877653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.3e-37 Score=332.98 Aligned_cols=284 Identities=19% Similarity=0.213 Sum_probs=191.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-----------CCCcc
Q 003375 490 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIV 556 (825)
Q Consensus 490 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-----------HPNIV 556 (825)
++|+++++||+|+||+||+|++ ++..||||+++.. .... +.+.+|+.+++.+. |+||+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccch----HHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 3699999999999999999997 5789999997532 1112 23378888888775 57899
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEcccCCCC-HHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHh-CCcc
Q 003375 557 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIM 634 (825)
Q Consensus 557 ~l~g~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGS-L~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs-~gIV 634 (825)
++++++...... ..+++|+++..+. ....... .....+++..++.++.||+.||+|||+ .||+
T Consensus 84 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~Iv 148 (362)
T d1q8ya_ 84 KLLDHFNHKGPN------------GVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148 (362)
T ss_dssp CCCEEEEEEETT------------EEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred EEEEEeeecccc------------ceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcc
Confidence 999988654321 3456666654443 3333332 334678999999999999999999998 8999
Q ss_pred ccCCCCCCEEEecCccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 003375 635 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 714 (825)
Q Consensus 635 HrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~~~~~~~~~~~~s~~~~~~~~~~vGT~~YmAPEvl~~~~~~~~~s~kS 714 (825)
||||||+||||+.++. ......++|+|||.+....... ...+||+.|+|||++.+ ..++.++
T Consensus 149 HrDlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~ 210 (362)
T d1q8ya_ 149 HTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGCGA 210 (362)
T ss_dssp CSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCTHH
T ss_pred cccCChhHeeeeccCc-ccccceeeEeeccccccccccc-------------ccccccccccChhhccc----cCCCccc
Confidence 9999999999987642 1122359999999987654321 23469999999999986 6689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCCchhHHhhhccCcccc-----ccccCCCC--------
Q 003375 715 DIWSYGCLLLELLTLQVPYMGLSEL------EIHDLIQMGKRPRLTDELEALGSCHEHE-----VAQSGSGF-------- 775 (825)
Q Consensus 715 DVWSLGvILyELLTG~~PF~~~~~~------~i~~~I~~~~~p~l~~~l~~~~~~~~~~-----~~~~~~~~-------- 775 (825)
||||+||++++|++|+.||...... .....+...... .+..+.......... ........
T Consensus 211 DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred cccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC-CCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence 9999999999999999999654321 111111111000 111111100000000 00000000
Q ss_pred --CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 003375 776 --EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 816 (825)
Q Consensus 776 --~~~~~~~~~s~~L~dLI~~CL~~DP~eRPSa~EIL~hL~~l 816 (825)
.........++.+.+||.+||.+||.+|||++|+|+|-+..
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence 01112245678899999999999999999999999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.5e-23 Score=203.15 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=106.8
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCC----------hHHHHhhHHhHHHHHHHHhhCCCCCcceeee
Q 003375 492 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS----------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 560 (825)
Q Consensus 492 y~i~~~LG~G~fG~Vy~a~~-~~~~vAVKI~~lk~~~~~----------~~~~~~~~~~~lrEv~iLk~L~HPNIV~l~g 560 (825)
+.+.++||+|+||.||+|.+ ++..||||+.+....... ..........+.+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999987 678999998654321100 0011112234467899999999999999886
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEcccCCCCHHHHHHHhhccCCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 003375 561 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 640 (825)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~L~~~~~~~~~~ls~~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP 640 (825)
+.. .++||||+++..+. .++...+..++.||+.+|.|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ecC------------------CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 632 18999999875432 244556678999999999999999999999999
Q ss_pred CCEEEecCccCCCCCCeEEEeecCCccccc
Q 003375 641 ENILIDLERKKADGKPVVKLCDFDRAVPLR 670 (825)
Q Consensus 641 ~NILLd~~~~~~~~~~~vKL~DFGlA~~~~ 670 (825)
+|||++.+ .++|+|||+|....
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~~ 153 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEVG 153 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEETT
T ss_pred hheeeeCC--------CEEEEECCCcccCC
Confidence 99999865 38999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=3.9e-06 Score=84.36 Aligned_cols=87 Identities=10% Similarity=0.082 Sum_probs=58.3
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 003375 489 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 567 (825)
Q Consensus 489 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~~~~ 567 (825)
++.|++.+..+.++.+.||+....+..+++|+........ . ..+.+|+..+..|. +--+.+++.+....+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~----~----~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----T----YDVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS----T----TCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc----h----hhHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence 4567777776666668999998888888888764222111 1 12377888888775 433566777665443
Q ss_pred CCCCCCCCccccceEEEEEcccCCCCHHHH
Q 003375 568 LPSADGNPEHHLLQSAIFMEYVKGGSVKNY 597 (825)
Q Consensus 568 ~~~~~~~~~~~~~~~~LVmEy~~gGSL~~~ 597 (825)
..++||++++|.++.+.
T Consensus 84 -------------~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 84 -------------WSNLLMSEADGVLCSEE 100 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHH
T ss_pred -------------ceEEEEEeccccccccc
Confidence 34999999998777543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.00019 Score=77.21 Aligned_cols=79 Identities=14% Similarity=0.027 Sum_probs=46.1
Q ss_pred eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC---hHHHHhhHHhHHHHHHHHhhCC-C--CCcceeeeeEecCC
Q 003375 495 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS---ADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSK 566 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~--~~~~vAVKI~~lk~~~~~---~~~~~~~~~~~lrEv~iLk~L~-H--PNIV~l~g~~~~~~ 566 (825)
.+.||.|....||++.. ++..++||.-.......+ ..... +...|+..|+.+. + ..+.+++.+...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~----R~~~E~~~L~~~~~~~p~~vP~v~~~d~~-- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTID----RARIESSALIRQGEHVPHLVPRVFYSDTE-- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTT----HHHHHHHHHHHHHTTCGGGSCCEEEEETT--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHH----HHHHHHHHHHHhhhhCCCCcceEEEEcCC--
Confidence 55789999999999975 455788886432111111 01111 2256887777663 2 345666655322
Q ss_pred CCCCCCCCCccccceEEEEEcccCCCC
Q 003375 567 WLPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 567 ~~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
. .++|||++.+..
T Consensus 105 ~--------------~~lvmE~L~~~~ 117 (392)
T d2pula1 105 M--------------AVTVMEDLSHLK 117 (392)
T ss_dssp T--------------TEEEECCCTTSE
T ss_pred C--------------CEEEEeccCCcc
Confidence 1 289999998643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.20 E-value=0.0003 Score=69.74 Aligned_cols=73 Identities=14% Similarity=0.108 Sum_probs=45.3
Q ss_pred eecccCc-eEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCC
Q 003375 497 EAGKSVS-SSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 572 (825)
Q Consensus 497 ~LG~G~f-G~Vy~a~~-~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~H--PNIV~l~g~~~~~~~~~~~~ 572 (825)
.+..|.. +.||+... .+..+++|+..... .. .+..|+..|+.|.. -.+.+++.+....+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~------ 79 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LN----ELQDEAARLSWLATTGVPCAAVLDVVTEAG------ 79 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSS------
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------Hh----HHHHHHHHHHHHHhcCCCCCceeeeccccc------
Confidence 4444554 68999987 45567888754221 11 12678888777742 33566777665443
Q ss_pred CCCccccceEEEEEcccCCCCH
Q 003375 573 GNPEHHLLQSAIFMEYVKGGSV 594 (825)
Q Consensus 573 ~~~~~~~~~~~LVmEy~~gGSL 594 (825)
..++||+|++|.++
T Consensus 80 --------~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 80 --------RDWLLLGEVPGQDL 93 (255)
T ss_dssp --------CEEEEEECCSSEET
T ss_pred --------ceEEEEEeeecccc
Confidence 24999999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.67 E-value=0.011 Score=60.95 Aligned_cols=27 Identities=30% Similarity=0.288 Sum_probs=22.8
Q ss_pred CccccCCCCCCEEEecCccCCCCCCeEEEeecCCcc
Q 003375 632 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 667 (825)
Q Consensus 632 gIVHrDLKP~NILLd~~~~~~~~~~~vKL~DFGlA~ 667 (825)
++||+|+.|.|||++.+ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~---------~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---------PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS---------EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC---------ceEEechhcc
Confidence 68999999999999743 4589999775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.29 E-value=0.032 Score=56.66 Aligned_cols=54 Identities=15% Similarity=0.092 Sum_probs=33.3
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC
Q 003375 488 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 551 (825)
Q Consensus 488 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~ 551 (825)
.++.+.-.+.|..|---+.|+....+..+++|++.... .. +.+ ..|+.+|..|.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~---~~---~~l----~~~~~~l~~L~ 69 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---EK---NDL----PFFLGLMQHLA 69 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------C---CHH----HHHHHHHHHHH
T ss_pred CCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC---CH---HHH----HHHHHHHHhhh
Confidence 34555566778888889999999988889999964221 11 111 44677777764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.90 E-value=0.03 Score=59.16 Aligned_cols=71 Identities=15% Similarity=0.243 Sum_probs=46.1
Q ss_pred eeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhHHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 003375 495 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 564 (825)
Q Consensus 495 ~~~LG~G~fG~Vy~a~~~---------~~~vAVKI~~lk~~~~~~~~~~~~~~~~lrEv~iLk~L~-HPNIV~l~g~~~~ 564 (825)
++.|+.|-.-.+|++... ...+.+++.. . .... .. . .+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~--id-r----~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETE--SH-L----VAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCH--HH-H----HHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchh--hH-H----HHHHHHHHHHHhCCCCCeEEEEcC-
Confidence 467888999999999863 2456666643 2 1111 11 1 57888888886 433457777753
Q ss_pred CCCCCCCCCCCccccceEEEEEcccCCCC
Q 003375 565 SKWLPSADGNPEHHLLQSAIFMEYVKGGS 593 (825)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~LVmEy~~gGS 593 (825)
+ ++||||++|.+
T Consensus 116 -~----------------g~I~efi~g~~ 127 (395)
T d1nw1a_ 116 -G----------------GRLEEYIPSRP 127 (395)
T ss_dssp -T----------------EEEECCCCEEE
T ss_pred -C----------------ceEEEEecccc
Confidence 1 78999998743
|